Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,positive regulation of nervous system development (GO:0051962),-0.6058160955803407,-2.3316239343603495,0.0,0.00891231889658257,0.01,12/42,6.24%,CX3CR1;NUMB;IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;TGM2;GRID2;CLSTN3;RGS14;EPHB1
prerank,regulation of synapse assembly (GO:0051963),-0.5090818196247356,-2.018100905823021,0.0,0.2437519218215333,0.387,25/46,21.18%,MEF2C;IL1RAPL1;NRXN1;NLGN1;LRFN5;PTPRD;CLSTN2;GRID2;IL1RAPL2;CLSTN3;PDLIM5;EPHB1;APP;ROBO2;MDGA1;TLR2;CUX2;CLSTN1;DLG5;IL1RAP;GPC4;NLGN2;NLGN3;SYNDIG1;LHFPL4
prerank,positive regulation of synapse assembly (GO:0051965),-0.5834255673733765,-2.0147254375942283,0.0,0.16725451795919957,0.395,19/27,26.87%,IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;GRID2;CLSTN3;EPHB1;CUX2;CLSTN1;DLG5;IL1RAP;NLGN2;NLGN3;SYNDIG1;SEMA4A;BDNF;VSTM5;GHRL
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5710884098217709,-1.9915006387534768,0.0,0.16443228364194842,0.477,20/26,24.95%,NRXN1;NLGN1;RIMS1;SLC8A3;LRRK2;SHANK3;RIMS2;APP;SLC8A2;PRKCZ;GRIN1;CUX2;CHRNA7;TMEM25;SHANK1;NLGN2;NLGN3;RELN;CBLN1;MTMR2
prerank,T cell activation (GO:0042110),0.6817267288616131,1.960830264178339,0.0,0.02450352109660679,0.02,26/69,11.71%,LCP1;LCK;CD3E;NLRC3;ITK;CD8B;PTPRC;CD4;MSN;KIF13B;LAT;CD8A;CD44;CD2;CD7;CD3G;CD28;NCK2;PTPN22;GATA3;NCK1;RASGRP1;PTPN2;JAML;CRTAM;DLL4
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8537361820514937,1.9557897177957497,0.0,0.013272740593995342,0.022,7/15,8.95%,OSBPL8;PLIN2;LPL;APOC4;PPARG;TREM2;ABHD5
prerank,potassium ion export across plasma membrane (GO:0097623),-0.6667919173055266,-1.8890973411722733,0.0,0.36558332113781705,0.824,9/13,32.03%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,regulation of T cell activation (GO:0050863),0.6763924448669212,1.8815729524476124,0.0,0.053090962375981376,0.13,22/42,16.82%,LGALS3;GPNMB;LCK;LAX1;SIRPA;PRKCQ;CD4;LAT;TBX21;CD2;IL27;PTPN22;METTL3;CRTAM;CCR2;CCL5;TNFRSF1B;TNFSF8;HSPD1;TNFSF9;DUSP3;SPINK5
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7873578268075572,1.8799869034107022,0.0,0.04083920182767798,0.133,7/18,8.88%,GPR137B;LTF;FSTL3;FBXW7;TCTA;LILRB1;LILRB3
prerank,innate immune response in mucosa (GO:0002227),0.8735251323468357,1.8634134331895003,0.0,0.04819025815666002,0.182,3/10,4.47%,CAMP;LTF;RNASE3
prerank,cytoplasmic translation (GO:0002181),0.6259082911138403,1.85029901048782,0.0,0.05445226910357064,0.241,53/91,21.89%,RPS12;EIF4A1;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPS20;RPL36A;RPL41;RPS26;RPL17;RPL23;RPS25;ETF1;RPL35A;RPS28;RPL28;RPL27A;RPL11;RPS2;TMA7;RPL32;DRG1;RWDD1;RPL21;RPL9;RPL36;RPL37;RPS18;RPL38;RPS19;RPS27;EIF3M;RPS23;RPL14;RPS16;RPL30;RPL12;DRG2;GSPT1;RPL13A;RPL31;RPS9;RPL4;RPS3;RPS13;EIF4A2;RPSA;RPL15
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5378045148522994,-1.8477171078404429,0.012903225806451613,0.43506970080150575,0.913,12/29,13.42%,KCNIP4;DPP10;FGF12;KCNIP3;SNTA1;DPP6;WNK1;WNK3;KCNN2;KCNAB2;KCNIP1;KCNH2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5972458113532678,-1.8416725209202605,0.009900990099009901,0.3922693502910128,0.926,10/18,17.46%,GRIK2;GRIK3;GRIK4;GRID2;UNC13B;GRID1;CDH8;NAPB;GRIA2;UNC13C
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6296962803155399,-1.8399712982947367,0.013452914798206279,0.3478032449391348,0.93,8/15,13.34%,GRM7;GRIK3;GRM1;GRM5;GRM3;HOMER3;GRM8;DAGLB
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5025517722662804,-1.8396632096259389,0.0,0.30975259453900306,0.93,18/37,11.54%,GRIA4;GRM7;GRIK2;GRIK3;GRIN2A;PLCB1;GRIA3;GRIK4;KCNB1;GRID2;GRM1;GRIN2B;GRM5;GRM3;APP;HOMER3;GRM8;GRIN1
prerank,amino acid transmembrane transport (GO:0003333),0.6686887740514342,1.8381776832021794,0.0,0.05936269694237478,0.298,20/45,19.68%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC7A11;SLC6A14;SLC36A4;SLC36A3;SFXN1;SLC7A6;SLC38A11;SLC7A8;SFXN2;SLC38A7;SLC38A10;SLC25A18;SLC16A2;SLC38A2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6225645920365414,1.8372102778030663,0.0,0.05270809485884689,0.302,49/87,21.89%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPS20;RPL36A;RPL41;RPS26;RPL17;RPL23;RPS25;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;SEC61B;RPL32;SRP14;RPL21;SEC63;RPL9;RPL36;RPL37;RPS18;RPL38;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL12;RPL13A;RPL31;RPS9;RPL4;RPS3;RPS13;RPSA;RPL15
prerank,granulocyte chemotaxis (GO:0071621),0.6421242776280381,1.8153200095365727,0.0,0.07203581433493199,0.422,17/55,19.05%,LGALS3;S100A8;S100A9;ANXA1;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6165976471228078,1.813965183208342,0.0,0.06626160496540752,0.428,56/91,26.87%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;RPL18;RPS24;RPS7;RPS20;RPL36A;RPL41;RPS26;RPL17;RPL23;RPS25;RPL35A;RPS28;RPLP2;RPL28;SIL1;RPL27A;RPL11;RPS2;RPL32;SRP14;RPL21;SEC63;RPL9;RPL36;RPL37;RPS18;RPL38;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL12;RPL13A;RPL31;RPS9;RPL4;RPS3;RPS13;RPSA;RPL15;RPL7A;RPL23A;RPL8;RPLP1;RPL29;SSR1;RPL37A
prerank,neuron projection regeneration (GO:0031102),-0.6925957766063101,-1.8136256122197634,0.007547169811320755,0.34365901665222387,0.97,3/10,4.04%,GAP43;RTN4RL1;NREP
prerank,protein targeting to ER (GO:0045047),0.610749013203665,1.8102872547930584,0.0,0.06460019198196335,0.448,54/99,21.89%,RPS12;UBA52;RPS27A;RPS6;RPS14;RPL10A;EDEM1;RPL18;RPS24;RPS7;RPS20;RPL36A;RPL41;ZFAND2A;RPS26;RPL17;RPL23;RPS25;CHMP4A;CHMP4B;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;RPL32;SRP14;RPL21;SPCS3;SEC63;RPL9;RPL36;RPL37;RPS18;RPL38;RPS19;RPS27;RPS23;RPL14;RPS16;SRP9;RPL30;RPL12;RPL13A;RPL31;RPS9;GET3;RPL4;RPS3;RPS13;RPSA;RPL15
prerank,regulation of T cell proliferation (GO:0042129),0.6268094268580116,1.8043161183617504,0.0,0.06610845795855373,0.49,21/61,18.32%,LGALS3;GPNMB;CD3E;PTPRC;ANXA1;SLC7A1;SPN;CD6;CD28;NCK2;IL27;CD274;NCK1;LILRB1;CCL5;TNFRSF1B;TNFSF8;TFRC;TNFSF9;RIPK3;IL6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6032170577684095,1.7956209030073773,0.0,0.07327495251004529,0.55,58/110,22.01%,RPS12;UBA52;RPS27A;EIF4G1;RPS6;RPS14;RPL10A;RPL18;RPS24;PPP2R1A;RPS7;RPS20;RPL36A;RPL41;RPS26;RPL17;RPL23;RPS25;ETF1;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;PABPC1;DHX34;RPL32;SMG9;RPL21;RPL9;RPL36;RPL37;DCP1A;RPS18;RPL38;RPS19;RPS27;EIF4A3;HELZ2;RPS23;RPL14;RPS16;RPL30;RPL12;GSPT1;RPL13A;RPL31;RPS9;EIF3E;UPF3A;RPL4;RPS3;RPS13;RPSA;RPL15;UPF3B
prerank,positive chemotaxis (GO:0050918),0.764404050706206,1.7908083732038291,0.002554278416347382,0.07467739762775402,0.584,7/17,10.16%,LGALS3;GPNMB;FPR2;NRP1;VEGFA;ANGPT1;FGF7
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7917265918836569,1.7885262066272873,0.0,0.07323830194430252,0.602,6/14,11.68%,IGF1;PTPRC;CST7;CD200R1;TREM2;TNFRSF1B
prerank,regulation of microglial cell activation (GO:1903978),0.7816308116975055,1.7863949764765148,0.0,0.07300007326697439,0.622,6/15,7.32%,STAP1;MMP8;PTPRC;CST7;SPHK1;TREM2
prerank,regulation of platelet activation (GO:0010543),0.7241189489310355,1.7840486389504366,0.0,0.07260969854362159,0.641,7/21,7.52%,APOE;PLEK;PRKCQ;TEC;PDGFA;HRG;TXK
prerank,reverse cholesterol transport (GO:0043691),0.8068599446552672,1.7827730704281763,0.0012674271229404308,0.07022073869814631,0.647,4/13,3.55%,APOE;ABCG1;ABCA1;APOA2
prerank,neutrophil chemotaxis (GO:0030593),0.6321810188744414,1.7799989702814427,0.0,0.07055509473650157,0.664,16/53,19.05%,LGALS3;S100A8;S100A9;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6628126429688279,1.7779915916857965,0.0,0.06947769210933716,0.683,12/37,9.92%,BCL2;S100A8;S100A9;LCK;BCL2L1;CAV1;BID;RPS7;NCK1;BCL2L11;RACK1;BAX
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7213409781868396,1.7757956537281494,0.0,0.06879460784067183,0.702,9/21,8.41%,LCK;STAP1;PRKCH;PTPRC;KCNN4;CD226;TESPA1;TRAT1;PRKCB
prerank,negative regulation of lipid storage (GO:0010888),0.7299222243731287,1.771578362411849,0.0012610340479192938,0.07072607225611505,0.726,8/19,9.40%,OSBPL8;ABCG1;ABCA1;PPARG;TREM2;PPARD;ABHD5;PTPN2
prerank,detection of visible light (GO:0009584),0.7715381268194637,1.77139921484175,0.001272264631043257,0.06796175869366845,0.727,6/16,14.11%,GNAQ;ABCA4;PDE6B;CNGB1;GNA11;CEP250
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6894065082189089,-1.7710969418848603,0.007782101167315175,0.4433473545645438,0.992,6/10,15.77%,PRKCE;HECW1;COMMD1;HECW2;OSR1;NEDD4L
prerank,"wound healing, spreading of cells (GO:0044319)",0.7058054738134645,1.7595638129760263,0.0011806375442739079,0.08112537279727282,0.801,8/24,2.97%,LCP1;MMP12;ARHGAP24;FLNA;MRTFA;ITGA5;PDPN;CD44
prerank,proteoglycan biosynthetic process (GO:0030166),0.6712768854410506,1.752814473352073,0.0011682242990654205,0.08768176632402462,0.831,5/31,2.56%,IGF1;XYLT1;CHST11;HS3ST3B1;B4GALT7
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.7943195289828044,1.750721958690954,0.0013089005235602095,0.08752940468643675,0.843,4/12,2.97%,LCK;SKAP1;GCNT2;CD44
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.6313929085078374,1.7467856596558196,0.0,0.09094285221811625,0.865,16/49,9.92%,BCL2;S100A8;S100A9;LCK;BCL2L1;PLAUR;MCL1;SGMS1;MMP9;CAV1;BID;NOC2L;BCL2L11;P4HB;RACK1;BAX
prerank,negative regulation of blood coagulation (GO:0030195),0.6415864970369849,1.7455111666477179,0.001148105625717566,0.08940868114416642,0.871,14/38,19.21%,PLAU;APOE;PLAUR;PDGFA;HRG;A2M;TFPI;F11;SERPINE2;SERPINE1;KLKB1;APOH;SERPINF2;F8
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6744553935814386,1.7444668950650384,0.00243605359317905,0.0879451087633962,0.873,5/25,6.37%,IGF1;NIBAN2;TRIM6;DOT1L;GATA3
prerank,mucosal immune response (GO:0002385),0.7481621847860882,1.7441625625048782,0.0025477707006369425,0.08535393181984699,0.873,3/15,4.47%,CAMP;LTF;RNASE3
prerank,defense response to bacterium (GO:0042742),0.5791536817696084,1.7419796107491752,0.0,0.08638808580161236,0.885,36/105,19.31%,LYST;COLEC12;S100A8;S100A9;CAMP;LCN2;FPR2;LTF;FGR;SPN;OPTN;RNASE3;PRKCD;ADGRB1;TREM2;DMBT1;ADAM17;DEFB130A;SERPINE1;MPEG1;MBL2;RPS19;TIRAP;SYK;GBP2;ANXA3;RAB1A;RNASE7;RPL30;CFP;PGLYRP2;IL6;JCHAIN;RNASE6;FCER1G;SLC11A1
prerank,fibrinolysis (GO:0042730),0.775667538450328,1.7400399405588693,0.002663115845539281,0.08684711513667145,0.895,4/13,11.25%,PLAU;PLAUR;HRG;SERPINE1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6641847103098066,1.7388321843449543,0.0023014959723820483,0.08560762989180679,0.899,11/32,18.63%,S100A9;CAMP;LTF;HRG;RNASE3;CXCL14;CCL13;RPS19;RNASE7;RPL30;RNASE6
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6486763287285058,1.7380448425724278,0.001152073732718894,0.08444105554369888,0.905,15/33,16.70%,LGALS3;LCK;DGKZ;KCNN4;CD226;SH2D1A;TESPA1;PTPN22;TRAT1;CD300A;PTPN2;PHPT1;PRKD2;UBASH3A;DUSP3
prerank,cholesterol efflux (GO:0033344),0.7248836500561572,1.735282787404985,0.0024154589371980675,0.08628739929019391,0.919,9/20,13.59%,APOE;ABCG1;ABCA1;APOA2;SOAT1;APOC1;SOAT2;ABCA7;NPC1
prerank,chemical synaptic transmission (GO:0007268),-0.31477074683334694,-1.7352521103010976,0.0,0.5293917424570047,0.997,74/284,12.18%,CACNB2;FCHSD2;SNAP25;GRIA4;GABRB2;GRM7;NRXN1;GABRB3;SYNJ2BP;NLGN1;SYN2;RPS6KA1;GRIK2;CHRM2;GLRA3;KCND2;AMPH;DLGAP1;GRIK3;DLG2;SLC1A3;GRIN2A;CPLX1;SYT10;RIMS1;LIN7A;GRIA3;PLP1;GRIK4;GABRG3;KCNQ3;RIT2;GRID2;GRM1;RAB3A;GABRA2;HTR2A;GRIN2B;SNAPIN;GAD2;APBA2;GRM5;HTR2C;UNC13B;APBA1;GRID1;SYT1;GRM3;CHRM3;CAMKK2;STXBP3;PENK;HRH2;SLC12A6;HTR1F;HAP1;SLC6A1;TSPOAP1;CDH8;SHISA6;CAMK1;PRKAR2A;SLC32A1;GABRA1;BSN;STXBP1;STX1A;CBLN2;GRIN1;BRSK1;PRKAR2B;GAD1;PDE7B;GABRB1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6753003287982685,1.734243857770393,0.001177856301531213,0.08579068439494852,0.925,7/26,9.40%,GPR137B;CDK6;FSTL3;TCTA;LILRB3;HOXA7;PTPN2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.6054236474457971,1.7307950632109792,0.0,0.08841135314586503,0.932,27/64,17.91%,PLAU;PEAK1;CDK6;SKAP1;CD3E;CORO1C;CSF1;SLC9A1;PTPRA;MACF1;PIK3CB;PTK2B;JAG1;ACTG1;HOXA7;JUP;MYOC;RHOA;CCL28;UTRN;ROCK1;ADAM15;RASA1;NF1;DUSP3;MINK1;DAPK3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7063601630944667,1.7236547526700257,0.004878048780487805,0.09715431171637078,0.95,8/20,11.60%,PLAU;IGF1;LRP1;PDGFA;NRP1;S100A11;SERPINE1;CCL5
prerank,amino acid transport (GO:0006865),0.6240492220610819,1.721500840408334,0.0,0.09772611565559096,0.955,21/49,20.29%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC7A11;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC16A10;SLC7A6;SLC1A5;SLC38A11;SLC7A8;SLC43A2;SLC38A7;SLC38A10;SLC38A2;SLC25A44
prerank,primary alcohol metabolic process (GO:0034308),0.6810986946487286,1.720892853822354,0.0023781212841854932,0.09625289380760854,0.956,9/25,14.67%,IGF1;GPD2;RDH12;GDPD3;DHRS3;DHRS9;NAPEPLD;RBP4;CYP1B1
prerank,neurotransmitter secretion (GO:0007269),-0.4386819133971993,-1.7188259874838299,0.0,0.5450225786756263,0.999,18/44,11.72%,SNAP25;NRXN1;SYN2;CPLX1;SYT10;RIMS1;LIN7A;RAB3A;SNAPIN;GAD2;SYT1;STXBP3;RIMS2;SLC32A1;STXBP1;STX1A;BRSK1;GAD1
prerank,regulation of immune response (GO:0050776),0.5648440596990028,1.7185187264716009,0.0,0.09796428048175924,0.964,44/135,17.41%,COLEC12;CD3E;CD96;CD247;CD300LF;CD8B;ITGAL;PDCD1;CD226;FGR;CD300LB;CD8A;KLRC1;SPN;SH2D1A;GPR151;CD3G;ADCY7;NCR1;TRAF3;ITGA4;CD22;BCL6;PTPN22;CD200R1;SELL;TREM2;IFITM1;LILRB1;CD300A;KLRK1;B2M;C3;FCRLB;JAML;CRTAM;TREML4;RSAD2;ITGB2;APPL2;TIRAP;SYK;SPINK5;RIPK3
prerank,positive regulation of DNA binding (GO:0043388),0.6408846893446015,1.718389038388864,0.0011876484560570072,0.0958991971489224,0.964,8/31,6.37%,IGF1;MMP8;NIBAN2;PLAUR;TRIM6;MMP9;PPARG;GATA3
prerank,leukotriene biosynthetic process (GO:0019370),-0.6011308592118899,-1.7180409975620914,0.011627906976744186,0.5083204742086558,0.999,3/14,3.80%,LTC4S;ALOX5;GGT5
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4863202762303711,-1.7167736574894117,0.014184397163120567,0.4784726938278629,0.999,15/34,19.76%,MEF2C;GRIN2A;LRRK2;GABRG3;GRID2;GABRA2;GRIN2B;GABRA1;GRIN1;MPP2;GLRA1;ARRB2;GABRE;GABRG2;NLGN3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.7414969453329899,1.7164370610964639,0.0,0.09663694851084266,0.968,9/16,19.45%,LYST;PLEKHM2;GZMB;ARL8B;KLRK1;CEBPG;TUBB;VAMP2;SLAMF7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.700397862352896,1.715676607390846,0.005044136191677175,0.09543843018024972,0.969,4/20,6.37%,IGF1;NIBAN2;TRIM6;GATA3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7022120597035233,1.712626697886248,0.0012376237623762376,0.09794601905004768,0.978,8/21,11.15%,IGF1;NR4A3;MEF2D;MMP9;FGF2;ERN1;DNMT1;JUN
prerank,neutrophil activation involved in immune response (GO:0002283),0.5426798796404476,1.7122926528839124,0.0,0.09637163822596619,0.978,176/428,20.19%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;CYBA;FTL;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;FGR;CTSA;COTL1;CYBB;CXCR2;GNS;ATP6V0A1;ALDOA;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;PSAP;RNASE3;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;CAP1;S100A11;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;MOSPD2;DPP7;PDXK;CD53;CSTB;PSMD6;LILRB3;PFKL;PLEKHO2;ABCA13;MVP;LAMP2;CD300A;CDK13;VCP;B2M;PSMC3;JUP;NHLRC3;ARSA;NRAS;GLA;C3;RHOG;RAB7A;CD63;ERP44;HRNR;HUWE1;DIAPH1;GUSB;FUCA1;TNFRSF1B;RHOA;GSN;ADGRE5;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;PSMD14;PRG2;NEU1;CPNE3;ROCK1;PSMD2;CCT8;PPIA;MGAM;CAB39;GCA;NFKB1;APRT;MCEMP1;ACP3;ITGB2;TIMP2;CAT;ARL8A;APAF1;QPCT;PLAC8;SYK;CKAP4;ANXA3;GGH;PPIE;CLEC12A;ARHGAP9;HK3;TUBB;C5AR1;GPI;VAMP2;CFP;RAB37;ATP6V0C;PSMA5;GPR84;ANO6;ORMDL3;ALDH3B1;FCER1G;DDOST;ASAH1;NPC2;BST2;SLC11A1;AGA;GLIPR1;VPS35L;CLEC4D;CYB5R3;TMC6;B4GALT1;OSTF1;FTH1;AGPAT2;HMGB1;CYSTM1
prerank,regulation of postsynapse organization (GO:0099175),-0.496383734511855,-1.7122448094599134,0.0,0.46344058262229365,0.999,13/28,10.25%,TANC2;IL1RAPL1;CDKL5;ABI3;EPHA4;ARHGAP44;LRRK2;SIPA1L1;PDLIM5;SHANK3;PPFIA2;FCGR2B;WNT5A
prerank,neutrophil degranulation (GO:0043312),0.5424289767918258,1.7113718818295311,0.0,0.09577661747778309,0.98,175/425,20.19%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;CYBA;FTL;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;FGR;CTSA;COTL1;CYBB;CXCR2;GNS;ATP6V0A1;ALDOA;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;PSAP;RNASE3;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;CAP1;S100A11;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;MOSPD2;DPP7;PDXK;CD53;CSTB;PSMD6;LILRB3;PFKL;PLEKHO2;ABCA13;MVP;LAMP2;CD300A;CDK13;VCP;B2M;PSMC3;JUP;NHLRC3;ARSA;NRAS;GLA;C3;RHOG;RAB7A;CD63;ERP44;HRNR;HUWE1;DIAPH1;GUSB;FUCA1;TNFRSF1B;RHOA;GSN;ADGRE5;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;PSMD14;PRG2;NEU1;CPNE3;ROCK1;PSMD2;CCT8;PPIA;MGAM;CAB39;GCA;NFKB1;APRT;MCEMP1;ACP3;ITGB2;TIMP2;CAT;ARL8A;APAF1;QPCT;PLAC8;CKAP4;ANXA3;GGH;PPIE;CLEC12A;ARHGAP9;HK3;TUBB;C5AR1;GPI;VAMP2;CFP;RAB37;ATP6V0C;PSMA5;GPR84;ANO6;ORMDL3;ALDH3B1;FCER1G;DDOST;ASAH1;NPC2;BST2;SLC11A1;AGA;GLIPR1;VPS35L;CLEC4D;CYB5R3;TMC6;B4GALT1;OSTF1;FTH1;AGPAT2;HMGB1;CYSTM1
prerank,T cell differentiation (GO:0030217),0.6222789964392565,1.7107089324580618,0.0,0.09475971049078406,0.98,17/40,20.34%,LCK;TCF7;PTPRC;ANXA1;CD4;CD8A;CD28;PTPN22;GATA3;ADAM17;PTPN2;DLL4;RIPK3;FCER1G;IL2;GPR89A;GPR89B
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4442936317435272,-1.7087963458305628,0.0,0.4478178118506371,0.999,18/46,11.46%,OPHN1;MEF2C;GRM7;NRXN1;NLGN1;TSHZ3;GRIK3;CACNG3;LRRK2;GRM1;GRM5;SYT1;GRM3;CDH2;SHANK3;CACNG8;CCL2;GRM8
prerank,neutrophil mediated immunity (GO:0002446),0.5413801746636803,1.7087190884323042,0.0,0.09599296062250635,0.981,177/432,20.19%,LGALS3;PLAU;IQGAP1;S100A8;CTSB;S100A9;CYBA;FTL;CAMP;ITGAX;LCN2;CTSD;GALNS;ANPEP;TBC1D10C;MMP8;CTSZ;TCIRG1;SDCBP;IGF2R;ATG7;FPR2;SIRPA;FABP5;OLR1;PLAUR;DOCK2;PTPRC;PSMD1;ITGAL;LTF;PKM;FGR;CTSA;COTL1;CYBB;CXCR2;GNS;ATP6V0A1;ALDOA;ADAM8;ARPC5;CCT2;CD44;PRDX6;RETN;TARM1;PKP1;ATP8B4;DNAJC5;MMP9;PSAP;RNASE3;PRKCD;C3AR1;MAGT1;TOM1;EEF2;DYNC1H1;CAP1;S100A11;DERA;GLB1;GYG1;SYNGR1;GAA;EEF1A1;CRACR2A;SELL;UBR4;LRG1;RAB5C;VAT1;HP;CAPN1;MOSPD2;DPP7;PDXK;CD53;CSTB;PSMD6;LILRB3;ADAM17;PFKL;PLEKHO2;ABCA13;MVP;LAMP2;CD300A;CDK13;VCP;B2M;PSMC3;JUP;NHLRC3;ARSA;NRAS;GLA;C3;RHOG;RAB7A;CD63;ERP44;HRNR;HUWE1;DIAPH1;GUSB;FUCA1;TNFRSF1B;RHOA;GSN;ADGRE5;SRP14;TMBIM1;IQGAP2;HSPA8;ALDOC;PSMD14;PRG2;NEU1;CPNE3;ROCK1;PSMD2;CCT8;PPIA;MGAM;CAB39;GCA;NFKB1;APRT;MCEMP1;ACP3;ITGB2;TIMP2;CAT;ARL8A;APAF1;QPCT;PLAC8;CKAP4;ANXA3;GGH;PPIE;CLEC12A;ARHGAP9;HK3;TUBB;C5AR1;GPI;VAMP2;CFP;RAB37;ATP6V0C;PSMA5;GPR84;ANO6;IL6;ORMDL3;ALDH3B1;FCER1G;DDOST;ASAH1;NPC2;BST2;SLC11A1;AGA;GLIPR1;VPS35L;CLEC4D;CYB5R3;TMC6;B4GALT1;OSTF1;FTH1;AGPAT2;HMGB1;CYSTM1
prerank,natural killer cell mediated immunity (GO:0002228),0.7477118441538404,1.7058459298360138,0.0,0.09866751161567,0.983,9/15,19.45%,LYST;PLEKHM2;KLRC2;GZMB;ARL8B;KLRK1;CEBPG;TUBB;SLAMF7
prerank,cellular response to oxygen levels (GO:0071453),0.8099153194393731,1.705145346696883,0.002857142857142857,0.0978138922206052,0.984,6/10,9.10%,ATP6V1A;ATP6V0D1;CPEB4;ATP6V1G1;TMEM199;ATP6AP1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5743174162174436,-1.7041134550581827,0.00975609756097561,0.4381394995325509,0.999,8/17,17.32%,NLGN1;SCAMP5;SYT10;KCNB1;RAB3A;STX1A;RAB15;CACNA1G
prerank,eosinophil migration (GO:0072677),0.7610971101033398,1.7037178191388116,0.003911342894393742,0.0963381360095366,0.986,5/14,11.60%,LGALS3;CCL4;CCL13;CCL7;CCL5
prerank,eosinophil chemotaxis (GO:0048245),0.7610971101033398,1.7037178191388116,0.003911342894393742,0.0963381360095366,0.986,5/14,11.60%,LGALS3;CCL4;CCL13;CCL7;CCL5
prerank,integrin-mediated signaling pathway (GO:0007229),0.5786843774110607,1.7023295490634573,0.0,0.09670949877248744,0.986,33/73,21.76%,FN1;PLEK;PTPRA;FGR;LAT;ITGA5;TEC;ADAMTS13;PTK2B;NEDD9;NRP1;DAB2;PLPP3;ERBIN;TXK;ILK;PRAM1;FBLN1;CDC42;ADAM15;ITGB2;LAMA5;SYK;ITGA11;ZYX;FERMT2;CUL3;COL16A1;ITGB1BP1;DST;ITGA2B;LAMA3;CD47
prerank,intracellular pH reduction (GO:0051452),0.6434758466770828,1.7015503546106197,0.0,0.09600925084215933,0.986,19/33,20.69%,TCIRG1;ATP6V1C1;DMXL2;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB7A;ATP6V1F;ATP6V0C;DMXL1;SLC11A1;ATP6V0A4;GPR89A;GPR89B;ATP6V1E1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5760622695694555,-1.696751098642115,0.015306122448979591,0.43670362593254597,0.999,10/17,26.33%,CACNA2D1;NOS1AP;SNTA1;KCNH2;KCNQ1;ANK2;SCN4B;KCNE3;KCNE4;GJA5
prerank,neutrophil migration (GO:1990266),0.595738565445788,1.6959944311677644,0.0,0.1027178853112222,0.992,16/58,19.05%,LGALS3;S100A8;S100A9;CXCR2;CCL4;CCL13;PIP5K1C;JAML;CCL7;CCL5;CCL14;PPIA;ITGB2;SYK;FCER1G;PIKFYVE
prerank,myotube cell development (GO:0014904),0.8151087075137196,1.6954349017873034,0.001394700139470014,0.10177558981792381,0.993,2/10,3.06%,IGF1;SELENON
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.575113648684943,1.6953406416132895,0.0,0.10007364758204712,0.993,50/86,32.63%,HIF1A;ATF3;PSMD8;NFE2L2;PSMD1;UBA52;RPS27A;MUC1;VEGFA;PSMD6;PSMA1;PSMC3;HMOX1;PSMA8;PSMD14;PSMD2;STOX1;DDIT3;INO80;PSMC6;PSMA6;PSMD5;ELOB;PSMA5;DNAJB1;UBC;EGLN1;EPO;VHL;CUL2;EGLN3;MAPK7;PSMA3;BAG3;ATF4;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;PSMD12;EP300;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.6688047327460834,1.695149010213381,0.0011933174224343676,0.09872357899445038,0.994,7/26,5.50%,APOE;HIF1A;ATP7A;PIK3CB;CYP27B1;VDR;POR
prerank,positive regulation of calcium ion import (GO:0090280),0.7760178275096592,1.694476324597449,0.00535475234270415,0.09813319872509121,0.994,2/12,2.87%,LGALS3;SPHK2
prerank,ganglion development (GO:0061548),0.7845316487876237,1.6941868059054945,0.004267425320056899,0.09679225580715645,0.994,3/11,4.72%,CTNNB1;NRP2;NRP1
prerank,regulation of fibroblast proliferation (GO:0048145),0.6105082750991703,1.6926413215193061,0.0021953896816684962,0.09773413824486646,0.995,22/45,25.13%,IGF1;CTNNB1;FN1;CDK6;NLRC3;B4GALT7;PDGFA;SPHK1;S100A6;PEX2;CD300A;GAS6;NF1;DDR2;BMI1;DHX9;FTH1;CD74;MIF;PDGFRA;CDK4;SFRP1
prerank,maturation of 5.8S rRNA (GO:0000460),0.717608532237059,1.6905404853879518,0.003896103896103896,0.09950503937378682,0.995,8/17,12.26%,C1D;EIF6;NSA2;EXOSC4;WDR12;MAK16;EXOSC10;FTSJ3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8162158676289467,1.6897865540494366,0.0013157894736842105,0.09906697005854698,0.995,4/10,3.96%,APOE;ABCA1;APOA2;BMP1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7290896353211402,1.687929103489106,0.0024968789013732834,0.10052726603736117,0.995,9/16,15.46%,APOE;LRP1;TREM2;HDAC1;LRPAP1;ABCA7;ROCK1;CLU;SRF
prerank,regulation of mast cell activation (GO:0033003),0.7825735139346005,1.6875966173757235,0.004189944134078212,0.09963837082275524,0.995,4/10,5.38%,CD84;CD300LF;CD226;MILR1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5765356597666229,-1.6866903527820927,0.019801980198019802,0.44343242669946575,0.999,5/17,8.81%,FCHSD2;WASF2;CTNNA2;NCKAP1;ARF1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.45795399157938804,-1.6865032653795706,0.0,0.4226985533807733,0.999,14/31,13.11%,TANC2;NLGN1;ABI3;EPHA4;ARHGAP44;LRRK2;SIPA1L1;PDLIM5;SHANK3;PPFIA2;LRP8;DBN1;CUX2;CAMK2B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6244619986634389,-1.6864409609985453,0.029787234042553193,0.40352549331299536,0.999,5/13,10.51%,SCAMP5;SYT10;KCNB1;SYT1;STX1A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.6200929232136249,1.6859549675687897,0.0,0.1006960618198866,0.996,22/39,23.30%,RPS6;RPS14;RRP7A;RPS24;METTL17;RPS7;RPS25;RIOK2;RPS28;RIOK3;LSM6;MRPS7;RPS19;RPS27;DDX52;RPS16;UTP4;SRFBP1;RPSA;NPM1;WDR3;SNU13
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6169633483451615,1.6819796758936232,0.001142857142857143,0.10535613206794721,0.997,24/42,27.47%,CDK6;SKAP1;CD3E;CSF1;HRG;PTK2B;NRP1;VEGFA;RIN2;JUP;MYOC;CCL28;UTRN;ROCK1;EFEMP2;KDR;FERMT2;COL16A1;GSK3B;GFUS;SFRP1;CX3CL1;S100A10;LIMS1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5380749195111887,-1.681430614274342,0.010050251256281407,0.39776066727573944,0.999,12/18,19.76%,NRXN1;NLGN1;RIMS1;SHANK3;RIMS2;PRKCZ;GRIN1;CUX2;CHRNA7;SHANK1;NLGN2;NLGN3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4599395686272119,-1.6797297949753063,0.0064516129032258064,0.38501217633236706,0.999,15/32,13.93%,MEF2C;GRIA4;NLGN1;NEFL;DLG2;GRIN2A;GRIA3;LRRC7;GRIN2B;APP;CCL2;GRIN1;SLC6A9;CAMK2B;CAMK2A
prerank,vesicle transport along actin filament (GO:0030050),0.6871769726046653,1.679217429130325,0.0,0.10782437091242372,0.997,4/19,3.42%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,negative regulation of platelet activation (GO:0010544),0.7174561556336635,1.6779102424848205,0.00516795865633075,0.10847183714015754,0.997,5/16,10.26%,CD9;APOE;PDGFA;PRKCD;SERPINE2
prerank,neuron cell-cell adhesion (GO:0007158),-0.6008226830822917,-1.6756652368139022,0.024691358024691357,0.38019952412821245,0.999,7/14,10.35%,NRXN3;NRXN1;NLGN1;ASTN2;CNTN4;NCAM2;RET
prerank,sympathetic nervous system development (GO:0048485),0.7296441367127107,1.6740300839313444,0.003937007874015748,0.1130699450602225,0.997,4/15,6.37%,CTNNB1;NRP2;NRP1;GATA3
prerank,neurotransmitter transport (GO:0006836),-0.39316515149028636,-1.6714982735957715,0.0,0.3759627448373754,0.999,25/73,11.72%,SNAP25;NRXN1;SYN2;CASK;PPFIA4;SLC1A3;CPLX1;RIMS1;LIN7A;RAB3A;GABRA2;SNAPIN;GAD2;UNC13B;APBA1;SYT1;STXBP3;PPFIA2;GLUL;TSPOAP1;SLC32A1;STXBP1;STX1A;BRSK1;GAD1
prerank,regulation of cytoplasmic translation (GO:2000765),0.7394484866150761,1.6696375973182,0.003870967741935484,0.11881655281740061,0.997,9/14,18.34%,PKM;UNK;CPEB4;CPEB2;CPEB3;YBX3;DHX36;CNBP;DHX9
prerank,acylglycerol metabolic process (GO:0006639),0.6246194003651829,1.6686274841745286,0.0055617352614015575,0.11883928011293828,0.997,16/37,17.29%,LPL;APOE;DGKZ;PLAAT3;GK;APOA2;ABHD12;CAV1;MGLL;APOBR;APOC1;LYPLA2;DGKA;APOH;DGKH;DGKD
prerank,plasma membrane repair (GO:0001778),0.741902263823949,1.668117907224355,0.005333333333333333,0.11815774474737643,0.997,5/13,7.33%,MYOF;AHNAK2;FER1L5;ARL8B;ANXA6
prerank,transferrin transport (GO:0033572),0.6352903789566489,1.6658695843247588,0.0011534025374855825,0.12091126354447862,0.997,18/33,20.83%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;REP15;ATP6AP1;DNM2;ATP6V1F;TFRC;ATP6V0C;ATP6V0A4;ATP6V1E1;LMTK2
prerank,proteoglycan metabolic process (GO:0006029),0.6619936649354836,1.6655793650347182,0.004739336492890996,0.1198039479931685,0.997,4/26,2.56%,IGF1;XYLT1;CHST11;B4GALT7
prerank,secretory granule organization (GO:0033363),0.8024203967098674,1.665295395673369,0.0027210884353741495,0.11865909647918514,0.997,4/10,8.56%,LYST;ABCA1;BLOC1S3;DTNBP1
prerank,endosome organization (GO:0007032),0.6078544121943846,1.6645159629369,0.0011235955056179776,0.11864311710451064,0.998,23/41,28.13%,CORO1C;EEA1;ALS2;SQSTM1;WASHC5;PI4K2A;SNX33;HOOK1;VPS18;SNX10;ARFGEF2;PLEKHF1;ALS2CL;VPS11;RAB22A;HOOK3;LAPTM4B;USP50;USP8;PLEKHJ1;RILP;PI4K2B;LAMTOR1
prerank,cellular potassium ion homeostasis (GO:0030007),0.7363345530085907,1.6639990418339339,0.00945945945945946,0.11796842857058373,0.999,6/13,7.23%,ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5876145960114578,-1.6617719612054251,0.020833333333333332,0.3870917174082363,1.0,8/14,29.32%,CACNA2D1;SLC8A3;SLC8A2;TRPV4;TRPM2;SLC24A1;SLC24A2;SLC8A1
prerank,rRNA processing (GO:0006364),0.5363925065000718,1.6614239471116172,0.0,0.12090956191106912,0.999,86/172,26.87%,C1D;UBA52;ESF1;EIF6;RPS6;RPS14;RPL10A;NSA2;RRP7A;RPL18;RPS24;EXOSC4;RPS7;RPL36A;RPL41;RPL17;RPL23;RPS25;WDR12;RIOK2;MAK16;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;BMS1;NOLC1;DDX49;WDR43;MRM2;NOL6;UTP11;UTP20;RPL32;NVL;EXOSC9;RIOK3;EXOSC10;RPL21;RPL9;RPL36;RPL37;LSM6;RPL38;RPS19;RPS27;MDN1;SART1;DDX52;RPL14;RPS16;UTP4;RPL30;UTP14A;RPL12;RPL13A;RPL31;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5;SRFBP1;RRP9;DKC1;RPL15;WDR3;MRPL1;SNU13;RPL7A;RRP1B;RRP1;RPL23A;RPL8;RPLP1;NAT10;RPL29;PIH1D1;RPL37A
prerank,cellular response to increased oxygen levels (GO:0036295),0.7745652782262811,1.6603234276200416,0.0040595399188092015,0.12155964889695262,0.999,7/11,9.10%,ATG7;ATP6V1A;ATP6V0D1;ATP6V1G1;CAV1;TMEM199;ATP6AP1
prerank,wound healing (GO:0042060),0.5797704606408483,1.660136951714935,0.0,0.12028888074914541,0.999,17/62,11.06%,IGF1;MYOF;AHNAK2;MMP12;MACF1;PDGFA;NRG1;FER1L5;RAF1;FGF2;ARL8B;DCBLD2;ANXA6;EVPL;HMOX1;PLEC;JAML
prerank,Rac protein signal transduction (GO:0016601),-0.5396866626700467,-1.659842000382957,0.017467248908296942,0.37772317266337624,1.0,7/18,11.54%,ELMO1;EPS8;NCKAP1;FARP2;AIF1;TIAM1;CDH13
prerank,positive regulation of phospholipase activity (GO:0010518),0.6739050333128916,1.6597714517765796,0.004895960832313341,0.11945466534595808,0.999,8/22,11.60%,FLT1;ABL2;GNA13;FGF2;PDPK1;ARL1;PLAA;CCL5
prerank,signal release from synapse (GO:0099643),-0.42873713354761417,-1.6596734436505793,0.0,0.36512848555275007,1.0,17/43,11.72%,SNAP25;NRXN1;SYN2;CPLX1;SYT10;RIMS1;LIN7A;RAB3A;SNAPIN;GAD2;SYT1;STXBP3;SLC32A1;STXBP1;STX1A;BRSK1;GAD1
prerank,natural killer cell activation (GO:0030101),0.676092775000331,1.6587562787420973,0.0012345679012345679,0.12003808251492491,0.999,14/23,21.25%,ELF4;PTPRC;CD2;AXL;NFIL3;NCR1;PRDX1;RASGRP1;KLRK1;TOX;KAT7;SLAMF7;IL2;PBX1
prerank,steroid catabolic process (GO:0006706),0.7919408198115903,1.657357273364398,0.0014285714285714286,0.12124438330840633,0.999,3/10,4.05%,SPP1;CYP19A1;CYP27B1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6694045294893944,1.6572587522512248,0.007272727272727273,0.11996515536880406,0.999,10/22,16.22%,RAB7B;LTF;WDFY1;MFHAS1;PTPN22;TREM2;ACOD1;APPL2;TIRAP;NINJ1
prerank,positive regulation of lipid transport (GO:0032370),0.7549240200371627,1.6570717161247122,0.002617801047120419,0.11897351383017223,0.999,4/12,3.76%,SPP1;APOE;LRP1;CYP19A1
prerank,negative regulation of anoikis (GO:2000811),0.740621649088283,1.6546350484422099,0.006811989100817439,0.12198391136824041,0.999,4/14,5.31%,BCL2;ITGA5;MCL1;CAV1
prerank,regulation of cholesterol storage (GO:0010885),0.7167997277438833,1.6540083625314985,0.008905852417302799,0.12171458746956836,0.999,6/15,8.91%,LPL;ABCG1;ABCA1;PPARG;TREM2;PPARD
prerank,actin filament-based transport (GO:0099515),0.6660946786112684,1.653926021429027,0.0012578616352201257,0.12046430116892012,0.999,4/21,3.42%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,neutral amino acid transport (GO:0015804),0.6426942531038297,1.650116731236437,0.008413461538461538,0.1259507911311849,0.999,13/28,19.68%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SLC1A5;LLGL2;SLC7A8;SLC43A2;SLC38A2
prerank,translation (GO:0006412),0.5337598023212902,1.6496923968851473,0.0,0.1253807886546483,0.999,104/208,26.87%,EPRS1;MRPS12;RPS12;AARS1;UBA52;AGO2;RPS27A;TNIP1;EIF4G1;RPS6;MRPL47;RPS14;MRPL51;RPL10A;EEF2;RPL18;VARS1;RPS24;IGHMBP2;RPS7;RPS20;RPL36A;CARS1;RPL41;EEF1A1;RPS26;MRPL23;RPL17;RPL23;RPS25;ETF1;RPL35A;RPS28;RPLP2;RPL28;LARS2;GARS1;RPL27A;EEF1D;RPL11;RPS2;TMA7;GTPBP2;MRPL52;RARS1;RPL32;DRG1;RWDD1;MRPS15;RPL21;MRPL24;RPL9;RPL36;RPL37;MRPS33;MRPS16;RPS18;RPL38;MRPS7;RPS19;RPS27;FARSA;RPS23;RPL14;SARS2;SARS1;MRPL11;RPS16;RPL30;RPL12;GATB;DRG2;GSPT1;FARSB;RPL13A;RPL31;FARS2;RPS9;NARS1;RPL4;RRBP1;RPS3;MRPS28;RPS13;YARS1;RPSA;PABPC4;GFM2;RPL15;MRPS14;LARS1;TRMT112;AIMP2;TARS1;RPL7A;AIMP1;MRPL37;MRPL18;RPL23A;RPL8;RPLP1;RPL29;FASTKD2;RPL37A
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.7365629271122088,1.6486908805380946,0.006765899864682003,0.12571228498084422,0.999,6/12,18.31%,APOE;TREM2;IAPP;PFDN1;CLU;PFDN2
prerank,androgen metabolic process (GO:0008209),0.6915101284726443,1.6483429047094778,0.0037926675094816687,0.12495057920893816,0.999,4/18,7.87%,SPP1;CYP19A1;DHRS9;SRD5A3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.740515381510959,1.6481316560030088,0.004032258064516129,0.12397921902212977,0.999,5/13,10.06%,PLXNC1;NRP2;PLXNA2;NRP1;PLXND1
prerank,sodium ion export across plasma membrane (GO:0036376),0.72974621606425,1.6453907945955442,0.009421265141318977,0.12780330426125164,0.999,6/13,15.29%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1;ATP1A2
prerank,amino sugar biosynthetic process (GO:0046349),0.7414235605686886,1.645108865656785,0.006756756756756757,0.12712780403986976,0.999,9/12,23.29%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;NANP;UAP1;AMDHD2
prerank,lymphocyte migration (GO:0072676),0.6271907419731866,1.644318810550942,0.0034883720930232558,0.12714327017984237,0.999,10/32,13.81%,MSN;TBX21;CCL4;ADAM8;GATA3;CCL13;CRTAM;CCL7;CCL5;CCL14
prerank,carboxylic acid transmembrane transport (GO:1905039),0.615306264938836,1.6439968033028152,0.0011185682326621924,0.1264468317194848,1.0,19/40,19.68%,SLC27A1;SLC38A1;SLC38A6;SLC7A11;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC36A3;SLC7A6;SLC38A11;SLC25A14;SLC7A8;SLC25A21;SLC38A7;SLC19A1;SLC38A10;SLC13A3;SLC38A2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.6678178787166873,1.643463694608605,0.004914004914004914,0.1262646022507234,1.0,8/21,11.01%,STAP1;PRKCH;CD22;RUNX1;PTPN22;PRKCB;CD300A;ELF2
prerank,calcium ion import into cytosol (GO:1902656),-0.5710576533297325,-1.6392387023920907,0.026200873362445413,0.4027179832069111,1.0,8/15,29.32%,CACNA2D1;SLC8A3;SLC8A2;TRPV4;TRPM2;SLC24A1;SLC24A2;SLC8A1
prerank,carboxylic acid transport (GO:0046942),0.5781340134721211,1.6389846095351552,0.0,0.13357653785914278,1.0,23/55,19.68%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC17A5;PSAP;SLC36A3;SLC6A7;SLC7A6;SLC16A9;CLN3;SLC1A5;SLC16A3;LLGL2;SLC7A8;SLC13A3;SLC16A2;SLC38A2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6881287273373877,1.6380815520604135,0.007566204287515763,0.1340386646260872,1.0,8/17,16.70%,LGALS3;DGKZ;SH2D1A;PTPN22;PTPN2;PHPT1;UBASH3A;DUSP3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6557215734192277,1.637705184017226,0.007326007326007326,0.133441100729175,1.0,10/22,16.70%,LGALS3;DGKZ;SH2D1A;CD22;PTPN22;CD300A;PTPN2;PHPT1;UBASH3A;DUSP3
prerank,positive regulation of transport (GO:0051050),0.5531041657111804,1.637610937913231,0.0,0.13227581861205123,1.0,36/85,22.36%,CYBA;APOE;LRP1;IL2RB;FPR2;KMT2A;SIRPA;DOCK2;ANXA1;SGK1;SCIN;APOA2;PON1;SGK2;DYNC1H1;BID;DAB2;TREM2;PLAA;BAX;KCTD7;GAS6;ABCA7;ACTB;NUMA1;CHP1;SMPD1;HIP1R;LMAN2;LYAR;FCER1G;SLC11A1;MLC1;GSK3B;CD47;CALR
prerank,rRNA metabolic process (GO:0016072),0.5307362863774814,1.6363540920382103,0.0,0.13331082310892028,1.0,82/160,27.98%,C1D;DEDD2;UBA52;ESF1;RPS6;RPS14;RPL10A;RRP7A;RPL18;RPS24;EXOSC4;RPS7;RPL36A;RPL41;ERN2;RPL17;RPL23;RPS25;WDR12;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;BMS1;NOLC1;DDX49;WDR43;MRM2;NOL6;UTP11;UTP20;RPL32;NVL;EXOSC9;EXOSC10;RPL21;RPL9;RPL36;RPL37;RPL38;RPS19;RPS27;MDN1;DDX52;RPL14;RPS16;UTP4;RPL30;UTP14A;RPL12;RPL13A;RPL31;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5;RRP9;DKC1;RPL15;WDR3;SNU13;XRN1;RPL7A;RRP1B;RRP1;RPL23A;RPL8;RPLP1;RPL29;PIH1D1;RPL37A;BYSL;TRIR;NOP14
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.48759431148904164,-1.6359339669455555,0.016574585635359115,0.3978631651929232,1.0,9/25,14.34%,MEF2C;GRIN2A;LRRK2;GRID2;GRIN2B;GRIN1;MPP2;GLRA1;ARRB2
prerank,"phototransduction, visible light (GO:0007603)",0.7159036815357686,1.6343182157510203,0.003896103896103896,0.13611783024262858,1.0,7/14,19.06%,GNAQ;ABCA4;SAG;PDE6B;CNGB1;GNA11;GNB1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7519923830403248,1.631805601700978,0.004081632653061225,0.1394830496067749,1.0,6/12,12.78%,APOC4;SOAT1;P4HB;APOC1;SOAT2;LPCAT3
prerank,fatty acid transport (GO:0015908),0.6739643748847263,1.6317468569064437,0.006305170239596469,0.13831443563443438,1.0,6/17,8.91%,APOE;FABP5;SLC27A1;PPARG;ACSL1;PPARD
prerank,excitatory postsynaptic potential (GO:0060079),-0.5272290402940819,-1.6310497885247501,0.019230769230769232,0.3979071877358599,1.0,8/19,14.34%,MEF2C;GRIN2A;LRRK2;GRID2;GRIN2B;GRIN1;MPP2;ARRB2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5642842026496269,1.630894765750278,0.0,0.13852544858475452,1.0,34/67,27.47%,FN1;CDK6;SKAP1;CD3E;CSF1;FLNA;PTK2B;NEDD9;NRP1;CRKL;LIMS2;P4HB;ILK;JUP;MYOC;CCL28;UTRN;CDC42;DOCK5;C1QBP;MYADM;TESK1;FERMT2;ECM2;GSK3B;TRIOBP;CALR;CSPG5;JAK2;SFRP1;MDK;CX3CL1;S100A10;LIMS1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5936126879071382,1.6284661244998726,0.0033632286995515697,0.1420740141764243,1.0,14/41,12.95%,LCK;SKAP1;CD3E;PLAUR;GCNT2;CD44;FSTL3;PTPN23;PIEZO1;PLPP3;JAK1;MAGI1;CCL5;SMAD7
prerank,antibacterial humoral response (GO:0019731),0.7045229923881443,1.6270415784349495,0.014175257731958763,0.1436362557975269,1.0,7/16,18.63%,CAMP;LTF;RNASE3;DMBT1;RNASE7;JCHAIN;RNASE6
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6436300678245465,1.6262528583162723,0.010778443113772455,0.14382144804358826,1.0,11/24,21.70%,NIBAN2;KMT2A;ERCC1;ZRANB3;H1-0;BLM;ERCC4;RTEL1;DACH1;RPS3;DFFA
prerank,regulation of ATP metabolic process (GO:1903578),0.5777119184211491,1.6234145262040365,0.0021482277121374865,0.14821377583655523,1.0,33/54,31.50%,HIF1A;NUP205;ATP7A;EIF6;GCK;SPHK2;GCKR;COX7A1;SLC25A33;AK4;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;COX7A2L;NUP50;JMJD8;NUP54;COX7A2;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214;FIS1;SHMT2;EP300
prerank,negative regulation of T cell activation (GO:0050868),0.6069983948189914,1.6232143484712513,0.003374578177727784,0.14731667343497262,1.0,8/35,8.87%,LGALS3;GPNMB;LAX1;SPN;RIPOR2;CD274;PTPN22;LILRB1
prerank,myoblast differentiation (GO:0045445),0.7206950626625721,1.6228648545950537,0.005121638924455826,0.1467281496969639,1.0,5/14,8.70%,IGF1;NRG1;PLEKHM3;JAG1;DDX17
prerank,regulation of neuroinflammatory response (GO:0150077),0.6809079998201346,1.6221219960538815,0.004884004884004884,0.1468803017457522,1.0,7/19,11.68%,IGF1;MMP8;SPHK1;MMP9;CD200R1;TREM2;TNFRSF1B
prerank,iron ion transport (GO:0006826),0.5890080648066077,1.6218176374381803,0.001095290251916758,0.14623575731372382,1.0,24/47,21.63%,TCIRG1;ATP6V1C1;ATP6V0D2;LTF;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;HEPH;REP15;ATP6AP1;DNM2;ATP6V1F;MELTF;TFRC;ATP6V0C;SLC11A1;ATP6V0A4;FTH1;ATP6V1E1;LMTK2;ABCB7
prerank,glycolytic process (GO:0006096),0.6234412597145218,1.6199613742734298,0.002364066193853428,0.14882082021950452,1.0,12/28,17.53%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;LDHA;ENO1;ALDOC;ENO2;HK3;GPI
prerank,B cell receptor signaling pathway (GO:0050853),0.6131627425510856,1.6199351275412643,0.003468208092485549,0.14761312341285707,1.0,10/32,9.92%,BCL2;RFTN1;LCK;ITK;PTPRC;TEC;BLNK;PRKCB;PLEKHA1;BAX
prerank,neuron projection extension (GO:1990138),0.6191827019688533,1.6170179840040033,0.0034522439585730723,0.15212602680810047,1.0,8/32,8.76%,ALCAM;IQGAP1;CTNNB1;NRP2;CDK5;NRP1;LLPH;USP9X
prerank,response to muscle stretch (GO:0035994),0.69693330000553,1.6165546894600893,0.009079118028534372,0.1518982048144337,1.0,5/15,12.03%,CTNNB1;SLC9A1;NPPA;CSRP3;GSN
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4787862528155946,-1.616170651835851,0.012422360248447204,0.4218497611049083,1.0,14/25,23.55%,MEF2C;NLGN1;CACNG3;SHANK3;SHISA6;CACNG8;CNIH3;SHISA7;SHANK1;NLGN2;NLGN3;CACNG2;MAPK8IP2;RELN
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7526021304638617,1.616134778781876,0.011688311688311689,0.15141468825167573,1.0,5/12,8.91%,MYO1E;IQGAP1;CD24;JAG1;BASP1
prerank,superoxide metabolic process (GO:0006801),0.6196315621563719,1.6146144858939255,0.009378663540445486,0.1531553075045704,1.0,9/29,12.66%,SH3PXD2B;CYBA;CYBB;ATP7A;PRDX1;TAFA4;CYB5R4;NCF4;NRROS
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.6494956570122945,1.6141051836804463,0.009696969696969697,0.15293293039259892,1.0,10/23,12.22%,UBA52;RPS27A;COPS3;COPS8;COPS4;DDB2;DDB1;COPS2;XPA;COPS6
prerank,positive regulation of T cell proliferation (GO:0042102),0.5689626307649118,1.61263851109393,0.00544069640914037,0.15457637891776116,1.0,22/55,20.12%,IGF1;CD3E;PTPRC;ANXA1;SLC7A1;CD24;CD6;CD28;NCK2;IL12RB1;CD274;NCK1;IL27RA;CCR2;CCL5;TFRC;SYK;TNFSF9;IL6;IL2;RPS3;HMGB1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.605575274648855,1.6124957551717864,0.004624277456647399,0.15360077576298883,1.0,17/33,26.95%,IGF1;BCL2L1;VAT1;IAPP;SLC35F6;TRIAP1;HUWE1;MPV17L;GHITM;CLU;TFRC;PRELID1;BNIP3;ACAA2;GPX1;PSMD10;NOL3
prerank,T cell mediated immunity (GO:0002456),0.7264570485752414,1.6095596180103446,0.005148005148005148,0.15787406407321655,1.0,7/13,21.40%,CD8A;JAG1;CADM1;BTN3A3;CRTAM;CD55;MYO1G
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6530114142764492,1.607141875483917,0.018703241895261846,0.16208058225359698,1.0,8/20,9.10%,SLC9A1;ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1;ATP6AP1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5242679972286993,1.6068679197511915,0.0,0.1613623346633137,1.0,53/163,17.90%,BCL2;THEMIS;RFTN1;LCK;LAX1;SKAP1;CD3E;CD247;PSMD8;ITK;GRAP2;PTPRC;PSMD1;PRKCQ;CD4;MALT1;LAT;TEC;PIK3CB;CD3G;CD28;PTPN22;BLNK;PDPK1;TRAT1;GATA3;NCK1;TXK;BTN3A3;PRKCB;SPG21;PLEKHA1;PSMD6;PSMA1;NFKBIZ;PSMC3;FYN;PRAM1;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;PRKD2;SPPL3;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;EIF2B2;PSMA5
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6126826607451906,1.6065748112884197,0.009269988412514484,0.16063942965063951,1.0,8/30,9.50%,CD300LF;UBA52;TANK;RPS27A;TRAF3;IKBKE;TNIP3;TICAM1
prerank,cell differentiation in spinal cord (GO:0021515),-0.6379394087657062,-1.6060379532887845,0.058823529411764705,0.4330862729686389,1.0,6/10,30.65%,MDGA2;MDGA1;SOX13;ISL1;ZC4H2;SOX4
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6613459138980581,1.6054773186096032,0.004801920768307323,0.16163439059240717,1.0,7/21,7.32%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2
prerank,canonical glycolysis (GO:0061621),0.6415648856551037,1.6024868617321792,0.004807692307692308,0.16526826619324797,1.0,12/24,17.53%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.6415648856551037,1.6024868617321792,0.004807692307692308,0.16526826619324797,1.0,12/24,17.53%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,positive regulation of cholesterol transport (GO:0032376),0.6284501343669017,1.6013984949229587,0.0011587485515643105,0.16622164684190724,1.0,10/27,13.25%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2;ABCA13;LPCAT3;ABCA7
prerank,positive regulation of lipid localization (GO:1905954),0.7454429096034559,1.5997939977084752,0.01366120218579235,0.16846927035432493,1.0,5/11,14.32%,LPL;LRP1;IKBKE;C3;NFKB1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7024950939690751,1.5983488893481428,0.007594936708860759,0.1703835523310624,1.0,4/15,10.97%,APOE;ABCG1;APOA2;APOC1
prerank,negative regulation of protein polymerization (GO:0032272),-0.4682226651955883,-1.5981047519774128,0.024539877300613498,0.4411597853808372,1.0,7/27,7.95%,SSH2;CYRIB;TUBB4A;KANK1;TWF2;STMN1;MAP2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5892151337849327,1.5976529009261489,0.0033632286995515697,0.1706899778578716,1.0,26/42,31.01%,EPRS1;AARS1;VARS1;VARS2;CARS1;LARS2;GARS1;RARS1;EARS2;FARSA;SARS2;SARS1;FARSB;FARS2;NARS1;YARS1;LARS1;AIMP2;TARS1;AIMP1;TARS2;RARS2;MARS2;PPA1;QARS1;NARS2
prerank,T cell receptor signaling pathway (GO:0050852),0.5254569729550337,1.596887368505355,0.0,0.1711621257759656,1.0,45/138,17.90%,THEMIS;RFTN1;LCK;SKAP1;CD3E;CD247;PSMD8;ITK;GRAP2;PTPRC;PSMD1;PRKCQ;CD4;MALT1;LAT;TEC;PIK3CB;CD3G;CD28;PTPN22;PDPK1;TRAT1;GATA3;NCK1;TXK;BTN3A3;PSMD6;PSMA1;NFKBIZ;PSMC3;FYN;PRAM1;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;PRKD2;SPPL3;PSMC6;PSMA6;PIK3R2;PSMD5;EIF2B2;PSMA5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7489111878123238,1.5966229285341755,0.008053691275167786,0.17042287064852238,1.0,5/11,15.48%,PRKCQ;MALT1;IL12RB1;NFKBIZ;CLEC6A
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6156913044162459,1.5956902580930417,0.007009345794392523,0.17112354837258284,1.0,6/27,5.48%,LPL;ABCG1;PRKCH;ABCA1;CSF1;PPARG
prerank,homotypic cell-cell adhesion (GO:0034109),0.5839687076854377,1.5955836304255326,0.005580357142857143,0.17016334094865826,1.0,12/39,8.79%,FN1;TLN1;PLEK;FLNA;PIK3CB;TJP2;MYL9;HSPB1;PLPP3;ACTN1;ACTG1;ILK
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5460779217470577,1.5952857992324552,0.0,0.16952582758679424,1.0,36/88,22.36%,APOE;EPRS1;RGP1;GZMB;NCL;CDK5;NELL1;LSM14A;PUS7;RIC1;PATL2;CSTB;RACK1;CPEB3;SERPINE2;CLN3;SHMT1;CNOT10;LARP1;ENC1;DNAJC1;ILF3;NFKB1;SYNCRIP;DAPK1;EIF4A3;EIF4ENIF1;DHX36;EIF4E2;FXR2;DAPK3;RPL13A;RPS3;GIGYF2;SAMD4A;CALR
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5977139243155396,-1.5946954664252013,0.034482758620689655,0.4376443707049629,1.0,4/11,1.66%,CACNB2;CACNA2D1;BIN1;NOS1AP
prerank,response to interleukin-4 (GO:0070670),0.7552969096993054,1.5941739230635925,0.0068212824010914054,0.17067502092493742,1.0,4/10,6.37%,TCF7;LEF1;RUFY4;GATA3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6348090151086697,1.5938526527750672,0.012315270935960592,0.1702058817838954,1.0,9/23,11.11%,KLRC2;CD226;KLRC1;NCR1;CADM1;RASGRP1;LILRB1;KLRK1;CRTAM
prerank,phagosome acidification (GO:0090383),0.629055588649792,1.5936473983571176,0.008284023668639054,0.1695531000018079,1.0,11/26,11.94%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB7A;ATP6V1F
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.641193473128342,-1.5932764681790295,0.03260869565217391,0.42988690634407867,1.0,6/10,18.06%,GABRB2;GABRG3;GABRA2;GABRA1;GABRE;GABRG2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6497966094793826,1.5927334385309293,0.007326007326007326,0.17055961174264828,1.0,6/21,8.22%,LGALS3;GPNMB;LAX1;FOXJ1;PTPN22;SAMSN1
prerank,monocyte chemotaxis (GO:0002548),0.6094416813329824,1.5910909016475427,0.004618937644341801,0.1727956636514967,1.0,9/32,14.80%,LGALS3;FLT1;ANXA1;CCL4;CCL13;CCL7;CCL5;CCL14;RPS19
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6472420891003818,1.5895794584933296,0.008663366336633664,0.173861253015717,1.0,4/21,2.63%,BCL2;BCL2L1;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6472420891003818,1.5895794584933296,0.008663366336633664,0.173861253015717,1.0,4/21,2.63%,BCL2;BCL2L1;EYA4;MCL1
prerank,epiboly involved in wound healing (GO:0090505),0.6809806107748548,1.5880895703902456,0.0199501246882793,0.17598292720910236,1.0,5/16,2.97%,LCP1;FLNA;MRTFA;PDPN;CD44
prerank,cellular component disassembly (GO:0022411),0.5680494328044202,1.5879526475742702,0.005376344086021506,0.17498651379144142,1.0,20/53,17.28%,SH3PXD2B;LCP1;MMP8;MMP12;CAPG;ADAM8;CD44;BMP1;A2M;MMP9;CAPN1;SCUBE3;GSN;KLKB1;MMP19;ADAM15;LAMC1;TIMP2;FURIN;CAPNS1
prerank,regulation of integrin activation (GO:0033623),0.6912154251933487,1.5875621781605995,0.015604681404421327,0.17462117268324748,1.0,4/15,4.50%,FBLIM1;SKAP1;PLEK;PIEZO1
prerank,lipid droplet formation (GO:0140042),-0.6361494495733524,-1.5875104952935508,0.06451612903225806,0.43339668655249824,1.0,3/10,15.79%,CDS1;PLA2G4C;SQLE
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6771583054068453,1.5867276613909196,0.013888888888888888,0.1753216257546705,1.0,8/16,16.48%,LGALS3;IKZF3;CD22;IL27;PTPN22;TNFRSF1B;TNFSF8;TNFSF9
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6303048545993905,1.5861460886446739,0.007075471698113208,0.17549586226955582,1.0,13/24,28.89%,NFE2L2;PDPK1;GATA3;ANGPT1;SERPINE1;TNIP2;GAS6;KDR;KRIT1;MAPK7;PAK4;TNFAIP3;NDNF
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7392790403336121,1.585568500933639,0.015427769985974754,0.1757271332836763,1.0,8/11,23.29%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,cellular response to interleukin-4 (GO:0071353),0.752126072789253,1.5851736173207593,0.011157601115760111,0.17558238888348474,1.0,4/10,6.37%,TCF7;LEF1;RUFY4;GATA3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6340922617250064,1.5842729304927237,0.014018691588785047,0.17642145006099935,1.0,10/25,16.74%,ITGAX;ITGA5;CD2;ITGA4;CD200R1;JUP;PARVA;ITGB2;NINJ1;PKP2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.713514831884158,1.580528703265624,0.008032128514056224,0.1834662370714293,1.0,3/12,5.48%,ABCG1;ABCA1;PPARG
prerank,platelet degranulation (GO:0002576),0.5210857952769985,1.5800959502242249,0.0,0.1833590264448655,1.0,42/118,21.82%,IGF1;CD9;FN1;TLN1;PLEK;FLNA;ANXA5;TMSB4X;TAGLN2;ALDOA;CHID1;PDGFA;CTSW;HRG;A2M;LHFPL2;PSAP;APLP2;ACTN1;TOR4A;VEGFA;LAMP2;GTPBP2;CYB5R1;SERPINE1;CD63;F5;ECM1;LY6G6F;GAS6;PROS1;CLU;APOH;FAM3C;SERPINF2;OLA1;F8;ACTN2;CDC37L1;TIMP1;ITGA2B;SRGN
prerank,epithelial cell differentiation (GO:0030855),0.5327116000518257,1.579984155801526,0.002072538860103627,0.1824682775410081,1.0,36/88,24.86%,LGALS3;CTSB;ANXA1;TAGLN2;ANXA4;TAGLN;IRF6;OVOL1;GSTA2;JAG1;PPARG;DAB2;GATA3;DHRS9;VEGFA;HDAC1;DMBT1;BASP1;PGK1;PCK2;ALDOC;FSTL1;EHF;PTER;KDR;SPINK5;TST;CBR1;ANXA7;TPP1;BMP4;LATS1;FGFR2;EDF1;CPT1A;HDAC2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6825267111445635,1.5787054200598358,0.007702182284980745,0.18444226477608913,1.0,5/15,10.54%,SLC27A1;FBXW7;CTDNEP1;SIK1;C3
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5368886779459312,-1.5786724981338212,0.027522935779816515,0.43316097917115437,1.0,3/14,3.59%,SLCO2B1;HMOX2;SLCO1B1
prerank,heme catabolic process (GO:0042167),-0.5368886779459312,-1.5786724981338212,0.027522935779816515,0.43316097917115437,1.0,3/14,3.59%,SLCO2B1;HMOX2;SLCO1B1
prerank,monosaccharide transmembrane transport (GO:0015749),0.6770433547252573,1.5783766725004504,0.02199223803363519,0.1840285020629934,1.0,8/16,21.79%,SLC23A1;SLC23A2;SLC5A1;SLC2A8;SLC45A3;SLC50A1;SLC5A3;SLC2A6
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6169497601263887,1.5777557089257481,0.012775842044134728,0.18431508481307549,1.0,14/27,24.92%,IGF1;FN1;CDK6;PDGFA;SPHK1;S100A6;GAS6;DDR2;BMI1;DHX9;CD74;MIF;PDGFRA;CDK4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5783142101446321,1.5772789895275794,0.007856341189674524,0.1842184178784785,1.0,23/41,29.19%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP50;JMJD8;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,regulation of hemopoiesis (GO:1903706),0.7401545100195512,1.5771291997399934,0.022377622377622378,0.18351652239473842,1.0,4/10,12.01%,LGALS3;RUNX1;PRKCB;MYSM1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.648596647154217,1.5767284765593776,0.008631319358816275,0.18346273363219975,1.0,10/21,24.20%,CILP;VEPH1;DAB2;RBPMS;SH2B1;BMP6;FAM89B;NUP93;BMP4;JAK2
prerank,peptide biosynthetic process (GO:0043043),0.5175586565340101,1.576597595867534,0.0,0.18265760973136752,1.0,65/153,21.89%,MRPS12;RPS12;AGO2;RPS27A;TNIP1;EIF4G1;RPS6;RPS14;MRPL51;RPL10A;RPL18;RPS24;IGHMBP2;RPS7;RPS20;RPL36A;RPL41;EEF1A1;RPS26;MRPL23;RPL17;RPL23;RPS25;RPL35A;RPS28;RPLP2;RPL28;RPL27A;RPL11;RPS2;MRPL52;RPL32;MRPS15;RPL21;MRPL24;RPL9;RPL36;RPL37;MRPS33;MRPS16;RPS18;RPL38;MRPS7;RPS19;RPS27;FURIN;RPS23;RPL14;SARS1;MRPL11;RPS16;RPL30;RPL12;GSPT1;FARSB;RPL13A;RPL31;RPS9;RPL4;RRBP1;RPS3;RPS13;RPSA;PABPC4;RPL15
prerank,cellular response to copper ion (GO:0071280),0.6804069225917525,1.5763969295835758,0.01950585175552666,0.1820200794554737,1.0,11/16,26.21%,DAXX;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;HSF1;MT2A
prerank,ribosome biogenesis (GO:0042254),0.509083696001632,1.575968818332343,0.0,0.18186735677816832,1.0,87/187,26.87%,DDX31;C1D;UBA52;ESF1;EIF6;RPS6;RPS14;RPL10A;RRP7A;RPL18;RPS24;EXOSC4;METTL17;RPS7;RPL36A;NOC2L;RPL41;RPL17;RPL23;RPS25;WDR12;RIOK2;RPL35A;RPS28;RRP12;RPLP2;EIF2A;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;BMS1;NOLC1;DDX49;WDR43;MRM2;NOL6;UTP11;UTP20;RPL32;NVL;EXOSC9;EXOSC10;RPL21;DHX29;XPO1;RPL9;RPL36;RPL37;RPL38;RPS19;RPS27;MDN1;DDX52;RPL14;RPS16;UTP4;RPL30;UTP14A;RPL12;RPL13A;RPL31;KRR1;RPS9;LYAR;NOC4L;RPL4;EXOSC5;RRP9;NPM1;DKC1;RPL15;WDR3;SNU13;RPL7A;RRP1B;RRP1;MALSU1;RPL23A;CUL4A;RPL8;RPLP1;RPL29;PIH1D1;RPL37A
prerank,cellular response to interleukin-6 (GO:0071354),-0.46425374485739385,-1.5759061550860045,0.018633540372670808,0.4287477510151088,1.0,7/26,6.06%,SELPLG;IL6R;ST3GAL6;FER;RELA;STAT3;ST18
prerank,vacuolar acidification (GO:0007035),0.639496421865669,1.5750802089051765,0.012239902080783354,0.18298965301287065,1.0,10/21,19.88%,TCIRG1;DMXL2;ATP6V0D2;ATP6V0A1;ATP6V0D1;TMEM199;CLN3;DMXL1;SLC11A1;ATP6V0A4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5427677954673625,1.5740182723599536,0.0010482180293501049,0.18414061748061644,1.0,42/74,32.63%,HIF1A;PSMD8;NFE2L2;PSMD1;UBA52;RPS27A;VEGFA;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;STOX1;PSMC6;PSMA6;PSMD5;ELOB;PSMA5;UBC;EGLN1;EPO;VHL;CUL2;EGLN3;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;SIRT2;PSMD12;EP300;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,relaxation of cardiac muscle (GO:0055119),0.7053803288952785,1.5735603559878883,0.010854816824966078,0.18396042206999538,1.0,5/13,15.29%,P2RX4;KCNJ2;ATP1A1;GSN;ATP1A2
prerank,regulation of calcium ion import (GO:0090279),0.647262908407932,1.572047986226972,0.011235955056179775,0.18624328486674302,1.0,5/21,10.34%,LGALS3;CTNNB1;SPHK2;PSEN2;FYN
prerank,extracellular matrix disassembly (GO:0022617),0.5628956314058944,1.5719752248591157,0.006472491909385114,0.18537242300862108,1.0,20/53,17.28%,SH3PXD2B;LCP1;MMP8;MMP12;CAPG;ADAM8;CD44;BMP1;A2M;MMP9;CAPN1;SCUBE3;GSN;KLKB1;MMP19;ADAM15;LAMC1;TIMP2;FURIN;CAPNS1
prerank,P-body assembly (GO:0033962),0.7116776948164615,1.5719233426085406,0.018518518518518517,0.1844240012821041,1.0,10/12,27.13%,DYNC1H1;PATL1;LSM14A;PATL2;EIF4ENIF1;ATXN2;LSM4;EDC3;LSM3;RC3H1
prerank,negative regulation of translation (GO:0017148),0.5350779965010197,1.5714771693514398,0.0020639834881320948,0.18454794428180676,1.0,38/87,22.36%,EPRS1;AGO2;UNK;GZMB;NCL;CPEB4;CPEB2;CELF1;LSM14A;PUS7;PATL2;RACK1;CPEB3;METTL3;SHMT1;CNOT10;YTHDF3;LARP1;ENC1;ILF3;ROCK1;SYNCRIP;DAPK1;TPR;EIF4A3;EIF4ENIF1;YTHDF2;DHX36;EIF4E2;PUM1;FXR2;DAPK3;RPL13A;EIF3E;RPS3;GIGYF2;SAMD4A;CALR
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6811172617217548,1.5707372290120483,0.01376720901126408,0.18509733721022015,1.0,8/16,17.12%,SIRPA;NLRC3;CHID1;ADCY7;TREM2;ABCD2;APPL2;PDCD4
prerank,regulation of translational initiation (GO:0006446),0.5497236405827847,1.5704385634978497,0.002136752136752137,0.18477444489842956,1.0,30/63,24.66%,ATF3;EIF1;AGO2;EIF4G1;HSPB1;NCK2;NCK1;EIF4G2;MIF4GD;DDX1;ALKBH1;CCL5;YTHDF3;LARP1;EIF4G3;POLR2D;EIF5B;TPR;PPP1R15B;YTHDF2;KLHL25;EIF2B2;EIF3E;EIF4A2;NPM1;CDC123;EIF3B;EIF4B;ATF4;EIF3H
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.44098286322392405,-1.5700758917687627,0.0072992700729927005,0.433075038953223,1.0,10/31,14.07%,SCAMP5;SYT10;KCNB1;SYT1;SYT2;STXBP3;REST;STXBP1;STX1A;SYT9
prerank,lymphocyte differentiation (GO:0030098),0.5397446141848616,1.5684210979055506,0.002098635886673662,0.1881512221633538,1.0,24/68,21.25%,LCK;PTPRC;CD4;HDAC9;AXL;NFIL3;ITGA4;HDAC4;KLF6;PTPN22;BLNK;GATA3;TPD52;ADAM17;PTPN2;DLL4;DNAJB9;CEBPG;TOX;KAT7;IL2;GPR89A;GPR89B;PBX1
prerank,retinol metabolic process (GO:0042572),0.6865745562481277,1.567098947912636,0.020512820512820513,0.18973779726911888,1.0,6/14,21.90%,RDH12;DHRS3;DHRS9;RBP4;CYP1B1;RDH10
prerank,acylglycerol homeostasis (GO:0055090),0.6536514440660706,1.5669361542240627,0.008663366336633664,0.18903360934380448,1.0,4/20,4.96%,LPL;APOE;GCKR;APOC4
prerank,tRNA aminoacylation (GO:0043039),0.5906742558013058,1.5664242528415142,0.00805523590333717,0.1891281387937274,1.0,23/37,30.57%,EPRS1;AARS1;VARS1;CARS1;LARS2;GARS1;RARS1;FARSA;SARS2;SARS1;GATB;FARSB;FARS2;NARS1;YARS1;LARS1;AIMP2;TARS1;AIMP1;RARS2;MARS2;PPA1;QARS1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.580556158896782,1.5652204665072653,0.009237875288683603,0.19074473651454676,1.0,11/37,15.31%,APOE;SDCBP;OPTN;TRAT1;LRPAP1;ANKRD13B;SIRT5;BRCA1;TRAP1;NFKB1;ANKRD13A
prerank,cholesterol transport (GO:0030301),0.5742948030931393,1.5650472165962153,0.007743362831858407,0.19010759426876023,1.0,16/45,20.65%,APOE;ABCG1;ABCA1;CEL;APOA2;SOAT1;CAV1;APOC1;SOAT2;OSBPL2;ABCA7;NPC1;CLU;NPC2;STARD4;SERAC1
prerank,ncRNA processing (GO:0034470),0.5011517018910773,1.5616182075009681,0.0,0.19677320826565653,1.0,74/200,19.62%,C1D;AARS1;UBA52;AGO2;ESF1;THG1L;RPS6;RPS14;RPL10A;RRP7A;RPL18;RPS24;EXOSC4;RPS7;RPL36A;RPL41;RPL17;RPL23;RPS25;WDR12;RPL35A;RPS28;RRP12;RPLP2;RPL28;NOL8;XRN2;RPL27A;RPL11;RPS2;BMS1;NOLC1;DDX49;WDR43;MRM2;NOL6;METTL3;UTP11;UTP20;RPL32;NVL;EXOSC9;EXOSC10;RPL21;RPL9;SMAD1;RPL36;RPL37;HNRNPA2B1;RPL38;RPS19;RPS27;MDN1;DDX52;INTS6;INTS2;RPL14;SARS1;RPS16;UTP4;RPL30;UTP14A;RPL12;RPL13A;RPL31;KRR1;FARS2;RPS9;LYAR;NOC4L;AGO3;ADAR;RPL4;EXOSC5
prerank,macrophage chemotaxis (GO:0048246),0.7472874461533556,1.5607314413022062,0.015942028985507246,0.1977901827226775,1.0,3/10,11.60%,LGALS3;TAFA4;CCL5
prerank,negative regulation of endocytosis (GO:0045806),0.6203396245143181,1.5596283121249404,0.0196078431372549,0.1993204199362353,1.0,8/24,13.25%,LGALS3;MCTP1;CAV1;SNX33;LILRB1;CD300A;APOC1;ABCA7
prerank,positive regulation of bone resorption (GO:0045780),0.7221605209488156,1.5593630930366238,0.016483516483516484,0.19890103283759386,1.0,5/11,16.06%,SPP1;ADAM8;PLEKHM1;ATP6AP1;SYK
prerank,cellular sodium ion homeostasis (GO:0006883),0.6690434114629746,1.5575539209248284,0.026041666666666668,0.20193256660323156,1.0,5/15,7.23%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.618632034649125,1.5574446552881818,0.011918951132300357,0.20109008036781123,1.0,12/25,17.53%,PKM;ALDOA;GCK;HK1;PFKL;PGK1;ENO1;ALDOC;PFKP;ENO2;HK3;GPI
prerank,inorganic anion transport (GO:0015698),0.5506038040825105,1.557416849696395,0.005417118093174431,0.20010139806509128,1.0,19/53,22.91%,PACC1;SLC26A1;ANO9;ANO8;CLIC4;SLC13A4;SLC26A11;CLCN1;SLC25A14;SLC26A4;RACGAP1;ANO5;ANO6;CLCN4;XPR1;SLC11A1;SLC26A6;FXYD1;CLIC5
prerank,carbohydrate catabolic process (GO:0016052),0.5745234866166091,1.5569728347579594,0.002285714285714286,0.20022907625252429,1.0,14/38,17.53%,PKM;ALDOA;GCK;DERA;HK1;PFKL;PGK1;LDHA;ENO1;ALDOC;NEU1;ENO2;HK3;GPI
prerank,regulation of hippo signaling (GO:0035330),-0.5232463606362106,-1.5563239426869049,0.03571428571428571,0.4569117908724716,1.0,10/17,23.77%,MAPK14;SCHIP1;WWC1;MOB3B;VGLL4;AJUBA;DLG5;NEK8;CIT;WWC2
prerank,alanine transport (GO:0032328),0.7407455389352012,1.554434280700449,0.016877637130801686,0.2051429284553788,1.0,4/10,5.04%,SLC6A6;SLC6A14;SLC36A4;SLC36A3
prerank,response to amyloid-beta (GO:1904645),0.5612349137834596,1.554380392354059,0.011148272017837236,0.20421706027335262,1.0,12/44,10.34%,CACNA1A;IGF1;LRP1;MMP12;FPR2;MMP9;CDK5;ITGA4;ATP1A3;TREM2;IGF1R;FYN
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6436449333470419,1.5523710254431058,0.018564356435643563,0.2074526736943919,1.0,10/19,19.27%,MTHFD2;SLC46A1;MTHFS;SHMT1;MTHFD1;FPGS;GGH;MTRR;SLC19A1;ALDH1L2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7142265590181424,1.5515497321167842,0.02677376171352075,0.20830597473048656,1.0,5/11,15.98%,CYBA;MFHAS1;TREM2;ACOD1;TIRAP
prerank,acylglycerol catabolic process (GO:0046464),0.5960641433357625,1.5514683890702734,0.01853997682502897,0.2074040631905895,1.0,5/30,5.88%,LPL;FABP5;APOA2;ABHD12;MGLL
prerank,relaxation of muscle (GO:0090075),0.6936140620073882,1.5513970320939847,0.016238159675236806,0.20653188772777603,1.0,5/13,15.29%,P2RX4;KCNJ2;ATP1A1;GSN;ATP1A2
prerank,regulation of lymphocyte activation (GO:0051249),0.7061011139155545,1.5494911124473636,0.02080624187256177,0.21009614508083083,1.0,6/12,11.60%,LCK;IKZF3;CD4;LAT;CRTAM;CCL5
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6998054428932686,1.5487554836977182,0.020242914979757085,0.21087321863721525,1.0,5/12,11.01%,PTPRC;RUNX1;PTPN22;CD300A;ELF2
prerank,positive regulation of lipid storage (GO:0010884),0.6389432620462113,1.5485022729994018,0.013647642679900745,0.21047427449398814,1.0,6/21,14.32%,PLIN2;LPL;APOC4;IKBKE;C3;NFKB1
prerank,detection of mechanical stimulus (GO:0050982),0.6414537481225348,1.546898714673609,0.026184538653366583,0.213207927066453,1.0,5/19,10.04%,CTNNB1;PIEZO1;CSRP3;PIEZO2;JUP
prerank,endoderm formation (GO:0001706),0.5736534025217092,1.546740458220242,0.013729977116704805,0.21251976271287354,1.0,8/35,9.79%,FN1;MMP8;ITGA5;EOMES;MMP9;ITGA4;COL12A1;SOX7
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5558037655441198,1.5463634344276722,0.007760532150776054,0.21234883509148883,1.0,12/48,11.68%,FNIP2;BCL2;BCL2L1;MCL1;DYRK2;IKBKE;BCL2L11;AEN;BAX;BRCA1;HIPK1;TNFRSF1B
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5927138000642729,1.545645172471888,0.015240328253223915,0.21295153557900673,1.0,7/29,9.50%,CD300LF;UBA52;TANK;RPS27A;TRAF3;IKBKE;TICAM1
prerank,positive regulation of phagocytosis (GO:0050766),0.5589358448679093,1.5455465371103383,0.0077348066298342545,0.2121556885237359,1.0,26/47,27.21%,CYBA;STAP1;IL2RB;FPR2;CD300LF;SIRPA;DOCK2;PTPRC;APOA2;TREM2;C3;GAS6;ABCA7;APPL2;ANO6;LMAN2;LYAR;FCER1G;SLC11A1;CD47;CALR;TNF;PLA2G5;NCKAP1L;RAB31;C2
prerank,response to lipid (GO:0033993),0.5122369615594349,1.5453701587215545,0.0,0.21159934753734455,1.0,26/105,15.98%,S100A8;CTNNB1;SPP1;S100A9;ABCG1;ANXA1;TRIM6;CD6;CYP19A1;CYP27B1;PPARG;PTPN22;SOX9;ERBIN;NOCT;TRIM16;MAPKAPK3;PPARD;ADAM17;MAPKAPK2;PCK2;VPS4B;RBP4;ASXL1;FOXO1;TIRAP
prerank,lipid catabolic process (GO:0016042),0.653800158969731,1.5451949715440234,0.022756005056890013,0.2109943618464829,1.0,3/18,2.40%,LPL;PLAAT3;CEL
prerank,regulation of vasculature development (GO:1901342),0.6050203195361588,1.5448259556866384,0.021505376344086023,0.21083970704337102,1.0,11/26,20.00%,GPNMB;CTNNB1;FGF2;PLXND1;HMOX1;RNH1;SP100;HTATIP2;NF1;IL6;EGLN1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5032680573700663,1.5448189565782615,0.0,0.20984543205788536,1.0,73/168,22.14%,RPS12;UBA52;RPS27A;EIF4G1;RPS6;CNOT4;RPS14;RPL10A;RPL18;RPS24;PPP2R1A;EXOSC4;RPS7;RPS20;RPL36A;RPL41;RPS26;RPL17;RPL23;RPS25;ETF1;PATL1;RPL35A;RPS28;RPLP2;RPL28;XRN2;PATL2;RPL27A;RPL11;RPS2;PABPC1;DHX34;CNOT10;RPL32;SMG9;DXO;EXOSC9;EXOSC10;RPL21;RPL9;RPL36;RPL37;DCP1A;POLR2D;RPS18;RPL38;RPS19;RPS27;EIF4A3;HELZ2;RPS23;RPL14;RPS16;RPL30;RPL12;GSPT1;ATM;RPL13A;RPL31;RPS9;EIF3E;UPF3A;RPL4;EXOSC5;RPS3;CNOT6;RPS13;RPSA;RPL15;UPF3B;SAMD4A;PAN2
prerank,water transport (GO:0006833),0.7116952276594398,1.5440794293509401,0.014705882352941176,0.2105444727400384,1.0,3/12,17.05%,PDPN;SLC5A1;AQP4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6231330218982853,1.5438427250749422,0.016867469879518072,0.21008109223195387,1.0,11/22,24.21%,APOE;ADAM8;SNX33;TNFRSF1B;TIMP4;ROCK1;TIMP2;FURIN;SH3D19;TIMP1;TNF
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6506115885422266,1.5433544611133303,0.02574002574002574,0.21035064941382872,1.0,7/17,12.77%,FOXN1;MAFF;CD24;CAV1;GATA3;SOX9;MAFG
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6976832033954659,1.5432570647272714,0.014864864864864866,0.20965395854152816,1.0,3/13,4.25%,IGF1;GCK;DYRK2
prerank,regulation of neuron differentiation (GO:0045664),-0.3536434746956293,-1.5429713930620421,0.0,0.4809411360919467,1.0,20/76,14.02%,ZFHX3;MEF2C;BIN1;NLGN1;ZEB1;MMD;CNTN4;BEND6;LRRK2;NREP;BRINP1;TIAM1;PCP4;ECT2;REST;DISP3;YWHAH;DTX1;SIN3A;VWC2
prerank,positive regulation of cell development (GO:0010720),-0.43738644565046414,-1.5414836621668984,0.037037037037037035,0.4742740013699174,1.0,5/31,5.38%,CX3CR1;NUMB;TGM2;BAD;RGS14
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5154608400265147,1.5409056050569137,0.0010204081632653062,0.21441055833970796,1.0,37/113,21.27%,LGALS3;FNIP2;LCP1;SKAP1;ABCA1;PLEK;ASAP1;CAPG;EIF4G1;NRG1;PIEZO1;ERCC1;BID;VEGFA;BCL2L11;DDB2;RACK1;VCP;DDB1;BAX;PSMC3;XPA;CLU;ERCC4;PSMC6;TFRC;TIRAP;SYK;DHX33;GTF2H1;ATM;FERMT2;IL5;TERF1;RPS3;BIK;GSK3B
prerank,cellular response to peptide (GO:1901653),0.5391445267408717,1.5408082415545634,0.008676789587852495,0.21360698724474486,1.0,13/56,8.10%,CACNA1A;IGF1;LRP1;FPR2;VIM;CDK5;ITGA4;CAV1;PTPN22;RPL23;ATP1A3;TREM2;IGF1R
prerank,platelet aggregation (GO:0070527),0.5826727534063779,1.5404031721201827,0.008092485549132947,0.21354009379619732,1.0,12/33,14.03%,FN1;TLN1;PLEK;FLNA;PIK3CB;MYL9;HSPB1;ACTN1;ACTG1;ILK;ACTB;PPIA
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5567702211944693,-1.5386077697829954,0.05714285714285714,0.47082230762141963,1.0,6/13,20.04%,CACNB2;KCNJ3;KCNN2;CACNA1C;KCNQ1;ANK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7077118350526455,1.5384413706835538,0.01780821917808219,0.21747343312709025,1.0,3/12,4.25%,IGF1;GCK;DYRK2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6746234815588508,1.5383628957433078,0.020860495436766623,0.2166762081444052,1.0,6/15,16.71%,APOE;ADAM8;SNX33;TNFRSF1B;FURIN;SH3D19
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5810471175284448,1.5377620455253262,0.011135857461024499,0.21715317408189866,1.0,16/33,28.89%,NFE2L2;PDPK1;GATA3;ANGPT1;CAST;SERPINE1;TNIP2;GAS6;KDR;KRIT1;WFS1;MAPK7;MDK;PAK4;TNFAIP3;NDNF
prerank,positive regulation of macrophage activation (GO:0043032),0.6369732946246478,1.5376074989310131,0.027742749054224466,0.2165401660709188,1.0,6/17,14.76%,STAP1;MMP8;TREM2;CEBPA;TNIP2;HSPD1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5422406041977894,-1.5338682527034082,0.0599250936329588,0.47176506771931437,1.0,5/13,7.03%,TMEM30A;SORL1;CD81;INSIG1;SAR1B
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5160636967214892,1.5324638976965383,0.0020768431983385254,0.2282672233688028,1.0,33/88,24.68%,LGALS3;FNIP2;PLEK;SDCBP;ATP13A2;NRG1;CLDN19;ERCC1;BID;VEGFA;BCL2L11;PDCD6IP;RACK1;VCP;BAX;RAB7A;VPS4B;LIMK1;CLU;TPR;SLX4;TFRC;TIRAP;SYK;RPS3;EMILIN1;BIK;GSK3B;PFN1;TRABD2B;SUMO1;TNF;SDC4
prerank,regulation of anoikis (GO:2000209),0.636657790437018,1.532051416528535,0.034394904458598725,0.2282783187363256,1.0,7/19,16.85%,BCL2;ITGA5;MCL1;CAV1;SIK1;TLE5;MYBBP1A
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.536994458817089,1.5318310328137605,0.005285412262156448,0.22778338296185344,1.0,31/67,29.24%,CYBA;PSMD8;PSMD1;CYBB;SEC22B;TAPBP;PSMD6;PSMA1;NCF4;B2M;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CALR;PSMA3;NCF2;PSMB10;PSMB8;PSMD7;PSMB6;NCF1;PSMD10;PSMB5;PSMB7;VAMP3;PSMC4
prerank,response to peptide (GO:1901652),0.5697121165600583,1.530849216320586,0.011286681715575621,0.22926674137149222,1.0,8/33,11.52%,CACNA1A;MMP12;ANXA1;STAT4;MMP9;ERBIN;FYN;IRF5
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7293256677891993,1.5307542444823021,0.03314917127071823,0.22847816730473602,1.0,6/10,21.33%,FN1;CD24;LILRB1;FURIN;LAPTM4B;HSP90AB1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6406434884675081,1.530054539039743,0.0319693094629156,0.22939667520011672,1.0,6/18,10.75%,APOE;ABCG1;KLK6;PSEN2;ADAM17;CLN3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.727075594540176,1.5300463721435804,0.020604395604395604,0.22843085127560409,1.0,5/10,26.06%,SAG;PDE6B;CNGB1;GNB1;PDE6G
prerank,epidermal cell differentiation (GO:0009913),0.5582597429334109,1.5299894517044885,0.015659955257270694,0.22752250520415535,1.0,9/41,9.63%,CTNNB1;ANXA1;ST14;OVOL1;JAG1;CLIC4;HDAC1;UGCG;EVPL
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5510556269703574,1.529515773758489,0.009814612868047983,0.22777620915019703,1.0,26/48,24.50%,ERCC6;ZMIZ1;SPHK2;CDCA4;TAF1D;DDX21;ZMIZ2;POLR1G;POLR2H;H1-0;ACTB;ELOF1;DEK;POLR1A;MYBBP1A;TBP;BAZ1B;WBP2;ARID1B;TAF1A;SERTAD1;ATAD2B;TAF1C;POLR1F;POLR2F;SF3B1
prerank,regulation of oxidoreductase activity (GO:0051341),0.693022151123859,1.5282207241226997,0.022106631989596878,0.23007851627073647,1.0,4/13,7.55%,ABL2;ATP7A;GZMA;HP
prerank,regulation of T cell differentiation (GO:0045580),0.5715155037643859,1.5280252562719758,0.013856812933025405,0.22956648311862304,1.0,14/33,19.53%,ZMIZ1;TCF7;TBX21;CD2;RUNX1;GATA3;METTL3;CRTAM;CCR2;CLPTM1;SPINK5;CAMK4;FANCA;IL2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.598117017847164,1.5272996652849193,0.015384615384615385,0.23053115967319085,1.0,12/26,21.58%,CYBA;LTF;WDFY1;MFHAS1;CAV1;PTPN22;TREML4;RSAD2;TIRAP;NINJ1;HMGB1;LBP
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3760551691005767,-1.5270692775310943,0.0,0.47953845862924593,1.0,20/57,13.93%,MEF2C;GRIA4;NLGN1;NEFL;DLGAP1;DLG2;GRIN2A;GRIA3;CACNG3;NETO1;LRRC7;GRIN2B;APP;SHISA6;CACNG8;BEGAIN;GRIN1;CAMK2B;CNIH3;CAMK2A
prerank,pre-replicative complex assembly (GO:0036388),0.5350314319425373,1.526374132483434,0.00211864406779661,0.2319806285014939,1.0,29/64,27.96%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;GMNN;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;UBC;MCM6;MCM8;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7
prerank,triglyceride metabolic process (GO:0006641),0.541389788461149,1.5259798723260978,0.013259668508287293,0.23207093668374965,1.0,11/48,10.97%,LPL;APOE;FABP5;PLAAT3;GK;APOA2;SLC27A5;CAV1;APOBR;LPGAT1;APOC1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5933887253696051,1.5253599562326254,0.020432692307692308,0.23269260049844442,1.0,12/25,20.87%,LYST;CHMP4A;CHMP4B;VCP;VTA1;VPS4B;CHMP7;MVB12A;TMEM50B;LAPTM4B;CHMP6;UBXN6
prerank,positive regulation of histone methylation (GO:0031062),0.603356803365632,1.5249978655897172,0.027644230769230768,0.23273606315825976,1.0,12/24,18.59%,CTNNB1;KMT2A;FAM47E;DNMT1;MTF2;BRCA1;WDR5;OGT;PHF1;CHTOP;PAF1;DNMT3B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5735175314335731,1.5236843474618242,0.0176678445229682,0.2350356122832614,1.0,9/30,9.55%,PTPRC;PRKCD;CAV1;PPP2R1A;SAMSN1;MVP;CD300A;PTPN2;CADM4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5905845374099377,1.5233747320637556,0.020761245674740483,0.23479977921093018,1.0,11/29,19.31%,TENT5C;PKP1;NOCT;PABPC1;DHX34;TAF15;LARP1;EIF4ENIF1;VIP;HNRNPU;SLC11A1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5839420821398711,1.5232318202589081,0.01643192488262911,0.23418729798059093,1.0,8/32,13.48%,IGF1;HIF1A;TMSB4X;PFKFB3;TREM2;VCP;ENO1;ENTPD5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6928963075137579,1.5230834722039783,0.03541076487252125,0.2335756631503138,1.0,4/11,7.32%,P2RX4;CCL4;TRAT1;TREM2
prerank,membrane raft organization (GO:0031579),0.6631116665768548,1.5224980390897525,0.019329896907216496,0.2340195956796973,1.0,6/15,16.37%,RFTN1;FLOT2;CLN3;ABCA7;NPC1;MYADM
prerank,response to exogenous dsRNA (GO:0043330),0.6396603550699176,1.5218029204931567,0.02192448233861145,0.2348464183290186,1.0,5/18,9.50%,COLEC12;RFTN1;SLC3A2;CAV1;TICAM1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5933535179360124,1.521041139552809,0.023391812865497075,0.2357375975991518,1.0,3/27,0.19%,XYLT1;CHST11;CSPG4
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5300699221648082,1.519990590643193,0.009857612267250822,0.2372674280878238,1.0,27/52,32.05%,CXXC1;TLN1;GOSR2;ATP6V0D1;EDEM1;MYDGF;ERN2;ERN1;TATDN2;LMNA;EXTL2;DCTN1;DNAJB9;VAPB;WFS1;ARFGAP1;TPP1;HSPA5;PARP16;SSR1;GSK3A;ZBTB17;HDGF;CTDSP2;XBP1;FKBP14;SYVN1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5226415510407386,1.5196941980859897,0.00720164609053498,0.23703753394148094,1.0,35/84,22.36%,IGF1;APOE;EPRS1;GZMB;SPHK1;NCL;ORMDL1;LSM14A;PUS7;PATL2;RACK1;CPEB3;SHMT1;CNOT10;LARP1;ENC1;ABCA7;ILF3;ROCK1;CLU;SYNCRIP;DAPK1;EIF4A3;EIF4ENIF1;DHX36;EIF4E2;FXR2;DAPK3;PIN1;RPL13A;ORMDL3;RPS3;GIGYF2;SAMD4A;CALR
prerank,regulation of lipid storage (GO:0010883),0.6044384466872803,1.519068502365919,0.02804878048780488,0.23769407509097107,1.0,8/22,18.32%,LPL;FBXW7;IKBKE;ALKBH7;PTPN2;C3;NFKB1;IL6
prerank,cellular response to interleukin-12 (GO:0071349),0.5380694758880514,1.5187464669092914,0.021040974529346623,0.23749724941904385,1.0,21/48,24.20%,LCP1;SIRPA;MSN;STAT4;GSTA2;IL12RB1;P4HB;JAK1;CDC42;PAK2;PPIA;HNRNPA2B1;HSPA9;PDCD4;HNRNPF;SOD2;CFL1;CD47;MIF;TALDO1;JAK2
prerank,regulation of DNA binding (GO:0051101),0.5441122178598726,1.5185360354191804,0.011198208286674132,0.23710108892424492,1.0,13/44,13.08%,IGF1;MMP8;PLAUR;LEF1;GZMA;DOT1L;MMP9;PPARG;MDFI;JUN;ILRUN;SP100;TFAP4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5925838682170954,1.518383775295005,0.024096385542168676,0.23659374794828683,1.0,13/24,26.28%,HIF1A;ATF3;NFE2L2;MUC1;VEGFA;DDIT3;CHD6;MBTPS2;HSF1;MAPK7;ATF4;HSPA5;SESN2
prerank,T cell activation involved in immune response (GO:0002286),0.6934017911008483,1.5178014199047172,0.033783783783783786,0.23706261778058493,1.0,7/12,25.28%,LCP1;ITGAL;LILRB1;FCER1G;SLC11A1;CD74;MDK
prerank,phospholipid homeostasis (GO:0055091),0.7111469998606603,1.5171479252740963,0.03363518758085381,0.23778301143516076,1.0,5/11,14.51%,ABCG1;ABCA1;TLCD1;TLCD2;RCN3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7174283145600888,1.5169834116613887,0.023709902370990237,0.23721442310618251,1.0,4/10,14.45%,HIF1A;ITGA5;PRKCB;PRKD2
prerank,morphogenesis of an epithelium (GO:0002009),0.5971229496758873,1.5157688792860826,0.035,0.2391866835389742,1.0,13/25,25.93%,DAG1;TBX18;SOX9;ACTG1;ACTB;ARHGAP12;LRP6;LAMA5;RIPK4;LAMA3;FGFR2;SOX10;TRAF3IP1
prerank,cellular zinc ion homeostasis (GO:0006882),0.5903951485497255,1.5155380926446638,0.023557126030624265,0.23878521154910656,1.0,13/26,20.07%,LCK;ATP13A2;SLC39A6;SLC39A7;SLC30A9;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5202106239964854,1.5154929187649564,0.0031914893617021275,0.237944185492473,1.0,31/73,24.22%,S100A8;S100A9;LCK;XDH;TRAF2;TNFSF15;MTCH1;PPARG;BID;DLC1;DIABLO;RACK1;VCP;BAX;DAP;HIP1;HSPD1;APAF1;CASP4;HIP1R;CASP9;CRADD;LAPTM5;TNFSF10;SENP1;EGLN3;F2R;HSPE1;JAK2;TNF;ANP32B
prerank,regulation of phagocytosis (GO:0050764),0.5356930723300712,1.5148521502559071,0.004314994606256742,0.2386908330167681,1.0,19/53,19.31%,CYBA;IL2RB;FPR2;SIRPA;DOCK2;PTPRC;FGR;FER1L5;APOA2;SPHK1;TREM2;RACK1;GAS6;ABCA7;SYK;LMAN2;LYAR;FCER1G;SLC11A1
prerank,intestinal lipid absorption (GO:0098856),0.7001611025859128,1.5142775800383526,0.02912621359223301,0.23921799907782307,1.0,3/11,11.27%,CEL;UGCG;SOAT2
prerank,triglyceride catabolic process (GO:0019433),0.6200017198647674,1.5132155488323933,0.04094292803970223,0.2407344803488867,1.0,2/19,1.30%,LPL;FABP5
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7252621814801886,1.513035940789607,0.035161744022503515,0.24032692221689617,1.0,4/10,8.87%,FPR2;FGR;CD24;LILRB1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5976555469459687,1.5130235982461648,0.015439429928741092,0.23945698282370495,1.0,4/26,2.63%,BCL2;BCL2L1;EYA4;MCL1
prerank,AMP metabolic process (GO:0046033),0.6797130714418242,1.5130168818272745,0.0199203187250996,0.23856250922601316,1.0,7/13,24.91%,XDH;AMPD2;AK4;AK3;ADSS1;NUDT2;ADSL
prerank,superoxide anion generation (GO:0042554),0.6774116139109594,1.5121882653581278,0.030463576158940398,0.239848787616089,1.0,4/13,9.57%,CYBA;CYBB;TAFA4;NCF4
prerank,DNA geometric change (GO:0032392),0.5925430289572454,1.5119870583714867,0.03132530120481928,0.23940048397147254,1.0,12/24,20.59%,ANXA1;ASCC3;ZRANB3;RAD50;DDX1;BLM;HNRNPA2B1;DHX36;DHX9;RTEL1;HMGB1;RECQL5
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5911138241196975,1.5115092383649833,0.025423728813559324,0.2396875871795757,1.0,7/25,7.43%,PLEK;P2RX4;CCL4;CD22;TRAT1;TREM2;HTT
prerank,positive regulation of organelle assembly (GO:1902117),0.5549349927671007,1.5113234621075713,0.01564245810055866,0.2392893195059143,1.0,22/44,26.11%,LCP1;SDCBP;ASAP1;CAPG;KCTD17;DYNC1H1;HTT;PDCD6IP;NUMA1;PLK4;RALB;RAB3GAP2;IL5;CNOT6;MARK4;CEP120;G3BP1;CCDC88A;TNF;SDC4;RAB3GAP1;CNOT6L
prerank,gliogenesis (GO:0042063),0.6480933875657134,1.5113031120137062,0.03608247422680412,0.2384619349415568,1.0,3/15,1.53%,CD9;CDK6;ANXA1
prerank,positive regulation of telomere maintenance (GO:0032206),0.5817773191281922,1.5102513776886133,0.02097902097902098,0.2400941247001632,1.0,13/31,18.35%,PRKCQ;TNKS2;ERCC1;RAD50;PKIB;HNRNPA2B1;SLX4;DHX36;PPP1R10;ATRX;GNL3;ATM;RTEL1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.33387205654770014,-1.5096230674609548,0.0,0.5157322496175485,1.0,33/107,9.54%,CX3CR1;OPHN1;MEF2C;GRM7;SNCAIP;NLGN1;LRRC4C;GRIK2;DLGAP1;GRIK3;CPLX1;NRG3;RIMS1;CLSTN2;CNTNAP4;SLC8A3;LRRK2;GRIK4;GRID2;GRM1;CLSTN3;GRM5;GRID1;SYT1;SLC12A2;GRM3;CDH2;PXK;RIMS2;APP;LRP8;SLC8A2;IQSEC2
prerank,positive regulation of T cell activation (GO:0050870),0.5234991202272778,1.5093934605409807,0.00966702470461869,0.2415319969059427,1.0,17/62,11.60%,LCK;CD3E;ZMIZ1;SIRPA;PTPRC;ANXA1;PRKCQ;SLC7A1;CD6;CD28;NCK2;CD274;GATA3;NCK1;FLOT2;CCR2;CCL5
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7063254748411251,1.5091151874788067,0.03424657534246575,0.24133321294854043,1.0,5/11,16.06%,PLAUR;PRKCQ;JAK1;CCL5;SYK
prerank,cell projection assembly (GO:0030031),0.608046944502627,1.5077042382449994,0.02,0.2438899049369522,1.0,9/22,13.01%,CAPG;PDGFA;SCIN;RHOQ;RHOG;PARVA;GSN;RHOU;CDC42
prerank,lymphocyte proliferation (GO:0046651),0.6134930061886282,1.5065187300293568,0.03140096618357488,0.24603366939310486,1.0,5/22,7.85%,BCL2;ELF4;PTPRC;MSN;RASGRP1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5892983624759107,1.5059460658610668,0.023399014778325122,0.24662090891249053,1.0,5/26,10.54%,IGF1;OSBPL8;NR4A3;RHOQ;C3
prerank,B cell activation (GO:0042113),0.5191452229309825,1.5058465705044597,0.006263048016701462,0.2459481310799165,1.0,20/68,16.34%,BCL2;LAX1;PTPRC;MALT1;HDAC9;CHRNB2;ITGA4;HDAC4;CD22;KLF6;BLNK;TPD52;RASGRP1;PRKCB;ADAM17;PTPN2;DNAJB9;HSPD1;CEBPG;LAT2
prerank,regulation of viral genome replication (GO:0045069),0.5306139555058003,1.505437658458774,0.008602150537634409,0.24612673145128036,1.0,24/56,19.33%,LTF;ADARB1;SHFL;SRPK1;TNIP1;TRIM6;CD28;IFITM2;IFITM1;RNASEL;PABPC1;DDB1;CCL5;LARP1;ILF3;PKN2;RSAD2;PPIA;VAPB;ZC3HAV1;PPIE;ISG20;BST2;ADAR
prerank,muscle contraction (GO:0006936),0.49714086544188263,1.502978319554192,0.0010152284263959391,0.25172706930902705,1.0,26/126,15.12%,MYOF;MYOM3;TLN1;ASPH;TNNT3;CHRNB2;SNTB1;ALDOA;VIM;EDNRA;TPM2;SGCA;SCN4A;MYL9;SLC6A8;TPCN2;PABPN1;LTB4R;TPM4;UTRN;DTNA;ROCK1;CLCN1;SORBS1;ACTA2;ARHGEF11
prerank,sodium ion homeostasis (GO:0055078),0.6076761320615064,1.5028535491283674,0.033707865168539325,0.2511094893606539,1.0,5/21,7.23%,SLC9A1;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,fatty acid transmembrane transport (GO:1902001),0.6339068613790987,1.502723694145546,0.023017902813299233,0.25048900725330725,1.0,10/19,18.57%,SLC27A1;ACACA;SLC27A5;SLC2A1;ABCD4;ABCD2;MID1IP1;ABCD3;CPT2;ACACB
prerank,response to axon injury (GO:0048678),-0.48821485052185115,-1.5026338800405015,0.0297029702970297,0.5241869482214004,1.0,8/18,11.81%,P2RY12;GAP43;RTN4RL1;NREP;FLRT3;MORN4;APOD;SOD1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5627042687943882,1.5008423111754383,0.026166097838452786,0.2545350826456962,1.0,4/32,4.27%,OSBPL8;SLC27A1;PLAAT3;ABHD12
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6320658183193636,1.499910619920973,0.03234152652005175,0.25601074645725636,1.0,7/16,15.56%,KLRC2;CD226;CADM1;RASGRP1;KLRK1;CRTAM;AP1G1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.543175018720007,1.498637361516341,0.01520086862106406,0.2583697190361371,1.0,25/50,29.24%,PSMD8;PSMD1;AZIN1;PSMD6;PSMA1;PSMC3;OAZ3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;PSMC4
prerank,regulation of phospholipase C activity (GO:1900274),0.6626420148174347,1.498572053923316,0.033766233766233764,0.25762729819626856,1.0,4/15,7.85%,FLT1;ABL2;FGF2;RASGRP1
prerank,aminoglycan metabolic process (GO:0006022),0.7157610314554779,1.4982580412895947,0.03879310344827586,0.25759362629841304,1.0,3/10,10.43%,XYLT1;B4GALT7;B3GALT6
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5234327092175058,1.4979978182079183,0.007383966244725738,0.25734808651710633,1.0,32/70,29.24%,CYBA;PSMD8;PSMD1;CYBB;SEC22B;TAPBP;PSMD6;PSMA1;NCF4;B2M;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;FCER1G;CALR;PSMA3;NCF2;PSMB10;PSMB8;PSMD7;PSMB6;NCF1;PSMD10;PSMB5;PSMB7;VAMP3;PSMC4
prerank,regulation of monocyte differentiation (GO:0045655),0.6457833965445728,1.4978559608317983,0.035667107001321,0.25679260222908884,1.0,7/14,22.90%,CDK6;CSF1;CD4;HOXA7;ACIN1;IL34;CD74
prerank,mRNA stabilization (GO:0048255),0.5577139182510985,1.4972694157145996,0.014412416851441241,0.2572691222128732,1.0,16/40,19.64%,TENT5C;NOCT;HNRNPC;MAPKAPK2;PABPC1;TAF15;LARP1;YBX3;SYNCRIP;EIF4ENIF1;VIP;TIRAP;HNRNPU;DHX9;SLC11A1;TARDBP
prerank,glycolipid metabolic process (GO:0006664),0.5373237738019627,1.4963793799403495,0.015486725663716814,0.2588664667766961,1.0,20/47,19.63%,CTSA;CERK;ESYT1;PSAP;HEXA;GLB1;GLTP;UGCG;PGAP1;SMPD4;GALC;ST8SIA6;ARSA;GLA;FUCA1;NEU1;B4GALNT1;SMPD1;ASAH1;GBA2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6213072220514607,1.4952245968593432,0.03949044585987261,0.2610731058504789,1.0,7/17,15.56%,KLRC2;CD226;CADM1;RASGRP1;KLRK1;CRTAM;AP1G1
prerank,positive regulation of glucose import (GO:0046326),0.6055698894912565,1.494835951982687,0.03128911138923655,0.26121544836838323,1.0,2/21,0.09%,IGF1;OSBPL8
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4375649663433887,-1.494630510053049,0.050955414012738856,0.5357701667653431,1.0,8/29,10.52%,SSH2;CYRIB;KANK1;TWF2;TJP1;SHANK3;PRKN;FKBP4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5472039570502999,1.4939470508238015,0.019144144144144143,0.26277914003602454,1.0,23/41,29.19%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP50;JMJD8;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,proton transmembrane transport (GO:1902600),0.5618648625738042,1.4929746498676628,0.016091954022988506,0.2644408488792025,1.0,17/36,25.81%,SLC9A1;ATP6V1A;ATP6V0D1;UCP2;SLC36A3;SLC46A1;ATP1A4;ATP1A3;ATP1A1;ATP6V1F;SLC25A14;ATP1A2;ATP6V0C;ATP6V0A4;ATP5F1B;ATP6V0E1;ATP5MF
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6791298655776427,1.4929351375687514,0.0318118948824343,0.26363662823689377,1.0,8/13,23.29%,RENBP;GNPNAT1;GNPDA1;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,positive regulation of growth (GO:0045927),0.5223421963215403,1.4922563396421595,0.010649627263045794,0.264611545084489,1.0,17/64,15.63%,BCL2;RFTN1;S100A8;S100A9;SDCBP;EIF4G1;SPHK1;EXOSC4;SLC25A33;EIF4G2;ADAM17;DDX49;EXOSC9;CDC42;CXCL16;INO80;USP47
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5134554753812218,1.4918174702592093,0.00944386149003148,0.264920012808354,1.0,14/74,12.28%,LGALS3;IGF1;BCL2;BCL2L1;EYA4;TRAF2;MCL1;SIAH2;HTT;HMOX1;BRCA1;SERPINE1;BIRC6;TMBIM1
prerank,regulation of cholesterol esterification (GO:0010872),0.7102993946650045,1.491674164269775,0.04096045197740113,0.264378456645296,1.0,4/10,10.97%,APOE;ABCG1;APOA2;APOC1
prerank,regulation of dephosphorylation (GO:0035303),-0.5162744731587753,-1.4913536968061625,0.05314009661835749,0.535013358991772,1.0,11/15,30.69%,MTMR9;SMG6;INPP5K;SMG5;SRC;MTMR4;MTMR2;SMG7;PPP1R17;MTMR3;IGBP1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3182314803095599,-1.4912957047032163,0.0,0.5250364771849011,1.0,58/224,12.56%,CACNB2;SNAP25;GRIA4;GABRB2;GRM7;NRXN1;GABRB3;SYNJ2BP;NLGN1;SYN2;RPS6KA1;GRIK2;CHRM2;GLRA3;KCND2;AMPH;DLGAP1;DLG2;SLC1A3;GRIN2A;CPLX1;SYT10;GRIA3;PLP1;GRIK4;GABRG3;KCNQ3;RIT2;GRM1;GABRA2;HTR2A;GRIN2B;GAD2;APBA2;GRM5;HTR2C;UNC13B;APBA1;SYT1;GRM3;CHRM3;CAMKK2;PENK;HRH2;SLC12A6;HTR1F;HAP1;SLC6A1;CAMK1;PRKAR2A;GABRA1;BSN;GRIN1;PRKAR2B;GAD1;PDE7B;GABRB1;GLRA2
prerank,regulation of stem cell differentiation (GO:2000736),0.5081701811211048,1.4912582068961515,0.002072538860103627,0.26459939616594874,1.0,39/89,29.24%,KMT2A;PSMD8;PSMD1;TCF15;JAG1;RUNX1;GATA3;PUS7;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;SP7;YTHDF2;PSMC6;PSMA6;PSMD5;HNRNPU;TCF12;PSMA5;NSUN2;HOXB4;PSMA3;SMYD5;PDGFRA;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;HES1;PSMB5;PSMB7;NUDT21;PSMC4
prerank,B cell homeostasis (GO:0001782),-0.5863687045204189,-1.4912021644257716,0.055944055944055944,0.5155281352845429,1.0,4/10,7.75%,MEF2C;TNFRSF13B;DOCK10;CAMLG
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6026332611859477,1.4902801714918987,0.022443890274314215,0.26641047670382056,1.0,11/20,24.41%,CCT2;HSPA4;BBS10;LONP1;CLU;HSPD1;NDUFAF1;MKKS;PTGES3;HSP90AB1;PSMG3
prerank,positive regulation of endocytosis (GO:0045807),0.5398200732987213,1.4900543725227207,0.017448200654307525,0.26612290284940326,1.0,19/45,18.11%,APOE;STAP1;LRP1;AXL;DAB2;TREM2;ABCA13;B2M;HIP1;C3;CLN3;SERPINE1;HNRNPK;CDC42;CLU;CBL;APPL2;SMPD1;ANO6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5316422390963351,1.4897611759757101,0.018338727076591153,0.2659977410680842,1.0,12/55,9.92%,BCL2;S100A8;S100A9;LCK;BCL2L1;DEDD2;TRAF2;CAV1;BID;BCL2L11;RACK1;BAX
prerank,endomembrane system organization (GO:0010256),0.4820883403244957,1.4896324062227522,0.0,0.265434392278993,1.0,63/178,25.41%,MYOF;PLEKHM2;ARHGAP21;SYNE1;OPTN;ALS2;FER1L5;ATP8B4;SQSTM1;GOLGB1;SYNGR1;TLCD1;TOR1AIP2;CTDNEP1;WASHC5;ARL1;PI4K2A;TRAPPC8;SNX33;HTT;HOOK1;SMPD4;TLCD2;VPS18;COG4;SNX10;LEMD2;GAK;ARFGEF2;REEP3;DOP1B;HUWE1;OSBPL2;LMAN1;PLEKHF1;CDC42;ALS2CL;VPS11;CSNK1D;VAPB;AP3D1;RAB22A;RAB1A;TRAPPC11;HOOK3;VPS51;TBC1D20;LMAN2;ARFGEF1;SUN1;LAPTM4B;NUP93;SRGN;TMED3;TOR1B;USP50;SYNGR2;USP8;GOLPH3;MAPK15;TRAPPC12;GOLGA2;PLEKHJ1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5438086640507407,-1.4890924578086222,0.06538461538461539,0.5118587805550004,1.0,5/12,8.11%,RIMS1;UNC13B;SYT1;SYT2;RIMS2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5529957467118424,1.4880771104647734,0.02593010146561443,0.26869074199150195,1.0,9/40,9.74%,CTNNB1;SDCBP;LEF1;GCNT2;PDPN;GLIPR2;JAG1;DAB2;BAMBI
prerank,phospholipid transport (GO:0015914),0.5290498719591741,1.486891064360937,0.014176663031624863,0.27108034431709693,1.0,14/52,13.26%,OSBPL8;APOE;ABCG1;ABCA1;APOA2;ATP8B4;ABCA4;ATP9B;TRIAP1;APOC1;PITPNC1;OSBPL2;ABCA7;PRELID2
prerank,regulation of mRNA stability (GO:0043488),0.4917310361092535,1.4854760989798008,0.0010090817356205853,0.2741449357671661,1.0,73/145,32.24%,PSMD8;PSMD1;UBA52;TENT5C;RPS27A;VIM;EIF4G1;PRKCD;HSPB1;EXOSC4;NOCT;CELF1;PSMD6;PSMA1;MAPKAPK2;PABPC1;PSMC3;METTL3;TAF15;YTHDF3;PSMA8;EXOSC9;LARP1;XPO1;HSPA8;PCBP4;PSMD14;ROCK1;DCP1A;PSMD2;EIF4ENIF1;YTHDF2;VIP;PSMC6;PSMA6;DHX36;PUM1;FXR2;PSMD5;HNRNPU;PSMA5;YWHAB;SLC11A1;EXOSC5;UBC;FASTKD3;NPM1;GIGYF2;SAMD4A;PSMA3;XRN1;TNPO1;KHSRP;PSMB10;PSMB8;YWHAZ;PSMD7;PSMB6;PSMD10;RC3H1;PSMB5;FUS;PSMB7;RIDA;NUP214;PSMC4;SAMD4B;PSMD12;SET;DCP2;CIRBP;PSMD3;UBB
prerank,mitochondrion distribution (GO:0048311),-0.5472671560454406,-1.4844538139785854,0.06367041198501873,0.5148614796845405,1.0,8/12,21.21%,MEF2A;LRRK2;ATCAY;HAP1;MSTO1;ARMC1;DNM1L;TRAK2
prerank,dendrite morphogenesis (GO:0048813),-0.4100072121743814,-1.484306891437696,0.027972027972027972,0.5063135272090118,1.0,13/35,12.96%,CTNNA2;CTNND2;BTBD3;MEF2A;DOCK10;EPHB1;SHANK3;MAP6;MAP2;PHACTR1;DCDC2;KLF7;PAK3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5151869960683992,1.4805908300757584,0.0096051227321238,0.28687188343049097,1.0,31/70,29.24%,KMT2A;PSMD8;PSMD1;TCF15;RUNX1;GATA3;PUS7;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;YTHDF2;PSMC6;PSMA6;PSMD5;TCF12;PSMA5;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;N4BP2L2;PSMC4
prerank,cellular response to insulin stimulus (GO:0032869),0.48952507645522286,1.4803817868095772,0.0,0.2865506028567943,1.0,31/124,12.40%,BCAR3;MYO5A;TCIRG1;EPRS1;ATP6V1C1;ATP6V0D2;SLC27A1;ATP6V1A;PKM;HDAC9;ATP6V0A1;GCK;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;PPARG;SLC25A33;PDPK1;CPEB2;GRB2;DENND4C;IGF1R;RHOQ;ATP6AP1;PTPN2;RAB8A;RAB8B;PCK2;ATP6V1F;NAMPT
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5240427521261195,1.480260866616673,0.008629989212513484,0.2859745088766569,1.0,29/61,29.24%,PSMD8;PSMD1;NCOR2;AZIN1;CAV1;PSMD6;PSMA1;PSMC3;OAZ3;SIRT5;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;SIRT1;PSMC4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5585732227426287,1.4800673279823755,0.02304147465437788,0.28557842835053227,1.0,10/34,15.36%,RAB7B;CD300LF;GRAMD4;MFHAS1;TREM2;OTUD4;CD300A;TICAM1;SARM1;ACOD1
prerank,response to cAMP (GO:0051591),-0.3784716857415481,-1.479986953049006,0.02912621359223301,0.5085553555194772,1.0,17/37,28.71%,RAPGEF2;HCN1;IGFBP5;NDUFS4;AKAP6;DMTN;INPP5K;EZR;PDE2A;STAT1;RAPGEF3;KCNQ1;VGF;AQP1;SLC5A5;WT1;HCN2
prerank,response to interferon-gamma (GO:0034341),0.5112998917118246,1.4798802483952882,0.012738853503184714,0.2851020480189204,1.0,28/67,22.90%,EPRS1;SIRPA;SHFL;CCL4;CYP27B1;IL12RB1;IFITM2;IFITM1;IRF8;CCL13;CCL7;CCL5;SP100;CCL14;CXCL16;SYNCRIP;DAPK1;ACOD1;GBP2;AQP4;DAPK3;RPL13A;BST2;SLC11A1;CD47;SLC26A6;TRIM21;CD74
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6366909854658227,1.4796145396914204,0.04441453566621804,0.2849029948861943,1.0,5/15,8.10%,ITK;TEC;PTK2B;TXK;IGF1R
prerank,response to interleukin-6 (GO:0070741),-0.569024078788803,-1.47931679440256,0.06597222222222222,0.501672920126108,1.0,3/10,4.59%,SELPLG;ST3GAL6;RELA
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6518091473868785,1.4787772302856412,0.041666666666666664,0.28635855494444495,1.0,5/14,6.30%,LCK;KCNN4;CD226;TESPA1;TRAT1
prerank,regulation of leukocyte activation (GO:0002694),0.6461863344486668,1.4785562014973674,0.03805774278215223,0.2859893140850617,1.0,3/14,4.80%,GPR137B;LCK;MFHAS1
prerank,regulation of cellular component movement (GO:0051270),0.5354010838479121,1.477838004453498,0.018763796909492272,0.2870884627839757,1.0,18/49,14.84%,CD9;CDK6;ABL2;PDPN;NRG1;RAF1;ACTN1;VEGFA;ADAM17;CADM4;DIAPH1;RHOA;MEMO1;SP100;PKN2;ROCK1;RPS19;ZSWIM8
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5364284608381741,1.4777341962213333,0.021134593993325918,0.28647134361918236,1.0,16/42,21.58%,CAMP;LTF;OPTN;RNASE3;ADGRB1;TREM2;DMBT1;SERPINE1;MPEG1;RPS19;RNASE7;RPL30;IL6;RNASE6;SLC11A1;LBP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5545683039424304,1.4766077651280651,0.02576112412177986,0.2888560647106233,1.0,10/33,17.80%,BCAR3;PLAUR;MMP9;FBXW7;ADAM17;HIP1;DOK1;CBL;DGKD;HIP1R
prerank,phagosome maturation (GO:0090382),0.5570666441598419,1.4759016148139585,0.02502844141069397,0.29009446364927255,1.0,16/35,20.69%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;RAB32;RAB7A;ATP6V1F;ATP6V0C;PIKFYVE;ATP6V0A4;ATP6V1E1
prerank,glycosphingolipid metabolic process (GO:0006687),0.5429576195787582,1.4743436263453507,0.021468926553672316,0.293567303581064,1.0,18/42,19.63%,CTSA;CERK;ESYT1;LARGE1;PSAP;HEXA;GLB1;GLTP;UGCG;SMPD4;GALC;ARSA;GLA;NEU1;B4GALNT1;SMPD1;ASAH1;GBA2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5295906680663318,-1.4741700249165082,0.0871559633027523,0.5070069681617548,1.0,3/13,1.78%,P2RY12;NLGN1;EPS8
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4601119583744787,-1.4740041868731089,0.06282722513089005,0.499075247849777,1.0,8/22,10.63%,CASK;FGF10;EPB41L4B;PTPRK;NOTCH2;KLF9;STXBP4;PRKD1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5590533858667603,-1.4739407547999703,0.07003891050583658,0.4911406447411881,1.0,7/11,15.47%,SYNJ2BP;EPN2;ALOX5;SEMA6A;THBS1;E2F2;CREB3L1
prerank,cellular response to zinc ion (GO:0071294),0.6441081826297881,1.4735410289916522,0.04842931937172775,0.2950052595746187,1.0,10/15,20.07%,P2RX4;ATP13A2;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,lymphocyte mediated immunity (GO:0002449),0.663684392258444,1.472973792634151,0.06501950585175553,0.29574709719784253,1.0,6/12,21.40%,KLRC2;CD8A;JAG1;BTN3A3;CD55;MYO1G
prerank,intracellular sterol transport (GO:0032366),0.6568016786074511,1.4727428887793095,0.04669260700389105,0.295428097547321,1.0,9/13,24.34%,ABCG1;ABCA1;ARV1;OSBPL2;NPC1;NPC2;STARD4;SERAC1;OSBP
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.48842234274174007,1.4723441671786688,0.003089598352214212,0.29578430036224335,1.0,41/108,24.22%,S100A8;S100A9;LCK;CTSD;GRAMD4;MALT1;XDH;TRAF2;TNFSF15;MTCH1;PPARG;BID;DLC1;DIABLO;RACK1;VCP;SOX7;BAX;DAP;HIP1;GSN;HSPD1;DAPK1;APAF1;CASP4;SYK;HIP1R;ARL6IP5;CASP9;RPS3;HMGB1;CRADD;LAPTM5;TNFSF10;SENP1;EGLN3;F2R;HSPE1;JAK2;TNF;ANP32B
prerank,regulation of protein transport (GO:0051223),0.5705041609151567,1.471999423858806,0.03734939759036145,0.2957629703079398,1.0,14/27,24.21%,LCP1;ATP13A2;RHBDF2;P3H1;RHBDF1;DNAJC1;HSPA8;LLGL2;CHP1;DISP1;SNX12;DNAJA1;LLGL1;TNF
prerank,insulin receptor signaling pathway (GO:0008286),0.5047452429853442,1.4719099370310038,0.009513742071881607,0.29511713587819316,1.0,25/69,21.27%,BCAR3;TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;GRB2;IGF1R;RHOQ;ATP6AP1;PTPN2;ATP6V1F;NAMPT;SORBS1;FOXO1;PIK3R2;ATP6V0C;ATP6V0A4;ATP6V1E1;BAIAP2;GSK3B
prerank,long-chain fatty acid import into cell (GO:0044539),0.7038092056247878,1.4718424540163202,0.04126547455295736,0.2943962771998929,1.0,4/10,6.96%,SLC27A1;SLC27A5;SLC2A1;ACSL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5990457614544191,1.4716247093501704,0.028014616321559074,0.29402964846735935,1.0,10/22,24.26%,LCK;SKAP1;GCNT2;CD44;FLOT2;MBP;MYADM;MAPK7;TNF;MAP2K5
prerank,androgen receptor signaling pathway (GO:0030521),0.6867815280921734,1.4712744657587893,0.04252400548696845,0.29409879974642744,1.0,5/11,8.90%,ZMIZ1;RNF14;DAXX;DDX17;KDM3A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6959170163318464,1.4711386039999175,0.04696132596685083,0.29355681786148313,1.0,3/10,7.55%,GZMA;ETFBKMT;HP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5376618037744368,1.4708472087419693,0.02127659574468085,0.2934396563739036,1.0,13/40,18.63%,CAMP;FGR;RNASE3;DMBT1;ADAM17;MPEG1;MBL2;TIRAP;GBP2;RNASE7;PGLYRP2;IL6;RNASE6
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5857031769859367,1.4701139767975315,0.02916160388821385,0.2944936010453343,1.0,5/23,14.09%,PLEK;GCK;HDAC4;SIK1;GIT1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.7017591479763783,1.469672051229266,0.03477051460361613,0.29478083446893094,1.0,3/10,10.26%,CD9;PRKCD;SERPINE2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7012448990250248,1.4692983847871917,0.038781163434903045,0.29496113520040423,1.0,8/10,27.16%,STAP1;TREM2;CD300A;C3;APPL2;ANO6;NCKAP1L;RAB31
prerank,positive regulation of viral process (GO:0048524),0.5229813863874357,1.4692561557727866,0.00857449088960343,0.29418722615670595,1.0,28/60,27.88%,MDFIC;ADARB1;SRPK1;AXL;CD28;POLR2H;PABPC1;DDB1;KPNA6;RAB7A;CCL5;LARP1;GTF2F1;PKN2;PPIA;POLR2D;VAPB;PPIE;TBC1D20;DHX9;ADAR;SRPK2;POLR2F;TARBP2;TMEM39A;PPIH;SUPT4H1;RSF1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6117586166789469,1.4687519928581771,0.0410958904109589,0.2948233643990578,1.0,10/18,25.85%,IKZF3;TBX21;CD2;METTL3;CRTAM;CCR2;SPINK5;PRELID1;NCKAP1L;TLR9
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6328100515491593,1.4677818563625649,0.050387596899224806,0.2968016586881786,1.0,9/15,26.95%,IGF1;BCL2L1;TRIAP1;GHITM;CLU;PRELID1;GPX1;PSMD10;NOL3
prerank,cellular response to cadmium ion (GO:0071276),0.5834248047108184,1.4673914196732085,0.04886769964243146,0.2970593408990957,1.0,17/24,28.10%,MMP9;DAXX;JUN;MAPK9;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;HSF1;SUMO1;NCF1;MT2A;MAPK3
prerank,response to unfolded protein (GO:0006986),0.5219484112667956,1.4672500656565066,0.01425438596491228,0.2965901317210679,1.0,24/48,26.92%,OPTN;HSPA4;HSPB1;DAXX;STT3B;ERN1;BAX;ERP44;HSPA8;DDIT3;HSPD1;DNAJC4;DERL1;HSPA9;DNAJB1;HSF1;HSP90AB1;TOR1B;DNAJA1;HSPE1;BAG3;HSPA5;HSPA2;PACRG
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6455220288943726,1.4671619884151468,0.044270833333333336,0.2959322816962469,1.0,4/13,16.12%,IGF1;SOAT1;ALG10B;CHP1
prerank,response to copper ion (GO:0046688),0.6044227723201625,1.4664162564527017,0.05308641975308642,0.2972536444009238,1.0,12/20,30.17%,DAXX;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;HSF1;MT2A;ATP7B
prerank,cellular response to amyloid-beta (GO:1904646),0.5483462735032015,1.4660463404766668,0.026467203682393557,0.2974223616537468,1.0,10/35,10.34%,CACNA1A;IGF1;LRP1;FPR2;CDK5;ITGA4;ATP1A3;TREM2;IGF1R;FYN
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5678861228094818,1.4658583411604356,0.03259604190919674,0.29709013459361844,1.0,6/28,9.92%,BCL2;DEDD2;DAXX;BID;DIABLO;BAX
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6777564012048988,1.4658397021895304,0.04832214765100671,0.2962763977298544,1.0,4/11,15.88%,CTNNB1;FZD1;LRP6;NR4A2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.650754509919447,1.4656191936140326,0.05012853470437018,0.2960872073270457,1.0,6/14,11.60%,CCL4;PTK2B;ADAM17;CCR2;CCL7;CCL5
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.593564842017832,1.465436113579444,0.033582089552238806,0.29564835627209507,1.0,5/22,11.33%,GPNMB;RAP2A;PDGFA;VEGFA;RAD50
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5979134289936059,1.4653349228345116,0.03836930455635491,0.29511383571452665,1.0,12/22,27.96%,NFE2L2;PSMA1;PSMA8;ENC1;PSMA6;PSMA5;PSMA3;PSMB10;PSMB8;PSMB6;PSMB5;PSMB7
prerank,folic acid metabolic process (GO:0046655),0.6151900518443748,1.464435255827678,0.043532338308457715,0.2969567950339021,1.0,9/18,19.27%,MTHFD2;SLC46A1;MTHFS;SHMT1;MTHFD1;FPGS;MTRR;SLC19A1;ALDH1L2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6357437538661926,1.4642563909711386,0.06337135614702155,0.296554751880419,1.0,7/15,13.29%,PKM;ITGA5;FGF2;PDPK1;VEGFA;JAK1;SMAD1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.636747524019793,1.463657990654303,0.04118404118404118,0.2973442088561869,1.0,6/15,13.49%,NR4A3;PPARG;PPARD;LPGAT1;MID1IP1;SLC45A3
prerank,cellular protein metabolic process (GO:0044267),0.46668207560608105,1.4631421866044765,0.0,0.2979496350056184,1.0,132/396,21.97%,IGF1;FAM20C;SPP1;APOE;FN1;ABL2;CSF1;IGFBP7;MRPS12;RPS12;LGALS1;MSRA;UBL4A;CSF2RA;UBA52;AGO2;PARP4;RPS27A;B4GALT7;TNIP1;EIF4G1;RPS6;SERPINA10;APOA2;MATN3;ENAM;FSTL3;RPS14;SFTPA1;SFTPA2;MRPL51;RPL10A;RPL18;RPS24;ANO8;IGHMBP2;SIAH2;MSRB1;RPS7;RPS20;RPL36A;RPL41;EEF1A1;RPS26;MRPL23;RPL17;RPL23;APLP2;RPS25;GNMT;DMBT1;LMCD1;RPL35A;RPS28;NAPSA;RPLP2;RPL28;UBE2L3;P4HB;PSEN2;ADAM17;RPL27A;RPL11;RPS2;ERO1A;TTF1;MRPL52;RABGGTB;C3;RPL32;BAP1;F5;MRPS15;RPL21;SPCS3;MRPL24;AFG3L2;TGM5;RPL9;FSTL1;GAS6;RPL36;RPL37;MRPS33;MRPS16;RPS18;UBE2L6;RPL38;MRPS7;LAMC1;RPS19;RPS27;ADORA2A;SPPL3;STK38;QPCT;MELTF;FURIN;CKAP4;RPS23;RPL14;SARS1;MRPL11;RPS16;KLK3;RIPK3;RPL30;RPL12;GSPT1;UBL5;FARSB;IL6;RPL13A;RPL31;RPS9;WFS1;SPARCL1;STOML2;RPL4;RRBP1;RPS3;SHISA5;TIMP1;CALU;RPS13;DUSP12;CDC34;RPSA;PABPC4;BMP4;RPL15;FBXO11
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6112670710631624,1.463081562330283,0.0379746835443038,0.2972548196823639,1.0,11/19,32.03%,ZMIZ1;AXL;GATA3;GAS6;SYK;BTK;NCKAP1L;MDK;XBP1;ZBTB1;IL7
prerank,pinocytosis (GO:0006907),0.6960378457535211,1.462928610985372,0.03932584269662921,0.2967921707608586,1.0,4/10,9.26%,DOCK2;SNX33;MAPKAPK3;MAPKAPK2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5261702239451989,1.4627456340449976,0.01733477789815818,0.29645468315295925,1.0,14/48,10.09%,HIF1A;P2RX4;ANXA1;TMSB4X;HDAC9;HDAC7;FGF2;HSPB1;ANGPT4;PDPK1;VEGFA;ANGPT1;ADAM17;HMOX1
prerank,zinc ion homeostasis (GO:0055069),0.5596810412815628,1.4623478378979546,0.03944315545243619,0.2966397892869251,1.0,13/28,20.07%,LCK;ATP13A2;SLC39A6;SLC39A7;SLC30A9;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,retinoid metabolic process (GO:0001523),0.49950151202175713,1.4600462610070577,0.009483667017913594,0.30236092012247606,1.0,15/71,16.03%,LPL;APOE;LRP1;RDH12;DHRS3;APOA2;ABCA4;DHRS9;AKR1B10;NAPEPLD;SCPEP1;RBP4;CYP1B1;RDH13;HSPG2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4322692315059182,-1.4591001818612614,0.05263157894736842,0.5221062754224967,1.0,13/27,14.06%,F11R;WASF2;PIK3R1;TMEFF2;TJP1;STMN1;SHANK3;PRKN;CGNL1;CLASP2;INPP5K;PHLDB2;ARHGAP28
prerank,protein deneddylation (GO:0000338),0.6958959278272261,1.4580414731087399,0.043785310734463276,0.3070055182153475,1.0,5/10,12.22%,COPS3;COPS8;COPS4;COPS2;COPS6
prerank,histone H4 deacetylation (GO:0070933),0.6961970232696144,1.4577268760837658,0.043478260869565216,0.3069948559423395,1.0,4/10,7.34%,HDAC9;RCOR1;HDAC4;HDAC1
prerank,vesicle organization (GO:0016050),0.519806311644718,1.4576667787627866,0.019801980198019802,0.3062911377074561,1.0,24/46,28.13%,ALS2;SQSTM1;CAV1;WASHC5;PI4K2A;SNX33;HOOK1;VPS18;SNX10;ARFGEF2;PLEKHF1;ALS2CL;VPS11;RAB22A;SAR1A;HOOK3;LAPTM4B;SRGN;SNX11;USP50;USP8;PLEKHJ1;PI4K2B;LAMTOR1
prerank,regulation of vacuole organization (GO:0044088),0.597359679402134,1.4574679555729604,0.06148055207026349,0.3059986177954886,1.0,9/20,20.41%,NPRL2;ENO1;RAB5A;ENO2;IFT88;TBC1D12;PIKFYVE;NPRL3;LAPTM4B
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6815842043767943,1.4574332584725143,0.04583333333333333,0.30525015455722754,1.0,2/11,3.55%,ABCG1;APOA2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6103937267265173,1.4574167872828492,0.031525851197982346,0.30446594608387384,1.0,8/18,20.50%,COLGALT1;PDPN;RUNX1;EFEMP2;MELTF;DDR2;IL6;EMILIN1
prerank,positive regulation of cellular component organization (GO:0051130),0.4856369022677517,1.4570878223845911,0.006153846153846154,0.3045762645499304,1.0,27/107,16.45%,LGALS3;FNIP2;PLEKHM2;APOE;LRP1;ASAP1;NRG1;CLDN19;PTPN23;BID;LRP4;RUNX1;DAB2;VEGFA;TREM2;BCL2L11;IGF1R;RACK1;VCP;BAX;DCTN1;LMAN1;CLU;TFRC;TIRAP;SYK;SMPD1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5049027350060022,1.4569615810200955,0.012711864406779662,0.3040818902752523,1.0,30/73,27.96%,KMT2A;PSMD8;PSMD1;RUNX1;GATA3;PUS7;KITLG;PSMD6;PSMA1;PSMC3;METTL3;PSMA8;PSMD14;PSMD2;SETD1A;YTHDF2;PSMC6;PSMA6;DHX36;PSMD5;TCF12;PSMA5;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7
prerank,actomyosin structure organization (GO:0031032),-0.34809391707494997,-1.4564258812764659,0.0,0.5215516869276672,1.0,17/75,9.50%,CAPN3;F11R;ROCK2;EPB41L4B;EPB41L2;EPB41L5;MYH10;EPB41L3;EPB41L4A;TJP1;PDCD10;MYH14;PGM5;FRMD3;CDC42BPB;PHACTR1;EPB41L1
prerank,cellular response to hypoxia (GO:0071456),0.4813396972405141,1.4543161369262148,0.0020181634712411706,0.3109124636095653,1.0,65/126,32.63%,HIF1A;PSMD8;PSMD1;UBA52;RPS27A;ADAM8;MGARP;ANGPT4;CPEB2;AK4;VEGFA;P4HB;LMNA;PSMD6;PSMA1;PGK1;PSMC3;HMOX1;NDRG1;PSMA8;HP1BP3;PSMD14;PSMD2;STOX1;UBQLN1;PSMC6;PSMA6;PSMD5;ELOB;PSMA5;PTGIS;UBC;EGLN1;EPO;VHL;CUL2;TERT;EGLN3;PSMA3;BNIP3;CPEB1;MDM2;PLK3;PSMB10;SFRP1;PSMB8;PSMD7;ACAA2;PSMB6;PSMD10;PSMB5;PSMB7;BNIP3L;NDNF;SIRT1;PSMC4;SUV39H2;SIRT2;PSMD12;EP300;CREBBP;PSMD3;UBB;ARNT;EPAS1
prerank,keratan sulfate catabolic process (GO:0042340),0.6793964660646917,1.454198842297654,0.06684856753069578,0.31037511350348607,1.0,4/11,5.33%,GALNS;GNS;HEXA;GLB1
prerank,positive regulation of leukocyte migration (GO:0002687),0.5614213553120627,1.45393470491759,0.04503464203233257,0.3102823049053567,1.0,5/27,8.93%,LGALS3;CSF1;ADAM8;VEGFA;ADAM17
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5369121014639042,1.4537725280838267,0.03479236812570146,0.3099179318917442,1.0,17/38,27.83%,LGALS3;BCL2L1;TRAF2;HMOX1;BRCA1;SERPINE1;TMBIM1;SP100;ARHGEF2;GSK3B;TNFSF10;SFRP1;BMP5;GPX1;STX4;TNFAIP3;RIPK1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.48140310257604557,1.4534525591252236,0.006141248720573183,0.30992758378800633,1.0,42/110,26.59%,LGALS3;FNIP2;FBLIM1;APOE;ABCA1;TRAF2;NRG1;HRG;RAF1;BBS10;BID;VEGFA;NAPA;BCL2L11;RACK1;VCP;BAX;IAPP;RIOK3;GSN;HSPA8;CDC42;CLU;TFRC;TIRAP;SYK;SAR1A;RALB;GFAP;RPS3;BIK;GSK3B;HSF1;LATS1;TRABD2B;SUMO1;TNF;HSPA5;MAPK15;TRAF3IP1;HCFC1;PIH1D1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.7023167225815998,1.452451983382804,0.0553306342780027,0.3119066143959242,1.0,3/10,3.44%,MFSD12;ATP7A;TYRP1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.48538627334470535,1.4521733744300218,0.0051440329218107,0.3118356819664905,1.0,53/109,29.24%,PSMD8;ITK;GRAP2;PSMD1;PRKCQ;MALT1;LAT;TEC;PIK3CB;MS4A2;NR4A3;PDPK1;GRB2;TAB1;PSMD6;PSMA1;PSMC3;JUN;PSMA8;PAK2;PSMD14;PSMD2;MAP3K1;NFKB1;MAPK9;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;PSMA5;FCER1G;GAB2;NFATC3;FBXW11;CUL1;VAV3;PSMA3;PPP3R1;PSMB10;BTK;PSMB8;VAV1;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;MAPK3;TAB2;PSMC4
prerank,regulation of cholesterol efflux (GO:0010874),0.5580582902180833,1.4520809695543977,0.0286368843069874,0.31125187061424653,1.0,7/30,7.32%,APOE;LRP1;EEPD1;PON1;CAV1;PPARG;TREM2
prerank,lipid oxidation (GO:0034440),-0.531203521959051,-1.4518935128725747,0.10714285714285714,0.525360632063781,1.0,2/12,4.85%,ALOX5;PPARGC1A
prerank,regulation of extracellular matrix organization (GO:1903053),0.6370965650989696,1.451883147690494,0.04113110539845758,0.3109562125612188,1.0,6/15,17.24%,LRP1;RUNX1;RIC1;AEBP1;EFEMP2;DDR2
prerank,neutrophil activation (GO:0042119),0.6640940873662242,1.4505615647728283,0.04806408544726302,0.3138934165341676,1.0,5/12,18.98%,CXCR2;PRKCD;CCL5;SYK;FCER1G
prerank,actin crosslink formation (GO:0051764),0.6751690243625479,1.4500319627260752,0.048582995951417005,0.314585692623137,1.0,3/12,1.02%,GAS2L3;LCP1;FLNA
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5180667888388727,1.4500313372661102,0.019801980198019802,0.31374277672911155,1.0,24/47,22.83%,CORO1C;FLNA;PDPN;NEDD9;NRP1;CRKL;LIMS2;P4HB;ILK;MYOC;FBLN1;CDC42;DOCK5;SPRY4;C1QBP;MELTF;MYADM;TESK1;FERMT2;ITGB1BP1;TRIOBP;CALR;CSPG5;ACTN4
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5890376246045791,1.4489171069542266,0.044902912621359224,0.31607954631709884,1.0,10/21,17.91%,PEAK1;CORO1C;SLC9A1;PTPRA;MACF1;ACTG1;RHOA;ROCK1;DUSP3;DAPK3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5766545369453749,1.4486691150007733,0.04921968787515006,0.31589777788069795,1.0,11/24,23.47%,BCL2;BCL2L1;MUC1;CD44;TPT1;TRIAP1;CLU;ING2;CCAR2;CD74;MIF
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5685507763637657,1.4479267972793861,0.046798029556650245,0.31718174491484374,1.0,8/25,17.80%,BCAR3;PLAUR;MMP9;HIP1;DOK1;CBL;DGKD;HIP1R
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5152145723122422,1.4473345085131217,0.037694013303769404,0.318048861095352,1.0,19/46,24.20%,LCP1;MSN;STAT4;GSTA2;IL12RB1;P4HB;JAK1;CDC42;PAK2;PPIA;HNRNPA2B1;HSPA9;PDCD4;HNRNPF;SOD2;CFL1;MIF;TALDO1;JAK2
prerank,regulation of mRNA catabolic process (GO:0061013),0.4816589727279737,1.4471658234922613,0.0020387359836901123,0.3177170742718518,1.0,60/121,32.24%,PSMD8;PSMD1;UBA52;RPS27A;VIM;EIF4G1;PKP1;PRKCD;HSPB1;EXOSC4;PSMD6;PSMA1;MAPKAPK2;PABPC1;PSMC3;YTHDF3;PSMA8;EXOSC9;XPO1;HSPA8;PCBP4;PSMD14;DCP1A;PSMD2;YTHDF2;PSMC6;ZC3HAV1;PSMA6;DHX36;PUM1;FXR2;PSMD5;PSMA5;YWHAB;EXOSC5;UBC;SAMD4A;PSMA3;XRN1;PRR5L;TNPO1;KHSRP;PSMB10;PSMB8;YWHAZ;PSMD7;PSMB6;PSMD10;RC3H1;PSMB5;PSMB7;NUP214;PSMC4;SAMD4B;PSMD12;SET;DCP2;PSMD3;ZC3H12A;UBB
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6203550159765099,1.4467365103904768,0.05317769130998703,0.31810280936833935,1.0,6/16,11.25%,TMSB4X;SPHK2;AK4;TREM2;VCP;ENO1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6805618266330987,1.446603973076222,0.06862745098039216,0.3175759779064183,1.0,4/11,11.93%,COLEC12;RFTN1;TICAM1;TNIP2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5780293671660046,1.4463140454058434,0.04342581423401689,0.31753016778938414,1.0,4/23,4.50%,IGF1;NIBAN2;NRG1;PIEZO1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.4898721383679357,1.445887669247308,0.01037344398340249,0.3178651208920936,1.0,35/91,21.63%,LCK;FTL;LCN2;SLC31A2;ATP6V1A;ATP7A;ATP13A2;ATP6V0D1;ATP6V1G1;ATOX1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;HMOX1;FRRS1;SLC39A6;SLC39A7;SLC30A9;TFRC;BMP6;SLC11A1;FTH1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;CAND1;CUL1;ABCB7
prerank,regulation of plasminogen activation (GO:0010755),0.6628078231886251,1.445850717771368,0.05733333333333333,0.3171185403700256,1.0,7/12,17.53%,CTSZ;RUNX1;SERPINE2;ENO1;SERPINE1;MELTF;SERPINF2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5435527646999327,1.4457833592505958,0.0399529964747356,0.3164878196990366,1.0,8/32,12.61%,CDK14;CDK18;ID2;CDK5;BRD4;FBXO5;CDK17;NPAT
prerank,diterpenoid metabolic process (GO:0016101),0.5118676785776302,1.445680157754304,0.018458197611292075,0.31602257096588393,1.0,9/55,7.18%,LPL;APOE;LRP1;RDH12;DHRS3;APOA2;ABCA4;AKR1B10;NAPEPLD
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.627238411971059,1.445677832471503,0.0649867374005305,0.31521234070410953,1.0,5/15,5.36%,P2RX4;TMSB4X;HRG;FGF2;HSPB1
prerank,long-chain fatty acid transport (GO:0015909),0.5555046374305229,1.4450526050491403,0.031652989449003514,0.31608590005253717,1.0,12/30,18.57%,APOE;FABP5;SLC27A1;ACACA;ABCD4;PPARG;ACSL1;ABCD2;MID1IP1;ABCD3;CPT2;ACACB
prerank,response to histamine (GO:0034776),-0.5603708810961248,-1.4446228855650474,0.06862745098039216,0.5371967732482542,1.0,2/10,0.58%,GABRB2;GABRB3
prerank,triglyceride homeostasis (GO:0070328),0.5770493496649665,1.4444416432812597,0.03214285714285714,0.31704200519634196,1.0,4/26,4.96%,LPL;APOE;GCKR;APOC4
prerank,lipoprotein transport (GO:0042953),0.6911077020992822,1.44416684539308,0.04613297150610583,0.31704851228166475,1.0,3/10,8.41%,LRP1;PPARG;PRKCB
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.617936388140867,1.4436204705877973,0.05186170212765957,0.3179237375699525,1.0,6/15,12.95%,RPS7;RPL23;FBXO5;RPL11;LIMK1;SMAD7
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3446425028100641,-1.443313539776498,0.0,0.5325044030865573,1.0,26/72,15.30%,NRXN1;NLGN1;LGMN;GRIK2;TSHZ3;GRIN2A;RIMS1;CLSTN2;SLC8A3;CACNG3;GRIN2B;CLSTN3;RGS14;SYT1;SHANK3;RIMS2;APP;HAP1;SLC8A2;CACNG8;CCL2;PRKCZ;MPP2;CLSTN1;FLOT1;SHISA7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6564056924575107,1.4427542402824456,0.05829015544041451,0.31961649435508827,1.0,11/13,30.97%,NCK1;RACK1;DNAJB9;ABCA7;BFAR;PPP1R15B;WFS1;PPP1R15A;HSPA5;UFL1;PTPN1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6490878779937007,1.442506004239954,0.06084656084656084,0.31947797342804174,1.0,7/12,24.26%,LPL;MBP;TIRAP;HMGB1;CD74;TNF;MAP2K5
prerank,dopaminergic neuron differentiation (GO:0071542),0.5947565997905543,1.4420009180218574,0.055970149253731345,0.3200902670290906,1.0,4/19,15.88%,CTNNB1;VEGFA;LRP6;NR4A2
prerank,histone H3-K4 methylation (GO:0051568),0.5655174105876895,1.441569648506675,0.044794188861985475,0.3204968073711927,1.0,9/26,14.75%,CXXC1;KMT2A;DYDC1;TET3;RBBP5;WDR5;PRDM9;OGT;SETD1A
prerank,positive regulation of viral genome replication (GO:0045070),0.5566202428782612,1.4414153574827162,0.04050925925925926,0.3201316620425976,1.0,16/29,27.19%,ADARB1;SRPK1;CD28;PABPC1;DDB1;CCL5;LARP1;PKN2;PPIA;VAPB;PPIE;ADAR;SRPK2;TARBP2;TMEM39A;PPIH
prerank,cellular response to alcohol (GO:0097306),0.5288085495251889,1.441302355076762,0.02491506228765572,0.3196442970898606,1.0,20/42,25.13%,CTNNB1;ADCY8;ADCY3;SPHK2;PTGFR;ADCY7;CDH1;JUP;BRCA1;LARP1;BLM;ADAM15;LRP6;GRAMD1B;GNB1;MLC1;PTGER4;AHR;GOLPH3;SFRP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5630330629929249,1.4400682118739905,0.04062126642771804,0.3225265651411114,1.0,12/26,21.63%,CYBA;MMP8;SPHK2;SLC25A33;ADGRB1;ABCD2;TRAP1;CCN6;SLC18A2;SLC5A3;PIKFYVE;ABCB7
prerank,regulation of glycolytic process (GO:0006110),0.49543147462611076,1.439697831347945,0.014629049111807733,0.322693987892415,1.0,26/68,26.60%,IGF1;HIF1A;NUP205;EIF6;GCK;GCKR;HDAC4;PFKFB3;NUP188;OGT;ENTPD5;GIT1;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP50;JMJD8;NUP54;NUP98;NUP42;NUP133;NUP210
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6834646152731327,1.4389412710625007,0.0577716643741403,0.32402777012936484,1.0,6/10,21.58%,LTF;WDFY1;PTPN22;TIRAP;NINJ1;LBP
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5409409653335017,1.438186634016135,0.0294811320754717,0.32536510212999614,1.0,20/34,27.47%,FLNA;NEDD9;NRP1;CRKL;LIMS2;P4HB;ILK;MYOC;CDC42;DOCK5;C1QBP;MYADM;TESK1;FERMT2;TRIOBP;CALR;CSPG5;MDK;S100A10;LIMS1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6892952062601516,1.4381226132856575,0.07468879668049792,0.3247482280334668,1.0,3/10,14.88%,CTNNB1;FZD1;LRP6
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6752645944646264,1.4378016154970605,0.05405405405405406,0.3248880717467078,1.0,5/10,14.48%,PRKCH;CYP27B1;VDR;TRIM16;NUMA1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6541940808563252,1.4376118808624059,0.048239895697522815,0.32457768372981455,1.0,6/13,16.36%,RGPD1;IPO5;KPNA4;KPNA6;RANBP2;CBLB
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6355954525733798,1.4364301799373447,0.0683311432325887,0.3270682975157089,1.0,6/13,16.05%,CTNNB1;NRP1;COL4A1;VEGFA;DLL4;KDR
prerank,Fc receptor signaling pathway (GO:0038093),0.4780507953872689,1.4354823914162245,0.008188331627430911,0.32880864545775706,1.0,52/110,29.24%,PSMD8;ITK;GRAP2;PSMD1;PRKCQ;MALT1;LAT;TEC;PIK3CB;MS4A2;PDPK1;GRB2;TAB1;PSMD6;PSMA1;PSMC3;JUN;PSMA8;PAK2;PSMD14;PSMD2;MAP3K1;NFKB1;MAPK9;PSMC6;PSMA6;SYK;LAT2;PIK3R2;PSMD5;PSMA5;FCER1G;GAB2;NFATC3;FBXW11;CUL1;VAV3;PSMA3;PPP3R1;PSMB10;BTK;PSMB8;VAV1;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;MAPK3;TAB2;PSMC4
prerank,keratan sulfate metabolic process (GO:0042339),0.5542888918015033,1.4353756848246941,0.03905325443786982,0.32830180580361135,1.0,8/31,5.83%,B4GALT5;GALNS;GNS;B4GAT1;B3GNT3;HEXA;GLB1;SLC35D2
prerank,positive regulation of cell growth (GO:0030307),0.481872552389988,1.4352914316072847,0.012422360248447204,0.32774465358382215,1.0,25/96,15.76%,IGF1;BCL2;S100A8;S100A9;SDCBP;MACF1;EIF4G1;GOLGA4;SPHK1;EXOSC4;SLC25A33;ITSN2;EIF4G2;ADAM17;PLAA;DDX49;RUFY3;RASAL1;EXOSC9;LIMK1;CDC42;CXCL16;INO80;USP47;RNF157
prerank,regulation of protein autophosphorylation (GO:0031952),0.5285025609661009,1.435280659078944,0.04971098265895954,0.32697199532094784,1.0,7/36,11.33%,GPNMB;RAP2A;PDGFA;PPP2R5C;VEGFA;MVP;RAD50
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5106874758660223,1.4352757435724277,0.01611170784103115,0.32619061258821397,1.0,25/55,29.24%,PSMD8;PSMD1;PSMD6;PSMA1;PSMC3;ATF5;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5297423901579239,1.4350621744030265,0.03615819209039548,0.3260396180142433,1.0,10/37,13.67%,IGF1;NR4A3;MEF2D;MMP9;FGF2;PPARG;ERN1;DNMT1;JUN;EFEMP2
prerank,negative regulation of protein metabolic process (GO:0051248),0.51301728450329,1.434951471740625,0.030371203599550055,0.3254959091522937,1.0,15/48,18.31%,CD84;APOE;FLNA;AZIN1;ADGRB1;SF3B3;TREM2;FLOT2;IAPP;ROCK1;PFDN1;NFKB1;CLU;PIN1;PFDN2
prerank,regulation of acute inflammatory response (GO:0002673),0.5985068025378745,1.4348077173606084,0.05131414267834793,0.3251212832119627,1.0,5/18,18.32%,PTGES;ADAM8;OSMR;KLKB1;IL6
prerank,peptide cross-linking (GO:0018149),0.5708706152373045,1.4342149848025265,0.03930635838150289,0.3260816973601339,1.0,7/25,13.25%,FN1;CD247;ANXA1;CD3G;EVPL;TGM5;ABCA7
prerank,negative regulation of histone modification (GO:0031057),0.6448243068297237,1.434138619911262,0.04285714285714286,0.32551464289706405,1.0,6/14,18.91%,SPHK2;NOC2L;THAP7;BRCA1;PRMT6;TAF7
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.677491064844993,1.4340372030611344,0.0651872399445215,0.32503664256569786,1.0,5/10,14.09%,XDH;PIK3CB;HRG;CADM4;DCN
prerank,regulation of osteoclast differentiation (GO:0045670),0.5346045672248233,1.4339766039681885,0.04602991944764097,0.32445023717073324,1.0,5/33,8.88%,GPR137B;CSF1;FSTL3;TCTA;LILRB3
prerank,membrane depolarization (GO:0051899),0.5476762209651629,1.4335632027739613,0.037800687285223365,0.32489253963607906,1.0,5/32,5.31%,CACNA1A;P2RX4;CHRNB2;SCN4A;CAV1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6167542066469829,1.4329514964517864,0.06218905472636816,0.3258493317530084,1.0,9/17,21.77%,MGARP;TFPI;ATP1A3;ATP1A1;UBE2L3;ATP1A2;ACOD1;NR3C1;BMP4
prerank,protein-containing complex subunit organization (GO:0043933),0.4763049183308624,1.4325820931878168,0.009249743062692703,0.32616892909465517,1.0,52/109,29.10%,MITF;CD3E;CD247;IL2RB;EPRS1;KMT2A;NUP205;CAPG;TRAF2;TUBGCP4;CD3G;PTK2B;SLC2A1;PPP2R1A;SOX9;WIPF1;TAPBP;SKAP2;RANBP9;TRAF1;CARD10;MAGI1;AFG3L2;GPAA1;TFAP4;TSPAN4;LAMC1;NDUFAF1;TPR;MDN1;VAMP2;ELOB;JCHAIN;FANCA;TEAD1;WAS;CD74;PEX14;LLGL1;NUP54;MDM2;NCKAP1L;NUP98;ST13;NUP133;GEMIN5;PPIH;HES1;NUP35;VAMP3;MNAT1;SPG7
prerank,cellular response to tumor necrosis factor (GO:0071356),0.46594652786362817,1.4322913262763788,0.0020161290322580645,0.3262360201370429,1.0,67/175,29.28%,PSMD8;NFE2L2;PSMD1;TMSB4X;TANK;TRAF2;CCL4;LTB;TNFSF15;PTK2B;TRAF3;GATA3;ERBIN;SMPD4;ILK;PSMD6;PSMA1;ADAM17;CCL13;TRAF1;PSMC3;BRCA1;CCL7;CCL5;TNFRSF1B;PSMA8;TNFRSF9;PSMD14;YBX3;CCL14;PSMD2;TNFSF8;ACOD1;PSMC6;PSMA6;GBP2;TNFSF9;PSMD5;PSMA5;DHX9;ASAH1;ARHGEF2;RPS3;EIF5A;TNFRSF11B;CDIP1;ACTN4;PSMA3;JAK2;TNF;BIRC2;PSMB10;SFRP1;PSMB8;PSMD7;AIM2;PSMB6;CX3CL1;PSMD10;PSMB5;LIMS1;RIPK1;PSMB7;ZFAND6;SIRT1;PSMC4;TNFRSF8
prerank,negative regulation of cell activation (GO:0050866),0.6315015566024231,1.4312579257692737,0.05844155844155844,0.3283544754091431,1.0,3/14,7.32%,APOE;PDGFA;TREM2
prerank,negative regulation of hemostasis (GO:1900047),0.6496612282274072,1.4308836750586886,0.05277401894451962,0.32864886895981377,1.0,5/12,16.10%,APOE;TFPI;SERPINE2;SERPINE1;APOH
prerank,protein-containing complex disassembly (GO:0032984),0.5052393349371125,1.4306772165597117,0.026200873362445413,0.3284483129455023,1.0,19/54,22.11%,CTNNB1;TECPR1;CAV1;RPL23;LIX1;LAMP2;LIX1L;VCP;CLN3;MAP1LC3B;HSPA8;FRAT1;FZD1;UBQLN1;LRP6;VIPAS39;GSK3B;MAP1LC3A;GABARAP
prerank,epithelial cell morphogenesis (GO:0003382),0.61386402978458,1.430091286671562,0.04949238578680203,0.32933968150017756,1.0,4/17,8.66%,CCDC88C;POF1B;RILPL2;COL18A1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5822419533129622,1.430009133170629,0.05054151624548736,0.32879651023350764,1.0,11/22,29.06%,LGALS3;MGAT5;PTPA;BOD1L1;ROCK1;GSK3B;PPP1R15A;TNF;NCKAP1L;FKBP1B;FKBP1A
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.512850623226674,1.4299515449085964,0.03587443946188341,0.32819583741716957,1.0,13/47,14.32%,PLEK;SIRPA;SLC27A1;GCK;FBXW7;CAV1;SIK1;GLA;FYN;BRCA1;APOC1;MPV17L;NFKB1
prerank,plasma membrane organization (GO:0007009),0.49824352368397173,1.4295427500935913,0.02280130293159609,0.328491941367676,1.0,19/61,18.11%,MYOF;AHNAK2;PLSCR2;FER1L5;ARL8B;TLCD1;ANXA6;SNX33;CHMP4A;UGCG;TLCD2;ARV1;CLN3;ABCD2;OSBPL2;ABCA7;CAVIN2;SMPD1;ANO6
prerank,sphingolipid metabolic process (GO:0006665),0.4757792529471509,1.4292909440043688,0.0030706243602865915,0.3284638661283243,1.0,39/108,21.82%,CTSA;CERK;ESYT1;SGMS1;TEX2;SPHK2;SPHK1;HACD2;PSAP;HEXA;GLB1;PPP2R1A;CERS6;ORMDL1;SPTSSA;PLPP3;GLTP;UGCG;SMPD4;GALC;ARV1;ARSA;GLA;KDSR;NEU1;HACD1;B4GALNT1;PRKD2;VAPB;SMPD1;ALDH3A2;ORMDL3;ALDH3B1;ASAH1;GBA2;ELOVL2;SAMD8;CERKL;ELOVL1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4949126246534695,1.4289737491512355,0.013584117032392894,0.3285933629298473,1.0,31/73,24.50%,ERCC6;DNMT3A;SPHK2;TAF1D;HDAC4;DDX21;DNMT1;POLR1G;POLR2H;MTF2;PRMT7;PHF1;EED;ACTB;DEK;POLR1A;MYBBP1A;TBP;BAZ1B;BMI1;WBP2;DNMT3B;ZFP57;TAF1A;TAF1C;CREBZF;RBBP7;SMYD5;POLR1F;POLR2F;SF3B1
prerank,retina homeostasis (GO:0001895),0.5789496461724176,1.428073749082515,0.046762589928057555,0.3303263132446415,1.0,10/23,18.55%,LTF;HSPB1;PRDX1;ACTG1;B2M;CNGB1;POTEF;ACTB;SLC28A2;JCHAIN
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6218460047837493,1.4280469766539845,0.056847545219638244,0.32962696930994484,1.0,8/15,21.28%,ATF3;MAPK13;DAXX;CPEB2;VCP;DHX36;GSTO2;HSF1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6178144900486091,1.4278699963901593,0.06997455470737914,0.32939753664408966,1.0,7/15,16.05%,P2RX4;TMSB4X;FGF2;HSPB1;VEGFA;PRKD2;KDR
prerank,synaptic membrane adhesion (GO:0099560),-0.5067948059331484,-1.4273858076546755,0.08936170212765958,0.5678195645228578,1.0,3/14,1.36%,LRRC4C;LRFN5;PTPRD
prerank,sodium ion transport (GO:0006814),0.4807851459818007,1.4273808062626094,0.013513513513513514,0.33008852088357227,1.0,15/85,7.43%,FGF13;SLC24A4;SLC6A6;SGK1;ATP1B3;SLC23A1;SLC5A1;SLC6A19;SLC6A14;SCN4A;ASIC3;SLC6A8;SLC6A7;ATP1A4;SLC6A4
prerank,regulation of endocytosis (GO:0030100),0.49962520132769933,1.427092448066769,0.028969957081545063,0.33014203260395525,1.0,17/61,13.64%,LGALS3;APOE;LRP1;ABL2;MCTP1;SPHK1;CD22;DAB2;RAB5C;SNX33;LILRB1;LRPAP1;HIP1;RAB5A;ABCA7;RUFY2;ROCK1
prerank,cellular response to chemical stress (GO:0062197),0.47335762170400536,1.4268233704391124,0.016511867905056758,0.3301294280461812,1.0,43/96,28.32%,CYBA;ATG7;NFE2L2;MSRA;SLC25A24;CYBB;ATP13A2;PRDX5;PRDX6;CAV1;PRDX1;CPEB2;SRXN1;EIF2S1;ERO1A;NCF4;GSR;LONP1;TXNRD1;CHCHD2;RBM11;PPIA;STOX1;CAT;FOXO1;SOD3;ATM;ALDH3B1;SOD2;NUDT2;PRR5L;ATF4;NCF2;NOX4;NCF1;GPX1;SESN2;STX4;PYCR2;KEAP1;ZFAND1;CYCS;PRDX3
prerank,toll-like receptor signaling pathway (GO:0002224),0.47853420684201065,1.4267449479237677,0.015463917525773196,0.32962164744122224,1.0,22/84,15.98%,COLEC12;RFTN1;S100A8;CTSB;S100A9;UBA52;IRAK2;RPS27A;TNIP1;SFTPA1;SFTPA2;TRAF3;TAB1;TNIP3;MAPKAPK3;MAPKAPK2;TICAM1;TNIP2;MAP3K1;HSPD1;ITGB2;TIRAP
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.4560287197342146,1.4267038937782826,0.001002004008016032,0.3290084780268782,1.0,119/306,25.78%,B4GALT5;APOE;MRPS12;RPS12;ORC3;AGO2;LARGE1;RPS27A;TNIP1;EIF4G1;RPS6;RPS14;MCM7;MCM2;MRPL51;RPL10A;EEF2;GRWD1;RPL18;RPS24;IGHMBP2;RPS7;RPS20;RPL36A;RPL41;EEF1A1;RPS26;MRPL23;RPL17;RPL23;RPS25;ING4;EIF4G2;RPL35A;RPS28;PTMS;RPLP2;RPL28;POLR2H;RMI1;POLE;RPL27A;RNASEH2A;EEF1D;RPL11;RPS2;GTPBP2;MRPL52;BRCA1;ALAS1;RAD50;RPL32;DRG1;MRPS15;RPL21;MRPL24;PWP1;RPL9;CDK2;RPL36;RPL37;BLM;MRPS33;MRPS16;POLR2D;RPS18;RPL38;MRPS7;RPS19;RPS27;CDC7;BARD1;NR4A2;ING5;RPS23;RPL14;SARS1;MRPL11;RPS16;RPL30;RPL12;GSPT1;KAT7;FARSB;ATM;KIN;RPL13A;RPL31;RPS9;RAD1;RPL4;RRBP1;TOP1;RPS3;MCM6;DUT;TBRG1;RECQL5;DBF4;RPS13;MCM8;RPSA;PABPC4;RPL15;TERT;TOPBP1;MRPS14;ST3GAL2;REV1;POLA2;RPL7A;POLR2F;GOLPH3;MRPL37;RRAGC;RFC2;MRPL18;RPL23A;RPL8
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6360858565486986,1.4265221799198013,0.06568364611260054,0.3287649200679171,1.0,3/12,5.92%,CYBA;MMP8;ADGRB1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5790188696266994,1.4263718714020752,0.05307599517490953,0.32847119214300313,1.0,5/22,8.85%,RFTN1;PRKCQ;SPHK1;ZBTB7B;LY9
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4759820578536401,-1.4257552147113781,0.08095238095238096,0.5643693650250418,1.0,5/18,5.89%,GNA15;CHRM2;RGS10;PLCB1;CHRM3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6520884545549929,1.4249714812951748,0.08401084010840108,0.3318208405447485,1.0,4/11,12.95%,ANXA1;TBX21;SOCS5;SMAD7
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6732054704484864,1.4248534862194682,0.06557377049180328,0.33141476364999634,1.0,4/11,16.16%,PCBP4;PCBP1;NOVA2;RASA1
prerank,negative regulation of binding (GO:0051100),0.4853469296827542,1.4247439576983445,0.017838405036726127,0.33098737689885543,1.0,38/81,29.44%,CTSZ;LEF1;NES;GZMA;GTPBP4;PRKCD;CAV1;WAPL;DAB2;MDFI;RACK1;LRPAP1;BAX;JUN;TLE5;ILRUN;SP100;TFAP4;GTF2F1;ROCK1;ACTB;PSME3IP1;SYMPK;RALB;PIN1;ITGB1BP1;IFIT2;GSK3B;USP33;PEX14;SUMO1;JAK2;GOLGA2;KDM1A;DACT1;RSF1;CSNK1E;PEX19
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6061352203884212,1.424139946253986,0.07712082262210797,0.3319894481607008,1.0,5/17,16.89%,EIF6;CAV1;PPARG;PPARD;ADIPOR1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5817897829256367,1.4234261989115526,0.0547945205479452,0.3332819964052208,1.0,5/22,7.41%,IGF1;P2RX4;SLC9A1;NR4A3;LMCD1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6791379290172802,1.4231878355691612,0.068,0.33314302950375424,1.0,4/10,11.60%,SKAP1;CD3E;PIEZO1;CCL5
prerank,anion transmembrane transport (GO:0098656),0.487875919600978,1.4224038910837815,0.029850746268656716,0.33468184765218373,1.0,21/67,18.86%,MFSD12;LRRC8C;SLC3A2;SLC27A1;SLC7A1;SLC23A1;SLC23A2;SLC36A4;SLC25A1;SLC6A8;SFXN1;SLC13A4;SLC25A14;SLC35B1;SLC7A8;SFXN2;SLC25A21;SLC19A1;SLC13A3;ARL6IP5;SLC25A18
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6882359929654489,1.422242298790278,0.05241935483870968,0.33361607927037473,1.0,2/10,14.11%,CNGB1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6882359929654489,1.422242298790278,0.05241935483870968,0.33361607927037473,1.0,2/10,14.11%,CNGB1;CEP250
prerank,positive regulation of calcium ion transport (GO:0051928),0.5302373130040199,1.4214852342445154,0.045871559633027525,0.3350637728522615,1.0,7/36,6.20%,LGALS3;P2RX4;ATP2B1;CCL4;SPHK2;CAV1;CRACR2A
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6203641258586636,1.421159896240319,0.0549738219895288,0.3352793870760376,1.0,3/15,3.90%,IGF1;SLC9A1;NR4A3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.629897077257529,1.421106584094774,0.06460296096904442,0.33472036702419466,1.0,6/14,12.34%,CTNNB1;KMT2A;DNMT1;BRCA1;WDR5;PRDM9
prerank,lipoprotein localization (GO:0044872),0.6648877370447384,1.420234587495809,0.05333333333333334,0.33637783594084497,1.0,3/11,8.41%,LRP1;PPARG;PRKCB
prerank,response to cadmium ion (GO:0046686),0.5593274800106874,1.420095025668539,0.06580493537015276,0.3360018224707276,1.0,17/26,28.10%,MMP9;DAXX;JUN;MAPK9;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;HSF1;SUMO1;NCF1;MT2A;MAPK3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6029592620724451,1.4199462618590208,0.05875,0.33568156076228095,1.0,6/16,19.72%,TCF15;SOX9;SP7;DHX36;HOXB4;LTBP3
prerank,DNA double-strand break processing (GO:0000729),0.5878507883025716,1.4198709464787713,0.07369758576874205,0.33518055266554314,1.0,8/18,21.83%,BRCA1;RAD50;BLM;SLX4;BARD1;UBE2V2;ATM;SETMAR
prerank,tRNA export from nucleus (GO:0006409),0.5379716216141969,1.4194325010877908,0.04387990762124711,0.3349889265707165,1.0,17/32,29.19%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP50;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5379716216141969,1.4194325010877908,0.04387990762124711,0.3349889265707165,1.0,17/32,29.19%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP50;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,negative regulation of cell development (GO:0010721),0.5679649211796283,1.419304546315095,0.05052878965922444,0.33457761847445594,1.0,12/25,27.34%,IGF1;LTF;FBXW7;LILRB1;B2M;APPL2;HOOK3;IL6;GSK3B;TNF;RFLNA;GSK3A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.5048554280143488,1.4190276878830042,0.023076923076923078,0.33461172008405826,1.0,18/57,16.84%,DDX31;RPS6;RPS24;METTL17;RPS7;NOC2L;RPS25;WDR12;RIOK2;RPL35A;RPS28;RPL11;NVL;XPO1;RPL38;RPS19;RPL14;RPS16
prerank,intracellular cholesterol transport (GO:0032367),0.6233159996361353,1.4186537090027938,0.0821566110397946,0.3348970254887456,1.0,9/15,24.34%,ABCG1;ABCA1;OSBPL2;NPC1;LRP6;NPC2;STARD4;SERAC1;OSBP
prerank,neurotrophin signaling pathway (GO:0038179),-0.4424625340706624,-1.4186526566382034,0.07222222222222222,0.5770089891330314,1.0,7/21,10.32%,ZFYVE27;RAPGEF2;CASP3;HAP1;NTRK2;SORT1;DDIT4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4783853578838312,1.4184559697197805,0.02100840336134454,0.3347771374605518,1.0,29/86,19.73%,IGF1;CSPG4;PTPRC;ITGA5;TEC;PDGFA;CD44;HRG;PTK2B;PRKCD;NRP1;ANGPT4;VEGFA;ANGPT1;TREM2;SAMSN1;CADM4;FGF7;FYN;EFNA1;GHR;PAK2;ITGB2;CLEC6A;BMP6;HAX1;IL6;ARHGEF2;IL5
prerank,positive regulation of myelination (GO:0031643),0.6643948756260802,1.4184115231086072,0.06986301369863014,0.3341926810298874,1.0,5/11,15.72%,ITGAX;CST7;EGR2;TNFRSF1B;NCMAP
prerank,positive regulation of transporter activity (GO:0032411),0.6300815948321452,1.4173355304086783,0.06631989596879063,0.336488062115137,1.0,5/13,12.15%,KMT2A;SGK1;PON1;SGK2;KCTD7
prerank,regulation of peptidase activity (GO:0052547),0.5832857001228424,1.416791916118234,0.07888349514563107,0.3372696221348738,1.0,11/19,25.33%,ATP13A2;CST7;CAV1;HDAC1;CSTB;ECM1;RCN3;FURIN;PSMA3;PSMB8;MAPK12
prerank,lipoxygenase pathway (GO:0019372),-0.5098671929455297,-1.416702025835698,0.07692307692307693,0.5743550189183549,1.0,4/14,4.18%,HPGD;LTC4S;ALOX5;PON3
prerank,homocysteine metabolic process (GO:0050667),0.6586529408072314,1.4164420137864986,0.05785123966942149,0.3374999167420746,1.0,9/11,34.17%,MMUT;BLMH;MTRR;TST;MPST;MTHFR;NOX4;CBS;CTH
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6145744262361001,1.4161612469526572,0.06283422459893048,0.33758211188201553,1.0,8/15,21.77%,PRKCH;CYP27B1;VDR;TRIM16;NUMA1;SULT2B1;ETV4;BMP4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6149838743823356,1.4152675936572199,0.06675392670157068,0.3393772726988905,1.0,10/15,25.47%,RENBP;LARGE1;GNPDA1;EXTL2;OGA;NAGK;GNPDA2;AMDHD2;CHST2;CHST3
prerank,negative regulation of catalytic activity (GO:0043086),0.5646325353776099,1.415137650676402,0.044902912621359224,0.3390593840390308,1.0,10/24,20.86%,NES;GZMA;PPP1R12A;HP;CLN3;PHPT1;TMBIM1;CCAR2;CAND1;TIMP1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.47289773037613075,1.414620405045091,0.013211382113821139,0.3398881840571796,1.0,43/105,29.24%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;KRAS;NRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;TAB2;PSMC4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5192487747794841,1.414349587957371,0.05082872928176796,0.3399885321451541,1.0,17/40,26.95%,IGF1;BCL2L1;PLAUR;MMP9;BID;BCL2L11;BAX;TRIAP1;GHITM;CLU;BIK;TNFSF10;PRELID1;BNIP3;GPX1;PSMD10;NOL3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.38217402003912104,-1.4140376975199727,0.046875,0.5739780933812968,1.0,12/36,9.96%,ELMO1;ITGAM;RHOBTB1;BIN2;XKR4;MEGF10;AIF1;FCGR1A;THBS1;XKR6;FCGR2B;RHOBTB2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.5090934098253176,1.4135285968146467,0.03131749460043196,0.34164816316213054,1.0,25/53,29.24%,PSMD8;PSMD1;AZIN1;PSMD6;PSMA1;PSMC3;OAZ3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;ODC1;PSMD5;PSMA5;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;NQO1;PSMB7;PSMC4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6178379683464497,1.413458777938625,0.08445040214477212,0.3411373964134286,1.0,6/14,15.28%,AK8;DCTPP1;AK4;AK3;ITPA;AK5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6608461028502084,1.413228438240966,0.07639836289222374,0.34107655424725974,1.0,9/11,29.22%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;KDM1A;SIRT1
prerank,cellular response to lectin (GO:1990858),0.47291614151582534,1.4130040372564736,0.013224821973550356,0.340283602570494,1.0,43/104,29.24%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;KRAS;NRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;TAB2;PSMC4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.47291614151582534,1.4130040372564736,0.013224821973550356,0.340283602570494,1.0,43/104,29.24%,KLRC2;PSMD8;PSMD1;MALT1;MUC1;MUC16;RAF1;PRKCD;PDPK1;TAB1;PSMD6;PSMA1;PSMC3;KRAS;NRAS;FYN;PSMA8;PAK2;PSMD14;PSMD2;NFKB1;CLEC6A;PSMC6;PSMA6;SYK;CLEC4E;PSMD5;PSMA5;FCER1G;CLEC4D;FBXW11;CUL1;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;TAB2;PSMC4
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.49195351513623425,1.4129357303293655,0.02900107411385607,0.3397434694361282,1.0,26/67,16.59%,FLT1;CYBA;NRP2;CYBB;PIK3CB;AXL;SH2D2A;PTK2B;NRP1;HSPB1;NCK2;NCK1;VEGFA;MAPKAPK3;CYFIP2;MAPKAPK2;NCF4;FYN;RHOA;CDC42;PAK2;AAMP;ROCK1;PRKD2;KDR;PIK3R2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6682809121791109,1.4125247426247776,0.07637906647807638,0.3403188172050877,1.0,8/10,23.29%,RENBP;GNPDA1;NAGK;NPL;ST6GAL1;GNPDA2;NANP;AMDHD2
prerank,pseudouridine synthesis (GO:0001522),0.6286544827939448,1.4123745630286404,0.06852791878172589,0.33998849563480216,1.0,4/13,12.89%,PUS1;TRUB2;PUS7;GAR1
prerank,negative regulation of reproductive process (GO:2000242),0.5826949764766369,1.4122820617491885,0.07860824742268041,0.3395527590872278,1.0,5/17,22.36%,IGF1;NPPC;TIMP1;ARHGDIB;CALR
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.6387899744675674,1.4122417172994834,0.08277703604806408,0.3389206140403754,1.0,2/12,0.64%,LCK;SKAP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.49558517517160694,1.4121540755955575,0.023835319609967497,0.3384633933139287,1.0,12/56,9.26%,S100A8;CTSB;S100A9;UBA52;IRAK2;RPS27A;SFTPA1;SFTPA2;TRAF3;TAB1;MAPKAPK3;MAPKAPK2
prerank,glycoprotein biosynthetic process (GO:0009101),0.48045775161955406,1.4121354287128327,0.022198731501057084,0.3378064248475904,1.0,11/79,5.75%,IGF1;XYLT1;CHST11;B4GALT5;ATP7A;LARGE1;B4GALT7;GCNT2;TNIP1;B3GNT3;B3GALNT2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6381902217685858,1.4116988832361295,0.08376963350785341,0.3383044918206486,1.0,4/13,10.84%,TSR1;KRI1;BMS1;UTP20
prerank,response to estrogen (GO:0043627),0.534276929794692,1.4114813261910346,0.056753688989784334,0.33820439625368354,1.0,11/31,25.13%,CD24;CYP27B1;CAV1;SERPINB9;GATA3;BRCA1;RBBP5;WBP2;TRIM24;KMT2D;SFRP1
prerank,cellular response to superoxide (GO:0071451),0.6625969518674214,1.4107809534328897,0.08378378378378379,0.33959610457811956,1.0,5/10,20.37%,ATP7A;PRDX1;ADPRS;SOD3;SOD2
prerank,glucose import (GO:0046323),0.6383415847870938,1.409436445731578,0.06282722513089005,0.3427124771930915,1.0,3/13,4.49%,SLC27A1;SLC5A1;SLC2A1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.595430062701622,1.4093591579985592,0.07323232323232323,0.3422047809937128,1.0,6/18,10.09%,ANXA1;HDAC9;HDAC7;FGF2;VEGFA;HMOX1
prerank,ncRNA export from nucleus (GO:0097064),0.5255427231268839,1.4092100330727892,0.039503386004514675,0.3419759036001454,1.0,18/36,29.19%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NPM1;NUP50;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5477265092507084,1.4085879768427545,0.05693950177935943,0.3432606047471976,1.0,5/26,8.75%,B4GALT5;LARGE1;TNIP1;GK;ST8SIA6
prerank,membrane fusion (GO:0061025),0.5304110292739158,1.4085509225811264,0.06098964326812428,0.34265468343299443,1.0,9/33,17.56%,MYOF;RABEP1;FER1L5;NAPA;DNM2;HUWE1;GCA;CHP1;VAMP2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6370713230480567,1.4079041959471488,0.06961178045515395,0.34380982130489823,1.0,7/13,18.98%,LPL;CD9;ABCA1;PPARG;ITGB2;SYK;FCER1G
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6475684666210553,1.4066921192361281,0.08613728129205922,0.3466216858178693,1.0,2/11,6.69%,GCK;SIK1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5383127927698758,1.4061311711526738,0.05336426914153132,0.34756899970110694,1.0,14/29,24.83%,ACACA;ACSBG1;ACSBG2;HACD2;SLC25A1;ACSL1;SCD5;HSD17B8;HACD1;GCDH;ELOVL2;ELOVL1;HSD17B12;FASN
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5524940096731389,1.4060552385612128,0.06042654028436019,0.3470917964664721,1.0,9/26,16.12%,IGF1;SLC9A1;DYRK2;LMCD1;RCAN1;CHERP;HOMER2;SPPL3;CHP1
prerank,regulation of glucose import (GO:0046324),0.5302029904700162,1.4059332109127578,0.0611764705882353,0.34674259766353044,1.0,2/30,0.09%,IGF1;OSBPL8
prerank,thyroid hormone generation (GO:0006590),-0.5548732448362403,-1.4057466246677985,0.13768115942028986,0.5892874089044485,1.0,7/10,35.11%,TG;CTSK;FOXE1;SLC5A5;DUOX1;DIO2;CPQ
prerank,cytoplasmic microtubule organization (GO:0031122),0.4966438869658532,1.405601287379419,0.03406593406593406,0.3470238984798655,1.0,18/54,20.14%,CCDC88C;MAP10;TUBGCP4;FIGNL1;DYNC1H1;CLIP2;HOOK1;DCTN1;VPS4B;WDR73;RHOA;CRIPT;NUMA1;CHP1;HOOK3;RAB11A;DST;SLAIN2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.6042645276846098,1.4047629496306673,0.083223249669749,0.3488869957750401,1.0,8/16,18.99%,ACACA;SLC25A1;SCD5;DIP2A;HSD17B8;PPCS;ACAT1;GCDH
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6107229184946277,1.4046431371466,0.07051282051282051,0.3485136955970435,1.0,3/16,3.02%,APOE;HIF1A;PIK3CB
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6216383524819222,1.404613896086068,0.07785234899328859,0.34790817629283627,1.0,5/13,10.61%,RENBP;LARGE1;EXTL2;OGA;NAGK
prerank,regulation of cell communication (GO:0010646),0.5251386843633246,1.4044522769343495,0.04632768361581921,0.3476713272627518,1.0,9/35,11.49%,IGFBP7;ANXA1;TBX18;MTCH1;VEPH1;MGLL;UGCG;SRI;YWHAG
prerank,regulation of translation (GO:0006417),0.4592627644161949,1.4044137531273038,0.004012036108324975,0.3470801245728869,1.0,77/173,27.39%,EPRS1;EIF1;SHFL;EIF6;VIM;EIF4G1;GZMB;NCL;CD28;EEF2;HSPB1;PIWIL2;ETF1;RBM4B;EIF4G2;LSM14A;PUS7;EIF2A;PATL2;RACK1;NOLC1;LARP4;CPEB3;MIF4GD;METTL3;SHMT1;CNOT10;DDX1;ALKBH1;OGFOD1;YTHDF3;TRAP1;LARP1;ENC1;EIF4G3;ILF3;YBX2;SYNCRIP;EIF5B;DAPK1;EIF4A3;EIF4ENIF1;DHX36;TCOF1;KLHL25;EIF4E2;FXR2;MTRF1;EIF2B2;DAPK3;GSPT1;IL6;RPL13A;DHX9;EIF3E;NSUN3;UPF3A;ATXN2;RPS3;EIF4A2;NPM1;UPF3B;GIGYF2;SAMD4A;CALR;EIF3B;POLDIP3;EIF4B;EIF2B4;EIF3H;PYM1;MALSU1;NAT10;GEMIN5;EIF1B;CYFIP1;EIF4E
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5212191820377242,1.4030106159480025,0.054272517321016164,0.35044273967538997,1.0,11/33,24.21%,CSF1;CD4;LEF1;ID2;RUNX1;HAX1;ACIN1;HSF1;IL34;CD74;TNF
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5806333344455712,1.4025921707644529,0.07028360049321825,0.35024284064460687,1.0,3/20,7.02%,IGF1;HIF1A;PFKFB3
prerank,positive regulation of glycolytic process (GO:0045821),0.5806333344455712,1.4025921707644529,0.07028360049321825,0.35024284064460687,1.0,3/20,7.02%,IGF1;HIF1A;PFKFB3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4116248427897483,-1.4021243804789136,0.043243243243243246,0.5916334506428678,1.0,12/25,20.36%,CTSS;WNK1;GLRX;WNK3;DMD;SLC6A9;COX17;STAC;TRPC6;ANK2;ANK3;PDZK1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3663167057313556,-1.4019844297378503,0.034782608695652174,0.5840420819308488,1.0,12/40,16.70%,MEF2C;ZEB1;MMD;BEND6;BRINP1;PCP4;ECT2;REST;SIN3A;VWC2;BMP2;TCF4
prerank,positive regulation of viral life cycle (GO:1903902),0.5648232624495667,1.401191620320399,0.069221260815822,0.3535872679669584,1.0,7/22,10.94%,LGALS1;CD4;AXL;TMPRSS2;P4HB;DDB1;KPNA6
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5834283568813831,1.4007136242932852,0.08364544319600499,0.3543265759363954,1.0,3/18,6.08%,GPNMB;LAX1;PTPN22
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4654912164771096,1.4003876230998167,0.012244897959183673,0.35462511061363083,1.0,49/114,31.31%,PSMD8;PSMD1;TMSB4X;TRAF2;LTB;TNFSF15;PTK2B;TRAF3;ILK;PSMD6;PSMA1;ADAM17;TRAF1;PSMC3;TNFRSF1B;PSMA8;TNFRSF9;PSMD14;PSMD2;TNFSF8;PSMC6;PSMA6;TNFSF9;PSMD5;PSMA5;EIF5A;TNFRSF11B;CDIP1;ACTN4;PSMA3;JAK2;TNF;BIRC2;PSMB10;PSMB8;PSMD7;AIM2;PSMB6;PSMD10;PSMB5;LIMS1;RIPK1;PSMB7;PSMC4;TNFRSF8;PYDC1;TXNDC17;TNFSF12;PSMD12
prerank,regulation of myeloid cell differentiation (GO:0045637),0.49463515579043915,1.3999306862193368,0.0322234156820623,0.35523862911299475,1.0,21/62,19.10%,LGALS3;CDK6;KMT2A;PRKCQ;EIF6;CNOT4;NR4A3;PTK2B;MYL9;RUNX1;HDAC1;PRKCB;RBBP5;WDR5;ZBTB16;RBM15;SETD1A;HSPA9;PRMT6;PAF1;AGO3
prerank,cholesterol homeostasis (GO:0042632),0.49413723848105845,1.3993194881774609,0.031880977683315624,0.35634213397888587,1.0,10/64,5.31%,LPL;APOE;ABCG1;ABCA1;HDAC9;CD24;APOA2;MALL;SOAT1;CAV1
prerank,base conversion or substitution editing (GO:0016553),0.6601418454772063,1.3992054332415758,0.07832167832167833,0.35597903479165083,1.0,3/11,10.42%,APOBEC1;ADARB1;METTL3
prerank,regulation of mitotic spindle organization (GO:0060236),0.5156405696079382,1.398916753839602,0.06004618937644342,0.35613785915393414,1.0,13/35,18.86%,DYNC1H1;CHMP4B;PDCD6IP;DCTN1;DRG1;VPS4B;NUMA1;TPR;TACC3;RAE1;HNRNPU;PARP3;CCSAP
prerank,negative regulation of telomere maintenance (GO:0032205),0.6083556652122946,1.3987566079039684,0.08964646464646464,0.35595240520587784,1.0,8/15,19.74%,TNKS2;ERCC1;RAD50;ERCC4;SLX4;ATM;RTEL1;TERF1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6373403246220446,1.3987287142730267,0.07446808510638298,0.3553469202387885,1.0,7/13,21.77%,ADAM8;TESPA1;FOXJ1;CLPTM1;CAMK4;TOX;BMP4
prerank,DNA duplex unwinding (GO:0032508),0.5002909251808472,1.3978260128310513,0.03812636165577342,0.35729127041481784,1.0,25/50,27.23%,ANXA1;UBA52;RPS27A;MCM7;MCM2;ASCC3;DDB2;DDB1;RAD50;DDX1;XPA;BLM;TWNK;PURA;GTF2H1;DHX9;RTEL1;UBC;MCM6;RECQL5;XPC;GTF2H5;CUL4A;SUPV3L1;CETN2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4881785779087285,1.3977442261319448,0.02754237288135593,0.3568364986543391,1.0,31/72,27.96%,PSMD8;PSMD1;MALT1;TRAF2;TNFSF15;COPS8;PSMD6;PSMA1;CARD10;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;TIRAP;PSMD5;PSMA5;FBXW11;CUL1;REL;PSMA3;BIRC2;PSMB10;PSMB8;PSMD7;PSMB6;BTRC;PSMD10;PSMB5;PSMB7
prerank,regulation of phosphorylation (GO:0042325),0.4650044501885116,1.3973881680940388,0.009211873080859774,0.3572280318316966,1.0,47/120,26.60%,FNIP2;STAP1;HIF1A;FN1;CORO1C;SDCBP;CCDC88C;NUP205;EIF6;GCK;CD24;GCKR;MCM7;NRP1;HSPB1;ILK;CADM4;NUP188;CCL5;OGT;ROCK1;RANBP2;TPR;BARD1;KDM4D;PRKAG1;RAE1;PIN1;TESK1;PTGES3;DSCAM;NLRC5;NUP93;AAAS;BMP4;SLC2A6;MIF;NUP50;JMJD8;NUP54;CCDC88A;NCKAP1L;NUP98;SESN2;NUP42;NUP133;NUP210
prerank,positive regulation of immune response (GO:0050778),0.48597941792072796,1.3972366940931118,0.0334051724137931,0.3569591591532981,1.0,16/64,15.23%,CYBA;SKAP1;FPR2;PTPRC;CD226;ADAM8;SPHK2;HRG;GPR151;IL12RB1;LILRB1;POLR3D;CCL5;RIOK3;RSAD2;ITGB2
prerank,negative regulation of interferon-beta production (GO:0032688),0.6706451564968285,1.3964556530971328,0.07387140902872777,0.3585259309774231,1.0,4/10,13.55%,SIRPA;NLRC3;LILRB1;YY1
prerank,cellular protein catabolic process (GO:0044257),0.4899293402700045,1.396013864515493,0.04520990312163617,0.3591464846057115,1.0,13/59,11.22%,CTSB;CTSZ;TCIRG1;MYLIP;MALT1;CTSW;GZMB;GZMA;SIAH2;CLPP;AFG1L;LONP1;RAB7A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5819675999879056,1.3959533806927882,0.07604562737642585,0.3586256344696219,1.0,9/19,23.29%,RENBP;GNPNAT1;GNPDA1;NANS;NAGK;UAP1L1;GNPDA2;UAP1;AMDHD2
prerank,positive regulation of type 2 immune response (GO:0002830),-0.48705065852491863,-1.3956402273699717,0.09583333333333334,0.5937246128078625,1.0,5/14,11.22%,IL18;CD86;CD81;NLRP3;PRKCZ
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6298715400783932,1.3951613388303976,0.08377659574468085,0.36028422389304104,1.0,7/13,24.20%,DAB2;RBPMS;SH2B1;BMP6;NUP93;BMP4;JAK2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6531189079156501,1.3950278135230119,0.07650273224043716,0.35998463039063283,1.0,4/10,12.90%,GDF6;SOX9;PKDCC;ZBTB16
prerank,negative regulation of phagocytosis (GO:0050765),0.5911048264873364,1.3947675857678958,0.07788944723618091,0.36004020274124204,1.0,5/17,9.42%,CD300LF;SIRPA;FER1L5;CD300A;RACK1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6518014489965382,1.3945911916270053,0.09433962264150944,0.35983397304438675,1.0,1/10,0.06%,XYLT1
prerank,innate immune response (GO:0045087),0.4493790318882387,1.3945172167622568,0.0,0.35934405894433047,1.0,73/217,26.15%,COLEC12;LCK;CYBA;CAMP;LCN2;KLRC2;LTF;MALT1;FGR;CD300LB;CYBB;SHFL;SRPK1;TRIM6;TRIM43;CYP27B1;PTK2B;RNASE3;MFHAS1;OTULIN;PPARG;MSRB1;IFITM2;TRIM28;AKAP1;TREM2;DMBT1;PPP1R14B;IFITM1;B2M;FYN;C3;MASP1;IRF5;ATAD3A;NRROS;SP100;ZDHHC1;MBL2;CXCL16;ADAM15;CLEC6A;SYK;SMPD1;CLEC4E;RNASE7;CFP;PGLYRP2;S100B;JCHAIN;RNASE6;FCER1G;BST2;SLC11A1;ADAR;CLEC4D;CYBC1;MASP2;HMGB1;NLRC5;LBP;SRPK2;TRIM21;CD74;REL;IRAK4;KYNU;NCF2;BTK;TREML1;YES1;TLR9;NCF1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.6004169241566598,1.3943438456471522,0.07760814249363868,0.35916716700715196,1.0,11/15,29.22%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;MDM2;KDM1A;PTTG1IP;SIRT1
prerank,UV-damage excision repair (GO:0070914),0.6324038503906025,1.3943411417899965,0.08785529715762273,0.3584921038002615,1.0,5/12,14.38%,ERCC1;DDB2;DDB1;XPA;INO80
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5965755527774179,1.3943385641994253,0.08213820078226858,0.35782153984661486,1.0,8/16,22.76%,PIGQ;PIGZ;PIGA;PIGN;PIGL;PIGC;PIGX;PIGH
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6386288436129162,1.3939828131842555,0.06992084432717678,0.35818029697662285,1.0,5/12,19.31%,PRKCQ;IL12RB1;CCR2;CLEC6A;SLC11A1
prerank,sterol transport (GO:0015918),0.5788145302231639,1.393570686346499,0.07749077490774908,0.3586998193421283,1.0,8/19,26.08%,APOA2;CAV1;ARV1;OSBPL2;NPC1;NPC2;OSBP;MSR1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.47000426882905105,1.3935295394379499,0.012409513960703205,0.35813475712195475,1.0,35/94,24.47%,FNIP2;BCL2;BCL2L1;TRAF2;MCL1;CD24;PRKCD;ERN2;STK24;ERN1;IKBKE;BCL2L11;DIABLO;ERO1A;BAX;BRCA1;TNFRSF1B;DDIT3;CYP1B1;APAF1;CASP4;C1QBP;MYBBP1A;GSKIP;STK11;ATM;ARL6IP5;CUL3;CASP9;CUL1;CUL2;PPP1R15A;DNAJC10;BNIP3;ATF4
prerank,aerobic respiration (GO:0009060),0.5720739164171874,1.3932936578204216,0.07785888077858881,0.3581544163298132,1.0,11/20,24.40%,NDUFS7;SDHB;SLC25A14;SURF1;UQCRH;MTFR2;MTFR1;SDHC;UQCR10;UQCRB;SIRT3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5997555611480524,1.3916777657915038,0.08997429305912596,0.3620660082712197,1.0,3/15,0.83%,LPL;PRKCH;CSF1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5025221577178689,1.3915569308963465,0.052689352360043906,0.36172767513775245,1.0,10/43,13.20%,IGF1;SIRPA;NLRC3;LTF;POMC;CD274;PTPN22;LILRB1;ILRUN;GAS6
prerank,sterol homeostasis (GO:0055092),0.49091304508257216,1.391525507944838,0.03825717321997875,0.3611477918178883,1.0,10/65,5.31%,LPL;APOE;ABCG1;ABCA1;HDAC9;CD24;APOA2;MALL;SOAT1;CAV1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.56217806511753,1.3908096551222733,0.0691358024691358,0.3626540206036976,1.0,9/22,18.87%,ERCC6;BRD4;THOC1;EAPP;HMGN1;CDK13;DDX39B;KAT7;CCNT2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.582684484652913,1.3906450728088142,0.07604562737642585,0.3624898221180399,1.0,8/18,20.12%,IGF1;CD24;IL12RB1;IL27RA;TNFSF9;IL2;RPS3;HMGB1
prerank,regulation of cation channel activity (GO:2001257),-0.3144511934366914,-1.390164892155589,0.0,0.6021486730854697,1.0,27/89,14.11%,CACNB2;MEF2C;GRIA4;NLGN1;FGF12;CTSS;NEFL;FGF14;DLG2;GRIN2A;GRIA3;CACNG3;NETO1;LRRC7;GRIN2B;DMD;APP;SHISA6;CACNG8;FGF11;NOS1;GRIN1;STAC;CAMK2B;CNIH3;CAMK2A;PDE4D
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5438504816881824,1.3901037234352596,0.06498194945848375,0.3633738329473683,1.0,10/27,15.23%,LCK;SKAP1;SIRPA;PRKCQ;CD44;NR4A3;CCR2;RHOA;HSPD1;ITGB2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.654486056620083,1.3898707520339302,0.09536784741144415,0.363349339123437,1.0,5/10,24.26%,PTPRC;TLE5;SIGIRR;MAPK7;MAP2K5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.47455381814282216,1.3890099072117206,0.018691588785046728,0.36520209986894653,1.0,35/84,27.96%,PSMD8;PSMD1;UBA52;RPS27A;ANAPC15;FZR1;FBXO31;FBXO5;PSMD6;PSMA1;CCNB1;PSMC3;PSMA8;ANAPC1;CDK2;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CDC26;CUL3;BUB1B;UBC;ANAPC7;PSMA3;PSMB10;PSMB8;PSMD7;UBE2C;PSMB6;PSMD10;PSMB5;PSMB7
prerank,regulation of embryonic development (GO:0045995),0.5218970004883141,1.3884603555434403,0.057803468208092484,0.36613857001543965,1.0,13/34,22.93%,B4GALT5;NIBAN2;DAG1;TRIP12;PHLDB1;RBM19;RACGAP1;DHX36;CCSAP;EHMT1;CFL1;NIPBL;ZBED3
prerank,B cell differentiation (GO:0030183),0.5006042774187428,1.3883991270439846,0.05660377358490566,0.3656372993578313,1.0,10/46,11.72%,PTPRC;HDAC9;ITGA4;HDAC4;KLF6;BLNK;TPD52;ADAM17;PTPN2;DNAJB9
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5992010321214937,1.3881724010169951,0.08854166666666667,0.3656747406085947,1.0,11/16,33.77%,SOX9;BRCA1;APOC1;APPL2;SIRT4;ACADL;WDTC1;ERLIN1;CEACAM1;ACADVL;ERLIN2
prerank,organelle fusion (GO:0048284),0.5597294998584421,1.3879195410231564,0.08024691358024691,0.3656988821488214,1.0,13/22,32.14%,EEA1;THG1L;VPS18;BAX;AFG3L2;VPS11;STX4;USP30;SPG7;FIS1;MFF;MIGA2;MFN1
prerank,regulation of aerobic respiration (GO:1903715),0.6111007989733213,1.3877540413463394,0.07632600258732213,0.36546956672351716,1.0,5/15,9.73%,ATP7A;COX7A1;SLC25A33;AK4;VCP
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5589195536424253,1.387533051835608,0.06463414634146342,0.3653422541483376,1.0,9/24,16.06%,OLR1;ITGAL;MSN;TNIP1;ITGA4;CCL5;ROCK1;ITGB2;SYK
prerank,response to interleukin-1 (GO:0070555),0.4760600642909859,1.387458613094236,0.029015544041450778,0.3649386587496928,1.0,18/73,16.45%,HIF1A;SIRPA;ANXA1;IRAK2;TANK;CCL4;MAPK13;HDAC4;SOX9;CCL13;CCL7;CCL5;TLE5;CCL14;NFKB1;ACOD1;GBP2;SMPD1
prerank,O-glycan processing (GO:0016266),0.4861268172887611,1.3865574708280737,0.04475982532751092,0.3668958055239034,1.0,6/54,3.88%,B4GALT5;GALNT7;GALNT15;MUC1;MUC16;B3GNT3
prerank,macrophage migration (GO:1905517),0.6169092066482575,1.3861469938993487,0.09078590785907859,0.36735719071041995,1.0,5/13,11.60%,LGALS3;P2RX4;TAFA4;CCR2;CCL5
prerank,axon extension (GO:0048675),0.5617917695984006,1.385914904912801,0.06699147381242387,0.3673389499550133,1.0,5/23,8.76%,ALCAM;NRP2;CDK5;NRP1;USP9X
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5392809006343382,1.385166984135416,0.08180708180708181,0.36870373940969997,1.0,8/24,14.48%,PRKCH;CYP27B1;VDR;RUNX1;TRIM16;HOXA7;ROCK1;NUMA1
prerank,zymogen activation (GO:0031638),0.5110539085330897,1.3848343609762186,0.0757918552036199,0.36901294762152514,1.0,13/39,17.36%,PLAU;ASPH;KLK1;HP;HPR;F11;CYFIP2;PGK1;CD5L;KLKB1;FURIN;APOH;KLK3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.49846716796645796,1.384826042466947,0.04299889746416759,0.3683740395293323,1.0,25/48,31.50%,HIF1A;NUP205;EIF6;GCK;GCKR;NUP188;OGT;RANBP2;TPR;PRKAG1;RAE1;NUP93;AAAS;SLC2A6;NUP50;JMJD8;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214;NOA1;EP300
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.650922001555902,1.384556296973894,0.10483870967741936,0.3685184087888792,1.0,4/10,12.95%,MALT1;TBX21;NFKBIZ;SMAD7
prerank,cellular response to cAMP (GO:0071320),-0.37849756890903397,-1.3838493086212347,0.05303030303030303,0.6128590367384606,1.0,14/30,28.71%,RAPGEF2;HCN1;IGFBP5;AKAP6;DMTN;INPP5K;EZR;PDE2A;RAPGEF3;KCNQ1;AQP1;SLC5A5;WT1;HCN2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5407420853537618,1.3837254668484196,0.08004778972520908,0.37015871136716755,1.0,7/24,21.27%,IGF1;GCK;DYRK2;SORBS1;EPM2AIP1;PPP1R3F;GSK3B
prerank,response to iron ion (GO:0010039),0.6342407594523343,1.3835644276559549,0.09375,0.3699755745034735,1.0,2/12,0.52%,BCL2;HIF1A
prerank,regulation of store-operated calcium entry (GO:2001256),0.67281840964478,1.3833320257174058,0.07607192254495158,0.3700042703357902,1.0,4/10,14.36%,CD84;SARAF;SLC8B1;HOMER2
prerank,regulation of activated T cell proliferation (GO:0046006),0.5285017043063703,1.38267195864722,0.06924882629107981,0.37125730598652273,1.0,12/30,21.64%,IGF1;CD24;IL12RB1;CD274;IL27RA;CRTAM;TNFSF9;RIPK3;IL2;RPS3;HMGB1;PRKAR1A
prerank,lymphocyte chemotaxis (GO:0048247),0.5210190366215706,1.3825498891426022,0.06136363636363636,0.3709505941280444,1.0,9/34,14.65%,CCL4;ADAM8;CCL13;CCL7;CCL5;GAS6;CCL14;CXCL16;CH25H
prerank,positive regulation of protein processing (GO:0010954),0.5787671762254105,1.3824245950246716,0.07512315270935961,0.37066872335062323,1.0,6/19,15.84%,ADAM8;ENO1;GSN;LPCAT3;KLKB1;MELTF
prerank,regulation of synapse organization (GO:0050807),-0.40743294999577195,-1.3820623085870338,0.041666666666666664,0.6102907789220599,1.0,10/26,13.11%,MEF2C;IL1RAPL1;CTNNA2;CDKL5;EPHA4;PDLIM5;SLITRK4;WNT5A;MDGA1;CAMK2B
prerank,keratinocyte differentiation (GO:0030216),0.5328168621125423,1.381719709813724,0.07259953161592506,0.3721545193693277,1.0,6/29,9.63%,ANXA1;ST14;JAG1;CLIC4;UGCG;EVPL
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.52643208787799,-1.3807143565335798,0.12350597609561753,0.6067840916752035,1.0,4/12,11.55%,TUBB4A;STMN1;MAP2;DYRK1A
prerank,transition metal ion transport (GO:0000041),0.5134648668385348,1.3800766496377421,0.07191780821917808,0.37642314932379445,1.0,11/35,19.96%,TRPC4;SLC31A2;LTF;ATP7A;ATOX1;HEPH;SLC30A9;MELTF;TFRC;SLC11A1;FTH1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5533425119165307,1.3799287320903033,0.08992805755395683,0.3761911796470826,1.0,7/22,11.40%,SASH1;XDH;GDF6;SPHK1;MFHAS1;VEGFA;RELL1
prerank,response to amino acid starvation (GO:1990928),0.4814872324274201,1.3798107301953924,0.03563941299790356,0.3758403454167967,1.0,16/72,12.29%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;EIF2S1;DAPL1;DAP;NPRL2;ATP6V1F;LARP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6293135521395348,1.3790367862937034,0.09176788124156546,0.3774928899081346,1.0,9/12,29.22%,BCL2;MUC1;CD44;TRIAP1;ING2;CD74;MIF;KDM1A;SIRT1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4754156063727101,1.3787624507910434,0.042598509052183174,0.37773912532974874,1.0,20/71,12.24%,CTSB;CTSZ;MALT1;FBXL17;UBA52;RPS27A;CTSW;GZMB;GZMA;CLPP;CHMP4B;ATXN3;PDCD6IP;USP9X;VCP;DDB1;LONP1;VPS4B;PSMA8;DDI2
prerank,positive regulation of protein depolymerization (GO:1901881),0.6429751603285851,1.3786344358631706,0.09866666666666667,0.3774559621219796,1.0,2/11,3.12%,PLEK;NES
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6332835739599265,1.3782266954495095,0.08525033829499323,0.3779750959984229,1.0,6/11,27.83%,YBX3;RIPK3;ARHGEF2;BIRC2;PELI1;RIPK1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5415456407590887,-1.377564397022574,0.11811023622047244,0.608656366322413,1.0,5/10,15.77%,PRKCE;HECW1;HECW2;OSR1;NEDD4L
prerank,regulation of synapse maturation (GO:0090128),-0.5518279182709844,-1.3775600925266756,0.11387900355871886,0.6012554650718875,1.0,6/10,27.49%,NRXN1;CAMK2B;ADGRL1;ARHGEF15;RELN;CDC20
prerank,negative regulation of programmed cell death (GO:0043069),0.4408006965339856,1.3768326150747525,0.0,0.381307287064656,1.0,119/355,25.31%,IGF1;BCL2;CTNNB1;ARHGAP10;BCL2L1;NIBAN2;IL2RB;FLNA;ANXA5;PLAUR;ANXA1;LTF;MALT1;LEF1;UBA52;RPS27A;MCL1;PDPN;FIGNL1;ANXA4;CD44;PRDX5;AXL;SPHK1;PTK2B;MMP9;RAF1;SQSTM1;CD28;HYPK;SERPINB9;HSPB1;ANGPT4;BID;SIAH2;MYDGF;DAB2;TPT1;SOX9;APIP;VEGFA;ANGPT1;TREM2;HDAC1;PLK2;IGF1R;PSEN2;NAA16;SON;UFM1;MGMT;NAT8;ATF5;CLN3;TRIAP1;PIM1;RAB7A;WDR73;ATAD3A;BIRC6;PRDM9;HNRNPK;FSTL1;GAS6;PAK2;BIRC5;IL31RA;NFKB1;BFAR;HSPD1;CIAPIN1;CBL;HSPA9;CAT;VIP;USP47;RNF157;FOXO1;BARD1;TFRC;HTATIP2;CCND2;KDR;RASA1;RIPK3;HAX1;IL6;WFS1;HIGD2A;BNIP2;AIFM2;IL2;UBC;MTDH;LAPTM5;VHL;CFL1;GSK3B;NPM1;BMP4;HTR2B;CD74;PRELID1;AVEN;MIF;DNAJA1;SOCS2;BNIP3;BAG3;PLK3;TCIM;BIRC2;GOLPH3;HDAC2;HSPA5;SFRP1;KANK2;NCKAP1L;YWHAZ
prerank,endodermal cell differentiation (GO:0035987),0.5198843134755596,1.3767212730145197,0.07514450867052024,0.38097089866647327,1.0,6/31,9.37%,FN1;MMP8;ITGA5;MMP9;ITGA4;COL12A1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.48796440050038226,1.3764828919615753,0.04618689581095596,0.3810781152649262,1.0,19/54,16.45%,APOE;HIF1A;P2RX4;TMSB4X;HRG;FGF2;HSPB1;ANGPT4;PPARG;PDPK1;VEGFA;ANGPT1;ADAM17;JUP;ANGPT2;PRKD2;KDR;NF1;MAP2K3
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5730707150715052,1.3764205359062587,0.08354430379746836,0.3805734411298878,1.0,11/19,27.47%,HRG;NRP1;VEGFA;MYOC;ROCK1;KDR;FERMT2;COL16A1;SFRP1;S100A10;LIMS1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6030533893999774,1.3761868372600812,0.07518796992481203,0.3805649572412248,1.0,6/15,15.02%,ARPC2;ARPC3;ARPC5;IQGAP2;ACTR3;ARPC1B
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6549073650206523,1.3757957849826448,0.09817671809256662,0.38104472029897873,1.0,4/10,10.59%,KMT2A;SPHK2;SMARCB1;BRCA1
prerank,tRNA transport (GO:0051031),0.5136676469197095,1.3756050433424403,0.06598407281001138,0.380925164852433,1.0,17/35,29.19%,NUP205;XPOT;NUP188;NOL6;RANBP2;TPR;RAE1;NUP93;AAAS;NUP50;NUP54;NUP98;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5926117148343036,1.3751385575215331,0.10125,0.3816636484892999,1.0,5/16,9.73%,ATP7A;COX7A1;SLC25A33;AK4;VCP
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5943948177691419,1.375127150760227,0.07151979565772669,0.3810311710800767,1.0,2/16,3.74%,IGF1;CILP
prerank,inflammatory response (GO:0006954),0.4456944512312947,1.3750483588201143,0.0070140280561122245,0.380572523860196,1.0,46/195,16.03%,S100A8;S100A9;CYBA;CD96;FPR2;OLR1;PTGIR;ANXA1;ITGAL;CYBB;LAT;HDAC9;ADCY8;CXCR2;PARP4;CCL4;ADAM8;PTGFR;CD44;PRDX5;C3AR1;MFHAS1;HDAC4;MGLL;BLNK;NFX1;HP;HPR;TAC4;CCL13;CRH;MAPKAPK2;LTB4R;CCR2;CCL7;CCL5;ADGRE5;NRROS;CCL14;NFKB1;SIGLEC1;TPST1;ADORA2A;ITGB2;TUSC2;HSPG2
prerank,lipoprotein biosynthetic process (GO:0042158),0.6406777972643478,1.3748123590798915,0.08413793103448276,0.38060299045874213,1.0,4/11,9.57%,APOE;ATG7;UGCG;WDR45
prerank,regulation of neuron projection development (GO:0010975),-0.2858010117200565,-1.3745788162953005,0.0,0.6024727574089817,1.0,45/163,13.11%,CSMD3;TANC2;IL1RAPL1;LRRC4C;CTNNA2;ARSB;CDKL5;ABI3;EPHA4;SERPINI1;KANK1;ARHGAP44;PTPRO;TWF2;LRRK2;RTN4RL1;SIPA1L1;LRRC7;PRKCI;RIT2;RAPGEF2;PDLIM5;PSEN1;CDH2;ITGA6;NDRG4;CAMK1D;SHANK3;PPFIA2;NCS1;CRMP1;NTRK2;CAMK1;WNT5A;RET;DBN1;FKBP4;PRKD1;TRPV4;NTRK3;BRSK1;ARHGAP35;MAG;PAK3;CAMK2B
prerank,lamellipodium organization (GO:0097581),-0.40158863593324134,-1.3741965593597338,0.05263157894736842,0.5963614530227537,1.0,8/29,11.67%,P2RY12;SNX2;PTPRO;CARMIL1;ABLIM3;DMTN;CDH13;ARHGEF4
prerank,mesoderm development (GO:0007498),0.5747611741092873,1.3735627370384675,0.10115236875800256,0.3836892385529481,1.0,4/18,7.63%,IKZF3;TCF15;VEGFA;HES7
prerank,regulation of platelet aggregation (GO:0090330),0.5906167635061247,1.3733373569616996,0.06455862977602109,0.3836754996189166,1.0,5/17,10.26%,CD9;PRKCQ;PDPN;PRKCD;SERPINE2
prerank,protein-DNA complex assembly (GO:0065004),0.45966102316825247,1.3729645803908093,0.017382413087934562,0.3841011281363326,1.0,57/116,32.73%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;GRWD1;DAXX;SOX9;GMNN;PSMD6;PSMA1;DDB2;DDB1;PSMC3;XPA;PSMA8;DMC1;PSMD14;PSMD2;CHAF1B;PSMC6;PSMA6;PSMD5;PSMA5;ATRX;GTF2H1;UBC;MCM6;MCM8;NPM1;NAP1L3;PSMA3;XPC;ANP32B;GTF2H5;PSMB10;PSMB8;PSMD7;CUL4A;PSMB6;PSMD10;H3-3A;CETN2;PSMB5;RSF1;PSMB7;MNAT1;PSMC4;HMGB2;ASF1A;ERCC2;PSMD12;PSMD3;UBB;SART3
prerank,positive regulation of biosynthetic process (GO:0009891),0.5020197429528728,1.3729527559673518,0.06696428571428571,0.38347800004839994,1.0,12/40,17.53%,CYBA;APOE;MMP8;VIM;ADGRB1;SUCO;RUNX1;CCL5;SORBS1;SIRT4;SLC5A3;SERPINF2
prerank,positive regulation of immune system process (GO:0002684),0.5876120890000541,1.3729245662166336,0.0840764331210191,0.3828920346655954,1.0,5/16,14.03%,ANXA1;PIK3CB;GPR151;VEGFA;RSAD2
prerank,histone H3-K4 trimethylation (GO:0080182),0.6266806810930179,1.3726722953924835,0.10724233983286909,0.3829182164860651,1.0,5/11,14.75%,KMT2A;TET3;PRDM9;OGT;SETD1A
prerank,regulation of cytokine production (GO:0001817),0.452694680181952,1.3721819711440417,0.017189079878665317,0.3837034990864237,1.0,41/126,24.21%,GPNMB;PLD3;SIRPA;ITK;PTPRC;ANXA1;LTF;FGR;HDAC9;ATP2B1;NPTN;CD28;TRAF3;BCL6;GATA3;CADM1;TREM2;TXK;BTN3A3;IRF8;MAPKAPK2;PLA2R1;CRTAM;CCR2;TNFRSF1B;DTX4;CLEC6A;ASB1;RIPK3;IL6;SLC11A1;AGPAT2;CD47;SRGN;TRIM21;NLRP4;PTGER4;HTR2B;MIF;AGPAT1;TNF
prerank,oligosaccharide metabolic process (GO:0009311),-0.3577764273643421,-1.370946799430592,0.052083333333333336,0.5984150310407729,1.0,9/46,6.81%,ST3GAL6;B3GALT5;AMY1C;AMY1B;AMY1A;ST8SIA4;ST6GAL2;GAL3ST4;B3GALT1
prerank,early endosome to late endosome transport (GO:0045022),0.5674300218032606,1.3708644018845995,0.08739076154806492,0.38715354258226636,1.0,12/20,30.12%,EEA1;WDR91;PTPN23;HOOK1;RAB7A;RAB5A;HOOK3;LMTK2;RILP;KIF16B;SNF8;BECN1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6202216694976086,1.370671698474183,0.09947643979057591,0.38709232212764244,1.0,3/12,7.28%,APOBEC1;TRIM28;DNMT1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5598580655194284,1.3706603925740894,0.08837772397094432,0.38647046542497565,1.0,2/21,1.75%,OSBPL8;PLAAT3
prerank,regulation of trophoblast cell migration (GO:1901163),0.6011294084054362,1.3706197961815578,0.09041835357624832,0.3859685923496642,1.0,7/14,22.36%,AGO2;VEGFA;YTHDF3;C1QBP;TIMP1;ARHGDIB;CALR
prerank,cytoplasmic translational initiation (GO:0002183),0.5860282186390474,1.3705294342988097,0.07566204287515763,0.3855722490182379,1.0,12/17,29.87%,EIF4A1;EIF3A;EIF4G1;DENR;DHX29;EIF3M;EIF2S2;EIF4A2;EIF4B;EIF3I;EIF2D;EIF5
prerank,positive regulation of angiogenesis (GO:0045766),0.4555545099652394,1.370257456851275,0.018537590113285273,0.3857542475174781,1.0,29/108,16.39%,FLT1;HIF1A;ITGAX;PKM;SASH1;ITGA5;AGO2;SPHK1;FGF2;HSPB1;ANGPT4;MYDGF;RUNX1;PDPK1;VEGFA;PRKCB;JUP;HMOX1;BRCA1;HIPK1;SERPINE1;JAK1;ECM1;SMAD1;PRKD2;CYP1B1;KDR;NINJ1;ANXA3
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.467719695899106,1.3693022930655945,0.035233160621761656,0.3878378963434071,1.0,17/77,15.88%,LGALS3;IGF1;BCL2;BCL2L1;PLAUR;MCL1;MMP9;SIAH2;NOC2L;HTT;SLC35F6;TRIAP1;BIRC6;MPV17L;GHITM;CLU;NR4A2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5895283247278797,1.369112549455554,0.08634020618556701,0.3877003855801089,1.0,3/16,3.90%,IGF1;SLC9A1;NR4A3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6034354222243361,1.368722508638061,0.09326424870466321,0.3882336782500539,1.0,6/14,15.98%,MALT1;TRAF2;TNFSF15;COPS8;CARD10;TIRAP
prerank,positive regulation of protein sumoylation (GO:0033235),0.649299364626689,1.3683853422928163,0.10043041606886657,0.3885369592705587,1.0,8/10,31.93%,HDAC4;GNL3;PIAS1;SAE1;RWDD3;PIAS4;MUL1;PIAS3
prerank,DNA alkylation (GO:0006305),0.5737637598548987,1.367772414406735,0.08603491271820449,0.3889557733533476,1.0,7/19,20.35%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.5737637598548987,1.367772414406735,0.08603491271820449,0.3889557733533476,1.0,7/19,20.35%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1
prerank,regulation of mitochondrial translation (GO:0070129),0.5519129243379175,1.3675816095844273,0.08353221957040573,0.38889095793916534,1.0,17/21,36.51%,TRUB2;TRMT10C;RCC1L;ALKBH1;C1QBP;NSUN3;FASTKD3;MRPS27;RPUSD4;MALSU1;FASTKD2;MTG1;SHMT2;RMND1;NGRN;UQCC2;TSFM
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.46934089415546293,1.367578227480156,0.04058272632674298,0.3882502466575114,1.0,33/72,27.83%,PTPRC;IRAK2;TRAF2;CD24;AXL;SPHK1;OTULIN;RUNX1;RNASEL;PTPN2;RACK1;TRAF1;HIPK1;JAK1;SHARPIN;GAS6;SIGIRR;SYK;USP18;PIAS1;AGPAT2;HSP90AB1;CD74;AGPAT1;SUMO1;JAK2;TNF;BIRC2;PTPN6;IFNAR2;IFNGR2;TNFAIP3;RIPK1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5810993290083143,1.367392186641974,0.09815950920245399,0.3881442823372989,1.0,6/18,13.20%,MSN;RGP1;WDR91;NELL1;RIC1;VPS11
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5094658321848486,1.3667537803544956,0.07093821510297482,0.38931107339622745,1.0,19/35,32.57%,CTNNB1;PRKCQ;CCT2;TNKS2;PKIB;CCT8;HNRNPA2B1;DHX36;ATM;RTEL1;CCT5;ACD;MAPK15;ATR;MAPK3;XRCC5;PNKP;MAPK1;MAP3K4
prerank,regulation of dendrite development (GO:0050773),-0.370628842028457,-1.3663877201812626,0.057692307692307696,0.6044313949339284,1.0,10/37,10.42%,CSMD3;CDKL5;ADGRB3;HECW1;BCL11A;HECW2;CAMK1D;LRP8;VLDLR;DBN1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5408142716039024,1.3658501126534384,0.08866995073891626,0.39128975452136844,1.0,14/22,32.33%,RPS7;RPS20;RPL23;PLA2R1;RPL37;CHD5;ATM;SPRED2;EIF5A;SPRED3;ATR;HEXIM1;UBB;RPS15
prerank,activation of protein kinase B activity (GO:0032148),0.5237388233384925,1.3655049068345688,0.07910271546635184,0.3916838406799504,1.0,4/29,6.23%,IGF1;OSBPL8;NRG1;PDPK1
prerank,regulation of p38MAPK cascade (GO:1900744),0.5083054101698496,1.3653216563392934,0.07587768969422423,0.39154415715854857,1.0,10/35,11.40%,SASH1;XDH;GDF6;SPHK1;MFHAS1;PTPN22;VEGFA;TREM2;RASGRP1;RELL1
prerank,catecholamine biosynthetic process (GO:0042423),0.6293915851357104,1.3651158255634865,0.11382113821138211,0.3915045020499379,1.0,2/11,6.37%,TH;GATA3
prerank,DNA replication initiation (GO:0006270),0.5106527421353481,1.3649262289889044,0.07037457434733257,0.39146329303071925,1.0,16/37,24.14%,ORC3;MCM7;MCM2;POLE;GMNN;NOC3L;CDK2;CDC7;PURA;MCM6;DBF4;MCM8;CDC34;TOPBP1;POLE4;POLA2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5861393045623112,1.3646608928523447,0.09205548549810845,0.39164424510551993,1.0,9/16,24.21%,SHFL;ETF1;IGF1R;CLN3;OGFOD1;MTRF1;GSPT1;BNIP3;TNF
prerank,positive regulation of inflammatory response (GO:0050729),0.4596246452413704,1.3646541626468016,0.032224532224532226,0.391013527334566,1.0,33/86,28.18%,LPL;S100A8;S100A9;MMP8;TNIP1;ADAM8;OSMR;MAPK13;NAPEPLD;NFKBIZ;CEBPA;CCR2;SERPINE1;GPRC5B;RPS19;NINJ1;SNX4;PDCD4;IL6;DHX9;IL2;GPSM3;LBP;CD47;PTGER4;IL17RA;TNF;MDK;TLR9;CX3CL1;CCN4;RIPK1;ABCC1
prerank,regulation of amyloid fibril formation (GO:1905906),0.585700226873887,1.3639018408976358,0.09554973821989529,0.3925089887974932,1.0,6/15,18.31%,APOE;TREM2;IAPP;PFDN1;CLU;PFDN2
prerank,mitochondrial membrane organization (GO:0007006),0.52051408285385,1.363524500388036,0.07621247113163972,0.3929852620135103,1.0,11/32,17.67%,BCL2;BCL2L1;IMMT;SAMM50;RCC1L;MTX3;GHITM;CHCHD6;SLC25A31;HSPA9;TMEM11
prerank,actin nucleation (GO:0045010),0.5637162548867798,1.3630584760280824,0.07065868263473053,0.3937473879650871,1.0,7/21,15.02%,ARPC2;ARPC3;ARPC5;SCIN;IQGAP2;ACTR3;ARPC1B
prerank,regulation of protein kinase activity (GO:0045859),0.4518086431527527,1.3630498259570418,0.01940755873340143,0.393127365632856,1.0,31/106,19.26%,IQGAP1;CSF1;SMCR8;PTPRC;CD4;FGR;LAT;ALS2;GNAQ;PTK2B;HSPB1;DAXX;PDPK1;DBNDD1;TAB1;DTNBP1;YWHAG;GAS6;PAK2;JTB;PPIA;LRP6;CHP1;NF1;MAP2K3;PRKAG1;GSKIP;DDR2;C5AR1;TAF7;ITGB1BP1
prerank,cellular response to amino acid starvation (GO:0034198),0.4761029126640486,1.3626339539502645,0.042105263157894736,0.39370689419380117,1.0,15/71,11.94%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;EIF2S1;DAPL1;DAP;NPRL2;ATP6V1F
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5263194915534497,1.362516309894883,0.09188544152744631,0.39339990737782443,1.0,5/27,4.64%,FLT1;FPR2;FGR;PTK2B;FGF2
prerank,histone lysine methylation (GO:0034968),0.517417340878307,1.3620996483192327,0.06235294117647059,0.39397212774526713,1.0,15/33,27.03%,CXXC1;KMT2A;DYDC1;DOT1L;RBBP5;SMYD3;WDR5;PRDM9;SMYD2;SMYD1;SETMAR;KMT2D;TRMT112;WDR5B;SETDB1
prerank,cellular response to interleukin-1 (GO:0071347),0.4481376796880749,1.361774719036682,0.012133468149646108,0.3943087918997595,1.0,57/143,29.24%,HIF1A;SIRPA;PSMD8;PSMD1;UBA52;IRAK2;TANK;CCL4;RPS27A;MAPK13;SQSTM1;SOX9;TAB1;PSMD6;PSMA1;CCL13;PSMC3;CCL7;CCL5;PSMA8;TNIP2;PSMD14;CCL14;PSMD2;NFKB1;ACOD1;PSMC6;PSMA6;GBP2;IL1R2;PSMD5;MAP3K8;PSMA5;PTGIS;UBC;FBXW11;CUL1;CD47;EGR1;IRAK4;PSMA3;PSMB10;SFRP1;PSMB8;PSMD7;PSMB6;CX3CL1;BTRC;PELI1;PSMD10;RC3H1;PSMB5;PSMB7;MAPK3;IL1R1;TAB2;PSMC4
prerank,positive regulation of multicellular organismal process (GO:0051240),0.43397056000756934,1.3617218289793769,0.001,0.39380871658685573,1.0,94/308,23.57%,B4GALT5;CTNNB1;APOE;ITGAX;LCN2;PRKCH;ABCA1;LRP1;NIBAN2;SDCBP;FABP5;SLC27A1;ITK;FGR;LEF1;AGO2;GCNT2;PDPN;PEMT;BMP1;CYP27B1;VDR;GLIPR2;FGF2;CD28;DYNC1H1;UCP2;CAV1;FOXJ1;DAB2;ZBTB7B;SOX9;ACSL1;VEGFA;CADM1;TREM2;TXK;IGF1R;TRIM16;FBXO5;KDM3A;CRH;LRPAP1;BAMBI;PLA2R1;CRTAM;CCR2;ENO1;SERPINE1;KMT5B;RBM19;PPARGC1B;ZBTB16;OGT;GAS6;ABCA7;GHR;ROCK1;YBX2;NUMA1;RPS19;CLEC6A;VIP;C1QBP;APPL2;TFRC;PLAC8;SYK;CPT2;ADIPOR1;SNX4;DECR1;IL6;FERMT2;SLC11A1;IL2;AGPAT2;EHMT1;CFL1;FABP4;HSF1;LBP;ETV4;BMP4;ACADL;PTGER4;TERT;F2R;HTR2B;ZBED3;GNAS;TGFBR2;MIF;AGPAT1
prerank,mammary gland development (GO:0030879),0.5572044842296399,1.3611987972944084,0.085995085995086,0.3947442575041889,1.0,5/21,7.00%,NRG1;CSN3;CAV1;ZBTB7B;VEGFA
prerank,cellular response to oxidative stress (GO:0034599),0.44876529564000106,1.3610017095905316,0.019427402862985686,0.39473331753627083,1.0,51/118,28.32%,CYBA;HIF1A;NFE2L2;MSRA;SLC25A24;CYBB;ATP13A2;PRDX5;PRDX6;MMP9;PRKCD;PRDX1;CPEB2;SRXN1;EIF2S1;AGAP3;ERO1A;NCF4;GSR;PLA2R1;HMOX1;LONP1;JUN;TXNRD1;CHCHD2;RBM11;PPIA;DAPK1;MAPK9;CAT;FOXO1;SOD3;ALDH3B1;RPS3;SOD2;NUDT2;PRR5L;ATF4;PDGFRA;NCF2;NOX4;NCF1;GPX1;SESN2;STX4;PYCR2;KEAP1;ZFAND1;CYCS;MAPK3;PRDX3
prerank,regulation of MAPK cascade (GO:0043408),0.4419071265027265,1.3604672123384003,0.011099899091826439,0.39563964815768554,1.0,46/157,22.90%,BCAR3;IGF1;IQGAP1;FLT1;FN1;MMP8;PTPRC;CD4;DAG1;PDGFA;CD24;PAK6;FGF2;TAOK3;CAV1;MYDGF;STK3;APIP;RASGRP1;IGF1R;PRDM15;IAPP;MYOC;ABCA7;PAK2;ROCK1;LPAR1;TMEM106A;KDR;SYK;NF1;PIK3R2;DUSP3;MINK1;DHX33;IL6;FAM83D;HMGB1;LAPTM5;RNF41;TAOK1;FGFR3;ARHGEF5;F2R;MAP2K2;CD74
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.46451945650936377,-1.3604655666870102,0.102803738317757,0.6142329207345872,1.0,6/15,10.32%,ZFYVE27;CASP3;HAP1;NTRK2;SORT1;DDIT4
prerank,positive regulation of vasculature development (GO:1904018),0.4539547822096437,1.3603185982690866,0.03608247422680412,0.3954464516426761,1.0,25/94,16.39%,FLT1;HIF1A;ITGAX;SASH1;AGO2;SPHK1;FGF2;HSPB1;ANGPT4;MYDGF;RUNX1;PDPK1;VEGFA;PRKCB;JUP;HMOX1;BRCA1;HIPK1;SERPINE1;ECM1;PRKD2;CYP1B1;KDR;NINJ1;ANXA3
prerank,response to interferon-alpha (GO:0035455),0.582480176766521,1.3602595560384503,0.09462915601023018,0.3949699060040739,1.0,8/16,19.33%,AXL;IFITM2;GATA3;IFITM1;GAS6;TPR;BST2;ADAR
prerank,positive regulation of T cell differentiation (GO:0045582),0.5093689917371422,1.3601599332893353,0.07701149425287357,0.39460796825380223,1.0,7/36,6.37%,ZMIZ1;LEF1;ADAM8;TESPA1;IL12RB1;BCL6;GATA3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5454299910775408,1.3597115979773107,0.0883054892601432,0.3952878048377625,1.0,5/23,14.32%,IGF1;HIF1A;PFKFB3;ENTPD5;NFKB1
prerank,negative regulation of histone methylation (GO:0031061),0.6373346407165199,1.3597083332815298,0.09932885906040269,0.3946684128946069,1.0,6/10,18.59%,DNMT1;MTF2;BRCA1;WDR5;PHF1;DNMT3B
prerank,respiratory system development (GO:0060541),0.5143729114567002,1.3592059558613918,0.08060747663551401,0.39558573182506546,1.0,17/32,27.42%,PDPN;FGF2;VEGFA;BASP1;NKX2-1;FGF7;CEBPA;RBP4;ITGA3;DISP1;BMP4;FGFR2;FGF1;CCDC40;SMCHD1;CCDC39;CHD7
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4369838812561324,1.3582370521119431,0.015120967741935484,0.39790214035916016,1.0,35/170,16.16%,IGF1;APOE;HIF1A;CDK6;C1D;SIRPA;PTPRC;AFF1;HRG;TRIM6;TRIM43;DHH;NELL1;TFEB;UBAP2;FUBP1;TREM2;TXK;CDH1;TAPBP;NFKBIZ;AFF4;HMG20B;PRDM9;ZFP64;NPAT;HNRNPK;PCBP4;CDK2;YBX3;YBX2;STOX1;PCBP1;NOVA2;RASA1
prerank,negative regulation of immune effector process (GO:0002698),0.607879956463538,1.3579382001019542,0.11473272490221642,0.3981529540605889,1.0,7/13,21.76%,LGALS3;LILRB1;CD300A;RPS19;HAVCR2;CD55;CD47
prerank,response to hydrogen peroxide (GO:0042542),0.4867746890371967,1.3577721108109417,0.066006600660066,0.39796471173699427,1.0,23/45,29.22%,SIRPA;NFE2L2;ANXA1;MAPK13;PRKCD;STK24;HP;PLEKHA1;HMOX1;FYN;CYP1B1;CAT;GLRX2;RIPK3;IL6;RPS3;MAPK7;GPX1;TNFAIP3;RIPK1;PRDX3;APTX;SIRT1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4135200134113831,-1.3568751307378604,0.07954545454545454,0.6175325508171843,1.0,11/24,14.06%,F11R;WASF2;PIK3R1;TMEFF2;TJP1;STMN1;CGNL1;CLASP2;INPP5K;PHLDB2;ARHGAP28
prerank,regulation of multicellular organismal development (GO:2000026),0.5350391544065337,1.3566141770514648,0.09349112426035502,0.4008626955906135,1.0,12/25,22.68%,CD24;DUSP9;TRIP12;GATA3;DUSP6;MYSM1;GBX1;RACGAP1;DHX36;CCSAP;EHMT1;NIPBL
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5179525095443337,1.3564182936923252,0.09049255441008018,0.4008050524538803,1.0,13/30,27.83%,BCL2L1;TRAF2;HMOX1;BRCA1;SERPINE1;TMBIM1;ARHGEF2;GSK3B;TNFSF10;BMP5;GPX1;TNFAIP3;RIPK1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5451559903289236,1.3561117207305358,0.10353227771010962,0.4011482294715857,1.0,6/21,10.78%,ADCY8;ADCY3;NPPA;ADCY7;AMPD2;NPR2
prerank,regulation of cell cycle phase transition (GO:1901987),0.4601062958619544,1.355921218402096,0.03441084462982273,0.40108870445862316,1.0,37/91,27.96%,PSMD8;PSMD1;FBXW7;ANAPC15;FZR1;FBXO5;PSMD6;PSMA1;DDB1;CCNB1;PSMC3;PSMA8;TFAP4;ANAPC1;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;CDC26;BUB1B;DBF4;CUL1;ANAPC7;PSMA3;XPC;TCIM;PSMB10;PSMB8;PSMD7;UBE2C;PSMB6;BTRC;PSMD10;PSMB5;PSMB7
prerank,positive regulation of locomotion (GO:0040017),-0.3932939570864843,-1.3556135020993387,0.0684931506849315,0.6144192702669851,1.0,4/27,8.20%,P2RY12;CSF1R;AIF1;THBS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4588269400079819,1.3550892055026198,0.028955532574974147,0.4029006271792884,1.0,33/87,27.96%,GPNMB;CDK6;PSMD8;PSMD1;FBXO5;PSMD6;PSMA1;WEE1;PSMC3;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PRMT2;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;DCUN1D3;CDK4;PSMB10;KANK2;PSMB8;PSMD7;PSMB6;PSMD10;CDK2AP2;DACT1;PSMB5;PSMB7
prerank,regulation of leukocyte migration (GO:0002685),0.5737409108280803,1.3549412950399728,0.11764705882352941,0.4027034711875544,1.0,5/16,11.03%,ANXA1;VEGFA;HOXA7;HMOX1;RHOG
prerank,positive regulation of proteolysis (GO:0045862),0.4741970890886914,1.3548452533964905,0.07243243243243243,0.4023576409312514,1.0,20/55,26.16%,APOE;ASPH;TANK;TNIP1;ADAM8;SNX33;CYFIP2;TNFRSF1B;OGT;RCN3;FURIN;SH3D19;FBXW11;WDR48;TBC1D10A;TNF;IST1;HDAC2;MAPK12;BTRC
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5680406133025071,1.354224598379401,0.10419313850063533,0.403636527231932,1.0,12/18,30.07%,RAD51B;BRD4;FBXO5;CCNB1;VPS4B;STOX1;CDC7;RAB11A;CDK4;CDC25B;CDC25A;CCND1
prerank,ribosome assembly (GO:0042255),0.4879781945849686,1.354082772725167,0.07540983606557378,0.40339593723814304,1.0,15/47,15.78%,EIF6;BRIX1;RPS14;RRP7A;RPS28;EIF2A;PPAN;RPL11;DHX29;EFL1;MRPS7;RPS19;RPS27;MDN1;C1QBP
prerank,T-helper cell differentiation (GO:0042093),0.5990657743747172,1.3540550024114815,0.1081441922563418,0.40282536024987725,1.0,7/14,26.03%,LEF1;ATP7A;TMEM98;IL6;HMGB1;PTGER4;GPR183
prerank,nucleus organization (GO:0006997),0.4832611833764179,1.353864018234989,0.0753045404208195,0.40281172421454475,1.0,21/47,26.39%,NUP205;SYNE1;CTDNEP1;CHMP4A;CHMP4B;PDCD6IP;LEMD2;REEP3;VPS4B;WDR73;CHMP7;NUMA1;RPS19;TPR;SUN1;CHMP6;NUP93;USP36;NUP54;NUP98;NUP133
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6575510997183407,1.3533630300694812,0.11662198391420911,0.4036805378163168,1.0,5/10,16.05%,BCL2;RACK1;MYOC;DCN;KDR
prerank,negative regulation of cytokine production (GO:0001818),0.44099348958363693,1.3533474190886943,0.011033099297893681,0.4030851484754184,1.0,52/163,22.29%,GPNMB;CD84;FN1;MMP8;SIRPA;NLRC3;PTPRC;ANXA1;TMSB4X;RNF125;LEF1;HDAC9;HDAC7;TBX21;ATP2B1;CHID1;ANXA4;AXL;APOA2;ADCY7;NPTN;FOXJ1;CD274;PTPN22;CD200R1;IKBKE;TREM2;LILRB1;ABCD2;ILRUN;GAS6;DDIT3;UBE2L6;HOMER2;ACOD1;C1QBP;APPL2;SIGIRR;SARS1;PDCD4;ASB1;PIN1;IL6;HAVCR2;SLC11A1;HMGB1;LAPTM5;NLRC5;RNF216;SRGN;TRIB2;PTGER4
prerank,regulation of T cell cytokine production (GO:0002724),0.5869160704481432,1.3533251983048988,0.10786802030456853,0.40252813132695026,1.0,6/15,12.95%,MALT1;TRAF2;B2M;CCR2;TNFRSF1B;SMAD7
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6239454305916714,1.353237645697227,0.09695290858725762,0.4021694302653809,1.0,5/12,14.09%,XDH;PIK3CB;HRG;CADM4;DCN
prerank,lysosome localization (GO:0032418),0.5032966633662733,1.3530600983041408,0.07457627118644068,0.4020619419934897,1.0,9/37,15.35%,PLEKHM2;PLEKHM1;NR4A3;ARL8B;TFEB;MILR1;SPAG9;BORCS5;HPS6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5289665809898907,1.3530555325152844,0.10476190476190476,0.40145061833764817,1.0,8/28,11.68%,MFSD12;MITF;SIRPA;EIF6;SIRT5;C3;CCL5;TNFRSF1B
prerank,regulation of presynapse assembly (GO:1905606),-0.4446817696711561,-1.352964587579253,0.1276595744680851,0.6082510740562166,1.0,6/18,11.50%,IL1RAPL1;LRFN5;PTPRD;IL1RAPL2;APP;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.4446817696711561,-1.352964587579253,0.1276595744680851,0.6082510740562166,1.0,6/18,11.50%,IL1RAPL1;LRFN5;PTPRD;IL1RAPL2;APP;MDGA1
prerank,regulation of cholesterol transport (GO:0032374),0.5560954344620079,1.3528426615877176,0.09090909090909091,0.4014439886922641,1.0,6/20,14.32%,LRP1;APOA2;ABCA13;ARV1;APOC1;NFKB1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5549469531547737,1.3527550057199247,0.10776942355889724,0.4010875993079096,1.0,3/19,5.53%,CYBA;PRDX5;PRDX1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5102515873949497,1.3524662383313213,0.07755581668625147,0.40134898643615907,1.0,16/30,27.54%,CCT2;DNAJB14;ERO1A;GAK;SDF2L1;DNAJB13;HSPA8;ENTPD5;HSPA9;DNAJB1;PTGES3;HSPE1;HSPA5;HSPA2;ST13;DNAJB12
prerank,gene expression (GO:0010467),0.43313885752545805,1.352321461100837,0.001001001001001001,0.4012106017092358,1.0,148/348,28.22%,APOBEC1;MRPS12;RPS12;NUP205;ADARB1;DEDD2;AGO2;RPS27A;TNIP1;EIF4G1;RPS6;RPS14;MRPL51;RPL10A;RPL18;HNRNPUL1;RPS24;IGHMBP2;RPS7;RPS20;RPL36A;RPL41;EEF1A1;RPS26;MRPL23;RPL17;RPL23;RPS25;TSPAN17;RPL35A;THOC1;RPS28;RPLP2;RPL28;POLR2H;XRN2;ATXN1;DDX17;RPL27A;RNASEL;RPL11;RPS2;PABPN1;M1AP;MRPL52;NUP188;TASP1;SRSF11;RBPMS;RPL32;PRPF4;ANGPT2;DRG1;MRPS15;SRSF7;RPL21;MRPL24;PWP1;HNRNPK;TSPAN5;RPL9;AGFG1;RPL36;RPL37;MRPS33;MRPS16;DDX39B;POLR2D;RPS18;HNRNPA2B1;RPL38;MRPS7;SYNCRIP;RANBP2;HSPD1;RPS19;RPS27;TPR;EIF4A3;DUSP11;NR4A2;SYMPK;CHTOP;RPS23;RPL14;SARS1;MRPL11;RPS16;THOC2;RBM15B;RBM39;RAE1;RPL30;HNRNPU;RPL12;GSPT1;HNRNPF;FARSB;RPL13A;RPL31;RPS9;SNRNP40;SRSF2;ADAR;RPL4;RRBP1;RPS3;RPS13;NUP93;AAAS;RPSA;PABPC4;DKC1;RPL15;UPF3B;MRPS14;RBMS2;POLDIP3;SRRM1;NUP50;NUP54;RPL7A;POLR2F;GOLPH3;MRPL37;HNRNPL;RRAGC;NUP98;MRPL18;MCM3AP;RPL23A;RPL8;NOX4;RPLP1;NUP42;NUP133;RPL29;NUP210;FASTKD2;RPL37A;THOC6;EIF4E;MRPL41;MRPL27;CREBL2;SRSF1;SMG1;NUP35
prerank,glycerolipid catabolic process (GO:0046503),0.5652148458974601,1.3519952336438807,0.1227217496962333,0.4015572547758189,1.0,7/19,16.77%,GDPD3;PRDX6;ABHD12;MGLL;SMPD4;LYPLA2;PNPLA6
prerank,DNA-dependent DNA replication (GO:0006261),0.44939793380804566,1.3515752162460803,0.015166835187057633,0.4022019352696935,1.0,53/128,27.96%,PSMD8;PSMD1;ORC3;UBA52;RPS27A;MCM7;MCM2;DDX21;POLE;GMNN;NOC3L;PSMD6;PSMA1;PSMC3;PSMA8;CDK2;PSMD14;BLM;PSMD2;TWNK;PSMC6;CDC7;PSMA6;POLG2;POLB;PSMD5;WDHD1;RFC1;PSMA5;PURA;POLG;GINS1;UBC;MCM6;RECQL5;DBF4;MCM8;CDC34;SRPK2;TOPBP1;POLE4;PSMA3;POLA2;PSMB10;RFC2;PSMB8;BAZ1A;PSMD7;PSMB6;PSMD10;PSMB5;POLD4;PSMB7
prerank,sulfate transport (GO:0008272),0.6039503622699263,1.3514328152298947,0.10677083333333333,0.4019893945599214,1.0,7/14,21.80%,SLC26A1;SLC13A4;SLC26A11;SLC25A14;SLC26A4;RACGAP1;SLC26A6
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5624586103714538,1.3506766025407753,0.08405438813349815,0.4036508617037424,1.0,8/20,15.41%,LCP1;PLEK;FMNL2;STRIP1;FMNL3;RHOQ;ROCK1;LLGL2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.45320289320821294,1.3503870820248471,0.03611971104231166,0.4038981473275739,1.0,30/84,22.36%,HIF1A;NRP2;P2RX4;TMSB4X;SASH1;PIK3CB;PTK2B;FGF2;NRP1;HSPB1;ANGPT4;PDPK1;GATA3;PLPP3;VEGFA;ANGPT1;RIN2;ADAM17;AAMP;PRKD2;KDR;ANXA3;MAP2K3;GPI;SP1;ITGB1BP1;HMGB1;BMP4;FGF18;CALR
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5077522479121139,1.3503809110518212,0.08151549942594719,0.40330735088459135,1.0,14/34,20.05%,FLT1;ANXA1;SPHK1;NRP1;HSPB1;ERN1;VEGFA;MAPKAPK2;DLL4;PRKD2;KDR;MAP2K3;ITGB1BP1;MT1G
prerank,RNA metabolic process (GO:0016070),0.4470178398791027,1.3503793059350153,0.02014098690835851,0.4026997048713466,1.0,46/127,19.41%,APOBEC1;ADARB1;DEDD2;AGO2;RNASE3;HNRNPA3;HNRNPUL1;HNRNPM;THOC1;POLR2H;XRN2;PAPOLA;ATXN1;DDX17;HNRNPC;RNASEH2A;RNASEL;PABPN1;M1AP;METTL3;RBPMS;RNASEH1;ALKBH1;PRPF4;HNRNPK;GTF2F1;DDX39B;POLR2D;HNRNPA2B1;RBFOX2;SYNCRIP;PCBP1;DUSP11;RNASEH2B;DHX36;RBM39;ISG20;HNRNPU;HNRNPF;DHX9;RNASE6;SNRNP40;TP53RK;AGO3;ADAR;ATXN2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.46145670227776336,1.3501023216550296,0.05448717948717949,0.40297368648414106,1.0,20/65,17.80%,BCAR3;PLAUR;MMP9;RHBDF2;SH3KBP1;GRB2;RHBDF1;MVP;PTPN2;HIP1;PTPN12;DOK1;STAM2;CDC42;MVB12A;CBL;DUSP3;DGKD;EPS15L1;HIP1R
prerank,regulated exocytosis (GO:0045055),0.43785826686263474,1.3500338506697935,0.010030090270812437,0.4025883896710711,1.0,52/173,21.21%,IGF1;CD9;FN1;TLN1;PLEK;FLNA;ANXA5;TMSB4X;TAGLN2;ALDOA;CHID1;PDGFA;CTSW;SCIN;HRG;CPLX4;A2M;LHFPL2;DNAJC5;PSAP;CDK5;SYNGR1;APLP2;ACTN1;TOR4A;VEGFA;RAB11FIP1;LAMP2;GTPBP2;CYB5R1;PIP5K1C;SERPINE1;CD63;F5;ECM1;LY6G6F;CPLX2;GAS6;PROS1;CLU;APOH;FAM3C;SERPINF2;VAMP2;OLA1;ARHGAP17;F8;SYT8;ACTN2;CDC37L1;TIMP1;ITGA2B
prerank,protein methylation (GO:0006479),0.4940130529162071,1.3493883347401452,0.08445945945945946,0.4039368326228513,1.0,18/40,26.19%,ETFBKMT;ETF1;METTL22;PRMT5;PRMT7;CARM1;EEF1AKMT3;PRMT2;PRMT6;GSPT1;FAM98A;EHMT1;EEF2KMT;PRMT3;NSD3;TRMT112;NTMT1;NSD1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6336080485449437,1.3487609586134994,0.12108843537414966,0.40510511126129956,1.0,3/10,20.79%,DNMT3A;PRMT7;ZFP57
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5011976278804299,1.348295792971495,0.07424071991001124,0.4058765825448711,1.0,17/39,28.89%,NFE2L2;ITGA4;PDPK1;GATA3;ANGPT1;SERPINE1;TNIP2;GAS6;KDR;PDCD4;KRIT1;ANO6;MAPK7;TNF;PAK4;TNFAIP3;NDNF
prerank,macrophage differentiation (GO:0030225),0.6034564881753061,1.3480869643152578,0.10249671484888305,0.40591117536032467,1.0,6/13,14.16%,CSF1;CD4;MMP9;VEGFA;CDC42;IL31RA
prerank,regulation of phospholipase activity (GO:0010517),0.646474913375268,1.3476219821861373,0.12165775401069519,0.4066775713627037,1.0,6/10,25.17%,LRP1;PDPK1;RASGRP1;FGFR3;FGFR2;PLA2G5
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5545249507249559,1.3467858538602837,0.09650180940892641,0.4085916083609,1.0,9/21,29.06%,PTPA;MFHAS1;BOD1L1;YWHAB;GSK3B;PPP1R15A;PPP1R8;FKBP1B;FKBP1A
prerank,regulation of mast cell degranulation (GO:0043304),0.5949994604477835,1.3463534963509867,0.10026737967914438,0.4092964900890294,1.0,6/14,19.65%,CD84;FGR;SPHK2;CD300A;SYK;GAB2
prerank,sulfur compound transport (GO:0072348),0.5189276386253517,1.3456841879516899,0.08640552995391705,0.41068042182746867,1.0,8/27,15.53%,SLC27A1;SLC26A1;SLC6A6;SLC13A4;SLC26A11;SLC25A14;SLC26A4;RACGAP1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.46973515936400434,1.3455683925374722,0.05832449628844114,0.4104324499549217,1.0,12/63,13.50%,LGALS3;IGF1;DEDD2;TRAF2;CAV1;BID;SIAH2;HTT;TRAF1;BIRC6;SP100;PAK2
prerank,JNK cascade (GO:0007254),0.4995122680715794,1.3453332076233795,0.07085714285714285,0.410496549641517,1.0,14/40,22.29%,UBA52;IRAK2;RPS27A;DUSP9;MAP4K2;MAP4K3;CRKL;TAB1;MAP3K12;MAPK9;MINK1;UBC;SH2D3C;PTGER4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.47179675930640114,1.3446138281412707,0.07354555433589462,0.41198678234810415,1.0,15/52,17.04%,LGALS3;PRKCH;LRP1;SQSTM1;PDPK1;TREM2;STAC2;RANGRF;RACK1;CLN3;RHOG;STX3;SORBS1;CNPY4;ITGA3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4637685084330657,1.344509849611641,0.059498956158663886,0.41166950116563295,1.0,24/68,22.86%,FLAD1;SLC23A1;SLC23A2;ACP5;MTHFD2;SLC2A1;ABCD4;SLC46A1;MTHFS;PDXK;MMUT;SHMT1;SLC52A2;MTHFD1;FPGS;MMAB;MTRR;SLC19A1;AASDHPPT;ALDH1L2;CYB5R3;GSTO2;PDZD11;SLC19A2
prerank,negative regulation of dephosphorylation (GO:0035305),0.5598423621846502,1.343878864597372,0.11097410604192355,0.41289982749637505,1.0,9/18,23.69%,PTPA;MFHAS1;ZCCHC9;PPP1R35;SH2D4A;CHP1;YWHAB;PPP1R15A;PPP1R8
prerank,protein-containing complex assembly (GO:0065003),0.42764913421212386,1.3436017388251906,0.0050150451354062184,0.4130888298985662,1.0,107/259,29.59%,SH3PXD2B;CTNNB1;MITF;FN1;CD3E;CTSZ;CD247;TCF7;IL2RB;EPRS1;SLC9A1;KMT2A;GOSR2;LEF1;ADCY8;CAPG;TRAF2;TUBGCP4;CD3G;PTK2B;SLC2A1;SEC22B;PPP2R1A;DNAJB14;ANKRD28;SOX9;WIPF1;SAMM50;HDAC1;NAPA;TAPBP;SKAP2;RANBP9;TRAF1;CARD10;RBBP5;MAGI1;SEC24A;F5;AFG3L2;LMAN1;GPAA1;TFAP4;TSPAN4;BLM;LAMC1;NDUFAF1;MCFD2;SEC24D;CSNK1D;MDN1;RAB1A;PPP6C;AFDN;VAMP2;ELOB;GRIA1;TBC1D20;ANO6;DHX9;JCHAIN;FERMT2;CUL3;FANCA;COL16A1;F8;ITGB1BP1;STOML2;TCF7L1;CAND1;CUL1;GSK3B;HSF1;PDZD11;CDC123;TEAD1;TERT;WAS;CD74;KMT2D;PEX14;LLGL1;MDM2;TNF;USO1;NCKAP1L;GOLGA2;AIM2;ST13;SMARCA4;CX3CL1;GEMIN5;NOL3;STX5;PPIH;HES1;DNAJB12;TMED2;RIPK1;VAMP3;MNAT1;ZNHIT6;TRAPPC4;SPG7;CLDN1;LEO1;TLE1
prerank,protein localization to Golgi apparatus (GO:0034067),0.526872817781573,1.342912746899303,0.09101796407185629,0.41451032451498426,1.0,10/27,16.72%,VPS13C;OPTN;ZDHHC15;ARL1;VPS13A;GAK;PAQR3;GCC2;CSNK1D;VPS13D
prerank,regulation of calcium ion transport (GO:0051924),0.47811396185152144,1.342370594188335,0.06783369803063458,0.41560391880694164,1.0,15/54,14.36%,BCL2;CTNNB1;CD84;P2RX4;CD4;ATP2B1;CCL4;CRACR2A;LILRB1;SRI;CCL5;CACNA1D;SARAF;SLC8B1;HOMER2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6189451935905627,1.3423659740064733,0.11005434782608696,0.4149981820635499,1.0,10/12,33.77%,BRCA1;APOC1;ACADL;WDTC1;ERLIN1;SIRT1;PIBF1;CEACAM1;ACADVL;ERLIN2
prerank,hexose transmembrane transport (GO:0008645),0.5443712151161729,1.3417100412936893,0.12792127921279212,0.41641658965510603,1.0,8/21,21.79%,SLC5A1;SLC2A1;PPARD;SLC2A8;SLC45A3;SLC50A1;SLC5A3;SLC2A6
prerank,negative regulation of T cell proliferation (GO:0042130),0.5145650800964596,1.3414210232219113,0.1010332950631458,0.4166607519506655,1.0,5/28,11.11%,GPNMB;SPN;CD274;LILRB1;CRTAM
prerank,negative regulation of immune system process (GO:0002683),0.5758586673897274,1.3405215620530744,0.1118508655126498,0.4188574396582466,1.0,6/16,16.82%,PDCD1;SOX9;HOXA7;HMOX1;FCRLB;SPINK5
prerank,maturation of SSU-rRNA (GO:0030490),0.5053117909490115,1.3403812214711157,0.08200455580865604,0.41866938358966416,1.0,15/34,23.30%,TSR1;RPS14;RIOK2;RPS28;BMS1;RIOK3;LSM6;RPS19;DDX52;RPS16;UTP4;SRFBP1;WDR3;NOL10;SNU13
prerank,regulation of B cell activation (GO:0050864),0.530937354762686,1.3401450622967097,0.10047846889952153,0.4187082645240725,1.0,12/25,28.05%,IKZF3;CD22;FOXJ1;SH3KBP1;SAMSN1;TNIP2;IL6;LAPTM5;AHR;TLR9;TNFAIP3;THEMIS2
prerank,Golgi organization (GO:0007030),0.44697998700251235,1.339885382453384,0.02553626149131767,0.41889224414259113,1.0,29/112,18.45%,PLEKHM2;ARHGAP21;GOSR2;SYNE1;OPTN;ATP8B4;SEC22B;GOLGB1;VTI1A;ARL1;PI4K2A;TRAPPC8;STX6;HTT;COG4;GAK;PRMT5;HUWE1;GCC2;LMAN1;CDC42;CSNK1D;VAMP4;RAB1A;TRAPPC11;VPS51;TBC1D20;LMAN2;ARFGEF1
prerank,regulation of inflammatory response (GO:0050727),0.43302203278331985,1.3394705862029495,0.01407035175879397,0.4195465616163893,1.0,50/190,19.84%,LPL;S100A8;S100A9;APOE;MMP8;FPR2;SIRPA;NLRC3;ANXA1;TMSB4X;PTGES;TNIP1;MAPK13;SPHK1;MMP9;PRKCD;MFHAS1;OTULIN;PPARG;MGLL;BCL6;CD200R1;GATA3;BRD4;NAPEPLD;CELF1;PPARD;PTPN2;NFKBIZ;CEBPA;CCR2;SERPINE1;CCL5;TNFRSF1B;SHARPIN;LPCAT3;GPRC5B;ACOD1;CASP4;PSMA6;NINJ1;PDCD4;SBNO2;VAMP2;USP18;IL6;DHX9;IL2;PTGIS;GPSM3
prerank,mononuclear cell differentiation (GO:1903131),0.5244274118569774,1.3392241386738906,0.0970414201183432,0.4196675786059566,1.0,10/24,14.16%,PDE1B;AXL;PPARG;VEGFA;TREM2;LILRB1;IRF8;GAS6;PIR;IL31RA
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5350520739840416,1.338499536857753,0.1037394451145959,0.4213040622706913,1.0,10/24,24.47%,CTNNB1;MCL1;CDK5;FBXW7;BAX;DDIT3;NF1;SRPK2;TNF;ATF4
prerank,cardiocyte differentiation (GO:0035051),0.6354842042437887,1.3384650540730947,0.12258953168044077,0.4207851681900114,1.0,3/10,6.69%,AKAP13;NRG1;SIK1
prerank,regulation of DNA replication (GO:0006275),0.48060015228587183,1.3383717132462976,0.05953693495038589,0.4204505802720411,1.0,14/49,19.74%,BCAR3;ORC3;GTPBP4;S100A11;PPP2R1A;WAPL;FBXO5;GMNN;OBI1;BLM;SMC3;KAT7;DHX9;TERF1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.5126994316863605,1.338023890249674,0.11044417767106843,0.4209331554368709,1.0,14/29,22.38%,ANKRD28;RAD50;GAR1;CDK2;PPIA;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,negative regulation of neuron death (GO:1901215),0.44547228368539615,1.337149087293663,0.03668763102725367,0.42299099565001214,1.0,18/93,11.68%,GPNMB;BCL2;APOE;CSF1;TRAF2;ADAM8;ATP13A2;EIF4G1;PTK2B;CDK5;CPEB4;CD200R1;CHMP4A;CHMP4B;INPP5A;CLN3;FGF20;TNFRSF1B
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5838918423316344,1.3369634070566716,0.11300919842312747,0.42292100823134393,1.0,7/14,27.54%,ERCC6;ARID2;RAD51AP1;WAS;WDR48;ACTR2;FUS
prerank,metallo-sulfur cluster assembly (GO:0031163),0.5407899307657799,1.3366994823145844,0.085,0.42313195595524994,1.0,8/22,21.89%,HSCB;NFU1;ISCA1;IBA57;CIAPIN1;HSPA9;ABCB7;CIAO1
prerank,synapse assembly (GO:0007416),-0.3053285633727319,-1.3365702718911958,0.0,0.6496208618325332,1.0,16/67,10.29%,GABRB2;NRXN1;GABRB3;NLGN1;ADGRL3;LRRTM3;SDK1;GRID2;GABRA2;CDH2;FLRT3;SHANK3;DNER;WNT5A;SDK2;GABRA1
prerank,entry into host (GO:0044409),0.6070363679165093,1.336544680378103,0.13305898491083676,0.42295573797479313,1.0,6/13,15.17%,CTNNB1;CD4;GRB2;CDH1;PPIA;CBL
prerank,positive regulation of binding (GO:0051099),0.4509759568422804,1.3362083552531843,0.038461538461538464,0.423410590550638,1.0,29/84,22.83%,IGF1;APOE;LRP1;MMP8;PLAUR;PON1;MMP9;CAV1;PPARG;STK3;GMNN;RPL11;BAMBI;B2M;NVL;SPPL3;DERL1;CEBPG;KDM4D;RALB;HIP1R;PIN1;DHX9;HMGB1;GSK3B;BMP4;TRIM21;TERT;USP33
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.616229816469611,1.3355839529468774,0.1164021164021164,0.4239799596650349,1.0,5/12,14.95%,IGF1;SLC9A1;LMCD1;CHERP;SPPL3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.616229816469611,1.3355839529468774,0.1164021164021164,0.4239799596650349,1.0,5/12,14.95%,IGF1;SLC9A1;LMCD1;CHERP;SPPL3
prerank,activation of protein kinase activity (GO:0032147),0.4428372649173837,1.3352797560071086,0.03775510204081633,0.42425094826812415,1.0,40/106,26.36%,IGF1;OSBPL8;MALT1;ADCY8;ADCY3;TRAF2;NRG1;TNFSF15;PTK2B;ADCY7;PAK6;PRKCD;TAOK3;PDPK1;STK3;VEGFA;ANGPT1;COPS8;CARD10;GAS6;GHR;PAK2;PPIA;TIRAP;MINK1;RIPK3;STK11;ITGB1BP1;SLC11A1;MARK2;PRRC1;PRKAR1A;TAOK1;TGFBR2;CCDC88A;JAK2;TXN;PAK4;FGF1;MAPKAP1
prerank,protein deacetylation (GO:0006476),0.4878856538120731,1.3352752651865765,0.07752808988764046,0.42365837987821664,1.0,20/41,26.77%,FLNA;HDAC9;HDAC7;RCOR1;HDAC4;MSL3;HDAC1;MIDEAS;SIRT5;SUDS3;SIRT4;RCOR3;MIER2;MORF4L1;MTA3;SIRT3;HDAC11;HDAC2;HDAC3;MORF4L2
prerank,skeletal system development (GO:0001501),0.43806469139637494,1.3352668615174585,0.02721774193548387,0.4230718975583907,1.0,26/148,14.78%,IGF1;XYLT1;SH3PXD2B;ANKH;ATP7A;KIAA1217;DEAF1;AKAP13;CD44;BMP8B;COL10A1;MATN3;BMP1;PRDX1;SHOX2;SOX9;P3H1;PKDCC;ANKRD11;CREB3L2;MYOC;CHRD;ZBTB16;RBP4;HAPLN2;EVC
prerank,negative regulation of autophagy (GO:0010507),0.4760738597641794,1.3350059146906217,0.06357758620689655,0.4232583056945947,1.0,13/54,13.43%,BCL2;ATG7;SMCR8;CTSA;MCL1;EIF4G1;PTPN22;TREM2;EIF4G2;DAPL1;DAP;ZKSCAN3;EIF4G3
prerank,positive regulation of MAPK cascade (GO:0043410),0.42868660219285964,1.334431230951063,0.005025125628140704,0.42434847784802254,1.0,55/245,18.81%,GPNMB;BCAR3;IGF1;IQGAP1;FLT1;APOE;MMP8;FPR2;PTPRC;CD4;CCL4;GCNT2;ADAM8;PDGFA;CD44;CD24;ALKAL2;GLIPR2;PTK2B;FBXW7;FGF2;NRP1;MFHAS1;TAOK3;MYDGF;PIK3R5;PTPN22;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;IGF1R;CCL13;P2RY1;ATP6AP1;IAPP;CCL7;CCL5;MAP3K12;GAS6;ABCA7;ROCK1;CCL14;PRKD2;LPAR1;TMEM106A;TIRAP;KDR;C5AR1;SERPINF2;DHX33;IL6;ARL6IP5;FERMT2
prerank,limb development (GO:0060173),-0.3836898114532743,-1.3343172627509148,0.0718562874251497,0.6489413964729912,1.0,6/28,5.81%,SALL1;PCSK5;FGF10;BMPR1B;COMP;KAT2B
prerank,epidermis development (GO:0008544),0.47176647352439866,1.3337431715186037,0.07582417582417582,0.42580693754402466,1.0,17/56,25.20%,FOXN1;FABP5;OVOL1;HDAC1;UGCG;FLOT2;EVPL;FGF7;TGM5;SPINK5;ALDH3A2;LAMA3;ATP2A2;WAS;FGFR2;HDAC2;GRHL1
prerank,cell-substrate junction assembly (GO:0007044),0.5013230652312619,1.3336608524794462,0.10139860139860139,0.4254403488972941,1.0,12/33,21.45%,PEAK1;FN1;ACTN1;DLC1;RHOD;PLEC;LAMC1;SORBS1;FERMT2;ACTN2;DST;LAMA3
prerank,regulation of autophagy (GO:0010506),0.4311484687788529,1.333085892689261,0.009,0.42659683317400393,1.0,87/216,28.30%,BCL2;GPR137B;ABL2;RRAGD;ATP6V1C1;ATP6V0D2;SMCR8;ATP6V1A;CTSA;ATP6V0A1;MCL1;ATP13A2;OPTN;ATP6V1B2;EIF4G1;PIK3CB;TRIM6;PSAP;CDK5;FBXW7;ATP6V0D1;ATP6V0B;ATP6V1G1;TFEB;HSPB1;PTPN22;EEF1A1;ERN1;TREM2;EIF4G2;CAPN1;PLK2;DAPL1;TPCN2;VPS26A;TICAM1;RAB8A;DAP;NPRL2;ZKSCAN3;PLEKHF1;EIF4G3;ROCK1;DRAM1;DCN;DDIT3;UBQLN1;RMC1;DAPK1;FOXO1;PIK3R2;PRKAG1;CAPNS1;STK11;ATP6V0C;DAPK3;HAX1;GFAP;ATM;ORMDL3;CSNK2A2;HMGB1;SREBF1;MTDH;ATP6V1E1;GSK3B;TRIM21;USP36;HTR2B;USP33;VPS35;BNIP3;PIK3C2A;MAPK15;RRAGC;GOLGA2;ATP6V0E1;LAMTOR3;KEAP1;TRIM8;GSK3A;EIF4E;UFL1;EXOC4;ATG13;LAMTOR1;ITPR1
prerank,potassium ion homeostasis (GO:0055075),0.5262337946342475,1.3325595625087105,0.10748792270531402,0.4274715828806481,1.0,7/23,9.49%,ATP1B3;KCNJ2;KCNMA1;ATP1A4;ATP1A3;ATP1A1;SLC12A4
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.582209701999342,1.3324484005671946,0.11710526315789474,0.42723018626878106,1.0,7/14,29.38%,TMSB4X;MDFI;SUFU;CCDC22;KEAP1;PSMD10;FAF1
prerank,phagosome-lysosome fusion (GO:0090385),0.6443078354118009,1.332225931125234,0.10664819944598337,0.4273423334591414,1.0,7/10,25.17%,RAB7B;ARL8B;CLN3;RAB7A;PIKFYVE;RAB20;PLA2G5
prerank,glial cell development (GO:0021782),0.5185171403570052,1.3322154126728878,0.12604042806183116,0.42676388269162135,1.0,10/25,25.70%,S100A9;CDK6;NRROS;NF1;EIF2B2;CSPG5;EIF2B4;SOX10;MDK;MYRF
prerank,stress granule assembly (GO:0034063),0.5517240162051666,1.3321910183284609,0.10804020100502512,0.4262332119565832,1.0,11/20,23.96%,DYNC1H1;LSM14A;EIF2S1;OGFOD1;YTHDF3;YTHDF2;RPS23;UBAP2L;ATXN2;PRRC2C;G3BP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.633733210158065,1.3320050414556552,0.12198581560283688,0.42618068753550004,1.0,7/10,29.58%,CPEB3;DHX36;PAF1;HSF1;CPEB1;NUDT21;LEO1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.589876669531889,1.3311131979334112,0.12817089452603472,0.4282637411660996,1.0,6/13,16.12%,MDFIC;UFM1;SP100;TPR;BARD1;CHP1
prerank,response to muramyl dipeptide (GO:0032495),0.6015942811708646,1.3310203823686824,0.1068090787716956,0.42792274908051564,1.0,5/12,19.59%,VIM;PTPN22;ERBIN;IRF5;ARHGEF2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4349253175234859,1.3309305163227663,0.014112903225806451,0.4275741110734388,1.0,47/166,22.12%,BCAR3;IGF1;HIF1A;MMP8;P2RX4;SLC27A1;ATP7A;EIF6;VIM;GCK;TYRP1;DYRK2;FGF2;CD28;EEF2;PIWIL2;CTDNEP1;PTPN2;LARP4;DDB1;CPEB3;METTL3;LPGAT1;CCL5;YTHDF3;MID1IP1;PAOX;SLC45A3;PRKD2;CLU;SORBS1;EIF4A3;CHP1;FXR2;KAT7;IL6;DHX9;EPM2AIP1;SP1;EIF3E;UPF3A;STARD4;SREBF1;HSP90AB1;NPM1;UPF3B;SAMD4A
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5253038351537256,1.3306358534679303,0.0997624703087886,0.4278436212791353,1.0,11/27,20.96%,CCDC88C;UBA52;RPS27A;MAPK13;TNIP2;NFKB1;MAP3K8;KAT7;UBC;FBXW11;CUL1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4066115526182451,-1.330506822059806,0.11917098445595854,0.6531497196454007,1.0,7/19,13.11%,IL1RAPL1;PTPRD;CDKL5;LRP8;DBN1;CUX2;CAMK2B
prerank,regulation of spindle organization (GO:0090224),0.5624526596077692,1.3300782954068118,0.12628865979381443,0.42887453672844855,1.0,6/18,17.85%,DYNC1H1;DCTN1;NUMA1;TACC3;RAE1;PARP3
prerank,regulation of interleukin-1 production (GO:0032652),0.5761462308931948,1.3299965060081953,0.12992125984251968,0.4285388818637276,1.0,5/15,22.64%,SIRPA;ANXA1;GAS6;HMGB1;F2R
prerank,regulation of macrophage activation (GO:0043030),0.5088248478736868,1.3298570316190708,0.08670520231213873,0.4283724266569971,1.0,12/30,23.47%,GPR137B;MMP8;SPHK1;MFHAS1;CEBPA;TNIP2;IL31RA;HSPD1;IL6;LBP;CD74;MIF
prerank,fluid transport (GO:0042044),0.6030915622244977,1.3298521699757697,0.14246947082767977,0.42778921518391466,1.0,3/12,21.80%,PDPN;AQP4;SLC26A6
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4471939955425721,-1.329622878043715,0.13302752293577982,0.6487980528945867,1.0,5/16,10.24%,MEF2C;MAPK14;PLCB1;LRRC8A;IGFBP3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4679031139520231,1.3295730224889812,0.08076514346439957,0.42805654898969614,1.0,18/63,15.32%,BCL2;RGP1;MCL1;EIF4G1;NELL1;PTPN22;TREM2;EIF4G2;HP;RIC1;DAPL1;DAP;APOC1;ZKSCAN3;TIMP4;EIF4G3;ROCK1;TIMP2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4877275464918509,1.3294653197050108,0.09201773835920177,0.42777359914416424,1.0,13/40,17.29%,DAB2;VEGFA;ANGPT1;B2M;HIP1;C3;SERPINE1;CD63;HNRNPK;SCYL2;CLU;CBL;DGKD
prerank,negative regulation of cell death (GO:0060548),0.4460301520234445,1.3294357982244438,0.05480868665977249,0.42725887870446233,1.0,30/88,26.92%,GPNMB;CSF1;TRAF2;ATP13A2;EIF4G1;CDK5;FGF2;CD200R1;NCK1;CHMP4A;CHMP4B;LRPAP1;FYN;INPP5A;TNFRSF1B;VPS4B;CLU;CCN6;WFS1;FERMT2;TMEM109;GSK3B;BMP4;HTR2B;VPS35;BNIP3;KANK2;PARP16;CCN4;PACRG
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5582473105294994,1.3293712193622418,0.1113892365456821,0.4268560388257081,1.0,6/18,18.98%,LAX1;FPR2;C3AR1;SPG21;C5AR1;FCER1G
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4629966835930726,1.3293574429118753,0.04951560818083961,0.4263072484691223,1.0,11/66,7.85%,FLT1;SASH1;TRAF2;ADAM8;PDGFA;CD24;FGF2;TAOK3;PIK3R5;VEGFA;RASGRP1
prerank,organic acid transport (GO:0015849),0.4475686718702894,1.3290619477509624,0.039337474120082816,0.42660020183024033,1.0,31/94,24.09%,SLC3A2;SLC27A1;SLC26A1;SLC38A1;SLC6A6;SLC7A1;PDPN;SLC7A11;SLC23A1;SLC23A2;SLC27A5;SLC6A19;SLC6A14;SLC16A10;SLC46A1;ACSL1;SLC7A6;PPARD;SLC1A5;SFXN5;SLC25A14;SLC7A8;SLC43A2;SLC19A1;SLC13A3;SLC38A2;SLC13A5;SLC26A6;SLC7A2;RXRA;SLC16A1
prerank,regulation of blood coagulation (GO:0030193),0.5092143289699463,1.3289079236728856,0.11583924349881797,0.42647210828481363,1.0,7/27,16.10%,APOE;HRG;CAV1;TFPI;SERPINE2;SERPINE1;APOH
prerank,Golgi ribbon formation (GO:0090161),0.6028606017018621,1.3286952216354393,0.1328125,0.4264809681897634,1.0,8/13,25.29%,OPTN;VTI1A;STX6;PRMT5;GCC2;VAMP4;GOLPH3;GOLGA2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.509028759747172,1.3285571597015897,0.11150652431791222,0.42630979618609266,1.0,5/29,4.64%,FLT1;DGKZ;FGR;PTK2B;FGF2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6351029262052346,1.3276264812502443,0.145748987854251,0.4285082743627378,1.0,5/10,16.09%,RGP1;NELL1;RIC1;EFNA1;FURIN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5238844435227392,1.3275745570019366,0.11071849234393404,0.4280879575098811,1.0,10/25,18.87%,ERCC6;THOC1;HMGN1;ZNF326;WDR43;DDX39B;KAT7;EAF1;CCAR2;CCNT2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5445347261564429,1.3274586137687008,0.11013767209011265,0.4278634662538102,1.0,9/19,24.86%,VIM;SUCO;RUNX1;SERPINF2;IL6;EMILIN1;BMP4;F2R;HDAC2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5144241929317863,1.3269920102524124,0.12529550827423167,0.4287346960364913,1.0,7/27,19.70%,NIBAN2;PARP4;PDGFA;FGF2;PRKD2;ATM;DACH1
prerank,sensory perception of pain (GO:0019233),0.5388492633824031,1.3264965365248522,0.10987654320987654,0.42960773222214327,1.0,5/21,16.04%,P2RX4;PTGES;CHRNB2;CCR2;RETREG1
prerank,regulation of focal adhesion assembly (GO:0051893),0.47014301111278667,1.3257970943928878,0.0665938864628821,0.43121064334169823,1.0,20/54,19.26%,PEAK1;CORO1C;SLC9A1;PTPRA;MACF1;HRG;NRP1;VEGFA;DLC1;ACTG1;ARHGAP6;MYOC;RHOA;ROCK1;KDR;DUSP3;DAPK3;FERMT2;COL16A1;ITGB1BP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.628239100727979,1.3256788465280396,0.1545827633378933,0.4309552594229788,1.0,4/10,11.31%,LRP1;PTGIR;PTPN2;PTPN12
prerank,negative regulation of gene expression (GO:0010629),0.4244618484262676,1.3254859878555927,0.002,0.43098433149493875,1.0,100/302,23.47%,GPNMB;IGF1;APOE;HIF1A;CD3E;DNMT3A;MMP8;EPRS1;SMCR8;HDAC9;AGO2;ATP2B1;XDH;ID2;GZMB;TRIM6;CILP;VDR;CLDN19;NCOR2;NCL;NPTN;FBXW7;FGF2;CD28;PTBP3;RUNX1;PTPN22;RPS26;ERN1;VEGFA;CRKL;DNMT1;HDAC1;NOCT;CELF1;LSM14A;PUS7;MTF2;PATL2;DIP2A;FLOT2;RACK1;CPEB3;METTL3;SHMT1;ZNF148;RNH1;CNOT10;DLL4;DXO;LARP1;ENC1;TLE5;TIPARP;PHF1;ILF3;YY1;EED;STOX1;LSM6;NFKB1;SYNCRIP;DAPK1;EIF4A3;EIF4ENIF1;YTHDF2;KDR;DHX36;MYADM;EIF4E2;FXR2;ASB1;DAPK3;BMI1;RPL13A;DNMT3B;HAVCR2;AGO3;SLC11A1;TARDBP;RPS3;ANXA7;EMILIN1;VHL;RPS13;ZC3H12D;BMP4;SRGN;GIGYF2;SAMD4A;PTGER4;SNX12;CALR;TERT;MAP2K2;CREBZF;REL;RBBP7;MIF
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5767535647090327,1.3252364014385818,0.11853720050441362,0.4311425096894911,1.0,9/15,24.40%,SPHK2;SPHK1;PRKCD;ORMDL1;RACK1;ORMDL3;SAMD8;TNF;SIRT3
prerank,negative regulation of axon extension (GO:0030517),-0.3726613916097101,-1.325051671883143,0.07432432432432433,0.6554732038470963,1.0,13/30,25.82%,SEMA6D;DIP2B;SEMA6A;MAP2;MAG;SEMA6C;SEMA4B;RTN4R;SEMA3B;SEMA4A;CDKL3;SEMA7A;PTPRS
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5121497315071599,1.3242824001411595,0.10996563573883161,0.43349342306862193,1.0,10/29,20.19%,APOE;SLC27A1;CTDNEP1;LPGAT1;MID1IP1;SLC45A3;SORBS1;CHP1;SIRT4;SREBF1
prerank,synapse organization (GO:0050808),-0.29405709835608157,-1.3241950580406296,0.07142857142857142,0.6510035495860427,1.0,27/125,10.29%,CX3CR1;CACNB2;NRXN1;NLGN1;LRRC4C;LRFN5;ADGRL3;CTNND2;PTPRD;PPFIA4;SLC8A3;LRRK2;SDK1;GRM5;UNC13B;ARHGAP39;PSEN1;CDH2;FLRT3;SHANK3;PPFIA2;APP;SLC6A1;SLC8A2;DNER;REST;SDK2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.4505458591369825,-1.32416190427773,0.10526315789473684,0.6444606924554325,1.0,7/18,10.63%,NRXN1;NLGN1;TSHZ3;CACNG3;SHANK3;CACNG8;CCL2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.6148522037537761,1.3241152105926495,0.1278295605858855,0.4334385843909052,1.0,4/11,12.95%,PTPRC;KLRC1;LILRB1;SMAD7
prerank,pyroptosis (GO:0070269),0.5829479024400864,1.3241137899727105,0.14086294416243655,0.432855419561293,1.0,6/15,18.34%,GZMB;GZMA;APIP;TREM2;CASP4;DHX9
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5926241483079244,1.3236470046658122,0.13534822601839686,0.4336512580269637,1.0,7/12,36.49%,NCOR2;PPARG;TERT;TNF;ZC3H12A;TGFB1;ELAVL1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2973813071264364,-1.323410928479596,0.0,0.6400935459633439,1.0,21/75,13.24%,OPHN1;MEF2C;CTNNA2;BTBD3;MEF2A;CNTN4;PLPPR4;RAB3A;DSCAML1;MAP6;MAP2;APP;PAX2;SLITRK4;APBB1;DCDC2;BRSK1;MAP1B;KLF7;PAK3;RAB10
prerank,engulfment of apoptotic cell (GO:0043652),-0.45274788871242794,-1.3232125978278835,0.13636363636363635,0.6343788590587474,1.0,6/15,9.96%,RHOBTB1;XKR4;MEGF10;THBS1;XKR6;RHOBTB2
prerank,negative regulation of protein transport (GO:0051224),0.5188661367095083,1.3230771591446617,0.11124401913875598,0.4347305440501032,1.0,6/25,14.03%,APOE;RHBDF2;SERGEF;RHBDF1;PKDCC;RSAD2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4945688537433657,1.3230238976004278,0.10739030023094688,0.4342981813254978,1.0,18/37,23.69%,RNASE3;NUDT5;NUDT1;XRN2;RNASEH2A;RNASEH1;ENTPD5;DFFB;NUDT9;RNASEH2B;ISG20;ENTPD6;RNASE6;NUDT15;DNASE1L1;PABPC4;SND1;PPP1R8
prerank,cardiac cell development (GO:0055006),0.6132639805374982,1.3230131065469917,0.1193029490616622,0.43375277733627887,1.0,4/11,20.48%,JAG1;VEGFA;MYH11;ALPK3
prerank,positive regulation of translation (GO:0045727),0.44711066164436636,1.3228200896834479,0.04737384140061792,0.43372963747262616,1.0,37/94,22.12%,PKM;AGO2;EIF6;VIM;TRUB2;CD28;EEF2;PIWIL2;TRMT10C;RCC1L;LARP4;CPEB3;METTL3;CCL5;YTHDF3;LARP1;YBX3;POLR2D;EIF4A3;YTHDF2;C1QBP;DHX36;FXR2;CNBP;IL6;DHX9;RPS9;EIF3E;UPF3A;FASTKD3;EIF5AL1;EIF5A;NPM1;CDC123;UPF3B;MRPS27;SAMD4A
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5695778163103296,1.3226257339812726,0.10533159947984395,0.43376556806823696,1.0,7/16,24.86%,VIM;SUCO;RUNX1;SERPINF2;BMP4;F2R;HDAC2
prerank,negative regulation of MAPK cascade (GO:0043409),0.4470574990734661,1.3226194063018484,0.04338842975206612,0.43320114816558697,1.0,32/87,21.97%,APOE;SIRPA;PTPRC;DAG1;TNIP1;PIK3CB;DUSP9;PRKCD;CAV1;PRDM15;CD300A;PTPN2;RANBP9;DUSP6;FBLN1;PAQR3;CNKSR3;ABCA7;PPIA;SPRY4;STK38;FOXO1;NF1;SMPD1;PIK3R2;DUSP3;PIN1;ITGB1BP1;EMILIN1;SPRED2;BMP4;LMO3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.35914981892172554,-1.3224192498633052,0.05714285714285714,0.6305509739722746,1.0,14/37,17.98%,BICD1;CYLD;EFNA5;TRIM36;STMN3;STMN1;MAP6;SKA2;CLASP2;PHLDB2;STMN4;TPPP;CAMSAP3;SKA3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.43235891740109994,1.322308697237644,0.029352226720647773,0.4335469958100479,1.0,27/142,15.29%,CACNA1A;TRPC4;ABL2;FPR2;PTGIR;ADCY8;ATP2B1;CXCR2;PTGFR;CD24;EDNRA;BDKRB1;HCRTR1;NPTN;C3AR1;CD52;CAV1;TAC4;P2RY1;IAPP;CLN3;CCR2;SLC8B1;SPPL3;LPAR1;GLP1R;ATP1A2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6084412276806269,1.3220958348068257,0.13020134228187918,0.4336158291780448,1.0,7/11,31.66%,PAPOLA;BARD1;DHX36;PAF1;ZC3H3;LEO1;AHCYL1
prerank,negative regulation by host of viral transcription (GO:0043922),0.60363235895098,1.3213820640098113,0.1322314049586777,0.4350780889630409,1.0,7/12,19.64%,CCL4;HDAC1;PSMC3;JUN;CCL5;TFAP4;TARDBP
prerank,negative regulation of inflammatory response (GO:0050728),0.4270000958599449,1.3211526724521594,0.01,0.43519240369513684,1.0,43/182,16.09%,IGF1;APOE;CD247;FPR2;SIRPA;NLRC3;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;PRKCD;MFHAS1;OTULIN;PPARG;CD200R1;GATA3;GPR83;SCTR;TREM2;PLK2;PPARD;ADAM17;CRH;PTPN2;IAPP;FYN;GPR176;TNFRSF1B;SHARPIN;LPCAT3;GIT1;GIPR;RPS19;ADORA2A;GLP1R;ACOD1;VIP;SYK;FURIN
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.541843870590974,1.321115656102073,0.12779156327543426,0.43473330345563205,1.0,13/20,33.77%,SLC27A1;FBXW7;SIK1;BRCA1;APOC1;PRMT3;ACADL;WDTC1;BMP5;ERLIN1;CEACAM1;ACADVL;ERLIN2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5756585508294383,1.3210185735485978,0.13376623376623376,0.4345065398449511,1.0,5/14,13.25%,ABCG1;PSEN2;ADAM17;CLN3;ABCA7
prerank,cellular metal ion homeostasis (GO:0006875),0.4393899383368357,1.320754607709355,0.04933196300102775,0.4347175542953528,1.0,24/102,15.29%,SLC9A1;SLC24A4;ATP1B3;ATP2B1;ATP13A2;NPTN;CSRP3;KCNJ2;CAV1;KCNMA1;TPT1;ATP1A4;ATP1A3;ATP1A1;TPCN2;CCL13;CHERP;CCR2;CCL7;CCL5;CCL14;SLC8B1;VAPB;ATP1A2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5927105979940638,1.320646615950214,0.1440107671601615,0.43444938151463885,1.0,3/13,4.05%,APOE;PLEK;CYP27B1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6111849730649908,1.3198381616619703,0.14157014157014158,0.43622117198906224,1.0,8/11,33.65%,TRIM28;DNMT1;TPR;RESF1;SETDB1;ATF7IP;TASOR;MPHOSPH8
prerank,cellular iron ion homeostasis (GO:0006879),0.46821027658759395,1.319521090366176,0.0854978354978355,0.43651156671402275,1.0,20/55,21.63%,FTL;LCN2;ATP6V1A;ATP13A2;ATP6V0D1;ATP6V1G1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;HMOX1;FRRS1;TFRC;BMP6;SLC11A1;FTH1;CAND1;CUL1;ABCB7
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5938029394104559,1.3191905106542943,0.13368983957219252,0.43689302738297414,1.0,7/13,26.55%,SNX33;RANGRF;ABCA7;STX3;HSP90AB1;TNF;STX4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.44810342916940327,1.3189455736935,0.057022175290390706,0.43704824420916666,1.0,37/78,30.96%,NFE2L2;RNF14;PRICKLE1;CAV1;DAB2;FZR1;RNF180;RACK1;VCP;USP5;SOCS5;CEBPA;SMAD7;SUMO2;CLU;UBQLN1;CSNK1D;ELOB;HECTD1;PIAS1;RNF19A;GSK3B;TRIB2;GABARAP;MDM2;SUMO1;PLK3;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;RNF19B;RCHY1;NUB1;HERPUD1;SIRT2
prerank,cellular component maintenance (GO:0043954),0.5940801502634406,1.3186502444864803,0.13918918918918918,0.437380847489685,1.0,6/12,29.29%,TREM2;IGF1R;FYN;ITGA3;SUPV3L1;CLDN1
prerank,glucan biosynthetic process (GO:0009250),0.6007100168088078,1.318387794990494,0.1342281879194631,0.4369754293717635,1.0,3/12,5.70%,NHLRC1;GYG1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),0.6007100168088078,1.318387794990494,0.1342281879194631,0.4369754293717635,1.0,3/12,5.70%,NHLRC1;GYG1;GYS1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.40866600608054066,-1.3176581549462365,0.10666666666666667,0.63822688380586,1.0,9/25,19.60%,ACVR2B;RBPJ;BMPR1B;UBE2O;ENG;ACVR2A;SULF1;FOXD1;FBXL15
prerank,regulation of programmed cell death (GO:0043067),0.42503855311148403,1.3174235947000539,0.02620967741935484,0.4394265917550271,1.0,56/161,24.50%,CTSB;IKZF3;CD3E;LGALS1;MALT1;SGK1;TRAF2;RAF1;CDK5;DAXX;BID;RBM25;BCL6;RTKN;ACTN1;TPT1;SOX9;BCL2L11;VCP;BAX;HIP1;RABGGTB;TRIAP1;NDRG1;GLS2;HS1BP3;BIRC5;CLU;DAPK1;APAF1;HTATIP2;TNFSF9;RIPK3;DAPK3;HAX1;ATM;WFS1;ASAH1;AIFM2;TARDBP;ACTN2;RPS3;CRADD;TRIM24;MARK4;DFFA;FBXO11;USP36;CALR;ACTN4;PRELID1;BNIP3;JAK2;TNF;ANP32B;BIRC2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5610595404381109,1.317359842245049,0.11648079306071871,0.4390361582046283,1.0,2/19,2.27%,APOE;CHRNB2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4386201368741064,1.3165182846379915,0.04815573770491803,0.440940273363819,1.0,35/107,22.65%,LCK;SLC24A4;ATP2B1;ATP13A2;NPTN;CSRP3;CAV1;TPT1;TPCN2;CCL13;CHERP;SLC39A6;CCR2;SLC39A7;CCL7;CCL5;SLC30A9;CCL14;SLC8B1;VAPB;TMEM165;SLC11A1;STOML2;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;ATP13A1;ATP2A2;CALR;HTR2B
prerank,lipoprotein catabolic process (GO:0042159),0.6165957951268503,1.316495349146326,0.12096774193548387,0.4404406353655027,1.0,6/11,20.46%,APOE;CTSD;LYPLA2;ABHD17C;ABHD17A;ABHD10
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.39275248189580414,-1.3164008966136092,0.08433734939759036,0.6354829482735084,1.0,7/26,6.10%,ROCK2;VSIR;EPHA4;PICALM;GRIN2B;STAT3;APH1B
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4996955582893862,1.3150949834368466,0.1214622641509434,0.44395148538451357,1.0,12/29,24.21%,LGALS3;FPR2;MOSPD2;CCR2;SERPINE1;CCL5;GAS6;C1QBP;ANO6;HMGB1;CALR;TNF
prerank,protein import (GO:0017038),0.44733849988097724,1.3146777540272039,0.05130890052356021,0.4446514714921894,1.0,39/84,29.57%,APOE;MMP12;TOMM22;HSPA4;GCKR;PRICKLE1;IPO5;SAMM50;SNX33;PEX2;E2F3;LAMP2;NUP188;RAB8B;NXT2;ABCD2;CLU;TPR;EIF4ENIF1;APPL2;ABCD3;SYK;PPP1R10;PXMP2;ALDH3A2;PEX16;NUP93;ACBD5;PEX14;NUP50;TNPO2;TNPO1;NUP133;NUTF2;IPO13;PTTG1IP;NUP214;PEX19;FIS1
prerank,chloride transmembrane transport (GO:1902476),-0.3536067911372138,-1.3143233733665236,0.06666666666666667,0.6351484035173175,1.0,21/48,18.06%,GABRB2;GABRB3;GLRA3;SLC1A3;GABRG3;GABRA2;SLC12A2;SLC12A9;SLC12A6;SLC6A1;LRRC8A;GABRA1;SLC12A8;GABRB1;ANO7;GLRA2;GABRR2;GLRA1;GABRE;SLC1A1;GABRG2
prerank,negative regulation of leukocyte activation (GO:0002695),0.5719692084454897,1.314246567962959,0.13974358974358975,0.44535362574578674,1.0,6/15,18.81%,CD84;CD300LF;MILR1;CD300A;IL31RA;HAVCR2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4627364586483292,1.3140240305760758,0.0932475884244373,0.4454676855870699,1.0,22/61,20.12%,ERCC6;EYA4;FGF2;TRIM28;OTUD4;USP9X;ABRAXAS1;BRCA1;RAD50;PRKD2;CEBPG;DHX36;TOX;PPP1R10;PARP3;UIMC1;ATRX;GNL3;DHX9;RTEL1;RPS3;HMGB1
prerank,regulation of cellular catabolic process (GO:0031329),0.4595058683994777,1.313476311447627,0.07309322033898305,0.446562598658631,1.0,17/62,18.28%,GPR137B;ABL2;RRAGD;SMCR8;WDR91;PSAP;HSPB1;TPCN2;RAB8A;ROCK1;DRAM1;DDIT3;RMC1;DAPK1;PIK3R2;DAPK3;ATM
prerank,copper ion transport (GO:0006825),0.6132760653288001,1.3132335028683835,0.150066401062417,0.4466800959383392,1.0,3/11,6.01%,SLC31A2;ATP7A;ATOX1
prerank,response to interferon-beta (GO:0035456),0.5242912814215243,1.3131158858634753,0.12740384615384615,0.44647417671258927,1.0,11/22,26.97%,SHFL;TRIM6;IFITM2;IKBKE;IRGC;IFITM1;ACOD1;BST2;CDC34;AIM2;IFNAR2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5407887723026413,1.3122683759334095,0.15375,0.448322653664833,1.0,9/18,29.71%,BID;BAX;SLC35F6;MPV17L;HIP1R;GSK3B;ACAA2;GSK3A;MUL1
prerank,renal filtration (GO:0097205),0.6204980618508115,1.3114020861879059,0.15127175368139223,0.4504688116993004,1.0,1/10,0.01%,MYO1E
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42528912459926843,1.3111084077584385,0.027190332326283987,0.450837878625973,1.0,50/151,26.13%,GPNMB;APOE;FPR2;PTPRC;CD4;CCL4;GCNT2;PDGFA;CD44;ALKAL2;GLIPR2;PTK2B;FBXW7;FGF2;NRP1;MFHAS1;PTPN22;CRKL;ANGPT1;TREM2;RASGRP1;CCL13;P2RY1;ATP6AP1;CCL7;CCL5;MAP3K12;GAS6;ABCA7;CCL14;PRKD2;TIRAP;KDR;C5AR1;SERPINF2;FERMT2;SCIMP;HMGB1;FGFR3;F2R;HTR2B;CD74;MIF;FGFR2;TNF;PDGFRA;PLA2G5;DSTYK;GPR183;CX3CL1
prerank,microtubule depolymerization (GO:0007019),-0.4353833529598912,-1.3109850212791747,0.1391304347826087,0.6386397962835896,1.0,8/17,18.98%,STMN3;STMN1;KIF14;STMN4;KIF2C;KIF2A;KIF18B;KIF19
prerank,regulation of nuclear division (GO:0051783),0.5474994769001956,1.3106482608214647,0.1391941391941392,0.45171450705430205,1.0,7/20,18.13%,FBXO5;CDK13;CUL9;PRMT5;RCC1;DAPK3;PIN1
prerank,modified amino acid transport (GO:0072337),0.5587076351254168,1.310285613481218,0.14417989417989419,0.45226389923502475,1.0,3/15,6.93%,PDPN;SLC6A8;SLC46A1
prerank,cholesterol biosynthetic process (GO:0006695),-0.375701690046161,-1.3099454862047566,0.08843537414965986,0.6358266904870412,1.0,13/31,18.12%,IDI1;DHCR7;HMGCS1;SC5D;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,connective tissue development (GO:0061448),0.4942564232682104,1.309795621970844,0.1134020618556701,0.4533072562714287,1.0,8/35,12.90%,SH3PXD2B;ARID5B;ATP7A;CD44;SOX9;CREB3L2;NAMPT;ZBTB16
prerank,pyruvate metabolic process (GO:0006090),0.4658272044925761,1.3092856284178296,0.08360477741585233,0.4542757539034807,1.0,24/52,28.49%,PKM;ALDOA;GCK;NR4A3;HK1;PFKL;PGK1;LDHA;ENO1;PCK2;ALDOC;ME2;SLC16A3;ENO2;HK3;GPI;PDHB;SLC16A1;PDHX;ME1;DLAT;SRR;BSG;PGM1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4488287389061813,1.3092778694367968,0.07043756670224119,0.453714882153639,1.0,17/72,16.05%,IGF1;FLT1;FN1;FGR;PDGFA;PIK3CB;FGF2;MYDGF;PIK3R5;SOX9;TREM2;IGF1R;MYOC;CCL5;DCN;CBL;KDR
prerank,atrial septum morphogenesis (GO:0060413),-0.509784528290517,-1.308839649122596,0.15436241610738255,0.6331911051572028,1.0,5/10,30.65%,NOTCH2;ZFPM1;ISL1;BMPR2;SOX4
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3883652983635722,-1.3088038665736506,0.115,0.6274685110550452,1.0,11/23,26.65%,GRIK3;LRRK2;SLC30A1;ARF1;STXBP1;ACHE;IL1B;TMEM25;CBLN1;MTMR2;SLC24A1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5546621948495298,1.3087072954154184,0.14212548015364918,0.4548138866363503,1.0,6/18,8.93%,FLT1;FGF2;ITGA4;PPARG;PDPK1;ADAM17
prerank,regulation of nervous system process (GO:0031644),-0.42703507356531967,-1.3081567992830736,0.115,0.6236006767014307,1.0,7/18,11.25%,ROCK2;DLGAP1;SLC8A3;HTR2C;APP;SLC8A2;BEGAIN
prerank,ether lipid biosynthetic process (GO:0008611),-0.5084865073708627,-1.3067936873224262,0.16666666666666666,0.6218611020630926,1.0,3/10,5.98%,LPCAT2;PEX7;AGPS
prerank,DNA methylation (GO:0006306),0.5263863158442211,1.3067339847954582,0.11613691931540342,0.4603025133272044,1.0,8/23,20.79%,DNMT3A;DNMT1;GATAD2A;MTRR;ATRX;DNMT3B;EHMT1;ZFP57
prerank,lipid homeostasis (GO:0055088),0.46230275956293826,1.3065608401854332,0.10043196544276457,0.46025963243944484,1.0,18/57,21.85%,APOE;ABCG1;ABCA1;ATP13A2;FBXW7;PPARG;TLCD1;ORMDL1;TREM2;TLCD2;ABHD5;CEBPA;RCN3;THADA;USF2;ORMDL3;TM6SF2;ACOX3
prerank,regulation of mononuclear cell migration (GO:0071675),0.5260046598459459,1.306473154247512,0.14337349397590363,0.459943035015517,1.0,3/23,1.78%,LGALS3;CSF1;MSN
prerank,negative regulation of hippo signaling (GO:0035331),-0.49319485416814984,-1.3062439190990105,0.14682539682539683,0.6179528932942171,1.0,7/12,23.77%,MAPK14;WWC1;VGLL4;AJUBA;DLG5;CIT;WWC2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6249281947928118,1.3058552067801452,0.14402173913043478,0.46120429477294217,1.0,4/10,13.49%,LPGAT1;ABCD2;MID1IP1;SLC45A3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5621564173578412,1.3054193200109594,0.1348464619492657,0.4619733111969979,1.0,10/16,29.05%,CTNNB1;KMT2A;DNMT1;BRCA1;WDR5;DNMT3B;SNW1;PIH1D1;KDM1A;CTR9
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4858917288359472,1.3050106775202324,0.12247191011235956,0.46259228976093025,1.0,13/37,18.32%,HIF1A;PLD3;SIRPA;NLRC3;CHID1;CD6;ADCY7;TREM2;TICAM1;ABCD2;APPL2;PDCD4;IL6
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.594544873939804,1.3046397439973965,0.14905149051490515,0.46316428959712813,1.0,3/12,7.32%,STAP1;MMP8;TREM2
prerank,synaptic vesicle cycle (GO:0099504),-0.36663256672877664,-1.3037770510718825,0.09615384615384616,0.6189605473676595,1.0,11/30,11.62%,SNAP25;NLGN1;CPLX1;SYT10;RIMS1;RAB3A;SNAPIN;PLD2;SLC32A1;STX1A;BRSK1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6133071814173134,1.3037750903273955,0.13437057991513437,0.4653699605221468,1.0,8/10,36.14%,DNMT1;BRCA1;ATRX;DNMT3B;KDM1A;SIRT1;MYB;RIF1
prerank,hexose metabolic process (GO:0019318),0.483329076107434,1.3030886131659585,0.10034207525655645,0.46682080408556126,1.0,10/39,13.80%,SORD;ALDOA;GAA;HK1;PPARD;GALK2;FUCA1;ALDOC;AKR1A1;FUOM
prerank,cellular response to alkaloid (GO:0071312),-0.43067188232108566,-1.302718780705202,0.10476190476190476,0.6163696652813521,1.0,4/17,6.88%,RYR3;TGM2;CASP3;CASP6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5298641983097641,1.3025196453871006,0.13226205191594562,0.46800820628655687,1.0,10/20,27.83%,SDCBP;MLKL;PDCD6IP;FLOT2;OGT;RIPK3;ASAH1;BIRC2;PELI1;RIPK1
prerank,negative regulation of protein binding (GO:0032091),0.4506999355483662,1.3024647825173838,0.08148148148148149,0.467581755261983,1.0,25/71,23.35%,CTSZ;NES;PRKCD;ITGA4;CAV1;DAB2;RACK1;LRPAP1;B2M;BAX;TLE5;GTF2F1;ROCK1;ACTB;ADAM15;PSME3IP1;SYMPK;RALB;PIN1;ITGB1BP1;IFIT2;GSK3B;ATP2A2;USP33;PEX14
prerank,iron ion homeostasis (GO:0055072),0.4610710451293015,1.3019745819766488,0.09032258064516129,0.4685035075831126,1.0,21/58,21.63%,FTL;LCN2;ATP6V1A;ATP13A2;ATP6V0D1;ATP6V1G1;SLC46A1;HEPH;CYBRD1;TMEM199;ATP6AP1;B2M;HMOX1;FRRS1;TFRC;BMP6;SLC11A1;FTH1;CAND1;CUL1;ABCB7
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5919547891803297,1.301964448340933,0.14342105263157895,0.46794232099227756,1.0,7/13,21.62%,ZMIZ1;CDCA4;FAM47E;ZMIZ2;ELOF1;ARID1B;SERTAD1
prerank,ribosomal small subunit assembly (GO:0000028),0.5597615007553267,1.3017144920560322,0.14559386973180077,0.4681424965931121,1.0,6/16,14.89%,RPS14;RRP7A;RPS28;MRPS7;RPS19;RPS27
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6286757485822118,1.3007620305662388,0.14540466392318244,0.4704945743390762,1.0,6/10,31.65%,NOC2L;THAP7;BRCA1;TAF7;SIRT1;SET
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.49703730191491036,1.300307109250331,0.11938534278959811,0.4713208160176572,1.0,8/31,12.66%,CDK6;HDAC7;PPARG;SOX9;NOCT;BAMBI;RIOX1;CHRD
prerank,metal ion export (GO:0070839),0.49743792175796636,1.3002372532416038,0.11627906976744186,0.4709805290326358,1.0,6/31,7.23%,SLC9A1;ATP7A;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of embryonic development (GO:0040019),0.54667643614419,1.3001112437495965,0.14105793450881612,0.4707779932241296,1.0,4/19,12.65%,B4GALT5;NIBAN2;RACK1;RBM19
prerank,cellular response to osmotic stress (GO:0071470),-0.3885407504352594,-1.2999460646095036,0.11475409836065574,0.6185696561879848,1.0,5/21,10.91%,CAPN3;RCSD1;SCN2A;WNK3;TRPV4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5518607025837096,1.2998098027645912,0.1532567049808429,0.47108837114520974,1.0,8/17,23.62%,PTPRC;PTPA;PPP1R12A;CD300A;PPP1R15B;HSP90AB1;PPP1R15A;CALM3
prerank,positive regulation of ERAD pathway (GO:1904294),0.5802062966139917,1.2993590522411351,0.16150740242261102,0.4718752812928481,1.0,5/13,17.31%,NFE2L2;CAV1;ATXN3;UBQLN1;RNFT1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5480422868414465,1.2991297011131306,0.13411458333333334,0.47194770746316184,1.0,4/17,6.08%,ANXA1;TMSB4X;ANXA4;PTPN22
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5215831117397335,1.2990258049173269,0.13776137761377613,0.4716953271945827,1.0,6/24,14.45%,HIF1A;NIBAN2;ITGA5;PRKCB;CADM4;PRKD2
prerank,cellular copper ion homeostasis (GO:0006878),0.584353663289585,1.2989304784896794,0.14097496706192358,0.4713850884931708,1.0,3/14,6.01%,SLC31A2;ATP7A;ATOX1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4713751751190998,1.2988203067286894,0.09836065573770492,0.4711835609625134,1.0,15/49,16.48%,RAB7B;KMT2A;PRKCQ;EIF6;CNOT4;SCIN;NR4A3;MYL9;RUNX1;HDAC1;RBBP5;WDR5;RBM15;SETD1A;PRMT6
prerank,lamellipodium assembly (GO:0030032),-0.3884076358185267,-1.298506136700794,0.08875739644970414,0.6172827064623462,1.0,9/26,16.43%,P2RY12;PTPRO;CARMIL1;ABLIM3;DMTN;CDH13;ARHGEF4;SPATA13;SRGAP2
prerank,sodium ion transmembrane transport (GO:0035725),0.44214596744478313,1.29821521070056,0.0703781512605042,0.4724918089715266,1.0,15/84,7.43%,SLC9A1;SLC24A4;SLC6A6;ATP1B3;SLC5A1;SLC6A19;SLC6A14;SCN4A;ASIC3;SLC6A8;SLC6A7;ATP1A4;ATP1A3;ATP1A1;SLC6A4
prerank,negative regulation of transport (GO:0051051),0.4595796816315544,1.2974838953716636,0.10485651214128035,0.4740514223566762,1.0,12/51,15.15%,LGALS3;SIRPA;MCTP1;NRG1;FER1L5;TRAT1;SNX33;LILRB1;RACK1;RAB7A;ABCA7;YRDC
prerank,chromatin assembly or disassembly (GO:0006333),0.611635193170176,1.297451302108471,0.13305898491083676,0.4735563543529324,1.0,4/11,15.06%,NOC2L;M1AP;HIRIP3;CHAF1B
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4946192887309836,1.296975748793757,0.1477139507620164,0.47449036752200985,1.0,15/30,31.50%,NCOR2;RNF14;DAB2;RNF6;HDAC1;SAFB2;PRMT2;KLK3;SFRP1;SMARCA4;H3-3A;KDM1A;SIRT1;TRIM68;EP300
prerank,phagolysosome assembly (GO:0001845),0.5999698785645031,1.2968229203765025,0.14419225634178906,0.47438973334409806,1.0,7/12,25.17%,RAB7B;ARL8B;CLN3;RAB7A;PIKFYVE;RAB20;PLA2G5
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5377605327193283,1.296796064164295,0.1643312101910828,0.4739023836036288,1.0,6/18,19.96%,NLRC3;B4GALT7;PEX2;CD300A;NF1;FTH1
prerank,regulation of immunoglobulin production (GO:0002637),0.5170456485435875,1.2958257344670108,0.1383495145631068,0.47630040992254447,1.0,13/23,31.98%,PTPRC;CD22;DNAJB9;RBP4;GPI;IL6;IL2;SASH3;TLR9;STX4;VAMP3;XBP1;EPHB2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.43777105050909065,1.2957554948666083,0.06367432150313153,0.47593009977221995,1.0,13/85,10.16%,IGF1;CDK6;NLRC3;DEAF1;NR4A3;FGF2;MTSS1;SOX9;VEGFA;ANGPT1;PEX2;B2M;FGF7
prerank,regulation of protein phosphorylation (GO:0001932),0.4122126551055152,1.295165114482213,0.009027081243731194,0.47725103164133204,1.0,59/256,16.77%,GPNMB;FNIP2;FN1;CORO1C;ATF3;CCDC88C;RAP2A;FPR2;SIRPA;PLAUR;CD4;FGR;XDH;PDGFA;HRG;CLDN19;MMP9;NPTN;FGF2;PPP2R5C;HSPB1;DAXX;MYDGF;DAB2;PLPP3;SOX9;BRD4;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;ILK;ADAM17;P2RY1;RACK1;CADM4;FGF7;KRAS;FYN;C3;FGF20;FBLN1;PAQR3;PTPN13;EFNA1;GAS6;PPIA;LRP6;PPP1R15B;CSNK1D;ITGB2;TFRC;CCND2;KDR;CHP1;KDM4D;MYADM;FXR2
prerank,cAMP biosynthetic process (GO:0006171),0.6103568032561731,1.2950489219749506,0.17475728155339806,0.47704226501001984,1.0,3/10,4.20%,ADCY8;ADCY3;ADCY7
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5215726755037648,1.2949844870723055,0.12015018773466833,0.47668242960292123,1.0,6/22,13.67%,APOE;AKAP13;AEBP1;HSPA8;PRUNE1;EFEMP2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.517154134138634,1.2945914296110983,0.13080684596577016,0.47736697780969656,1.0,10/24,19.20%,IQSEC1;HRG;NRP1;VEGFA;MYOC;ROCK1;KDR;DUSP3;FERMT2;COL16A1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5140947621665839,1.2944876527123756,0.13145539906103287,0.4770988517065759,1.0,5/25,3.46%,CD226;MALT1;TRAF2;SPHK2;TRIM6
prerank,positive regulation of cell migration (GO:0030335),0.41263007421273334,1.2938404693065544,0.009018036072144289,0.4783828215068797,1.0,44/253,11.60%,GPNMB;PLAU;IGF1;FLT1;HIF1A;ITGAX;FN1;CSF1;SDCBP;MGAT5;PTPRC;FGR;LEF1;AGO2;GCNT2;PDPN;PDGFA;FAM110C;SPHK1;GLIPR2;PTK2B;MMP9;NEDD9;NRP1;S100A11;CAV1;FAM83H;DAB2;SOX9;VEGFA;CRKL;RHOD;ACTG1;IGF1R;FBXO5;SPAG9;ADAM17;RACK1;PLAA;RUFY3;MYOC;CCR2;CCL7;CCL5
prerank,positive regulation of secretion (GO:0051047),0.6044789439286785,1.2936988030930126,0.17131474103585656,0.4782487445532631,1.0,2/11,3.41%,SCIN;TRH
prerank,regulation of B cell proliferation (GO:0030888),0.4675893345382855,1.2932362781337137,0.10690423162583519,0.4790488178291295,1.0,19/44,27.13%,BCL2;IKZF3;PTPRC;CHRNB2;CD22;CD300A;TFRC;TIRAP;ATM;IL2;CD74;AHR;MIF;VAV3;NCKAP1L;SASH3;TLR9;GPR183;RC3H1
prerank,regulation of RNA metabolic process (GO:0051252),0.45704948951981117,1.2932061835934456,0.09978540772532189,0.4785685407596572,1.0,28/59,29.16%,AHNAK2;MITF;MBNL3;PTBP3;GRSF1;CELF1;SON;HNRNPLL;ZNF326;TNFRSF1B;PCBP4;MBNL2;FASTK;PCBP1;YTHDF2;NOVA2;RASA1;HNRNPF;CLK4;AHNAK;USP36;HNRNPL;RRP1B;RC3H1;FUS;OASL;TRA2B;MED1
prerank,actin filament organization (GO:0007015),0.41829408112168737,1.293102576179258,0.04225352112676056,0.47828816315666883,1.0,27/151,12.03%,MYO1E;GAS2L3;LCP1;MYO5A;ARHGAP25;CORO1C;FLNA;MYO1F;CAPG;PPP1R9B;ALDOA;SCIN;POF1B;MYO1A;TPM2;NEDD9;ACTN1;INPPL1;RHOD;FAT1;CORO7;TPM4;RUFY3;HIP1;RHOG;RHOA;GSN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.5158439307396814,1.2928286609084545,0.10340632603406326,0.47861137857605246,1.0,16/25,31.38%,SF3B3;PRPF4;SMNDC1;PRPF6;SNRNP40;PRPF8;SF3A3;SRRM1;SF3B1;KHSRP;GEMIN2;SRSF10;TRA2B;WDR83;DBR1;MPHOSPH10
prerank,endochondral bone morphogenesis (GO:0060350),-0.50236687085082,-1.2925792791245831,0.16176470588235295,0.6276884734594852,1.0,3/11,3.33%,MEF2C;TMEM119;BMPR1B
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4913151228386968,1.2924824354865023,0.1216374269005848,0.4791295799376456,1.0,14/31,27.54%,OPTN;DAXX;DNAJB14;ERN1;ATXN3;BAX;HSPA8;HSPA9;HSF1;BAG3;HSPA5;HSPA2;PACRG;DNAJB12
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5827325629566991,1.292172953561709,0.15234375,0.47886189038935784,1.0,5/12,21.27%,DYRK2;RCAN1;HOMER2;CHP1;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5827325629566991,1.292172953561709,0.15234375,0.47886189038935784,1.0,5/12,21.27%,DYRK2;RCAN1;HOMER2;CHP1;GSK3B
prerank,negative regulation of DNA replication (GO:0008156),0.5789148879940873,1.2919415097513118,0.14285714285714285,0.47901865244116315,1.0,4/13,8.67%,GTPBP4;S100A11;WAPL;GMNN
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5984810679106979,1.2917084622662653,0.1609353507565337,0.47918859958523785,1.0,6/11,21.63%,FYN;ABCD2;TRAP1;MPV17L;SLC18A2;ABCB7
prerank,nucleosome organization (GO:0034728),0.45404677865002496,1.2917019121790256,0.1134133042529989,0.47862780962269796,1.0,33/55,34.26%,GRWD1;DAXX;SOX9;BPTF;SMARCB1;PRDM9;ACTR6;SMARCC1;H1-0;ARID2;INO80;CHAF1B;PAF1;ATRX;SRCAP;VPS72;NPM1;SMARCD2;NAP1L3;ANP32B;MCM3AP;SMARCA4;H3-3A;NASP;RSF1;HMGB2;ASF1A;SET;DMAP1;ANP32E;SART3;SETD2;NFE2
prerank,brain development (GO:0007420),-0.25512199089548204,-1.291661237492521,0.0,0.6248982846154254,1.0,32/136,11.54%,ZFHX3;CX3CR1;CTNNA2;ADGRL3;PHF8;GRIN2A;ROGDI;PBX3;CNTN4;EML1;DSCAML1;GRIN2B;RAPGEF2;UBE3A;CDH2;NDRG4;NNAT;SHANK3;CNTNAP2;ADGRG1;NDUFS4;HAP1;PAX2;PAFAH1B2;ROBO2;PAFAH1B3;MEIS1;APOD;DDIT4;DNAJC30;MDGA1;GRIN1
prerank,regulation of apoptotic process (GO:0042981),0.4072418667972038,1.2916457943137116,0.001,0.47821721263058437,1.0,223/676,25.31%,IGF1;BCL2;CTNNB1;CTSB;ABR;IKZF3;ARHGAP10;CD3E;CTSD;BCL2L1;NIBAN2;IL2RB;FLNA;ATG7;ANXA5;PLAUR;LGALS1;ANXA1;LTF;MALT1;SGK1;GNA13;LEF1;UBA52;TRAF2;RPS27A;MCL1;PDPN;FIGNL1;SPHK2;AKAP13;PTPA;ANXA4;RPS6;CD44;PRDX5;AXL;SCIN;HRG;GZMA;DUSP9;SPHK1;PTK2B;MMP9;MTCH1;RAF1;SQSTM1;CDK5;CD28;HYPK;SERPINB9;HSPB1;DAXX;ANGPT4;BID;SIAH2;MYDGF;RBM25;BCL6;DAB2;RTKN;KCNMA1;ACTN1;STK3;TPT1;SOX9;APIP;VEGFA;ANGPT1;ING4;HDAC1;HTT;TFPT;BCL2L11;PLK2;IGF1R;PSEN2;DIABLO;NAA16;LILRB1;SON;UFM1;RACK1;VCP;BAX;MGMT;IAPP;HIP1;NAT8;UTP11;ARHGEF1;RABGGTB;DNM2;ATF5;CLN3;SUDS3;DUSP6;TRIAP1;PIM1;JUN;TCTN3;IRF5;ARHGEF18;NDRG1;WDR73;ATAD3A;BIRC6;PRDM9;HNRNPK;GLS2;HS1BP3;TFAP4;FSTL1;GAS6;PAK2;BIRC5;PPIA;MTCH2;IL31RA;NFKB1;CLU;CYP1B1;BFAR;HSPD1;CIAPIN1;DAPK1;ARHGEF11;CBL;ING3;HSPA9;CAT;VIP;USP47;APAF1;PRMT2;RNF157;C1QBP;FOXO1;BARD1;TFRC;HTATIP2;CCND2;KDR;KALRN;RASA1;NF1;ING5;SMPD1;TNFSF9;RPS6KA2;RIPK3;HIP1R;DAPK3;HAX1;ANO6;ATM;IL6;WFS1;ARL6IP5;CCAR2;CCAR1;HIGD2A;BNIP2;AIFM2;CASP9;IFIT2;IL2;ARHGEF2;TARDBP;UBC;ACTN2;RPS3;HMGB1;CRADD;MTDH;CTNNBL1;VHL;TRIM24;CFL1;GSK3B;NPM1;DFFA;TNFSF10;BMP4;MELK;FBXO11;NSMF;PLEKHG2;LATS1;USP36;CALR;KLF11;EGLN3;ARHGEF5;HTR2B;ACTN4;CD74;ADAMTSL4;PRELID1;AVEN;MIF;DNAJA1;VAV3;SOCS2;BNIP3;JAK2;TNF;ANP32B;BAG3;PLK3;TCIM;ATF4;BIRC2;GADD45A;GOLPH3;DCUN1D3;HDAC2;RRP1B;HSPA5;SFRP1;NCKAP1L;VAV1;YWHAZ
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.48912168875925227,1.2910749214766302,0.13425925925925927,0.4794121765694671,1.0,16/32,32.57%,CTNNB1;PRKCQ;CCT2;TNKS2;PKIB;CCT8;ATM;CCT5;ACD;MAPK15;ATR;MAPK3;XRCC5;PNKP;MAPK1;MAP3K4
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.5223437821956597,1.2910003779577541,0.1513317191283293,0.47905316369869544,1.0,6/23,10.98%,TOMM22;HSPA4;SAMM50;BCL2L11;BAX;TIMM9
prerank,positive regulation of exosomal secretion (GO:1903543),0.5474416311821432,1.2909461744421857,0.15714285714285714,0.47864230915178557,1.0,5/15,11.70%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5294550937415802,1.2907655760316954,0.1486810551558753,0.47862663120416415,1.0,4/22,4.78%,MAN1C1;UBA52;RPS27A;EDEM1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5563037430410862,1.2905345636404275,0.17100371747211895,0.4787723912468739,1.0,2/16,0.97%,GPR137B;RRAGD
prerank,negative regulation of viral genome replication (GO:0045071),0.47226918038732923,1.2902944582896627,0.12641083521444696,0.4789165813133504,1.0,16/40,21.65%,LTF;SHFL;SRPK1;TNIP1;TRIM6;IFITM2;IFITM1;RNASEL;CCL5;ILF3;RSAD2;ZC3HAV1;ISG20;BST2;RESF1;SRPK2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4307128378688849,1.2902406911606175,0.05822267620020429,0.47851151283658383,1.0,27/102,17.56%,MYO5A;EPRS1;PKM;HDAC9;ADCY8;ADCY3;GCK;MGARP;NR4A3;ADCY7;PRKCD;CAV1;PPARG;SLC25A33;PDPK1;CPEB2;DENND4C;RHOQ;RAB8A;RAB8B;PCK2;NFKB1;SORBS1;FOXO1;NR4A2;PIK3R2;VAMP2
prerank,ceramide transport (GO:0035627),0.5902151383140429,1.2897965923508385,0.15641711229946523,0.4793708434580705,1.0,3/12,9.11%,PSAP;GLTP;ABCA13
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3862196460770978,-1.2897941226194056,0.14367816091954022,0.6248970580902984,1.0,2/25,0.31%,CACNB2;CAPN3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5313109361383221,1.2894306578976125,0.1432129514321295,0.4799847453901871,1.0,13/21,30.07%,RAD51B;BRD4;FBXO5;CCNB1;VPS4B;STOX1;CDC7;RAB11A;NPM1;CDK4;CDC25B;CDC25A;CCND1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4412695911972967,1.2894080852626675,0.09799789251844046,0.4794899084824353,1.0,37/73,28.10%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;NR4A3;PRKCD;GRB2;NCK1;WIPF1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTB;ACTR3;ARPC1B;SYK;PIK3R2;FCER1G;BAIAP2;HSP90AB1;MYO1G;ABI1;WAS;VAV3;NCKAP1L;VAV1;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,regulation of protein import into nucleus (GO:0042306),0.47488142013581736,1.2892664132182645,0.11757990867579908,0.47935680849190815,1.0,17/36,25.91%,MDFIC;FLNA;PRKCD;IPO5;TRIM28;CDH1;UFM1;JUP;TPR;CHP1;PIK3R2;BMP4;SUFU;RBM22;BAG3;HDAC3;ZPR1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5750112172282075,1.2891974219335651,0.15485564304461943,0.47898757440526585,1.0,7/15,24.88%,IRX5;MTHFD1;EIF4A3;NIPBL;TGFBR2;FGFR2;PDGFRA
prerank,dermatan sulfate metabolic process (GO:0030205),0.5780575976287219,1.2889114230280498,0.17177097203728361,0.4792708026350598,1.0,8/13,29.81%,CSPG4;DCN;BGN;CHST12;IDUA;CSPG5;DSEL;DSE
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5096272311206143,1.288316749466035,0.16428571428571428,0.4805271617657095,1.0,7/25,6.02%,PTPRC;ANXA1;CD4;MALT1;TRAF2;CD28;RUNX1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5819418052362049,1.288293729249167,0.1568627450980392,0.480021320109627,1.0,7/13,25.28%,FGF2;ITGA4;PDPK1;ADAM17;SP1;HMGB1;MDK
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5561984889751845,1.2878757274388433,0.16370558375634517,0.48078384811227814,1.0,8/16,19.74%,TNKS2;HNRNPA2B1;ERCC4;SLX4;DHX36;ATM;RTEL1;TERF1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.40683003888349156,1.2872123522955499,0.001,0.48227987407463035,1.0,200/532,29.28%,BCL2;LCP1;LCK;HIF1A;ITGAX;FN1;LCN2;ABL2;CSF1;BCL2L1;IL2RB;CD300LF;PSMD8;SLC27A1;GRAP2;IL18R1;ANXA1;PSMD1;TMSB4X;CD4;IL18RAP;MSN;CSF2RA;UBA52;TEC;CXCR2;IRAK2;TRAF2;CCL4;RPS27A;MCL1;VIM;MUC1;LTB;CD44;PIK3CB;OSMR;STAT4;IRF6;TNFSF15;POMC;GSTA2;PTK2B;MMP9;SQSTM1;PRKCD;FGF2;PLP2;TRAF3;IL3RA;IL27;IL12RB1;IFITM2;BCL6;GATA3;GRB2;VEGFA;CRKL;IL27RA;INPPL1;UGCG;BCL2L11;P4HB;TAB1;IFITM1;ILK;PSMD6;PSMA1;ADAM17;IRF8;CCL13;RNASEL;TRAF1;B2M;PSMC3;HMOX1;FYN;SOCS5;PIM1;CEBPA;CCR2;CCL7;JAK1;IRF5;CCL5;TNFRSF1B;PSMA8;TNIP2;RHOU;HSPA8;SP100;CDC42;TNFRSF9;GHR;PAK2;PSMD14;BIRC5;CCL14;PSMD2;STX3;TNFSF8;RSAD2;PPIA;IL31RA;NFKB1;HNRNPA2B1;CBL;ITGB2;LAMA5;HSPA9;PSMC6;APPL2;FOXO1;PSMA6;SYK;GBP2;TNFSF9;IL1R2;ADIPOR1;PDCD4;PSMD5;ISG20;MAP3K8;PSMA5;HNRNPF;IL6;FCER1G;BST2;ADAR;IFIT2;IL2;CNTFR;GAB2;IL5;UBC;SOD2;FBXW11;EIF5A;TIMP1;EPO;CUL1;TNFRSF11B;CFL1;LBP;TRIM21;CDIP1;CANX;IL34;ACTN4;IL17RA;EGR1;STAT5B;IL20RA;IRAK4;MIF;TALDO1;PSMA3;SOCS2;JAK2;TNF;BIRC2;POU2F1;PSMB10;PSMB8;VAV1;YWHAZ;COL1A2;PSMD7;AIM2;SMARCA4;PSMB6;CX3CL1;BTRC;MT2A;PTPN6;PELI1;STX4;IL12RB2;PSMD10;IFNAR2;IFNGR2;TRIM8;PSMB5;LIMS1;GREM2;RIPK1;ITGB1;PSMB7;MAPK3;OASL;IL1R1;HSP90B1;IL21R;JUNB;CTR9;GSTO1;TAB2;SIRT1;PSMC4;TNFRSF8
prerank,regulation of protein sumoylation (GO:0033233),0.5442066750174482,1.2865508691587777,0.15019255455712452,0.48379404342011667,1.0,9/17,25.69%,CTNNB1;ZMIZ1;HDAC4;GNL3;PIAS1;SAE1;RWDD3;EGR1;PIAS4
prerank,negative regulation of axonogenesis (GO:0050771),0.5065147480261376,1.2863916119221679,0.14437869822485208,0.48372687688970345,1.0,6/27,11.87%,FGF13;LRP4;RNF6;GDI1;RUFY3;RHOA
prerank,alcohol catabolic process (GO:0046164),0.6190694254396828,1.2863592869118932,0.14423076923076922,0.48326589021584765,1.0,3/10,7.87%,APOE;CEL;SRD5A3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4451515098381911,1.286314519153731,0.11122994652406418,0.4828443786710281,1.0,11/63,6.93%,BCL2;CD3E;PTPRC;ANXA1;SLC7A1;CHRNB2;CD6;CD28;NCK2;CD274;NCK1
prerank,midbody abscission (GO:0061952),0.5358806127317024,1.2849559666338268,0.16795865633074936,0.486495793438827,1.0,6/17,13.37%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;CHMP7;KIF20A
prerank,regulation of spindle assembly (GO:0090169),0.5074373014941862,1.2848709753099596,0.13267813267813267,0.4861792072445103,1.0,9/25,18.86%,DYNC1H1;CHMP4B;PDCD6IP;DRG1;VPS4B;NUMA1;TPR;HNRNPU;CCSAP
prerank,regulation of actin filament polymerization (GO:0030833),-0.3035531291000044,-1.2847139459856154,0.03278688524590164,0.633343831771766,1.0,10/69,4.88%,SSH2;CYRIB;FCHSD2;BIN1;PRKCE;FER;KANK1;TWF2;CARMIL1;NCKAP1
prerank,autophagosome maturation (GO:0097352),0.4875550187615536,1.2846440921188436,0.15240328253223914,0.4863427687910731,1.0,12/32,22.31%,TECPR1;LIX1;LAMP2;LIX1L;VCP;CLN3;MAP1LC3B;UBQLN1;VIPAS39;MAP1LC3A;GABARAP;ATP2A2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.584461698389126,1.2838782497912822,0.18010752688172044,0.48816339838480244,1.0,3/12,11.55%,PTK2B;ANXA6;DIAPH1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.41712997598227863,1.283671791716138,0.04838709677419355,0.4882073718954876,1.0,58/158,27.83%,LITAF;FLNA;LGALS1;LTF;CD4;MALT1;TRAF2;AKAP13;TRIM6;CC2D1A;DDX21;IKBKE;BRD4;PLK2;PRKCB;EEF1D;TICAM1;HMOX1;WLS;DDX1;RHOA;SHARPIN;TNIP2;ECM1;GPRC5B;LPAR1;CLEC6A;TMEM106A;TFRC;TIRAP;DHX36;NEK6;S100B;BST2;SHISA5;GPR89A;MTDH;TNFSF10;TRIM21;F2R;HTR2B;CCDC22;CD74;REL;IRAK4;JMJD8;TNF;BIRC2;SLC20A1;SLC44A2;TLR9;CX3CL1;PELI1;PPM1A;TERF2IP;TRIM8;TBK1;RIPK1
prerank,regulation of wound healing (GO:0061041),0.4599740693847379,1.2834153623167364,0.122334455667789,0.4884644929921209,1.0,9/42,11.25%,PLAU;ANXA1;HRG;CLDN19;FGF2;CAV1;ACTG1;CADM4;SERPINE1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.49023133074880987,1.283046051321608,0.136568848758465,0.48899470402851625,1.0,14/32,23.62%,PTPA;PRKCD;DLC1;CD300A;PPIA;SPPL3;PPP1R15B;SYMPK;SMPD1;PIN1;HSP90AB1;NSMF;PPP1R15A;CALM3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4474426318421671,1.2826967519371015,0.10264550264550265,0.48953556626209926,1.0,28/65,32.15%,PSMD8;PSMD1;PSMD6;PSMA1;PSMC3;PSMA8;PSMD14;PSMD2;USP47;PSMC6;PSMA6;PSMD5;PSMA5;CUL1;AVEN;PSMA3;ZFYVE19;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;PSMB5;PSMB7;PSMC4;NABP1;PSMD12;PSMD3
prerank,cellular defense response (GO:0006968),0.4728347851363627,1.2822601051653062,0.1262683201803833,0.49025799733587916,1.0,11/40,11.65%,TCIRG1;KLRC2;ITK;CXCR2;SPN;PTK2B;NCR1;TRAT1;PRF1;ZNF148;CD5L
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.41236459309853346,1.2819240480839738,0.023115577889447236,0.49072380172908836,1.0,72/214,26.28%,GPNMB;APOE;FN1;FPR2;SIRPA;PTPRC;CD4;CCL4;GCNT2;TNIP1;PDGFA;CD44;ALKAL2;DUSP9;GLIPR2;PTK2B;FBXW7;FGF2;NRP1;MFHAS1;PTPN22;APIP;CRKL;ANGPT1;TREM2;RASGRP1;CCL13;P2RY1;ATP6AP1;PTPN2;RANBP9;DUSP6;CCL7;CCL5;FBLN1;CNKSR3;MAP3K12;GAS6;ABCA7;CCL14;PRKD2;TIRAP;KDR;SYK;DUSP3;C5AR1;SERPINF2;PIN1;FERMT2;ITGB1BP1;FAM83D;SCIMP;HMGB1;EMILIN1;SPRED2;LMO3;FGFR3;ARHGEF5;F2R;HTR2B;CD74;MIF;FGFR2;SPRED3;TNF;PDGFRA;PLA2G5;YWHAZ;DSTYK;GPR183;CX3CL1;PTPN6
prerank,cellular component assembly (GO:0022607),0.4131956477315976,1.2817788818182305,0.006,0.49056196104926125,1.0,82/253,23.52%,FBLIM1;LCP1;MITF;CD3E;CD247;IL2RB;FLNA;EPRS1;KMT2A;CAPG;TRAF2;TUBGCP4;PDGFA;SCIN;CD3G;PKP1;PTK2B;MICAL1;SLC2A1;NEDD9;PPP2R1A;FOXJ1;TLCD1;SPAG16;NOC2L;SOX9;WIPF1;LIMS2;RHOD;ACTG1;RHOQ;TAPBP;ILK;TLCD2;SKAP2;RANBP9;M1AP;TRAF1;CARD10;RHOG;PARVA;MAGI1;YTHDF3;RHOA;GSN;DNAJB13;RHOU;AFG3L2;GPAA1;FZD1;CDC42;TFAP4;GAS6;DCX;TSPAN4;ACTB;LAMC1;NDUFAF1;ESPN;CHAF1B;MDN1;YTHDF2;PKP2;VAMP2;ELOB;JCHAIN;FERMT2;FANCA;PARVB;VASP;MYO9A;TRIP13;PLS1;BAIAP2;SYCE2;ACD;TEAD1;WAS;CD74;PEX14;BAIAP2L2;LLGL1
prerank,proteolysis (GO:0006508),0.4132266821459875,1.2811685559323678,0.018,0.4919396553877478,1.0,75/252,24.02%,PLAU;ADAM33;CTSB;CTSD;ANPEP;MMP8;CTSZ;MMP12;CAPN15;PGPEP1L;OLR1;ST14;MALT1;CTSA;CTSW;ATG4D;GZMB;CPA4;CPA3;GZMA;TMPRSS2;ADAMTS13;BMP1;MMP9;ECEL1;CPXM2;CLPP;SDE2;CAPN1;NAPSA;DPP7;CNDP2;PSEN2;PSMD6;ADAM17;CPA6;AEBP1;TASP1;CLN3;LONP1;CTSE;DDI2;SPCS3;AFG3L2;OGT;KLKB1;MMP19;CPD;CASP7;ATG4A;SPPL3;CASP4;PSMA6;FURIN;XPNPEP1;KLK3;TMPRSS5;FBXL6;TMPRSS7;DESI1;DESI2;VHL;MMP17;TPP1;SRGN;SENP1;PITRM1;SUFU;TMPRSS4;CLPX;ECE1;TRABD2B;PARL;NLN;MDM2
prerank,microvillus assembly (GO:0030033),0.5603466741164348,1.2809097172161452,0.164021164021164,0.4921809200358462,1.0,5/14,17.07%,RAP2A;FXYD5;RAPGEF6;ESPN;MINK1
prerank,response to steroid hormone (GO:0048545),0.4951059102928024,1.2806265462389,0.13729977116704806,0.49252195436554863,1.0,10/31,19.81%,MGARP;SOX30;CAV1;TFPI;ATP1A3;ATP1A1;UBE2L3;ATP1A2;WBP2;NR3C1
prerank,DNA catabolic process (GO:0006308),0.5956783068695525,1.2804438139069523,0.17842323651452283,0.49252737622223053,1.0,5/11,21.83%,XRN2;DFFB;ISG20;DNASE1L1;SETMAR
prerank,regulation of viral entry into host cell (GO:0046596),0.4890799467360145,1.2796041927341741,0.13114754098360656,0.4946242049040974,1.0,8/30,12.03%,LGALS1;CD4;TRIM6;TMPRSS2;IFITM2;P4HB;IFITM1;GSN
prerank,protein polymerization (GO:0051258),0.4518088235720584,1.2795218336899554,0.09750812567713976,0.4943272500258674,1.0,12/55,12.56%,FGF13;GAS7;TRIM6;MSRB1;WASHC5;CHMP4A;CHMP4B;CORO7;ARHGAP6;DIAPH1;GSN;MID1IP1
prerank,carbohydrate transport (GO:0008643),0.5915688620405904,1.279154468344254,0.18245125348189414,0.49491214663673483,1.0,3/11,3.29%,SLC23A1;SLC23A2;SLC5A1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5001906323208372,1.279114605128115,0.15942028985507245,0.49445242134663425,1.0,10/26,24.18%,KMT2A;ETFBKMT;TET3;PRDM9;KMT5B;OGT;SETD1A;EEF2KMT;KMT2D;SMYD5
prerank,chromosome organization (GO:0051276),0.42751768455839695,1.2790938872828013,0.07851239669421488,0.49395389712315463,1.0,40/99,29.79%,UBA52;RPS27A;COPS3;DOT1L;SATB1;COPS8;COPS4;HDAC1;MTF2;GEM;HMGN1;DDB2;DDB1;COPS2;XPA;COPS6;PHF1;CENPT;RAE1;UBC;TCF7L1;GATAD1;EHMT1;LATS1;XPC;MTHFR;HDAC11;HDAC2;CUL4A;HDAC3;SMARCA4;NUP133;H3-3A;SUPT4H1;CETN2;SAFB;SIRT1;HMGB2;CENPH;COPS7A
prerank,histone H3 deacetylation (GO:0070932),0.5569618823029538,1.2787208409819941,0.16103896103896104,0.49452081775057044,1.0,8/15,30.96%,HDAC9;HDAC4;HDAC1;ELK4;HDAC2;HDAC3;SIRT1;SIRT2
prerank,negative regulation of coagulation (GO:0050819),0.5645479944628715,1.2782848860938467,0.16688741721854305,0.4953460702552932,1.0,6/14,16.10%,APOE;TFPI;SERPINE2;SERPINE1;PROCR;APOH
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5283035985245885,1.2781710255110639,0.16774193548387098,0.4951449497564902,1.0,11/18,33.93%,KMT2A;PRDM9;SETD1A;SMYD2;EHMT1;SETMAR;KMT2D;ASH1L;SUV39H2;KMT2B;SETD2
prerank,neuropeptide signaling pathway (GO:0007218),-0.30972760394263815,-1.2781662245016736,0.06153846153846154,0.6466704322036174,1.0,19/58,20.35%,SORCS1;GLRA3;PPY;CPE;GPR37;CYSLTR1;RAPGEF2;SORL1;PENK;SORT1;GPR149;GLRA2;GLRA1;OPRD1;PDYN;SSTR2;NXPH2;NPY;NMU
prerank,stress-activated MAPK cascade (GO:0051403),0.4464661302180257,1.2780940853698988,0.10204081632653061,0.4948241050248774,1.0,21/61,22.29%,UBA52;IRAK2;RPS27A;MAPK13;DUSP9;MAP4K2;MAP4K3;CRKL;TAB1;TNIP2;MAP3K12;NFKB1;MAPK9;MAP2K3;MINK1;MAP3K8;UBC;FBXW11;SH2D3C;CUL1;PTGER4
prerank,striated muscle cell development (GO:0055002),-0.4498645253679806,-1.277975543134655,0.17721518987341772,0.6419005615853507,1.0,2/14,8.85%,CAPN3;PGM5
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5232390591299841,1.2776138047842682,0.14764267990074442,0.49576156983523373,1.0,10/21,23.55%,GCK;DERA;PGLS;HK1;TKT;HK3;GPI;RPIA;PGM2;TALDO1
prerank,regulation of pH (GO:0006885),0.5944775696143683,1.2774374494025302,0.1638888888888889,0.49575391632559995,1.0,6/11,19.88%,SLC9A1;ATP1A4;ATP6AP1;SLC9A7;SLC26A4;ATP6V0A4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40587601571225906,1.2772760740992746,0.004,0.4956916264206038,1.0,91/390,16.16%,BCAR3;IGF1;FLT1;LCK;CYBA;STAP1;NRP2;CD3E;CSF1;TCIRG1;SDCBP;ATP6V1C1;ATP6V0D2;CD8B;ATP6V1A;ARPC2;CD4;FGR;CYBB;CD8A;ARPC3;ATP6V0A1;ATP6V1B2;ARPC5;PDGFA;PIK3CB;AXL;NRG1;CD7;SH2D2A;NR4A3;PTK2B;MMP9;NEDD9;FGF2;NRP1;ATP6V0D1;ATP6V0B;ATP6V1G1;NCK2;BLNK;MTSS1;GRB2;NCK1;VEGFA;HNRNPM;ANGPT1;CLNK;ACTG1;POLR1G;IGF1R;POLR2H;PSEN2;RHOQ;MAPKAPK3;ATP6AP1;CYFIP2;MVP;MAPKAPK2;PTPN2;NCF4;FGF7;FYN;ANGPT2;FGF20;RHOA;ATP6V1F;NAMPT;CDC42;EFNA1;GTF2F1;GHR;PAK2;AAMP;ROCK1;ACTB;GIT1;POLR2D;IL31RA;ACTR3;PRKD2;RBFOX2;SORBS1;ARPC1B;CBL;FOXO1;EFNB2;KDR;SYK;KALRN;RASA1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.46708477483194305,1.2771976332201878,0.13053348467650397,0.4953994963913333,1.0,11/43,11.60%,IGF1;ID2;NR4A3;MEF2D;MMP9;FGF2;ERN1;DNMT1;HMOX1;JUN;CCL5
prerank,telomere maintenance via telomerase (GO:0007004),0.4963573063803927,1.276957842453096,0.15873015873015872,0.495644044817936,1.0,13/28,22.38%,ANKRD28;RAD50;GAR1;CDK2;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4860253134761937,1.276700467842693,0.12298850574712644,0.4958880380835246,1.0,5/31,9.28%,GPNMB;SPN;CD274;LILRB1;CD300A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5757987454597158,1.2765639985545978,0.16533333333333333,0.4957679999195459,1.0,4/13,11.25%,TMSB4X;TREM2;VCP;ENO1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.44750749157449743,1.2764591661090976,0.12286324786324786,0.49556382645884295,1.0,35/60,37.40%,CTNNB1;PRKCQ;CCT2;FGF2;TNKS2;NVL;PKIB;CCT8;PRKD2;POLG2;ATM;PTGES3;CCT5;HSP90AB1;ACD;DKC1;MAPK15;RFC2;ATR;MAPK3;PARM1;XRCC5;PNKP;MAPK1;RFC4;MAP3K4;RFC5;PCNA;NAF1;MYC;PDGFB;SMOC2;HGF;FGFR4;GREM1
prerank,regulation of cell projection organization (GO:0031344),0.5681213389688,1.2761953742044467,0.17546174142480211,0.49586598513268126,1.0,3/13,7.32%,MACF1;FAM110C;TREM2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.519758380482139,1.2760250283460686,0.15384615384615385,0.49524907241220306,1.0,13/23,34.02%,SDCBP;DAB2;ADAM17;RNF111;ING2;STK11;HSP90AB1;GIPC1;SNW1;TGFB1I1;EP300;CREBBP;HIPK2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.519758380482139,1.2760250283460686,0.15384615384615385,0.49524907241220306,1.0,13/23,34.02%,SDCBP;DAB2;ADAM17;RNF111;ING2;STK11;HSP90AB1;GIPC1;SNW1;TGFB1I1;EP300;CREBBP;HIPK2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5241041644576925,1.275556857457716,0.15560916767189384,0.4961203330033386,1.0,2/21,0.19%,CHST11;CSPG4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5862730268651675,1.2754819996958895,0.16373477672530445,0.49578928989077514,1.0,3/12,7.34%,NCOR2;DAB2;HDAC1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4255274577877483,1.2750853742128772,0.07365145228215768,0.49647422928284246,1.0,22/100,16.05%,IGF1;FLT1;FN1;NLRC3;FGR;PDGFA;PIK3CB;FGF2;PPP2R5C;MYDGF;PIK3R5;SOX9;TREM2;IGF1R;PIP5K1C;MYOC;CCL5;PTPN13;ENTPD5;DCN;CBL;KDR
prerank,positive regulation of metabolic process (GO:0009893),0.42579290832800154,1.2749464723888124,0.07098765432098765,0.49636837749488727,1.0,38/103,27.22%,LCN2;FABP5;ACACA;PEMT;DYNC1H1;UCP2;CAV1;PIGA;ZBTB7B;ACSL1;VEGFA;IGF1R;KDM3A;CCR2;PPARGC1B;OGT;YBX2;APPL2;PLAC8;SYK;CPT2;ADIPOR1;DECR1;JCHAIN;ACACB;EHMT1;FABP4;HSF1;ACADL;GNAS;AGPAT1;JAK2;TNF;FASN;HADH;HDAC3;CXCR4;KDM1A
prerank,mitochondrial fusion (GO:0008053),0.52670254584288,1.274933492823107,0.16308470290771176,0.4958468084757195,1.0,10/18,32.14%,THG1L;BAX;AFG3L2;STOML2;USP30;SPG7;FIS1;MFF;MIGA2;MFN1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4857093421395715,1.2746931916505075,0.13410404624277455,0.4960131667720826,1.0,13/30,31.99%,NIBAN2;HNRNPC;EXOSC10;ERCC4;HNRNPU;DACH1;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4476660382942945,1.2746713219032864,0.1309655937846837,0.49552631977988715,1.0,14/52,17.04%,LGALS3;PRKCH;LRP1;SQSTM1;PDPK1;TREM2;STAC2;RANGRF;RHOG;STX3;NUMA1;SORBS1;CNPY4;ITGA3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5397130300139019,1.2745864506479858,0.15572715572715573,0.4952312819170148,1.0,7/17,23.37%,STAP1;CDK5;NRP1;CDC42;HAX1;BAIAP2;BAIAP2L2
prerank,positive regulation of cell motility (GO:2000147),0.40843348030533005,1.273967613822651,0.0321285140562249,0.4964723660845639,1.0,33/205,11.90%,GPNMB;PLAU;IGF1;FLT1;ITGAX;CSF1;SDCBP;MGAT5;FGR;LEF1;GCNT2;PDPN;PDGFA;FAM110C;SPHK1;PTK2B;MMP9;NEDD9;CAV1;FAM83H;DAB2;VEGFA;RHOD;ACTG1;IGF1R;SPAG9;ADAM17;RACK1;RUFY3;MYOC;CCL7;CCL5;PHPT1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4825056880553701,1.2738836847318518,0.14485981308411214,0.4961940232329711,1.0,8/29,11.11%,STAP1;KLRC2;CD226;IL12RB1;CADM1;RASGRP1;KLRK1;CRTAM
prerank,defense response to fungus (GO:0050832),0.5398386387136436,1.2737209039546946,0.17543859649122806,0.49614508247155376,1.0,4/17,3.32%,S100A8;S100A9;LTF;HRG
prerank,regulation of interferon-gamma production (GO:0032649),0.43267907985169063,1.2736932017000426,0.09753483386923902,0.49567899049048586,1.0,25/71,21.76%,SIRPA;IL18R1;CD226;CD2;AXL;IL27;IL12RB1;CD274;PTPN22;TXK;RASGRP1;LILRB1;CRTAM;CCR2;GAS6;DDIT3;HSPD1;CEBPG;C1QBP;RIPK3;HAVCR2;SLC11A1;HMGB1;LAPTM5;CD47
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5484263122234799,1.2736023443177449,0.16752577319587628,0.49539223783214964,1.0,7/15,20.99%,TTLL12;PTPN2;METTL3;YTHDF3;YTHDF2;USP18;NLRC5
prerank,sulfur compound catabolic process (GO:0044273),0.46446910494650906,1.273109402238181,0.14732142857142858,0.49630974443358655,1.0,14/38,24.28%,CSPG4;GALNS;GNS;HEXA;GLB1;DCN;ACAT1;BGN;TST;IDUA;MPST;LUM;CSPG5;OGN
prerank,regulation of receptor recycling (GO:0001919),0.5465216934857937,1.2730654866496582,0.1801470588235294,0.4958971471207572,1.0,7/16,28.43%,OPTN;TRAT1;ECE1;TBC1D16;KIF16B;LAMTOR1;VAMP3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.48540702619700205,1.2729764769463774,0.1368421052631579,0.4956371401856978,1.0,10/33,11.87%,APOE;HRG;FGF2;ANGPT4;PPARG;CARD10;JUP;ANGPT2;DLL4;RHOA
prerank,melanosome organization (GO:0032438),0.49846567357604504,1.2728778154777156,0.14487632508833923,0.4954172819942368,1.0,9/26,19.05%,LYST;BLOC1S3;TYRP1;DTNBP1;RAB32;HPS1;AP1G1;AP3D1;PIKFYVE
prerank,cellular response to ketone (GO:1901655),0.47714920607071154,1.2727317444330986,0.1439820022497188,0.4953323091366477,1.0,16/35,25.13%,SPP1;MSN;ADCY8;ADCY3;SPHK2;PTGFR;PCK2;LARP1;ADAM15;ACOD1;GNB1;NR3C1;PTGER4;AHR;GOLPH3;SFRP1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4919771869072432,1.272718410070466,0.1552346570397112,0.49482446603439634,1.0,9/30,18.99%,MGAT5;DERL3;MAGT1;STT3B;LMAN1;MCFD2;TUSC3;ST6GAL1;DDOST
prerank,carboxylic acid catabolic process (GO:0046395),0.586021187513221,1.2726953414381048,0.17786561264822134,0.49434253600853556,1.0,8/12,27.19%,RENBP;PON1;GNPDA1;NAGK;NPL;GNPDA2;AMDHD2;ACOT8
prerank,protein polyglutamylation (GO:0018095),-0.47497901642776597,-1.2725146650476158,0.16731517509727625,0.6519653480027087,1.0,7/11,22.83%,TTLL7;TPGS1;TTLL5;TTLL4;TTLL9;CFAP20;TTLL6
prerank,regulation of tissue remodeling (GO:0034103),0.5382211613312804,1.2724254585468002,0.16623376623376623,0.49461924262082496,1.0,3/18,6.02%,GPNMB;SUCO;RUNX1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4039344594657239,1.2722268623265016,0.008,0.4946704542745649,1.0,77/348,18.32%,GPNMB;BCAR3;IGF1;FNIP2;CSPG4;IQGAP1;CSF1;SDCBP;RAP2A;FPR2;PLAUR;PTPRC;CD4;LAT;ITGA5;TEC;PDGFA;EIF4G1;CD44;ALS2;BMP8B;TRIM6;GDF6;SPHK1;CLDN19;PTK2B;MMP9;NPTN;RAF1;FGF2;NRP1;CAV1;DAXX;ANGPT4;MYDGF;DAB2;SOX9;VEGFA;CRKL;ANGPT1;TREM2;RASGRP1;ILK;ADAM17;P2RY1;RACK1;FGF7;KRAS;C3;RBPMS;RAD50;FGF20;EFNA1;GAS6;GHR;PAK2;JTB;PPIA;CAB39;STOX1;PRKD2;CSNK1D;DOCK7;CLEC6A;TFRC;CCND2;KDR;MAP2K3;BMP6;FXR2;PRKAG1;DDR2;RALB;HAX1;PIN1;TESK1;IL6
prerank,regulation of cell motility (GO:2000145),0.4150978175632565,1.2719047317961187,0.06504065040650407,0.49508883650215957,1.0,28/121,13.64%,PLXNC1;CDK6;ABL2;FLNA;PLXNA2;TMSB4X;SGK1;MACF1;NRG1;SGK3;RAF1;FGF2;LMO4;GATA3;TMSB10;LMNA;CADM4;PLXND1;FGF7;SERPINE2;DIAPH1;FGF20;FBLN1;RHOA;PHPT1;MEMO1;PKN2;ROCK1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.44806216365022583,-1.271765034285917,0.17094017094017094,0.6487588493694446,1.0,5/14,8.55%,PIK3R1;STAT5A;PRLR;STAT3;PTK2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4653294749485199,1.2713361548615347,0.125,0.49630961977179827,1.0,17/43,25.84%,HIF1A;FGF2;PPARG;GATA3;SOX9;PPARD;JUN;SRF;GNL3;NR3C1;NFATC3;BMP4;TEAD1;TERT;EGR1;TNF;SMARCA4
prerank,cellular response to unfolded protein (GO:0034620),0.4952550815496566,1.271228268137355,0.15338164251207728,0.4961133685911599,1.0,12/26,26.92%,OPTN;DAXX;ERN1;BAX;HSPA8;HSPD1;HSPA9;HSF1;BAG3;HSPA5;HSPA2;PACRG
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.43056826683886484,1.2711928598738607,0.07644628099173553,0.49567125873980766,1.0,40/94,29.24%,PSMD8;PSMD1;UBA52;IRAK2;RPS27A;SQSTM1;TAB1;PSMD6;PSMA1;PSMC3;PSMA8;TNIP2;PSMD14;PSMD2;NFKB1;PSMC6;PSMA6;IL1R2;PSMD5;MAP3K8;PSMA5;UBC;FBXW11;CUL1;EGR1;IRAK4;PSMA3;PSMB10;PSMB8;PSMD7;PSMB6;BTRC;PELI1;PSMD10;PSMB5;PSMB7;MAPK3;IL1R1;TAB2;PSMC4
prerank,protein import into nucleus (GO:0006606),0.443226560138531,1.2711272796139588,0.11324786324786325,0.4953408260453298,1.0,29/66,29.19%,MMP12;RGPD1;GCKR;PRICKLE1;IPO5;RPL23;KPNA4;E2F3;NUP188;NXT2;KPNA6;RANBP2;TPR;EIF4ENIF1;APPL2;SYK;CBLB;PPP1R10;NUP93;NUP50;NUP54;TNPO2;TNPO1;NUP133;NUTF2;IPO13;NUP35;PTTG1IP;NUP214
prerank,global genome nucleotide-excision repair (GO:0070911),0.5068183978292119,1.2709709438605714,0.15429917550058891,0.49527697334676396,1.0,14/26,27.23%,UBA52;RPS27A;ERCC1;DDB2;DDB1;RNF111;XPA;ERCC4;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5534535536264291,1.270914221425819,0.16796875,0.4949231456684355,1.0,5/15,19.81%,ANXA1;BCL2L11;UBE2L3;HNRNPU;NR3C1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5200219100670901,1.2705463141692948,0.17164179104477612,0.4954662345971955,1.0,5/21,14.88%,CTNNB1;CAV1;FRAT1;FZD1;LRP6
prerank,RNA stabilization (GO:0043489),0.48171413532285184,1.2704740911554788,0.1399548532731377,0.4951318998903861,1.0,12/33,21.84%,TENT5C;NOCT;PABPC1;TAF15;LARP1;EIF4ENIF1;VIP;DHX36;HNRNPU;NSUN2;SLC11A1;DKC1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4748066320506177,1.2702262631494308,0.13898305084745763,0.4953477098589422,1.0,10/37,11.11%,ALCAM;ITGAL;NECTIN1;CD6;AMIGO1;CADM1;FAT4;NECTIN3;JAML;CRTAM
prerank,calcium ion transport into cytosol (GO:0060402),-0.4002732327704249,-1.2701496836286905,0.14361702127659576,0.6482993261868933,1.0,9/21,22.22%,CACNA2D1;GRIN2A;GRIN2B;TRPV4;GRIN1;CACNA1C;ADRA1A;TRPM2;TRPM1
prerank,positive regulation of protein catabolic process (GO:0045732),0.4345712282305917,1.2700693904007492,0.09100310237849017,0.49530752741134343,1.0,38/84,29.73%,APOE;ATG7;MSN;ADAM8;C4BPA;C4BPB;SEC22B;SNX33;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TNFRSF1B;TIPARP;VPS11;VIP;FOXO1;BARD1;FURIN;SH3D19;GSK3B;RNF41;VPS35;TNF;PLK3;VPS28;RILP;STX5;GSK3A;DACT1;TNFAIP3;WWP2;PTTG1IP;FAF1;SNF8
prerank,import into cell (GO:0098657),0.4647394667643887,1.2691641648398801,0.14510686164229472,0.4975568690932639,1.0,14/41,18.91%,LRRC8C;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC6A14;SLC46A1;TREM2;SLC12A4;ATP1A2;SLC7A8;SLC5A3;SLC19A1;SLC16A2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.4957223697589107,1.2690868262002453,0.14354066985645933,0.4972771442742024,1.0,15/25,29.89%,DNAJB14;ERO1A;GAK;SDF2L1;DNAJB13;HSPA8;HSPA9;DNAJB1;PTGES3;HSPE1;HSPA5;HSPA2;ST13;DNAJB12;SDF2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4306890230925544,1.268801325190506,0.10319148936170212,0.49759046042486244,1.0,25/73,27.99%,BCAR3;FNIP2;EIF4G1;CD44;TRIM6;RAF1;CAV1;VEGFA;GAS6;STOX1;PRKD2;DOCK7;TFRC;HAX1;IL6;SH2D3C;HSP90AB1;LATS1;MIF;TNF;TXN;TERF2IP;TBK1;CREBL2;FNIP1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6072283806595127,1.2687255992293591,0.19151846785225718,0.4972781207162406,1.0,8/10,35.00%,MTHFD2;MTHFS;SHMT1;MTHFD1;MTHFR;SHMT2;MTHFD1L;TYMS
prerank,neuron apoptotic process (GO:0051402),0.5271742885618323,1.268716439707489,0.1658354114713217,0.4967664598941413,1.0,4/19,8.39%,BCL2;CDK5;BID;DIABLO
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.41010586331403687,1.2685240763736858,0.045180722891566265,0.4968188240936067,1.0,40/182,14.32%,IGF1;APOBEC1;APOE;HIF1A;CD3E;MMP8;SDCBP;SMCR8;AGO2;XDH;OPTN;ID2;TRIM6;CILP;VDR;CLDN19;FBXW7;FGF2;CD28;RUNX1;PTPN22;TRAT1;VEGFA;CRKL;DNMT1;HDAC1;NOCT;CELF1;DIP2A;FLOT2;RACK1;LRPAP1;ANKRD13B;ZNF148;DLL4;TLE5;TIPARP;YY1;STOX1;NFKB1
prerank,presynapse assembly (GO:0099054),-0.4229444189131676,-1.2685209841245608,0.1657754010695187,0.6478043762445593,1.0,6/16,10.32%,IL1RAPL1;NLGN1;PTPRD;LRRTM3;WNT5A;BSN
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43918294001560415,1.2681106393121409,0.1102863202545069,0.4974554374246246,1.0,24/65,25.66%,HIF1A;ADAM8;MGARP;CPEB4;ANGPT4;CPEB2;AK4;VEGFA;P4HB;LMNA;PGK1;HMOX1;NDRG1;HP1BP3;UBQLN1;PTGIS;EGLN1;TERT;EGLN3;BNIP3;CPEB1;MDM2;SFRP1;ACAA2
prerank,axon development (GO:0061564),-0.2803484410803007,-1.2680439954188836,0.023255813953488372,0.644035285850505,1.0,22/78,15.33%,GRM7;GAP43;CTNNA2;CNTN4;RTN4RL1;PLP1;PLPPR4;NREP;RAB3A;DSCAML1;APP;PAX2;SLITRK4;APBB1;BRSK1;MAP1B;ARHGAP35;KLF7;PAK3;RAB10;CCK;SVBP
prerank,response to glucose (GO:0009749),0.455282030474953,1.267590034839891,0.13646288209606988,0.4985081006053246,1.0,15/46,23.92%,LPL;ADCY8;GCK;APOA2;ERN1;IGF1R;PFKL;RACK1;PCK2;GAS6;VAMP2;EIF2B2;PDK3;ZBED3;EIF2B4
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4221508235721551,1.2674782791165444,0.08066184074457083,0.49828887122235005,1.0,29/92,22.59%,HIF1A;NRP2;IQSEC1;SASH1;PIK3CB;GLIPR2;PTK2B;MMP9;FGF2;NRP1;ANGPT4;GATA3;SOX9;VEGFA;ANGPT1;RIN2;FGF7;DOCK5;AAMP;PRKD2;KDR;ANXA3;GPI;RAB11A;ITGB1BP1;BMP4;CALR;PFN1;INSL3
prerank,GTP metabolic process (GO:0046039),0.553858208487681,1.2673599265869466,0.17024128686327078,0.4980975890513327,1.0,5/15,13.19%,GIMAP7;AK4;AK3;RHOQ;EFL1
prerank,actin polymerization or depolymerization (GO:0008154),0.4563469097176467,1.2671722986366967,0.12639821029082773,0.49814384908914505,1.0,19/50,25.37%,MICAL2;GAS7;CAPG;SCIN;MICAL1;MSRB1;WASHC5;CORO7;ARHGAP6;DIAPH1;GSN;MICALL2;SVIL;EVL;CFL1;ABI1;WAS;JAK2;ABI2
prerank,negative regulation of leukocyte migration (GO:0002686),0.5955780838941511,1.267005915096151,0.18707015130674004,0.49809350465424346,1.0,6/10,25.16%,CD200R1;HOXA7;CD300A;HMOX1;EMILIN1;BMP5
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5369281957352059,1.2669604637051521,0.16959798994974876,0.49768504886089626,1.0,5/17,14.54%,BCL2;BCL2L1;BID;BAX;CLU
prerank,nucleic acid metabolic process (GO:0090304),0.43561343175847833,1.266613088806716,0.1111111111111111,0.4982218478274834,1.0,27/69,24.89%,HNRNPA3;HNRNPM;POLR2H;XRN2;HNRNPC;METTL3;RAD50;DDX1;DXO;HNRNPK;GTF2F1;DNASE2;POLR2D;HNRNPA2B1;RBFOX2;PCBP1;DUSP11;HNRNPU;HNRNPF;ATXN2;POLG;RECQL5;DNASE1L1;SETMAR;TOPBP1;POLR2F;HNRNPL
prerank,regulation of response to stress (GO:0080134),0.5961428447045156,1.2664888972739772,0.1896792189679219,0.4980917833617799,1.0,5/10,20.26%,ADCY8;EIF4G1;STOX1;SLC38A2;MLC1
prerank,regulation of biomineral tissue development (GO:0070167),0.49113370078939467,1.2663077726086338,0.16019417475728157,0.49815199767348983,1.0,8/26,17.24%,ANKH;CYP27B1;SOX9;FBXO5;ECM1;GAS6;ROCK1;DDR2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3604486614798273,-1.2659993796275497,0.14942528735632185,0.6452518881125782,1.0,8/26,12.82%,LRP5;EFNA5;ADCY5;TRPM4;EPHA5;STXBP4;PPP3CB;KLF7
prerank,icosanoid biosynthetic process (GO:0046456),-0.4956472369527144,-1.2650750314288541,0.21897810218978103,0.6426826336806726,1.0,2/10,1.62%,LTC4S;ALOX5
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5548824828750208,1.2647269262638545,0.19605263157894737,0.5025545208882729,1.0,5/14,27.71%,ADAM8;OSMR;IL6;TNF;PTGER3
prerank,response to laminar fluid shear stress (GO:0034616),0.5890560158293519,1.2644529235840327,0.18292682926829268,0.5028789816302243,1.0,5/10,24.26%,ABCA1;NFE2L2;SMAD7;MAPK7;MAP2K5
prerank,negative regulation of interleukin-6 production (GO:0032715),0.49824886444643846,1.264413583873687,0.16159250585480095,0.5024734790970182,1.0,12/27,27.73%,SIRPA;NLRC3;FOXJ1;PTPN22;CD200R1;GAS6;TNF;NCKAP1L;TLR9;CX3CL1;PTPN6;TNFAIP3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4342285568673733,1.264233823075264,0.12076271186440678,0.5024950640856202,1.0,36/71,28.10%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;PRKCD;GRB2;NCK1;WIPF1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTB;ACTR3;ARPC1B;SYK;PIK3R2;FCER1G;BAIAP2;HSP90AB1;MYO1G;ABI1;WAS;VAV3;NCKAP1L;VAV1;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5964930209228476,1.2639463986292045,0.14718019257221457,0.5028543954829807,1.0,3/11,2.97%,CORO1C;PDPN;CD44
prerank,response to insulin (GO:0032868),0.43092745691273093,1.2637687044462333,0.09176225234619395,0.5028907197216108,1.0,23/80,18.34%,MYO5A;EPRS1;SLC27A1;PKM;HDAC9;EIF6;GCK;PPARG;SLC25A33;PDPK1;CPEB2;ZBTB7B;DENND4C;RHOQ;RAB8A;RAB8B;PCK2;OGT;SORBS1;FOXO1;PIK3R2;VAMP2;EPM2AIP1
prerank,muscle cell development (GO:0055001),0.4853865947987464,1.2637448280139243,0.1605231866825208,0.5024186445017412,1.0,4/30,7.00%,IGF1;MYOF;FER1L5;VEGFA
prerank,icosanoid metabolic process (GO:0006690),-0.3330479780063431,-1.263499833038857,0.07377049180327869,0.6419011325584365,1.0,13/40,15.59%,PTGS1;HPGD;LTC4S;ALOX5;GGT5;PON3;PNPLA8;PON2;EPHX1;DAGLB;PLA2G4C;PTGR1;ALOXE3
prerank,regulation of interleukin-6 production (GO:0032675),0.42453757190079044,1.262886452991688,0.08401639344262295,0.504425856105868,1.0,36/96,26.28%,RAB7B;LPL;CYBA;MMP8;SIRPA;NLRC3;SPHK2;MAPK13;FOXJ1;PTPN22;CD200R1;TREM2;MAPKAPK2;POU2AF1;GAS6;MBP;HSPD1;TMEM106A;TIRAP;SYK;IL6;DHX9;SCIMP;ARHGEF2;HMGB1;LBP;CD47;F2R;CD74;IL17RA;IL17D;TNF;NCKAP1L;TLR9;CX3CL1;PTPN6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.46418502987387444,1.2628085261195507,0.1552511415525114,0.5041413439601573,1.0,14/36,23.57%,HIF1A;CSF1;CD300LF;AXL;TRIM6;TXK;ADAM17;GAS6;CASP4;AGPAT2;LAPTM5;NLRC5;CD74;AGPAT1
prerank,aggrephagy (GO:0035973),0.49637877696785615,1.2628004759717704,0.1649122807017544,0.5036273082954612,1.0,11/27,24.29%,UBA52;RPS27A;VIM;SQSTM1;DYNC1H1;UBQLN1;IFT88;DYNC1LI2;UBC;ACBD5;WDFY3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4804156330967892,1.262740844059292,0.15529411764705883,0.5032881202615114,1.0,9/32,11.87%,ANXA1;HDAC9;HDAC7;FGF2;VEGFA;CARD10;HMOX1;DLL4;RHOA
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42325845172783916,1.262513952928478,0.11635220125786164,0.5034498964485423,1.0,20/78,17.04%,LGALS3;PRKCH;LRP1;BCL2L1;SQSTM1;CDK5;PDPK1;DAB2;TREM2;STAC2;RANGRF;RHOQ;CLN3;RHOG;TMBIM1;STX3;ACTB;SORBS1;CNPY4;ITGA3
prerank,response to fatty acid (GO:0070542),0.5320198218458535,1.2624451914756967,0.17691342534504392,0.5031299198583599,1.0,4/17,19.98%,LPL;SOX9;FOXO1;PDK3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4725676950218879,1.2619918805338382,0.15855039637599094,0.5039660786973172,1.0,17/34,31.98%,PTPRC;SPHK2;TRIM6;PTPN22;DNAJB9;RBP4;GPI;IL6;SCIMP;IL2;LAPTM5;SASH3;TLR9;STX4;VAMP3;XBP1;EPHB2
prerank,maturation of LSU-rRNA (GO:0000470),0.49337650643034414,1.2616266111824685,0.16526946107784432,0.5045554419909106,1.0,10/26,24.23%,EIF6;RPL10A;NSA2;WDR12;MAK16;FTSJ3;DDX18;MRPL1;SNU13;RPL7A
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4233874130502188,1.2615045532488942,0.0784313725490196,0.5043920558012531,1.0,31/98,24.83%,APOE;CSF1;ACACA;XDH;EIF4G1;APOA2;PPARG;GATA3;GRB2;VEGFA;ANGPT1;PPARD;CCNB1;APOC1;CD63;CCL5;CHCHD2;SCYL2;GHITM;ACOD1;RAB1A;CBR1;ACACB;STARD4;RNF41;PRELID1;TGFBR2;AGPAT1;ECE1;GADD45A;FASN
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3229907380464726,-1.2611331002843065,0.0594059405940594,0.6434831355931024,1.0,9/44,7.40%,FCHSD2;BIN1;PRKCE;FER;SPIRE1;CARMIL1;NCKAP1;CDC42EP4;ARPC4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.40705505360829874,1.2611287358828935,0.054490413723511606,0.5050312114672226,1.0,50/150,24.24%,CORO1C;SIRPA;SMCR8;PTPRC;SNX25;XDH;EIF4G1;GNAQ;PRKCD;CAV1;HSPB1;NCK2;PDPK1;DBNDD1;PLPP3;NCK1;CRKL;TAB1;SAMSN1;DTNBP1;MVP;RACK1;CADM4;YWHAG;FBLN1;PAQR3;CNKSR3;SMAD7;PTPN13;PAK2;PPIA;LRP6;PPP1R15B;CHP1;MYADM;NF1;GSKIP;TESK1;TAF7;ITGB1BP1;TARDBP;EMILIN1;SPRED2;TRIB2;ZBED3;DNAJC10;CALM3;PMEPA1;SPRED3;PRR5L
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5355863449956012,1.260981497800785,0.1858974358974359,0.5049405195545957,1.0,4/18,14.87%,BCL2;BCL2L1;ALKBH7;SLC25A31
prerank,regulation of myotube differentiation (GO:0010830),0.49502840528036485,1.2608558202154054,0.17801672640382318,0.5047879456096575,1.0,6/24,8.66%,HDAC9;PIEZO1;HDAC4;SIK1;HDAC1;BHLHE41
prerank,RNA modification (GO:0009451),0.451248204514052,1.2607334059647621,0.1254054054054054,0.5046634875066855,1.0,16/54,19.33%,AARS1;ADARB1;THG1L;METTL1;PUS7;ANKRD16;MRM2;METTL3;ALKBH1;FTSJ3;QTRT1;RBM15;RBM15B;NSUN3;NSUN2;ADAR
prerank,positive regulation of lymphocyte activation (GO:0051251),0.48762647305685886,1.26061528715513,0.15119047619047618,0.5045286100687232,1.0,8/28,14.76%,LCK;SIRPA;PRKCQ;SH3KBP1;TICAM1;CCR2;TNIP2;HSPD1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4407969442712458,1.260601523357115,0.1281779661016949,0.504036618147552,1.0,20/62,24.02%,BCL2;BCL2L1;NFE2L2;PLAUR;MCL1;MMP9;HSPB1;NOC2L;TPT1;ENO1;YBX3;PPIA;CLU;CCAR2;ARHGEF2;SOD2;EPO;MAPK7;DNAJA1;MDM2
prerank,bone development (GO:0060348),0.4650269697595976,1.26059124110941,0.1489841986455982,0.5035467190905645,1.0,12/39,23.64%,SH3PXD2B;PTPRC;LTF;AKAP13;P3H1;MYOC;LRP6;MBTPS2;PTGER4;FGFR3;GNAS;FGFR2
prerank,amino acid import (GO:0043090),0.5166241360681443,1.260517023422931,0.17879161528976573,0.5032718323248158,1.0,7/21,18.91%,SLC6A6;SLC7A1;SLC6A14;SFXN1;SLC7A8;SFXN2;SLC16A2
prerank,glycoprotein metabolic process (GO:0009100),0.44532191016991207,1.2600720459647574,0.1331168831168831,0.5040780554548532,1.0,11/53,11.28%,B4GALT5;HIF1A;MAN1C1;LARGE1;B4GALT7;TNIP1;ADAMTS13;STT3B;ST8SIA6;OGA;ERP44
prerank,regulation of histone methylation (GO:0031060),0.5592626954037934,1.2598908113633882,0.1814621409921671,0.5041144752349473,1.0,8/13,29.05%,TTLL12;FAM47E;CHTOP;PAF1;MTHFR;NSD1;PIH1D1;CTR9
prerank,cellular response to cytokine stimulus (GO:0071345),0.39910367218806125,1.2596114902894946,0.006,0.5044373729493207,1.0,118/416,20.05%,BCL2;LCK;HIF1A;ITGAX;FN1;LCN2;ABL2;CSF1;BCL2L1;TCF7;IL2RB;EPRS1;SIRPA;GRAP2;NFE2L2;IL18R1;ANXA1;CD4;CSF2RA;LEF1;UBA52;TEC;IRAK2;TANK;CCL4;RPS27A;MCL1;VIM;MUC1;PIK3CB;OSMR;PDE1B;STAT4;AXL;MAPK13;TRIM6;RUFY4;POMC;RIPOR2;PTPN23;MMP9;FGF2;PLP2;IL3RA;IL12RB1;IFITM2;BCL6;GATA3;SOX9;ERBIN;GRB2;VEGFA;CRKL;IRGC;IL27RA;INPPL1;BCL2L11;SMPD4;IRF8;CCL13;PTPN2;HMOX1;FYN;BRCA1;SHMT1;NPR2;SOCS5;PIM1;CEBPA;CCR2;PTPN12;CCL7;JAK1;IRF5;CCL5;TNFRSF1B;RHOA;RHOU;HSPA8;PTPN13;GAS6;GHR;YBX3;BIRC5;CCL14;STX3;IL31RA;NFKB1;SYNCRIP;DAPK1;TPR;CBL;ITGB2;ACOD1;LAMA5;FOXO1;SIGIRR;SYK;GBP2;IL1R2;AQP4;SBNO2;HNRNPU;DAPK3;HAX1;IL6;RPL13A;DHX9;ASAH1;IL2;CNTFR;ARHGEF2;PTGIS;GAB2;IL5;UBC;RPS3;MT1X
prerank,regulation of protein neddylation (GO:2000434),0.5947435252740747,1.259343741895821,0.19183673469387755,0.5047140111233063,1.0,5/10,24.63%,HIF1A;RPL11;DCUN1D2;DCUN1D4;DCUN1D3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5996919556646241,1.259330052651898,0.1940700808625337,0.5042328131883522,1.0,5/10,25.22%,RUNX1;ZBTB7B;HMGB1;RUNX3;NCKAP1L
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41618493770695486,1.259304998684891,0.0836734693877551,0.5037854108775294,1.0,31/112,20.23%,IGF1;LPL;CYBA;MMP8;SIRPA;NLRC3;PTPRC;LTF;SPN;SPHK2;CD2;POMC;HSPB1;PTPN22;RASGRP1;LILRB1;MAPKAPK2;ARFGEF2;CCR2;ILRUN;GAS6;CLU;TMEM106A;TIRAP;SYK;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8
prerank,cellular response to fatty acid (GO:0071398),0.5789570886846065,1.2590596800664504,0.17496635262449528,0.5040100759928305,1.0,1/12,0.31%,LPL
prerank,mitochondrial transport (GO:0006839),0.4468506853073243,1.2590312344771575,0.1256890848952591,0.5035712201164823,1.0,24/53,32.62%,BCL2;BCL2L1;SLC25A24;TOMM22;MGARP;TIMM44;TIMM9;TOMM5;SLC25A31;TOMM40;TMEM14C;FBXO7;TIMM17A;PITRM1;TIMM23;BNIP3;FLVCR1;SPG7;TOMM7;FIS1;MFF;BCS1L;TSPO;SLC25A13
prerank,polyol metabolic process (GO:0019751),-0.32192781121990405,-1.2581428255123448,0.11578947368421053,0.6469050892514098,1.0,18/46,19.67%,INPP5D;INPP4B;PLD4;PLCB1;PLCG2;IP6K1;INPP5J;ITPK1;IPPK;INPP1;PPIP5K2;NUDT11;PLCE1;INPP5B;ITPKA;IMPA2;PLCH1;IP6K3
prerank,negative regulation of secretion by cell (GO:1903531),0.4604930021319402,1.258045044027777,0.14752252252252251,0.5060939021533672,1.0,9/38,14.03%,APOE;ANXA1;TRH;RHBDF2;SERGEF;LILRB1;RHBDF1;TNFRSF1B;RSAD2
prerank,positive regulation of chromosome organization (GO:2001252),0.5450707764732584,1.2569237087503375,0.19790301441677588,0.5090359955363206,1.0,6/15,18.35%,RAD50;DHX36;PPP1R10;ATRX;GNL3;RTEL1
prerank,negative regulation of peptidase activity (GO:0010466),0.44720233043084134,1.2569236011966525,0.1474147414741474,0.508511216159479,1.0,13/47,17.53%,LRP1;CST7;HRG;SERPINA10;SERPINB9;CSTB;SERPINE2;SERPINE1;ECM1;TIMP4;TIMP2;SPINK5;SERPINF2
prerank,tRNA modification (GO:0006400),0.44230374643909875,1.2563895774137042,0.11919831223628692,0.5096036313130002,1.0,33/62,34.01%,PUS1;AARS1;THG1L;METTL1;PUS7;ANKRD16;ALKBH1;QTRT1;METTL2B;METTL2A;TRMT13;THADA;TPRKB;NSUN2;TRMT112;TARBP1;GTPBP3;THUMPD2;ELP5;MOCS3;TRMT5;TRMT6;CDKAL1;WDR4;OSGEP;ALKBH8;METTL6;TRMT12;LCMT2;PUSL1;NSUN6;TRMT10A;MTO1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5644216438361016,1.256349659795241,0.19775596072931276,0.5091969915329637,1.0,5/13,13.19%,GIMAP7;AK4;AK3;RHOQ;EFL1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5100389942131305,-1.2561448845200038,0.22826086956521738,0.6478108039169755,1.0,5/10,21.69%,POGLUT3;GALNT2;POGLUT1;GALNT4;GALNT13
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5017288700636158,1.2557229256766886,0.16666666666666666,0.5105960033029273,1.0,12/26,30.10%,NCOR2;DAB2;HDAC1;VPS18;BRCA1;VPS11;CALR;SFRP1;KANK2;SMARCA4;SIRT1;CNOT9
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.47526534488615235,1.2556745262269742,0.16821345707656613,0.5102373984198847,1.0,13/33,25.84%,HIF1A;FGF2;PPARG;GATA3;JUN;SRF;GNL3;NR3C1;TEAD1;TERT;EGR1;TNF;SMARCA4
prerank,intracellular lipid transport (GO:0032365),0.5162142636197317,1.2551943563066281,0.17139334155363747,0.5111507801883661,1.0,9/21,19.08%,ACACA;ABCD4;ARV1;ABCD2;MID1IP1;ABCD3;CPT2;ACACB;NPC2
prerank,peptidyl-asparagine modification (GO:0018196),0.4807297070561594,1.2551314719685656,0.1773809523809524,0.5108415077797375,1.0,9/31,18.99%,MGAT5;DERL3;MAGT1;STT3B;LMAN1;MCFD2;TUSC3;ST6GAL1;DDOST
prerank,mitochondrion transport along microtubule (GO:0047497),0.5630446871621267,1.255116161595433,0.19397116644823068,0.5103677560441877,1.0,3/13,3.64%,UXT;HIF1A;MGARP
prerank,membrane lipid biosynthetic process (GO:0046467),0.44348581653368085,1.255019998897863,0.12513484358144553,0.5101121140765059,1.0,21/58,24.30%,SGMS1;SPHK2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;ST8SIA6;KDSR;HACD1;PRKD2;VAPB;ALDH3A2;ALDH3B1;ELOVL2;SAMD8;ELOVL1;ST3GAL2;SPTLC3;PRKD3;GBGT1
prerank,negative regulation of viral process (GO:0048525),0.44247000890774774,1.2547381563632425,0.1264864864864865,0.5104191069694609,1.0,19/57,22.06%,LTF;SHFL;SRPK1;TNIP1;TRIM6;IFITM2;TRIM28;IFITM1;RNASEL;CCL5;ILF3;MBL2;RSAD2;PPIA;ZC3HAV1;ISG20;BST2;SRPK2;TRIM21
prerank,amino acid import across plasma membrane (GO:0089718),0.5014889183600202,1.2543158691192118,0.17216117216117216,0.5112036670615859,1.0,7/24,18.91%,SLC3A2;SLC6A6;SLC7A1;SLC6A14;SLC1A5;SLC7A8;SLC16A2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.46966585647807396,1.2542184505319174,0.15617977528089888,0.5109999924916313,1.0,17/36,28.68%,MACF1;OPTN;GOLGA4;RILPL2;NECTIN3;RAB7A;GCC2;GGA2;VAMP4;AFDN;VAMP2;RILPL1;GOLPH3;GGA1;GOLPH3L;RAB31;ARFRP1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.45592058131147634,1.2540341241680715,0.12874583795782463,0.5110462594289129,1.0,8/41,13.20%,IGF1;SIRPA;NLRC3;POMC;PTPN22;LILRB1;ILRUN;GAS6
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.48085741824863204,1.2535821990296803,0.17208182912154033,0.5119337280987842,1.0,15/27,29.22%,CD44;KMT5A;PLA2R1;SMYD2;ATM;SPRED2;CD74;MIF;SPRED3;MDM2;PSMD10;KDM1A;ATR;PTTG1IP;SIRT1
prerank,regulation of protein modification process (GO:0031399),0.44972072376085476,1.253532732547628,0.13691128148959475,0.5115587316336401,1.0,17/50,26.28%,FNIP2;FN1;CORO1C;CCDC88C;ATG7;HSPB1;CADM4;HPF1;KDM4D;ASPSCR1;PIN1;CCAR2;SPRED2;SPRED3;CCDC88A;ATG10;SESN2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.48278449457907335,-1.253024625819629,0.19678714859437751,0.6516781391064297,1.0,3/11,8.58%,LGALS9;THBS1;CD34
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4804736336158888,1.2529673349006514,0.1623529411764706,0.5127434346422531,1.0,17/30,29.22%,BCL2L1;CD44;TPT1;THOC1;FBXO5;DDX39B;CLU;RTEL1;CCAR2;RPS3;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1
prerank,DNA dealkylation (GO:0035510),0.5889747676143388,1.2525960436827814,0.21195652173913043,0.5128092095353783,1.0,6/10,26.37%,ASCC3;MGMT;ALKBH1;ALKBH3;ASCC1;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5889747676143388,1.2525960436827814,0.21195652173913043,0.5128092095353783,1.0,6/10,26.37%,ASCC3;MGMT;ALKBH1;ALKBH3;ASCC1;ASCC2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.533634422394308,1.2525098777611468,0.19135802469135801,0.5125443835047151,1.0,3/16,8.95%,SLC27A1;CTDNEP1;ABHD5
prerank,response to chemokine (GO:1990868),-0.456669976967781,-1.2524290549105022,0.17872340425531916,0.6486638430334338,1.0,4/13,5.58%,DOCK8;LRCH1;WNK1;SLC12A2
prerank,DNA metabolic process (GO:0006259),0.4006942950302746,1.2524155590077426,0.018018018018018018,0.5122986750603856,1.0,114/270,32.25%,DCTPP1;ORC3;UBA52;PARP4;RAD51B;RPS27A;DOT1L;MCM7;MCM2;ERCC1;NUDT1;IGHMBP2;DDX21;TRIM28;DNMT1;LIG1;POLE;GMNN;NOC3L;RNASEH2A;DDB2;ZRANB3;VCP;DDB1;MGMT;SMARCB1;BRCA1;LONP1;RNASEH1;RAD50;ALKBH1;XPA;DMC1;KMT5B;SP100;CDK2;MBD4;BLM;ADPRS;DNASE2;INO80;ERCC4;DFFB;SLX4;CDC7;BARD1;GLRX2;POLB;WDHD1;RFC1;PARP3;CNBP;PURA;RAD54L;UBE2V2;GTF2H1;ATM;RTEL1;RAD1;PTGES3;FANCA;POLG;TOP1;TERF1;UBC;RAD51AP1;HMGB1;MCM6;RECQL5;DBF4;NUDT15;DNASE1L1;MCM8;ALKBH3;CDC34;ACD;SRPK2;NPM1;SETMAR;TERT;TOPBP1;POLE4;XPC;SUMO1;POLA2;PARP2;GADD45A;GEN1;RFC2;LIG3;HMGB3;CENPS;TERF2IP;SUPV3L1;ATR;PDS5A;POLD4;RAD9A;MNAT1;HINFP;TICRR;CSNK1E;XRCC5;HMGB2;PNKP;ASF1A;PARG;NABP1;RFC4;ZBTB1;TERF2;PDS5B;UBB;HUS1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.49079616837829987,1.252246951247797,0.1648616125150421,0.5122906603811042,1.0,11/27,25.22%,UBA52;IRAK2;RPS27A;TNIP1;TAB1;MAP3K1;HSPD1;TIRAP;UBC;IRAK4;BTK
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4917760821444514,1.2521542821765925,0.18171021377672208,0.5120426130870018,1.0,9/26,25.91%,IQGAP1;EEF1A1;PDPK1;SOX9;PTPN12;DUSP3;SYAP1;STAT5B;ZPR1
prerank,positive regulation of telomerase activity (GO:0051973),0.4778718519542004,1.2520405263807601,0.16666666666666666,0.5118609355686176,1.0,18/33,35.08%,CTNNB1;PRKCQ;CCT2;NVL;PKIB;PTGES3;HSP90AB1;ACD;DKC1;MAPK15;MAPK3;PARM1;XRCC5;PNKP;MAPK1;MAP3K4;NAF1;MYC
prerank,negative regulation of kinase activity (GO:0033673),0.43269044676807294,1.2519401762130344,0.12713675213675213,0.5116076515566164,1.0,19/62,19.26%,SMCR8;PTPRC;GNAQ;HSPB1;PDPK1;DBNDD1;TAB1;DTNBP1;NPRL2;YWHAG;PAK2;PPIA;LRP6;CHP1;NF1;GSKIP;HNRNPU;TAF7;ITGB1BP1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.44157759121435447,1.2513282346418728,0.14626218851570963,0.5129757086715023,1.0,25/51,32.57%,CTNNB1;PRKCQ;CCT2;TNKS2;HNRNPC;EXOSC10;PKIB;CCT8;HNRNPU;ATM;TERF1;CCT5;ACD;XRN1;MAPK15;NAT10;ATR;MAPK3;TENT4B;XRCC5;PNKP;MAPK1;TERF2;DCP2;MAP3K4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5293982879437094,1.2509040322212455,0.19490445859872613,0.5137879423101495,1.0,10/17,29.22%,NFE2L2;HSPB1;TREM2;P4HB;PPIA;UBQLN1;SOD2;MAPK7;NOL3;SIRT1
prerank,regulation of cellular localization (GO:0060341),-0.31555703359385134,-1.2508305247557612,0.13,0.648433916044543,1.0,12/46,12.85%,LRP5;FER;EFNA5;LRRK2;WWC1;ADCY5;MAP2;PRKN;EPHA5;STXBP4;BRSK1;GOSR1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.48799721284056125,1.2506566059654711,0.16802800466744458,0.5139906722998282,1.0,8/28,15.74%,BCL2;TRAF2;ERN2;ERN1;ERO1A;BAX;DDIT3;CASP4
prerank,neuromuscular process controlling balance (GO:0050885),-0.4698431326072557,-1.250595862634118,0.188,0.6443147839933051,1.0,3/12,2.70%,NRXN1;CDH23;PCDH15
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.43066302581765215,1.2504547534701556,0.13312034078807242,0.5141008309112804,1.0,35/70,28.10%,MYO10;CD247;ARPC2;FGR;ARPC3;ARPC5;PIK3CB;CD3G;PRKCD;GRB2;NCK1;WIPF1;ACTG1;CYFIP2;FYN;LIMK1;CDC42;ACTB;ACTR3;ARPC1B;SYK;PIK3R2;BAIAP2;HSP90AB1;MYO1G;ABI1;WAS;VAV3;NCKAP1L;VAV1;YES1;NCKIPSD;CYFIP1;ACTR2;MAPK3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.43253034038852,1.249787034089419,0.12016718913270637,0.5157054098930064,1.0,23/74,25.28%,CTNNB1;SDCBP;DAG1;LEF1;GCNT2;PDPN;GLIPR2;DAB2;GATA3;NKX2-1;BAMBI;PHLDB1;SMAD7;EFNA1;ADIPOR1;IL6;FERMT2;SPRED2;TGFBR2;SPRED3;SFRP1;BMP5;MDK
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4043033734213931,1.248915394861031,0.036,0.5178474155876528,1.0,61/234,20.44%,RAB7B;S100A8;CTNNB1;S100A9;PRKCH;IL18R1;LTF;PRKCQ;IL18RAP;MALT1;ARID5B;ADCY8;UBA52;IRAK2;TRAF2;RPS27A;ADAM8;TRIM6;SPHK1;HDAC4;CAV1;PPARG;PLPP3;STK3;IKBKE;VEGFA;TAB1;PRKCB;FLOT2;TICAM1;TRAF1;JUP;SMARCB1;CRTC1;PPARGC1B;FZD1;FZD4;PPIA;DDIT3;NFKB1;PRKD2;CLU;LRP6;NHLH2;SRF;CEBPG;PSMA6;TFRC;TIRAP;ANXA3;DDR2;MBTPS2;RIPK3;DHX33;IL6;DHX9;ARHGEF2;UBC;RPS3;MTDH;RIPK4
prerank,hyaluronan catabolic process (GO:0030214),0.5179775230749606,1.2488080030591762,0.18362282878411912,0.5176705755073262,1.0,6/18,16.12%,SLC9A1;CD44;FGF2;HEXA;GUSB;CHP1
prerank,negative regulation of immune response (GO:0050777),0.4037359559211014,1.2487392629380116,0.053266331658291456,0.5173665937431327,1.0,41/154,19.06%,LGALS3;CD247;NLRC3;PTGIR;PDCD1;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;SAMSN1;LILRB1;ADAM17;CRH;CD300A;IAPP;FYN;FCRLB;GPR176;CCR2;ILRUN;GIPR;ADORA2A;GLP1R;ACOD1;VIP;C1QBP;SYK;FURIN;SPINK5;GPR84;IL6;HAVCR2;LYAR;GNB1
prerank,regulation of protein dephosphorylation (GO:0035304),0.46517268202240364,1.2485542836967898,0.16870144284128746,0.5174229053119308,1.0,15/37,23.69%,PTPA;PRKCD;MFHAS1;HTT;DLC1;PPIA;SPPL3;SYMPK;SMPD1;YWHAB;PIN1;NSMF;PPP1R15A;CALM3;PPP1R8
prerank,regulation of gluconeogenesis (GO:0006111),0.48445042644353764,1.2483351813106875,0.1823671497584541,0.5175931123363421,1.0,6/27,13.03%,GCK;SIK1;GNMT;PTPN2;DDB1;OGT
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.49008866714403204,1.248263256212426,0.17159763313609466,0.5172972344255184,1.0,7/27,12.61%,FBXL17;ID2;SIK1;RBM4B;BHLHE40;CRTC1;PDE6B
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4401596727463815,1.2481750104918918,0.13260869565217392,0.5170618834584934,1.0,12/54,11.60%,XYLT1;HS3ST3B1;GNS;B4GALT7;GCNT2;HEXA;GLB1;SLC35D2;B3GALT6;NDST1;GUSB;FUCA1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.58194011167816,1.2472664429878861,0.20238095238095238,0.5192718720859076,1.0,4/11,13.20%,MSN;PTPN23;DAB2;VPS11
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.423992579614786,1.2470909300203976,0.1259259259259259,0.519271262345218,1.0,37/76,29.96%,MALT1;TANK;TNIP1;SPHK1;FBXW7;PRICKLE1;HDAC4;CAV1;ANGPT1;UBE2L3;BRCA1;HUWE1;SMAD7;DCUN1D2;CENPX;UBQLN1;DERL1;GNL3;WFS1;CUL3;PIAS1;SAE1;LAPTM5;DCUN1D4;RWDD3;WDR48;BIRC2;DCUN1D3;HDAC3;PIAS4;CENPS;PSMD10;GSK3A;PTTG1IP;FKBP1A;MUL1;RCHY1
prerank,response to hydroxyurea (GO:0072710),0.5829550784002252,1.2470112003185103,0.20994475138121546,0.5189536233041115,1.0,4/11,18.17%,DDI2;BLM;ATRX;KAT7
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4438203540461745,1.2468002987017106,0.15743756786102062,0.5190393394030126,1.0,23/52,29.63%,BCL2;GZMB;FBXW7;BID;UBE2L3;HUWE1;YWHAG;BAP1;RHOU;VPS11;MICALL2;YWHAB;UBL5;PPP3CC;CSNK2A2;SAE1;USP36;PPP3R1;YWHAZ;GSK3A;ATG13;TOMM7;LEPROT
prerank,amide transport (GO:0042886),0.4868980604632651,1.2467443326476244,0.19515151515151516,0.518714472006123,1.0,7/26,17.82%,SLC27A1;PDPN;SLC46A1;GLTP;ABCA13;DISP1;SLC19A1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5193327732882321,1.2463389282904478,0.1890547263681592,0.5193617436188765,1.0,9/18,22.26%,MDFIC;MFHAS1;UFM1;ILRUN;CHP1;POLR1A;GSK3B;SUFU;LATS1
prerank,negative regulation of cell adhesion (GO:0007162),0.4256545622129254,1.2459389871805624,0.12314225053078556,0.5200440554869854,1.0,19/72,16.16%,PLXNC1;PLXNA2;PTPRC;SPN;GCNT2;MUC1;HRG;GTPBP4;RIPOR2;JAG1;ANGPT1;CDH1;PLXND1;SERPINE1;FBLN1;RHOA;FZD4;CYP1B1;RASA1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5867938716263054,1.245925163083334,0.20810055865921787,0.5195730161053783,1.0,2/11,3.14%,CSF1;ID2
prerank,regulation of telomerase activity (GO:0051972),0.45237993975174745,1.245874517015751,0.1545253863134658,0.5192247387201144,1.0,19/45,31.23%,CTNNB1;PRKCQ;PARP4;CCT2;NVL;PKIB;ERCC4;ATM;PTGES3;TERF1;HSP90AB1;ACD;DKC1;MAPK15;MAPK3;PARM1;XRCC5;PNKP;MAPK1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4907366666784911,1.2457440056677167,0.18629807692307693,0.5190924084132236,1.0,14/26,34.99%,EIF6;BRCA1;LPGAT1;APOC1;MID1IP1;SLC45A3;ADIPOR1;ACADL;WDTC1;ERLIN1;CEACAM1;ACADVL;ERLIN2;NR1H2
prerank,positive regulation of telomere capping (GO:1904355),0.5296616047862248,1.2454199091842952,0.19798234552332913,0.519519063899658,1.0,9/17,32.57%,PRKCQ;TNKS2;PKIB;RTEL1;MAPK15;MAPK3;PNKP;MAPK1;MAP3K4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5254450507623462,1.2453643792610547,0.18829516539440203,0.5192090117317512,1.0,7/18,22.79%,HIF1A;NFE2L2;HSPB1;TRAP1;PPIA;SOD2;MAPK7
prerank,regulation of mitotic cell cycle (GO:0007346),0.40976835307505116,1.2452730477944733,0.0613682092555332,0.5189617501995699,1.0,58/171,27.45%,IQGAP1;SDCBP;PSMD8;PSMD1;SPHK1;TTLL12;ANAPC15;SIK1;BRINP2;FZR1;FBXO5;PSMD6;PSMA1;DYNLT3;CDK13;DDB1;CCNB1;CUL9;PSMC3;PRMT5;PSMA8;CDK11B;TFAP4;ANAPC1;PKN2;PSMD14;PSMD2;RCC1;PSMC6;PSMA6;DUSP3;PSMD5;HNRNPU;PSMA5;DAPK3;CDC26;NEK6;PIN1;BUB1B;RNF20;CUL1;HSF1;CKS2;ANAPC7;PSMA3;XPC;USP2;MDM2;CDC25B;PSMB10;PSMB8;PSMD7;UBE2C;PSMB6;BTRC;PSMD10;EIF4E;PSMB5
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5721322110604232,1.2452695366917292,0.19733333333333333,0.5184584765293782,1.0,7/12,27.09%,METTL3;BRCA1;RBM15;RBM15B;HNRNPU;CDYL;SMCHD1
prerank,fatty acid beta-oxidation (GO:0006635),0.4405412809354091,1.2444617937833666,0.1383442265795207,0.5203815177592374,1.0,23/51,28.01%,ACAD11;ABCD4;PEX2;PPARD;CRAT;ABCD2;ACAD10;ECI2;ACAT1;ABCD3;CPT2;DECR1;GCDH;EHHADH;ACADL;ACOX3;ACADS;ACADM;HADHA;HADH;ACAA2;ACOT8;ACOXL
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5574021983205656,1.2435282373217842,0.18834688346883469,0.5226627849382453,1.0,5/13,15.56%,KLRC2;AXL;TICAM1;GAS6;AP1G1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5331470575064452,1.2434385013760707,0.18766066838046272,0.5224241007577517,1.0,4/17,6.75%,FOXN1;FGF2;FOXJ1;SOX9
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4924258504033001,-1.2432729690261737,0.18840579710144928,0.6602401966802613,1.0,3/10,1.66%,CACNB2;CACNA2D1;NOS1AP
prerank,lipid transport (GO:0006869),0.4164261339057471,1.2429524455350343,0.11338100102145046,0.523370539434147,1.0,20/97,13.26%,OSBPL8;APOE;ABCG1;ABCA1;FABP5;SLC27A1;SLC27A5;ABCA4;ACSL1;GLTP;UGCG;PPARD;ABCA13;CLN3;TRIAP1;PITPNC1;ABCD2;OSBPL2;ABCA7;PRELID2
prerank,cellular response to light stimulus (GO:0071482),0.4314180125809387,1.2428980922600532,0.13936170212765958,0.5230239487779996,1.0,32/66,32.34%,MAPK13;PRKCD;NOC2L;SDE2;SAG;EIF2S1;METTL3;TRIAP1;PDE6B;CNGB1;RRH;YY1;INO80;ERCC4;USP47;DHX36;SMPD1;GNB1;CASP9;NPM1;USP28;ATF4;PDE6G;KDM1A;ATR;RUVBL2;CDC25A;ZBTB1;EP300;CREBBP;NEDD4;TMEM161A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.31654601494973184,-1.2428451825679794,0.11428571428571428,0.656702280434057,1.0,17/39,16.99%,PRKCE;FGF12;FGF14;WNK1;HECW1;NETO1;GLRX;HECW2;WNK3;DMD;FGF11;YWHAH;PTPN3;OSR1;FXYD2;NEDD4L;SCN2B
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5526366556664771,1.2427955528333037,0.17340286831812254,0.5228294382664936,1.0,11/14,35.06%,TRUB2;TRMT10C;RCC1L;C1QBP;FASTKD3;MRPS27;RPUSD4;FASTKD2;RMND1;NGRN;UQCC2
prerank,histone methylation (GO:0016571),0.4823377978080026,1.24241990323374,0.1773220747889023,0.5233955688621336,1.0,16/26,33.56%,PRMT5;PRMT7;SMYD3;CARM1;PRMT2;PRMT6;SMYD2;SMYD1;EHMT1;NSD3;TRMT112;NTMT1;NSD1;SUV39H2;CREBBP;PRMT1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5504647546147661,1.2421918046464921,0.20757180156657964,0.5235917716504287,1.0,9/13,30.70%,MGAT5;PTPRC;DOT1L;IL6;JAK2;HES1;PIGU;CRLF2;JAK3
prerank,telomere maintenance via recombination (GO:0000722),0.5839989505565346,1.241826546586406,0.21224489795918366,0.5241679773102448,1.0,6/11,24.69%,NSMCE2;ERCC1;RAD50;ERCC4;TPRKB;SMC6
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5464788994227978,1.2416127350690551,0.21024258760107817,0.5243035157479411,1.0,5/14,17.88%,SEC24A;SEC24D;SAR1A;RAB1A;TBC1D20
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.43280287448966365,1.2413058903648566,0.13894736842105262,0.5247262514054192,1.0,26/65,29.66%,SNX25;UBA52;RPS27A;CAV1;VEPH1;PDPK1;WFIKKN1;ADAM17;NKX2-1;BAMBI;NRROS;SMAD7;PIN1;DAND5;FAM89B;UBC;EMILIN1;SPRED2;TGFBR2;PMEPA1;SPRED3;ASPN;PPM1A;FKBP1A;SIRT1;TGFB1I1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.4924312440120573,1.2412888444857857,0.18181818181818182,0.5242658263528813,1.0,5/27,10.04%,FGF13;CAV1;RANGRF;SRI;JUP
prerank,positive regulation of DNA replication (GO:0045740),0.5291171086214265,1.2411317538739424,0.19167717528373265,0.5242227980535813,1.0,1/16,0.03%,BCAR3
prerank,positive regulation of cytokine production (GO:0001819),0.396479274994859,1.24105249083601,0.018,0.5239258435053517,1.0,95/292,24.47%,RAB7B;RFTN1;LPL;CTNNB1;CYBA;HIF1A;MMP8;ITK;IL18R1;PTPRC;ANXA1;PRKCQ;CD226;CD4;MALT1;FGR;TRAF2;SPHK2;LTB;CD2;MAPK13;TRIM6;APOA2;CD6;SPHK1;CD28;IL27;IL12RB1;RUNX1;CD274;PTPN22;GATA3;ZBTB7B;CADM1;TXK;RASGRP1;POLR2H;LY9;LILRB1;ADAM17;LRRFIP1;TICAM1;PLA2R1;HMOX1;POLR3E;POU2AF1;POLR3D;C3;BRCA1;CRTAM;CCR2;SERPINE1;IRF5;MBP;DDIT3;NFKB1;PRKD2;CYP1B1;HSPD1;CLEC6A;TMEM106A;CEBPG;TIRAP;SYK;DHX36;RAB1A;SERPINF2;DHX33;IL6;DHX9;HAVCR2;FCER1G;SLC11A1;STOML2;SCIMP;IL2;ARHGEF2;RPS3;AGPAT2;HMGB1;LAPTM5;LBP;PTGER4;F2R;HTR2B;CD74;IL17RA;EGR1;MIF;AGPAT1;IL17D;G3BP1;TNF;POLR2F;ATF4
prerank,regulation of G0 to G1 transition (GO:0070316),0.4607095332682963,1.2410473801167063,0.18771331058020477,0.5234359313363685,1.0,15/38,26.36%,UXT;BRCA1;RNF2;EED;MGA;APAF1;CDC7;CBX3;BMI1;YAF2;EHMT1;RBBP7;E2F6;L3MBTL2;PCGF6
prerank,digestive tract morphogenesis (GO:0048546),0.543676809145238,1.2409821848986173,0.20923913043478262,0.5231472160501036,1.0,5/14,26.06%,ID2;NIPBL;FGFR2;PDGFRA;BBS7
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.49285595125715764,1.2409663330983467,0.1871275327771156,0.5226925082955478,1.0,13/24,31.99%,TNKS2;HNRNPC;EXOSC10;ERCC4;SLX4;HNRNPU;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,epithelial to mesenchymal transition (GO:0001837),0.4478898670635601,1.2405652432606897,0.1397139713971397,0.5233965102316793,1.0,7/47,8.70%,CTNNB1;HIF1A;LEF1;EOMES;TRIM28;SOX9;DDX17
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5782603281822553,1.2405459872617126,0.19973190348525469,0.5229512908603017,1.0,2/11,6.44%,SLC27A1;CTDNEP1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5803827569792895,1.239385933622296,0.21659634317862167,0.5259796363784504,1.0,4/10,18.18%,CAV1;MVP;CHP1;TESK1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4631304774425196,1.2393768203178077,0.182648401826484,0.5255033380755584,1.0,15/36,26.36%,UXT;BRCA1;RNF2;EED;MGA;APAF1;CDC7;CBX3;BMI1;YAF2;EHMT1;RBBP7;E2F6;L3MBTL2;PCGF6
prerank,RNA catabolic process (GO:0006401),0.44558520960451503,1.239340505302213,0.14174107142857142,0.5251132817136663,1.0,22/46,28.61%,RNASE3;ERN1;XRN2;RNASEH2A;METTL3;RNASEH1;RNH1;CNOT10;DXO;LSM6;YTHDF2;RNASEH2B;ISG20;RNASE6;AGO3;ZC3H12D;PABPC4;SND1;PPP1R8;ZPR1;SUPV3L1;RIDA
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4822530204221056,-1.2392651939440662,0.21403508771929824,0.662082706172671,1.0,3/10,14.43%,PLA2G15;PNPLA8;ENPP2
prerank,cellular calcium ion homeostasis (GO:0006874),0.4054015512036252,1.239263727550472,0.07621951219512195,0.5248317550233194,1.0,26/133,15.26%,BCL2;TRPC4;SLC24A4;ADCY8;ATP2B1;ATP13A2;HCRTR1;NPTN;KCTD17;CSRP3;CAV1;TPT1;ANXA6;PACS2;TPCN2;CCL13;BAX;CHERP;CLN3;CCR2;CCL7;CCL5;AFG3L2;CCL14;SLC8B1;VAPB
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4221822920988744,1.239235017787014,0.1385099685204617,0.5244068716567154,1.0,21/69,20.23%,LPL;CYBA;MMP8;PTPRC;SPN;SPHK2;CD2;HSPB1;RASGRP1;ARFGEF2;CCR2;CLU;TMEM106A;TIRAP;SYK;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8
prerank,secondary alcohol metabolic process (GO:1902652),0.45800756045340857,1.2392197791872273,0.16956521739130434,0.5239495519349194,1.0,11/42,19.63%,APOE;ABCG1;ABCA1;APOA2;SOAT1;PPARD;SOAT2;CH25H;IDH3A;SULT2B1;GBA2
prerank,defense response to virus (GO:0051607),0.4179541792474899,1.2391947069614182,0.10655737704918032,0.5235214408837157,1.0,29/100,21.43%,LYST;BCL2;BCL2L1;FLNA;ATG7;PTPRC;SHFL;MLKL;AGBL5;EXOSC4;IFITM2;AKAP1;PRF1;IFITM1;LILRB1;RNASEL;ATAD3A;ZDHHC1;RSAD2;ACOD1;RIPK3;ISG20;IL6;RNASE6;BST2;IFIT2;EXOSC5;NLRC5;NDUFAF4
prerank,calcium ion import (GO:0070509),0.47943306669337044,1.238729189737828,0.18149466192170818,0.5244294263187536,1.0,2/28,0.25%,CACNA1A;TRPC4
prerank,mitochondrial gene expression (GO:0140053),0.4502852398126314,1.2386818056107063,0.1729490022172949,0.5240533575694984,1.0,16/42,23.56%,MRPS12;MRPL47;MRPL51;SLC25A33;MRPL23;LARS2;MRPS15;MRPL12;MRPS16;MRPS7;TWNK;GATB;MRPS28;GFM2;MRPS14;FASTKD5
prerank,negative regulation of apoptotic process (GO:0043066),0.3930173976163544,1.2386640128468862,0.01,0.5236020175358296,1.0,94/444,16.16%,IGF1;BCL2;CTNNB1;APOE;ARHGAP10;PRKCH;BCL2L1;NIBAN2;IL2RB;FLNA;ANXA5;PLAUR;ANXA1;LTF;MALT1;LEF1;ITGA5;UBA52;RPS27A;MCL1;ADAM8;PDPN;FIGNL1;ANXA4;CD44;PRDX5;AXL;SPHK1;PTK2B;MMP9;RAF1;SQSTM1;PRKCD;CD28;CPEB4;HYPK;CAV1;SERPINB9;HSPB1;ANGPT4;BID;SIAH2;MYDGF;DAB2;TPT1;SOX9;APIP;VEGFA;ANGPT1;TREM2;HDAC1;PLK2;IGF1R;PSEN2;NAA16;SON;UFM1;MGMT;NAT8;ATF5;CLN3;TRIAP1;PIM1;FGF20;WDR73;ATAD3A;BIRC6;PRDM9;HNRNPK;FSTL1;GAS6;PAK2;BIRC5;IL31RA;NFKB1;BFAR;HSPD1;CIAPIN1;CBL;HSPA9;CAT;VIP;USP47;RNF157;FOXO1;BARD1;NR4A2;TFRC;HTATIP2;CCND2;RETREG1;KDR;APOH;RASA1
prerank,bile acid and bile salt transport (GO:0015721),-0.38108169084928234,-1.238514589162487,0.13157894736842105,0.6597598700878007,1.0,4/24,6.00%,SLCO2B1;NCOA1;SLCO1B1;NCOA2
prerank,regulation of macrophage migration (GO:1905521),-0.4763009396634388,-1.238467375513632,0.18532818532818532,0.6552513834986728,1.0,4/10,6.02%,P2RY12;CX3CR1;MTUS1;CD81
prerank,negative regulation of autophagosome assembly (GO:1902902),0.552085801977355,1.2381863056681761,0.20280612244897958,0.5246416433077106,1.0,4/13,7.46%,SMCR8;SEC22B;CHMP4A;CHMP4B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4534797487380221,-1.2378833662758661,0.168141592920354,0.6522185599261039,1.0,4/12,16.20%,FDXR;TSPOAP1;STAR;STARD3
prerank,regulation of interleukin-17 production (GO:0032660),0.4766097540456007,1.2378439358860078,0.16333725029377202,0.5251221254436628,1.0,8/31,19.53%,RFTN1;PRKCQ;SPHK1;ZBTB7B;LY9;DDIT3;IL6;IL2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5168694202740394,1.2374549371340913,0.20127388535031848,0.5257794661753235,1.0,3/18,5.50%,ABL2;ATP7A;POR
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4902259584313396,1.2374217687025468,0.18531889290012032,0.5253631399564588,1.0,4/25,4.62%,STAP1;ARHGAP24;HRG;PRKCD
prerank,mesonephric tubule development (GO:0072164),-0.4337196410080268,-1.2371106981480648,0.19718309859154928,0.649801533423421,1.0,6/15,22.00%,SALL1;ROBO2;OSR1;NPNT;PKD1;SLIT2
prerank,epithelium development (GO:0060429),0.4102058656170316,1.2370409078236617,0.10754912099276112,0.5260228816607753,1.0,32/107,25.17%,LGALS3;CTSB;DAG1;TAGLN2;ANXA4;TAGLN;GSTA2;PPARG;FOXJ1;DHRS9;SOX9;VEGFA;DMBT1;PGK1;ALDOC;EHF;MTHFD1;RCN3;PTER;KDR;SPINK5;TST;CBR1;RIPK4;ANXA7;IFT122;TPP1;FGFR2;SOX10;JAK2;CPT1A;KANK2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5680638894967825,1.2368932090589566,0.21216216216216216,0.5259587423428009,1.0,7/12,29.81%,CSPG4;DCN;BGN;CHST12;CSPG5;DSEL;DSE
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5590239767132169,1.2368183781079567,0.2185792349726776,0.5257050449107793,1.0,2/12,6.22%,CTNNB1;WAPL
prerank,protein alkylation (GO:0008213),0.5091682479802041,1.2368132232892186,0.20418204182041821,0.5252236543955009,1.0,8/22,21.15%,ETFBKMT;ETF1;METTL22;PRMT2;GSPT1;FAM98A;EEF2KMT;PRMT3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4747695836366792,1.236809129538437,0.1895734597156398,0.524745106587055,1.0,5/29,11.07%,CTNNB1;TCF7;LEF1;HDAC1;RBBP5
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5291490207668612,1.236749880583522,0.190176322418136,0.524445990162418,1.0,7/17,26.50%,APOE;ABCG1;LPCAT3;MBTPS2;SREBF1;FGF1;ERLIN1
prerank,membrane organization (GO:0061024),0.39854776865303493,1.236728520214606,0.03811434302908726,0.5240086084934654,1.0,61/227,17.80%,MYOF;CORO1C;IGF2R;RABEP1;ARPC2;CD4;UBA52;ARPC3;RPS27A;ARPC5;FER1L5;CD3G;MTCH1;SYNGR1;TLCD1;SH3KBP1;DAB2;TOR1AIP2;CTDNEP1;GRB2;GLTP;CHMP4A;CHMP4B;NAPA;ACTG1;PDCD6IP;TLCD2;LEMD2;GAK;HIP1;REEP3;PIP5K1C;DNM2;CLN3;HUWE1;VPS4B;CHMP7;OSBPL2;RAB5A;LPCAT3;HSPA8;STAM2;AGFG1;KIF20A;SLC2A8;NPC1;FZD4;ACTB;GCA;ACTR3;CBL;VAPB;TFRC;AP3D1;CHP1;MYADM;SAR1A;VAMP4;EPS15L1;VAMP2;HIP1R
prerank,small GTPase mediated signal transduction (GO:0007264),0.41316677697855014,1.2361239623038307,0.1023541453428864,0.5252431845062234,1.0,32/103,19.06%,IGF1;ABR;CCDC88C;GRAP2;LAT;FGF2;BRAP;SIAH2;TRIM28;RAPGEF6;GRB2;CRKL;DNMT1;RASGRP1;RASGRP3;PLK2;RIN2;KRAS;NRAS;JUN;ARHGEF18;CDK2;RASGRP2;CHP1;NF1;RIT1;ARHGAP30;RALB;KRIT1;NTN1;RRAD;GNB1
prerank,positive regulation of nuclear division (GO:0051785),0.4834509919645992,1.235987595278903,0.18925518925518925,0.5251888637488442,1.0,2/25,4.70%,IGF1;CD28
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4616876632600237,1.2358760363216594,0.17172897196261683,0.5250385078096812,1.0,9/33,16.59%,IGF1;PIK3CB;PIK3R5;GATA3;IGF1R;PLEKHA1;C1QBP;NF1;PIK3R2
prerank,lytic vacuole organization (GO:0080171),0.471464541954167,1.2357818469398751,0.17198177676537585,0.5247943086601706,1.0,12/32,17.35%,ABCA1;GNPTAB;TFEB;GAA;HOOK1;TPCN2;VPS18;CLN3;HPS1;ZKSCAN3;ACP3;HOOK3
prerank,mitochondrial translational termination (GO:0070126),0.4182662809779523,1.2353925392320801,0.11740473738414006,0.5254458452070224,1.0,37/88,28.45%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MTRF1L;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;MRPS22;MRPS28;MRPS35;GFM2;MRPL19;MRPL15;MRPS27;MRPS30;MRPS14;MRPL1;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,B cell proliferation (GO:0042100),0.5190819255708481,1.235166787681525,0.2165206508135169,0.525599568855506,1.0,3/17,7.85%,BCL2;PTPRC;RASGRP1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.39960561282149826,1.2349582760134286,0.08316430020283976,0.5257300176743521,1.0,20/138,8.10%,FLT1;LCK;STAP1;CD3E;CSF1;CD8B;CD4;FGR;CD8A;PIK3CB;AXL;CD7;NPPA;PTK2B;NEDD9;BLNK;MTSS1;CLNK;POLR1G;IGF1R
prerank,muscle organ development (GO:0007517),0.4400266594473024,1.2348350230759728,0.15567567567567567,0.5256401419307364,1.0,15/54,17.76%,IGF1;SPEG;LARGE1;TAGLN;SGCA;MEF2D;ZBTB42;COL6A3;SRI;MEF2B;CHODL;UTRN;EVC;ITGA11;TCF12
prerank,regulation of interleukin-4 production (GO:0032673),0.5080903885288124,1.234588273959075,0.19461444308445533,0.5259108366259906,1.0,8/21,18.98%,PRKCQ;LEF1;CD28;GATA3;DDIT3;SYK;HAVCR2;FCER1G
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3989433410296415,1.234016087293055,0.072,0.5271055418870438,1.0,81/208,29.71%,LITAF;FLNA;NLRC3;LGALS1;LTF;CD4;MALT1;TANK;TRAF2;TNIP1;OPTN;SPHK2;AKAP13;TRIM6;SQSTM1;CC2D1A;TRAF3;HSPB1;DDX21;PDPK1;IKBKE;BRD4;TREM2;PLK2;PRKCB;TNIP3;EEF1D;TICAM1;TRAF1;HMOX1;WLS;DDX1;RHOA;SHARPIN;RIOK3;TNIP2;ECM1;GPRC5B;LPAR1;CLEC6A;TMEM106A;TFRC;TIRAP;DHX36;NEK6;S100B;CARD19;BST2;SHISA5;GPR89A;MTDH;TNFSF10;TRIM21;F2R;HTR2B;CCDC22;CD74;REL;IRAK4;JMJD8;TNF;BIRC2;SLC20A1;SLC44A2;TLR9;CX3CL1;PELI1;PPM1A;TERF2IP;TRIM8;TBK1;UFL1;TNFAIP3;RIPK1;ZFAND6;FKBP1A;TAB2;SIRT1;TRIM68;TLE1;MUL1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5557931105618373,1.2335513682033257,0.1902834008097166,0.527974544675189,1.0,9/13,26.75%,KLRC2;FGR;SPHK2;ITGB2;AP1G1;SYK;GAB2;STX4;LAMP1
prerank,negative regulation of complement activation (GO:0045916),0.5939578399695326,1.2334588821899357,0.211484593837535,0.5277847193809359,1.0,3/10,4.09%,C4BPA;C4BPB;A2M
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5877929405296051,1.233352752541231,0.21739130434782608,0.5276095343397367,1.0,5/10,22.91%,NAB2;CLU;C5AR1;HSP90AB1;EGR1
prerank,translational termination (GO:0006415),0.41599113294379264,1.2329690379519327,0.1101956745623069,0.5283319583881646,1.0,40/95,28.45%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;ETF1;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MTRF1L;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;GSPT1;MRPS22;MRPS28;MRPS35;GFM2;MRPL19;MRPL15;MRPS27;MRPS30;MRPS14;MRPL1;TRMT112;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,response to tumor necrosis factor (GO:0034612),0.4167108544164199,1.232931654100114,0.12551867219917012,0.527962660871876,1.0,22/91,19.95%,NFE2L2;TANK;CCL4;SPHK1;GATA3;ERBIN;MAP4K3;SMPD4;CCL13;BRCA1;CCL7;CCL5;YBX3;CCL14;CXCL16;ACOD1;GBP2;SMPD1;DHX9;ASAH1;ARHGEF2;RPS3
prerank,positive regulation of defense response (GO:0031349),0.416008293597583,1.232907922500304,0.12461059190031153,0.5275313669946731,1.0,17/89,11.91%,LPL;S100A8;S100A9;CYBA;FPR2;TNIP1;ADAM8;OPTN;MAPK13;NAPEPLD;NFKBIZ;POLR3D;CEBPA;CCR2;SERPINE1;CCL5;RIOK3
prerank,negative regulation of receptor internalization (GO:0002091),0.5591831393821548,1.2328774511863487,0.22886866059817945,0.5271236475680751,1.0,5/12,19.41%,SDCBP;LRPAP1;ANKRD13B;ANKRD13A;ATXN2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5553238304252284,1.23238738247477,0.20273972602739726,0.5280580843192925,1.0,6/13,26.73%,FLNA;MDFI;YWHAB;SUFU;LATS1;KEAP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.506738928512929,1.2322680738212102,0.19799498746867167,0.527927187615209,1.0,3/20,2.63%,BCL2;BCL2L1;MCL1
prerank,negative regulation of proteolysis (GO:0045861),0.4628968406696683,1.2322328214574578,0.18850574712643678,0.527548621792902,1.0,14/34,22.34%,CST7;CDK5;CSTB;SERPINE2;CLN3;ECM1;DNAJC1;TIMP4;EFNA1;ROCK1;TIMP2;TIMP1;TRIM21;SNX12
prerank,regulation of B cell differentiation (GO:0045577),0.5185483488254413,1.231812985269751,0.20742637644046094,0.5283411026633832,1.0,7/17,25.85%,IKZF3;ID2;SYK;SFRP1;BTK;NCKAP1L;TLR9
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5781507764157657,1.2318083579712815,0.22038567493112948,0.5278599063060309,1.0,4/10,13.08%,MUC1;ING4;SP100;TFAP4
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5721883923429747,1.2317015844774506,0.21399730820995963,0.527193369521478,1.0,6/11,22.95%,IL2RB;PTK2B;JAK1;SYK;IL2;STAT5B
prerank,cellular response to interleukin-2 (GO:0071352),0.5721883923429747,1.2317015844774506,0.21399730820995963,0.527193369521478,1.0,6/11,22.95%,IL2RB;PTK2B;JAK1;SYK;IL2;STAT5B
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4289992533039208,1.2315639931804818,0.1398527865404837,0.5271223905829434,1.0,36/72,33.61%,ERCC6;UBA52;RPS27A;COPS3;ERCC1;COPS8;COPS4;LIG1;POLR2H;HMGN1;DDB1;COPS2;XPA;COPS6;POLR2D;ERCC4;PPIE;RFC1;GTF2H1;UBC;POLR2F;GTF2H5;RFC2;CUL4A;LIG3;POLD4;MNAT1;ERCC8;COPS7A;TCEA1;ERCC2;RFC4;EP300;UBB;RFC5;PCNA
prerank,regulation of proteolysis (GO:0030162),0.44262870900723417,1.2314732529430175,0.16349384098544234,0.5269329770565011,1.0,12/48,13.03%,ASPH;PLAUR;CDK5;GSAP;TRAF3;CAV1;CSTB;CYFIP2;SERPINE2;CLN3;DNAJC1;OGT
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3593596184211007,-1.23130902070153,0.1566265060240964,0.6615106809884963,1.0,10/28,17.98%,STMN3;STMN1;MAP2;SKA2;CLASP2;FKBP4;MAP1B;STMN4;CAMSAP3;SKA3
prerank,myeloid leukocyte differentiation (GO:0002573),0.4256233766238912,1.2309618729801748,0.14103923647932132,0.5279952239977097,1.0,25/65,26.03%,CSF1;CD4;LEF1;PDE1B;MMP9;PPARG;RUNX1;VEGFA;TREM2;SNX10;CEBPA;CDC42;CDK2;PIR;IL31RA;DEK;CAMK4;SBNO2;GAB2;MT1G;BMP4;TGFBR2;RXRA;CDK4;GPR183
prerank,regulation of endothelial cell migration (GO:0010594),0.4139239460440536,1.230783038248281,0.11838006230529595,0.5280082370430315,1.0,24/85,17.75%,APOE;NRP2;SASH1;PIK3CB;PTK2B;FGF2;NRP1;ANGPT4;ADGRB1;GATA3;VEGFA;ANGPT1;RIN2;DLL4;SP100;AAMP;DCN;PRKD2;KDR;APOH;ANXA3;NF1;GPI;KRIT1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4938184420674806,1.2304163375807897,0.22738095238095238,0.5286405706803255,1.0,11/24,26.81%,DNMT3A;DNMT1;MTF2;PHF1;EED;BMI1;DNMT3B;CREBZF;RBBP7;SMYD5;H3-3A
prerank,negative regulation of GTPase activity (GO:0034260),-0.38731737367131513,-1.230014824810567,0.1834319526627219,0.6605319052000982,1.0,5/22,4.64%,F11R;LRCH1;WNK1;LRRK2;RCC2
prerank,sulfur amino acid metabolic process (GO:0000096),0.4978647068439156,1.2299817319017639,0.19852034525277434,0.5294780016020804,1.0,10/24,25.92%,MSRA;MMUT;MTHFD1;AHCY;MTRR;TST;CDO1;MPST;MTHFR;NOX4
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5760798461158562,1.2299668621184943,0.2217741935483871,0.528555099658108,1.0,6/11,31.41%,SRI;CALM3;FKBP1B;FKBP1A;GSTO1;CALM1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5760798461158562,1.2299668621184943,0.2217741935483871,0.528555099658108,1.0,6/11,31.41%,SRI;CALM3;FKBP1B;FKBP1A;GSTO1;CALM1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5554886368026073,1.229878956400401,0.2210386151797603,0.5283515638651131,1.0,5/12,13.64%,APOE;FLOT2;RANBP9;ABCA7;ROCK1
prerank,protein targeting to lysosome (GO:0006622),0.49941774610877926,1.2296811309779523,0.20935960591133004,0.5284659972277642,1.0,6/20,14.54%,GNPTAB;LAMP2;RAB7A;GCC2;HSPA8;CLU
prerank,regulation of autophagosome assembly (GO:2000785),0.46513907265818366,1.228889366748527,0.20368239355581128,0.5303450049959714,1.0,12/33,20.31%,SMCR8;SEC22B;CHMP4A;CHMP4B;NPRL2;RAB5A;IFT88;TBC1D12;RALB;RAB3GAP2;PIKFYVE;NPRL3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.518568053617583,1.2287004454348072,0.20154043645699615,0.5304350312088939,1.0,7/17,15.39%,IGF1;NR4A3;NRP1;S100A11;CCL5;DOCK5;DOCK7
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4058807561604136,1.2282606182054208,0.09494949494949495,0.5312850388678555,1.0,50/132,27.48%,IGF1;APOE;HIF1A;MSN;ADAM8;OPTN;PIK3CB;TRIM6;PRKCD;TFEB;PFKFB3;GRSF1;SNX33;PLK2;ABHD5;TICAM1;NPRL2;TNFRSF1B;ABCD2;DXO;PLEKHF1;VPS11;ENTPD5;ROCK1;DCN;ZSWIM8;DAPK1;ZC3HAV1;FOXO1;FURIN;SH3D19;STK11;ORMDL3;HMGB1;MTDH;LAPTM5;GSK3B;TRIM21;VPS35;BNIP3;TNF;PRR5L;PIK3C2A;KHSRP;RC3H1;SUPV3L1;TRIM8;GSK3A;DACT1;UFL1
prerank,apoptotic nuclear changes (GO:0030262),0.4844869899112765,1.2282435510184977,0.2088998763906057,0.5308565737483238,1.0,8/24,21.70%,DEDD2;ERN2;H1-0;DNASE2;DFFB;ACIN1;HMGB1;DFFA
prerank,cation transmembrane transport (GO:0098655),0.4479677226742118,1.2280214409901293,0.16610169491525423,0.5310258555500792,1.0,10/44,16.92%,MFSD12;SLC3A2;SLC7A1;ATP13A2;SLC36A4;SFXN1;TRPM7;ATP1A2;SLC7A8;SFXN2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4423821574556464,1.2279999683534775,0.1711111111111111,0.5306049090600986,1.0,10/49,10.65%,XYLT1;HS3ST3B1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;SLC35D2;B3GALT6;NDST1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.38848140551149923,1.2278328141015322,0.013,0.530633030983799,1.0,101/509,16.13%,BCAR3;IGF1;OSBPL8;BCL2;IQGAP1;FLT1;LITAF;S100A8;S100A9;LCK;FN1;MMP8;BCL2L1;RRAGD;FLNA;P2RX4;SMCR8;LGALS1;PTPRC;LTF;CD4;MALT1;SASH1;FGR;TRAF2;CCL4;GCNT2;ADAM8;PDGFA;SPHK2;AKAP13;PIK3CB;AXL;FAM110C;NRG1;TRIM6;SPHK1;FGF2;CD28;MFHAS1;CC2D1A;CAV1;BID;DDX21;MYDGF;RPS20;PIK3R5;PDPK1;TRAT1;RPL23;GATA3;SCTR;SOX9;IKBKE;BRD4;GRB2;VEGFA;ANGPT1;TREM2;BCL2L11;PLK2;IGF1R;PRKCB;KITLG;ILK;EEF1D;RACK1;TICAM1;BAX;HMOX1;FGF7;IAPP;HIP1;FYN;MYOC;RHOG;WLS;DDX1;CCL5;FGF20;RHOA;SHARPIN;TNIP2;ECM1;GAS6;RPL37;GPRC5B;ROCK1;DCN;DDIT3;PRKD2;CBL;LPAR1;CLEC6A;TMEM106A;C1QBP;TFRC;TIRAP;KDR;DHX36;CHD5
prerank,positive regulation of macroautophagy (GO:0016239),0.4427349466189622,1.2277486880709974,0.1735261401557286,0.5304005247179564,1.0,19/48,29.22%,SMCR8;OPTN;RUFY4;HTT;FYCO1;LARP1;DCN;KDR;VPS13D;RALB;RAB3GAP2;BNIP3;BAG3;RAB3GAP1;SESN2;TBK1;SPTLC2;BNIP3L;SIRT1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4129279075472713,1.2276939929494564,0.14616193480546794,0.5300683806731638,1.0,38/85,30.96%,RNF14;FBXW7;PRICKLE1;DAB2;TREM2;ATXN3;RNF180;RACK1;VCP;PSMC3;USP5;SOCS5;CEBPA;SMAD7;SUMO2;CLU;CSNK1D;PSMC6;RNFT1;ELOB;HECTD1;PIAS1;RNF19A;GSK3B;TRIB2;GABARAP;MDM2;SUMO1;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;USP13;RNF19B;RCHY1;NUB1;SIRT2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.43038080807183676,1.2276351053454446,0.16594360086767895,0.5297710875347901,1.0,19/54,25.59%,EIF6;BRIX1;RPL10A;NSA2;NOC2L;WDR12;MAK16;RPL35A;PPAN;RPL11;NVL;MDN1;RPL14;NPM1;MRPL1;SNU13;RPL7A;MALSU1;RPL23A
prerank,supramolecular fiber organization (GO:0097435),0.3899083247162917,1.2272556490676627,0.025025025025025027,0.5304241033576504,1.0,94/333,20.50%,MYO1E;FGF13;MYO5A;ARHGAP25;CORO1C;CCDC88C;MYO1F;LTF;MAP10;ATP7A;UBA52;COLGALT1;PPP1R9B;RPS27A;B4GALT7;ALDOA;VIM;TUBGCP4;FIGNL1;POF1B;MYO1A;COL10A1;NPPA;TPM2;BMP1;DYNC1H1;SIAH2;CLIP2;ACTN1;COL4A1;COL20A1;P3H1;INPPL1;RHOD;P4HB;FAT1;CORO7;HOOK1;COL18A1;USP9X;COL6A3;COL12A1;TPM4;CRTAP;ADAMTS14;B2M;RUFY3;IAPP;PLEC;HIP1;NAT8;DCTN1;RHOG;VPS4B;WDR73;RHOA;GSN;ADAMTS2;TSPAN5;CDC42;CRIPT;EFEMP2;UBE2L6;ARHGAP12;CYP1B1;KLHL24;P4HA3;GGA2;HSPG2;FURIN;CHP1;COL8A2;NF1;COL9A3;DDR2;HOOK3;RIPK3;SERPINF2;HIP1R;PIN1;GFAP;ARHGAP17;MYH11;COL16A1;EVL;ARHGEF2;LTBP3;LTBP2;UBC;P4HA1;DST;SLAIN2;COL9A1;EMILIN1
prerank,regulation of neuron death (GO:1901214),0.4196239992063738,1.227130986447491,0.11586638830897704,0.5303118191538746,1.0,21/82,16.12%,GPNMB;CTSZ;CSF1;TRAF2;ATP13A2;EIF4G1;CDK5;DAXX;CD200R1;CHMP4A;CHMP4B;EIF2S1;FYN;INPP5A;CCL5;TNFRSF1B;SARM1;CLU;ITGB2;EFNB2;CHP1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.4272561426230018,-1.2271208273558265,0.18834080717488788,0.6638822972032424,1.0,8/16,22.34%,TIPIN;RAD17;CLSPN;CDT1;ORC1;TIMELESS;RAD9B;CDC45
prerank,regulation of cell migration (GO:0030334),0.3878547082436056,1.227096613621315,0.014,0.5299338770072853,1.0,74/382,13.89%,GPNMB;PLAU;IGF1;PLXNC1;FLT1;MITF;ITGAX;CORO1C;CSF1;SDCBP;FLNA;RAP2A;PLXNA2;MGAT5;ANXA1;TMSB4X;SGK1;SASH1;FGR;DAG1;LEF1;ADARB1;GCNT2;MACF1;PDPN;PDGFA;MCTP1;FAM110C;GTPBP4;SPHK1;CLDN19;PTK2B;MMP9;SGK3;NEDD9;FGF2;LMO4;CAV1;FAM83H;JAG1;CLIC4;DAB2;STK24;VEGFA;DLC1;RHOD;ACTG1;TMSB10;IGF1R;CDH1;LMNA;SPAG9;IFITM1;ADAM17;RACK1;NKX2-1;RUFY3;PLXND1;FGF7;SERPINE2;CLN3;MYOC;SERPINE1;CCL7;CCL5;YTHDF3;FGF20;RHOA;CHRD;SMAD7;CPNE3;ROCK1;ARID2;CXCL16
prerank,peptide hormone secretion (GO:0030072),0.47033330368474585,1.2270687669019105,0.20793269230769232,0.529544627854101,1.0,7/26,19.69%,ANXA1;SNX19;CYB5R4;VIP;RAB1A;IL6;CDK16
prerank,metal ion transport (GO:0030001),0.41013009090749675,1.2266265143461734,0.14122533748701974,0.5303502962438075,1.0,20/86,17.16%,CACNA1A;TRPC4;SLC3A2;KCNN4;CHRNB2;CYP27B1;PANX1;MAGT1;CAV1;TPT1;PSEN2;FYN;CCL5;SLC30A9;CACNA1D;TRPM7;CACNG7;TUSC3;NIPAL1;CACNB3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5655247480232408,1.2261104570543253,0.21870882740447958,0.531374542536256,1.0,2/12,2.27%,B4GALT5;CHRNB2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3833081992572427,-1.2258338621285187,0.16230366492146597,0.6627855114111609,1.0,4/23,3.31%,HPGD;LTC4S;ALOX5;ELOVL6
prerank,regulation of microtubule nucleation (GO:0010968),0.5875823921469239,1.2254242964967168,0.2223756906077348,0.5329589422659413,1.0,3/10,14.09%,RANGRF;DCTN1;GIT1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5750228015393715,1.2250546826003113,0.23243243243243245,0.5336297866178229,1.0,6/11,21.62%,ZMIZ1;CDCA4;ZMIZ2;ELOF1;ARID1B;SERTAD1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5068434666939126,1.2250516638574633,0.19471153846153846,0.5331618396339884,1.0,12/20,33.18%,AMPD2;AK4;AK3;GART;ATIC;ADSS1;PPAT;ADSL;HPRT1;GMPS;NT5C2;ADSS2
prerank,regulation of protein catabolic process (GO:0042176),0.4125485859236611,1.2249293921429678,0.11030927835051546,0.5330387294975056,1.0,44/99,29.73%,FLNA;ATG7;CTSA;WDR91;ATP13A2;C4BPA;C4BPB;AZIN1;SEC22B;ADGRB1;EEF1A1;SF3B3;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;VIP;FOXO1;BARD1;FURIN;ODC1;PIN1;GFAP;FAM83D;CHMP6;GSK3B;RNF41;SNX12;MDM2;TNF;VPS28;RILP;STX5;GSK3A;DACT1;TNFAIP3;WWP2;FAF1;AZIN2;SNF8
prerank,translational elongation (GO:0006414),0.40864590196784284,1.224876034284697,0.12538540596094552,0.5327206260670734,1.0,40/101,28.45%,MRPS12;MRPL47;MRPL51;EEF2;MRPL4;EEF1A1;MRPL23;MRPL21;CHCHD1;EEF1D;RACK1;GTPBP2;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MRPS22;MRPS28;MRPS35;GFM2;MRPL19;MRPL15;MRPS27;MRPS30;MRPS14;MRPL1;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,phosphorylation (GO:0016310),0.38978616536554117,1.2245758082091984,0.017,0.5331493701201389,1.0,109/384,22.26%,FNIP2;FAM20C;CDK14;LCK;PEAK1;CDK18;CDK6;PRKCH;DGKZ;GNPTAB;CDK8;SGK1;FGR;CERK;TEC;SRPK1;GK;SPHK2;PIK3CB;SPHK1;MAP4K5;MAP4K2;PTK2B;DYRK2;PAK6;SGK3;SGK2;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;SIK1;ERN1;IKBKE;MAP4K3;COPS8;TXK;PLK2;PRKCB;HK1;ILK;RNASEL;MAPKAPK2;PGK1;CDK13;NEK4;FYN;COPS2;CDK17;PIM1;HIPK1;JAK1;BIRC6;RSKR;MAP3K12;CDK11B;LIMK1;GAS6;CDK2;ILF3;PKN2;PAK2;ROCK1;BIRC5;MAP3K1;PRKD2;FASTK;DAPK1;CSNK1D;MAPK9;STK38;DGKA;SYK;PLK4;DGKH;TLK1;PRKAG1;MINK1;CAMK4;DGKD;NLK;STK11;DAPK3;NEK6;MEX3B;ATM;TP53RK;CDK16;TOP1;MAP3K9;PDK3;MAK;LMTK2;MARK2;GSK3B;PRAG1;MARK4;RUNX3;NIM1K;PI4KA;SRPK2;CERKL;MELK;TAOK1;TRIB2;LATS1
prerank,regulation of exocytosis (GO:0017157),-0.31671162969703004,-1.224267847512017,0.12280701754385964,0.6630042638606357,1.0,17/46,16.42%,IL1RAPL1;CADPS;CPLX1;STXBP5L;RAB3A;RAB2B;SYT1;RIMS2;HAP1;RAB27B;CLASP2;RAB10;RAB15;LGI3;CPLANE2;RAB26;RAB3B
prerank,photoperiodism (GO:0009648),0.4796749583228339,1.2240792837579595,0.19621749408983452,0.5341537055178994,1.0,7/28,12.61%,FBXL17;ID2;SIK1;RBM4B;BHLHE40;CRTC1;PDE6B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4370459859683299,1.2238886576770072,0.18043478260869567,0.533764349719414,1.0,21/51,29.20%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;CCNB1;NUP188;LEMD2;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,mitotic nuclear membrane organization (GO:0101024),0.4370459859683299,1.2238886576770072,0.18043478260869567,0.533764349719414,1.0,21/51,29.20%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;CCNB1;NUP188;LEMD2;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.47412487624140187,-1.223773446378967,0.2198581560283688,0.6597388923860834,1.0,6/11,34.46%,PTS;PRKG2;QDPR;DHFR;GCH1;GCHFR
prerank,carnitine metabolic process (GO:0009437),0.5557598318509867,1.2236820937637747,0.23240371845949534,0.533871287055896,1.0,8/12,24.96%,BBOX1;SHMT1;CRAT;CPT2;ACADL;CPT1A;TMLHE;ACADM
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.41508811972954407,1.2236043947531774,0.14699792960662525,0.5336179556488769,1.0,35/85,31.31%,PSMD8;PSMD1;DAAM1;PRICKLE1;PSMD6;PSMA1;PSMC3;PSMA8;RHOA;FZD1;CDC42;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;PFN1;PSMA3;PSMB10;PSMB8;PSMD7;VANGL1;PSMB6;PSMD10;PSMB5;PARD6A;PSMB7;ARHGEF19;PSMC4;CELSR2;CELSR3;PSMD12
prerank,cellular response to UV (GO:0034644),0.4210813612725466,1.223442274689215,0.1446673706441394,0.533586394816271,1.0,35/76,32.34%,MAPK13;MMP9;PRKCD;ERCC1;NOC2L;SDE2;EIF2S1;DDB2;DDB1;METTL3;TRIAP1;XPA;YY1;INO80;ERCC4;USP47;DHX36;SMPD1;STK11;CASP9;TIMP1;NPM1;USP28;XPC;ATF4;KDM1A;ATR;RUVBL2;SIRT1;CDC25A;ZBTB1;EP300;CREBBP;NEDD4;TMEM161A
prerank,focal adhesion assembly (GO:0048041),0.4991762343066724,1.2233423390008216,0.22924411400247832,0.5334001962955168,1.0,7/21,19.78%,PEAK1;ACTN1;DLC1;RHOD;SORBS1;FERMT2;ACTN2
prerank,mitotic cytokinetic process (GO:1902410),0.49256326095432534,1.2232955288798903,0.22415940224159403,0.5330543182636315,1.0,7/20,13.37%,CHMP4A;CHMP4B;PDCD6IP;VPS4B;RHOA;CHMP7;KIF20A
prerank,positive regulation of cellular process (GO:0048522),0.38603223800825603,1.2231503149540859,0.004,0.5330260681605808,1.0,183/565,27.48%,IGF1;COLEC12;BCL2;FLT1;S100A8;S100A9;CYBA;ITGAX;FN1;LRP1;CSF1;TCIRG1;SDCBP;IL2RB;P2RX4;FPR2;SIRPA;DOCK2;SLC6A6;LEF1;ACACA;CXCR2;GCNT2;ADAM8;PDPN;PDGFA;PTGFR;CST7;EIF4G1;RPS6;OSMR;NRG1;APOA2;SPHK1;PTK2B;DOT1L;PRKCD;FGF2;DYNC1H1;HDAC4;CAV1;EXOSC4;SLC25A33;RPL23;ECHDC3;SOX9;VEGFA;CRKL;EGR2;TREM2;HDAC1;EIF4G2;HP;HPR;CAPN1;CELF1;RHOD;P4HB;IGF1R;FBXO5;LMNA;KITLG;EAPP;ADAM17;CDK13;DDX49;BAMBI;FGF7;KRAS;SLC35F6;RHOG;CCL5;FGF20;TNFRSF1B;EXOSC9;NAMPT;CHRD;CDC42;GAS6;ABCA7;CDCA7L;CDK2;BIRC5;CCL14;CXCL16;STX3;STOX1;IL31RA;INO80;PRKD2;NUMA1;RPS19;LRP6;SRF;VIP;USP47;NCMAP;CDC7;C1QBP;EFNB2;CCND2;KDR;DHX36;CHTOP;BMP6;FXR2;SINHCAF;CAPNS1;SERPINF2;CNBP;S100B;LMAN2;ATM;IL6;RPS9;ACACB;CCAR1;CUL3;LYAR;FCER1G;FAM98A;ITGB1BP1;SLC11A1;IL2;GAB2;MLC1;MEIS3;CNOT6;TIMP1;EPO;VHL;HSF1;HSP90AB1;LBP;SERTAD1;SRPK2;NPM1;CD47;BMP4;CIAO1;CDC123;TRIM21;FGF18;CALR;FGFR3;F2R;HTR2B;IL34;ACTN4;KMT2D;TGFBR2;AGPAT1;FGFR2;NSMCE1;MDM2;TNF;SMC6;FASN;HDAC2;PDGFRA;CDK4;CDC25B;MAPK15;SFRP1;BMP5;PLA2G5;MDK;MYRF;FGF1;CNOT6L;CX3CL1;PTPN6;HCFC1;STX4;IL12RB2;PSMD10;H3-3A;SSR1;CDKN2AIP;SUPV3L1;S1PR2;HES1;UFL1
prerank,regulation of macroautophagy (GO:0016241),0.40605757594873404,1.2225873449963855,0.12195121951219512,0.5342048935783982,1.0,38/105,28.47%,RRAGD;ATP6V1C1;ATP6V0D2;SMCR8;ATP6V1A;ATP6V0A1;ATP13A2;ATP6V1B2;RUFY4;CDK5;ATP6V0D1;ATP6V0B;ATP6V1G1;ERN1;CAPN1;VPS26A;CLN3;LARP1;DCN;UBQLN1;KDR;PRKAG1;CAPNS1;ATP6V0C;ATP6V1E1;USP36;VPS35;BNIP3;RRAGC;ATP6V0E1;SESN2;LAMTOR3;TBK1;EXOC4;ATG13;SMG1;LAMTOR1;BNIP3L
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.39678630357148864,1.2223241949582442,0.08980827447023208,0.5345265770477934,1.0,52/161,27.96%,DKK2;APOE;CCDC88C;PSMD8;PSMD1;TBX18;BICC1;PRICKLE1;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;ZNRF3;PSMD6;PSMA1;SFRP5;PSMC3;PSMA8;TLE5;PSMD14;FZD4;SCYL2;PSMD2;DDIT3;LRP6;PSMC6;PSMA6;LZTS2;PSMD5;STK11;PSMA5;CUL3;FRMD8;TPBG;GSK3B;LATS1;PSMA3;PSMB10;SFRP1;MDK;PSMB8;PSMD7;PSMB6;PSMD10;GSK3A;DACT1;PSMB5;RUVBL2;PSMB7
prerank,apoptotic mitochondrial changes (GO:0008637),0.4647464472860065,1.22232304645999,0.19069239500567536,0.5340550032794611,1.0,13/32,23.74%,BCL2;BCL2L1;BID;BAX;CLU;HSPD1;CCAR2;AIFM2;IFIT2;SOD2;BIK;VPS35;BNIP3
prerank,regulation of necroptotic process (GO:0060544),0.48414211337548674,1.2221108402230552,0.21284185493460167,0.5342314294049285,1.0,11/23,27.83%,SDCBP;MLKL;PDCD6IP;FLOT2;OGT;YBX3;RIPK3;ARHGEF2;BIRC2;PELI1;RIPK1
prerank,tRNA methylation (GO:0030488),0.47013571461965104,1.2219593858164317,0.20091848450057406,0.534196835864411,1.0,22/34,36.61%,METTL1;TRMT10C;PRORP;METTL2B;METTL2A;TRMT13;THADA;NSUN2;TRMT112;TARBP1;GTPBP3;THUMPD2;TRMT5;ALKBH8;METTL6;TRMT12;LCMT2;NSUN6;TRMT10A;MTO1;TRMT1L;TRMT44
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.41407267131000025,1.2213363756512268,0.1529656607700312,0.535598903792682,1.0,22/73,20.23%,LPL;CYBA;MMP8;PTPRC;SPN;ADAM8;SPHK2;CD2;HSPB1;RASGRP1;ARFGEF2;CCR2;CLU;TMEM106A;TIRAP;SYK;IL6;DHX9;HAVCR2;ARHGEF2;HMGB1;FRMD8
prerank,regulation of dendritic spine development (GO:0060998),-0.40212638805320106,-1.2212923797323667,0.18556701030927836,0.6624348389451892,1.0,9/19,14.16%,TANC2;MEF2C;NLGN1;PSEN1;SHANK3;PPFIA2;CAMK1;CAMK2B;DLG5
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4044119338135847,1.2209125331898285,0.10222672064777327,0.5364613720188813,1.0,52/136,27.73%,FLNA;NLRC3;TMSB4X;IRAK2;ANXA4;ID2;EOMES;TRAF3;HDAC4;OTULIN;FOXJ1;SIK1;ERBIN;BHLHE40;MDFI;SFRP5;DAP;PIM1;RNF2;SP100;SMAD7;GAS6;DDIT3;CYP1B1;ACOD1;CEBPG;PRMT2;SIGIRR;CHP1;WFS1;HAVCR2;PTGIS;EGLN1;NLRC5;RWDD3;TRIM21;ID1;SUFU;PEX14;SUMO1;GLIS2;MAP2K5;HDAC2;AIM2;TLR9;BTRC;KEAP1;PSMD10;KDM1A;HES1;UFL1;TNFAIP3
prerank,microvillus organization (GO:0032528),0.5462816827048318,1.2208465740377736,0.22072678331090176,0.5362012226362048,1.0,3/13,6.77%,RAP2A;FXYD5;RAPGEF6
prerank,positive regulation of transmembrane transport (GO:0034764),0.5438249721590522,1.2205824641107772,0.21322537112010798,0.5365326736142866,1.0,6/13,21.80%,NR4A3;AZIN1;ACSL1;C3;ANO6;SLC26A6
prerank,positive regulation of leukocyte activation (GO:0002696),0.5011228398847264,1.220429717650466,0.22824716267339218,0.5365556254057875,1.0,7/18,21.58%,CD226;CD2;CEBPA;TNIP2;HSPD1;CLEC4D;LBP
prerank,post-translational protein modification (GO:0043687),0.3882188563996291,1.2201193135416906,0.018,0.5370301067826225,1.0,126/332,30.58%,FAM20C;SPP1;APOE;HIF1A;FN1;CSF1;IGFBP7;PSMD8;LGALS1;PSMD1;SERPINA10;COPS3;APOA2;MATN3;ENAM;FSTL3;NEURL2;WSB2;FBXW7;FBXO32;RNF7;ANO8;STT3B;APLP2;COPS8;COPS4;SPSB2;P4HB;FBXO31;PSMD6;PSMA1;DDB2;FBXW4;RAB8A;DDB1;CUL9;PSMC3;KLHL13;COPS2;RABGGTB;C3;SOCS5;RBBP5;PSMA8;F5;KCTD7;COPS6;WDR5;RAB5A;ZBTB16;FSTL1;GAS6;UBE2F;PSMD14;PSMD2;LAMC1;FBXL19;PSMC6;PSMA6;MELTF;CKAP4;KLHL25;RAB1A;TULP4;ASB1;PSMD5;ELOB;DCAF17;PTP4A2;RAB11A;PSMA5;WSB1;IL6;WFS1;CUL3;SPARCL1;SPSB3;FBXO7;SHISA5;FBXW11;CAND1;TIMP1;VHL;CUL1;CALU;FBXW5;BMP4;FBXO11;CUL2;CCDC22;RBBP7;PSMA3;SOCS2;DCAF6;PRKCSH;WDTC1;DCUN1D3;PSMB10;FBXO41;PSMB8;PSMD7;CUL4A;PSMB6;KLHL21;BTRC;KEAP1;PSMD10;KLHL11;PSMB5;ASB18;PSMB7;KLHL41;DCAF7;UBA3;HSP90B1;ERCC8;RAB11B;PSMC4;CHML;SERPIND1;COPS7A;SKP2;DCAF13;KBTBD8;FBXW2;NUB1
prerank,protein modification by small protein removal (GO:0070646),0.39188586560768984,1.2198598899222255,0.043043043043043044,0.5373087240461928,1.0,115/252,32.24%,HIF1A;PSMD8;PSMD1;UBA52;TRAF2;RPS27A;TNIP1;COPS3;JOSD1;TRAF3;SIAH2;USP12;USPL1;GATA3;COPS8;COPS4;RNF128;OTUD4;TFPT;ATXN3;TAB1;TNIP3;USP9X;PSMD6;PSMA1;DDB2;VCP;ABRAXAS1;PSMC3;USP5;ASXL2;COPS2;BRCA1;SUDS3;BAP1;PSMA8;RHOA;TNIP2;MYSM1;COPS6;SMAD7;STAM2;OGT;SMAD1;USP40;PSMD14;YY1;PSMD2;ACTB;INO80;ASXL1;USP47;PSMC6;BARD1;PSMA6;SENP5;POLB;PSMD5;PSMA5;UIMC1;USP18;USP46;DESI1;DESI2;UBC;USP28;SENP1;USP36;WDR48;USP14;USP33;PSMA3;OTUD1;USP50;USP2;MDM2;USP8;BIRC2;PSMB10;PSMB8;PSMD7;USP1;USP32;PSMB6;OTUD5;HCFC1;BRCC3;USP19;KEAP1;PSMD10;PSMB5;TNFAIP3;RIPK1;STAMBP;USP42;PSMB7;USP30;USP34;PSMC4;CDC25A;USP13;COPS7A;SKP2;BECN1;PTEN;USP48;STAMBPL1;PSMD12;EP300;ACTR8;USP15;USP38;PSMD3;ZC3H12A;UBB
prerank,melanocyte differentiation (GO:0030318),0.5698632844355446,1.2197342699172613,0.22857142857142856,0.53719803471846,1.0,3/11,5.49%,MITF;TYRP1;LRMDA
prerank,negative regulation of DNA binding (GO:0043392),0.4729602386195169,1.219592767677998,0.20095124851367419,0.5371539305419015,1.0,7/28,13.08%,LEF1;GZMA;MDFI;JUN;ILRUN;SP100;TFAP4
prerank,regulation of potassium ion transport (GO:0043266),-0.3326488028903997,-1.2194652657343994,0.17142857142857143,0.6631178412913564,1.0,13/31,20.88%,KCNIP4;DPP10;KCNIP3;DPP6;KCNN2;NOS1;KCNAB2;KCNIP1;KCNH2;ANK2;ANK3;KCNIP2;ADRA2A
prerank,regulation of establishment of planar polarity (GO:0090175),0.4128262877689473,1.2193235157893656,0.14609053497942387,0.5374783171529924,1.0,36/88,31.31%,PSMD8;PSMD1;DAAM1;PRICKLE1;PSMD6;PSMA1;PSMC3;PSMA8;RHOA;FZD1;CDC42;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;PFN1;PSMA3;PSMB10;PSMB8;PSMD7;VANGL1;PSMB6;PSMD10;DACT1;PSMB5;PARD6A;PSMB7;ARHGEF19;PSMC4;CELSR2;CELSR3;PSMD12
prerank,nuclear pore organization (GO:0006999),0.541751860153945,1.218915028200551,0.2198952879581152,0.5382302298067313,1.0,8/14,28.22%,NUP205;AHCTF1;TPR;NUP93;NUP54;NUP98;NUP133;NUP35
prerank,iron-sulfur cluster assembly (GO:0016226),0.4833945985794203,1.218903998704488,0.20418204182041821,0.5377951990898747,1.0,8/24,21.89%,HSCB;NFU1;ISCA1;IBA57;CIAPIN1;HSPA9;ABCB7;CIAO1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4111560183088142,1.2184728829257592,0.12461059190031153,0.5386188277300429,1.0,31/90,27.22%,LCN2;FABP5;PEMT;DYNC1H1;UCP2;CAV1;ZBTB7B;ACSL1;VEGFA;IGF1R;KDM3A;CCR2;PPARGC1B;OGT;YBX2;APPL2;PLAC8;SYK;CPT2;ADIPOR1;DECR1;EHMT1;FABP4;HSF1;ACADL;GNAS;JAK2;HADH;HDAC3;CXCR4;KDM1A
prerank,cytosolic transport (GO:0016482),0.404556406427321,1.2184452600661533,0.14212678936605316,0.5382306670270851,1.0,27/108,12.70%,TBC1D10C;EEA1;GOSR2;VPS13C;RGP1;WDR91;PTPN23;TMEM87B;VTI1A;BET1L;ARL1;STX6;RIC1;CORO7;HOOK1;SPAG9;TBC1D23;VPS26A;VPS13A;GAK;VPS50;CLN3;DCTN1;DOP1B;RAB7A;GCC2;RAB5A
prerank,organelle organization (GO:0006996),0.3852876105025251,1.2182018481841064,0.018,0.5384768351299378,1.0,140/388,28.08%,PLEKHM2;APOE;ARHGAP21;ARHGAP10;ANK1;MICAL2;VPS13C;PLAAT3;ATP7A;SYNE1;OPTN;ODF2;MICAL1;ATP8B4;PAK6;FMNL2;NEDD9;ABCD4;GOLGB1;CAV1;SLC25A33;SH3KBP1;TOR1AIP2;ARL1;FGD6;PI4K2A;TRAPPC8;STRIP1;HTT;CHMP4A;CHMP4B;PEX2;FMNL3;PDCD6IP;SMPD4;GEM;VPS18;CCL13;COG4;RANBP9;LARP4;RAB32;GAK;SIRT5;AFG1L;NRF1;LONP1;DOP1B;ALAS1;RAB7A;HUWE1;CCL7;DIAPH1;YTHDF3;VPS4B;ABCD2;WDR73;ATAD3A;RHOU;CHMP7;LMAN1;PLEKHF1;CDC42;CHCHD2;VPS11;PALLD;CENPT;PPIA;MTX3;SLC25A36;NUMA1;TWNK;CSNK1D;VAPB;HPS6;YTHDF2;ABCD3;SAR1A;RAB1A;TRAPPC11;SIRT4;SH3D19;VPS13D;POLG2;VPS51;TMEM11;GABPB1;TBC1D20;HAX1;LMAN2;ARFGEF1;PEX16;AGTPBP1;PIKFYVE;RHOT2;MTFR2;STOML2;DST;CHMP6;FGD5;PYROXD2;CFL1;MARK4;ZMYM4;TMED3;MTFR1;TERT;TOR1B;PPRC1;CSPG5;SNX11;PEX14;SIRT3;SIPA1;GOLPH3;ATP5F1B;SIPA1L3;MAPK15;TRAPPC12;MDK;GOLGA2;NDP;ABI2;RAB3GAP1;PAK4;GOLPH3L;NCKIPSD;STX7;HCFC1;STX4;PI4K2B;SURF4;ARC;MREG;RAB31;PRPF40A;TMED2;TNFAIP3;PACSIN2;CYCS
prerank,positive regulation of hormone secretion (GO:0046887),0.5210502878792681,1.2181000767342356,0.20775969962453067,0.5383052643702669,1.0,2/17,3.76%,SPP1;CYP19A1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5140411794885367,1.2172626042872274,0.22391857506361323,0.5403104801665689,1.0,3/18,8.87%,HIF1A;FN1;LILRB1
prerank,protein stabilization (GO:0050821),0.3933782663694357,1.2166753790193836,0.08056394763343404,0.5416446013980395,1.0,65/168,29.71%,IGF1;FLNA;ATP1B3;CCT2;GNAQ;CSN3;APOA2;GTPBP4;FBXW7;PRKCD;HYPK;RPS7;RPL23;PLPP3;STK3;P3H1;NAA16;USP9X;FLOT2;RPL11;LAMP2;CRTAP;HIP1;PARVA;TNIP2;SMAD7;EFNA1;CCT8;CLU;HSPD1;CHP1;GET1;NLK;HIP1R;PIN1;WFS1;PTGES3;CDC37L1;CCT5;TBRG1;VHL;MCM8;HSP90AB1;USP36;CALR;PFN1;USP33;ZBED3;USP2;SUMO1;BAG3;ATP1B2;HCFC1;USP19;LAMP1;NAA15;CREBL2;AFM;PER3;ATF7IP;STK4;PEX19;RABL3;USP13;MUL1
prerank,mRNA modification (GO:0016556),0.4896079229965356,1.2165093460759868,0.21707317073170732,0.5416770500779257,1.0,11/22,29.54%,PUS1;TRUB2;TRMT10C;PUS7;METTL3;NSUN2;DKC1;CBLL1;METTL8;TRMT6;PCIF1
prerank,regulation of angiogenesis (GO:0045765),0.39282643499680553,1.2165065499032461,0.07537688442211055,0.5412100595210505,1.0,53/192,20.50%,GPNMB;FLT1;CTNNB1;HIF1A;ITGAX;NIBAN2;SASH1;AGO2;HRG;SPHK1;FGF2;HSPB1;ANGPT4;PPARG;MYDGF;ADGRB1;RUNX1;PDPK1;VEGFA;PRKCB;PGK1;JUP;PLXND1;HMOX1;BRCA1;HIPK1;RNH1;CCR2;SERPINE1;ECM1;SP100;ROCK1;DCN;PRKD2;CYP1B1;HTATIP2;HSPG2;KDR;APOH;NINJ1;ANXA3;NF1;CCN6;SARS1;SPINK5;KLK3;KRIT1;IL6;SP1;PTGIS;EGLN1;MTDH;EMILIN1
prerank,camera-type eye morphogenesis (GO:0048593),0.5843411365835499,1.216497537824338,0.23150684931506849,0.5407714031924625,1.0,5/10,21.13%,TH;VEGFA;LRP6;NF1;IFT122
prerank,regulation of histone deacetylation (GO:0031063),0.5539054320927324,1.2163664889812609,0.23513870541611626,0.5406546166199109,1.0,6/13,22.68%,SPHK2;ZBTB7B;SAP30BP;ING2;PRMT6;NIPBL
prerank,vitamin transport (GO:0051180),0.4722245891169978,1.2161208066661244,0.1983568075117371,0.5409049475057458,1.0,9/29,22.86%,SLC27A1;PDPN;SLC23A1;SLC46A1;SLC52A2;SLC2A8;SLC19A1;SLC2A6;SLC19A2
prerank,central nervous system development (GO:0007417),-0.2209098266966293,-1.2156706276986664,0.0,0.6694324164872534,1.0,48/250,10.32%,ZFHX3;CX3CR1;ITGAM;ADGRL3;PHF8;GRIN2A;ROGDI;PBX3;SERPINI1;SH3GL2;ADAM22;SLC8A3;VCAN;CNTN4;EML1;COX7B;SOX8;IL1RAPL2;PTS;DSCAML1;GRIN2B;TBX6;NCKAP1;CNTN6;PAX8;STAT3;UBE3A;CDH2;NDRG4;DHX30;NNAT;NPAS2;CNTNAP2;ADGRG1;NDUFS4;HAP1;PRKN;PAFAH1B2;MARCKS;ZIC4;DNER;ACAN;SH3GL3;ROBO2;PAFAH1B3;MEIS1;APOD;DDIT4
prerank,protein homotetramerization (GO:0051289),0.4400225505049734,1.2154581970803184,0.17532467532467533,0.5424202218638464,1.0,15/49,20.37%,ACACA;ALDOA;THG1L;KCNJ2;APIP;GNMT;B2M;SHMT1;UPB1;OSBPL2;GLS;APPL2;AQP4;ACACB;SOD2
prerank,regulation of defense response (GO:0031347),0.41577553569871756,1.215017729184616,0.1504237288135593,0.5433162123046476,1.0,20/76,18.53%,APOE;ANXA1;TMSB4X;FGR;PTGES;TRAF3;MGLL;BCL6;PTPN22;BRD4;TREM2;CELF1;CCR2;CASP4;APPL2;PSMA6;TIRAP;SBNO2;USP18;ELMOD2
prerank,GPI anchor metabolic process (GO:0006505),0.47378567597487337,1.2148973065110138,0.19304556354916066,0.543172875858415,1.0,7/26,15.34%,PIGQ;PIGZ;PIGA;PGAP1;PIGN;PIGL;PIGC
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4954396602789198,1.2146809951065833,0.21193666260657734,0.5433300756478465,1.0,10/22,25.22%,SPHK2;TRIM6;APOA2;LILRB1;CCR2;TNFRSF1B;SCIMP;LAPTM5;TNF;BTK
prerank,male meiosis I (GO:0007141),0.5236538734373328,1.2146116285048771,0.22786458333333334,0.543047549886428,1.0,5/16,16.55%,SYCP3;FOXJ3;SLC25A31;ING2;HSF2BP
prerank,regulation of cell growth (GO:0001558),0.39299476622673335,1.213871214427852,0.07028112449799197,0.5448762428477293,1.0,40/204,15.89%,APBB2;BCL2;S100A8;S100A9;SDCBP;PRKCQ;SGK1;PPP1R9B;SPHK2;EIF4G1;HRG;SPHK1;CYP27B1;SGK3;SGK2;PPP2R1A;EXOSC4;SLC25A33;BCL6;DCBLD2;EIF4G2;ADAM17;RACK1;DDX49;ENO1;BAP1;EXOSC9;ATAD3A;CDK11B;CDC42;CXCL16;INO80;ADAM15;ARHGEF11;RASGRP2;OSGIN2;USP47;SERTAD3;MELTF;TFRC
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3524983123110976,-1.2138512596002682,0.1610738255033557,0.6702063810230092,1.0,12/30,18.12%,IDI1;DHCR7;HMGCS1;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,protein sumoylation (GO:0016925),0.4341757400566744,1.2136639408781102,0.17770419426048564,0.5450051386097852,1.0,23/49,29.19%,NUP205;NSMCE2;TRIM28;EGR2;NUP188;SUMO2;RANBP2;TPR;RAE1;PIAS1;SAE1;NUP93;AAAS;NUP50;NUP54;SUMO1;NUP98;PIAS4;NUP42;NUP133;NUP210;NUP35;NUP214
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.38674905038932034,-1.2135312036774597,0.19393939393939394,0.666728261765317,1.0,9/20,15.79%,DIP2B;PAXIP1;PPARGC1A;RPS6KA5;NOS1;RPS6KA4;IL1B;TADA2B;TADA2A
prerank,sphingosine biosynthetic process (GO:0046512),0.5675575178991541,1.2134756167356486,0.22296395193591456,0.5446484448225573,1.0,5/11,27.42%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.5675575178991541,1.2134756167356486,0.22296395193591456,0.5446484448225573,1.0,5/11,27.42%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,COPII-coated vesicle budding (GO:0090114),0.4162971712664184,1.2132178703007503,0.17830290010741137,0.5449871988820827,1.0,19/68,19.21%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;MCFD2;SEC24D;CSNK1D;VAPB;SAR1A;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,cellular response to calcium ion (GO:0071277),-0.2925632639842249,-1.2126431793072134,0.109375,0.6649107386334915,1.0,17/67,12.20%,MEF2C;CAPN3;NLGN1;LGMN;RYR3;MEF2A;SYT10;PLCG2;SYT1;SYT2;ADGRV1;MCOLN1;KCNH1;ECT2;WNT5A;DMTN;CPNE5
prerank,long-term memory (GO:0007616),0.5013614256158402,1.212491214173906,0.23645320197044334,0.5466676562793068,1.0,5/19,17.11%,APOE;SGK1;CPEB3;NPAS4;CAMK4
prerank,positive regulation of ion transport (GO:0043270),0.43413099231654284,1.2124442235822257,0.18647764449291168,0.5463339657731238,1.0,16/48,19.78%,P2RX4;ATP2B1;CHRNB2;CCL4;PRSS8;CRACR2A;CCL5;SCN1B;CNKSR3;CACNA1D;SCN3B;PKP2;SNX4;ANO6;WFS1;ACTN2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42338653284209576,1.2124271074138542,0.17274678111587982,0.5459105812208516,1.0,14/59,15.34%,CTNNB1;MITF;CDK8;LEF1;MED15;TRIM28;SOX9;CCNC;CCNB1;BAX;JUN;MED17;NFKB1;MED13
prerank,lysosome organization (GO:0007040),0.4527913361848679,1.2124172858607074,0.1981981981981982,0.5454625297284246,1.0,13/36,18.61%,ABCA1;GNPTAB;TFEB;GAA;HOOK1;TPCN2;VPS18;CLN3;HPS1;ZKSCAN3;ACP3;HOOK3;TMEM165
prerank,negative regulation of endothelial cell migration (GO:0010596),0.46064597486736497,1.2123646576622575,0.1961231470923603,0.5451561011068983,1.0,14/36,20.12%,APOE;HRG;FGF2;ANGPT4;PPARG;ADGRB1;JUP;ANGPT2;DLL4;SP100;DCN;APOH;KRIT1;HMGB1
prerank,sensory organ development (GO:0007423),0.4303398534364821,1.212288320771589,0.18859649122807018,0.5449008965434998,1.0,17/51,27.42%,SH3PXD2B;BLOC1S3;SOX3;GATA3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;PBX2;ECE1;MYO7A;SIPA1L3;SMCHD1;CHD7
prerank,hexose biosynthetic process (GO:0019319),0.44343230256483074,1.2122223092883926,0.20758928571428573,0.5446269142624979,1.0,10/42,17.53%,SORD;ALDOA;SLC25A1;PGK1;ENO1;PCK2;ALDOC;RBP4;ENO2;GPI
prerank,chromatin assembly (GO:0031497),0.4522811063184227,1.211821843286019,0.19248291571753987,0.5453769982705204,1.0,20/38,32.73%,GRWD1;DAXX;NOC2L;SOX9;M1AP;PRDM9;H1-0;CHAF1B;PAF1;ATRX;NPM1;NAP1L3;ANP32B;H3-3A;RSF1;SIRT1;HMGB2;ASF1A;BAHD1;SART3
prerank,regulation of DNA recombination (GO:0000018),0.45697342203432045,1.211805929317184,0.20914285714285713,0.5449574721767126,1.0,9/32,19.82%,FIGNL1;PPP4C;THOC1;ZRANB3;RAD50;H1-0;BLM;RTEL1;RAD51AP1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5298499754579937,1.211694556392888,0.2232876712328767,0.5448139433069888,1.0,2/14,9.10%,CSF1;ATP6AP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.392201888077056,-1.2116026149139982,0.19886363636363635,0.6637220977232521,1.0,9/20,30.80%,SEMA6D;SEMA6A;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA7A;SEMA3C;SEMA3F
prerank,positive regulation of actin nucleation (GO:0051127),-0.46081503361162623,-1.211124267772722,0.233201581027668,0.6609137274983559,1.0,3/11,4.88%,FCHSD2;WASF2;NCKAP1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5121926487323571,1.2106787031365784,0.22693266832917705,0.547365419790378,1.0,6/18,19.81%,ANXA1;BCL2L11;UBE2L3;PCK2;HNRNPU;NR3C1
prerank,liver development (GO:0001889),0.4636221888624743,1.2103799731385305,0.20492721164613661,0.5478236279409575,1.0,14/32,33.22%,ANXA1;ARID5B;CEBPA;PCK2;CEBPG;NF1;IL6;GFER;PRKCSH;CCDC40;CCDC39;XBP1;CEBPB;PHF2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.46181399778674226,1.210283472942982,0.20477815699658702,0.5476258910951514,1.0,14/31,26.16%,FBXW7;UBE2L3;FZR1;RPS2;DCUN1D2;RAB1A;PIN1;BMI1;DCUN1D4;ARRDC4;DCUN1D3;GOLGA2;UBE2C;BTRC
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4361845750520624,1.2097500633037168,0.17328918322295805,0.5487767745594229,1.0,14/48,18.32%,STAP1;PTPRC;TTLL12;PPARG;TREM2;OTUD4;PTPN2;METTL3;YTHDF3;GAS6;YTHDF2;SIGIRR;USP18;IL6
prerank,cell-matrix adhesion (GO:0007160),0.40552604897985545,1.2097445747121052,0.14432989690721648,0.5483296078529197,1.0,26/95,20.89%,PEAK1;FN1;CD96;ITGAL;CD44;ADAMTS13;ITGA4;OTOA;ACTN1;DLC1;RHOD;ILK;CD63;ADAM15;SIGLEC1;SORBS1;ITGB2;ITGA11;ITGA3;ZYX;FERMT2;ECM2;ITGB1BP1;ACTN2;EMILIN1;PPFIA1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.49036010942992186,1.209730319035404,0.21811680572109654,0.5479126683577633,1.0,14/24,33.61%,UBA52;RPS27A;LIG1;POLE;POLB;RFC1;UBC;RFC2;LIG3;POLD4;RFC4;UBB;RFC5;PCNA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4953751430660144,1.2095522081790024,0.2080706179066835,0.5480160188595583,1.0,6/21,16.11%,MITF;JUN;MED17;MED13;SRF;DHX36
prerank,negative regulation of epithelial cell migration (GO:0010633),0.46646618011921204,1.2089707153271982,0.21354764638346727,0.5492535203265214,1.0,11/33,19.48%,APOE;CORO1C;PTPN23;ADGRB1;DLL4;SP100;DCN;APOH;ADIPOR1;KRIT1;EVL
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.42077414778409156,1.208917152105497,0.1725997842502697,0.5489570237884888,1.0,9/61,7.85%,IGF1;AKAP13;ALS2;PIK3CB;GPR174;ERBIN;GRB2;CRKL;RASGRP1
prerank,GPI anchor biosynthetic process (GO:0006506),0.4620422287231198,1.208797955027398,0.2130952380952381,0.5488225545445512,1.0,11/30,22.76%,PIGQ;PIGZ;PIGA;PGAP1;PIGN;GPAA1;PIGL;PIGC;PIGX;PIGT;PIGH
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5125450036175498,1.2087564889444327,0.22655298416565164,0.5484690996766762,1.0,7/18,18.85%,ABL2;RIPOR2;DLC1;MYOC;KCTD10;ITGA3;CUL3
prerank,mitochondrion localization (GO:0051646),-0.38642435914974377,-1.2086168283617507,0.17857142857142858,0.6636011117648458,1.0,8/19,16.79%,MEF2A;LRRK2;ATCAY;HAP1;NECTIN2;MSTO1;MARK1;BRAT1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.46575651315882355,1.2082029116965018,0.20412844036697247,0.5496666828424922,1.0,9/29,19.33%,AGO2;ZC3H7B;SNIP1;METTL3;SMAD1;HNRNPA2B1;PUM1;AGO3;ADAR
prerank,regulation of telomere capping (GO:1904353),0.4867766148072724,1.2080418789559595,0.23480333730631706,0.5496741169371343,1.0,12/23,32.57%,PRKCQ;TNKS2;RAD50;PKIB;ATM;RTEL1;MAPK15;MAPK3;PNKP;MAPK1;TERF2;MAP3K4
prerank,Golgi to endosome transport (GO:0006895),0.5223624694553469,1.207885919612809,0.21301020408163265,0.5496324694712423,1.0,4/16,11.08%,VPS13C;CORO7;VPS13A;DOP1B
prerank,regulation of stem cell proliferation (GO:0072091),0.5090405290028911,1.2077286831330578,0.2457516339869281,0.5496192766274559,1.0,7/17,29.67%,PTPRC;FBLN1;HNRNPU;AGO3;TERT;KDM1A;HMGB2
prerank,cellular response to starvation (GO:0009267),0.39744818279304184,1.2070884691287778,0.10414560161779575,0.551045619105405,1.0,50/147,28.13%,TCIRG1;RRAGD;ATG7;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V1B2;ATP6V0D1;CPEB4;ATP6V0B;ATP6V1G1;TFEB;STK24;SIK1;EIF2S1;DAPL1;FADS1;LAMP2;WDR45;DAP;NPRL2;ATP6V1F;MAP1LC3B;NUPR2;HSPA8;FOXO1;MYBBP1A;PRKAG1;RALB;ATP6V0C;XPR1;SREBF1;NPRL3;ATP6V1E1;NIM1K;MAP1LC3A;GABARAP;USP33;LARS1;ATF4;HSPA5;RRAGC;SFRP1;ATP6V0E1;SESN2;LAMTOR3;KLF10;FNIP1;MAPK3;LAMTOR1
prerank,regulation of mitotic nuclear division (GO:0007088),0.42499629883135126,1.2070165868593807,0.18230852211434737,0.5508062836746398,1.0,12/55,18.13%,IGF1;CD28;ANAPC15;FBXO5;CDK13;CCNB1;CUL9;PRMT5;RCC1;NME6;DAPK3;PIN1
prerank,histone H4-K16 acetylation (GO:0043984),0.5062002277631472,1.2069486081816663,0.23106060606060605,0.5505261680998984,1.0,10/19,27.05%,KMT2A;MSL3;ING4;WDR5;OGT;JADE3;KAT7;MSL1;HCFC1;KANSL1
prerank,negative regulation of cell cycle process (GO:0010948),0.42219980298556214,1.2068103644944532,0.19268030139935413,0.5504942670208366,1.0,23/61,26.51%,UXT;WAPL;FBXO5;BRCA1;RNF2;EED;MGA;APAF1;CDC7;NME6;PPP1R10;CBX3;BMI1;YAF2;TERF1;EHMT1;BMP4;RBBP7;E2F6;ZFYVE19;L3MBTL2;PCGF6;ESPL1
prerank,serine family amino acid metabolic process (GO:0009069),0.5184765345557238,1.2067312910377652,0.24744897959183673,0.5502482877460829,1.0,10/16,35.22%,SHMT1;MTHFD1;GLYAT;SARS1;CDO1;SRR;SHMT2;CBS;CTH;SEPSECS
prerank,type I interferon signaling pathway (GO:0060337),0.44231172018843057,1.2061650369407952,0.19550561797752808,0.5509906081760865,1.0,14/41,19.34%,IRF6;IFITM2;IFITM1;IRF8;RNASEL;JAK1;IRF5;SP100;RSAD2;GBP2;ISG20;BST2;ADAR;IFIT2
prerank,cellular response to type I interferon (GO:0071357),0.44231172018843057,1.2061650369407952,0.19550561797752808,0.5509906081760865,1.0,14/41,19.34%,IRF6;IFITM2;IFITM1;IRF8;RNASEL;JAK1;IRF5;SP100;RSAD2;GBP2;ISG20;BST2;ADAR;IFIT2
prerank,defense response to symbiont (GO:0140546),0.40822234265649204,1.2061486209933872,0.14933058702368693,0.5505927520381829,1.0,15/92,9.12%,LYST;BCL2;BCL2L1;FLNA;ATG7;PTPRC;SHFL;MLKL;AGBL5;EXOSC4;IFITM2;PRF1;IFITM1;LILRB1;RNASEL
prerank,regulation of execution phase of apoptosis (GO:1900117),0.563619168912195,1.2058582298216716,0.23119015047879618,0.5510133696427948,1.0,4/11,21.70%,BCL2L1;DLC1;PTGIS;DFFA
prerank,regulation of protein metabolic process (GO:0051246),0.4389866412776514,1.205832629112236,0.2110497237569061,0.5506195710412252,1.0,20/44,29.73%,APOE;PLAUR;GSAP;TRAF3;ABCA7;FURIN;ODC1;WFS1;FAM83D;CHMP6;HSP90AB1;MAPK7;VPS35;PARL;MDM2;MAP2K5;MTPN;FKBP1A;FAF1;SNF8
prerank,modulation by symbiont of host process (GO:0044003),0.5831650596631693,1.2054920869938952,0.24540682414698162,0.5511809354182684,1.0,5/10,11.25%,UBA52;RPS27A;PGK1;B2M;ENO1
prerank,nucleotide-excision repair (GO:0006289),0.40564398199088775,1.2053115382717488,0.14636642784032752,0.5512747269898126,1.0,46/101,32.25%,ERCC6;UBA52;RPS27A;COPS3;ERCC1;COPS8;COPS4;ATXN3;LIG1;POLR2H;POLE;HMGN1;DDB2;DDB1;RNF111;COPS2;XPA;COPS6;SLC30A9;POLR2D;ERCC4;SLX4;PPIE;POLB;RFC1;GTF2H1;UBC;XPC;POLR2F;GTF2H5;RFC2;CUL4A;LIG3;CETN2;POLD4;MNAT1;ERCC8;SIRT1;COPS7A;PNKP;TCEA1;ERCC2;RFC4;EP300;UBB;HUS1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4643668674716302,1.2053035437864397,0.20967741935483872,0.5508442591519491,1.0,12/29,24.63%,FBXW7;UBE2L3;FBXO5;RPS2;LIMK1;SMAD7;DCUN1D2;PIN1;BMI1;DCUN1D4;ARRDC4;DCUN1D3
prerank,COPII vesicle coating (GO:0048208),0.4192979735546778,1.2052973915922205,0.17297297297297298,0.5494926487643614,1.0,17/61,19.21%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;MCFD2;SEC24D;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4192979735546778,1.2052973915922205,0.17297297297297298,0.5494926487643614,1.0,17/61,19.21%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;MCFD2;SEC24D;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,vesicle coating (GO:0006901),0.4192979735546778,1.2052973915922205,0.17297297297297298,0.5494926487643614,1.0,17/61,19.21%,CTSZ;GOSR2;SEC22B;ANKRD28;NAPA;SEC24A;F5;LMAN1;MCFD2;SEC24D;CSNK1D;RAB1A;PPP6C;GRIA1;TBC1D20;CUL3;F8
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.4596725171392503,1.2049641499184394,0.2033898305084746,0.5500419757456125,1.0,11/30,21.82%,ACSBG1;SLC27A5;HACD2;ABCD4;ACSL1;PEX2;ABCD2;HACD1;ABCD3;ELOVL2;ELOVL1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.39530627147211655,1.204890399697284,0.10212335692618807,0.549808345684427,1.0,55/145,30.14%,PSMD8;PSMD1;RAD51B;ODF2;DYNC1H1;PPP2R1A;NINL;BRD4;FBXO5;PSMD6;PSMA1;HAUS8;CCNB1;PSMC3;CEP41;DCTN1;YWHAG;VPS4B;PSMA8;CDK2;PSMD14;PSMD2;CEP250;STOX1;CSNK1D;USP47;PSMC6;CDC7;PSMA6;PLK4;PSMD5;TUBB;RAB11A;PSMA5;HAUS2;CUL1;AVEN;PSMA3;CDK4;CDC25B;PSMB10;PSMB8;PSMD7;PSMB6;PSMD10;CETN2;MAPRE1;PSMB5;PSMB7;PSMC4;CSNK1E;CDC25A;ALMS1;CCND1;CEP57
prerank,extracellular matrix organization (GO:0030198),0.38593572079808025,1.20480190681844,0.041,0.5496301310155236,1.0,83/276,22.20%,SH3PXD2B;LCP1;SPP1;ITGAX;FN1;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;COLGALT1;CAPG;ADAM8;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;BMP1;A2M;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;COL20A1;P3H1;CAPN1;P4HB;CDH1;COL18A1;SCUBE3;COL6A3;COL12A1;CRTAP;ADAMTS14;PLEC;ADAMTSL5;SERPINE1;GSN;SMOC1;ADAMTS2;GAS6;KLKB1;MMP19;DCN;ADAM15;CYP1B1;LAMC1;ITGB2;TIMP2;LAMA5;P4HA3;HSPG2;KDR;FURIN;COL8A2;NF1;COL9A3;ITGA11;SPINK5;BGN;ITGA3;DDR2;CAPNS1;SERPINF2;ECM2;COL16A1;ADAMTSL1;P4HA1;DST;COL9A1;TIMP1;ITGA2B;LAMA4;LAMA3;MMP17;CD47;MMP28;LUM
prerank,ERBB signaling pathway (GO:0038127),0.41773428352076025,1.204188624650548,0.1689691817215728,0.5510289364249198,1.0,14/64,15.17%,IQGAP1;NRG1;PTK2B;NCK2;PDPK1;SOX9;ERBIN;GRB2;ADAM17;MVP;PTPN12;AAMP;CPNE3;CBL
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.43295991295887537,1.204088489087453,0.1883259911894273,0.5508584582121872,1.0,11/45,17.29%,IQGAP1;PTK2B;NCK2;PDPK1;SOX9;ERBIN;GRB2;ADAM17;AAMP;CBL;DGKD
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.44147184133778394,1.2034176719910201,0.20611551528878821,0.5523645609317325,1.0,12/40,20.49%,BCL2;BCL2L1;SLC25A33;VCP;BAX;STOX1;SLC25A36;TUSC2;CCN6;ARL6IP5;STOML2;SPART
prerank,peptidyl-amino acid modification (GO:0018193),0.572161393484014,1.2032974166507409,0.24732620320855614,0.5522708889141422,1.0,2/10,3.55%,ATP7A;APOA2
prerank,protein localization to vacuole (GO:0072665),0.5412227647023186,1.2031131536141688,0.24611398963730569,0.552352733984528,1.0,2/13,7.53%,ATP13A2;RNF128
prerank,regulation of protein processing (GO:0070613),0.49267485750132556,1.2026524107216419,0.22699386503067484,0.5532566193473683,1.0,4/21,10.75%,ADAM8;RUNX1;SERPINE2;CLN3
prerank,nuclear membrane reassembly (GO:0031468),0.4273557552182977,1.2025619886727865,0.18995633187772926,0.5530488143136763,1.0,21/54,29.20%,NUP205;PPP2R1A;CHMP4A;CHMP4B;AHCTF1;LMNA;CCNB1;NUP188;LEMD2;REEP3;CHMP7;RCC1;CHMP6;NUP93;SUMO1;IST1;NUP98;NUP133;NUP35;LBR;ANKLE2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5748430034597685,1.2021467482249484,0.2452054794520548,0.5537841182102053,1.0,2/10,2.55%,UBA52;RPS27A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.40692969127142503,1.2019314890378658,0.15321756894790603,0.5539022624513553,1.0,30/95,24.90%,SDCBP;SNX25;UBA52;RPS27A;CAV1;VEPH1;PDPK1;DAB2;WFIKKN1;ADAM17;NKX2-1;BAMBI;RNF111;SMAD7;ING2;ITGA3;STK11;PIN1;DAND5;FAM89B;UBC;EMILIN1;SPRED2;HSP90AB1;LATS1;TGFBR2;PMEPA1;SPRED3;GIPC1;ASPN
prerank,nucleosome assembly (GO:0006334),0.4633144472542164,1.201884482329689,0.21570926143024619,0.5535693354975887,1.0,17/31,30.37%,GRWD1;CABIN1;DAXX;SOX9;UBN1;CHAF1B;ATRX;NPM1;NAP1L3;ASF1B;ANP32B;HAT1;H3-3A;NASP;RSF1;HMGB2;ASF1A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4752699258698275,1.2018444658848255,0.21618357487922704,0.5532252106253897,1.0,6/24,10.11%,LCK;PTPRC;FGF2;ANXA6;ERO1A;CHERP
prerank,negative regulation of protein catabolic process (GO:0042177),0.44550660613511484,1.2016385685252216,0.21082299887260428,0.5533577728760948,1.0,14/40,22.34%,FLNA;CTSA;RGP1;AZIN1;NELL1;ADGRB1;SF3B3;RIC1;TIMP4;ROCK1;TIMP2;PIN1;TIMP1;SNX12
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.43246613709137716,-1.201444873602574,0.2015810276679842,0.6799538794891458,1.0,2/13,3.31%,CPE;RBPJ
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.531825640233924,1.2010017422168158,0.2342931937172775,0.554732212307489,1.0,9/15,34.17%,CSPG4;DCN;BGN;CHST12;CSPG5;DSEL;DSE;CSGALNACT2;B3GAT3
prerank,adenine nucleotide transport (GO:0051503),0.5057625154210714,1.2008707395231109,0.22095959595959597,0.5546641471999497,1.0,2/17,1.90%,LRRC8C;SLC25A24
prerank,regulation of biosynthetic process (GO:0009889),0.5607154482347716,1.2008384476627416,0.2513020833333333,0.5543035293604064,1.0,5/11,19.05%,SPHK2;SLC25A33;MID1IP1;CCN6;PIKFYVE
prerank,positive regulation of axonogenesis (GO:0050772),0.4378235806038439,1.2008168376797925,0.20763187429854096,0.5539075752636735,1.0,10/43,12.83%,PLXNC1;PLXNA2;MACF1;GOLGA4;AMIGO1;RUFY3;PLXND1;RHOA;LIMK1;CHODL
prerank,ketone body metabolic process (GO:1902224),0.569433390182448,1.2006725145975856,0.24147339699863574,0.5539063018617566,1.0,5/10,15.91%,SLC27A5;OXCT1;AACS;BDH1;ACAT1
prerank,autonomic nervous system development (GO:0048483),0.500407219200003,1.2006709691341124,0.23241206030150754,0.5534562664355109,1.0,3/17,6.37%,FN1;NRP1;GATA3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5040277299216447,1.2005955873726168,0.23896103896103896,0.5532019937860362,1.0,8/17,28.21%,PTPRC;HNRNPU;KAT7;FERMT2;LTBP3;TERT;KDM1A;N4BP2L2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.5640439327468475,1.2004923747226957,0.25268817204301075,0.5530447376378659,1.0,6/10,33.73%,NPPA;PTPN22;PDCD4;DNAJA1;AIDA;DUSP10
prerank,cell projection organization (GO:0030030),0.458145972872078,1.2002709224981647,0.21521997621878716,0.5532172472683349,1.0,10/30,13.01%,PLEK;CAPG;PDGFA;SCIN;RHOQ;RHOG;PARVA;GSN;RHOU;CDC42
prerank,positive regulation of cellular protein localization (GO:1903829),0.41394058657748334,1.2001905494853002,0.18609625668449198,0.5529820816205873,1.0,26/69,27.81%,GPR137B;SNX33;RANGRF;CARD10;FYN;ABCA7;STX3;CEP250;NUMA1;TFRC;SLC5A3;GNL3;KAT7;TESK1;ORMDL3;FERMT2;GSK3B;HSP90AB1;MARK4;CCDC88A;TNF;TRAPPC12;VPS28;SESN2;STX4;PARD6A
prerank,receptor internalization (GO:0031623),0.4391335346986538,1.2001836422883447,0.20689655172413793,0.5525645357622971,1.0,13/44,16.06%,CD9;LRP1;CXCR2;CAV1;GRB2;SAG;LILRB1;DNM2;RAB5A;SCYL2;ITGB2;TFRC;SYK
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5707469592197607,1.1997556667965648,0.24233983286908078,0.5533960867173705,1.0,8/10,36.04%,NCK1;JUN;DNAJB1;VHL;BAG3;SIRT2;HIF1AN;IMPACT
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.405604430028244,1.1996888649202806,0.16422594142259414,0.5531455904738684,1.0,34/83,30.07%,CDK14;CDK18;CDK6;CDK5;BRD4;PLK2;FBXO5;POLE;E2F3;CDK17;NPAT;CDK2;RCC1;CDC7;PPP6C;CDKN3;GSPT1;CUL3;CDK16;DBF4;CUL1;CDC34;CUL2;LATS1;KLF11;PLK3;CDK4;CUL4A;EIF4E;NASP;MNAT1;HINFP;CDC25A;CCND1
prerank,positive regulation of protein polymerization (GO:0032273),-0.29085223232498053,-1.1993689520331257,0.13043478260869565,0.6815751578154624,1.0,8/65,6.86%,NAV3;FCHSD2;BIN1;PRKCE;FER;CARMIL1;NCKAP1;CDC42EP4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.45402153703754744,1.19897229802413,0.21824480369515012,0.5547882918089759,1.0,2/31,0.62%,GPNMB;CDK6
prerank,regulation of protein localization (GO:0032880),0.41761518758954513,1.198652565988866,0.20106951871657755,0.5552955624018477,1.0,24/58,29.50%,PLEKHM2;CTSD;TRIM6;FBXW7;STX6;TRIM67;RACK1;SLC26A4;TPR;VIP;AFDN;TESK1;HSP90AB1;TRIM21;SUMO1;USP8;RAB9A;KDM1A;UFL1;DNAJB6;MMD2;FKBP1A;CSNK1E;TRIM68
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4329814549834302,1.1986043027823912,0.19308035714285715,0.554991183897504,1.0,7/46,5.65%,IGF1;CTNNB1;PTGIR;ID2;NR4A3;PPARG;ELN
prerank,cation transport (GO:0006812),0.3899161091728727,1.1985848994324126,0.12072434607645875,0.5545971875243575,1.0,38/167,18.13%,FGF13;SLC3A2;SLC6A6;KCNN4;SGK1;SLC7A1;SLC23A1;SLC5A1;PANX3;SLC6A14;SCN4A;SLC36A4;PANX1;PIEZO1;KCNA3;SLC36A3;KCNJ2;KCNMA1;SLC22A3;PIEZO2;ATP1A4;SLC7A6;KCNA4;CLN3;KCNMB4;CNGB1;KCNJ10;SLC8B1;TRPM7;ATP1A2;CHP1;SCN3B;SLC7A8;SLC18A2;NDUFA9;SLC38A7;ANO6;KCNC4
prerank,embryonic skeletal system development (GO:0048706),0.4522679653688696,1.1982825667348616,0.23024830699774265,0.5550827306021513,1.0,4/35,3.75%,XYLT1;KIAA1217;DEAF1;HOXA4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5047224179684642,1.1981579843416603,0.2121982210927573,0.5550045877645712,1.0,6/17,16.05%,FGF2;NRP1;VEGFA;SRF;EFNB2;KDR
prerank,toxin transport (GO:1901998),0.5763075557891155,1.1979541225525272,0.2619047619047619,0.555142642873394,1.0,2/10,6.71%,ANTXR2;SLC22A3
prerank,neuron remodeling (GO:0016322),-0.4658513433320547,-1.1978522188044958,0.20078740157480315,0.6816484699417895,1.0,4/10,8.25%,ADGRB3;ANKS1A;FARP2;APP
prerank,synaptic vesicle exocytosis (GO:0016079),-0.30252104702878824,-1.1977037403201722,0.12727272727272726,0.677880877850622,1.0,10/40,8.11%,SNAP25;CPLX1;SYT10;RIMS1;RAB3A;SNAPIN;UNC13B;SYT1;SYT2;RIMS2
prerank,regulation of complement activation (GO:0030449),0.44040323854498664,1.1976585440818315,0.21630804077010193,0.5555672395041561,1.0,14/40,27.21%,C4BPA;C4BPB;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L;SUSD4;C2
prerank,sterol biosynthetic process (GO:0016126),-0.3393437894592658,-1.1976192921375532,0.17164179104477612,0.6738861298680401,1.0,13/33,18.12%,IDI1;DHCR7;HMGCS1;SC5D;INSIG1;NSDHL;MVK;INSIG2;FDPS;LSS;SQLE;HMGCR;GGPS1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.506988225400445,1.1973337050285846,0.2393681652490887,0.5560907791931983,1.0,6/17,18.13%,IGF1;APOE;ABCA7;ROCK1;CLU;PIN1
prerank,regulation of mRNA metabolic process (GO:1903311),0.5668822756674381,1.1970293060640145,0.2590027700831025,0.5565394314660517,1.0,7/11,28.93%,SRPK1;CDK11B;SAFB2;DHX9;SRPK2;SLTM;SAFB
prerank,striated muscle tissue development (GO:0014706),-0.3386688208919257,-1.1966209035308564,0.15217391304347827,0.6725920566300823,1.0,6/29,8.85%,MEF2C;SGCZ;SGCD;ZBTB18;MYH14;PGM5
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.46203642606313794,1.1962936061217286,0.23809523809523808,0.5583264727806816,1.0,8/29,17.13%,TSR1;RPS14;KRI1;BMS1;UTP20;RPS19;RPS16;UTP4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5660560897964574,1.1961946635731604,0.2383638928067701,0.5581368534899801,1.0,3/11,9.42%,HIF1A;NR4A3;RACK1
prerank,phospholipid catabolic process (GO:0009395),0.4826704743601057,1.195935569578431,0.23190184049079754,0.5584539254587426,1.0,8/24,19.75%,GDPD3;PRDX6;APOA2;ABHD12;SMPD4;SMPD1;PNPLA6;PLBD2
prerank,monoacylglycerol metabolic process (GO:0046462),0.5352709299102636,1.195854088748362,0.24206349206349206,0.5582366262197276,1.0,2/13,5.88%,ABHD12;MGLL
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.38641215150472213,1.1958392735240886,0.10452261306532663,0.5578320317704515,1.0,58/186,27.96%,DKK2;APOE;LRP1;CCDC88C;PSMD8;PSMD1;SOX30;BICC1;PRICKLE1;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;ZNRF3;PSMD6;PSMA1;MDFI;RACK1;SFRP5;PSMC3;PSMA8;TLE5;PSMD14;FZD4;SCYL2;PSMD2;DDIT3;LRP6;PSMC6;PSMA6;LZTS2;PSMD5;NLK;STK11;PSMA5;CUL3;FRMD8;TPBG;GSK3B;LATS1;PSMA3;TRABD2B;WWOX;PSMB10;SFRP1;MDK;PSMB8;PSMD7;PSMB6;PSMD10;GSK3A;DACT1;PSMB5;RUVBL2;PSMB7
prerank,mitochondrial translation (GO:0032543),0.3991334101500337,1.1957098318626822,0.1403688524590164,0.5577629545846771,1.0,42/104,28.60%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;LARS2;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MTRF1L;MRPL12;EARS2;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MTRF1;GATB;MRPS22;MRPS28;MRPS35;GFM2;MRPL19;MRPL15;MRPS27;MRPS30;MRPS14;MRPL1;MRPL37;MRPL18;FASTKD2;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42;RARS2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5283872420892683,1.1957004440995793,0.2516914749661705,0.5573446623947849,1.0,9/14,31.97%,TNKS2;ATRX;ACD;TPP1;TERT;TERF2IP;ATR;XRCC5;TERF2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5171877090986846,1.195509000671701,0.2461734693877551,0.5570001562394441,1.0,4/15,16.11%,AGO2;PABPC1;CPEB3;DHX36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5171877090986846,1.195509000671701,0.2461734693877551,0.5570001562394441,1.0,4/15,16.11%,AGO2;PABPC1;CPEB3;DHX36
prerank,negative regulation of cellular component movement (GO:0051271),0.5207224166554263,1.1954797468451417,0.25902061855670105,0.5566479512586043,1.0,7/15,22.39%,CD9;GATA3;ACTN1;FBLN1;SP100;PIN1;WAS
prerank,macroautophagy (GO:0016236),0.3909917189130386,1.1948483473956446,0.14720812182741116,0.5580610060452079,1.0,36/118,22.93%,TECPR1;TCIRG1;ATG7;TOMM22;ATP13A2;PLEKHM1;SQSTM1;ARL8B;CHMP4A;CHMP4B;LIX1;LAMP2;LIX1L;PLAA;VCP;CLN3;VTA1;VPS4B;MTMR14;MAP1LC3B;ILRUN;STAM2;TOMM5;MVB12A;UBQLN1;TOMM40;VIPAS39;ATG16L1;PRKAG1;CSNK2A2;CHMP6;VPS39;UBXN6;MAP1LC3A;GABARAP;ACBD5
prerank,purine ribonucleotide transport (GO:0015868),0.5095254222719144,1.194363665812477,0.23943661971830985,0.5590440204219459,1.0,2/16,1.90%,LRRC8C;SLC25A24
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4521921318164864,1.1941649282669902,0.22863741339491916,0.5592031465411861,1.0,12/31,27.34%,BCL2;GZMB;BID;BAX;YWHAG;HIP1R;YWHAB;PPP3CC;GSK3B;PPP3R1;YWHAZ;GSK3A
prerank,response to glucocorticoid (GO:0051384),0.47169589622333835,1.194068146483196,0.24162679425837322,0.5590235906275607,1.0,7/26,24.21%,ANXA1;BCL2L11;UBE2L3;HNRNPU;IL6;NR3C1;TNF
prerank,photoreceptor cell development (GO:0042461),0.5262289511013005,1.1939457501530573,0.26648721399730824,0.5588979708563261,1.0,5/14,28.01%,TH;VEGFA;DCX;MYO7A;ARL3
prerank,synaptic vesicle transport (GO:0048489),0.5556760805095478,1.1938026482812218,0.2543507362784471,0.5588789538102531,1.0,3/11,10.64%,CDK5;TMEM230;DNM2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.4332959186895238,1.1937772997566425,0.21724524076147816,0.5585061138183696,1.0,12/44,17.12%,APOE;PIK3CB;NPPA;PRKCD;PTPN22;CD300A;PAQR3;SPRY4;STK38;NF1;SMPD1;PDCD4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.515372634759591,1.1934296667942899,0.2579013906447535,0.5590283386957333,1.0,5/16,19.95%,BCL2L1;TPT1;CLU;CCAR2;RPS3
prerank,positive regulation of apoptotic process (GO:0043065),0.3804877721701586,1.1933989915666205,0.054,0.5586900046221175,1.0,102/293,25.50%,CTNNB1;ABR;CTSD;ATG7;GNA13;UBA52;RPS27A;SPHK2;AKAP13;PTPA;RPS6;SCIN;HRG;GZMA;DUSP9;MTCH1;SQSTM1;CDK5;BID;BCL6;KCNMA1;STK3;SIK1;ING4;HTT;DLC1;TFPT;BCL2L11;PSEN2;DIABLO;LILRB1;RACK1;BAX;IAPP;UTP11;ARHGEF1;DNM2;SUDS3;DUSP6;JUN;TCTN3;IRF5;ARHGEF18;TLE5;TFAP4;MTCH2;DDIT3;CLU;CYP1B1;HSPD1;DAPK1;ARHGEF11;ING3;APAF1;PRMT2;C1QBP;FOXO1;BARD1;KALRN;NF1;ING5;SMPD1;MYBBP1A;RPS6KA2;HIP1R;DAPK3;ANO6;ATM;IL6;ARL6IP5;CCAR2;CCAR1;AIFM2;CASP9;IFIT2;ARHGEF2;PTGIS;UBC;RPS3;HMGB1;CRADD;CTNNBL1;SRPK2;TNFSF10;BMP4;MELK;PLEKHG2;LATS1;KLF11;ARHGEF5;ADAMTSL4;DNAJA1;VAV3;BNIP3;TNF;ATF4;GADD45A;DCUN1D3;RRP1B;SFRP1;VAV1;CSRNP3
prerank,cardiac muscle cell differentiation (GO:0055007),0.49312575054085417,1.1932953248566567,0.23886138613861385,0.5585497639658659,1.0,5/21,7.00%,AKAP13;NRG1;SHOX2;SIK1;VEGFA
prerank,protein-DNA complex disassembly (GO:0032986),0.5121811161434904,1.1932726443832242,0.24528301886792453,0.5581743214776144,1.0,10/16,35.08%,GRWD1;RPL23;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4;SET;NFE2;MYC
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4804480561502007,1.1928293602549944,0.23592814371257484,0.5590435655889642,1.0,5/25,10.04%,FGF13;TBX18;CAV1;RANGRF;JUP
prerank,inositol phosphate metabolic process (GO:0043647),-0.30586889058639316,-1.192128552682562,0.13186813186813187,0.6815223253189733,1.0,16/46,16.99%,INPP5D;INPP4B;PLD4;PLCB1;PLCG2;IP6K1;INPP5J;ITPK1;IPPK;INPP1;PPIP5K2;NUDT11;PLCE1;INPP5B;ITPKA;IMPA2
prerank,regulation of cell cycle (GO:0051726),0.3807412472798345,1.1921231629475144,0.07107107107107107,0.5606214354692541,1.0,80/271,25.33%,APBB2;IQGAP1;CDK6;SDCBP;PTPRC;FBXL17;ADARB1;MYBL2;PPP1R9B;FIGNL1;ID2;IRF6;TTLL12;CDK5;RPL23;GATA3;SIK1;ERN1;SOX9;NUDT6;WDR12;ING4;EIF4G2;FBXO5;GMNN;LILRB1;SON;DYNLT3;RACK1;CCNB1;METTL3;BRCA1;JUN;BAP1;PRCC;CDK11B;NUPR2;TFAP4;BIRC5;LRP6;BARD1;PUM1;MYBBP1A;RPS6KA2;PDCD4;CDKN3;HNRNPU;STK11;DAPK3;CDC26;NEK6;ATM;FBXL6;RNF167;CSNK2A2;TAF6;TARDBP;RNF20;TBRG1;HSP90AB1;RUNX3;CKS2;SRPK2;BMP4;SND1;SETMAR;CDC123;TRIM21;CALR;PPP1R15A;MIF;FGFR2;MDM2;SIPA1;BIRC2;GADD45A;DCUN1D3;CDK4;SFRP1;MAPK12
prerank,female gamete generation (GO:0007292),0.4542882904366027,1.1920927309254818,0.23176470588235293,0.5602525095631152,1.0,11/29,25.28%,PIWIL2;USP9X;M1AP;METTL3;DMC1;PRDM9;TRIP13;MCM8;KMT2D;MEI4;MDK
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.408350559690434,1.1915242594197568,0.18843683083511778,0.5614970891413337,1.0,16/75,16.05%,HIF1A;NRP2;FGF2;NRP1;ITGA4;MYDGF;PDPK1;VEGFA;ADAM17;HMOX1;NRAS;ECM1;EGFL7;PRKD2;VIP;KDR
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4443927768482793,-1.1909096543706754,0.2289156626506024,0.680890425965298,1.0,4/12,10.61%,DOCK4;MEF2C;IGFBP5;FGF9
prerank,organophosphate catabolic process (GO:0046434),0.5607296269539442,1.190558500391839,0.25651577503429357,0.5639444122153319,1.0,3/11,4.27%,APOA2;PON1;ABHD12
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.4661016845164699,-1.1905344183768112,0.23553719008264462,0.6778805813662941,1.0,7/10,32.68%,ABCA3;MTMR9;MTMR4;PHB2;MTMR2;MTMR3;GNB3
prerank,cAMP metabolic process (GO:0046058),0.5302519388371499,1.1904343895084053,0.2733245729303548,0.5638958142423548,1.0,3/13,4.20%,ADCY8;ADCY3;ADCY7
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4012120237949274,1.1903186356421143,0.16132368148914167,0.5637998241285189,1.0,12/95,7.19%,XYLT1;CHST11;CSPG4;B4GALT5;HS3ST3B1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;SLC35D2;ANGPT1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.36746738504312726,-1.1898863904777977,0.208955223880597,0.6756068218782003,1.0,3/20,6.81%,ST3GAL6;B3GALT5;B3GALT1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.39252941758104226,1.189715141415675,0.1381048387096774,0.5651317494015937,1.0,38/149,20.44%,RAB7B;S100A8;S100A9;PRKCH;IL18R1;LTF;PRKCQ;IL18RAP;MALT1;UBA52;IRAK2;TRAF2;RPS27A;ADAM8;TRIM6;SPHK1;CAV1;TAB1;PRKCB;FLOT2;TICAM1;TRAF1;PPIA;NFKB1;PRKD2;CLU;PSMA6;TFRC;TIRAP;RIPK3;DHX33;IL6;DHX9;ARHGEF2;UBC;RPS3;MTDH;RIPK4
prerank,negative regulation of phosphatase activity (GO:0010923),0.4736060094642322,1.1896135532307153,0.24557260920897284,0.5650148557031207,1.0,10/25,29.06%,PTPA;ZCCHC9;PPP1R35;BOD1L1;SH2D4A;CHP1;GSK3B;PPP1R15A;FKBP1B;FKBP1A
prerank,cGMP-mediated signaling (GO:0019934),0.5367406293951086,1.189552147642159,0.2582781456953642,0.5647384170033144,1.0,2/13,3.59%,APOE;NPPA
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4392385508319772,1.1894232832981093,0.22360953461975028,0.5646805638886048,1.0,7/38,9.75%,DAG1;XDH;PIK3CB;PPP2R5C;PLEKHA1;RACK1;SFRP5
prerank,protein deubiquitination (GO:0016579),0.38345213518298865,1.1893334802381441,0.07607607607607608,0.5645114073829046,1.0,108/242,32.24%,HIF1A;PSMD8;PSMD1;UBA52;TRAF2;RPS27A;TNIP1;JOSD1;TRAF3;OTULIN;SIAH2;USP12;GATA3;RNF128;OTUD4;TFPT;ATXN3;TAB1;TNIP3;USP9X;PSMD6;PSMA1;DDB2;VCP;ABRAXAS1;PSMC3;USP5;ASXL2;BRCA1;SUDS3;BAP1;PSMA8;RHOA;TNIP2;MYSM1;SMAD7;STAM2;OGT;SMAD1;USP40;PSMD14;YY1;PSMD2;ACTB;INO80;ASXL1;USP47;PSMC6;BARD1;PSMA6;POLB;PSMD5;PSMA5;UIMC1;USP18;USP46;DESI2;UBC;USP28;USP36;WDR48;USP14;USP33;PSMA3;OTUD1;USP50;USP2;MDM2;USP8;BIRC2;PSMB10;PSMB8;PSMD7;USP1;USP32;PSMB6;OTUD5;HCFC1;BRCC3;USP19;KEAP1;PSMD10;PSMB5;TNFAIP3;RIPK1;STAMBP;USP42;PSMB7;USP30;USP34;PSMC4;CDC25A;USP13;SKP2;BECN1;PTEN;USP48;SHMT2;MINDY2;STAMBPL1;PSMD12;EP300;ACTR8;USP15;USP38;PSMD3;ZC3H12A;UBB
prerank,response to molecule of bacterial origin (GO:0002237),0.40681336111747113,1.189303380126719,0.1896186440677966,0.564162343271503,1.0,28/69,29.67%,S100A8;S100A9;CD24;TRIM6;CD6;CYP27B1;PTPN22;ERBIN;NOCT;MAPKAPK3;ADAM17;MAPKAPK2;IRF5;ACOD1;TIRAP;IL6;SLC11A1;LBP;F2R;JAK2;TLR9;OTUD5;PELI1;SRR;TNFAIP3;PRDX3;TAB2;HMGB2
prerank,tyrosine metabolic process (GO:0006570),0.5504558647342035,1.1892983519633886,0.27323162274618584,0.5637378128778775,1.0,1/11,3.76%,TH
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39488785938641413,1.1892530705492164,0.1395112016293279,0.5634298769771355,1.0,51/124,31.41%,CTNNB1;CCDC88C;PSMD8;PSMD1;LEF1;AGO2;DAAM1;PRICKLE1;PLCB2;PSMD6;PSMA1;SFRP5;PSMC3;PSMA8;RHOA;PDE6B;FZD1;CDC42;CELSR1;PSMD14;FZD4;PSMD2;PSMC6;PSMA6;PSMD5;NLK;PSMA5;GNB1;AGO3;PFN1;PSMA3;PPP3R1;PSMB10;SFRP1;PSMB8;PSMD7;VANGL1;PSMB6;PDE6G;PSMD10;PSMB5;PARD6A;PSMB7;ARHGEF19;PSMC4;CELSR2;PLCB3;FRZB;CELSR3;PSMD12;CALM1
prerank,positive regulation of programmed cell death (GO:0043068),0.37950685857698874,1.1889982735858773,0.074,0.5637319752287134,1.0,98/272,25.50%,CTNNB1;ABR;CTSD;ATG7;GNA13;UBA52;RPS27A;SPHK2;AKAP13;PTPA;RPS6;SCIN;HRG;GZMA;DUSP9;MTCH1;SQSTM1;BID;BCL6;KCNMA1;STK3;ING4;HTT;TFPT;BCL2L11;PRF1;PSEN2;DIABLO;LILRB1;RACK1;BAX;IAPP;UTP11;ARHGEF1;DNM2;SUDS3;DUSP6;JUN;TCTN3;IRF5;ARHGEF18;TFAP4;MTCH2;CLU;CYP1B1;HSPD1;DAPK1;ARHGEF11;ING3;APAF1;PRMT2;C1QBP;FOXO1;BARD1;HTATIP2;SYK;KALRN;NF1;ING5;SMPD1;RPS6KA2;HIP1R;DAPK3;ANO6;ATM;IL6;ARL6IP5;CCAR2;CCAR1;AIFM2;CASP9;IFIT2;ARHGEF2;UBC;HMGB1;CRADD;CTNNBL1;LAPTM5;MARK4;TNFSF10;BMP4;MELK;PLEKHG2;LATS1;KLF11;ARHGEF5;ADAMTSL4;DNAJA1;VAV3;BNIP3;TNF;ATF4;GADD45A;DCUN1D3;RRP1B;SFRP1;VAV1;CSRNP3
prerank,tRNA wobble uridine modification (GO:0002098),0.5270128552501637,1.1888432014214965,0.25,0.5637765599766039,1.0,12/14,39.60%,KTI12;ELP3;TRMU;GTPBP3;MOCS3;ALKBH8;ELP1;DPH3;MTO1;CTU1;URM1;CTU2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.42890861879823416,1.1888001460947,0.22063666300768386,0.5634509697942626,1.0,17/48,24.91%,SLC26A1;ADCY8;ADCY3;NPPA;ADCY7;AMPD2;NPR2;PPCS;AK5;ACAT1;ADSS1;NPPC;COASY;NUDT2;ADCY10;SLC35B3;ADSL
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4342825068784571,1.1887823331957696,0.22737556561085973,0.5630637205461918,1.0,21/42,32.07%,ERCC6;HDAC1;CHD3;HNRNPC;SMARCB1;GATAD2B;ACTR6;SMARCC1;ACTB;INO80;SRCAP;ARID1B;VPS72;SMARCD2;HDAC2;SMARCA4;NASP;PBRM1;ACTR8;DMAP1;ANP32E
prerank,regulation of macrophage differentiation (GO:0045649),0.5187207610549625,1.1885658981803329,0.2467700258397933,0.5633022465199341,1.0,3/15,9.40%,CSF1;ID2;PTPN2
prerank,nuclear envelope organization (GO:0006998),0.4884385422844292,1.1881356193513206,0.2670807453416149,0.5641165421749964,1.0,9/20,33.11%,CTDNEP1;LEMD2;REEP3;SUN1;NUP93;TOR1B;SPAG4;TMEM43;NEMP1
prerank,glial cell differentiation (GO:0010001),-0.350087935120964,-1.1881260388041694,0.1566265060240964,0.6761655054923219,1.0,11/28,15.15%,FGF10;SLC8A3;SOX8;ADGRG6;STAT3;CDH2;ERBB3;PAX2;GPC1;NFIB;TPPP
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.516748880445566,1.1879560459631375,0.24740932642487046,0.5641972309660458,1.0,7/15,24.21%,HIF1A;CD6;TICAM1;IL6;IL17RA;IL17D;TNF
prerank,cell-cell junction assembly (GO:0007043),0.416417298342228,1.1878616191199232,0.1824973319103522,0.5640378439972658,1.0,17/63,18.60%,CTNNB1;CD9;TLN1;GJB2;PKP1;PKP4;ACTG1;JUP;PIP5K1C;RHOA;SMAD7;PKN2;PAK2;ACTB;PKP2;PATJ;GJB6
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3863636860938159,1.1877452201287206,0.1231079717457114,0.5639311035735503,1.0,29/150,11.66%,OSBPL8;LCK;P2RX4;GCNT2;ADAM8;PDGFA;PIK3CB;AXL;FAM110C;NRG1;FGF2;CD28;MFHAS1;MYDGF;PIK3R5;PDPK1;TRAT1;GATA3;GRB2;ANGPT1;IGF1R;KITLG;FGF7;IAPP;HIP1;FYN;MYOC;RHOG;FGF20
prerank,positive regulation of protein localization to membrane (GO:1905477),0.39249796807535986,1.1876978463223031,0.18275154004106775,0.5636484159165045,1.0,24/98,19.26%,LGALS3;BCL2;PRKCH;LRP1;GZMB;SQSTM1;BID;PDPK1;TREM2;STAC2;RANGRF;FYN;RHOG;YWHAG;STX3;SORBS1;ITGB2;CHP1;CNPY4;ITGA3;SLC5A3;YWHAB;PPP3CC;ITGB1BP1
prerank,negative regulation of protein modification process (GO:0031400),0.4030614369092221,1.1875424235738683,0.189873417721519,0.5636436074452555,1.0,30/79,27.07%,CORO1C;SIRPA;XDH;PTPA;MFHAS1;PLPP3;CRKL;P3H1;CADM4;CRTAP;FBLN1;PAQR3;PTPN13;PPIA;LRP6;PPP1R15B;CHP1;MYADM;YWHAB;TARDBP;GSK3B;FXYD1;PPP1R15A;ZBED3;DNAJC10;PPP1R8;PRR5L;TRAF3IP1;CDYL;TERF2IP
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5476976053553192,1.187488000115049,0.27459016393442626,0.5633671259416327,1.0,6/11,18.76%,PRKCD;STK24;DIABLO;CYP1B1;GSKIP;ARL6IP5
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.41901897792784515,-1.1869460735437696,0.2288135593220339,0.6754698917125204,1.0,9/15,24.79%,IL16;F3;NTRK3;CDH13;VEGFD;F7;VEGFC;CXCL12;PGF
prerank,response to reactive oxygen species (GO:0000302),0.4231122860193415,1.1869274617013081,0.21871599564744287,0.5645805959178545,1.0,23/54,29.22%,APOE;HIF1A;PRDX5;MMP9;STK24;HP;AGAP3;HMOX1;FYN;JUN;MAPK9;CAT;GLRX2;RPS3;SOD2;PLK3;PDGFRA;NCF1;GPX1;MAPK3;PRDX3;APTX;SIRT1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5483929446521058,1.1864917593152886,0.2641770401106501,0.5653050258878031,1.0,8/11,38.94%,PRDX5;PRDX1;CAT;GPX1;PRDX3;PXDNL;GPX3;PXDN
prerank,canonical Wnt signaling pathway (GO:0060070),0.40902815216258837,1.186027752834088,0.2118279569892473,0.566231424133141,1.0,15/68,15.88%,CTNNB1;TCF7;LEF1;CAV1;GATA3;PLPP3;WNT6;SFRP5;RAB5A;FRAT1;FZD1;FZD4;SCYL2;LRP6;NR4A2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5245286938114648,1.1858058029522307,0.26973684210526316,0.5664591540282571,1.0,6/13,22.67%,CSPG4;HEXA;DCN;BGN;IDUA;CSPG5
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3931805952708261,1.185733738522884,0.16475495307612095,0.5662249605953052,1.0,32/93,27.99%,BCAR3;FNIP2;EIF4G1;CD44;TRIM6;RAF1;CAV1;NCK2;NCK1;VEGFA;RACK1;PAQR3;CNKSR3;SMAD7;GAS6;STOX1;PRKD2;DOCK7;TFRC;HAX1;IL6;SH2D3C;HSP90AB1;LATS1;MIF;TNF;TXN;NSD1;TERF2IP;TBK1;CREBL2;FNIP1
prerank,protein kinase A signaling (GO:0010737),0.5443298172072971,1.1848603159429867,0.280794701986755,0.5683681596138028,1.0,1/12,0.30%,LCP1
prerank,regulation of cell cycle process (GO:0010564),0.39387341621915717,1.184822582453728,0.16973415132924335,0.5680430461623877,1.0,38/104,27.41%,CTNNB1;BCL2L1;DYNC1H1;SOX9;PLK2;FBXO5;AHCTF1;CDK13;CUL9;KLHL13;PRMT5;ATF5;BIRC6;CDC42;KIF20A;GIT1;CEP250;NUMA1;RCC1;YTHDF2;RACGAP1;PLK4;RAB11A;DAPK3;PIN1;CSNK2A2;DBF4;RAB11FIP4;MARK4;SND1;CALM3;PLK3;DCUN1D3;SFRP1;KLHL21;USP19;CETN2;PRPF40A
prerank,RNA processing (GO:0006396),0.38494047044170626,1.184694247333881,0.11534603811434303,0.5679742694432413,1.0,73/176,28.79%,APOBEC1;SNRNP35;ADARB1;DEDD2;SRPK1;PPP1R9B;HNRNPUL1;PPP2R1A;ZRSR2;PIWIL2;SF3B3;THOC1;CELF1;XRN2;ATXN1;DDX17;HNRNPC;SON;RNASEL;PABPN1;M1AP;METTL3;SRSF11;RBPMS;PRPF4;SRSF7;HNRNPK;DDX39B;LSM6;HNRNPA2B1;SYNCRIP;DUSP11;RBM39;PRPF6;HNRNPU;HNRNPF;KIN;SNRNP40;CCAR2;ZMAT5;SRSF2;ADAR;TARDBP;PPIG;PRPF8;USB1;SMU1;SRPK2;PABPC4;DKC1;SF3A3;LSM4;RBMS2;SRRM1;FASTKD5;SNRPG;SF3B2;SF3B1;KHSRP;HNRNPL;SNRPF;RRAGC;GEMIN2;LSM3;MTPAP;FASTKD2;NOL3;SUPT4H1;FUS;SRSF1;NUDT21;WBP4;TENT4B
prerank,cellular response to heat (GO:0034605),0.4435615486459295,1.1846102986470408,0.20527522935779816,0.5677962641625286,1.0,16/35,28.76%,DAXX;ATXN3;VCP;HMOX1;POLR2D;TPR;DHX36;HSF1;HSP90AB1;RBBP7;SUMO1;BAG3;TCIM;FGF1;ZFAND1;IER5
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.5473998105531868,1.1845542243768952,0.2697095435684647,0.567528145952876,1.0,3/11,13.36%,IGF1;IGF1R;GHR
prerank,positive regulation of cartilage development (GO:0061036),0.4953584070795475,1.184133175796973,0.24461343472750316,0.5683528888816671,1.0,5/17,12.90%,GDF6;BMP1;SOX9;PKDCC;ZBTB16
prerank,retinoic acid metabolic process (GO:0042573),-0.4173915765334988,-1.1838586580919563,0.24669603524229075,0.680056838750811,1.0,9/14,29.09%,BCO2;CYP26C1;ALDH1A2;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.49244507752663164,1.1837556455982252,0.2503037667071689,0.5690225498928462,1.0,7/19,18.13%,IGF1;APOE;FLOT2;ABCA7;ROCK1;CLU;PIN1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4157183174622886,1.1836439499119018,0.20562770562770563,0.5689227026345933,1.0,20/55,24.68%,CSPG4;GALNS;SLC9A1;GNS;CD44;FGF2;HEXA;GLB1;GUSB;FUCA1;DCN;HSPG2;CHP1;BGN;IDUA;SDC3;LUM;CSPG5;OGN;SDC4
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41923171906347423,1.18348913487084,0.21516164994425863,0.5689522962067746,1.0,13/48,15.63%,IL18R1;CD226;CD2;IL27;IL12RB1;PTPN22;TXK;RASGRP1;LILRB1;CRTAM;CCR2;HSPD1;CEBPG
prerank,histone H4 acetylation (GO:0043967),0.42786276701165304,1.1832836957934398,0.22234273318872017,0.5691032032144909,1.0,22/47,28.98%,KMT2A;LEF1;MSL3;ING4;TRIM16;WDR5;OGT;ING3;CHD5;ING5;JADE3;KAT7;EP400;MORF4L1;MSL1;ZZZ3;HAT1;HCFC1;MORF4L2;KANSL1;RUVBL2;BRD8
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5617317213825568,1.1831128758626475,0.2766531713900135,0.569159213364319,1.0,4/10,17.34%,HK1;PFKL;PFKP;HK3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4467421450844075,1.1830746700122399,0.2402745995423341,0.5688461464836218,1.0,10/33,19.95%,SIRPA;NFE2L2;ANXA1;MAPK13;PRKCD;PLEKHA1;CYP1B1;RIPK3;IL6;RPS3
prerank,mitotic recombination (GO:0006312),0.5135301366752939,1.1828708709911182,0.2608695652173913,0.5690303783349989,1.0,7/15,24.69%,NSMCE2;ERCC1;RAD50;DMC1;TPRKB;GEN1;SMC6
prerank,hyaluronan metabolic process (GO:0030212),0.47243912828488355,1.1827796649088023,0.24150485436893204,0.5688404374756812,1.0,6/23,16.12%,SLC9A1;CD44;FGF2;HEXA;GUSB;CHP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5389008028376837,1.182763676453081,0.26258503401360545,0.5684550144851562,1.0,4/11,13.08%,MUC1;ING4;SP100;TFAP4
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4928106343946303,1.1825241555726844,0.2515802781289507,0.5687022523061102,1.0,6/18,21.58%,DOCK2;FER1L5;SYK;SBNO2;FCER1G;LBP
prerank,negative regulation of type I interferon production (GO:0032480),0.43772597377221883,1.1824964773109377,0.2242152466367713,0.5683502314460732,1.0,18/40,27.73%,SIRPA;NLRC3;RNF125;IKBKE;LILRB1;ILRUN;YY1;UBE2L6;ACOD1;PIN1;HAVCR2;NLRC5;RNF216;REL;TRAF3IP1;OTUD5;TBK1;TNFAIP3
prerank,mitochondrial translational elongation (GO:0070125),0.39880811624120105,1.1816250530959203,0.17440660474716202,0.5705099534588777,1.0,35/88,28.45%,MRPS12;MRPL47;MRPL51;MRPL4;MRPL23;MRPL21;CHCHD1;MRPL52;MRPL17;MRPS15;MRPL24;DAP3;MRPL12;MRPS33;MRPS16;MRPS7;MRPL53;MRPL11;MRPS22;MRPS28;MRPS35;GFM2;MRPL19;MRPL15;MRPS27;MRPS30;MRPS14;MRPL1;MRPL37;MRPL18;MRPL39;MRPL41;MRPL27;MRPL33;MRPL42
prerank,regulation of transmembrane transport (GO:0034762),0.4519235202028667,1.181418918456005,0.25879682179341656,0.5707270679484672,1.0,7/31,14.00%,BCL2;SLC2A1;KCNJ2;PRKCB;PIM1;KCNJ10;ACTB
prerank,regulation of cell adhesion (GO:0030155),0.3875467081872011,1.1813213873990083,0.14300202839756593,0.5705957552771364,1.0,31/129,17.07%,PLAU;PLXNC1;ABL2;CYTH1;PLXNA2;SPN;ADAM8;HRG;PKP4;RIPOR2;PTK2B;PPP2R1A;VEGFA;ANGPT1;PPP1R12A;RHOD;ATXN3;P4HB;PLXND1;CCL5;FBLN1;CHRD;EFNA1;ROCK1;STX3;PRKD2;YTHDF2;C1QBP;RASA1;MYADM;MINK1
prerank,regulation of lymphocyte migration (GO:2000401),0.554838567803842,1.1810682168320297,0.2692307692307692,0.5708924446062004,1.0,3/10,14.36%,MSN;SPN;SLC8B1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28079011290532246,-1.1806096532029335,0.1,0.685258873112877,1.0,11/76,7.11%,P2RY12;CX3CR1;GNA15;CHRM2;TGM2;GRM1;HTR2A;GRM5;HTR2C;AGT;C5AR2
prerank,regulation of regulated secretory pathway (GO:1903305),-0.3361665834371114,-1.1801617903279795,0.17777777777777778,0.682601201407505,1.0,11/34,14.30%,SYT10;RIMS1;LRRK2;RAB3A;SNAPIN;SYT1;SYT2;RIMS2;SYN1;SYT9;RAB15
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.49957187507370915,1.180081586964436,0.25584255842558423,0.57338037652677,1.0,9/18,31.55%,MSN;PTPN23;DAB2;VPS11;SNX12;MAP2K2;MAPK3;MAPK1;RDX
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.509198240356211,1.1799287792311388,0.287001287001287,0.5733992937099505,1.0,4/15,8.57%,RIPOR2;ADGRB1;TREM2;CD53
prerank,positive regulation of B cell proliferation (GO:0030890),0.4535974175567824,1.1797184830962124,0.23404255319148937,0.5735924769598338,1.0,13/29,26.03%,BCL2;PTPRC;CHRNB2;TFRC;TIRAP;IL2;CD74;MIF;VAV3;NCKAP1L;SASH3;TLR9;GPR183
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.506377029238409,1.179550693180983,0.24646983311938384,0.5736413928442898,1.0,7/16,20.59%,MCM7;MCM2;BLM;TWNK;PURA;MCM6;RECQL5
prerank,actin filament polymerization (GO:0030041),0.4560164716296687,1.1795121783472096,0.24278846153846154,0.5733143283242195,1.0,8/29,16.52%,GAS7;MSRB1;WASHC5;CORO7;ARHGAP6;DIAPH1;GSN;MICALL2
prerank,blood vessel morphogenesis (GO:0048514),0.4168971249951546,1.179491745753919,0.23326133909287258,0.5729429316969498,1.0,14/54,17.53%,FLT1;NRP1;CAV1;COL4A1;VEGFA;SMAD7;EGFL7;CYP1B1;EFNB2;KDR;SYK;RASA1;NF1;SERPINF2
prerank,membrane assembly (GO:0071709),0.44428468992436904,1.1791695157282605,0.2574712643678161,0.5734656475553989,1.0,10/34,12.26%,RFTN1;CEL;LRP4;TLCD1;CHMP4B;UGCG;TLCD2;FLOT2;GAK;CHMP7
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5419761239090286,1.1791154541643363,0.27956989247311825,0.5731880756141096,1.0,8/12,26.35%,AMPD2;GART;PRPSAP1;MTHFD1;PRPS2;PPAT;ADSL;HPRT1
prerank,carboxylic acid metabolic process (GO:0019752),0.44011595096793693,1.1789214267660897,0.26091954022988506,0.5733188523042808,1.0,16/33,29.21%,SLC23A1;SLC23A2;PON1;SLC2A1;GNMT;GLYAT;SIRT4;ST6GAL1;PTGIS;CYB5R3;GSTO2;MIF;TBXAS1;LIPT2;ST3GAL1;GSTO1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4340362849283926,1.1788918842794374,0.24255788313120177,0.572974001642322,1.0,8/42,14.70%,CCL4;PTK2B;CCL13;CCR2;CCL7;CCL5;CCL14;RBM15
prerank,atrial septum development (GO:0003283),-0.41409520593922466,-1.178623493464551,0.21223021582733814,0.6827963119700208,1.0,7/13,29.49%,NOTCH2;ZFPM1;ANK2;ISL1;GJA5;BMPR2;NPHP3
prerank,glycoprotein catabolic process (GO:0006516),0.5023746702503606,1.178530579424053,0.2693298969072165,0.5735328457729126,1.0,4/17,9.08%,MMP12;EDEM1;STT3B;OGA
prerank,regulation of gene silencing by RNA (GO:0060966),0.4227466295776644,1.178529745156639,0.21311475409836064,0.5726737043487623,1.0,22/50,29.19%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;NUP93;AAAS;NUP50;NUP54;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.4227466295776644,1.178529745156639,0.21311475409836064,0.5726737043487623,1.0,22/50,29.19%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;NUP93;AAAS;NUP50;NUP54;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,negative regulation by host of viral process (GO:0044793),0.5511866866478686,1.1783681356778493,0.2933709449929478,0.5727321622755923,1.0,2/10,10.00%,LTF;PSMC3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4726817781909963,1.1782376495798617,0.2490613266583229,0.5726654046661054,1.0,9/21,26.16%,RPS7;RPL23;FZR1;FBXO5;RPL11;RAB1A;GOLGA2;UBE2C;BTRC
prerank,regulation of cell development (GO:0060284),0.442275690611571,1.178136168977273,0.25198637911464244,0.5725113005427267,1.0,10/36,15.80%,CTNNB1;HDAC9;HES7;BHLHE40;BHLHE41;PRUNE1;RPS19;DOCK7;YTHDF2;FOXO1
prerank,regulation of humoral immune response (GO:0002920),0.4297596338486855,1.177995974235738,0.23295454545454544,0.5724884995695434,1.0,12/44,22.26%,C4BPA;C4BPB;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L
prerank,endoderm development (GO:0007492),0.5240539107398522,1.1775174577817609,0.2766251728907331,0.5734338639224672,1.0,5/13,29.27%,EOMES;SOX7;LAMC1;KIF16B;DUSP5
prerank,sensory perception of smell (GO:0007608),0.5481538916785414,1.1773385430805734,0.28053691275167786,0.5734907675545043,1.0,2/11,2.15%,SLC24A4;ADCY3
prerank,positive regulation by host of viral transcription (GO:0043923),0.5106273693371544,1.1772833529935856,0.27214377406931967,0.5732156718254222,1.0,8/15,26.43%,LEF1;SMARCB1;JUN;TFAP4;SP1;RRP1B;SMARCA4;SNW1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.46310528353273184,1.1771932689934181,0.24606060606060606,0.5730548547028267,1.0,7/26,18.32%,HIF1A;C3;BRCA1;CCR2;CYP1B1;SARS1;IL6
prerank,regulation of actomyosin structure organization (GO:0110020),0.5319799626304207,1.1768711964409415,0.2728494623655914,0.5735227497805675,1.0,7/13,22.39%,SLC9A1;AKAP13;ACTG1;CDC42;ROCK1;PTGER4;WAS
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4919443152861311,1.1767303192127356,0.2698019801980198,0.5734710617333263,1.0,6/18,24.21%,NCOR2;PTBP3;RPS26;RPS13;TERT;TNF
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.40405096883735486,1.1766900995862706,0.21512247071352503,0.5731617277717093,1.0,24/66,26.28%,FLNA;CCT2;PRKCD;IPO5;TRIM28;CDH1;CARD10;JUP;CCT8;TPR;TFRC;PIK3R2;KAT7;TESK1;ORMDL3;FERMT2;CCT5;DKC1;TERT;RBM22;BAG3;HDAC3;ZPR1;SESN2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.44113097003922,1.1765694442865176,0.2445961319681456,0.5731103862902167,1.0,2/33,0.62%,GPNMB;CDK6
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4185142568102121,1.1761292204883733,0.2159468438538206,0.5739148869073974,1.0,17/47,29.54%,APOE;CSF1;WDR91;EIF4G1;RBM4B;EIF2A;NOLC1;NFKB1;TCOF1;ATXN2;VPS35;EIF2B4;GEMIN5;CYFIP1;EIF4E;MTPN;PCIF1
prerank,chromatin remodeling (GO:0006338),0.3889534094909441,1.1760865087225618,0.19424460431654678,0.5736135216321944,1.0,44/100,32.27%,ERCC6;NUDT5;HDAC4;DAXX;SOX9;SATB1;BPTF;HDAC1;CHD3;NPM3;HNRNPC;SMARCB1;GATAD2B;MYSM1;SMARCC1;ACTB;INO80;KDM4D;ATRX;CBX3;BAZ1B;SRCAP;DR1;TOP1;GATAD1;ARID1B;NPM1;SMARCD2;HDAC2;KDM5C;BAZ1A;SMARCA4;HCFC1;PIH1D1;RUVBL2;RSF1;SIRT1;PBRM1;SUV39H2;SATB2;ZBTB1;ACTR8;MYB;BAHD1
prerank,body fluid secretion (GO:0007589),0.5220031684695623,1.175896716749364,0.2729693741677763,0.5737314882525435,1.0,4/15,15.59%,CSN3;ZBTB7B;VEGFA;VIP
prerank,axonogenesis (GO:0007409),-0.22703392746009537,-1.1756832391179413,0.0,0.6876694333066559,1.0,67/237,15.06%,OPHN1;NRXN3;NRXN1;PIK3R1;CTNNA2;EPHA6;ROBO1;SEMA6D;GAB1;EPHA4;CNTN4;PTPRO;EFNA5;SEMA6A;GFRA1;PLPPR4;NOTCH2;RAB3A;DSCAML1;TNR;NCAM1;CNTN6;RPS6KA5;DOK6;FEZ1;IRS2;FEZ2;EPHB1;SHANK3;UNC5D;APP;PAX2;PTK2;SLITRK4;SPTBN1;VLDLR;APBB1;EPHA5;GPC1;SPTBN2;ULK1;ROBO2;ULK2;NTN4;WNT5A;RAP1GAP;RET;TUBB3;B4GALT6;BRSK1;MAP1B;ARHGAP35;PPP3CB;KLF7;SEMA6C;PAK3;VSTM2L;EZR;SRC;RAB10;SEMA4B;EFNA3;PIK3CD;SIAH1;CNTN2;NOTCH3;CCK
prerank,error-free translesion synthesis (GO:0070987),0.4777592594691871,1.1755916190601687,0.2602905569007264,0.5742245502667402,1.0,12/22,33.61%,UBA52;RPS27A;VCP;RFC1;UBC;REV1;RFC2;RCHY1;RFC4;UBB;RFC5;PCNA
prerank,response to cytokine (GO:0034097),0.3843270273855453,1.1755211786964612,0.15136226034308778,0.5740298999646696,1.0,37/141,19.33%,BCL2;BCL2L1;IL18R1;ANXA1;LEF1;SHFL;IRAK2;MCL1;OSMR;SPHK1;CYP27B1;PTPN23;HDAC4;IFITM2;CD274;IKBKE;MAP4K3;MAPKAPK3;IFITM1;MAPKAPK2;PTPN2;PTPN12;RHOA;TLE5;SP100;TIMP4;PTPN13;CXCL16;TIMP2;SRF;SIGIRR;SMPD1;HAX1;DDOST;BST2;SLC11A1;ADAR
prerank,negative regulation of protein kinase activity (GO:0006469),0.3955131281549915,1.175499045959808,0.1935483870967742,0.573668662508477,1.0,24/88,19.33%,CORO1C;SMCR8;PTPRC;ADARB1;GNAQ;CAV1;HSPB1;PDPK1;DBNDD1;TAB1;DTNBP1;MVP;YWHAG;PAK2;PPIA;LRP6;CHP1;NF1;DUSP3;GSKIP;TESK1;TAF7;ITGB1BP1;ADAR
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.48151942058892117,1.1753956366797593,0.252760736196319,0.5735452047324731,1.0,8/20,24.63%,HIF1A;ZMIZ1;DAXX;DCUN1D2;UBQLN1;HSP90AB1;EGR1;DCUN1D3
prerank,adipose tissue development (GO:0060612),0.5498199855266177,1.1752468830272549,0.28454172366621067,0.5735272092279107,1.0,2/11,1.82%,SH3PXD2B;ARID5B
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4015935766119082,1.1749501371498086,0.2145922746781116,0.5739466951595372,1.0,35/76,30.96%,RNF14;FBXW7;PRICKLE1;DAB2;RNF180;RACK1;VCP;USP5;SOCS5;CEBPA;SMAD7;SUMO2;CLU;CSNK1D;ELOB;HECTD1;PIAS1;RNF19A;LAPTM5;GSK3B;TRIB2;GABARAP;CCDC22;MDM2;SUMO1;BBS7;KEAP1;PSMD10;GSK3A;CSNK1E;RNF19B;RCHY1;PTEN;NUB1;SIRT2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.49918304790307355,1.1749204157665594,0.24812967581047382,0.5736054967076204,1.0,4/18,13.20%,APOE;MSN;RNF128;VPS11
prerank,regulation of fibrinolysis (GO:0051917),0.5266403374816977,1.174746775985356,0.28218465539661897,0.5736630687079489,1.0,6/13,17.53%,HRG;F11;SERPINE1;KLKB1;APOH;SERPINF2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.47280986350085635,1.174516199476045,0.25634824667472794,0.5739244494866326,1.0,5/24,12.90%,SCIN;GDF6;SOX9;PKDCC;ZBTB16
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5389558468376858,1.1742895986046353,0.27320261437908494,0.5741590327315715,1.0,6/12,29.78%,ACSL1;FADS1;ELOVL2;ELOVL1;ACOT8;SCP2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.43104023432188304,1.174231334658853,0.2413793103448276,0.5738842875442123,1.0,8/39,11.98%,MYO1E;MYO5A;MYO1F;MYO1A;HTT;TRAK1;CLN3;KIF1A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4091275686490138,1.1734353213851114,0.22281449893390193,0.575770959523952,1.0,7/57,4.43%,RGS1;FLNA;FPR2;ADCY8;ADCY3;ADCY7;PSAP
prerank,mitochondrion organization (GO:0007005),0.382336107128893,1.1731941862178743,0.13562753036437247,0.5760646497924373,1.0,59/165,24.56%,BCL2L1;VPS13C;ATP7A;TOMM22;THG1L;MGARP;COX7A1;BID;SLC25A33;SAMM50;TRAK1;TIMM44;RAB32;BAX;SIRT5;DNM2;AFG1L;NRF1;TIMM9;LONP1;ALAS1;ATAD3A;AFG3L2;CHCHD2;MTFP1;TOMM5;MTX3;SLC25A36;HSPD1;TWNK;ATPAF1;TOMM40;SIRT4;VPS13D;POLG2;TMEM11;GABPB1;HAX1;HIGD2A;AGTPBP1;RHOT2;AIFM2;MTFR2;IFIT2;STOML2;FBXO7;BIK;PYROXD2;TIMM17A;COX7A2L;PITRM1;MTFR1;TERT;PPRC1;TIMM23;BNIP3;COX7A2;SIRT3;ATP5F1B
prerank,positive regulation of integrin activation (GO:0033625),0.5452582597605004,1.1729428390434007,0.2803234501347709,0.5763706976734797,1.0,3/11,4.50%,SKAP1;PLEK;PIEZO1
prerank,regulation of immune effector process (GO:0002697),0.4298751083110464,1.172690240726483,0.23959505061867267,0.576682309431255,1.0,12/41,22.26%,C4BPA;C4BPB;C3AR1;C3;C8G;PROS1;CLU;C1QBP;C5AR1;CFP;CD55;CR1L
prerank,positive regulation of phosphorylation (GO:0042327),0.37508530892609493,1.1726224607999416,0.09327983951855567,0.5764615612950896,1.0,51/240,18.18%,GPNMB;IGF1;FLT1;HIF1A;SDCBP;RAP2A;FPR2;PLAUR;CD4;AXL;CLDN19;MMP9;NPTN;FGF2;NRP1;LMO4;DAXX;MYDGF;DAB2;SOX9;VEGFA;PFKFB3;CRKL;ANGPT1;TREM2;RASGRP1;IGF1R;VAC14;ILK;ADAM17;P2RY1;RACK1;FGF7;KRAS;C3;RAD50;CCL5;FGF20;EFNA1;GAS6;ENTPD5;PPIA;CSNK1D;TFRC;CCND2;KDR;FXR2;DDR2;RALB;PIN1;TESK1
prerank,transcription by RNA polymerase III (GO:0006383),-0.3486959376128599,-1.172596105232206,0.2532467532467532,0.692350455190484,1.0,9/27,13.86%,IVNS1ABP;POLR3K;GTF3C2;BRF1;GTF3C1;GTF3C6;POLR2L;SNAPC5;ICE2
prerank,hepaticobiliary system development (GO:0061008),0.48980136259665374,1.1724077310074894,0.26150121065375304,0.5766555355717877,1.0,7/20,24.53%,ARID5B;CEBPA;CEBPG;NF1;GFER;NIPBL;PRKCSH
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4198262279429403,1.17240384556713,0.22555555555555556,0.5762393373828716,1.0,12/47,17.74%,CYBA;MMP8;FPR2;XDH;PRKCD;ADGRB1;GRB2;ITGB2;ACOD1;SYK;SLC5A3;CBR1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.554623291119435,1.1723544964668595,0.2838196286472148,0.5759496862160216,1.0,3/11,13.25%,AGO2;SOAT1;ABCA7
prerank,positive regulation of histone deacetylation (GO:0031065),0.541043428518519,1.1717251863387677,0.27631578947368424,0.5773331295057847,1.0,6/12,22.68%,ZBTB7B;VEGFA;SAP30BP;PRKD2;ING2;NIPBL
prerank,endodermal cell fate commitment (GO:0001711),0.5524240092532663,1.1715480971644172,0.28347578347578345,0.5774031388317418,1.0,4/10,29.58%,EOMES;PAF1;CTR9;LEO1
prerank,aortic valve development (GO:0003176),0.4414260294315517,1.1714054891308505,0.2497096399535424,0.5773847850338572,1.0,9/34,13.64%,NPPA;JAG1;ELN;GATA3;SOX9;TNFRSF1B;DLL4;EFNA1;ROCK1
prerank,positive regulation of neutrophil migration (GO:1902624),0.4889909999258481,1.1711262609698063,0.27757125154894674,0.5777610975403072,1.0,8/18,25.28%,ADAM8;RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,dendritic cell differentiation (GO:0097028),0.4789941371391018,1.1708861027104756,0.26140567200986436,0.5779822560639695,1.0,6/22,17.11%,AXL;TREM2;LILRB1;IRF8;GAS6;CAMK4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.49124136010886427,1.1708263667987662,0.26932668329177056,0.5777463370254892,1.0,10/18,29.54%,ACSBG1;ACSBG2;HACD2;ACSL1;HACD1;ELOVL2;ELOVL1;HSD17B12;ACSF3;TECR
prerank,nitrogen compound transport (GO:0071705),0.3842533530438774,1.1702988173097897,0.15431472081218275,0.578818870023693,1.0,32/141,19.68%,SLC3A2;SLC38A1;SLC6A6;SLC15A3;SLC7A1;PDPN;SLC7A11;SLC23A1;SLC48A1;HRG;CD3G;SLC6A19;SLC6A14;TOM1;SLC6A8;SLC16A10;SLC22A3;SLC6A4;SLC18A1;SLC7A6;RAB7A;SLC1A5;SLC52A2;RCN3;SLC7A8;SLC18A2;SNX4;SLC43A2;VAMP2;ARL6IP5;SLC11A1;SLC38A2
prerank,regulation of cellular component biogenesis (GO:0044087),0.43752866020134745,1.1702638324202617,0.23954802259887006,0.5784984725026976,1.0,9/39,13.64%,APOE;MSN;TRAF2;FAM110C;HRG;BBS10;HSPA8;VPS11;ROCK1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4034287222771653,1.170159884894379,0.209277238403452,0.5783468439717592,1.0,23/67,26.28%,FLT1;LCK;ABL2;ITK;FGR;TEC;PTK2B;TXK;IGF1R;PKDCC;FYN;GHR;KDR;SYK;DDR2;ABI1;FGFR3;FGFR2;JAK2;PDGFRA;BTK;ABI2;PTPN6
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5344982855238148,1.1696731454149998,0.2764227642276423,0.5792841345836117,1.0,2/11,6.37%,JAG1;GATA3
prerank,nuclear pore complex assembly (GO:0051292),0.5600459178460323,1.1693332732480686,0.2770745428973277,0.5798661002989071,1.0,5/10,25.24%,NUP205;AHCTF1;TPR;NUP93;NUP98
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.47686151618068545,1.169293350698646,0.24812030075187969,0.5795622209153308,1.0,5/21,14.95%,PRKCQ;DAG1;PSEN2;ADAM17;SPPL3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5054752847464101,1.169217151897407,0.276843467011643,0.5793664505247671,1.0,6/16,27.34%,KLK6;PRMT5;C3;ACP3;PDE6G;GSK3A
prerank,aortic valve morphogenesis (GO:0003180),0.44621016912328615,1.1691823760392752,0.2646370023419204,0.5790359222653556,1.0,8/30,13.64%,NPPA;JAG1;ELN;GATA3;SOX9;DLL4;EFNA1;ROCK1
prerank,cellular glucose homeostasis (GO:0001678),0.43012161481360234,1.1690038048566371,0.24584717607973422,0.5791188630996036,1.0,12/41,17.34%,HIF1A;ADCY8;GCK;ERN1;IGF1R;HK1;RACK1;PCK2;GAS6;FOXO1;PIK3R2;HK3
prerank,response to zinc ion (GO:0010043),0.46439058922208737,1.1687951451371017,0.26065773447015833,0.579287629625892,1.0,10/25,20.07%,P2RX4;ATP13A2;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of response to wounding (GO:1903035),-0.3686432592001343,-1.1687151585761333,0.233502538071066,0.6991437237906137,1.0,5/19,4.51%,CASK;ALOX5;EPHA4;RTN4RL1;AJAP1
prerank,positive regulation of axon extension (GO:0045773),0.4642471835390032,1.1685940493226874,0.2779126213592233,0.5794383823348134,1.0,8/22,20.70%,MACF1;GOLGA4;NRP1;VEGFA;RUFY3;LIMK1;NTN1;DSCAM
prerank,heart process (GO:0003015),-0.41498239428750405,-1.1685565702586411,0.2553191489361702,0.6956415383233685,1.0,2/14,0.77%,SGCZ;SGCD
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4385284119210156,1.1684810608946548,0.24746906636670415,0.5793381105938018,1.0,7/36,14.48%,APOE;HIF1A;PIK3CB;CAV1;GLA;DNM2;NOSTRIN
prerank,central nervous system neuron development (GO:0021954),0.5148113202275982,1.1679910968518024,0.26322751322751325,0.5803136726760806,1.0,2/15,2.16%,B4GALT5;ATP7A
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.472209345777917,1.1678870694832444,0.25334957369062117,0.5797837835175793,1.0,6/23,18.40%,BCL2;GZMB;BID;YWHAG;YWHAB;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.472209345777917,1.1678870694832444,0.25334957369062117,0.5797837835175793,1.0,6/23,18.40%,BCL2;GZMB;BID;YWHAG;YWHAB;PPP3CC
prerank,regulation of lipase activity (GO:0060191),0.5234742532011118,1.1677104433704684,0.28940568475452194,0.5798362563974057,1.0,4/13,16.09%,LPL;APOA2;RHOA;FURIN
prerank,cellular response to inorganic substance (GO:0071241),0.4766890570446923,1.1674560321579461,0.28860759493670884,0.5801591947869859,1.0,6/21,23.43%,DDI2;CDK2;BLM;FOXO1;ATRX;ADCY10
prerank,regulation of gene expression (GO:0010468),0.3653780762181927,1.1672349876103354,0.008,0.5803689615865445,1.0,240/903,23.47%,APBB2;IGF1;AHNAK2;CXXC1;MITF;APOE;STAP1;HIF1A;ITGAX;FN1;CDK6;CD3E;C1D;MMP8;CSF1;TCF7;SIRPA;NFYA;NFE2L2;SMCR8;PTPRC;LTF;PRKCQ;MSN;AFF1;LEF1;TBX21;AGO2;MYBL2;XDH;GCNT2;ATP13A2;JMJD1C;MBNL3;PIK3CB;ID2;HRG;SOX3;TRIM6;TRIM43;CILP;DHH;VDR;CLDN19;PKP1;RNF14;POU3F1;ZC3H7B;PAK6;NFIL3;FBXW7;FGF2;CD28;NELL1;TRAF3;PERM1;TFEB;HDAC4;SERPINB9;DAXX;PPP2R1A;PTBP3;RPS7;UBAP2;RUNX1;BCL6;PTPN22;RPL23;GATA3;RNF6;ZBTB7B;SOX9;FUBP1;VEGFA;GRSF1;MSL3;CRKL;ANGPT1;DNMT1;TREM2;HDAC1;NOCT;NFX1;TXK;CELF1;GON4L;ACTG1;BHLHE40;UBE2L3;ZNF395;CDH1;MTF2;BTN3A3;FADS1;ATXN1;CHD3;DTNBP1;TAPBP;LILRB1;DIP2A;FLOT2;SON;HNRNPLL;WNT6;RPL11;PABPN1;ZNF326;FOXN3;RACK1;NKX2-1;TICAM1;NFKBIZ;THAP7;LARP4;SOX7;FGF7;KRAS;NAT8;PRMT5;BRCA1;DNM2;ATF5;AFF4;ZNF148;SBNO1;HMG20B;NAB2;CEBPA;FGF20;DLL4;TGFBRAP1;HP1BP3;GSN;LARP1;PRDM9;TLE5;CARM1;ZFP64;CDK11B;NPAT;HNRNPK;PPARGC1B;PCBP4;TIPARP;PHF1;GAS6;SMAD1;CDK2;YY1;YBX3;ROCK1;NFYB;YBX2;STOX1;DDIT3;NFKB1;MBNL2;FASTK;CLU;ACTA2;ING2;PCBP1;MAPK9;YTHDF2;NOVA2;SERTAD3;MYT1;TFRC;KDR;DHX36;MYADM;BMP6;PUM1;MYBBP1A;PRKAG1;GLRX2;PSPC1;UTP4;AFDN;PPIE;SBNO2;NLK;CNBP;GPBP1L1;DAPK3;ATRX;GCFC2;HNRNPF;CLK4;PIN1;KAT7;BMI1;ATM;IL6;SP1;DNMT3B;CCAR2;HAVCR2;CCAR1;AGO3;FAM98A;SLC11A1;YAF2;TARDBP;SLC38A2;TCF7L1;NR3C1;RPS3;RNF20;PRDM6;ANXA7;EMILIN1;VHL;RFXANK;AHNAK;GSK3B;RUNX3;SRPK2;BMP4;TRIM21;SUFU;FGF18;SNX12;USP36;CALR;TERT;ARNT2;NSD3;PRRX2;MAP2K2;CD74;EGR1;AHR;VPS35;ASCC1;KMT2D;REL;TMPRSS4;AMH;MIF
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.40722690611318557,1.1672246599441636,0.2185145317545748,0.5799799711325005,1.0,12/66,9.89%,APOE;CDK6;NLRC3;XDH;VDR;FBXW7;CAV1;GATA3;MTSS1;SOX9;PEX2;B2M
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4319807471127145,-1.167168781205438,0.2397003745318352,0.69578324257147,1.0,5/12,19.29%,SNAP25;STX1A;SNAP23;STX19;SNAP47
prerank,regulation of cell morphogenesis (GO:0022604),0.4557551958424066,1.1671518277131945,0.259604190919674,0.5797717574018736,1.0,11/30,21.39%,MACF1;PDPN;CD44;FMNL2;STRIP1;LARP4;SH3D19;FERMT2;MYO9A;CFL1;ZMYM4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5380080959439155,1.167147653854871,0.2930800542740841,0.579363910737505,1.0,5/11,21.84%,CCT2;CCT8;TERF1;CCT5;DKC1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4627122756173409,1.1670893160951474,0.25448028673835127,0.5791292626372131,1.0,9/23,20.69%,AXL;CD274;LILRB1;GAS6;DDIT3;C1QBP;HAVCR2;HMGB1;LAPTM5
prerank,sterol metabolic process (GO:0016125),0.4119139740420949,1.1669067725232767,0.22659574468085106,0.5792230454331287,1.0,12/60,14.67%,APOE;ABCG1;ABCA1;LIPA;APOA2;CYP19A1;SOAT1;PPARD;ARV1;SOAT2;CH25H;CYP1B1
prerank,copper ion homeostasis (GO:0055070),0.5054170794160782,1.166761790112702,0.2848020434227331,0.5792338122012032,1.0,3/17,6.01%,SLC31A2;ATP7A;ATOX1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4597812774104001,1.1665957793974269,0.2845036319612591,0.5792694833397136,1.0,4/23,7.00%,ITGAX;FGF2;SOX9;VEGFA
prerank,synaptic vesicle recycling (GO:0036465),-0.32060488970104306,-1.1663245412574945,0.21568627450980393,0.6942151778727476,1.0,7/31,6.82%,OPHN1;NLGN1;AMPH;RAB3A;SYT1;SYT2;PLD2
prerank,lung development (GO:0030324),0.43746640632160255,1.1658353075181604,0.2552204176334107,0.5810489723738593,1.0,15/33,27.33%,PDPN;FGF2;FOXJ1;VEGFA;NKX2-1;FGF7;CEBPA;RBP4;RCN3;ITGA3;BMP4;FGFR2;FGF1;CCDC40;CCDC39
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4904736327898192,1.1650481544000344,0.26765799256505574,0.5829291060018217,1.0,7/18,18.90%,FLNA;MAF1;UBTF;WDR43;DHX33;RASL11A;LYAR
prerank,intestinal absorption (GO:0050892),0.512416132747715,1.1648574700092424,0.29310344827586204,0.5830563990018492,1.0,4/13,7.61%,SLC5A1;TJP2;SLC46A1;UGCG
prerank,establishment of spindle localization (GO:0051293),0.5143441247818468,1.1642615569433792,0.28425096030729835,0.5843440797803731,1.0,7/14,26.51%,DYNC1H1;LLGL2;CFL1;ZBED3;LLGL1;MAP4;ESPL1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.38310058621421295,1.1641811641382633,0.17258883248730963,0.5841685585324398,1.0,34/140,23.00%,CACNA1A;ABL2;P2RX4;FPR2;PTGIR;ADCY8;CXCR2;PTGFR;CD24;EDNRA;BDKRB1;NPTN;C3AR1;CD52;CAV1;GPR174;TAC4;P2RY1;IAPP;CCR2;JPH1;SPPL3;LPAR1;GLP1R;CACNB3;C5AR1;ITPR3;HMGB1;CXCR3;CD55;GPR65;PTGER4;F2R;S1PR4
prerank,regulation of TORC1 signaling (GO:1903432),0.4482385008554446,1.1638775625493831,0.2615558060879369,0.5846150716243388,1.0,3/33,1.37%,GPR137B;RRAGD;SMCR8
prerank,regulation of cell-substrate adhesion (GO:0010810),0.42615453599531733,1.1637549314890205,0.24336283185840707,0.5845293079451713,1.0,11/42,18.82%,CORO1C;GCNT2;PDPN;PIK3CB;ATXN3;RHOA;FZD4;MYADM;NF1;MINK1;ECM2
prerank,cellular protein-containing complex assembly (GO:0034622),0.38173019077295145,1.163745247000653,0.15593561368209255,0.5841346763059645,1.0,56/159,28.43%,CYBA;CD3E;NUP205;TRAF2;CCT2;HSPA4;NRG1;COX7A1;BBS10;TESPA1;NCK2;DNAJB14;NCK1;SAMM50;ANGPT1;CHMP4A;CHMP4B;AHCTF1;TBCA;COG4;HIP1;LONP1;MID1IP1;SMAD1;CENPT;RPL38;CLU;HSPD1;NDUFAF1;TPR;VAMP4;VAMP2;MKKS;HIP1R;DHX9;HIGD2A;PTGES3;FCHO1;NUP93;HSF1;HSP90AB1;COX7A2L;TTC12;EIF4B;COX7A2;PSMG3;CCDC65;PIK3C2A;NUP98;CENPA;CCDC40;CCDC39;DNAJB12;CALY;ARL6;VAMP3
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5430320608443471,1.1636902362150274,0.2764786795048143,0.5838651351454252,1.0,8/11,30.37%,CABIN1;UBN1;ATRX;ASF1B;HAT1;H3-3A;NASP;ASF1A
prerank,positive regulation of gene expression (GO:0010628),0.36788587992471006,1.1636758780841925,0.047,0.5834853659844409,1.0,130/442,24.50%,IGF1;MITF;STAP1;HIF1A;ITGAX;FN1;ERCC6;CD3E;MMP8;CSF1;ITK;NFE2L2;MSN;FGR;LEF1;AGO2;EIF6;VIM;ATP13A2;SPHK2;PIK3CB;ID2;VDR;CLDN19;PKP1;POU3F1;TAF1D;FGF2;CD28;EEF2;SERPINB9;DDX21;RPS7;PTPN22;PIWIL2;RPL23;ZBTB7B;ERN1;SOX9;FUBP1;VEGFA;CADM1;ANGPT1;DNMT1;TREM2;TXK;CELF1;ACTG1;POLR1G;POLR2H;DTNBP1;LILRB1;HNRNPLL;WNT6;RPL11;NKX2-1;TICAM1;LARP4;PLA2R1;CPEB3;FGF7;KRAS;NAT8;METTL3;BRCA1;CRTAM;YTHDF3;FGF20;DLL4;GSN;GAS6;SMAD1;ROCK1;ACTB;STOX1;CLU;ACTA2;EIF4A3;DEK;MAPK9;CLEC6A;TFRC;DHX36;POLR1A;BMP6;FXR2;MYBBP1A;PRKAG1;AFDN;TBP;BAZ1B;ATM;IL6;WBP2;SP1;DNMT3B;EIF3E;UPF3A;AGO3;FAM98A;SLC11A1;SLC38A2;RPS3;AGPAT2;EMILIN1;GSK3B;TAF1A;SRPK2;NPM1;BMP4;UPF3B;SAMD4A;FGF18;PTGER4;HTR2B;MAP2K2;TAF1C;CD74;EGR1;VPS35;POLDIP3;RBM22;AMH;MIF;AGPAT1;TNF;POLR1F;POLR2F;ATF4;SF3B1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.42768497037137904,1.1635741917201803,0.26994535519125684,0.5833635643978848,1.0,10/44,15.63%,LTF;CST7;CD44;RAF1;SIAH2;VEGFA;CAST;TRIAP1;GAS6;USP47
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5059554518101352,1.1635724438966115,0.28309305373525556,0.5829541724234846,1.0,2/14,3.87%,ATP1B3;LRRC52
prerank,cilium-dependent cell motility (GO:0060285),0.48054063563385163,1.163421816679264,0.2882991556091677,0.5829941292770973,1.0,10/22,28.82%,CFAP44;TEKT2;DNAH8;TEKT5;DNAH3;EFHC1;CCDC65;DNAI3;CCDC39;DNAH17
prerank,nuclear membrane disassembly (GO:0051081),0.5149170947513126,1.1633406946532532,0.28957528957528955,0.582811256857267,1.0,5/14,18.05%,CTDNEP1;PRKCB;CCNB1;DCTN1;NEK6
prerank,regulation of muscle contraction (GO:0006937),0.4611002139861329,1.1628694694805415,0.2647058823529412,0.5837025585798439,1.0,8/26,17.91%,TNNT3;MYL9;CAV1;ANXA6;SRI;ENO1;ATP1A2;DAPK3
prerank,DNA replication (GO:0006260),0.38674385485852325,1.1626530060985325,0.21936148300720906,0.583920154066901,1.0,38/105,25.32%,ORC3;MCM7;MCM2;GRWD1;IGHMBP2;ING4;PTMS;RMI1;POLE;RNASEH2A;BRCA1;RAD50;CDK2;BLM;CDC7;BARD1;ING5;POLG2;POLB;WDHD1;RFC1;KAT7;ATM;KIN;RAD1;POLG;TOP1;MCM6;DUT;TBRG1;RECQL5;DBF4;MCM8;TOPBP1;REV1;POLA2;RFC2;BAZ1A
prerank,regulation of protein kinase B signaling (GO:0051896),0.3749863680889792,1.162475572398638,0.13723511604439959,0.5840288260093994,1.0,35/193,11.66%,OSBPL8;LCK;P2RX4;DAG1;XDH;GCNT2;ADAM8;PDGFA;PIK3CB;AXL;FAM110C;NRG1;FGF2;CD28;MFHAS1;PPP2R5C;MYDGF;PIK3R5;PDPK1;TRAT1;GATA3;GRB2;ANGPT1;IGF1R;KITLG;PLEKHA1;RACK1;SFRP5;FGF7;IAPP;HIP1;FYN;MYOC;RHOG;FGF20
prerank,insulin secretion (GO:0030073),0.4806225381581012,1.162388178261972,0.2658536585365854,0.5838471858737918,1.0,3/19,8.30%,ANXA1;SNX19;CYB5R4
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3638430786115948,-1.162154243665092,0.24731182795698925,0.7021627067903137,1.0,9/23,16.82%,AGMO;LPIN2;PLA2G15;GPAM;GPAT3;PNPLA3;PNPLA2;PLCE1;MOGAT3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5464457063089266,1.162128884487902,0.30191256830601093,0.584169062304808,1.0,3/10,10.16%,IQSEC1;MMP9;FGF7
prerank,cellular response to glucagon stimulus (GO:0071377),0.48630984540303,1.1618026570113495,0.28426395939086296,0.5847231480931143,1.0,3/17,4.20%,ADCY8;ADCY3;ADCY7
prerank,sodium-independent organic anion transport (GO:0043252),-0.44691805712970667,-1.161757740383544,0.24468085106382978,0.6993917769700598,1.0,3/10,7.28%,SLCO2B1;SLCO1B1;SLCO4A1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.31582841169226883,-1.1615301244930096,0.19642857142857142,0.6962663910861859,1.0,18/38,24.96%,CACNB2;CACNA2D1;BIN1;KCNJ3;KCND3;TRPM4;KCNH2;CACNA1C;DSG2;SCN2B;CACNA1G;KCNQ1;ANK2;SCN4B;ISL1;KCNE3;DSP;KCNE4
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5247337721466045,1.1615017098045481,0.28252299605781866,0.5851515353527915,1.0,8/13,32.25%,ATG7;DESI1;DESI2;SAE1;UBA6;ATG10;UBA3;UBA5
prerank,positive regulation of B cell activation (GO:0050871),0.4137751823855073,1.1609753214323393,0.24053452115812918,0.5862734392410457,1.0,19/50,26.03%,BCL2;PTPRC;CHRNB2;SH3KBP1;TNIP2;KMT5B;TFRC;TIRAP;SYK;IL6;IL2;CD74;MIF;VAV3;BTK;NCKAP1L;SASH3;TLR9;GPR183
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.43523722177192875,1.160519893106785,0.2718786464410735,0.5871810543431024,1.0,3/34,4.70%,IGF1;NSMCE2;CD28
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3009081326431672,-1.1603776209077632,0.20952380952380953,0.6957082065613284,1.0,12/41,11.54%,CACNA2D1;GRIN2A;RYR3;SLC8A3;ITPR2;PLCG2;HTR2A;GRIN2B;HTR2C;SLC8A2;TRPV4;GRIN1
prerank,negative regulation of cellular component organization (GO:0051129),0.3997727529561604,1.160294125503942,0.22577209797657083,0.58743459523796,1.0,20/74,21.28%,LGALS3;MCTP1;APOA2;PON1;RAF1;VEGFA;SNX33;LILRB1;IAPP;DNM2;RIOK3;HSPA8;CDC42;ABCA7;CLU;BMP6;RTEL1;DNAJB1;GSK3B;HSF1
prerank,regulation of defense response to virus (GO:0050688),0.5048314905839522,1.159784443058584,0.2980392156862745,0.5883969924538451,1.0,8/14,27.73%,TRAF3;ILRUN;C1QBP;DHX9;ELMOD2;RNF216;TRAF3IP1;TNFAIP3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4510890163224814,1.159714989295627,0.278436018957346,0.5881708471258096,1.0,10/27,26.63%,AK8;AK4;GSR;TXNRD1;AK5;AK6;DUT;AK7;GUK1;DTYMK
prerank,response to organic cyclic compound (GO:0014070),0.41059906498545634,1.1597025804859316,0.2535364526659412,0.5877954683056276,1.0,6/52,4.05%,CTNNB1;SPP1;ANXA1;CHRNB2;CYP19A1;CYP27B1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.39887906252040545,1.1596730386470522,0.24552160168598525,0.5874608534827708,1.0,23/68,24.21%,RAB7B;LPL;CYBA;MMP8;SPHK2;MAPK13;POU2AF1;MBP;HSPD1;TMEM106A;TIRAP;SYK;IL6;DHX9;SCIMP;ARHGEF2;HMGB1;LBP;F2R;CD74;IL17RA;IL17D;TNF
prerank,negative regulation of histone acetylation (GO:0035067),0.5477934843384427,1.1594833047505335,0.2866666666666667,0.5876027358469319,1.0,4/11,18.91%,NOC2L;THAP7;BRCA1;TAF7
prerank,presynapse organization (GO:0099172),-0.46151051920450814,-1.159060962658242,0.29918032786885246,0.6956474383704971,1.0,5/10,19.76%,NLGN1;LRRTM3;WNT5A;NLGN2;NLGN3
prerank,response to lipopolysaccharide (GO:0032496),0.3777559515662079,1.1585242673953922,0.18329938900203666,0.5898954364909638,1.0,33/138,18.32%,S100A8;S100A9;STAP1;SIRPA;VIM;AXL;TRIM6;CD6;CYP27B1;CD274;PTPN22;ERBIN;NOCT;TNIP3;MAPKAPK3;LILRB1;ADAM17;PABPN1;MAPKAPK2;TICAM1;PLAA;SERPINE1;TNFRSF1B;RHOA;TNIP2;GIT1;NFKB1;ACOD1;TIRAP;PDCD4;SBNO2;PAF1;IL6
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.43712884470350677,1.1580534240863616,0.2606689734717416,0.590867107131295,1.0,16/33,32.25%,RNF14;RUNX1;RNF6;UFM1;CARM1;SAFB2;PRMT2;KLK3;LATS1;CALR;H3-3A;KDM1A;UFL1;TRIM68;EP300;UBA5
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3736779117627237,1.1580032330001453,0.12912912912912913,0.5906086555824034,1.0,58/248,18.85%,DKK2;CTNNB1;CDK14;APOE;CCDC88C;CCNY;PSMD8;PSMD1;GNAQ;BICC1;TNKS2;PRICKLE1;OTULIN;CAV1;SIAH2;LRP4;DAB2;STK3;SOX9;HDAC1;PRDM15;ZNRF3;ILK;PSMD6;PSMA1;CSNK1G1;VCP;BAMBI;SFRP5;SOX7;PSMC3;JUP;WLS;PSMA8;TLE5;FRAT1;GPRC5B;PSMD14;JRK;FZD4;SCYL2;PSMD2;DDIT3;NFKB1;LRP6;CSNK1D;USP47;PSMC6;PSMA6;LZTS2;GSKIP;PSMD5;STK11;PSMA5;DAPK3;PIN1;CCAR2;CUL3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4692153484752447,1.1578584885958199,0.27699530516431925,0.5906011576934628,1.0,3/23,2.08%,NLRC3;TMSB4X;HDAC7
prerank,DNA recombination (GO:0006310),0.42683545040930976,1.1575673728459919,0.26558891454965355,0.591001489952961,1.0,13/37,27.20%,RAD51B;ERCC1;IGHMBP2;RAD50;DMC1;BLM;RAD54L;RTEL1;HMGB1;RECQL5;GEN1;HMGB3;SUPV3L1
prerank,positive regulation of neuron death (GO:1901216),0.4183879959120402,1.1574960777284058,0.25609756097560976,0.5907720861447227,1.0,17/46,24.47%,CTNNB1;CDK5;DAXX;EIF2S1;BAX;FYN;SARM1;DDIT3;CLU;ITGB2;EFNB2;NF1;GSK3B;SRPK2;EGR1;TNF;ATF4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.48894123667731526,1.1574888695818857,0.2795425667090216,0.5903779604449947,1.0,7/17,20.12%,FPR2;MOSPD2;CCR2;SERPINE1;CCL5;ANO6;HMGB1
prerank,neurogenesis (GO:0022008),0.42001989308145743,1.157435684124334,0.25975473801560756,0.590115042856988,1.0,8/43,16.90%,CDK6;ERCC6;ANXA1;FAT4;TRAK1;METTL3;LPAR1;THOC2
prerank,regulation of steroid metabolic process (GO:0019218),0.4613097222169708,1.1566473250176443,0.26545454545454544,0.5919372612079665,1.0,2/23,0.50%,APOE;ABCG1
prerank,negative regulation of viral life cycle (GO:1903901),0.5029851894861537,1.1565709799691046,0.2986842105263158,0.5917156874447563,1.0,5/15,19.13%,IFITM2;IFITM1;GSN;PPIA;BST2
prerank,anion transport (GO:0006820),0.43333360563597123,1.1562855792515974,0.2722029988465975,0.5920665422399672,1.0,10/33,20.42%,LRRC8C;VDAC2;SLC17A5;SLC22A3;SLC13A4;SLC26A4;SLC4A2;SLC19A1;SLC13A3;SLC13A5
prerank,regulation of cell death (GO:0010941),0.38848702683829456,1.156044858840202,0.21495327102803738,0.5923172304270975,1.0,39/94,32.36%,LRP1;CTSZ;SLC25A24;EIF4G1;FGF2;NCK1;CHMP4B;HP;HPR;CELF1;LRPAP1;CCL5;TNFRSF1B;VPS4B;SARM1;CLU;CHP1;CCN6;RILPL1;FERMT2;TMEM109;BMP4;HTR2B;VPS35;BNIP3;PARP16;CCN4;PACRG;TBK1;BNIP3L;FAF1;CCN2;BECN1;OLFM4;GPR75;NOA1;ZC3H12A;UBB;ATG5
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5354486164209624,1.1555640906863005,0.2960969044414536,0.5932811880284821,1.0,4/11,12.70%,NPPA;LRRC52;TREM2;ALG10B
prerank,RNA splicing (GO:0008380),0.3875352002951555,1.1555177112885981,0.21792260692464357,0.5929931736134495,1.0,42/95,30.12%,SNRNP35;SRPK1;PPP1R9B;PPP2R1A;ZRSR2;SF3B3;HNRNPC;SRSF11;PRPF4;SMNDC1;SRSF7;DDX39B;LSM6;SYNCRIP;PRPF6;SNRNP40;CCAR2;ZMAT5;SRSF2;TARDBP;PPIG;PRPF8;USB1;SMU1;SRPK2;SF3A3;LSM4;SRRM1;SNRPG;SF3B2;SF3B1;KHSRP;SNRPF;RRAGC;GEMIN2;NOL3;FUS;SRSF10;WBP4;TRA2B;WDR83;DBR1
prerank,myotube differentiation (GO:0014902),0.4935468858623608,1.155268095018946,0.28241335044929394,0.5932839022645432,1.0,2/17,0.98%,IGF1;PLD3
prerank,protein deacylation (GO:0035601),0.45647176599881445,1.1549852348406457,0.28672985781990523,0.593704866570091,1.0,13/23,30.96%,HDAC7;HDAC4;HDAC1;SIRT5;LYPLA2;ABHD17C;ABHD17A;ABHD10;SIRT3;HDAC3;ABHD17B;SIRT1;SIRT2
prerank,protein localization to nucleus (GO:0034504),0.38596400043191487,1.1548798659880684,0.2085889570552147,0.5935831827286482,1.0,33/102,24.53%,MMP12;GCKR;PRICKLE1;IPO5;TOR1AIP2;CTDNEP1;NOL8;LMNA;E2F3;RPL11;NUP188;ARL2BP;NXT2;XPA;ABCA7;TPR;EIF4ENIF1;APPL2;SYK;GBP2;HNRNPU;PPP1R10;PAF1;PIKFYVE;TBRG1;NUP93;BMP4;CALR;TOR1B;NUP50;MDM2;TNPO2;TNPO1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.44194224544004956,-1.1547648777675017,0.25203252032520324,0.7046433895766323,1.0,1/11,0.29%,MEF2C
prerank,positive regulation of cell killing (GO:0031343),0.523878274703934,1.1547023620869756,0.32332878581173263,0.5936821712218532,1.0,3/13,16.06%,CYBA;PRF1;SYK
prerank,response to hexose (GO:0009746),0.4506379014705878,1.154414209713253,0.28966346153846156,0.5940693907363005,1.0,8/25,23.92%,LPL;APOA2;GCKR;PFKL;VAMP2;EIF2B2;ZBED3;EIF2B4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.45408130628892973,1.1542549896891776,0.2860727728983689,0.5940864812473637,1.0,7/23,20.45%,PTPRC;CAV1;MVP;SOCS5;CBL;CBLB;CHMP6
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.37533051894555025,1.1541392205317964,0.16431451612903225,0.5940002472485909,1.0,74/184,32.48%,PSMD8;PSMD1;UBA52;PPP1R9B;RPS27A;ODF2;ID2;ANAPC15;DYNC1H1;PPP2R1A;NINL;RIOK2;FZR1;FBXO5;PSMD6;PSMA1;HAUS8;DDB1;CCNB1;PSMC3;CEP41;DCTN1;YWHAG;PSMA8;TFAP4;ANAPC1;CDK2;PSMD14;PSMD2;CEP250;INO80;CSNK1D;PSMC6;APPL2;PSMA6;PLK4;PSMD5;TUBB;PSMA5;CDC26;NEK6;MAD2L1BP;HAUS2;CUL3;BUB1B;UBC;CUL1;ANAPC7;PSMA3;XPC;PSMB10;PSMB8;PSMD7;UBE2C;PSMB6;BTRC;PTPN6;PSMD10;CETN2;MAPRE1;PSMB5;PSMB7;KLHL18;PSMC4;CSNK1E;ALMS1;CEP57;SIRT2;ERCC2;PSMD12;APPL1;PSMD3;UBB;DYNC1I2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.44477823328364213,1.1541172896674996,0.28352941176470586,0.5936588876760667,1.0,16/30,31.29%,TAF1D;POLR1G;POLR2H;TTF1;UBTF;POLR1A;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MNAT1;POLR1H;ERCC2
prerank,regulation of receptor binding (GO:1900120),0.5446710320988803,1.1538918899731543,0.2838018741633199,0.5938486275730646,1.0,5/10,27.74%,MMP9;B2M;ADAM15;ATP2A2;GREM2
prerank,homologous chromosome segregation (GO:0045143),-0.36937057964971165,-1.1536863425926598,0.24742268041237114,0.7039778739113429,1.0,10/20,28.41%,PTTG1;FMN2;ZCWPW1;IHO1;SGO1;MAJIN;SIRT7;KASH5;MEIOB;TERB1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.43275053457771456,1.1530489380782691,0.2675893886966551,0.5957842209785011,1.0,5/34,4.64%,FLT1;FGR;WDR91;PTK2B;FGF2
prerank,tRNA wobble base modification (GO:0002097),0.5117605645322629,1.1530309192750576,0.2963917525773196,0.59542893015796,1.0,11/14,39.60%,KTI12;ALKBH1;ELP3;GTPBP3;MOCS3;ALKBH8;DPH3;MTO1;CTU1;URM1;CTU2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3678235028064179,1.1529936581807398,0.094,0.5951199613571777,1.0,121/336,30.37%,FNIP2;BCL2;BCL2L1;PARP4;RAD51B;TANK;MCL1;DOT1L;DYRK2;MCM7;TAOK3;TRIP12;SUSD6;ERCC1;NUDT1;IGHMBP2;BID;BCL6;TRIM28;IKBKE;GRB2;BCL2L11;LIG1;FBXO31;ALKBH7;DDB2;MAPKAPK2;ZRANB3;VCP;DDB1;NEK4;BAX;BOD1L1;MGMT;METTL3;FANCF;BRCA1;RBBP5;RAD50;ALKBH1;XPA;SHPRH;TNFRSF1B;HPF1;KMT5B;NUPR2;PHF1;MBD4;BLM;YY1;ADPRS;DDIT3;INO80;CHCHD6;ERCC4;SLX4;USP47;ZBTB40;FOXO1;BARD1;SIRT4;POLB;WDHD1;STK11;PARP3;RAD54L;CBX3;BAZ1B;GTF2H1;ATM;KIN;RTEL1;RAD1;FANCA;CASP9;RAD51AP1;RPS3;RECQL5;MCM8;ALKBH3;NPM1;USP28;TAOK1;TOPBP1;WDR48;PPP1R15A;NIPBL;UBA6;VAV3;XPC;ZBTB4;SUMO1;PARP2;PLK3;GADD45A;SMC6;MAPK15;RFC2;MAPK12;CUL4A;CENPS;CDKN2AIP;ATR;UFL1;PDS5A;MAPK3;RAD9A;RNF169;MNAT1;ERCC8;HINFP;APTX;SIRT1;TICRR;CSNK1E;XRCC5;ALKBH8;PNKP;CCND1;OARD1;ASF1A
prerank,sphingoid metabolic process (GO:0046519),0.5264583082737235,1.1527061263828349,0.2914438502673797,0.5955533734575102,1.0,4/12,13.47%,SPHK2;SPHK1;PLPP3;KDSR
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4439416978463899,1.1524831360311585,0.2703962703962704,0.595761572137997,1.0,5/29,7.85%,IGF1;ERBIN;GRB2;CRKL;RASGRP1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4283265217920671,-1.1524176875157985,0.27755102040816326,0.7041063769961273,1.0,4/13,7.03%,TMEM30A;SORL1;CD81;SAR1B
prerank,positive regulation of lipid metabolic process (GO:0045834),0.46919385884419224,1.1524091674247898,0.2734839476813318,0.5955838897279253,1.0,6/22,16.69%,APOE;APOA2;PPARG;PPARD;SORBS1;SIRT4
prerank,proteasomal protein catabolic process (GO:0010498),0.37296377140646925,1.152368440787289,0.15030060120240482,0.5953044946857564,1.0,82/201,32.18%,CTNNB1;PSMD8;NFE2L2;PSMD1;FBXL17;TBX21;KCTD17;FBXW7;NHLRC1;PPP2R5C;SIAH2;ZFAND2A;SPSB2;ATXN3;PSMD6;PSMA1;AGAP3;PLAA;VCP;DDB1;PSMC3;NHLRC3;HUWE1;PSMA8;SHARPIN;DDI2;ENC1;PSMD14;KCTD10;PSMD2;DDIT3;RCN3;BFAR;ZSWIM8;FBXL19;DERL1;PSMC6;PSMA6;RMND5B;PSMD5;UBE4B;PSMA5;CUL3;SPSB3;FBXW11;UBXN6;FBXW5;RNF41;CDC34;RNF216;PSMA3;MDM2;TRIM72;BIRC2;PSMB10;PSMB8;PSMD7;CUL4A;PSMB6;BTRC;KCTD2;PELI1;PSMD10;GSK3A;PSMB5;DNAJB12;TRIM3;PSMB7;WWP2;ERCC8;SIRT1;PSMC4;FAF1;SKP2;SIRT2;RNF34;PSMD12;ATE1;SYVN1;NEDD4;PSMD3;FEM1C
prerank,establishment of epithelial cell polarity (GO:0090162),0.48409835242538474,1.1522826385876515,0.2725,0.5951470461941649,1.0,9/19,24.75%,RAP2A;CYTH1;MSN;RHOA;CDC42;MYO9A;SYNE4;GOLPH3;SIPA1L3
prerank,regulation of protein secretion (GO:0050708),0.3794885658787649,1.152115646275246,0.2135523613963039,0.5952011725930388,1.0,26/119,18.96%,CACNA1A;IGF1;APOE;ABCG1;ADAM8;ATP13A2;GCK;SLC2A1;RHBDF2;TREM2;P3H1;SERGEF;RHBDF1;CCL5;DNAJC1;CACNA1D;RSAD2;PPIA;SLC8B1;GIPR;GLP1R;LLGL2;BMP6;DISP1;IL6;ITPR3
prerank,regulation of developmental growth (GO:0048638),0.44786399417593364,1.15192083986304,0.287396937573616,0.5953169745872549,1.0,9/29,22.95%,IGF1;APOE;DNM2;GHR;GSK3B;LATS1;FGFR3;NIPBL;STAT5B
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4811197198220635,1.1518823295184002,0.29115479115479115,0.595022402315868,1.0,2/19,2.10%,XYLT1;HS3ST3B1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5270522514604862,1.1517908106007506,0.30229419703103916,0.5948613752423012,1.0,5/12,21.84%,CCT2;CCT8;GNL3;CCT5;DKC1
prerank,positive regulation of TOR signaling (GO:0032008),0.42713977618988386,1.151745630322352,0.2760942760942761,0.5945801242224302,1.0,16/40,28.13%,GPR137B;RRAGD;SMCR8;TREM2;GAS6;LARS1;GOLPH3;SIK3;RRAGC;NCKAP1L;HDAC3;LAMTOR3;PIH1D1;RICTOR;FNIP1;LAMTOR1
prerank,glucose homeostasis (GO:0042593),0.3917424893643459,1.1516878535032733,0.2453416149068323,0.5943321484350385,1.0,21/83,18.67%,HIF1A;ADCY8;GCK;RPS6;GCKR;PPARG;IGF1R;CYB5R4;HK1;PTPN2;CEBPA;RBP4;SLC8B1;APPL2;FOXO1;PIK3R2;ADIPOR1;HK3;STK11;IL6;WFS1
prerank,regulation of multicellular organism growth (GO:0040014),0.503400482920851,1.1514993400344784,0.30739795918367346,0.594489407851777,1.0,1/15,0.06%,IGF1
prerank,positive regulation of chromatin organization (GO:1905269),0.5235397665524005,1.1511472570313632,0.2886178861788618,0.5950489738992378,1.0,7/12,31.97%,DAXX;ATRX;TERF1;ACD;H3-3A;TERF2IP;TERF2
prerank,Ras protein signal transduction (GO:0007265),0.3769792320491069,1.1506743671210211,0.2020304568527919,0.5959618352620685,1.0,37/137,17.91%,IGF1;MYO9B;RAP2A;GRAP2;GNA13;LAT;PDPN;FGF2;BRAP;RTKN;TRIM28;RAPGEF6;GRB2;CRKL;DNMT1;RHOD;RASGRP1;RASGRP3;PLK2;GDI1;ARHGAP6;KRAS;NRAS;ARHGEF1;RHOG;JUN;RHOA;LIMK1;CELSR1;CDK2;ROCK1;ARHGEF11;RASGRP2;NF1;RIT1;RALB;NTN1
prerank,positive regulation of behavior (GO:0048520),-0.4418523431374076,-1.1506592057711296,0.2779783393501805,0.7057189067426725,1.0,4/10,7.30%,MEF2C;NLGN1;NPAS2;SGIP1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.36446404251425657,1.150410681161977,0.061,0.5962753763091894,1.0,182/497,31.08%,MDFIC;CTNNB1;ZHX2;NIBAN2;EPRS1;ARID5B;SCML4;LEF1;HDAC9;DEDD2;TBX21;DEAF1;RCOR1;ID2;NRG1;GZMB;GTPBP4;VDR;NCOR2;NCL;CDK5;NFIL3;CIC;S100A11;PRICKLE1;HDAC4;DAXX;PPARG;ERN2;BCL6;WAPL;GATA3;TRIM28;SOX9;ING4;HDAC1;LSM14A;KMT5A;PUS7;BHLHE40;ATXN1;PATL2;BHLHE41;GMNN;BASP1;PPARD;MIDEAS;HOXA7;FOXN3;RACK1;NKX2-1;THAP7;SOX7;CPEB3;DAP;BRCA1;ATF5;SHMT1;SUDS3;ZNF148;JUN;CNOT10;CEBPA;ENO1;BAP1;RIOX1;ZKSCAN3;LARP1;ENC1;TLE5;HSPA8;ZBTB16;TFAP4;GATAD2A;GAS6;CBFA2T2;ILF3;BIRC5;EED;DDIT3;RBFOX2;SYNCRIP;RBM15;DAPK1;EIF4A3;EIF4ENIF1;USP47;PRMT2;FOXO1;DHX36;ELK3;PRMT6;EIF4E2;FXR2;MYBBP1A;RBM15B;RCOR3;PSPC1;PDCD4;SBNO2;DAPK3;UIMC1;GCFC2;CBX3;KAT7;RPL13A;CCAR2;TAF7;YAF2;DACH1;TERF1;NR3C1;RPS3;EHMT1;FBXW11;YEATS2;GSK3B;BMP4;GIGYF2;SAMD4A;ID1;CALR;NIPBL;AHR;CREBZF;ZNF568;PEX14;L3MBTL3;ZBTB4;MDM2;SUMO1;MTA3;TNF;GLIS2;CCDC85B;ZGPAT;POU2F1;HDAC2;KDM5C;SFRP1;MALSU1;DPF3;HDAC3;PIAS4;L3MBTL2;HIC2;SMARCA4;BTRC;TMPRSS6;PCGF6;SNW1;LBH;KDM1A;GSK3A;HES1;ATR;LIMS1;PDS5A;KLF10;RSF1;WWP2;RIDA;HINFP;ARID4A;ATF7IP;SIRT1;PBXIP1;XRCC5;PCIF1;TLE1;HMGB2;CNOT9;MTERF3;SUV39H2;GMNC;RUNX2;QARS1;HEXIM1;SAMD4B;CAPRIN1;SIRT2;GLI3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4804619902916014,1.1503354885511514,0.3099121706398996,0.5960563798857109,1.0,6/19,14.09%,XDH;PIK3CB;HRG;CADM4;CD63;DCN
prerank,negative regulation of phosphorylation (GO:0042326),0.3860115764216159,1.1500552905744086,0.228125,0.5964460889726325,1.0,26/85,24.24%,STAP1;CORO1C;SIRPA;XDH;HDAC4;PLPP3;CRKL;CADM4;NPRL2;FBLN1;PAQR3;PTPN13;ROCK1;PPIA;GIT1;LRP6;PPP1R15B;CHP1;MYADM;HNRNPU;TESK1;TARDBP;BMP4;ZBED3;DNAJC10;PRR5L
prerank,protein polyubiquitination (GO:0000209),0.36760147574353264,1.149924312372115,0.127,0.5964355102257198,1.0,78/297,22.06%,BCL2;CTNNB1;MYLIP;PSMD8;PSMD1;SASH1;RNF125;FBXL17;UBA52;TRAF2;RPS27A;TRIM6;RNF14;FBXW7;FBXO32;TNKS2;TRIP12;TRAF3;NHLRC1;HECTD2;SIAH2;TTC3;RNF6;UBE2L3;UBE2H;FZR1;FBXO31;PSMD6;PSMA1;DDB2;FBXW4;TRAF1;PSMC3;NHLRC3;UBE4A;BRCA1;HUWE1;SHPRH;PSMA8;UBE3B;SHARPIN;UBE2R2;UBE2Q1;ANAPC1;TPP2;PSMD14;PSMD2;BLMH;UBE2L6;BFAR;FBXL19;PSMC6;BARD1;PSMA6;UBE3C;PSMD5;UBE4B;PSMA5;WSB1;CDC26;UBE2V2;UBR2;RNF167;CUL3;HECTD1;FBXO7;UBC;RNF19A;RNF20;FBXW11;CUL1;FBXW5;RNF41;CDC34;RNF216;ZNRF2;FBXO11;TRIM21
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3775641942687069,1.1498838790992274,0.201417004048583,0.5961569995360004,1.0,51/132,28.57%,EIF6;EIF3A;SRPK1;LUC7L2;BRIX1;RPS14;RRP7A;ZRSR2;RPS28;CELF1;DENR;PPAN;RPL11;PRMT5;PRMT7;DDX1;DHX29;DDX39B;POLR2D;RPL38;MRPS7;PUF60;RPS19;RPS27;MDN1;SART1;PRPF6;CELF6;GCFC2;DHX9;PTGES3;EIF2S2;CPSF7;HSP90AB1;RPSA;SRPK2;LSM4;EIF4B;SNRPG;GEMIN8;SF3B1;SNRPF;RPL23A;GEMIN2;GEMIN5;TARBP2;NOL3;EIF2D;SRSF1;SRSF10;NUDT21
prerank,regulation of interleukin-13 production (GO:0032656),0.5195497495808775,1.149739976900339,0.3035230352303523,0.5961355042810493,1.0,3/13,6.37%,LEF1;SPHK2;GATA3
prerank,protein targeting to mitochondrion (GO:0006626),0.407669569072342,1.1496229924194759,0.27124183006535946,0.5960702522171336,1.0,16/52,22.78%,TOMM22;HSPA4;MGARP;SAMM50;PMPCA;TIMM44;DNAJC15;TIMM9;TOMM5;HSPD1;TOMM40;TIMM21;FBXO7;TIMM17A;PITRM1;TIMM23
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4584752874507604,1.149604203135985,0.30156815440289503,0.5957078239930628,1.0,9/24,22.66%,APOE;PTK2B;RHBDF1;EFNA1;PSMD14;TMF1;NUDT15;LATS1;USP14
prerank,nucleotide catabolic process (GO:0009166),0.49641705265543745,1.1495246057990844,0.2849673202614379,0.5955305117095779,1.0,4/16,11.91%,XDH;DERA;VCP;ITPA
prerank,defense response to protozoan (GO:0042832),0.5267641570279661,1.1491838870214481,0.2913907284768212,0.5961358217875793,1.0,1/12,0.11%,LYST
prerank,positive regulation of signaling receptor activity (GO:2000273),0.424449766970581,1.1491764816612804,0.267349260523322,0.595756065820069,1.0,6/36,11.21%,HIF1A;FBXW7;NRP1;HDAC1;ADAM17;CCR2
prerank,protein N-linked glycosylation (GO:0006487),0.39988973202634737,1.1490320629413844,0.24163969795037757,0.5957480905964027,1.0,18/66,19.88%,MAN1C1;MGAT5;B4GALT7;DERL3;MAGT1;STT3B;SRD5A3;MPDU1;ALG10B;LMAN1;ENTPD5;MCFD2;DPAGT1;TUSC3;ST6GAL1;TMEM165;DDOST;B4GALT1
prerank,cellular response to nutrient levels (GO:0031669),0.4017080590936314,1.148928025757576,0.24731182795698925,0.595632144568207,1.0,20/62,25.13%,LPL;RRAGD;ATG7;EIF4G1;TFEB;STK24;FADS1;LAMP2;WDR45;MAP1LC3B;NUPR2;HSPA8;FOXO1;RALB;SREBF1;MAP1LC3A;USP33;CD68;RRAGC;SFRP1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.48181668010775436,1.1487296374531233,0.30062111801242236,0.5957937357286149,1.0,10/18,36.41%,NCOR2;IL6;BMP4;TERT;MAP2K2;TNF;RIPK1;ZC3H12A;MAP2K1;TGFB1
prerank,T cell proliferation (GO:0042098),0.5124214178839227,1.1484499990255448,0.2900662251655629,0.5962108715299066,1.0,5/13,11.11%,MSN;CADM1;RASGRP1;LILRB1;CRTAM
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4571817323159121,1.1482603331660157,0.29691211401425177,0.5963677077582734,1.0,6/23,17.43%,MYO10;CCDC88C;HOOK1;KIF1A;HOOK3;TUBB
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.37128455351605777,1.1481259510497703,0.19858156028368795,0.5963186171941636,1.0,46/148,25.25%,SGK1;DYRK2;CDK5;PPP2R5C;DAXX;RPS20;NOC2L;PDPK1;RPL23;TAF4B;HDAC1;KMT5A;RMI1;CHD3;RPL11;PRMT5;BRCA1;HIPK1;RAD50;TAF15;CDK2;RPL37;BLM;ING2;BARD1;CHD5;ING5;PRKAG1;SMYD2;TBP;STK11;PIN1;ATM;RAD1;TP53RK;TAF7;CSNK2A2;TAF6;EHMT1;TOPBP1;RBBP7;USP2;MDM2;PLK3;HDAC2;RFC2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3951030382513287,1.1480373460465092,0.24050632911392406,0.5961543877878226,1.0,21/70,24.27%,BCL2;BCL2L1;DEDD2;TRAF2;MCL1;DAXX;BID;PDPK1;DIABLO;BAX;HIPK1;TNFRSF1B;CASP9;CRADD;GSK3B;RNF41;GABARAP;FGFR3;JAK2;TNF;BAG3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4098256589165113,1.1479710144829456,0.26174496644295303,0.5959331611600233,1.0,19/48,22.67%,FLNA;NEDD9;NRP1;CUX1;CRKL;LIMS2;P4HB;ILK;SS18L2;MYOC;CDC42;DOCK5;C1QBP;MYADM;TESK1;FERMT2;TRIOBP;CALR;CSPG5
prerank,regulation of chemotaxis (GO:0050920),-0.3226441896937309,-1.147870358650623,0.2602739726027397,0.7102695998102259,1.0,3/30,0.46%,P2RY12;CYRIB;ZSWIM6
prerank,regulation of neuron migration (GO:2001222),-0.33799395973394664,-1.147807552895181,0.2546583850931677,0.7067328900923538,1.0,13/26,23.16%,CTNNA2;SEMA6A;RAPGEF2;NEXMIF;ADGRG1;PHACTR1;CAMK2B;CAMK2A;SRGAP2;NTNG1;PLXNB2;TNN;SHTN1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.46241375214669,1.147682913113171,0.297029702970297,0.5963115938392467,1.0,6/22,12.26%,WDR12;KRI1;UTP20;EXOSC9;EXOSC10;FTSJ3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5359205335077638,1.1476766693581624,0.3076923076923077,0.5959342800751236,1.0,4/12,18.34%,COLEC12;CAV1;RALB;DHX9
prerank,protein modification by small protein conjugation (GO:0032446),0.36682307317168217,1.1476378025670744,0.085,0.5956599856198527,1.0,132/361,29.71%,HIF1A;ATG7;MYLIP;NFE2L2;NUP205;FBXL17;UBA52;RPS27A;NSMCE2;CNOT4;TRIM6;TRIM43;RNF14;FBXW7;FBXO32;BRAP;OTULIN;RNF7;RNF6;TRIM28;EGR2;TSPAN17;SDE2;KLHL7;NFX1;SPSB2;PEX2;UBE2L3;UBE2H;ZNRF3;USP9X;VPS18;UFM1;RACK1;VCP;DDB1;NUP188;CUL9;RNF111;USP5;KLHL13;BRCA1;HUWE1;SHPRH;UBE2R2;BIRC6;ENC1;VPS11;UBE2F;DCUN1D2;KCTD10;SUMO2;DTX2;MKRN2;RANBP2;ZSWIM8;TPR;DTX4;CBL;KLHL24;DERL1;RNF157;BARD1;KLHL25;ASB1;RAE1;ELOB;PAF1;UBE2V2;UBR2;CUL3;DTX3;FBXO7;PIAS1;UBC;SAE1;RNF20;FBXW11;CAND1;DCUN1D4;VHL;CUL1;TRIM24;FBXW5;NUP93;RNF41;AAAS;CDC34;FBXO11;TRIM21;CUL2;ARRDC4;CCDC22;UBA6;PEX14;ANAPC7;NUP50;NUP54;MDM2;SUMO1;TRIM72;DCUN1D3;NUP98;TRIM7;CUL4A;ATG10;PIAS4;ABCB11;UBE2C;KLHL21;BTRC;NUP42;NUP133;NUP210;KEAP1;CBLL1;ATG3;UFL1;MOCS3;OS9;KLHL41;NUP35;KLHL18;WWP2;UBA3;UBE2Z;CTR9;NUP214;SIRT1;TRIM68;LEO1;MUL1
prerank,regulation of urine volume (GO:0035809),-0.4579332833171662,-1.1471348228963483,0.28776978417266186,0.7051408143645095,1.0,6/10,36.22%,INPP5K;TFAP2B;HYAL2;ADM;HAS2;NPR3
prerank,regulation of protein binding (GO:0043393),0.37889122856869883,1.1470464400516949,0.21618852459016394,0.5969240621754393,1.0,36/114,23.35%,LRP1;CTSZ;NES;PRKCD;HDAC4;CAV1;DAB2;STK3;RPL11;RACK1;LRPAP1;BAMBI;B2M;BAX;PRMT7;NVL;TLE5;GTF2F1;ROCK1;ACTB;SPPL3;DERL1;PSME3IP1;SYMPK;RALB;HIP1R;PIN1;ITGB1BP1;IFIT2;MARK2;GSK3B;BMP4;TRIM21;TERT;USP33;PEX14
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.39340215755932656,1.1469648106571553,0.23719958202716823,0.59675321778323,1.0,19/80,12.79%,RAB7B;TBC1D10C;GOSR2;SNX8;RGP1;TMEM87B;VTI1A;BET1L;ARL1;STX6;RIC1;SPAG9;TBC1D23;VPS26A;VPS50;DCTN1;RAB7A;GCC2;LMAN1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.49793082359774277,1.1469207540042055,0.31512071156289706,0.5964645072988387,1.0,5/17,16.10%,LPL;HDAC9;APOC1;FURIN;APOH
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.43426066889283454,1.1464546634793866,0.27137970353477764,0.5972918525773937,1.0,5/35,10.06%,NRP2;FLNA;PLXNA2;NRP1;PLXND1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.44210319663425696,1.1464327198222055,0.3035294117647059,0.5969510563325606,1.0,15/30,29.63%,FBXW7;UBE2L3;HUWE1;BAP1;RHOU;VPS11;MICALL2;UBL5;CSNK2A2;SAE1;USP36;GSK3A;ATG13;TOMM7;LEPROT
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.45767724534656173,1.146221226870345,0.2996389891696751,0.5971403937573982,1.0,5/25,9.92%,PLAUR;MMP9;BID;BCL2L11;BAX
prerank,positive regulation of kinase activity (GO:0033674),0.37780258531226907,1.145941409175248,0.20307692307692307,0.5975390143607284,1.0,21/107,17.24%,IQGAP1;FLT1;CSF1;PTPRC;CD4;LAT;ALS2;AXL;PTK2B;LMO4;DAXX;TREM2;IGF1R;VAC14;RAD50;GAS6;JTB;KDR;MAP2K3;PRKAG1;DDR2
prerank,regulation of cellular metabolic process (GO:0031323),0.4112323978666223,1.1457629189865224,0.2689732142857143,0.5976319014911461,1.0,18/45,28.13%,ABCG1;ACACA;EIF6;NCOR2;CYP1B1;ACACB;NPC2;PDK3;RNF41;VPS35;AGPAT1;MBOAT7;PARL;TBC1D16;FASN;ABCB11;KIF16B;LAMTOR1
prerank,actin cytoskeleton reorganization (GO:0031532),0.39819095678401933,1.145242736098748,0.2663101604278075,0.5986471706090906,1.0,13/63,12.03%,PLEK;FLNA;RAP2A;ANXA1;CLDN19;NEDD9;NRP1;GRB2;DTNBP1;FGF7;PARVA;RHOA;GSN
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3782060743206667,1.1452233669074303,0.21428571428571427,0.598304557579154,1.0,32/122,22.12%,BCAR3;IGF1;EIF6;VIM;GCK;DYRK2;FGF2;CD28;EEF2;PIWIL2;LARP4;CPEB3;METTL3;YTHDF3;NAMPT;NFKB1;PRKD2;SORBS1;EIF4A3;TMEM106A;KDR;FXR2;KAT7;IL6;DHX9;EPM2AIP1;EIF3E;UPF3A;NLRC5;NPM1;UPF3B;SAMD4A
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.4351543194000766,-1.1450548548889166,0.25213675213675213,0.7071440177348041,1.0,2/12,3.41%,SERINC3;SEPHS1
prerank,axonal transport of mitochondrion (GO:0019896),0.5360169290081305,1.1446748594700749,0.31746031746031744,0.5994313848865708,1.0,3/11,7.96%,HIF1A;MGARP;TRAK1
prerank,establishment of protein localization to membrane (GO:0090150),0.40085441036148145,1.144513563750126,0.25500526870389884,0.5994947772971215,1.0,25/66,29.09%,RFTN1;SDCBP;ZDHHC15;ZDHHC18;NACA;BID;NECTIN3;SEC63;ZDHHC1;NPC1;YIF1B;AFDN;RAB3GAP2;RAB11A;REEP1;PIKFYVE;GRIN3B;RTP4;RAB3GAP1;NCF1;ATG3;ZDHHC21;ARL6;FRMPD1;RAB11B
prerank,regulation of Rac protein signal transduction (GO:0035020),0.48117934691641984,1.1443945529619142,0.31462140992167104,0.5994257736397463,1.0,7/16,22.11%,ARHGAP24;ALS2;PIK3CB;CADM4;OGT;ARHGAP17;GABARAP
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.4032220818144405,1.1440954707433935,0.2732181425485961,0.5998625811981374,1.0,22/53,29.22%,ERCC6;EYA4;PRKCD;TRIM28;PLA2R1;ABRAXAS1;BRCA1;CEBPG;FXR2;UIMC1;ATM;DHX9;CCAR2;RPS3;SPRED2;NSMCE1;SPRED3;BRCC3;SMCHD1;ATR;ERCC8;SIRT1
prerank,cellular amide metabolic process (GO:0043603),0.3822170258884616,1.1440670459096751,0.2417695473251029,0.5995318789856373,1.0,33/102,26.01%,PLAAT3;CERK;MTHFD2;PPP2R1A;ACOT9;CPXM2;ORMDL1;PLPP3;SLC46A1;NAPEPLD;MTHFS;AEBP1;DNPEP;SHMT1;ACOT6;MTHFD1;FPGS;CPD;GLYAT;SMPD1;ST6GAL1;MTRR;SLC19A1;ORMDL3;AASDHPPT;ALDH1L2;PDZD11;ABHD4;NLN;ATF4;MTHFR;ACOT1;HLCS
prerank,regulation of mitotic spindle assembly (GO:1901673),0.46696292048554905,1.1434540253901053,0.30467762326169406,0.6008712604108088,1.0,7/19,18.86%,CHMP4B;PDCD6IP;DRG1;VPS4B;TPR;HNRNPU;CCSAP
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3731824895103808,-1.1431367032064148,0.25263157894736843,0.709232231036653,1.0,4/18,6.06%,IL6R;FER;STAT3;ST18
prerank,negative regulation of signaling (GO:0023057),0.44947013319132634,1.1430440364062149,0.2885514018691589,0.6016524536679415,1.0,4/25,10.83%,OPTN;BRAP;TRAT1;SOCS5
prerank,Wnt signaling pathway (GO:0016055),0.38469197696099683,1.1429550501272396,0.24141519250780438,0.601487758343166,1.0,23/92,21.27%,CTNNB1;TCF7;CCDC88C;LEF1;UBA52;RPS27A;CD24;PLPP3;WNT6;VPS26A;CSNK1G1;SFRP5;WLS;FRAT1;FZD1;FZD4;LRP6;NR4A2;FERMT2;UBC;TCF7L1;CUL1;GSK3B
prerank,fatty acid oxidation (GO:0019395),0.4005326386614266,1.1425993994019639,0.2740174672489083,0.602071185720291,1.0,21/57,25.66%,ACAD11;ABCD4;PEX2;PPARD;ABCD2;ACAD10;ECI2;ACAT1;ABCD3;CPT2;ADIPOR1;DECR1;ALDH3A2;EHHADH;ACADL;ACADS;ADH5;ACADM;HADHA;HADH;ACAA2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4618100124233041,1.1422657049213831,0.29411764705882354,0.6025893471671666,1.0,9/22,22.19%,MDFIC;GDI1;UFM1;LMAN1;SP100;BARD1;CHP1;ITGB1BP1;SUFU
prerank,chondroitin sulfate metabolic process (GO:0030204),0.44306617453286773,1.1421753621667816,0.30117647058823527,0.6024087546008124,1.0,15/30,31.74%,CHST11;CSPG4;HEXA;DCN;BGN;CHST12;IDUA;CSPG5;CHST3;DSEL;HEXB;NDNF;DSE;CHST9;CSGALNACT2
prerank,protein trimerization (GO:0070206),0.5063508385513793,1.1420214025671862,0.32611464968152865,0.6020340611565173,1.0,7/14,24.12%,MLKL;SLC1A5;DISP1;CLYBL;MIF;ASIC1;STEAP4
prerank,protein homotrimerization (GO:0070207),0.5063508385513793,1.1420214025671862,0.32611464968152865,0.6020340611565173,1.0,7/14,24.12%,MLKL;SLC1A5;DISP1;CLYBL;MIF;ASIC1;STEAP4
prerank,skin development (GO:0043588),0.39595287777862265,1.1413834652888128,0.26100966702470463,0.6034147789807663,1.0,10/65,12.24%,ANXA1;ST14;ATP7A;PDGFA;JAG1;CLIC4;UGCG;EVPL;HRNR;ASCL4
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.391530117754606,-1.141178359472354,0.26666666666666666,0.7111984775273421,1.0,10/15,29.69%,WHRN;COL11A1;ADGRV1;HPN;TMC1;KCNK4;SCN1A;TMC2;PDZD7;LHFPL5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4885597457444496,1.1411332091680737,0.3012987012987013,0.6037199124656109,1.0,10/16,38.28%,CPEB3;DHX36;TARDBP;ZC3H12D;KHSRP;RC3H1;PLEKHN1;ZC3H12A;TRIM71;ZFP36L2
prerank,regulation of exosomal secretion (GO:1903541),0.46611483785373287,1.1406542700418627,0.3160621761658031,0.6046061271241807,1.0,5/19,11.70%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,positive regulation of organelle organization (GO:0010638),0.43670280498782416,1.1406293848883935,0.2853881278538813,0.6042843717027221,1.0,12/32,26.90%,SMCR8;ANXA1;MGARP;TREM2;FYCO1;LMAN1;RAB3GAP2;PFDN2;GSK3B;PLA2G5;RAB3GAP1;SURF4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5223410718323382,1.140362009712317,0.30892143808255657,0.6046524735150561,1.0,1/12,0.51%,CHAMP1
prerank,positive regulation of cell population proliferation (GO:0008284),0.36152792858820415,1.14032348696434,0.082,0.6043581049847274,1.0,137/423,27.48%,IGF1;BCL2;FLT1;ITGAX;FN1;CDK6;PRKCH;CSF1;TCIRG1;SDCBP;PTPRC;LTF;LEF1;CXCR2;GCNT2;PDGFA;PTGFR;RPS6;OSMR;NES;ID2;NRG1;NR4A3;SPHK1;PTK2B;DOT1L;FGF2;HDAC4;S100A6;SLC25A33;RPL23;SOX9;VEGFA;CRKL;HDAC1;CAPN1;IGF1R;FBXO5;KITLG;EAPP;ADAM17;CDK13;BAMBI;HMOX1;FGF7;KRAS;SLC35F6;PIM1;RHOG;CCL5;FGF20;DLL4;NAMPT;CHRD;GAS6;CDCA7L;CDK2;BIRC5;CCL14;STX3;STOX1;IL31RA;LAMC1;VIP;CDC7;EFNB2;CCND2;KDR;CHTOP;BMP6;SINHCAF;DDR2;CAPNS1;C5AR1;SERPINF2;HNRNPU;TOX;CNBP;S100B;BMI1;IL6;DHX9;RPS9;CCAR1;CUL3;BST2;FAM98A;ITGB1BP1;IL2;GAB2;MEIS3;CNOT6;TIMP1;EPO;HSF1;SERTAD1;SRPK2;NPM1;CD47;BMP4;CIAO1;CDC123;FGF18;CALR;TERT;FGFR3;F2R;HTR2B;IL34;CD74;KMT2D;TGFBR2;MIF;FGFR2;MDM2;TNF;HDAC2;PDGFRA;CDK4;CDC25B;MAPK15;SFRP1;BMP5;MDK;FGF1;CNOT6L;CX3CL1;PTPN6;STX4;IL12RB2;SSR1;CCN4;SAAL1;KDM1A;S1PR2;HES1;UFL1
prerank,lysine catabolic process (GO:0006554),0.5282913416821079,1.1398850587707958,0.3112313937753721,0.6047814050724004,1.0,5/12,18.99%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,lysine metabolic process (GO:0006553),0.5282913416821079,1.1398850587707958,0.3112313937753721,0.6047814050724004,1.0,5/12,18.99%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4901255666185634,1.1395497698611419,0.31544502617801046,0.6053495752178761,1.0,3/16,11.00%,IGF1;FGF2;PIM1
prerank,regulation of keratinocyte migration (GO:0051547),0.5185599058909192,1.1393263781527694,0.30596026490066225,0.6055798103975096,1.0,3/12,10.16%,IQSEC1;MMP9;FGF7
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42332815144902985,1.139192034230469,0.28,0.6055817368117619,1.0,9/40,10.16%,FLT1;ABL2;ITK;GNAQ;EDNRA;FGF2;TXK;PLCB2;ARHGAP6
prerank,ion transport (GO:0006811),0.37783471317328615,1.1391692244923677,0.2331288343558282,0.6052415416354375,1.0,23/111,14.85%,SLC9A1;SLC26A1;SLC24A4;KCNN4;SLC15A3;CHRNB2;VDAC2;PANX3;SLC17A5;PANX1;PIEZO1;PLP2;LASP1;SLC9A8;PIEZO2;ATP1A4;SLC12A4;SLC26A11;CNGB1;SLC8B1;SLC9A6;SLC9A7;SLC26A4
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3401938673870595,-1.1391074314929508,0.27848101265822783,0.7134038450625677,1.0,9/26,15.10%,FCHSD2;SNAP91;PICALM;SGIP1;ITSN1;LMBRD1;AP2A1;FCHO2;CLTB
prerank,L-amino acid transport (GO:0015807),0.43968592635007303,1.1385881208952036,0.27532777115613827,0.6064843131551679,1.0,9/28,19.68%,SLC3A2;SLC7A1;SLC36A4;SLC36A3;SFXN1;SLC7A8;ARL6IP5;SLC25A18;SLC38A2
prerank,positive regulation of protein modification process (GO:0031401),0.3677817859300679,1.1383449360076257,0.16129032258064516,0.6067494446160713,1.0,48/203,18.18%,GPNMB;ATG7;RAP2A;FPR2;PLAUR;CD4;PTPA;CLDN19;MMP9;NPTN;PRKCD;FGF2;DAXX;MYDGF;DAB2;SOX9;VEGFA;CRKL;ANGPT1;TREM2;DLC1;RASGRP1;ILK;ADAM17;P2RY1;RACK1;FGF7;KRAS;C3;FGF20;ALG10B;EFNA1;GAS6;PPIA;SPPL3;CSNK1D;TFRC;CCND2;SYMPK;KDR;CHP1;SMPD1;FXR2;ASPSCR1;RALB;RAB3GAP2;PIN1;TESK1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4380431938246298,1.1376438124697696,0.313953488372093,0.6083075585113851,1.0,13/29,32.25%,RUNX1;VPS18;UFM1;BRCA1;CARM1;VPS11;WBP2;LATS1;KMT2D;KANK2;UFL1;CNOT9;UBA5
prerank,intraciliary retrograde transport (GO:0035721),0.5227737294632078,1.1374253506514043,0.31057563587684067,0.6085201962153938,1.0,6/12,27.37%,TTC21A;IFT43;WDR35;IFT122;DYNC2I1;DYNLT2B
prerank,selective autophagy (GO:0061912),0.4029770600181217,1.137127333591955,0.28043478260869564,0.6089817704690018,1.0,29/56,32.69%,UBA52;RPS27A;VIM;SQSTM1;DYNC1H1;UFM1;RAB7A;MAP1LC3B;UBQLN1;IFT88;DYNC1LI2;RETREG1;ATM;UBC;ATG2B;ACBD5;WDFY3;STBD1;UFL1;ATG13;USP30;AMBRA1;BECN1;LGALS8;UBB;UBA5;ATG5;DYNC1I2;TEX264
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4681793742300898,1.136825616463348,0.29234629861982436,0.6093992221970511,1.0,2/20,6.69%,GCK;SIK1
prerank,activation of adenylate cyclase activity (GO:0007190),0.43306898714899755,1.1362168793137815,0.3134160090191657,0.6107447770705554,1.0,6/35,5.05%,ADCY8;ADCY3;EDNRA;ADCY7;RAF1;CAP1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3612669032929415,1.1358921629650776,0.123,0.6112447733799404,1.0,126/341,29.99%,CTNNB1;MYLIP;PSMD8;NFE2L2;PSMD1;RNF125;FBXL17;TBX21;WDR91;CNOT4;COPS3;RNF14;PTPN23;SQSTM1;KCTD17;FBXW7;ANAPC15;TRIP12;NHLRC1;PPP2R5C;RNF7;SIAH2;ZFAND2A;TTC3;RNF6;UBR4;RNF128;SPSB2;ATXN3;UBE2L3;UBE2H;FZR1;ZNRF3;USP9X;PSMD6;PSMA1;AGAP3;FBXW4;PLAA;VCP;DDB1;RNF111;PSMC3;NHLRC3;UBE4A;HUWE1;VPS4B;PSMA8;UBE3B;SHARPIN;UBE2R2;BIRC6;ANAPC1;PSMD14;UBAP1;KCTD10;PSMD2;DDIT3;UBE2L6;MVB12A;BFAR;UBQLN1;ZSWIM8;FBXL19;CBL;PSMC6;PSMA6;UBE3C;KLHL25;RMND5B;PSMD5;UBE4B;PSMA5;CDC26;RNF167;RNF149;CUL3;SPSB3;BUB1B;FBXO7;RNF19A;RNF20;FBXW11;FBXW5;CDC34;RNF216;FBXO11;USP33;UBA6;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;PSMB10;PSMB8;KCTD21;PSMD7;CUL4A;VPS28;UBE2C;PSMB6;BTRC;KCTD2;PELI1;KEAP1;PSMD10;RC3H1;GSK3A;PSMB5;RNF13;TNFAIP3;TRIM3;OS9;PSMB7;WWP2;ERCC8;UBAP1L;SIRT1;PSMC4;FAF1;TGFB1I1;RNF19B;SKP2;RCHY1;MVB12B
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4414983708008888,1.1357542014232542,0.3138424821002387,0.611217588885252,1.0,5/27,9.40%,PRKCQ;PRKCD;NCK1;PRKCB;PTPN2
prerank,hemopoiesis (GO:0030097),0.3808060649577183,1.1350882623086087,0.26519916142557654,0.6126007145445799,1.0,30/87,25.45%,FLT1;LCK;PLEK;KMT2A;PTPRC;FSTL3;JAG1;RUNX1;ZNF160;KITLG;CDK13;HIPK1;CEBPA;ZBTB16;ETV6;YTHDF2;TIRAP;KDR;TOX;BMI1;PRRC2C;RUNX3;BMP4;MELK;FUT10;TGFBR2;FGFR2;ATF4;SFRP1;NOTCH4
prerank,regulation of cell population proliferation (GO:0042127),0.3577216821437183,1.1349665010800094,0.039,0.6125373120664949,1.0,174/691,22.69%,GPNMB;IGF1;BCL2;FLT1;CTNNB1;ITGAX;FN1;CDK6;CSF1;NIBAN2;TCIRG1;SDCBP;IGFBP7;SPEG;SGK1;LEF1;ADARB1;CXCR2;PPP1R9B;GCNT2;PDPN;PDGFA;PTGFR;RPS6;OSMR;ID2;STAT4;SCIN;NRG1;HRG;IRF6;GTPBP4;NR4A3;CYP27B1;VDR;CLDN19;PTK2B;DOT1L;SGK3;SGK2;RAF1;FGF2;MNT;S100A11;PPP2R5C;HDAC4;JAG1;NCK2;ELN;SLC25A33;ADGRB1;RUNX1;BCL6;RPL23;GATA3;SOX9;NUDT6;VEGFA;CRKL;ING4;COPS8;HDAC1;P3H1;DLC1;CAPN1;CELF1;IGF1R;FBXO5;LMNA;IFITM1;COL18A1;KITLG;EAPP;ADAM17;CDK13;PTPN2;CADM4;BAMBI;SFRP5;SOX7;JUP;CHERP;FGF7;KRAS;ATF5;UTP20;SLC35F6;RHOG;JUN;CEBPA;BAP1;FGF20;DLL4;HP1BP3;RHOA;BIRC6;NAMPT;NUPR2;TFAP4;TNFRSF9;CDCA7L;CDK2;ARID2;BIRC5;CCL14;STX3;STOX1;IL31RA;RBFOX2;CLU;CYP1B1;VIP;CDC7;MELTF;TFRC;EFNB2;CCND2;KDR;CHD5;CHTOP;ING5;CCN6;BMP6;SMYD2;RPS6KA2;SINHCAF;CAPNS1;CDKN3;STK11;CNBP;GNL3;S100B;IL6;RPS9;CCAR1;CUL3;AGO3;FAM98A;ITGB1BP1;SULT2B1;IL2;ARHGEF2;GAB2;PIAS1;FTH1;GNRH1;SOD2;MEIS3;TBRG1;CNOT6;TIMP1;EPO;VHL;DUSP15;HSF1;RNF41;SERTAD1;SRPK2;NPM1;CD47;BMP4;CIAO1;TES;CDC123;CDCA7;FGF18;ABI1;CALR;FGFR3;KLF11;EGLN3;F2R;HTR2B;IL34
prerank,positive regulation of response to stimulus (GO:0048584),0.4114858548291912,1.1348618313735188,0.2893569844789357,0.6124346470033415,1.0,10/40,18.34%,SELENON;GPR151;PRKCD;GATA3;ECHDC3;ILK;B2M;RSAD2;FXR2;DHX9
prerank,regulation of glucose transmembrane transport (GO:0010827),0.478293205606861,1.13463496106876,0.3040629095674967,0.6126726647949365,1.0,4/18,10.54%,NR4A3;SLC2A1;PRKCB;C3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.37925619381680625,1.1332818303228844,0.24591836734693878,0.61613648252505,1.0,42/107,28.70%,BCL2;ATF3;TRAF2;ERN2;ERN1;NCK1;BCL2L11;EIF2S1;P4HB;UFM1;ERO1A;VCP;BAX;TMX1;CREB3L2;JUN;ERP44;DNAJB9;DDIT3;RCN3;UBQLN1;PPP1R15B;DERL1;CASP4;PIK3R2;MBTPS2;WFS1;UBXN6;GSK3B;ATP2A2;PPP1R15A;DNAJC10;ATF4;HSPA5;TMCO1;ATG10;USP19;UFL1;DNAJB12;OS9;ITPR1;HSP90B1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.37780016792214965,-1.1332536391290078,0.29464285714285715,0.7268516322433697,1.0,4/16,2.42%,MEF2C;SNCAIP;CPLX1;RIMS1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3598047448774912,1.1332282164322944,0.109,0.6158839160633226,1.0,87/351,22.64%,GPNMB;CTNNB1;CDK6;NIBAN2;IGFBP7;NLRC3;PTGIR;SPEG;ADARB1;B4GALT7;PDPN;SCIN;HRG;IRF6;GTPBP4;CYP27B1;VDR;CLDN19;PTK2B;RAF1;MNT;NELL1;S100A11;PPP2R5C;PPARG;NCK2;ADGRB1;GATA3;MTSS1;SOX9;NUDT6;ING4;COPS8;TREM2;P3H1;DLC1;CELF1;PEX2;LMNA;IFITM1;COL18A1;E2F3;CD300A;PTPN2;SFRP5;SOX7;B2M;HMOX1;CHERP;ATF5;UTP20;CEBPA;BAP1;DLL4;FBLN1;NUPR2;TFAP4;ARID2;RBP4;CYP1B1;VIP;APPL2;CHD5;NF1;ING5;CCN6;SMYD2;RPS6KA2;CDKN3;STK11;IL6;SLC16A2;ITGB1BP1;SULT2B1;FTH1;GNRH1;SOD2;TBRG1;VHL;RNF41;RUNX3;NPM1;BMP4;TES;ABI1;KLF11;F2R
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.43366281310406707,1.1331642793436378,0.2977725674091442,0.6156695912924928,1.0,16/29,32.77%,TRIM6;TTLL12;RNASEL;PTPN2;METTL3;YTHDF3;YTHDF2;USP18;NLRC5;HSP90AB1;PTPN6;IFNAR2;MUL1;PTPN1;MAVS;UBE2K
prerank,regulation of interleukin-2 production (GO:0032663),0.41045431814662914,1.1327318962157726,0.29637760702524696,0.6164280024958744,1.0,9/43,6.02%,PTPRC;ANXA1;CD4;MALT1;HDAC7;TBX21;TRAF2;CD28;RUNX1
prerank,prostanoid metabolic process (GO:0006692),-0.4030584029261633,-1.1327287488000486,0.2908366533864542,0.7247380696250789,1.0,3/13,7.45%,PTGS1;HPGD;HPGDS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5116965144811997,1.1326519244693751,0.32977303070761016,0.616228880785656,1.0,5/12,26.43%,DHRS3;TRIM16;ASXL1;CALR;SNW1
prerank,catecholamine metabolic process (GO:0006584),0.5089382612730189,1.132098196814444,0.3074866310160428,0.6173430859764776,1.0,3/14,8.46%,ATP7A;TH;RNF180
prerank,spindle assembly (GO:0051225),0.39350744768402024,1.1319412460830585,0.27058823529411763,0.6173983758955546,1.0,22/67,25.66%,FLNA;TUBGCP4;LSM14A;HAUS8;BCCIP;ABRAXAS1;RHOA;INO80;NUMA1;RCC1;SMC3;CSNK1D;KIFC1;RAB11A;NEK6;HAUS2;RPS3;TOGARAM2;AAAS;STAG1;GOLGA2;HDAC3
prerank,transcription by RNA polymerase I (GO:0006360),0.42905743327204443,1.1318681724328454,0.3109048723897912,0.617187078439173,1.0,18/34,31.29%,TAF1D;POLR1G;POLR2H;TTF1;UBTF;POLR1A;TCOF1;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MAPK3;MNAT1;POLR1H;ERCC2
prerank,protein ubiquitination (GO:0016567),0.3605183223607583,1.1315903495677326,0.099,0.6175067528267316,1.0,165/471,30.58%,BCL2;CTNNB1;HIF1A;MYLIP;PSMD8;NFE2L2;PSMD1;SASH1;RNF125;FBXL17;UBA52;TRAF2;RPS27A;CNOT4;TRIM6;TRIM43;RNF14;FBXW7;FBXO32;TNKS2;TRIP12;BRAP;NHLRC1;OTULIN;RNF7;HECTD2;SIAH2;RNF6;TSPAN17;SDE2;KLHL7;NFX1;SPSB2;PEX2;UBE2L3;UBE2H;FBXO31;ZNRF3;USP9X;PSMD6;VPS18;PSMA1;DDB2;RACK1;FBXW4;VCP;DDB1;OBI1;CUL9;RNF111;PSMC3;NHLRC3;USP5;KLHL13;UBE4A;BRCA1;HUWE1;SHPRH;PSMA8;UBE3B;UBE2R2;BIRC6;ENC1;UBE2Q1;VPS11;TPP2;PSMD14;KCTD10;PSMD2;BLMH;UBE2L6;DTX2;MKRN2;BFAR;ZSWIM8;DTX4;FBXL19;CBL;KLHL24;DERL1;PSMC6;RNF157;BARD1;PSMA6;UBE3C;KLHL25;ASB1;RNFT1;PSMD5;ELOB;UBE4B;PSMA5;WSB1;PAF1;UBE2V2;UBR2;RNF167;CUL3;DTX3;FBXO7;UBC;RNF19A;RNF20;FBXW11;CAND1;VHL;CUL1;TRIM24;FBXW5;RNF41;CDC34;ZNRF2;FBXO11;TRIM21;CUL2;ARRDC4;CCDC22;UBA6;PEX14;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;PSMB10;FBXO41;PSMB8;TRIM7;PSMD7;CUL4A;ABCB11;UBE2C;PSMB6;KLHL21;BTRC;PELI1;KEAP1;PSMD10;CBLL1;ATG3;RC3H1;PSMB5;RNF13;TRIM3;OS9;PSMB7;KLHL41;LONRF1;KLHL18;WWP2;ERCC8;UBE2Z;CTR9;SIRT1;PSMC4;TRIM68;LEO1;MUL1;RNF19B;SKP2;RCHY1;KBTBD8;FBXW2;TRIM37;NUB1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4552615105309571,1.1313311329786506,0.32,0.6178266747053867,1.0,6/21,22.73%,IGF1;SOX9;KDR;PTGER4;HTR2B;MAP2K2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5089745014447105,1.1310945079675587,0.3131578947368421,0.6180700881271319,1.0,5/12,24.21%,SMCR8;IGF1R;FYCO1;BNIP3;TNF
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5153802649440952,1.1308591890840902,0.33506493506493507,0.6183277338896556,1.0,4/12,18.05%,CTDNEP1;PRKCB;CCNB1;NEK6
prerank,positive regulation of reproductive process (GO:2000243),0.4299198030135759,1.130670733462723,0.29142185663924797,0.6184449504863463,1.0,7/31,15.78%,AGO2;LHFPL2;VEGFA;TAC4;PRDM9;VIP;C1QBP
prerank,negative regulation of defense response (GO:0031348),0.3806608801859936,1.1305774132039947,0.26403326403326405,0.6182879490027293,1.0,23/77,23.09%,APOE;FPR2;SIRPA;NLRC3;PRKCD;MFHAS1;OTULIN;PPARG;GATA3;PPARD;PTPN2;SHARPIN;ILRUN;LPCAT3;ACOD1;C1QBP;LYAR;PTGIS;METRNL;TRIM21;PTGER4;MAPK7;VPS35
prerank,striated muscle cell differentiation (GO:0051146),0.4888684332732842,1.1301123099069694,0.31282722513089006,0.6191646700495073,1.0,4/16,6.69%,PLD3;AKAP13;NRG1;SIK1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.42421788870942495,1.1300039169165441,0.29279811097992914,0.6190700635192139,1.0,13/33,22.38%,ANKRD28;RAD50;GAR1;CDK2;PPP6C;RFC1;RTEL1;PTGES3;TERF1;HSP90AB1;ACD;DKC1;TERT
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42724601287743463,1.1299636622957003,0.31890660592255127,0.6187844337479973,1.0,10/35,18.85%,ABL2;ARHGAP24;RIPOR2;DLC1;MYOC;KCTD10;SPRY4;SYNGAP1;ITGA3;CUL3
prerank,regulation of JUN kinase activity (GO:0043506),0.4262000640902671,1.1297435244244793,0.30210772833723654,0.618983973378827,1.0,11/33,25.85%,SASH1;TRAF2;NPPA;TAOK3;PTPN22;PDCD4;RPS3;ARHGEF5;DNAJA1;TNF;TLR9
prerank,membrane protein proteolysis (GO:0033619),0.4227788228059269,1.1297002194459926,0.2930648769574944,0.6186994257028577,1.0,10/37,17.28%,PRKCQ;DAG1;CLPP;NAPSA;PSEN2;ADAM17;AFG3L2;NFKB1;SPPL3;MBTPS2
prerank,cellular response to interferon-gamma (GO:0071346),0.38005952293742473,1.1294022368663055,0.26222684703433924,0.6191244048210945,1.0,23/88,18.33%,EPRS1;SIRPA;CCL4;CD44;IRF6;PRKCD;IL12RB1;IRF8;CCL13;B2M;CCL7;JAK1;IRF5;CCL5;SP100;CCL14;SYNCRIP;DAPK1;ACOD1;GBP2;AQP4;DAPK3;RPL13A
prerank,response to estradiol (GO:0032355),0.4326495093250396,1.1291594131939486,0.28722157092614303,0.6194101200965254,1.0,3/31,3.76%,CTNNB1;ANXA1;CYP19A1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.4834485610579807,1.1290488766461875,0.3104738154613466,0.6193098078832999,1.0,6/17,18.98%,PRKCQ;CD28;GATA3;SYK;HAVCR2;FCER1G
prerank,positive regulation of response to external stimulus (GO:0032103),0.37061287617490873,1.128875272244249,0.24318869828456105,0.6193954364915261,1.0,33/128,19.84%,LPL;S100A8;S100A9;CYBA;FPR2;SASH1;TNIP1;ADAM8;OPTN;MAPK13;HRG;NAPEPLD;TREM2;NFKBIZ;POLR3D;CEBPA;CCR2;SERPINE1;CCL5;RIOK3;GPRC5B;STX3;ACOD1;APOH;NINJ1;BMP6;PUM1;PDCD4;SERPINF2;DHX9;SCIMP;IL2;GPSM3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.46186814601135734,1.1285188085999138,0.3155339805825243,0.6199980066285368,1.0,11/22,27.23%,UBA52;RPS27A;DDB2;DDB1;XPA;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2
prerank,melanosome transport (GO:0032402),0.48458236309801705,1.1284330103320235,0.3193588162762022,0.6194039538947859,1.0,8/18,29.09%,MYO5A;BLOC1S3;MKKS;RAB11A;BBS7;MREG;ARL6;RAB11B
prerank,pigment granule transport (GO:0051904),0.48458236309801705,1.1284330103320235,0.3193588162762022,0.6194039538947859,1.0,8/18,29.09%,MYO5A;BLOC1S3;MKKS;RAB11A;BBS7;MREG;ARL6;RAB11B
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.35350606628454495,1.1283630509759257,0.03,0.619206388121881,1.0,325/1082,26.20%,IGF1;MDFIC;LITAF;CTNNB1;CXXC1;SPP1;MITF;APOE;HIF1A;ERCC6;SKAP1;CSRNP1;ZMIZ1;NIBAN2;MMP12;ATF3;CDK8;MRTFA;TOX2;ELF4;SLC9A1;KMT2A;NFYA;NFIC;NFE2L2;CD4;LEF1;UBA52;TBX21;AGO2;MYBL2;DEAF1;RPS27A;TNIP1;BCL11B;MAFF;CDCA4;ID2;EOMES;SOX3;GDF6;IRF6;TCF15;POMC;SOX30;NR4A3;FSTL3;VDR;MEF2D;DOT1L;RNF14;POU3F1;SQSTM1;NFIL3;FGF2;CSRP3;TFEB;HDAC4;JAG1;PPARG;NCK2;FOXJ1;MYDGF;ZMIZ2;KLF6;RUNX1;DAB2;GATA3;RNF6;RFX5;TRIM28;SOX9;BRD4;NCK1;VEGFA;EGR2;PPP1R12A;BPTF;HDAC1;TXK;THOC1;MED21;ZNF395;CDH1;MTF2;RHOQ;TRIM16;TNIP3;PRDM15;NAA16;DDX17;HMGN1;ILK;LILRB1;KDM3A;PPARD;IRF8;E2F3;RNASEL;HOXA7;CCNC;NKX2-1;TET3;UBTF;BAMBI;WDR43;NEK4;SS18L2;RNF111;PSMC3;JUP;ASXL2;FGF7;POU2AF1;SMARCB1;TASP1;BRCA1;MEF2B;DNM2;CRTC1;ATF5;CREB3L2;NRF1;PCBD2;TRIAP1;ELF2;RHOG;JUN;CEBPA;SERPINE1;MED17;MAML2;IRF5;TAF15;RAI1;TNIP2;MYSM1;MRTFB;ZKSCAN3;SLC30A9;NAMPT;MAP3K12;ZFP64;NPAT;SMARCC1;PPARGC1B;SP100;MRPL12;FZD1;ZBTB16;ELK4;SMAD7;OGT;CHCHD2;TFAP4;FOXJ3;GTF2F1;SMAD1;ILF3;H1-0;BLM;YY1;EHF;FZD4;DDX39B;NFYB;DCN;IL31RA;DDIT3;ACTR3;NFKB1;INO80;PRKD2;ELOF1;LRP6;ACTA2;SSBP4;SP7;PAXBP1;ARHGEF11;ING2;HELZ2;PCBP1;MED13;ASXL1;NHLH2;SRF;CEBPG;SERTAD3;PRMT2;FOXO1;MTF1;NR4A2;ECD;PLAC8;HTATIP2;ZNF296;DHX36;NPAS4;ELK3;ING5;MAP2K3;PIK3R2;BMP6;AKIRIN1;CAMK4;PRPF6;SBNO2;SERPINF2;HNRNPU;DHX33;GABPB1;GABPB2;TCF12;CNBP;ATRX;HAX1;PIN1;KAT7;USF2;GTF2H1;ATM;IL6;DHX9;RASL11A;WBP2;SP1;DR1;CCNT2;LYAR;TAF7;ITGB1BP1;TAF6;SLC11A1;HOXB4;YAF2;ARHGEF2;UBC;TMF1;NR3C1;NFATC3;HMGB1;SREBF1;SPIB;RNF20;FBXW11;MEIS3;ARID1B;EIF5A;EPO;VHL;RFXANK;NLRC5;PBX1;HSF1;RXRB;RUNX3;ETV4;SERTAD1;NPM1;ZXDC;BMP4;SENP1;ATAD2B;GLYR1;TEAD1;WAS;ARNT2;PPRC1;RLF;F2R;SMARCD2;NIF3L1;NSD3;MAP2K2;MAPK7;CD74;EGR1;AHR;ZBED3;STAT5B;PITHD1;KMT2D;PBX2;REL;LHX4;FGFR2;XPC;RXRA;DCAF6;WWOX;SOX10;PPP3R1;LPIN3;TNF;GLIS2;MAP2K5;ATF4;EDF1;POU2F1;HDAC2;RRP1B;SFRP1;BMP5;MED6;GRHL1;CREB5;NDP;NOTCH4;DPF3;CSRNP3;HDAC3;MYRF;LAGE3;SMARCA4;TLR9;MLLT6;TFCP2;ZPR1;FGF1;CX3CL1;NCF1;BTRC;NSD1;TMPRSS6
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5364864060303927,1.1282926569471987,0.338865836791148,0.619010384587205,1.0,5/10,29.24%,PSMC3;PSMC6;HMGB1;ATF7IP;PSMC4
prerank,regulation of myelination (GO:0031641),0.4372238728420931,1.1279470292114033,0.30952380952380953,0.6195484820251976,1.0,6/25,15.72%,ITGAX;CST7;EGR2;TMEM98;TNFRSF1B;NCMAP
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4311924575391707,-1.1274977668979953,0.29133858267716534,0.7366546601529568,1.0,4/11,6.25%,PARP8;PARP14;PARP12;PARP11
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4602372761094912,1.1271946561814241,0.3192771084337349,0.6211944578003336,1.0,11/22,26.59%,NCL;UBTF;WDR43;SMARCB1;PWP1;DHX33;RASL11A;LYAR;ATF4;SMARCA4;PIH1D1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.46759610041518224,1.1270653860652193,0.3135802469135803,0.6211628227189434,1.0,7/19,24.26%,IRAK2;CD24;RUNX1;TLE5;DHX9;MAPK7;MAP2K5
prerank,positive regulation of protein import (GO:1904591),0.4284345872828601,1.1269408772542397,0.3204225352112676,0.6211338392937843,1.0,13/30,25.91%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;TPR;PIK3R2;ARHGEF5;RBM22;BAG3;HDAC3;ZPR1
prerank,cell proliferation in forebrain (GO:0021846),-0.4252280525873992,-1.1269034897696506,0.30656934306569344,0.7346780959208875,1.0,1/10,0.09%,NUMB
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.33061548584569544,-1.1268161474805671,0.27564102564102566,0.7313289262913628,1.0,8/24,15.87%,PDE3B;RAPGEF2;PEX5L;PRKAR2A;PRKAR2B;GPR61;PDE4D;PDE2A
prerank,cellular response to hydroxyurea (GO:0072711),0.5378421078082234,1.1268047207234386,0.318941504178273,0.621105545291562,1.0,3/10,17.98%,DDI2;BLM;ATRX
prerank,protein O-linked glycosylation (GO:0006493),0.37155024469906345,1.126744441230402,0.2590299277605779,0.6208764816430635,1.0,14/96,10.14%,B4GALT5;GALNT7;GALNT15;LARGE1;MUC1;MUC16;B4GAT1;B3GNT3;B3GALNT2;TRAK1;ST8SIA6;OGA;TET3;SDF2L1
prerank,protein lipidation (GO:0006497),0.3962528162095959,1.1266696474266515,0.2722400857449089,0.6206894096028747,1.0,12/59,15.34%,ATG7;ZDHHC15;PIGQ;ZDHHC18;PIGZ;PIGA;UGCG;WDR45;PIGN;ZDHHC1;PIGL;PIGC
prerank,negative regulation of cholesterol transport (GO:0032375),0.5350389417966523,1.1263834116237006,0.32821229050279327,0.6210716683688179,1.0,3/10,14.32%,APOA2;APOC1;NFKB1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.478203913062961,1.1260284661616198,0.323037323037323,0.6216876991544662,1.0,7/17,24.86%,VIM;SUCO;RUNX1;SERPINF2;BMP4;F2R;HDAC2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.42330092627881083,1.1260244003203235,0.30590961761297797,0.6213053761492464,1.0,10/32,22.53%,TAOK3;FZR1;FOXN3;ABRAXAS1;BRCA1;BLM;UIMC1;ATM;TAOK1;TOPBP1
prerank,steroid biosynthetic process (GO:0006694),-0.2707048463941234,-1.1259695646307173,0.23943661971830985,0.7301351075439404,1.0,14/56,12.51%,CYP27A1;PRLR;FDXR;OSBPL9;DHCR7;SC5D;INSIG1;INSIG2;OSBPL7;SLC27A2;CYP7B1;STAR;CYP39A1;LSS
prerank,leukotriene metabolic process (GO:0006691),-0.3664395876337178,-1.1259440534063483,0.27586206896551724,0.7266349695834899,1.0,3/19,3.80%,LTC4S;ALOX5;GGT5
prerank,negative regulation of cell migration (GO:0030336),0.3688204917145803,1.1256015941648045,0.2198581560283688,0.6221030935189098,1.0,48/137,26.27%,MITF;CORO1C;LRP1;RAP2A;DAG1;ADARB1;MCTP1;GTPBP4;CLDN19;PTPN23;FGF2;JAG1;CLIC4;STK24;DLC1;CDH1;IFITM1;HOXA7;NKX2-1;HMOX1;SERPINE1;CHRD;SMAD7;ARID2;ADAM15;CYP1B1;NF1;DUSP3;ADIPOR1;SINHCAF;AFDN;BST2;ITGB1BP1;EVL;DACH1;RNF20;TIMP1;ARHGDIB;RNF41;SRGAP1;CALR;CD74;MIF;MAPK15;SFRP1;DNAI3;CX3CL1;ATP1B2
prerank,receptor metabolic process (GO:0043112),0.4022139195683946,1.125551321989466,0.313915857605178,0.6218515378424624,1.0,14/53,16.06%,CD9;LRP1;SNX25;CXCR2;CAV1;GRB2;REP15;LILRB1;ARFGEF2;DNM2;MVB12A;ITGB2;TFRC;SYK
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5372964185431574,1.1253144653964005,0.3275167785234899,0.6221150109565978,1.0,7/10,31.79%,PPARG;RXRB;ACTN4;RXRA;SNW1;RXRG;RARG
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3891303060646747,1.1252092766566917,0.26569037656903766,0.6220304712049649,1.0,21/72,22.64%,MYO9B;APOE;ABCA1;ABL2;AKAP13;RIPOR2;RAF1;NRP1;GPR174;DLC1;MYOC;ARHGEF18;KCTD10;LPAR1;ITGA3;CUL3;ARHGEF2;ARHGDIB;PRAG1;GPR65;F2R
prerank,rRNA catabolic process (GO:0016075),0.48407823485872414,1.1248812157005879,0.3249669749009247,0.6225916871390541,1.0,5/16,12.13%,DEDD2;EXOSC4;ERN2;EXOSC9;EXOSC10
prerank,peptidyl-tyrosine modification (GO:0018212),0.3954874981417034,1.1248503928453337,0.29714912280701755,0.6222795638895045,1.0,20/56,26.28%,FLT1;LCK;ABL2;FGR;TEC;PTK2B;PKDCC;FYN;TPST1;KDR;SYK;DDR2;ABI1;FGFR3;FGFR2;JAK2;PDGFRA;BTK;ABI2;PTPN6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.39451089665264943,1.1246610609102878,0.2823529411764706,0.6224171453946846,1.0,24/62,29.19%,NUP205;AGO2;EIF4G1;PPARG;POLR2H;NUP188;POLR2D;RANBP2;TPR;PUM1;RAE1;DHX9;NUP93;AAAS;NUP50;NUP54;POLR2F;NUP98;NUP42;NUP133;NUP210;H3-3A;NUP35;NUP214
prerank,regulation of telomere maintenance (GO:0032204),0.44181644691487154,1.1241935690912266,0.3400473933649289,0.6232973187436192,1.0,12/26,31.97%,ERCC1;RAD50;ERCC4;DHX36;PPP1R10;ATRX;GNL3;RTEL1;TERF2IP;SMG1;XRCC5;TERF2
prerank,regulation of receptor internalization (GO:0002090),0.42428839118354844,1.1240696753720532,0.30813287514318444,0.6232510938708417,1.0,8/35,15.31%,SDCBP;VEGFA;ANGPT1;LRPAP1;ANKRD13B;CD63;SCYL2;ANKRD13A
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5098333567537783,1.1238780872581835,0.330718954248366,0.6234194625581371,1.0,4/13,15.10%,AGO2;PABPC1;CPEB3;EIF4ENIF1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.44558545790387616,1.123846757315554,0.31145584725536996,0.6231071570573431,1.0,2/25,1.06%,MMP8;P2RX4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5256485098322891,1.123813499454482,0.32147742818057456,0.6228042816018344,1.0,5/11,24.97%,ATF3;DDIT3;MBTPS2;ATF4;HSPA5
prerank,apoptotic process (GO:0006915),0.36420875945036646,1.1237415468517138,0.19176706827309237,0.6226069181478158,1.0,69/203,25.12%,BCL2;CSRNP1;BCL2L1;CD2;PDE1B;GZMB;GZMA;GDF6;PTK2B;MCM2;PAK6;RAF1;CDK5;PRKCD;PPP2R1A;BID;STK3;AKAP1;ING4;THOC1;DLC1;BCL2L11;PRF1;DIABLO;PPARD;CYFIP2;SFRP5;BAX;DAP;IAPP;HIP1;CDK11B;ZBTB16;OGT;PPIA;ADAM15;CASP7;HSPD1;ADORA2A;DAPK1;ITGB2;APAF1;CASP4;FOXO1;GLRX2;PDCD4;STK11;DAPK3;BNIP2;AIFM2;CASP9;IFIT2;BIK;YARS1;MELK;CDIP1;MRPS30;EGLN3;PPP1R15A;AHR;NUDT2;TGFBR2;BNIP3;MDM2;JAK2;PLK3;GADD45A;ATN1;RRAGC
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4035918833656903,1.1224803455252088,0.3026315789473684,0.6257241216899183,1.0,15/46,21.97%,SIRPA;PTPRC;TNIP1;DUSP9;PTPN2;RANBP9;DUSP6;FBLN1;CNKSR3;DUSP3;PIN1;ITGB1BP1;EMILIN1;SPRED2;LMO3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41727390592046254,1.122198301949959,0.3141891891891892,0.6261319557689355,1.0,19/38,29.63%,FBXW7;UBE2L3;HUWE1;BAP1;RHOU;LMAN1;VPS11;MICALL2;HAX1;UBL5;CSNK2A2;SAE1;SREBF1;USP36;PARL;GSK3A;ATG13;TOMM7;LEPROT
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.37690722905638113,1.121850932383727,0.2626680455015512,0.6267381928529722,1.0,43/100,30.96%,SDCBP;RNF14;PRICKLE1;DAB2;RNF180;RPL11;RACK1;VCP;USP5;SOCS5;CEBPA;XPO1;SMAD7;OGT;SUMO2;CLU;CSNK1D;ELOB;CCAR2;DESI1;HECTD1;PIAS1;RNF19A;GSK3B;HSP90AB1;TRIB2;GABARAP;MDM2;SUMO1;EIF3H;GIPC1;BBS7;KEAP1;PSMD10;GSK3A;UFL1;GNA12;CSNK1E;RNF19B;RCHY1;NUB1;HERPUD1;SIRT2
prerank,regulation of protein localization to nucleus (GO:1900180),0.40868990479109407,1.1218211513048237,0.3239910313901345,0.6264217601955817,1.0,15/43,22.26%,ATP13A2;MFHAS1;CARD10;NVL;ILRUN;TPR;TFRC;PIN1;KAT7;TESK1;ORMDL3;FERMT2;GSK3B;BMP4;LATS1
prerank,regulation of actin nucleation (GO:0051125),0.5141337117254356,1.121716941906329,0.33469945355191255,0.6263275384834549,1.0,3/12,12.03%,SCIN;WASHC5;GSN
prerank,calcium ion transport (GO:0006816),0.369882351086228,1.1214737419868053,0.2740286298568507,0.6266080303081831,1.0,25/113,18.61%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC3A2;SLC24A4;KCNN4;CHRNB2;CYP27B1;PANX1;CAV1;CRACR2A;TPT1;PSEN2;FYN;CCL5;CACNA1D;GAS6;TRPM7;CRACR2B;CACNG7;MCOLN3;CACNB3;ANO6;TMEM165
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5095215133154715,1.1213631699976838,0.35400516795865633,0.6265414213729598,1.0,3/12,6.71%,ATP7A;TRH;SLC22A3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3933819527115589,1.1212297730899743,0.29775880469583776,0.6265563948913335,1.0,25/58,29.67%,ERCC6;NSMCE2;ERCC1;CYREN;MDC1;ABRAXAS1;BRCA1;RAD50;PSMD14;ERCC4;BARD1;POLB;UIMC1;UBE2V2;ATM;HMGB1;DCLRE1A;SETMAR;SUMO1;PIAS4;LIG3;BRCC3;ERCC8;XRCC5;HMGB2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3811018458890377,1.1211688536900146,0.29411764705882354,0.6263391920758021,1.0,35/88,31.31%,PSMD8;PSMD1;FBXL17;FBXW7;FBXO31;PSMD6;PSMA1;FBXW4;PSMC3;PSMA8;PSMD14;PSMD2;PSMC6;PSMA6;PSMD5;PSMA5;FBXL6;FBXW11;CUL1;FBXW5;CUL2;PSMA3;PSMB10;PSMB8;PSMD7;CUL4A;PSMB6;BTRC;PSMD10;PSMB5;PSMB7;PSMC4;SKP2;FBXL5;PSMD12
prerank,cellular response to dsRNA (GO:0071359),0.5008047407157079,1.1208436867550569,0.33031088082901555,0.6268605978090893,1.0,6/15,21.66%,COLEC12;CAV1;RIOK3;RALB;DHX9;NPM1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3961632307712754,1.1206657507746145,0.2924731182795699,0.6269727011078609,1.0,13/56,25.16%,SDCBP;SNX25;BMP8B;GDF6;DAB2;RBPMS;SMAD7;BMP6;PIN1;EMILIN1;BMP4;PMEPA1;BMP5
prerank,positive regulation of protein import into nucleus (GO:0042307),0.43210609347369144,1.1203386783251759,0.31666666666666665,0.627481533824646,1.0,16/28,32.86%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;TPR;PIK3R2;RBM22;BAG3;HDAC3;ZPR1;MAVS;DMAP1;ZC3H12A;UBR5
prerank,skeletal muscle organ development (GO:0060538),0.4425113529963481,1.120085541387314,0.3146198830409357,0.6277760651625496,1.0,7/26,17.62%,LARGE1;CSRP3;CAV1;BASP1;IGSF8;SVIL;DISP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4991527023397549,1.1199739194002172,0.34143049932523617,0.627721803020442,1.0,7/13,31.24%,SOCS5;CBL;CBLB;CHMP6;ZGPAT;ERRFI1;SOCS4
prerank,protein localization to chromatin (GO:0071168),0.47137433728009587,1.1198310336636852,0.3478802992518703,0.6277308609964869,1.0,8/18,27.83%,FAM47E;WAPL;LEMD2;CHMP7;MCM8;NIPBL;PIH1D1;RUVBL2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5349931004961532,1.1196393169252425,0.3547008547008547,0.62787974168301,1.0,5/10,20.63%,INO80;CDC7;ATRX;STOML2;DBF4
prerank,regulation of Wnt signaling pathway (GO:0030111),0.37220730610237535,1.11946671454062,0.2770961145194274,0.6279499484276622,1.0,16/108,11.09%,MDFIC;CTNNB1;CDK14;LRP1;CCNY;MACF1;GNAQ;SOX30;OTULIN;PPP2R1A;RUNX1;MDFI;RACK1;SFRP5;SOX7;WLS
prerank,positive regulation of cell death (GO:0010942),0.39128660910330487,1.119126001921221,0.30926724137931033,0.628498352936699,1.0,20/59,24.21%,LRP1;SLC6A6;EIF4G1;DAXX;HP;HPR;CELF1;EIF2S1;FYN;SARM1;CLU;ITGB2;EFNB2;HTATIP2;GSK3B;MARK4;BMP4;EGR1;BNIP3;TNF
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3882688086801734,1.1190941582388576,0.3055848261327713,0.6281952560911686,1.0,25/72,25.61%,UBA52;RPS27A;ERCC1;XRN2;DDB2;DDB1;RAD50;DDX1;XPA;DXO;DCP1A;EDC4;ERCC4;ISG20;RFC1;GTF2H1;RNASE6;UBC;DNASE1L1;SETMAR;MEI4;EDC3;GTF2H5;RFC2;CUL4A
prerank,pentose-phosphate shunt (GO:0006098),0.5247330202710382,1.1189483202979842,0.32226832641770403,0.6282103596427007,1.0,6/11,23.55%,DERA;PGLS;TKT;RPIA;PGM2;TALDO1
prerank,positive regulation of protein binding (GO:0032092),0.3911349379979542,1.1186825645446066,0.30528586839266453,0.6285367032411406,1.0,19/56,22.83%,APOE;LRP1;MMP9;CAV1;STK3;RPL11;BAMBI;B2M;NVL;SPPL3;DERL1;RALB;HIP1R;PIN1;GSK3B;BMP4;TRIM21;TERT;USP33
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4646375565732684,1.1186634758337888,0.3199498117942284,0.6282023428055463,1.0,7/18,17.31%,ERN1;NCK1;BCL2L11;ATXN3;BAX;DDIT3;RNFT1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4744185245644836,1.1186167871344954,0.3176620076238882,0.6279357859849674,1.0,8/17,34.56%,ATP1A3;ATP1A1;ATP1A2;PKP2;ATP1B2;FKBP1B;GJD3;GJC1
prerank,protein localization to organelle (GO:0033365),0.3701541870167229,1.1182702422486275,0.2537764350453172,0.6284897757434981,1.0,44/133,24.46%,TRAM1L1;OPTN;TTC21A;CSRP3;FAM83H;CTDNEP1;ARL1;TSPAN17;LMNA;WDR35;RPL11;LAMP2;SNX10;SEC61B;GAK;HMOX1;DDX1;XPA;PAQR3;GCC2;ABCA7;DCP1A;CEP250;MTCH2;CSNK1D;GET1;GBP2;VAMP2;RAB11A;PAF1;ALDH3A2;DHX9;PIKFYVE;IFT122;BMP4;CALR;TOR1B;PPP1R15A;CD68;VPS35;DNAJA1;EHD1;MDM2;WDR83OS
prerank,cellular response to lipid (GO:0071396),0.36096988505126815,1.1172807813702168,0.22745490981963928,0.6308507444887005,1.0,44/191,20.12%,LPL;SPP1;STAP1;ABL2;SIRPA;MSN;ADCY8;ADCY3;VIM;SPHK2;AXL;MGARP;PTK2B;TFPI;CD274;SOX9;ATP1A3;ATP1A1;UBE2L3;BRINP2;TNIP3;LILRB1;WNT6;PABPN1;TICAM1;PLAA;SERPINE1;TNFRSF1B;RHOA;TNIP2;FZD4;GIT1;NFKB1;ADAM15;ATP1A2;ACOD1;PDCD4;SBNO2;PAF1;ATM;IL6;NR3C1;PDK3;HMGB1
prerank,respiratory tube development (GO:0030323),0.43163045436617625,1.1171485892790607,0.33884297520661155,0.6308311450743639,1.0,13/28,27.33%,PDPN;FGF2;VEGFA;NKX2-1;FGF7;CEBPA;RBP4;ITGA3;BMP4;FGFR2;FGF1;CCDC40;CCDC39
prerank,sphingolipid catabolic process (GO:0030149),0.48728867201765613,1.1166181096700523,0.3346153846153846,0.6319232333736464,1.0,6/15,24.46%,SPHK1;SMPD4;GLA;SMPD1;ASAH1;PDXDC1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4499197363468983,-1.1165205823787971,0.3054545454545455,0.7506881156861681,1.0,3/10,15.86%,PRKCE;IRS2;PMAIP1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3760126336956456,1.1164080783732737,0.2679671457905544,0.6320931192005583,1.0,16/93,11.40%,MMP8;SDCBP;SASH1;XDH;TRAF2;GDF6;SPHK1;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;VEGFA;RASGRP1;TRAF1;RELL1
prerank,carbohydrate homeostasis (GO:0033500),0.3868672955576299,1.1159026610515945,0.31534391534391537,0.633119100095784,1.0,16/67,18.67%,ADCY8;GCK;RPS6;GCKR;PPARG;IGF1R;CYB5R4;PTPN2;CEBPA;RBP4;SLC8B1;APPL2;ADIPOR1;STK11;IL6;WFS1
prerank,regulation of adaptive immune response (GO:0002819),0.4663016161991156,1.1157244197284037,0.35578144853875476,0.6332449919478149,1.0,3/18,8.22%,SKAP1;ADCY7;SAMSN1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5231643797966024,1.1150576929523333,0.3611859838274933,0.6338984586906583,1.0,4/10,19.74%,ERCC1;BLM;SLX4;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5231643797966024,1.1150576929523333,0.3611859838274933,0.6338984586906583,1.0,4/10,19.74%,ERCC1;BLM;SLX4;TERF1
prerank,t-circle formation (GO:0090656),0.5231643797966024,1.1150576929523333,0.3611859838274933,0.6338984586906583,1.0,4/10,19.74%,ERCC1;BLM;SLX4;TERF1
prerank,external encapsulating structure organization (GO:0045229),0.3596152802610106,1.1147970868705472,0.2072072072072072,0.6342268691875314,1.0,58/205,22.20%,SPP1;ITGAX;FN1;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;CDH1;COL18A1;COL6A3;ADAMTS14;ADAMTSL5;SERPINE1;HRNR;SMOC1;ADAMTS2;MMP19;DCN;ADAM15;LAMC1;ITGB2;LAMA5;HSPG2;KDR;FURIN;COL8A2;NF1;COL9A3;ITGA11;SPINK5;BGN;ITGA3;DDR2;ECM2;COL16A1;ADAMTSL1;COL9A1;ITGA2B;LAMA4;LAMA3;MMP17;CD47;MMP28;LUM
prerank,divalent inorganic cation homeostasis (GO:0072507),0.44009577269218525,1.1145008271915249,0.32731648616125153,0.6346760283542309,1.0,7/25,18.67%,ATP13A2;SELENON;CYP27B1;CAV1;CNNM2;TRPM7;WFS1
prerank,amyloid fibril formation (GO:1990000),0.4005724241075117,1.1143617077910728,0.3106796116504854,0.6346472503912689,1.0,16/51,17.41%,LTF;UBA52;RPS27A;NPPA;SIAH2;USP9X;B2M;IAPP;NAT8;GSN;TSPAN5;UBE2L6;GGA2;HSPG2;FURIN;RIPK3
prerank,positive regulation of sodium ion transport (GO:0010765),0.5115643256181008,1.1142377611431544,0.3288948069241012,0.6345844752884663,1.0,5/12,16.74%,PRSS8;SCN1B;CNKSR3;SCN3B;PKP2
prerank,response to peptide hormone (GO:0043434),0.40357752948638137,1.1139555191367116,0.3303964757709251,0.6349595204706492,1.0,14/43,23.92%,SLC27A1;ANXA1;EIF6;STAT4;CAV1;ZBTB7B;TRIM16;OGT;ROCK1;EIF2B2;EPM2AIP1;ZBED3;STAT5B;EIF2B4
prerank,negative regulation of receptor binding (GO:1900121),0.5282886007260772,1.1133491570620915,0.3427041499330656,0.6362801778096205,1.0,3/10,22.31%,B2M;ADAM15;ATP2A2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5066002286186118,1.113133814496039,0.35753424657534244,0.6364826090883446,1.0,6/12,24.63%,TH;VEGFA;AGTPBP1;DSCAM;PROM1;MYO7A
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4490701721021414,1.113057005898384,0.31660692951015534,0.6363132398316247,1.0,7/23,20.12%,NPPA;PTK2B;PSEN2;FYN;DIAPH1;ATP1A2;CACNB1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.44281818978907767,1.112955735968913,0.3464285714285714,0.6361937143669802,1.0,18/26,36.86%,SPHK1;CCNB1;PKN2;DUSP3;PPP1R10;CUL3;HSF1;USP2;MDM2;CDC25B;HES1;EIF4E;KLHL18;ASNS;CCDC57;USP22;EIF4EBP1;SMOC2
prerank,peptidyl-lysine methylation (GO:0018022),0.43741515307471773,1.112720052344013,0.3268765133171913,0.6364171742380538,1.0,9/26,23.52%,ETFBKMT;KMT5A;SMYD3;EEF1AKMT3;SMYD2;SMYD1;EHMT1;EEF2KMT;TRMT112
prerank,regulation of endothelial cell proliferation (GO:0001936),0.376542750263551,1.1126164589280982,0.2828810020876827,0.636313419896744,1.0,19/88,17.75%,APOE;HIF1A;NRP2;XDH;FGF2;NRP1;CAV1;MYDGF;VEGFA;ANGPT1;NRAS;ECM1;EGFL7;PRKD2;VIP;KDR;APOH;NF1;KRIT1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3568267636125335,1.1125004610070233,0.19019019019019018,0.636244285586881,1.0,100/264,28.66%,SNRNP35;SRPK1;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;RBM4B;HNRNPM;POLR2H;PAPOLA;DDX17;HNRNPC;PABPN1;CDK13;PABPC1;CHERP;SYF2;PRMT5;METTL3;DNAJC8;SRSF11;PRMT7;DDX1;PRPF4;SMNDC1;SRSF7;PRCC;RBM19;HNRNPK;HSPA8;GTF2F1;DDX39B;POLR2D;LSM6;HNRNPA2B1;SYNCRIP;PUF60;RBM15;WBP11;EIF4A3;PCBP1;NOVA2;SART1;PNN;SYMPK;RBM15B;PSPC1;PPIE;PRPF6;HNRNPU;GCFC2;HNRNPF;UBL5;IK;CWC22;DHX9;SNRNP40;CCAR1;ZMAT5;SRSF2;ZMAT2;SNRPB2;CTNNBL1;CPSF7;RALY;PRPF8;SMU1;SRPK2;UPF3B;SF3A3;LSM4;SNU13;SRRM1;RBM22;SNRPG;GEMIN8;POLR2F;SF3B2;SF3B1;HNRNPL;SNRPF;GEMIN2;LSM3;SNW1;GEMIN5;SNRPA;SF3B5;PPIH;PRPF40A;FUS;SRSF1;SRSF10;CSTF2;PPIL3;DDX41;NUDT21;WBP4;TRA2B
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5334133241094889,1.1121435903238994,0.3433652530779754,0.6364394992924113,1.0,1/10,1.15%,MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5334133241094889,1.1121435903238994,0.3433652530779754,0.6364394992924113,1.0,1/10,1.15%,MYLIP
prerank,regulation of RNA splicing (GO:0043484),0.38402552501035436,1.1120450968065587,0.2869198312236287,0.6363265959576161,1.0,29/69,28.66%,AHNAK2;SRPK1;MBNL3;PTBP3;RPS26;ERN1;GRSF1;CELF1;SON;HNRNPLL;ZNF326;HNRNPK;MBNL2;FASTK;RBM39;HNRNPF;CLK4;CWC22;SLC38A2;RPS13;AHNAK;SRPK2;RBM22;HNRNPL;RRP1B;ZPR1;FUS;SRSF10;TRA2B
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.370148783366227,1.1119690225769734,0.26776519052523173,0.6361425125256768,1.0,36/101,26.17%,CSF1;ASPH;ATG7;MSN;EIF6;VIM;EIF4G1;CD28;EEF2;PIWIL2;CYFIP2;LARP4;CPEB3;METTL3;YTHDF3;OGT;VPS11;EIF4A3;FXR2;ASPSCR1;IL6;EIF3E;UPF3A;FBXW11;NPM1;UPF3B;SAMD4A;VPS35;TBC1D10A;POLDIP3;IST1;HDAC2;PYM1;ATG10;BTRC;NAT10
prerank,negative regulation of response to stimulus (GO:0048585),0.38626382783625157,1.111684783552168,0.3050847457627119,0.636554486748611,1.0,19/60,24.26%,CDK6;VPS13C;PDCD1;MCTP1;BRAP;FBXO5;FCRLB;SOCS5;ZKSCAN3;TLE5;LPCAT3;CLU;APPL2;SPINK5;WFS1;HHIP;TERT;MAPK7;MAP2K5
prerank,establishment of melanosome localization (GO:0032401),0.4718599510416176,1.1116087729717856,0.3333333333333333,0.636367364990995,1.0,2/19,1.28%,MYO5A;BLOC1S3
prerank,protein localization to condensed chromosome (GO:1903083),0.5058244961774717,1.1114687125716387,0.3391655450874832,0.6363615633904224,1.0,4/12,22.54%,CHAMP1;IK;KNL1;SPDL1
prerank,protein tetramerization (GO:0051262),0.3889751195172597,1.1111724870479078,0.3078534031413613,0.6368281905782299,1.0,19/67,20.94%,ACACA;ALDOA;THG1L;KCNJ2;APIP;GNMT;B2M;SHMT1;UPB1;OSBPL2;GLS;HSD17B8;APPL2;FARSA;AQP4;FARSB;ACACB;SOD2;CPSF7
prerank,extracellular structure organization (GO:0043062),0.35884167033407677,1.1108847738520269,0.22622622622622623,0.63719882314089,1.0,58/204,22.20%,SPP1;ITGAX;FN1;MMP8;MMP12;POSTN;ITGAL;DAG1;ITGA5;ATP7A;PDGFA;CD44;COL10A1;ADAMTS13;MATN3;MMP9;FGF2;ITGA4;ELN;ADAMTS10;COL4A1;CDH1;COL18A1;COL6A3;ADAMTS14;ADAMTSL5;SERPINE1;SMOC1;ADAMTS2;MMP19;DCN;ADAM15;LAMC1;ITGB2;LAMA5;HSPG2;KDR;FURIN;COL8A2;NF1;COL9A3;ITGA11;SPINK5;BGN;ITGA3;DDR2;TEX14;ECM2;COL16A1;ADAMTSL1;COL9A1;ITGA2B;LAMA4;LAMA3;MMP17;CD47;MMP28;LUM
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.36500920864211456,1.1102466589603335,0.28687690742624616,0.6385644275398413,1.0,21/113,17.49%,IGF1;HIF1A;NRP2;MMP12;NR4A3;FGF2;NRP1;MYDGF;SOX9;VEGFA;FGF7;NRAS;JAML;ECM1;EGFL7;PRKD2;LAMC1;VIP;KDR;BMP6;C5AR1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5045783943714983,1.110058388687083,0.3611898016997167,0.6386924751239963,1.0,3/11,14.77%,P4HB;FYN;UBQLN1
prerank,negative regulation of protein secretion (GO:0050709),0.40996547622644625,1.110030226478985,0.34015927189988626,0.6383789794474417,1.0,8/38,16.69%,APOE;FAM3D;RHBDF2;RAB11FIP1;SERGEF;RHBDF1;RSAD2;SIRT4
prerank,gluconeogenesis (GO:0006094),0.410955877200443,1.1099900079665606,0.3261608154020385,0.638120616760146,1.0,9/39,17.53%,ALDOA;SLC25A1;PGK1;ENO1;PCK2;ALDOC;RBP4;ENO2;GPI
prerank,phosphate ion transport (GO:0006817),0.4839977846074398,1.109967885794362,0.3564993564993565,0.6377979025506961,1.0,6/16,25.64%,SLC37A2;SLC25A3;SLC25A14;XPR1;SLC20A1;SLC37A3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2956017745408571,-1.109856879673261,0.25471698113207547,0.767620200298973,1.0,13/39,14.84%,EPN2;ROBO1;BMP2K;RBPJ;PRKCI;TSPAN14;STAT3;KAT2B;PDCD10;ROBO2;POGLUT1;SRC;JAG2
prerank,snRNA transcription (GO:0009301),0.38437287043457785,1.109702856330853,0.30922431865828093,0.6381094214970738,1.0,21/70,24.83%,SNAPC1;USPL1;POLR2H;GTF2A2;SNAPC2;INTS14;ELL2;GTF2F1;POLR2D;INTS6;INTS2;TBP;SP1;RPRD1A;CCNT2;TAF6;SNAPC4;GTF2E2;INTS7;POLR2F;POU2F1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.388750636073057,1.1096766944776124,0.3022269353128314,0.6377958011710311,1.0,18/57,23.74%,DDHD1;PLAUR;MGARP;MMP9;BID;TREM2;HTT;BCL2L11;BAX;DCN;KDR;HIP1R;FBXO7;BIK;GSK3B;TNFSF10;VPS35;BNIP3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4825549769197011,1.1096131418390307,0.36057068741893644,0.6375986249235275,1.0,4/15,19.39%,SAT1;TH;PAOX;SMOX
prerank,negative regulation of protein processing (GO:0010955),0.5069215095895381,1.1095839239562106,0.3333333333333333,0.6372925190675506,1.0,5/12,22.34%,CTSZ;SERPINE2;SERPINE1;SERPINF2;SNX12
prerank,skeletal muscle tissue development (GO:0007519),0.43109163512131965,1.1095029511739556,0.3272519954389966,0.637138661130764,1.0,6/32,9.97%,SELENON;CSRP3;CAV1;EGR2;IGSF8;LEMD2
prerank,regulation of cellular response to heat (GO:1900034),0.38005054527209464,1.1094085997781336,0.30471204188481676,0.6370376496865489,1.0,38/77,33.92%,NUP205;MAPKAPK2;NUP188;HSPA8;RANBP2;TPR;CHORDC1;RAE1;ATM;DNAJB1;CCAR2;PTGES3;NUP93;GSK3B;HSF1;HSP90AB1;AAAS;NUP50;NUP54;BAG3;NUP98;NUP42;NUP133;NUP210;ATR;DNAJB6;MAPK3;DNAJC2;NUP35;IER5;NUP214;SIRT1;MAPK1;EP300;CREBBP;BAG1;NUP62;CAMK2G
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.4782434461782561,1.1091239066591976,0.3582474226804124,0.6374624199777374,1.0,4/16,11.71%,FGF2;VEGFA;HMOX1;DLL4
prerank,establishment of vesicle localization (GO:0051650),0.46539209307294893,1.1090708891760164,0.3379571248423707,0.637212828565689,1.0,5/18,18.18%,CDK5;TMEM230;DNM2;RAB11A;TESK1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.40329107366612665,1.1089893208647397,0.33296337402885684,0.6370562996549597,1.0,14/44,20.75%,FLNA;KCNN4;ATP1B3;NPPA;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;ANO6;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,collagen fibril organization (GO:0030199),0.3710656954850385,1.1086644832616073,0.28365878725590954,0.6375705191748584,1.0,28/88,22.20%,ATP7A;COLGALT1;COL10A1;BMP1;COL4A1;COL20A1;P3H1;P4HB;COL18A1;COL6A3;COL12A1;CRTAP;ADAMTS14;PLEC;ADAMTS2;CYP1B1;P4HA3;COL8A2;NF1;COL9A3;DDR2;SERPINF2;COL16A1;P4HA1;DST;COL9A1;LAMA3;LUM
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2744310012953767,-1.1083406060196184,0.21348314606741572,0.7684582073052374,1.0,22/56,20.29%,IL1RAPL1;NRXN1;NLGN1;PTPRD;CLSTN2;PTPRJ;GRID2;CLSTN3;EPHB1;AGT;CNTNAP2;CUX2;CLSTN1;DLG5;FLOT1;IL1RAP;EPHA2;NPHP1;NLGN2;NLGN3;SYNDIG1;CLDN5
prerank,regulation of secretion (GO:0051046),0.4936242606921539,1.1079263222861944,0.34028683181225555,0.6392317153952143,1.0,3/13,3.32%,SGK1;SCIN;NRG1
prerank,regulation of DNA repair (GO:0006282),0.4034952890367563,1.1076726179021914,0.33858267716535434,0.6395001725373447,1.0,24/44,33.91%,ERCC6;EYA4;TRIP12;TRIM28;ABRAXAS1;BRCA1;DEK;CEBPG;UIMC1;UBE2V2;KAT7;DHX9;RPS3;USP1;BRCC3;SMCHD1;ERCC8;SIRT1;PARG;TMEM161A;UBR5;EYA3;PCNA;BABAM2
prerank,negative regulation of cellular process (GO:0048523),0.3499726034353292,1.1075127576963368,0.14,0.6395628754380858,1.0,149/521,26.28%,GPNMB;APBB2;PLXNC1;BCL2;CTNNB1;CD9;CDK6;NIBAN2;IGFBP7;SIRPA;PLXNA2;VPS13C;SPEG;ADARB1;SPN;PPP1R9B;PDPN;SPHK2;SCIN;HRG;FER1L5;IRF6;GTPBP4;CYP27B1;VDR;CLDN19;RIPOR2;PTK2B;RAF1;FGF2;MNT;S100A11;PPP2R5C;PPP2R1A;NCK2;ADGRB1;BCL6;PIWIL2;GATA3;ACTN1;NUDT6;NCK1;ANGPT1;ING4;COPS8;DCBLD2;TREM2;ANXA6;P3H1;CHMP4B;DLC1;CELF1;FBXO5;LMNA;IFITM1;COL18A1;GMNN;LILRB1;PTPN2;RACK1;LRPAP1;SFRP5;SOX7;PLXND1;CHERP;ATF5;UTP20;CEBPA;TMEM98;ENO1;BAP1;TNFRSF1B;VPS4B;DLL4;FBLN1;NUPR2;LPCAT3;SP100;TFAP4;BLM;ARID2;ADAM15;CLU;CYP1B1;OSGIN2;SERTAD3;APPL2;CHD5;RASA1;ING5;CCN6;SMYD2;RPS6KA2;SINHCAF;PDCD4;CDKN3;STK11;NME6;IL6;UBR2;RNF167;WFS1;CCAR2;FERMT2;TMEM109;BST2;ITGB1BP1;TAF6;SULT2B1;FTH1;GNRH1;SOD2;EMILIN1;TBRG1;DSCAM;EPO;VHL;ARHGDIB;RNF41;RUNX3;NPM1;BMP4;TES;ABI1;KLF11;F2R;HTR2B;VPS35;RBBP7;MIF;BNIP3;SMYD5;JAK2;ANP32B;CCDC85B;SIPA1;DCUN1D3;SFRP1;BMP5;KANK2;MDK;MALSU1;NOTCH4;SMARCA4;NOX4;PARP16;P3H3;PTPN6;SESN2
prerank,erythrocyte differentiation (GO:0030218),0.4103357190239511,1.1073402081770338,0.3285077951002227,0.6396649607767029,1.0,15/44,25.22%,ID2;RPS14;MFHAS1;VEGFA;PTPN2;ALAS1;RPS19;HSPA9;CEBPG;ACIN1;LYAR;EPO;JAK2;FLVCR1;NCKAP1L
prerank,melanosome localization (GO:0032400),0.4583076535822944,1.1070382412068123,0.33774038461538464,0.6401132058105534,1.0,2/21,1.28%,MYO5A;BLOC1S3
prerank,error-prone translesion synthesis (GO:0042276),0.4550944655575534,1.1069841106343992,0.3560794044665012,0.6398804620382775,1.0,12/21,35.67%,UBA52;RPS27A;RFC1;UBC;REV1;RFC2;RFC4;UBB;RFC5;PCNA;REV3L;POLK
prerank,MAPK cascade (GO:0000165),0.3547970141466138,1.1068470201186174,0.193,0.6398480100094583,1.0,95/295,26.48%,IGF1;FGF13;BCL2L1;IL2RB;PTPRA;PSMD8;PSMD1;PRKCQ;CSF2RA;LAT;UBA52;RPS27A;PDGFA;PIK3CB;MAPK13;NRG1;DUSP9;RAF1;FGF2;TAOK3;BRAP;IL3RA;SOX9;GRB2;ANGPT1;RASGRP1;RASGRP3;KITLG;PSMD6;PSMA1;PABPN1;MAPKAPK2;RANBP9;PSMC3;FGF7;KRAS;NRAS;FYN;RASAL1;DUSP6;JAK1;CCL5;FGF20;PSMA8;TNIP2;PAQR3;PSMD14;MBP;PSMD2;IL31RA;RASA2;NFKB1;ABHD17C;PSMC6;PSMA6;KDR;SYNGAP1;RASA1;NF1;PIK3R2;MINK1;PSMD5;MAP3K8;PSMA5;YWHAB;CUL3;IL2;ABHD17A;IL5;UBC;ACTN2;FBXW11;CUL1;HSF1;TAOK1;FGF18;RASAL2;PTGER4;FGFR3;HTR2B;MAP2K2;PSMA3;FGFR2;JAK2;TNF;PDGFRA;PSMB10;PSMB8;MAPK12;PSMD7;PSMB6;FGF1;BTRC;LAMTOR3;ABHD17B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4531913398365988,1.1067127603372435,0.3454317897371715,0.6398371237671794,1.0,5/20,16.14%,HIF1A;NFE2L2;VEGFA;SMAD1;CHD6
prerank,glucose metabolic process (GO:0006006),0.3888621109279073,1.10644626159163,0.33513513513513515,0.6401784610882153,1.0,12/58,14.77%,SORD;ALDOA;SLC25A1;GAA;PPARD;PGK1;ENO1;PCK2;ALDOC;AKR1A1;RBP4;ENO2
prerank,organelle transport along microtubule (GO:0072384),0.4217099258949735,1.1058878669311292,0.32712456344586727,0.6413155309390797,1.0,12/31,23.35%,UXT;ARHGAP21;HTT;TRAK1;CLN3;CDC42;BORCS5;RAB1A;RHOT2;FBXW11;TMEM201;PEX14
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4953056692091552,1.1057289397276981,0.3652058432934927,0.6413848217887,1.0,5/15,18.32%,LRP1;PDPN;MELTF;DDR2;IL6
prerank,mesenchymal cell differentiation (GO:0048762),0.39497542854646106,1.105462882521893,0.31297709923664124,0.6417141829253841,1.0,7/51,8.70%,CTNNB1;HIF1A;FBXL17;LEF1;TRIM28;SOX9;DDX17
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4195927209179499,1.105407989315842,0.3437862950058072,0.6414943333334391,1.0,10/32,16.16%,CORO1C;MMP12;JAG1;DLC1;HOXA7;ARHGAP6;MYOC;SERPINE1;ADAM15;RASA1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.275364932581071,-1.1043990260499885,0.2698412698412698,0.7766461625502142,1.0,19/63,13.00%,GABRB2;GABRB3;GLRA3;SLC1A3;GABRG3;GABRA2;SLC12A2;SLC12A9;SLC25A11;SLC12A6;SLC6A1;LRRC8A;GABRA1;SLC12A8;GABRB1;ANO7;GLRA2;SLC37A4;GABRR2
prerank,regulation of response to biotic stimulus (GO:0002831),0.42708404140642675,1.1043412022229484,0.3281807372175981,0.6440968443715032,1.0,11/28,28.20%,FGR;TRAF3;PTPN22;TREM2;APPL2;TIRAP;ELMOD2;CD55;BIRC2;CX3CL1;TKFC
prerank,chromatin disassembly (GO:0031498),0.4910696280713932,1.1041941305446752,0.3503267973856209,0.6437279188087741,1.0,6/14,25.84%,GRWD1;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.4910696280713932,1.1041941305446752,0.3503267973856209,0.6437279188087741,1.0,6/14,25.84%,GRWD1;SMARCB1;SMARCC1;ARID2;SMARCD2;SMARCA4
prerank,mitotic metaphase plate congression (GO:0007080),0.39101864800552905,1.1038837192517041,0.33035714285714285,0.6441564367967951,1.0,18/51,30.12%,CHAMP1;EML4;CHMP4A;CHMP4B;PDCD6IP;CCNB1;VPS4B;CHMP7;KIFC1;RAB11A;CUL3;CHMP6;SPDL1;EML3;KIF22;PIBF1;NUDC;BECN1
prerank,cellular respiration (GO:0045333),0.40300905041505164,1.1038518270030604,0.3246606334841629,0.643855082790513,1.0,14/41,24.40%,NDUFS7;NR4A3;COQ10B;SDHB;SLC25A14;SURF1;COX10;UQCRH;MTFR2;MTFR1;SDHC;UQCR10;UQCRB;SIRT3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.37805559098518704,1.1034231192532908,0.3224446786090622,0.6446172284775382,1.0,22/70,19.28%,PEAK1;FN1;UNK;POF1B;NRP1;ITGA4;RILPL2;ACTN1;ILK;METTL3;PARVA;RHOA;EFNA1;ATRN;MEGF9;LAMC1;LAMA5;YTHDF2;MICALL2;RILPL1;FERMT2;PARVB
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4427413198336694,1.1031713556314884,0.3433734939759036,0.6449412485640313,1.0,12/23,32.19%,RANGRF;VCP;SEC61B;LMAN1;DERL1;TECPR2;SURF4;OS9;HSP90B1;HERPUD1;SYVN1;FAF2
prerank,positive regulation of protein kinase activity (GO:0045860),0.359466449646729,1.1030771074468415,0.2732793522267207,0.6448151130415297,1.0,46/148,24.21%,IQGAP1;CSF1;SLC27A1;PTPRC;LTF;CD4;LAT;ALS2;PTK2B;PAK6;NEDD9;PRKCD;TAOK3;DAXX;STK3;VEGFA;NAB2;CCL5;RHOA;EFNA1;GAS6;GPRC5B;PAK2;JTB;CAB39;STOX1;CLU;MAP2K3;PRKAG1;MINK1;DDR2;RIPK3;RALB;STK11;SLC11A1;MARK2;HSP90AB1;SYAP1;TAOK1;IL34;MAP2K2;EGR1;TGFBR2;CALM3;CCDC88A;TNF
prerank,activation of protein kinase A activity (GO:0034199),0.4650007777179426,1.1028542958945993,0.366751269035533,0.645062999645106,1.0,3/16,4.20%,ADCY8;ADCY3;ADCY7
prerank,Rho protein signal transduction (GO:0007266),0.3926976941251266,1.10274334663747,0.3270718232044199,0.6449844861903824,1.0,15/53,15.12%,MYO9B;GNA13;PDPN;RTKN;RHOD;ARHGAP6;ARHGEF1;RHOG;RHOA;RHOU;LIMK1;CDC42;CELSR1;ROCK1;ARHGEF11
prerank,genitalia development (GO:0048806),-0.41776846479107566,-1.102635787461132,0.33458646616541354,0.7786024596026947,1.0,7/12,35.05%,WNT5A;TIFAB;PKD1;SHH;WT1;LHCGR;STRA6
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.39668946094207824,1.102109212104239,0.3288888888888889,0.6462992533987896,1.0,15/46,19.28%,PEAK1;FN1;NRP1;ITGA4;ILK;PARVA;RHOA;EFNA1;ATRN;MEGF9;LAMC1;LAMA5;MICALL2;FERMT2;PARVB
prerank,positive regulation of autophagy (GO:0010508),0.3740691084836738,1.1019487707670252,0.30434782608695654,0.6463710821172843,1.0,34/81,29.50%,OPTN;PIK3CB;TRIM6;RUFY4;TFEB;HTT;PLK2;TICAM1;NPRL2;LARP1;PLEKHF1;ROCK1;DCN;DAPK1;FOXO1;KDR;STK11;ORMDL3;FBXO7;HMGB1;MTDH;GSK3B;TRIM21;BNIP3;PLK3;PIK3C2A;SESN2;TRIM8;GSK3A;TBK1;UFL1;BNIP3L;SIRT1;TRIM68
prerank,cardiac conduction system development (GO:0003161),0.44224982731922524,1.101841480202003,0.3568862275449102,0.6462797604724404,1.0,6/24,21.77%,NPPA;TBX18;SHOX2;SMAD1;GJB6;BMP4
prerank,outer dynein arm assembly (GO:0036158),0.48890695824972186,1.101347217532636,0.380352644836272,0.6472885791170226,1.0,3/14,10.27%,ODAD2;DNAH8;DNAAF5
prerank,positive regulation of protein maturation (GO:1903319),0.5138937683418944,1.1013403688497894,0.3588709677419355,0.6469215200826499,1.0,1/11,2.68%,ADAM8
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.41377646571646404,1.1012482472111749,0.3306997742663657,0.646795414181033,1.0,17/35,30.70%,PTPRC;DOT1L;CAV1;CCL5;GHR;CYP1B1;ADIPOR1;NLK;IL6;VHL;F2R;JAK2;TNF;HES1;LEPROT;PIGU;JAK3
prerank,regulation of lamellipodium assembly (GO:0010591),-0.29202664012168295,-1.1012269143413331,0.27941176470588236,0.7791157707927312,1.0,6/34,4.88%,WASF2;PIK3R1;ABI3;FER;TWF2;NCKAP1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5004430129852168,1.1009252843071395,0.3605898123324397,0.6472339715697234,1.0,6/12,28.21%,TCF15;JAG1;YTHDF2;HNRNPU;HES1;N4BP2L2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.40360935954932275,1.100877115746863,0.34498308906426156,0.6469549558575314,1.0,21/38,33.35%,CABIN1;UBN1;CENPO;CENPT;CENPX;ATRX;KNL1;NPM1;RBBP7;ASF1B;CENPK;CENPA;HAT1;CENPS;H3-3A;NASP;RSF1;CENPH;ASF1A;CENPC;CENPW
prerank,regulation of osteoblast differentiation (GO:0045667),0.3693949559093691,1.1003017164506659,0.3048907388137357,0.6481155866179621,1.0,16/82,12.66%,IGF1;CDK6;LTF;HDAC7;NELL1;PPARG;SUCO;SOX9;NOCT;FBXO5;IFITM1;ATP6AP1;BAMBI;RIOX1;SMOC1;CHRD
prerank,modification-dependent protein catabolic process (GO:0019941),0.35517603471182835,1.099887953043594,0.25855130784708247,0.6488234272326593,1.0,50/193,20.24%,MYLIP;RNF125;UBA52;WDR91;RPS27A;CNOT4;COPS3;RNF14;SQSTM1;ANAPC15;TRIP12;RNF7;SIAH2;TTC3;RNF6;UBR4;RNF128;SPSB2;ATXN3;UBE2L3;UBE2H;FZR1;ZNRF3;FBXW4;DDB1;RNF111;UBE4A;LONP1;UBE3B;UBE2R2;BIRC6;ANAPC1;PSMD14;KCTD10;UBE2L6;BFAR;UBQLN1;CBL;UBE3C;KLHL25;UBE4B;CDC26;RNF167;RNF149;CUL3;BUB1B;FBXO7;UBC;RNF19A;RNF20
prerank,postreplication repair (GO:0006301),0.4004368868033149,1.0997486645223566,0.3458980044345898,0.6487801350135239,1.0,21/45,35.70%,UBA52;RPS27A;VCP;BRCA1;UBE2L6;RFC1;UBE2V2;UBC;NSMCE1;REV1;RFC2;POLD4;RFC4;ZBTB1;UBB;WDR33;RFC5;PCNA;PCLAF;POLK;UBE2A
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4783150131662751,1.0996217201931415,0.36329588014981273,0.6487538398457918,1.0,8/16,28.88%,AMPD2;GART;ATIC;ADSS1;PPAT;NUDT2;ADSL;GMPS
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.34860758915091955,1.0993584646964785,0.166,0.649127379038568,1.0,124/417,26.43%,MDFIC;CTNNB1;ZHX2;NIBAN2;ARID5B;SCML4;LEF1;HDAC9;DEDD2;TBX21;DEAF1;RCOR1;ID2;NRG1;VDR;NCOR2;CDK5;NFIL3;CIC;PRICKLE1;HDAC4;DAXX;PPARG;ERN2;BCL6;GATA3;TRIM28;SOX9;ING4;HDAC1;KMT5A;BHLHE40;ATXN1;BHLHE41;GMNN;BASP1;PPARD;MIDEAS;HOXA7;FOXN3;NKX2-1;THAP7;SOX7;DAP;COPS2;BRCA1;ATF5;SUDS3;ZNF148;JUN;CEBPA;ENO1;BAP1;RIOX1;ZKSCAN3;TLE5;HSPA8;ZBTB16;TFAP4;GATAD2A;GAS6;CBFA2T2;ILF3;BIRC5;EED;DDIT3;RBFOX2;RBM15;USP47;PRMT2;FOXO1;ELK3;PRMT6;MYBBP1A;RBM15B;RCOR3;PSPC1;PDCD4;SBNO2;UIMC1;GCFC2;CBX3;KAT7;CCAR2;TAF7;YAF2;DACH1;NR3C1;EHMT1;FBXW11;YEATS2;EIF4A2;BMP4;ID1;CALR;NIPBL;NIF3L1;AHR;CREBZF;ZNF568;PEX14;L3MBTL3;ZBTB4;MDM2;SUMO1;MTA3;TNF;GLIS2;CCDC85B;ZGPAT;POU2F1;HDAC2;KDM5C;SFRP1;DPF3;HDAC3;PIAS4;L3MBTL2;HIC2;SMARCA4;BTRC;TMPRSS6;PCGF6;SNW1
prerank,negative regulation of transferase activity (GO:0051348),0.4206328662850698,1.099338001617585,0.3498233215547703,0.6487908071289002,1.0,10/28,21.43%,FBXO5;NPRL2;PHPT1;LIMK1;SMAD7;ERCC4;HNRNPU;TERF1;GSK3B;EIF4A2
prerank,calcium ion homeostasis (GO:0055074),0.3695192841752056,1.0992742448837316,0.30434782608695654,0.6485935834762316,1.0,25/95,22.65%,SLC24A4;ATP2B1;ATP13A2;SELENON;CYP27B1;NPTN;CSRP3;CAV1;TPT1;TPCN2;CCL13;CHERP;CCR2;CCL7;CCL5;CCL14;SLC8B1;VAPB;TMEM165;WFS1;STOML2;ATP13A1;ATP2A2;CALR;HTR2B
prerank,cholesterol metabolic process (GO:0008203),0.3835695996814877,1.0991753953827137,0.324468085106383,0.6485046684430095,1.0,10/68,11.27%,APOE;ABCG1;ABCA1;PLPP6;CEL;APOA2;SOAT1;PPARD;ARV1;SOAT2
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.30884585942634096,-1.0990200452080239,0.2913907284768212,0.7822427174758108,1.0,7/32,4.87%,MEF2C;SNCAIP;CPLX1;RIMS1;LRRK2;SNAPIN;SLC30A1
prerank,regulation of interleukin-8 production (GO:0032677),0.37331270639781144,1.0986369580336097,0.32800851970181044,0.6495695900985754,1.0,21/69,24.26%,PTPRC;ANXA1;TMSB4X;ANXA4;CD2;APOA2;PTPN22;SERPINE1;DDIT3;PRKD2;TIRAP;SYK;RAB1A;IL6;HMGB1;LBP;F2R;CD74;IL17D;TNF;MAP2K5
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.26956290501038094,-1.0986195119762883,0.2988505747126437,0.7797518741902456,1.0,15/53,19.57%,CHRM2;CALCRL;HTR2A;HTR2C;CCR1;CHRM3;AGT;HRH2;HTR1F;CCL2;OPRD1;SSTR2;CNR1;HTR6;NPY
prerank,smooth muscle contraction (GO:0006939),0.47810947463013354,1.0986060046076447,0.37041719342604296,0.6492866214497461,1.0,6/14,19.14%,CHRNB2;EDNRA;TPCN2;ROCK1;ACTA2;MYH11
prerank,positive regulation of lipid catabolic process (GO:0050996),0.45885114556865825,1.0985734345197993,0.3552795031055901,0.6489828922552843,1.0,4/19,11.70%,APOA2;PRKCD;ABHD5;ABCD2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4592499026669029,1.0981881547460395,0.3610421836228288,0.6496336408488843,1.0,9/18,27.22%,CCT2;TREM2;CCT8;CHP1;CCT5;CEP120;DKC1;TNF;CEP295
prerank,sphingolipid biosynthetic process (GO:0030148),0.38010293417724705,1.0976354462477906,0.3305351521511018,0.6507333107850225,1.0,22/71,24.04%,LARGE1;SGMS1;SPHK2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;SMPD4;KDSR;HACD1;PRKD2;VAPB;SMPD1;ALDH3A2;ALDH3B1;ASAH1;ELOVL2;SAMD8;ELOVL1;SPTLC3;PRKD3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.31702931376974164,-1.0976173769049482,0.26993865030674846,0.7791847030777781,1.0,6/27,11.62%,IL1RAPL1;CTNNA2;PSEN1;NCS1;FCGR2B;BRSK1
prerank,T cell differentiation in thymus (GO:0033077),0.4696008845435642,1.0974523232253355,0.36863270777479895,0.6508401849314301,1.0,3/14,17.41%,PTPRC;ADAM17;RIPK3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4301205475896842,1.0965008413621173,0.3448275862068966,0.6529882920029447,1.0,4/27,4.18%,SLC3A2;SLC38A1;SLC7A1;SLC36A4
prerank,carbohydrate derivative transport (GO:1901264),0.4543064827996741,1.0962059352549096,0.36612702366127026,0.6534212199429907,1.0,5/18,21.58%,ABCG1;SLC15A3;CLN3;NPC2;LBP
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.29892122825383677,-1.0961637698549074,0.2900763358778626,0.7798571927619026,1.0,8/35,11.54%,NLGN1;CDH23;CDH9;CDH10;CDH6;CDH8;CDH12;CDH13
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4474262041493199,1.0960929853564898,0.348780487804878,0.6533497548746746,1.0,4/20,13.91%,SLC27A1;CNDP2;MTHFS;FPGS
prerank,regulation of cellular response to stress (GO:0080135),0.36487195721831117,1.0953626382395674,0.3023493360572012,0.6549668023276213,1.0,57/115,33.92%,ATF3;NUP205;ADCY8;MCL1;EIF4G1;MAPKAPK2;NUP188;NEK4;CLN3;HSPA8;CHCHD2;RANBP2;TPR;ING2;CHORDC1;MBTPS2;RAE1;NEK6;ATM;DNAJB1;CCAR2;PTGES3;AIFM2;CASP9;SLC38A2;NUP93;GSK3B;HSF1;HSP90AB1;AAAS;NPM1;NUP50;NUP54;BAG3;ATF4;NUP98;NUP42;NUP133;USP19;NUP210;ATR;DNAJB6;SMG1;MAPK3;DNAJC2;NUP35;NUP214;SIRT1;MAPK1;EP300;RSL1D1;CREBBP;CEBPB;BAG1;NUP62;OPRM1;CAMK2G
prerank,regulation of autophagosome maturation (GO:1901096),0.48635226280944155,1.0951897481049957,0.3632862644415918,0.655075074240213,1.0,3/13,10.75%,SMCR8;FYCO1;CLN3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.39621639306604023,-1.0947745139475076,0.332,0.7803776352707641,1.0,1/13,0.08%,CYRIB
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.42875489811615786,1.0946781117508895,0.35526315789473684,0.6560950866728706,1.0,9/26,22.65%,LCK;PTPRC;FGF2;ERO1A;CHERP;SLC8B1;ITPR3;F2R;HTR2B
prerank,phospholipid biosynthetic process (GO:0008654),0.40633026609346906,1.094403451073313,0.33747178329571104,0.6564733927125062,1.0,18/36,33.73%,SGMS1;SPHK2;SRD5A3;FADS1;CLN3;CPNE3;DPAGT1;SAMD8;CPNE6;HDHD5;NUS1;PCYT2;DOLPP1;GNPAT;LPCAT1;PIP5K1A;AGPAT3;SGMS2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.36053632902798055,1.0939344223655358,0.2966360856269113,0.6573309060275198,1.0,27/116,19.06%,CD247;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;ADAM17;CRH;IAPP;FYN;GPR176;GIPR;ADORA2A;GLP1R;VIP;SYK;FURIN;GPR84;IL6;GNB1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3369351282157387,-1.09392490861854,0.266304347826087,0.779367779080035,1.0,4/22,3.26%,SSH2;CYRIB;KANK1;TWF2
prerank,histone mRNA catabolic process (GO:0071044),0.47376536158235705,1.0930933699045469,0.36964980544747084,0.6592149772040943,1.0,9/15,33.75%,EXOSC4;EXOSC10;ATM;XRN1;MTPAP;TENT4B;DCP2;TUT1;ERI1
prerank,actin filament network formation (GO:0051639),0.5150608039132296,1.092832278812086,0.375,0.6595614831084695,1.0,2/11,6.52%,LCP1;ACTN1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3350113003563807,-1.0928009969960202,0.2875,0.7793451528440767,1.0,8/24,10.82%,MEF2C;MAPK14;CTNNA2;MEF2A;OLFM2;CDH2;CAMK1;RBM4
prerank,synaptic vesicle endocytosis (GO:0048488),-0.30127690386731465,-1.0925049761454309,0.2833333333333333,0.7767024312480719,1.0,7/33,6.38%,OPHN1;NLGN1;SNAP91;AMPH;PICALM;SYT1;SYT2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4706259601206757,1.0924574993437217,0.34980494148244473,0.6602052694876374,1.0,3/16,8.87%,MMP8;CD274;LILRB1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4192708570547238,1.0920799035538122,0.3770491803278688,0.6608524843557237,1.0,4/30,3.92%,FLT1;PLEK;PTPRC;FSTL3
prerank,fatty acid catabolic process (GO:0009062),0.3797785246629374,1.0918474216189524,0.3655913978494624,0.661103685644872,1.0,24/67,25.66%,AIG1;CEL;ACAD11;ABCD4;PEX2;PPARD;MMUT;ABCD2;ACAD10;ECI2;ACAT1;ABCD3;CPT2;DECR1;ALDH3A2;EHHADH;ACADL;ACADS;ACBD5;LPIN3;ACADM;HADHA;HADH;ACAA2
prerank,negative regulation of bone remodeling (GO:0046851),0.5008160376531835,1.0915973013087648,0.38645418326693226,0.6614023305348832,1.0,1/11,0.21%,GPR137B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3642787330506843,1.0914729404758678,0.3087790110998991,0.6613660647383215,1.0,49/129,29.39%,DKK2;PSMD8;PSMD1;TNKS2;CAV1;PRDM15;ILK;PSMD6;PSMA1;CSNK1G1;VCP;BAMBI;PSMC3;JUP;WLS;PSMA8;FRAT1;GPRC5B;PSMD14;JRK;PSMD2;NFKB1;CSNK1D;USP47;PSMC6;PSMA6;GSKIP;PSMD5;PSMA5;DAPK3;PIN1;CCAR2;ZBED3;PSMA3;FGFR2;USP8;PSMB10;SFRP1;PSMB8;PSMD7;PSMB6;PSMD10;PPM1A;DACT1;PSMB5;PSMB7;USP34;PSMC4;CSNK1E
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4896518118249851,1.091431539864964,0.3637602179836512,0.6611045462122336,1.0,8/13,29.22%,CD44;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4945738417305008,1.0912875419558856,0.3837981407702523,0.6611286592374517,1.0,3/13,9.42%,NFE2L2;NR4A3;RACK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.35010397735770443,1.091093917033597,0.2625250501002004,0.661299789082049,1.0,91/241,28.66%,SNRNP35;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;RBM4B;HNRNPM;POLR2H;PAPOLA;HNRNPC;PABPN1;PABPC1;CHERP;SYF2;METTL3;DNAJC8;SRSF11;PRPF4;SMNDC1;SRSF7;PRCC;RBM19;HNRNPK;HSPA8;GTF2F1;DDX39B;POLR2D;LSM6;HNRNPA2B1;SYNCRIP;PUF60;RBM15;WBP11;EIF4A3;PCBP1;NOVA2;SART1;PNN;SYMPK;RBM15B;PSPC1;PPIE;PRPF6;HNRNPU;GCFC2;HNRNPF;UBL5;IK;CWC22;DHX9;SNRNP40;CCAR1;ZMAT5;SRSF2;ZMAT2;SNRPB2;CTNNBL1;CPSF7;RALY;PRPF8;SMU1;UPF3B;SF3A3;LSM4;SNU13;SRRM1;RBM22;SNRPG;POLR2F;SF3B2;SF3B1;HNRNPL;SNRPF;LSM3;SNW1;GEMIN5;SNRPA;SF3B5;PPIH;PRPF40A;FUS;SRSF1;SRSF10;CSTF2;PPIL3;DDX41;NUDT21;WBP4;TRA2B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.34240486846833545,1.091034340872737,0.14,0.6610703001443388,1.0,241/834,26.20%,IGF1;LITAF;CTNNB1;MITF;HIF1A;SKAP1;CSRNP1;MICAL2;ZMIZ1;MMP12;ATF3;CDK8;MRTFA;TOX2;ELF4;SLC9A1;KMT2A;NFIC;NFE2L2;LEF1;UBA52;AGO2;MYBL2;RPS27A;TNIP1;BCL11B;MAFF;MUC1;EOMES;SOX3;IRF6;TCF15;POMC;SOX30;NR4A3;FSTL3;VDR;MEF2D;DOT1L;SQSTM1;FGF2;CSRP3;TFEB;HDAC4;JAG1;PPARG;NCK2;FOXJ1;MYDGF;ZMIZ2;KLF6;RUNX1;DAB2;GATA3;RFX5;SOX9;BRD4;NCK1;VEGFA;EGR2;PPP1R12A;BPTF;HDAC1;TXK;MED21;ZNF395;MTF2;RHOQ;TNIP3;PRDM15;DDX17;EAPP;LILRB1;PPARD;IRF8;E2F3;RNASEL;HOXA7;CCNC;CDK13;NKX2-1;TET3;SS18L2;RNF111;PSMC3;JUP;PLXND1;ASXL2;POU2AF1;SMARCB1;BRCA1;MEF2B;CRTC1;ATF5;NRF1;TRIAP1;JUN;CEBPA;SERPINE1;MED17;MAML2;IRF5;TNIP2;MYSM1;MRTFB;SLC30A9;NAMPT;ZFP64;NPAT;PPARGC1B;ELK4;SMAD7;OGT;CHCHD2;FOXJ3;GTF2F1;SMAD1;YY1;EHF;NFYB;DCN;DDIT3;ACTR3;NFKB1;INO80;PRKD2;LRP6;SSBP4;SP7;PAXBP1;HELZ2;PCBP1;MED13;ASXL1;NHLH2;SRF;CEBPG;FOXO1;MTF1;NR4A2;ECD;PLAC8;HTATIP2;ZNF296;DHX36;NPAS4;ELK3;PIK3R2;BMP6;AKIRIN1;PRPF6;SBNO2;SERPINF2;HNRNPU;GABPB1;GABPB2;TCF12;CNBP;ATRX;HAX1;PIN1;GNL3;KAT7;USF2;ATM;IL6;DHX9;WBP2;SP1;DR1;CCNT2;TAF7;ITGB1BP1;TAF6;SLC11A1;HOXB4;ARHGEF2;UBC;TMF1;NR3C1;NFATC3;HMGB1;SREBF1;SPIB;MEIS3;EIF5A;RFXANK;NLRC5;PBX1;HSF1;RXRB;ETV4;NPM1;BMP4;SENP1;ATAD2B;GLYR1;TEAD1;TERT;WAS;ARNT2;PPRC1;RLF;SMARCD2;MAPK7;EGR1;AHR;ZBED3;STAT5B;KMT2D;PBX2;REL;LHX4;FGFR2;RXRA;DCAF6;WWOX;PPP3R1;LPIN3;TNF;GLIS2;MAP2K5;ATF4;POU2F1;HDAC2;RRP1B;BMP5;MED6;GRHL1;NOTCH4;DPF3;CSRNP3;HDAC3;LAGE3;SMARCA4;TLR9;MLLT6;TFCP2;FGF1;CX3CL1;TMPRSS6
prerank,blood vessel endothelial cell migration (GO:0043534),0.43837834993252955,1.0909419711516388,0.36341756919374246,0.660946328065081,1.0,6/22,16.05%,FGF2;NRP1;VEGFA;SRF;EFNB2;KDR
prerank,aorta morphogenesis (GO:0035909),0.47029412541853144,1.0903803342030771,0.36996336996337,0.6621144738923966,1.0,4/17,13.67%,LRP1;JAG1;DLL4;EFEMP2
prerank,membrane repolarization (GO:0086009),0.4749442080875309,1.0901027405604746,0.36585365853658536,0.6624580620495644,1.0,4/15,15.29%,ATP1B3;KCNJ2;ATP1A1;ATP1A2
prerank,ncRNA transcription (GO:0098781),0.48641924069744297,1.090018456255152,0.3786531130876747,0.6622913542558232,1.0,3/13,8.46%,USPL1;POLR1G;SNAPC2
prerank,histone H3-K9 demethylation (GO:0033169),0.5025334173034486,1.0898594574409644,0.37244201909959074,0.6623550204733056,1.0,5/11,16.18%,JMJD1C;HR;KDM3A;KDM3B;KDM4D
prerank,cell differentiation in hindbrain (GO:0021533),-0.4103459062167685,-1.0888704776402547,0.3258426966292135,0.7841941220663649,1.0,2/11,3.91%,OPHN1;GRID2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4117753235563017,1.0886518024096623,0.36394557823129253,0.6652603998304898,1.0,3/33,3.24%,RAB7B;HIF1A;SCIN
prerank,ceramide metabolic process (GO:0006672),0.39420697494507323,1.0885937858434536,0.35815991237677985,0.6650396180736226,1.0,8/49,8.59%,CERK;SGMS1;PPP2R1A;CERS6;ORMDL1;SPTSSA;PLPP3;SMPD4
prerank,presynaptic endocytosis (GO:0140238),-0.3181896287389335,-1.0884669724583937,0.3103448275862069,0.7818626794547607,1.0,5/24,6.38%,OPHN1;NLGN1;AMPH;SYT1;SYT2
prerank,cellular response to interferon-beta (GO:0035458),0.47487030778349587,1.0879950218605234,0.361323155216285,0.6662996319534974,1.0,6/14,25.47%,TRIM6;IFITM2;IRGC;ACOD1;CDC34;AIM2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.40668881894038333,1.0879468298859003,0.37232845894263217,0.6660418076276782,1.0,12/38,19.49%,CYBA;FPR2;SASH1;ADAM8;POLR3D;CCL5;RIOK3;ACOD1;BMP6;PUM1;DHX9;SCIMP
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.35817067684806386,1.0877258835114185,0.3072227873855544,0.6662687447769882,1.0,27/117,19.06%,CD247;PTGIR;FGR;ADCY8;ADCY3;CD3G;POMC;ADCY7;RHBDF2;GPR83;SCTR;TREM2;PLK2;ADAM17;CRH;IAPP;FYN;GPR176;GIPR;ADORA2A;GLP1R;VIP;SYK;FURIN;GPR84;IL6;GNB1
prerank,long-term synaptic potentiation (GO:0060291),-0.3346988372270451,-1.0867729022855035,0.3333333333333333,0.7836034858198908,1.0,8/21,12.31%,TSHZ3;GRIN2A;SLC8A3;GRIN2B;RGS14;SLC8A2;PRKCZ;MPP2
prerank,regulation of axonogenesis (GO:0050770),0.3872653119779863,1.0865214583133493,0.3735070575461455,0.6691776347884903,1.0,11/51,13.50%,PLXNC1;PLXNA2;KIF13B;LRP4;AMIGO1;GDI1;RUFY3;PLXND1;RHOA;CHODL;PAK2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.382870507142929,1.0861509559990825,0.34044823906083244,0.6698196310875685,1.0,12/54,16.06%,TRAF2;SPHK1;OTULIN;ADAM17;PTPN2;RACK1;TRAF1;HIPK1;SHARPIN;GAS6;CASP4;SYK
prerank,peptidyl-lysine modification (GO:0018205),0.3624171916112763,1.0861215608608048,0.33746130030959753,0.6695107651043349,1.0,39/99,29.22%,NUP205;HDAC9;ATP7A;NSMCE2;HDAC4;ETFBKMT;USPL1;TRIM28;EGR2;NUP188;SIRT5;SUMO2;RANBP2;TPR;EEF1AKMT3;VIPAS39;SIRT4;SENP5;RAE1;PIAS1;SAE1;NUP93;AAAS;GCSH;SENP1;NUP50;NUP54;SUMO1;SIRT3;NUP98;PIAS4;P3H3;NUP42;NUP133;NUP210;NUP35;LIPT2;NUP214;SIRT1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37864273786610586,1.0859178778802479,0.3447905477980666,0.669662582454978,1.0,16/60,19.10%,CTNNB1;CDK8;LEF1;MED15;TRIM28;SOX9;CCNC;CCNB1;BAX;MED17;NFKB1;MED13;SRF;DHX36;IL6;AGO3
prerank,regulation of cellular protein localization (GO:1903827),0.39135577179822445,1.0858668195661971,0.3639380530973451,0.6694107868732382,1.0,5/45,9.73%,LCP1;CTNNB1;ATP13A2;TRIM67;VCP
prerank,regulation of cell differentiation (GO:0045595),0.3558041896893641,1.085692089272699,0.3059777102330294,0.6694858541878478,1.0,25/148,13.64%,LGALS3;CDK6;CSF1;SLC6A6;DAG1;CD24;ID2;SCIN;RAF1;PPP2R1A;ZFHX2;RUNX1;BCL6;KLK6;GATA3;SIK1;FADS1;PRKCB;DDX17;FLOT2;PHLDB1;YWHAG;SMOC1;SMAD7;ROCK1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4191191201959454,1.0855835040703772,0.3805620608899297,0.6694094258265356,1.0,7/28,15.49%,NIBAN2;FBXW7;METTL3;DLL4;DLK2;EGFL7;YTHDF2
prerank,regulation of actin filament-based movement (GO:1903115),0.5216852564871443,1.0855590746537371,0.3795918367346939,0.6690863782135382,1.0,2/10,9.77%,PDPN;SRI
prerank,negative regulation of cation channel activity (GO:2001258),0.4275166576843069,1.0840663032366356,0.38562874251497004,0.6727222809536219,1.0,12/26,31.98%,MMP9;SRI;UBQLN1;EPO;CALM3;KCNAB1;FKBP1B;DRD3;FKBP1A;GSTO1;CALM1;EPHB2
prerank,muscle filament sliding (GO:0030049),0.40343046330717575,1.0835300000933406,0.3664383561643836,0.6734230382091082,1.0,8/38,24.25%,TNNT3;VIM;TPM2;TPM4;ACTN2;MYL1;TNNI1;MYL4
prerank,actin-myosin filament sliding (GO:0033275),0.40343046330717575,1.0835300000933406,0.3664383561643836,0.6734230382091082,1.0,8/38,24.25%,TNNT3;VIM;TPM2;TPM4;ACTN2;MYL1;TNNI1;MYL4
prerank,snRNA 3'-end processing (GO:0034472),0.4452017095606335,1.0834058545279948,0.3717146433041302,0.6733645375113972,1.0,8/19,23.54%,EXOSC4;EXOSC9;INTS14;INTS6;INTS2;EXOSC5;USB1;INTS7
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3915903790700987,-1.083342545281889,0.3392857142857143,0.7905952751495611,1.0,5/14,13.61%,DDX60;DHX58;TLR2;TLR5;ZCCHC3
prerank,regulation of metal ion transport (GO:0010959),0.46273028426858476,1.083024683046436,0.36178343949044584,0.673995955476759,1.0,3/16,9.77%,BCL2;CD4;SRI
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.4438244921004615,1.0829709404838943,0.3693467336683417,0.6737529469340943,1.0,10/19,31.99%,HNRNPC;EXOSC10;HNRNPU;TERF1;ACD;XRN1;NAT10;TENT4B;TERF2;DCP2
prerank,diol metabolic process (GO:0034311),0.44959828337863805,1.0828653139483746,0.36855345911949683,0.6736638630261548,1.0,3/19,6.40%,SPHK2;SPHK1;PLPP3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.41180374279131804,1.0827243359867165,0.3707995365005794,0.6736850675317665,1.0,5/34,12.95%,P2RX4;SLC9A1;NPPA;SRI;SMAD7
prerank,autophagosome organization (GO:1905037),0.3884085728852681,1.0827118839075127,0.3511705685618729,0.6733243320495397,1.0,25/50,32.40%,ATG7;ATP13A2;RUFY4;PACS2;WDR45;TMEM41B;RAB7A;MAP1LC3B;UBQLN1;RAB1A;ATG16L1;ATG2B;MAP1LC3A;GABARAP;ATP2A2;ATG3;ATG13;AMBRA1;RAB43;TP53INP2;BECN1;ATG16L2;VMP1;ATG5;UBQLN2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4378628238189891,1.0825396897754207,0.37407407407407406,0.6734101036004445,1.0,7/21,12.95%,CAV1;NCK2;NCK1;RACK1;PAQR3;CNKSR3;SMAD7
prerank,manganese ion transport (GO:0006828),0.473466807436211,1.0823450122778067,0.3771353482260184,0.6735525304644328,1.0,1/14,0.25%,TRPC4
prerank,cellular response to estradiol stimulus (GO:0071392),-0.36882236102757326,-1.081479066742554,0.3282051282051282,0.7927989405477578,1.0,10/18,34.93%,NRIP1;EGFR;KAT5;FAM210B;SSTR2;RAMP3;NCOA3;GPER1;POU4F2;POU4F1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5025899763179767,1.0812373797739512,0.4161073825503356,0.675806971583848,1.0,4/11,21.84%,CCT2;CCT8;CCT5;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5025899763179767,1.0812373797739512,0.4161073825503356,0.675806971583848,1.0,4/11,21.84%,CCT2;CCT8;CCT5;DKC1
prerank,telomere organization (GO:0032200),0.39414757812712053,1.0810541703000014,0.3694690265486726,0.6759337647695342,1.0,24/43,37.64%,DOT1L;RAD50;SP100;BLM;ERCC4;PARP3;ATM;RTEL1;PTGES3;TERF1;ACD;TERT;H3-3A;TERF2IP;ATR;POLD4;XRCC5;TERF2;HUS1;PCNA;RIF1;RAD51D;TINF2;CTC1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.46289898105524446,1.0809542276485957,0.3864795918367347,0.6758274964202846,1.0,9/16,29.73%,CHMP4A;CHMP4B;VTA1;CHMP7;TMEM50B;CHMP6;VPS28;LEPROT;SNF8
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4926364359522752,1.0804054628841957,0.39594594594594595,0.6768963516988763,1.0,3/12,12.03%,IFITM2;IFITM1;GSN
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4857127487445833,1.0803454695128376,0.40443213296398894,0.6766905307179886,1.0,6/13,21.77%,PPARG;SOX9;PPARD;SRF;NFATC3;BMP4
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4112624257117161,-1.080219954584565,0.32954545454545453,0.7930644954624017,1.0,1/11,0.29%,MEF2C
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.508028905228144,1.0802007597666867,0.40437158469945356,0.6766749215732066,1.0,4/10,21.84%,CCT2;CCT8;CCT5;DKC1
prerank,replicative senescence (GO:0090399),0.4838133390423968,1.0801002061167055,0.4032042723631509,0.6765696377514441,1.0,5/12,27.40%,PLA2R1;SERPINE1;ATM;TERT;ATR
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.33821160919815707,1.0799524102968607,0.15,0.6765779808832468,1.0,233/807,26.43%,FNIP2;MDFIC;CTNNB1;MITF;UXT;ZHX2;DNMT3A;NIBAN2;ATF3;SDCBP;FLNA;NFIC;ARID5B;SCML4;LEF1;HDAC9;DEDD2;UBA52;TBX21;DEAF1;RPS27A;RCOR1;MUC1;PRDX5;ID2;EOMES;NRG1;SOX3;SOX30;NR4A3;VDR;NCOR2;RPS14;CDK5;NFIL3;MNT;TGIF1;CIC;PRICKLE1;HDAC4;CAV1;DAXX;PPARG;SHOX2;FOXJ1;KLF12;NOC2L;RUNX1;ERN2;BCL6;DAB2;RPL23;GATA3;CUX1;TRIM28;ZBTB7B;SOX9;VEGFA;SATB1;MAF1;ING4;BPTF;HDAC1;NFX1;ZBTB2;PEX2;KMT5A;BHLHE40;MTF2;ATXN1;CHD3;BHLHE41;GMNN;USP9X;BASP1;PPARD;MIDEAS;IRF8;HOXA7;LRRFIP1;FOXN3;MDFI;NKX2-1;THAP7;OTP;AEBP1;SOX7;CPEB3;DAP;FOXP4;BRCA1;ATF5;SUDS3;ZNF148;FOSB;JUN;NAB2;CEBPA;ENO1;GATAD2B;RNF2;BAP1;DLL4;RIOX1;ZKSCAN3;TLE5;NUPR2;HSPA8;SP100;ZBTB16;ELK4;SMAD7;TFAP4;GATAD2A;EFNA1;GAS6;CBFA2T2;ILF3;H1-0;MAFK;YY1;BIRC5;EED;ETV6;DDIT3;NFKB1;RBFOX2;RBM15;TCF25;TPR;USP47;PRMT2;C1QBP;FOXO1;NR4A2;ELK3;PRMT6;SARS1;BMP6;MYBBP1A;SMYD2;RBM15B;RCOR3;PSPC1;PDCD4;SBNO2;HNRNPU;CNBP;PAF1;UIMC1;PURA;GCFC2;CBX3;KAT7;BMI1;CBX2;DNMT3B;DNAJB1;WFS1;ZNF177;CCAR2;DR1;LYAR;TAF7;MIER2;YAF2;DACH1;UBC;NR3C1;JDP2;HMGB1;PRDM6;EHMT1;FBXW11;MTDH;YEATS2;ZFP57;EPO;VHL;VPS72;HSF1;RUNX3;BMP4;ID1;SUFU;CALR;KLF11;NIPBL;AHR;CREBZF;ZNF568;PEX14;FGFR2;L3MBTL3;ZBTB4;E2F6;RXRA;USP2;WWOX;MDM2;SUMO1;SOX10;MTA3;TNF;GLIS2;MAP2K5;CCDC85B;PLK3;ATF4;GADD45A;ZGPAT;ATN1;MCPH1;POU2F1;HDAC2;KDM5C;SFRP1;KANK2;NOTCH4;DPF3;HDAC3;PIAS4;L3MBTL2;HIC2;SMARCA4;BTRC;NSD1;TMPRSS6;FST;NR6A1;PCGF6;SNW1;HCFC1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.38310485482536777,1.0798482748172353,0.3625541125541126,0.6764728722799079,1.0,26/52,36.51%,MDH1B;MTHFD2;SLC46A1;MTHFS;SHMT1;ME2;MTHFD1;FPGS;MTRR;DLST;SLC19A1;ALDH1L2;MTHFR;ME1;SDHAF3;ACOT8;MDH2;IDH2;SHMT2;MTHFD1L;SLC25A32;HOGA1;ACLY;ACOT4;IDH1;L2HGDH
prerank,protein localization to cell periphery (GO:1990778),0.35319613016945556,1.0795436287745495,0.32454361054766734,0.6768597678541671,1.0,36/133,19.78%,FGF13;MYO5A;ANK1;FLNA;RAP2A;RABEP1;ATP1B3;TTC7B;RAB40C;CAV1;RAPGEF6;EFR3B;DENND4C;TSPAN17;PACS2;CDH1;FLOT2;P2RY1;RAB8A;GAK;JUP;RAB8B;PRAM1;TSPAN5;PLEKHF1;GAS6;ROCK1;LRP6;SCN3B;MYADM;PKP2;CACNB3;RAB11A;EHD4;ITGB1BP1;ACTN2
prerank,Golgi to plasma membrane transport (GO:0006893),0.38812245345959046,1.0792548368400179,0.35043668122270744,0.6772404120956969,1.0,20/47,28.68%,RABEP1;MACF1;OPTN;GOLGA4;ARFGEF2;EXOC2;GCC2;GGA2;VAMP4;VAMP2;VPS35L;CCDC22;LLGL1;GOLPH3;GGA1;GOLPH3L;RAB31;EXOC4;ARL3;ARFRP1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3379356992631528,-1.0792005654874035,0.3157894736842105,0.7925796811579154,1.0,6/20,11.67%,LRRK2;ADGRV1;PRKAR2A;AKAP6;AKAP12;PRKAR2B
prerank,protein transport (GO:0015031),0.345951651820843,1.078977827119946,0.249,0.6776171387213238,1.0,131/332,31.21%,APOE;ABCG1;ABCA1;LRP1;TBC1D10C;TCIRG1;ATP6V1C1;ATP6V0D2;TBC1D22A;ATP6V1A;CTSA;SNX8;ARF3;ATP6V0A1;MACF1;OPTN;ATP6V1B2;GOLGA4;CD3G;ATP6V0D1;TOM1;ATP6V0B;ATP6V1G1;PPARG;TBC1D2;ARL1;STX6;RAB5C;SNX33;REP15;NAPA;RIC1;PRKCB;SIL1;ATP6AP1;VPS26A;LAMP2;RAB32;ARL11;RAB8A;MON1A;RAB8B;DNM2;WLS;RAB7A;ATP6V1F;GCC2;RAB5A;STX3;RCN3;CLU;GGA2;VPS26C;TFRC;AP3D1;RAB22A;SAR1A;VAMP4;TBC1D22B;TLK1;RAB1A;VIPAS39;TBC1D12;SNX4;VAMP2;RAB3GAP2;ATP6V0C;TMEM167A;ARL6IP5;ARHGEF2;LTBP2;ATP6V0A4;ATP6V1E1;LAPTM5;LMTK2;ARL4C;ARFGAP3;SNX31;ACD;NPM1;RAB3D;TMED3;CANX;ARRDC4;CD74;VPS35;RAB20;TBC1D10A;SNX1;SCAMP3;EHD1;SGSM1;GOLPH3;USO1;TBC1D16;ATP6V0E1;ARRDC2;GGA1;RILP;GOLPH3L;STX7;COPZ2;STX4;TBC1D15;STX5;RAB31;EIF2D;TMED2;COPA;RAB5B;ARL6;AFM;ARHGAP1;ARFRP1;HSP90B1;SNX27;RAB43;RAB11B;SNX17;RABL3;TANGO2;AP3B1;COPG1;RUFY1;SEC23IP;COPG2;ARF6;UNC119B;TBC1D8B;COG7;RAB24
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.30071582558244464,-1.0787629648942578,0.3053435114503817,0.7902889853202525,1.0,7/32,5.31%,IL1RAPL1;PTPRD;CDKL5;ADGRB3;HECW1;RAPGEF2;HECW2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.49218501534088116,1.0787235867103242,0.38179347826086957,0.6778999874387031,1.0,6/12,24.97%,CHMP4A;CHMP4B;SEC61B;SEC63;GET3;HSPA5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4620531909646091,1.0783746302877533,0.38238993710691827,0.6784975102852734,1.0,8/15,37.73%,APOA2;LILRB1;SMAD7;TNF;JAK3;CUEDC2;TGFB1;TGFB2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4971837433170248,1.078300222227317,0.40268456375838924,0.6782983263468189,1.0,3/12,15.37%,UMPS;UCKL1;CAD
prerank,establishment of protein localization to organelle (GO:0072594),0.37027600907884745,1.0781484883088532,0.3707627118644068,0.6783183982682671,1.0,29/72,29.44%,MMP12;GCKR;ZDHHC15;PRICKLE1;IPO5;TSPAN17;HK1;E2F3;LAMP2;NUP188;NXT2;TPR;EIF4ENIF1;APPL2;SYK;PPP1R10;RAB11A;NUP93;CD68;NUP50;TNPO2;TNPO1;NUP133;LAMP1;NUTF2;IPO13;PTTG1IP;NUP214;PEX19
prerank,RNA methylation (GO:0001510),0.3807972581908254,1.0775818143801026,0.35698924731182796,0.6794683011172832,1.0,36/60,36.70%,METTL1;TRMT10C;MRM2;METTL3;FTSJ3;METTL2B;METTL2A;RBM15;TRMT13;RBM15B;THADA;NSUN3;NSUN2;TRMT112;DIMT1;TARBP1;GTPBP3;THUMPD2;CBLL1;METTL8;NSUN4;TRMT5;TRMT6;PCIF1;ALKBH8;METTL6;TRMT12;LCMT2;ZCCHC4;NSUN6;TRMT10A;MTO1;TGS1;TRMT44;METTL14;ZC3H13
prerank,cellular protein modification process (GO:0006464),0.3383524436175921,1.0773481224324037,0.126,0.6797151502719194,1.0,293/982,26.16%,FNIP2;FAM20C;B4GALT5;SPP1;CDK14;LCK;APOE;PEAK1;HIF1A;CDK18;FN1;CDK6;PRKCH;ABL2;CD247;CSF1;IGFBP7;CDK8;ATG7;PTPRA;PSMD8;LGALS1;PTPRC;ANXA1;PSMD1;MSRA;UBL4A;SGK1;FGR;UBA52;LARGE1;TEC;PARP4;CEL;SRPK1;B4GALT7;GCNT2;SERPINA10;COPS3;APOA2;CD3G;MATN3;ENAM;B3GNT3;FSTL3;DUSP9;MAP4K5;MAP4K2;PTK2B;DYRK2;NEURL2;PAK6;SGK3;SGK2;WSB2;CDK5;FBXW7;PRKCD;FBXO32;PPM1J;TNKS2;TAOK3;PPP2R5C;RNF7;ANO8;PPP2R1A;PPM1H;B3GALNT2;ERN2;PTPN22;STT3B;PDPK1;APLP2;CTDNEP1;STK24;STK3;SIK1;ERN1;IKBKE;MAP4K3;GNMT;PPP1R12A;COPS8;COPS4;P3H1;TXK;UGCG;SPSB2;PLK2;UBE2L3;P4HB;TAB1;FBXO31;PRKCB;PGAP1;ST8SIA6;PTAR1;ILK;PSMD6;PSMA1;OGA;DDB2;RNASEL;MAPKAPK2;CDK13;ERO1A;FBXW4;WDR45;EVPL;RAB8A;DDB1;NEK4;CUL9;PSMC3;KLHL13;FYN;COPS2;SIRT5;RABGGTB;C3;CDK17;DUSP6;SOCS5;PIM1;HIPK1;RBBP5;PTPN12;ART4;JAK1;OGFOD1;BAP1;PSMA8;F5;PHPT1;BIRC6;KCTD7;COPS6;RSKR;WDR5;MAP3K12;TGM5;CDK11B;RAB5A;ALG10B;LIMK1;GPAA1;ZBTB16;TIPARP;PTPN13;FSTL1;GAS6;ABCA7;CDK2;UBE2F;ILF3;PKN2;PAK2;PSMD14;NPC1;ROCK1;BIRC5;PSMD2;MAP3K1;UBE2L6;PRKD2;FASTK;LAMC1;DAPK1;FBXL19;CSNK1D;MAPK9;STK38;PSMC6;QPCT;ZC3HAV1;PSMA6;MELTF;DUSP11;SYK;PLK4;CKAP4;KLHL25;TLK1;RAB1A;TULP4;SIRT4;PRKAG1;PPP6C;MINK1;CAMK4;ASB1;PSMD5;RIPK3;NLK;ELOB;STK11;DCAF17;PTP4A2;RAB11A;PARP3;PSMA5;DAPK3;WSB1;NEK6;UBL5;MEX3B;ATM;IL6;PPP3CC;WFS1;TP53RK;CUL3;DDOST;SPARCL1;SPSB3;AGA;PTPN21;FBXO7;CDK16;MAP3K9;PDK3;SHISA5;FBXW11;MAK;CAND1;LMTK2;TIMP1;MARK2;VHL;CUL1;CALU;FBXW5;DUSP12;GSK3B;PRAG1;MARK4;RUNX3;NIM1K;PIGT;CDC34;SRPK2;BMP4;TRIOBP;MELK;FBXO11;TAOK1;TRIB2;CUL2;LATS1;FUT10;EGLN3;PIGH;CCDC22;ST3GAL2;DUSP16;TGFBR2;RBBP7;PSMA3;SOCS2;PTPN9;DCAF6;NAA80;JAK2;PARP2;SIRT3;PRKCSH;STK38L;WDTC1;DCUN1D3;COQ8B;CDK4;SIK3;CDC25B;PTPN18;PSMB10;FBXO41;BTK;PSMB8;GOLGA2;YWHAZ;PSMD7;SLC35A1;HCST;CUL4A;ATG10;YES1;PAK4;PSMB6;HLCS;PARP16;METAP1D;KLHL21;BTRC
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34938847525246947,1.077157884575034,0.31947261663286003,0.6798385079545775,1.0,65/173,32.92%,ANK1;CTSZ;GOSR2;SEC22B;DYNC1H1;GOLGB1;VTI1A;BET1L;TRAPPC8;NAPA;RANGRF;PGAP1;COG4;DCTN1;SEC24A;F5;LMAN1;GAS6;PROS1;DYNC1LI2;MCFD2;SEC24D;VAPB;YIF1B;SAR1A;VAMP4;RAB1A;TRAPPC11;GRIA1;TBC1D20;LMAN2;CUL3;F8;YKT6;ARFGAP3;CD55;ARFGAP1;DCTN4;TMED3;DCTN6;USO1;F9;TRAPPC12;GOLGA2;ARFGAP2;COPZ2;COG6;STX5;TMED2;COPA;TEX261;COG8;USE1;TRAPPC4;KDELR2;SPTAN1;COPG1;COPG2;COG7;COPB2;DYNC1I2;MIA3;CNIH4;DCTN5;ACTR10
prerank,positive regulation of nervous system process (GO:0031646),0.4543853012478356,1.0769764074958026,0.3969465648854962,0.6799461163866132,1.0,5/18,15.72%,ITGAX;CST7;EGR2;TNFRSF1B;NCMAP
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.35634512247236094,-1.0768709523045568,0.29743589743589743,0.7925457036463194,1.0,7/17,24.96%,SNTA1;KCNH2;NEDD4L;KCNQ1;ANK2;KCNE3;KCNE4
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4415411975995295,1.0767743556931682,0.39434889434889436,0.6800911602946567,1.0,2/21,2.10%,XYLT1;HS3ST3B1
prerank,negative regulation of wound healing (GO:0061045),0.41605381183010065,1.076192415982072,0.36823529411764705,0.6812217940500871,1.0,6/28,11.25%,APOE;CLDN19;FGF2;TFPI;SERPINE2;SERPINE1
prerank,endocytic recycling (GO:0032456),0.3890341039997339,1.0760505043428326,0.3743139407244786,0.6812124306898243,1.0,26/50,30.71%,PTPN23;STX6;VPS26A;VPS50;RAB7A;VPS26C;MICALL2;SNX4;VPS51;EHD4;VPS35L;RAB11FIP4;VPS39;LMTK2;ARL4C;SNX31;SNX12;CCDC22;VPS35;EHD1;DENND1B;SNX27;RAB11B;SNX17;SNF8;ARF6
prerank,regulation of myoblast differentiation (GO:0045661),-0.3032579323770711,-1.076020895767664,0.3076923076923077,0.7918968322122502,1.0,7/32,11.28%,MEF2C;MAPK14;PLCB1;SOX8;LRRC8A;IGFBP3;EID2B
prerank,regulation of mitochondrial fusion (GO:0010635),0.5021283966734686,1.0757324240885484,0.39777468706536856,0.6817014546098998,1.0,7/11,33.13%,VAT1;HUWE1;TFRC;BNIP3;MUL1;ZDHHC6;PID1
prerank,substrate-dependent cell migration (GO:0006929),-0.3819182944508368,-1.0754529304338454,0.37209302325581395,0.7901708840651667,1.0,4/14,4.53%,P2RY12;OPHN1;ANKS1A;CD2AP
prerank,regulation of lipid biosynthetic process (GO:0046890),0.41066367450436975,1.0749067659205793,0.3791907514450867,0.6835372048534885,1.0,8/32,19.03%,APOE;EIF6;C3;MID1IP1;SORBS1;SIRT4;ADIPOR1;ASAH1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.40970974080270073,1.0746316360758856,0.3791907514450867,0.6839287200209743,1.0,6/32,12.78%,SLC27A1;PEMT;APOA2;STARD10;CHKB;LPCAT3
prerank,sensory perception of chemical stimulus (GO:0007606),0.46998571652922716,1.0745856346205824,0.4109947643979058,0.6836679326266676,1.0,5/15,22.98%,SLC24A4;ADCY3;C5AR1;MKKS;GNAS
prerank,protein localization to membrane (GO:0072657),0.3470733840098332,1.074570256153296,0.32232232232232233,0.6833205350789726,1.0,50/187,19.78%,SH3PXD2B;FGF13;RFTN1;MYO5A;ANK1;FLNA;RAP2A;RABEP1;ITGAL;ATP1B3;TTC7B;RAB40C;ZDHHC15;ITGA4;CAV1;BID;RAPGEF6;EFR3B;DENND4C;TSPAN17;PACS2;CDH1;FLOT2;P2RY1;RAB32;RAB8A;GAK;JUP;RAB8B;PRAM1;TSPAN5;PLEKHF1;GAS6;NPC1;ROCK1;SAV1;LRP6;ITGB2;HPS6;AP3D1;SCN3B;MYADM;PKP2;CACNB3;RAB11A;EHD4;FERMT2;ITGB1BP1;ABHD17A;ACTN2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.41017160759868704,-1.0745473651601656,0.31985294117647056,0.789429078436944,1.0,3/10,15.87%,PDE3B;PDE4D;PDE2A
prerank,sensory perception of taste (GO:0050909),0.5117098949769323,1.0743995245036992,0.39944521497919555,0.6834043537844148,1.0,3/10,28.64%,ASIC3;ASIC1;PKD2L1
prerank,stabilization of membrane potential (GO:0030322),0.4633736349738111,1.0739943378376533,0.39766839378238344,0.6840566306136061,1.0,2/16,2.49%,KCNN4;KCNK13
prerank,regulation of MAP kinase activity (GO:0043405),0.3619812602957951,1.0738636999683748,0.34196891191709844,0.6840221574550571,1.0,17/92,16.45%,FLT1;APOE;ADAM8;PDGFA;PIK3CB;CD24;PRKCD;FGF2;PIK3R5;VEGFA;RASGRP1;CD300A;PAQR3;SPRY4;STK38;NF1;SMPD1
prerank,regulation of type I interferon production (GO:0032479),0.3680252576761055,1.0734290930732329,0.3537981269510926,0.6848111681726833,1.0,34/84,29.46%,CTNNB1;RNF125;TRAF3;PTPN22;IKBKE;POLR2H;IRF8;LRRFIP1;POLR3E;POLR3D;IRF5;ILRUN;NFKB1;UBE2L6;DTX4;ACOD1;TIRAP;DHX36;DHX33;PIN1;DHX9;NLRC5;RNF216;TRIM21;NLRP4;G3BP1;POLR2F;TRAF3IP1;OTUD5;TBK1;TNFAIP3;DDX41;CRCP;XRCC5
prerank,transition metal ion homeostasis (GO:0055076),0.4208724524846809,1.0733596213604442,0.39171597633136096,0.6846247982612932,1.0,6/28,10.09%,FTL;ATP13A2;HEPH;CYBRD1;B2M;HMOX1
prerank,protein catabolic process (GO:0030163),0.3793079358994892,1.0730986690404156,0.36904761904761907,0.6849422447655996,1.0,11/59,12.82%,APOE;CTSD;SIAH2;STT3B;OGA;LAMP2;VCP;DDB1;PSMA8;DDI2;HSPA8
prerank,regulation of ruffle assembly (GO:1900027),0.4337788383884551,1.0728643344508006,0.40048250904704463,0.6851842374355467,1.0,5/23,5.31%,STAP1;ARHGAP24;P2RX4;PLEKHM1;CAV1
prerank,intermediate filament organization (GO:0045109),0.4599481366375825,1.072666951961765,0.40074906367041196,0.6853228292112375,1.0,5/17,18.15%,VIM;PKP1;KLHL24;PKP2;GFAP
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.35411290700384773,-1.0718539174868496,0.3253588516746411,0.7944751058114452,1.0,6/18,10.88%,NAT8L;NIT2;SLC25A12;FOLH1;ASPA;NAALAD2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5087641557319929,1.0717610344233868,0.39780521262002744,0.6874093160693135,1.0,1/10,2.16%,ATP7A
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42726803068622266,1.071520969844717,0.37812128418549346,0.6876752723338473,1.0,2/22,0.93%,STAP1;PLEK
prerank,positive regulation of ATPase activity (GO:0032781),0.3883755353648857,1.0714459361142235,0.36425339366515835,0.6874959320224272,1.0,13/41,26.27%,TNNT3;ATP1B3;TOR1AIP2;CHTOP;HNRNPU;DHX9;DNAJB1;DNAJC9;SETMAR;PFN1;DNAJC10;MYL4;ATP1B2
prerank,regulation of primary metabolic process (GO:0080090),0.3550233292036034,1.07113605099077,0.35234215885947046,0.6879902049105862,1.0,47/126,27.96%,APOE;PSMD8;NFYA;PSMD1;ACACA;ID2;NCOR2;AZIN1;PSAP;PPARG;PSMD6;PSMA1;PPARD;PSMC3;OAZ3;PSMA8;CARM1;ABCA7;PSMD14;NFYB;PSMD2;HELZ2;PSMC6;PSMA6;ADIPOR1;ODC1;PSMD5;PSMA5;SP1;ACACB;SREBF1;TM6SF2;PMVK;PSMA3;RXRA;EDF1;FASN;LACTB;PSMB10;PSMB8;PSMD7;HDAC3;PSMB6;PSMD10;PSMB5;NQO1;PSMB7
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5054498797426759,1.0707516501353391,0.39094650205761317,0.6886456131133251,1.0,5/10,24.96%,ACAD11;GCDH;ACADL;ACADS;ACADM
prerank,protein localization to plasma membrane (GO:0072659),0.35207905490441477,1.0705508318026953,0.3479591836734694,0.6887686705112851,1.0,36/129,19.78%,FGF13;MYO5A;ANK1;FLNA;RAP2A;ATP1B3;TTC7B;RAB40C;RAPGEF6;EFR3B;DENND4C;TSPAN17;PACS2;NECTIN3;CDH1;FLOT2;P2RY1;RAB8A;GAK;JUP;RAB8B;PRAM1;TSPAN5;PLEKHF1;GAS6;ROCK1;LRP6;SCN3B;MYADM;PKP2;AFDN;CACNB3;RAB11A;EHD4;ITGB1BP1;ACTN2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.35807078495095435,1.0704919141421338,0.35365853658536583,0.6885497417928866,1.0,24/104,20.51%,SNX25;UBA52;RPS27A;CILP;FSTL3;CAV1;VEPH1;PPARG;PDPK1;WFIKKN1;ADAM17;NKX2-1;BAMBI;LEMD2;CHRD;SMAD7;SMAD1;PIN1;DAND5;FAM89B;UBC;SPART;EMILIN1;SPRED2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4446235288542499,1.0703810862387781,0.389873417721519,0.6884571116485299,1.0,10/18,30.96%,TMEM98;TNFRSF1B;SLC45A3;NF1;IL34;MDK;CXCR4;HES1;DRD3;PTPRZ1
prerank,regulation of B cell apoptotic process (GO:0002902),0.4898319118458809,1.0702308975272805,0.3989071038251366,0.6884968391986952,1.0,6/12,27.99%,NOC2L;BCL6;ORMDL3;IL2;BTK;FNIP1
prerank,histone H2A acetylation (GO:0043968),0.4616540650491348,1.070089133436101,0.41802252816020025,0.6885000588370165,1.0,13/16,38.36%,SPHK2;MSL3;ING3;EP400;MORF4L1;MORF4L2;RUVBL2;BRD8;DMAP1;TRRAP;EPC1;RUVBL1;NAA40
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.34724903870135776,1.0700390780040985,0.35347432024169184,0.6882476028033958,1.0,41/151,24.90%,B4GALT5;APOE;SLC27A1;LARGE1;TNIP1;SGMS1;SPHK2;PEMT;APOA2;GSTA2;SPHK1;HACD2;CERS6;SPTSSA;PLPP3;STARD10;CHKB;MOCOS;ALAS1;LPCAT3;KDSR;AKR1A1;HACD1;PRKD2;VAPB;FURIN;NANP;CDO1;ALDH3A2;ALDH3B1;CSNK2A2;ELOVL2;GSTO2;SAMD8;ELOVL1;ST3GAL2;SPTLC3;PRKD3;LPIN3;GOLPH3;ASL
prerank,positive regulation of dephosphorylation (GO:0035306),0.4207240572070889,1.0699266375389236,0.3895953757225434,0.6881701444208868,1.0,11/27,23.62%,PTPA;PRKCD;DLC1;PPIA;SPPL3;SYMPK;SMPD1;RIPK3;PIN1;NSMF;CALM3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.37589477256344583,1.0695953988864677,0.37662337662337664,0.6886604258725647,1.0,21/59,29.43%,NLRC3;UBA52;IRAK2;TANK;TRAF2;RPS27A;TAB1;TICAM1;SHARPIN;ROCK1;NKIRAS2;TBKBP1;UBC;REL;TNF;BIRC2;TLR9;TBK1;RIPK1;TAB2;AZI2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5045198268781423,1.0690122837515401,0.41216216216216217,0.6898414262399766,1.0,5/11,26.59%,NCL;SMARCB1;PWP1;SMARCA4;PIH1D1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.36175901393017784,-1.0688619333662424,0.34051724137931033,0.8004149742874097,1.0,7/15,20.88%,CD33;SLC30A1;TRIM27;NOS1;INPP5K;PLN;ADRA2A
prerank,regulation of myoblast fusion (GO:1901739),0.5028484892640808,1.0685194773153932,0.42013422818791946,0.6908199842384903,1.0,3/11,8.57%,RIPOR2;ADGRB1;CD53
prerank,regulation of interleukin-1 beta production (GO:0032651),0.36741636189944765,1.0684065730737422,0.3698630136986301,0.6907208251721383,1.0,7/66,8.32%,IGF1;LPL;SIRPA;MALT1;PANX1;HSPB1;TRIM16
prerank,cellular response to reactive oxygen species (GO:0034614),0.37558946396765774,1.068368992345703,0.3870967741935484,0.6904413029393619,1.0,23/59,29.22%,SIRPA;NFE2L2;ANXA1;PRDX5;MAPK13;MMP9;PRKCD;PLEKHA1;AGAP3;JUN;CYP1B1;MAPK9;RIPK3;IL6;RPS3;MAPK7;PDGFRA;NCF1;TNFAIP3;RIPK1;MAPK3;PRDX3;SIRT1
prerank,estrogen metabolic process (GO:0008210),0.46490354530737077,1.068365041635559,0.4021164021164021,0.6900696358715952,1.0,3/15,14.67%,CYP19A1;HSD17B8;CYP1B1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.43955148078492057,1.0679626450738837,0.3926829268292683,0.6907641463829716,1.0,6/20,21.84%,APOE;ARV1;LPCAT3;MBTPS2;SREBF1;ACADL
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5141121474221897,1.0679296086743815,0.41346153846153844,0.6904709009228617,1.0,8/10,41.47%,SP7;HOXB4;SFRP1;UFL1;LMBR1L;MLLT3;BATF;TP53
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4970938003500543,1.0677787091973026,0.4016973125884017,0.6904860301914134,1.0,5/11,21.49%,TARM1;RUNX1;CD274;HMGB1;RUNX3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4121396853421191,1.0676738947585076,0.39811542991755006,0.6903805945995052,1.0,5/28,9.40%,PRKCQ;PRKCD;NCK1;PRKCB;PTPN2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33832627821198713,1.067018616102932,0.285,0.69179288772437,1.0,86/348,23.57%,IGF1;MITF;STAP1;HIF1A;ITGAX;FN1;CD3E;MMP8;CSF1;NFE2L2;MSN;LEF1;AGO2;ATP13A2;PIK3CB;ID2;VDR;CLDN19;PKP1;POU3F1;FGF2;CD28;SERPINB9;RPS7;PTPN22;RPL23;TRIM28;ZBTB7B;SOX9;FUBP1;VEGFA;ANGPT1;DNMT1;TREM2;CELF1;ACTG1;DTNBP1;LILRB1;WNT6;RPL11;NKX2-1;TICAM1;FGF7;KRAS;NAT8;BRCA1;CD63;FGF20;DLL4;GSN;GAS6;SMAD1;ROCK1;SCYL2;STOX1;CLU;ACTA2;MAPK9;TFRC;DHX36;BMP6;PRKAG1;AFDN;ATM;IL6;SP1;DNMT3B;WFS1;AGO3;FAM98A;SLC11A1;SLC38A2;RPS3;EMILIN1;LAPTM5;GSK3B;RESF1;SRPK2;BMP4;FGF18;MAPK7;CD74;EGR1;VPS35;AMH;ECE1
prerank,histone deacetylation (GO:0016575),0.3851409061200102,1.066972593643064,0.37843784378437845,0.6915274231406378,1.0,16/43,26.77%,HDAC9;RCOR1;HDAC4;MSL3;HDAC1;MIDEAS;SUDS3;ELK4;RCOR3;MIER2;MORF4L1;MTA3;HDAC11;HDAC2;HDAC3;MORF4L2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3352473979570139,1.0669379188453585,0.244,0.6912385217927929,1.0,174/572,27.52%,FNIP2;MITF;UXT;ZHX2;DNMT3A;ATF3;SDCBP;NFIC;ARID5B;HDAC9;UBA52;TBX21;DEAF1;RPS27A;ID2;EOMES;SOX3;SOX30;NR4A3;VDR;NCOR2;RPS14;NFIL3;MNT;TGIF1;CC2D1A;HDAC4;CAV1;PPARG;SHOX2;FOXJ1;KLF12;NOC2L;RUNX1;BCL6;DAB2;RPL23;GATA3;CUX1;ZBTB7B;SOX9;VEGFA;SATB1;BPTF;HDAC1;NFX1;ZBTB2;PEX2;KMT5A;BHLHE40;MTF2;ATXN1;CHD3;BHLHE41;USP9X;PPARD;IRF8;HOXA7;LRRFIP1;MDFI;NKX2-1;THAP7;OTP;AEBP1;CPEB3;FOXP4;SUDS3;ZNF148;FOSB;JUN;ENO1;GATAD2B;RNF2;DLL4;ZKSCAN3;TLE5;NUPR2;SP100;ZBTB16;ELK4;SMAD7;GATAD2A;EFNA1;H1-0;MAFK;YY1;EED;ETV6;DDIT3;NFKB1;TCF25;TPR;SRF;C1QBP;NR4A2;SARS1;BMP6;SMYD2;HNRNPU;CNBP;PAF1;PURA;ATRX;BMI1;CBX2;DNMT3B;DNAJB1;WFS1;ZNF177;DR1;LYAR;TAF7;MIER2;DACH1;UBC;NR3C1;JDP2;NFATC3;HMGB1;PRDM6;MTDH;YEATS2;ZFP57;EPO;VHL;VPS72;HSF1;RUNX3;BMP4;ID1;SUFU;CALR;KLF11;NIPBL;ZNF568;FGFR2;ZBTB4;E2F6;RXRA;USP2;WWOX;MDM2;SUMO1;SOX10;MTA3;TNF;GLIS2;MAP2K5;BAG3;PLK3;ATF4;GADD45A;ZGPAT;ATN1;MCPH1;HDAC2;KANK2;NOTCH4;HDAC3;SMARCA4;NSD1;TMPRSS6;FST;NR6A1;SNW1;HCFC1;PSMD10;CBX7;PPM1A;SUPT4H1;KDM1A;HES1;DACT1;FRK
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3970241492841909,-1.0666487541778464,0.34901960784313724,0.8040909233435678,1.0,5/12,24.90%,KHK;INPP5K;PPP1R3E;RUBCNL;PPP1R3D
prerank,protein localization to kinetochore (GO:0034501),0.4685966255726066,1.0663381935601297,0.3958333333333333,0.6924881865108553,1.0,5/14,22.54%,CHAMP1;CENPT;IK;KNL1;SPDL1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.41777648711787774,1.0658976786130414,0.39740566037735847,0.6932719773167892,1.0,7/26,27.31%,MMP8;P2RX4;CLU;TMEM106A;HSP90AB1;TNF;DDAH1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.49124687982972165,1.0658671297512876,0.4053333333333333,0.692964540492925,1.0,3/11,12.03%,PLAUR;MMP9;GSN
prerank,cellular response to acid chemical (GO:0071229),0.4202016579005875,1.0657811541418198,0.38552787663107946,0.6928141701109991,1.0,14/27,31.44%,RRAGD;CPEB4;IPO5;VEGFA;CPEB3;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3874657377829933,1.0657239925702884,0.3871331828442438,0.6926064933141193,1.0,21/46,32.93%,TOMM22;MGARP;HK1;TIMM44;DNAJC15;TIMM9;TOMM5;HSPD1;TOMM40;TIMM21;FBXO7;TIMM17A;PITRM1;TIMM23;TOMM7;FIS1;MFF;RALA;TSPO;GRPEL2;PAM16
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.3511257541775031,-1.065679962334019,0.3193717277486911,0.8036234124018934,1.0,6/19,14.68%,ITGAM;PRKCE;LGALS9;TRIL;NMI;PIK3AP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5059993719906041,1.0656588977139014,0.40186915887850466,0.6924159399342081,1.0,1/10,0.93%,PLEK
prerank,acute inflammatory response (GO:0002526),0.4253789003319444,1.065573158733078,0.38583638583638585,0.6922486728214597,1.0,8/23,21.58%,CD6;HP;HPR;MBL2;SIGIRR;ANO6;IL6;LBP
prerank,sphingosine metabolic process (GO:0006670),0.45019733092107594,1.0655034768893301,0.40226986128625475,0.6920568389936782,1.0,3/17,6.40%,SPHK2;SPHK1;PLPP3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5055051095420644,1.0650924313906633,0.4049586776859504,0.6923649470448672,1.0,3/10,9.42%,SPHK2;PRKCD;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5055051095420644,1.0650924313906633,0.4049586776859504,0.6923649470448672,1.0,3/10,9.42%,SPHK2;PRKCD;RACK1
prerank,diol biosynthetic process (GO:0034312),0.47018991970046997,1.0650403389618859,0.4127604166666667,0.6921396701062598,1.0,5/15,27.42%,SPHK2;SPHK1;ASAH1;SPTLC3;SPTLC2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3519973673822425,1.0649329589274237,0.35276073619631904,0.6920515947537029,1.0,37/121,24.88%,IGF1;CSPG4;PTPRC;ITGA5;TEC;CD44;PTK2B;NEDD9;NRP1;ANGPT4;VEGFA;ANGPT1;TREM2;FGF7;ARL2BP;CCL5;EFNA1;GAS6;GHR;GPRC5B;PAK2;IL31RA;CLEC6A;BMP6;HAX1;IL6;IL2;ARHGEF2;IL5;EPO;FGFR3;IL34;CD74;MIF;JAK2;TNF;PECAM1
prerank,protein phosphorylation (GO:0006468),0.3367456664355052,1.064857871575574,0.245,0.6918716157875262,1.0,122/478,22.27%,FNIP2;FAM20C;FLT1;CDK14;LCK;PEAK1;CDK18;CDK6;PRKCH;ABL2;CDK8;PRKCQ;SGK1;FGR;TEC;SRPK1;ATP13A2;MAPK13;GDF6;MAP4K5;MAP4K2;PTK2B;DYRK2;PAK6;SGK3;SGK2;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;SIK1;ERN1;IKBKE;MAP4K3;RIOK2;COPS8;TXK;SBK1;PLK2;IGF1R;PRKCB;MAPKAPK3;ILK;RNASEL;PKDCC;MAPKAPK2;CSNK1G1;CDK13;STK32A;NEK4;FYN;COPS2;CDK17;PIM1;HIPK1;JAK1;BIRC6;RSKR;MAP3K12;CDK11B;LIMK1;SMAD7;GAS6;CDK2;ILF3;PKN2;PAK2;ROCK1;BIRC5;MAP3K1;CAB39;PRKD2;FASTK;DAPK1;CSNK1D;CAD;MAPK9;STK38;CDC7;HTATIP2;KDR;SYK;PLK4;TLK1;PRKAG1;RPS6KA2;MINK1;CAMK4;DDR2;RIPK3;NLK;STK11;DAPK3;NEK6;BAZ1B;MEX3B;GTF2H1;ATM;TP53RK;CSNK2A2;CDK16;TOP1;MAP3K9;PDK3;MAK;LMTK2;MARK2;GSK3B;PRAG1;MARK4;RUNX3;NIM1K;SRPK2;BMP4;MELK;TAOK1;TRIB2;LATS1;ABI1
prerank,regulation of organelle organization (GO:0033043),0.3609793388233685,1.0647307686623293,0.3924843423799583,0.6918432153882189,1.0,38/80,33.48%,S100A8;S100A9;MYO5A;MSN;ATP13A2;SQSTM1;CLIC4;CLN3;DIAPH1;LMAN1;VPS11;PAK2;STOX1;SAR1A;PRMT6;RHOT2;MARK2;TAOK1;ARHGEF5;VPS35;PARL;GOLPH3;MAPK15;SURF4;STX5;MAPK3;FIS1;MUL1;MFF;MAVS;MAPK1;EP300;RDX;TBC1D25;ARMH3;PDE4DIP;PLXNB1;STX18
prerank,positive regulation of cell adhesion (GO:0045785),-0.24449685649114256,-1.0631934064007857,0.25,0.8077455519603554,1.0,7/74,3.98%,ZFHX3;P2RY12;EPB41L4B;EPHA4;TGM2;PTPRJ;MEGF10
prerank,microtubule anchoring at centrosome (GO:0034454),0.5083299205620689,1.0630799787174068,0.40607734806629836,0.695904369969295,1.0,3/10,17.35%,NINL;DCTN1;HOOK3
prerank,myeloid dendritic cell activation (GO:0001773),0.4891611158130513,1.063063647355209,0.42070773263433814,0.6955646382816687,1.0,4/12,23.23%,DOCK2;CAMK4;HMGB1;TGFBR2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.38621598084859426,1.062995988847715,0.38419319429198684,0.6953663355605392,1.0,18/45,29.54%,GCNT2;ZC3H7B;RBM4B;EIF2A;NOLC1;LARP4;LARP1;TCOF1;PUM1;ATXN2;EIF2B4;GEMIN5;CYFIP1;RC3H1;EIF4E;MTPN;NUDT21;PCIF1
prerank,regulation of gastrulation (GO:0010470),0.4726744537450705,1.0629816879107687,0.4302477183833116,0.6950295087594701,1.0,3/14,11.17%,DAG1;RACK1;PHLDB1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33770499426356726,1.062929759355909,0.301,0.6947858672493032,1.0,84/327,23.14%,APBB2;CXXC1;MITF;HIF1A;ZMIZ1;TCF7;NFYA;PRKCQ;TBX21;MYBL2;JMJD1C;SOX3;RNF14;PAK6;NFIL3;PERM1;TFEB;DAXX;PPP2R1A;RNF6;MSL3;NFX1;GON4L;BHLHE40;UBE2L3;ZNF395;MTF2;FADS1;ATXN1;CHD3;FOXN3;THAP7;SOX7;PRMT5;COPS2;DNM2;ATF5;SBNO1;NAB2;CEBPA;TGFBRAP1;HP1BP3;CARM1;CDK11B;PPARGC1B;PHF1;NFYB;DDIT3;ING2;SERTAD3;MYT1;MYBBP1A;GLRX2;PSPC1;UTP4;PPIE;SBNO2;NLK;CNBP;GPBP1L1;DAPK3;ATRX;GCFC2;KAT7;SP1;CCAR2;CCAR1;YAF2;TCF7L1;NR3C1;RNF20;VHL;RALY;RUNX3;SUFU;CALR;ARNT2;NIF3L1;NSD3;PRRX2;ACTN4;AHR;ASCC1;KMT2D
prerank,peptidyl-lysine monomethylation (GO:0018026),0.49523690315914576,1.062915002013959,0.3991825613079019,0.6944474915712395,1.0,3/10,20.35%,KMT5A;SMYD2;EHMT1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.33716442310997213,1.0628885090816902,0.279,0.6941385293033138,1.0,132/476,26.19%,IGF1;MDFIC;CTNNB1;CXXC1;SPP1;MITF;APOE;HIF1A;SKAP1;ZMIZ1;NIBAN2;ELF4;KMT2A;NFYA;CD4;LEF1;TBX21;DEAF1;ID2;EOMES;GDF6;IRF6;RNF14;POU3F1;NFIL3;FGF2;TFEB;HDAC4;PPARG;KLF6;RUNX1;GATA3;RNF6;TRIM28;SOX9;BRD4;EGR2;HDAC1;CDH1;TRIM16;NAA16;ILK;KDM3A;PPARD;NKX2-1;BAMBI;NEK4;RNF111;FGF7;TASP1;BRCA1;DNM2;ATF5;CREB3L2;PCBD2;ELF2;RHOG;JUN;MED17;TAF15;RAI1;ZKSCAN3;MAP3K12;NPAT;SMARCC1;SP100;MRPL12;FZD1;ZBTB16;TFAP4;ILF3;BLM;EHF;FZD4;IL31RA;DDIT3;NFKB1;LRP6;ACTA2;ARHGEF11;ING2;MED13;SERTAD3;PRMT2;FOXO1;ING5;MAP2K3;CAMK4;CNBP;GTF2H1;IL6;WBP2;SP1;YAF2;RNF20;FBXW11;ARID1B;EPO;VHL;RXRB;RUNX3;NPM1;ZXDC;BMP4;TEAD1;ARNT2;RLF;F2R;NIF3L1;NSD3;MAP2K2;CD74;EGR1;AHR;PITHD1;XPC;RXRA;SOX10;TNF;GLIS2;ATF4;EDF1;HDAC2;SFRP1;CREB5;NDP;NOTCH4;MYRF;SMARCA4;NCF1;BTRC;NSD1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.30743654943818555,-1.0628090087917892,0.3111111111111111,0.8055181367298899,1.0,9/32,13.78%,NAV3;TUBB4A;STMN1;APC;MAP2;CLASP2;FKBP4;DYRK1A;HDGFL3
prerank,chromatin organization (GO:0006325),0.346836496182182,1.0623410736934158,0.3665987780040733,0.6951846990722551,1.0,51/132,31.45%,NUDT5;HDAC4;DAXX;FAM47E;SOX9;SATB1;BPTF;HDAC1;MTF2;NPM3;HMGN1;HIRIP3;SMARCB1;HP1BP3;MYSM1;SMARCC1;PHF1;INO80;KDM4D;ATRX;CBX3;BAZ1B;DR1;TOP1;TCF7L1;GATAD1;EHMT1;NPM1;SMARCD2;HDAC11;HDAC2;KDM5C;BAZ1A;MCM3AP;HDAC3;SMARCA4;HCFC1;PIH1D1;SETDB1;SUPV3L1;SUPT4H1;RUVBL2;RSF1;SAFB;SIRT1;PBRM1;HMGB2;SUV39H2;SATB2;HMGN2;ZBTB1
prerank,methylguanosine-cap decapping (GO:0110156),0.5010050086422924,1.0622869797478411,0.4065040650406504,0.6949375999202346,1.0,4/10,14.75%,PATL1;PATL2;DCP1A;EDC4
prerank,RNA transport (GO:0050658),0.3638725221944911,1.0620998127431955,0.39416058394160586,0.6950420636448335,1.0,27/71,29.95%,RFTN1;SIDT1;THOC1;NUP188;SRSF11;SRSF7;DDX39B;HNRNPA2B1;TPR;EIF4A3;CHTOP;THOC2;RAE1;TST;SRSF2;ATXN2;UPF3B;TGFBR2;POLDIP3;SRRM1;ARC;THOC6;EIF4E;SRSF1;NUP214;NXF1;RTRAF
prerank,regulation of blood circulation (GO:1903522),-0.2957161962061817,-1.0617742553454546,0.3284671532846715,0.805220459493611,1.0,16/34,26.23%,CELF2;ADORA3;AGT;KCNMB2;TMIGD3;KCNJ12;KCNG2;BDKRB2;KCNQ1;PLN;KCNIP2;TBX2;DES;ACE;ACE2;TPM1
prerank,cellular response to ATP (GO:0071318),-0.375698087906614,-1.0608982976201335,0.3894230769230769,0.804466516704312,1.0,2/14,2.04%,P2RY12;RYR3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4646934452941791,1.0608181324411867,0.4177718832891247,0.6980984500629809,1.0,7/14,22.90%,NR4A3;LILRB1;TICAM1;GPRC5B;CAMK4;LAPTM5;CD74
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4062558938393246,1.060789970139997,0.4054696789536266,0.6978050487629867,1.0,4/33,2.40%,CACNA1A;ABR;FABP5;CEL
prerank,Rap protein signal transduction (GO:0032486),0.513404304831647,1.060607966205713,0.41530054644808745,0.6979216955089189,1.0,2/10,7.92%,RAP2A;PLK2
prerank,eye photoreceptor cell development (GO:0042462),0.4649960437693496,1.0605763576738274,0.4134742404227213,0.6976225900000155,1.0,2/15,7.00%,TH;VEGFA
prerank,ion homeostasis (GO:0050801),-0.30711845187012504,-1.060425000806115,0.3816793893129771,0.802404529765049,1.0,7/30,10.57%,UNC80;SLC4A7;WNK1;KLHL3;WNK3;SLC30A4;SLC4A10
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.338678417628634,1.0601929290963665,0.332,0.6982986349437895,1.0,119/314,32.40%,CTNNB1;PSMD8;NFE2L2;PSMD1;FBXL17;UBA52;TBX21;RPS27A;DERL3;KCTD17;FBXW7;ANAPC15;EDEM1;NHLRC1;PPP2R5C;SIAH2;DNAJB14;ZFAND2A;STT3B;SPSB2;ATXN3;FZR1;FBXO31;FBXO5;PSMD6;PSMA1;AGAP3;FBXW4;PLAA;VCP;DDB1;SEC61B;CCNB1;PSMC3;NHLRC3;UBE4A;HUWE1;DNAJB9;PSMA8;SHARPIN;UBXN4;ANAPC1;CDK2;PSMD14;KCTD10;PSMD2;DDIT3;BFAR;UBQLN1;ZSWIM8;FBXL19;DERL1;PSMC6;PSMA6;RNF121;RMND5B;PSMD5;UBE4B;PSMA5;CDC26;UBR2;FBXL6;WFS1;CUL3;SPSB3;BUB1B;UBC;FBXW11;CUL1;FBXW5;CDC34;RNF216;CUL2;DNAJC10;ANAPC7;PSMA3;MDM2;TRIM72;BIRC2;HSPA5;PSMB10;PSMB8;PSMD7;CUL4A;UBE2C;PSMB6;BTRC;ERLIN1;KCTD2;PELI1;USP19;ECPAS;PSMD10;GSK3A;PSMB5;DNAJB12;TRIM3;OS9;PSMB7;WWP2;HSP90B1;ERCC8;SIRT1;PSMC4;FAF1;SKP2;HERPUD1;SIRT2;FBXL5;RNF34;PSMD12;SYVN1;NEDD4;PSMD3;FEM1C;FAF2;NEMF;UBB;UBQLN2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3305004308262201,1.0599740821197015,0.149,0.6985115293770009,1.0,463/1668,26.43%,IGF1;FNIP2;LITAF;CTNNB1;MITF;APOE;UXT;HIF1A;IKZF3;ZHX2;SKAP1;DNMT3A;CSRNP1;ZMIZ1;TCF7;MMP12;ATF3;SDCBP;CDK8;MRTFA;TOX2;ELF4;FOXN1;SLC9A1;KMT2A;NFYA;NFIC;NFE2L2;ARID5B;LEF1;HDAC9;ZNF697;UBA52;TBX21;AGO2;MYBL2;DEAF1;RPS27A;TNIP1;BCL11B;MAFF;RCOR1;MUC1;JMJD1C;ANXA4;ID2;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;SEBOX;HOXA4;POMC;SOX30;NR4A3;FSTL3;TBX18;VDR;NCOR2;MEF2D;SIX5;DOT1L;RPS14;RNF14;POU3F1;SQSTM1;NFIL3;FGF2;MNT;TGIF1;CSRP3;CC2D1A;CIC;TFEB;HDAC4;CAV1;JAG1;PPARG;SHOX2;NCK2;FOXJ1;MYDGF;ZFHX2;KLF12;ZMIZ2;KLF6;CCNL1;NOC2L;ZKSCAN4;RUNX1;BCL6;DAB2;RPL23;MED15;GATA3;CUX1;ZBTB42;HR;RFX5;TRIM28;ZBTB7B;SOX9;BRD4;NCK1;VEGFA;SATB1;EGR2;PPP1R12A;BPTF;HDAC1;TOX4;NFX1;TXK;HES7;ZBTB2;PEX2;KMT5A;TRAK1;BHLHE40;MED21;ZNF395;MTF2;RHOQ;ZNF160;PRKCB;ATXN1;TNIP3;PRDM15;CHD3;BHLHE41;DDX17;USP9X;LILRB1;KDM3A;PPARD;MIDEAS;IRF8;E2F3;RNASEL;HOXA7;CCNC;LRRFIP1;CDK13;MDFI;NKX2-1;THAP7;TET3;OTP;AEBP1;CCNB1;ZFX;SS18L2;BAX;RNF111;PSMC3;JUP;CPEB3;ASXL2;KLF13;POU2AF1;IRX5;SMARCB1;FOXP4;BRCA1;MEF2B;CRTC1;ATF5;CCNL2;CREB3L2;KTI12;SUDS3;NFE2L1;NRF1;ZNF148;FOSB;TRIAP1;VRTN;ELF2;JUN;CEBPA;TADA1;ENO1;SERPINE1;MED17;MAML2;GATAD2B;IRF5;RNF2;DLL4;RAI1;ZFP41;ARID4B;TNIP2;MYSM1;DACH2;GBX1;ZNF83;MRTFB;ZKSCAN3;ASCL4;SLC30A9;NAMPT;MRGBP;TLE5;ZBTB34;ZSCAN12;KDM3B;ZFP64;NPAT;HNRNPK;SMARCC1;NUPR2;ZNF569;SAFB2;MAFG;PPARGC1B;SP100;ZBTB16;ELK4;SMAD7;OGT;CHCHD2;TFAP4;GATAD2A;EFNA1;FOXJ3;GTF2F1;SMAD1;H1-0;MAFK;YY1;EHF;EED;NFYB;ETV6;MGA;DCN;DDIT3;PRRX1;ACTR3;NFKB1;INO80;PRKD2;HSPD1;TCF25;LRP6;TPR;SSBP4;SP7;FBXL19;PAXBP1;DEK;HELZ2;PCBP1;MED13;ASXL1;NHLH2;SRF;CEBPG;ZBTB40;C1QBP;FOXO1;MYT1;MTF1;NR4A2;ECD;PLAC8;HTATIP2;ZNF296;DHX36;CHD5;HOXC5;NPAS4;ELK3;MED29;GMEB2;PIK3R2;SARS1;BMP6;GMEB1;SMYD2;AKIRIN1;DMRTA2;ZBTB25;RCOR3;PRPF6;SBNO2;SERPINF2;HNRNPU;TOX;GABPB1;GABPB2;TCF12;CNBP;PAF1;PURA;ATRX;HAX1;BAZ1B;PIN1;KAT7;BMI1;USF2;GTF2H1;ATM;IL6;DHX9;WBP2;SP1;SRCAP;CBX2;RPRD1A;DNMT3B;DNAJB1;WFS1;ZNF177;DR1;ZBTB6;CCNT2;LYAR;TAF7;MIER2;AGO3;ITGB1BP1;TAF6;SLC11A1;PHF20L1;HOXB4;ZBTB39;ARHGEF2;SP9;DACH1;PIAS1;UBC;TMF1;TCF7L1;NR3C1;JDP2;NFATC3;HMGB1;SREBF1;SPIB;PRDM6;SOD2;MEIS3;MTDH;ARID1B;YEATS2;SSU72;CHD2;EIF5A;ZFP57;EPO;VHL;RFXANK;NLRC5;TCF24;VPS72;HOXC9;ZNF18;PBX1;HSF1;RXRB;RUNX3;ETV4;PRKAR1A;NPM1;ZXDC;BMP4;CIAO1;SENP1;ID1;SUFU;ATAD2B;GLYR1;TEAD1;CALR;WAS;ZBTB43;ARNT2;PPRC1;KLF11;RLF;SMARCD2;NIPBL;PRRX2;SP110;MAPK7;MED7;EGR1;AHR;ZBED3;STAT5B;ELP3;CREBZF;KMT2D;PBX2;REL;ZNF568;LHX4;FGFR2;ZBTB4;ZSCAN22;E2F6;RXRA;DCAF6;USP2;WWOX;MDM2;SUMO1;TARBP1;SOX10;PPP3R1;ZSCAN20;MTA3;LPIN3;TNF;GLIS2;MAP2K5;PLK3;ATF4;GADD45A;ZGPAT;ATN1;MCPH1;POU2F1;HDAC2;GTF2H5;CDK4;RRP1B;BMP5;KANK2;MED6;GRHL1;BAZ1A;CREB5;NOTCH4;DPF3;CSRNP3;HDAC3;PIAS4;LAGE3;HIC2;SMARCA4;TLR9;MLLT6;TFCP2;FGF1;ZBTB12;BBS7;CX3CL1;CREG1;NSD1;TMPRSS6;FST;NR6A1;HMGB3;PCGF6;SLTM;SNW1;HCFC1
prerank,mitotic spindle assembly (GO:0090307),0.38582403628122225,1.059867164747785,0.41209406494960804,0.6984142319416801,1.0,14/42,25.29%,FLNA;MAP10;LSM14A;BCCIP;ABRAXAS1;RHOA;SMC3;RACGAP1;KIFC1;RAB11A;TOGARAM2;AAAS;STAG1;GOLGA2
prerank,regulation of cardiac conduction (GO:1903779),0.374641969029709,1.0592694576985522,0.3995656894679696,0.6996355980209807,1.0,20/54,29.96%,ASPH;ATP1B3;ATP2B1;NPPA;ATP1A4;ATP1A3;ATP1A1;NPR2;ATP1A2;FXYD4;ITPR3;NPPC;FXYD1;ATP2A2;CORIN;ATP1B2;FKBP1B;ITPR1;STIM1;NPR1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.41486538389833816,1.058945092094471,0.40669856459330145,0.7001415053769313,1.0,13/26,31.55%,PLEK;SLC9A1;ACTG1;LIMK1;CDC42;ROCK1;PTGER4;WAS;PFN1;CX3CL1;SYNPO;ALMS1;RDX
prerank,embryonic hemopoiesis (GO:0035162),0.4761777967397251,1.058914480018075,0.4013071895424837,0.6998460509725934,1.0,5/12,24.47%,KMT2A;KITLG;KDR;TGFBR2;ATF4
prerank,organelle fission (GO:0048285),0.42257785683710475,1.0588761932046695,0.4026442307692308,0.6995653285932265,1.0,12/24,31.95%,CORO1C;WASHC5;DNM2;MTFP1;MTFR2;MTFR1;ACOT8;PEX19;FIS1;MUL1;MFF;PEX11G
prerank,nuclear transport (GO:0051169),0.4582611554311299,1.0586878834895457,0.415929203539823,0.6997026096860303,1.0,8/16,27.56%,NUP205;NXT2;XPO1;RBM15B;AAAS;NPM1;NUP98;NUTF2
prerank,organophosphate biosynthetic process (GO:0090407),0.38778947598469876,1.0586462169951218,0.3940774487471526,0.699437218839895,1.0,18/37,33.69%,ITPKB;GK;FGF2;MOCOS;FADS1;TKT;MOCS3;PCYT2;ITPKC;GNPAT;LPCAT1;PIP5K1A;IP6K2;MOCS2;MOCS1;AGPAT3;GPHN;PNPO
prerank,regulation of amyloid-beta formation (GO:1902003),0.3976879648788298,1.058548482461168,0.40749148694665155,0.6993276145382213,1.0,10/34,18.44%,IGF1;APOE;ABCG1;GSAP;EFNA1;ABCA7;ROCK1;CLU;PIN1;SP1
prerank,plasma membrane invagination (GO:0099024),-0.30017885643964437,-1.0581621427816328,0.34615384615384615,0.8060316126084166,1.0,6/29,6.50%,ELMO1;ITGAM;BIN2;SPIRE1;AIF1;FCGR1A
prerank,positive regulation of superoxide anion generation (GO:0032930),0.46913193191641067,1.0581458111091686,0.40369393139841686,0.6999846936341275,1.0,4/13,16.06%,FPR2;PRKCD;ITGB2;SYK
prerank,organophosphate ester transport (GO:0015748),0.42175015272857896,1.0581280117550518,0.4056029232643118,0.699640533942327,1.0,5/24,13.26%,OSBPL8;TRIAP1;PITPNC1;OSBPL2;PRELID2
prerank,ether lipid metabolic process (GO:0046485),0.4676996022776948,1.0580242798858868,0.3966189856957087,0.6995470194237311,1.0,3/14,6.21%,NCEH1;PLAAT3;PEDS1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.43914563662172407,1.0579275642734667,0.39625,0.6994055664330214,1.0,7/18,29.53%,PABPN1;THOC2;NUP93;POLDIP3;MCM3AP;NUP133;NXF1
prerank,phospholipid translocation (GO:0045332),0.4088309991189996,1.0577784254060059,0.3971631205673759,0.6994193449551883,1.0,6/28,13.25%,ABCA1;PLSCR2;ATP8B4;ABCA4;ATP9B;ABCA7
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.47324599743249696,1.0567836844707335,0.4165588615782665,0.7016786027906815,1.0,7/14,30.97%,BCL2L11;BAX;DNAJB9;BFAR;HSPA5;UFL1;PTPN1
prerank,regulation of nervous system development (GO:0051960),0.39206468115687676,1.0567615450030892,0.39886363636363636,0.7013504448864768,1.0,9/37,15.49%,CTNNB1;HES7;BHLHE40;BHLHE41;TNFRSF1B;GBX1;PRUNE1;DOCK7;YTHDF2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4358754760338714,1.0567193041636875,0.4238329238329238,0.7010948205504286,1.0,7/19,25.28%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,regulation of interferon-alpha production (GO:0032647),0.42674041094533405,1.056706786478826,0.41502463054187194,0.7007469559775931,1.0,11/23,35.31%,NLRC3;IRF5;HSPD1;DHX36;DHX9;HAVCR2;TLR9;TBK1;MAVS;SETD2;DDX3X
prerank,protein neddylation (GO:0045116),0.4714083805451585,1.056604436386239,0.3956185567010309,0.7006493451351562,1.0,6/13,28.57%,RNF7;UBE2F;DCUN1D2;DCUN1D4;DCUN1D3;UBA3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.42222838458781814,1.0564856889466723,0.4196319018404908,0.7006007981104733,1.0,10/26,26.51%,NSMCE2;ANAPC15;RIOK2;FBXO5;CCNB1;NEK6;CUL3;ANAPC7;UBE2C;ESPL1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4544538084632748,1.0561330679769638,0.4096858638743455,0.7011818252626169,1.0,6/15,22.96%,ACACA;DIP2A;PPCS;ACAT1;ACACB;PMVK
prerank,gland development (GO:0048732),0.3684015903436882,1.0560381166141273,0.39328277356446373,0.7010379795651768,1.0,17/59,25.45%,ANXA1;MSN;ARID5B;NRG1;SOX3;CAV1;SOX9;NKX2-1;CEBPA;CEBPG;NF1;RIPK3;GFER;FGFR2;PRKCSH;MDK;NOTCH4
prerank,regulation of innate immune response (GO:0045088),0.37054329587078133,1.0560275599763538,0.3917634635691658,0.7006916304005688,1.0,28/57,32.07%,FPR2;NLRC3;FGR;ADAM8;PTPN22;TREM2;RNASEL;POLR3D;CCL5;RIOK3;ACOD1;APPL2;TIRAP;USP18;DHX9;LYAR;HSP90AB1;TRIM21;BIRC2;PTPN6;IFNAR2;TNFAIP3;TKFC;MUL1;PLSCR1;PTPN1;APPL1;PARP9
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.38014060653376114,1.0559303791922001,0.4008667388949079,0.7005399692115005,1.0,5/45,11.12%,SDCBP;BMP8B;GDF6;DAB2;RBPMS
prerank,autophagosome assembly (GO:0000045),0.37413945050114794,1.0558206188221053,0.4135667396061269,0.7004378467255438,1.0,25/52,32.40%,ATG7;RUFY4;TRAPPC8;PACS2;WDR45;TMEM41B;RAB7A;MAP1LC3B;UBQLN1;RAB1A;ATG16L1;ATG2B;MAP1LC3A;GABARAP;ATP2A2;ATG3;ATG13;AMBRA1;RAB43;TP53INP2;BECN1;ATG16L2;VMP1;ATG5;UBQLN2
prerank,TOR signaling (GO:0031929),0.41683849113883253,1.0550368398428627,0.4026442307692308,0.7020723773274915,1.0,12/26,28.06%,RPS6;GATA3;LARP1;NPRL3;SYAP1;RHEBL1;CCDC88A;PRR5L;MAPKAP1;RICTOR;FNIP1;SMG1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4759285736046069,1.054547141406194,0.40771349862258954,0.7029987424221389,1.0,4/12,19.43%,PLK2;WEE1;PRCC;BUB1B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.44524715552611854,1.0542754628445012,0.41759603469640644,0.703302980852621,1.0,4/16,8.87%,PTPRC;KLRC1;IL12RB1;LILRB1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.46329109595184637,1.0541820717262365,0.4096858638743455,0.7031755084236575,1.0,5/14,20.86%,FLNA;LIMS2;CD63;ITGB1BP1;TIMP1
prerank,negative regulation of cell motility (GO:2000146),0.3504761904678071,1.0539277826281004,0.3781855249745158,0.7034711188029349,1.0,39/108,26.13%,MITF;RAP2A;DAG1;ADARB1;MCTP1;GTPBP4;CLDN19;JAG1;CLIC4;GATA3;STK24;DLC1;CDH1;IFITM1;NKX2-1;SERPINE1;FBLN1;CHRD;SMAD7;ARID2;ADAM15;CYP1B1;NF1;DUSP3;SINHCAF;AFDN;PIN1;BST2;DACH1;RNF20;RNF41;SRGAP1;WAS;CD74;MIF;MAPK15;SFRP1;DNAI3;CX3CL1
prerank,regulation of transport (GO:0051049),0.38865090863012164,1.0536682098325216,0.40653153153153154,0.7037516474028914,1.0,10/36,18.76%,CLDN19;CDK5;NRP1;TRAT1;ACTG1;ACTB;YRDC;VAMP2;RAB11A;ARL6IP5
prerank,striated muscle contraction (GO:0006941),0.37717730229324614,1.053594562050444,0.40465631929046564,0.7035700297524146,1.0,10/53,16.20%,TNNT3;ALDOA;CSRP3;GAA;STAC2;SCN1B;DTNA;ARHGEF11;ATP1A2;SCN3B
prerank,tRNA metabolic process (GO:0006399),0.4367387784089425,1.053590634195607,0.41435768261964734,0.7032088833701389,1.0,4/17,18.52%,AARS1;THG1L;SARS1;FARS2
prerank,activation of GTPase activity (GO:0090630),0.3556091064915677,1.053570353601439,0.3995859213250518,0.7028912555527693,1.0,11/89,7.85%,ABR;ARHGAP25;CORO1C;TBC1D10C;ARHGAP24;TBC1D22A;RALGAPA2;SIPA1L2;FOXJ1;TBC1D2;RASGRP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.3509322860385291,-1.0534619952269912,0.36683417085427134,0.8176272759711057,1.0,4/17,6.45%,CX3CR1;SELPLG;JAM2;ADD2
prerank,ethanol metabolic process (GO:0006067),-0.3934381739168485,-1.0530701467201742,0.359504132231405,0.8155437440747071,1.0,4/12,22.59%,ACSS1;SULT1A1;ALDH1B1;ACSS2
prerank,regulation of epithelial cell migration (GO:0010632),0.3746743879268807,1.0530295869085788,0.39675675675675676,0.7039218137153537,1.0,7/51,6.75%,HIF1A;CORO1C;SASH1;MACF1;GLIPR2;PTPN23;SOX9
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3654979182722915,1.0528659997335992,0.41244725738396626,0.7039521066215103,1.0,20/69,24.83%,SNAPC1;POLR2H;GTF2A2;SNAPC2;INTS14;ELL2;GTF2F1;POLR2D;INTS6;INTS2;TBP;SP1;RPRD1A;CCNT2;TAF6;SNAPC4;GTF2E2;INTS7;POLR2F;POU2F1
prerank,regulation of coagulation (GO:0050818),0.480890609330011,1.0528127650507562,0.41388518024032045,0.7037103602171424,1.0,4/11,22.64%,HRG;CAV1;PROCR;F2R
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4132462781817917,1.0527875755798835,0.41440377804014167,0.7034067631017817,1.0,14/29,32.24%,UBA52;RPS27A;DDB2;DDB1;XPA;GTF2H1;UBC;XPC;GTF2H5;CUL4A;CETN2;MNAT1;ERCC2;UBB
prerank,vitamin D metabolic process (GO:0042359),0.47015484884918746,1.05273952941651,0.43271767810026385,0.7031519523428463,1.0,2/13,4.05%,CYP27B1;VDR
prerank,negative regulation of myotube differentiation (GO:0010832),0.4713523977623316,1.0525670418162352,0.403921568627451,0.7032217757676796,1.0,3/12,8.66%,HDAC4;HDAC1;BHLHE41
prerank,receptor-mediated endocytosis (GO:0006898),0.34765352716208936,1.052350315459778,0.3748743718592965,0.7033872586710384,1.0,31/132,19.05%,COLEC12;CD9;APOE;LRP1;IGF2R;FPR2;CXCR2;CAV1;DAB2;GRB2;HP;HPR;TPCN2;LILRB1;GAK;AP4E1;PIP5K1C;DNM2;MASP1;CLN3;CXCL16;LRP6;ITGB2;AP1G1;TFRC;HSPG2;SYK;HIP1R;JCHAIN;FCER1G;PIKFYVE
prerank,miRNA mediated inhibition of translation (GO:0035278),0.4952455453210363,1.0518562587667222,0.42567567567567566,0.7038883122036353,1.0,2/11,2.45%,AGO2;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4952455453210363,1.0518562587667222,0.42567567567567566,0.7038883122036353,1.0,2/11,2.45%,AGO2;EIF6
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.32858480060697054,1.0516415264384325,0.2,0.7040911917123411,1.0,445/1646,26.43%,APBB2;IGF1;MDFIC;LITAF;CTNNB1;CXXC1;SPP1;CDK14;MITF;APOE;UXT;HIF1A;IKZF3;CDK18;ZHX2;ERCC6;SKAP1;CSRNP1;ZMIZ1;NIBAN2;TCF7;ATF3;TOX2;ELF4;FOXN1;KMT2A;NFYA;NFIC;NFE2L2;PRKCQ;CD4;ARID5B;SCML4;LEF1;HDAC9;DEDD2;ZNF697;TBX21;MYBL2;DEAF1;BCL11B;MAFF;RCOR1;JMJD1C;ANXA4;ID2;STAT4;EOMES;NRG1;SOX3;GDF6;IRF6;TCF15;OVOL1;SEBOX;HOXA4;SOX30;NR4A3;FSTL3;TBX18;VDR;NCOR2;MEF2D;SIX5;RNF14;POU3F1;PAK6;CDK5;NFIL3;FGF2;MNT;TGIF1;CC2D1A;CIC;PERM1;TFEB;PRICKLE1;HDAC4;DAXX;PPP2R1A;PPARG;SHOX2;FOXJ1;ZFHX2;KLF12;FAM47E;ZMIZ2;KLF6;CCNL1;ZKSCAN4;RUNX1;ERN2;BCL6;GATA3;CUX1;RNF6;ZBTB42;HR;RFX5;TRIM28;ZBTB7B;SOX9;BRD4;VEGFA;MSL3;SATB1;EGR2;ING4;BPTF;HDAC1;TOX4;NFX1;THOC1;HES7;ZBTB2;KMT5A;GON4L;TRAK1;BHLHE40;MED21;UBE2L3;ZNF395;CDH1;MTF2;FADS1;TRIM16;ZNF160;FBXO5;PRKCB;ATXN1;PRDM15;CHD3;BHLHE41;GMNN;NAA16;DDX17;ILK;KDM3A;BASP1;PPARD;MIDEAS;IRF8;E2F3;HOXA7;CCNC;LRRFIP1;ZNF326;FOXN3;NKX2-1;THAP7;BAMBI;SOX7;NEK4;ZFX;RNF111;FGF7;KLF13;DAP;PRMT5;IRX5;SMARCB1;TASP1;FOXP4;BRCA1;MEF2B;DNM2;CDK17;ATF5;CCNL2;CREB3L2;KTI12;SUDS3;NFE2L1;NRF1;PCBD2;ZNF148;FOSB;VRTN;ELF2;RHOG;SBNO1;JUN;NAB2;CEBPA;TADA1;ENO1;MED17;IRF5;TAF15;BAP1;RIOX1;RAI1;TGFBRAP1;ZFP41;HP1BP3;ARID4B;DACH2;GBX1;ZNF83;ZKSCAN3;ASCL4;MRGBP;TLE5;ZBTB34;ZSCAN12;CARM1;MAP3K12;KDM3B;CDK11B;NPAT;HNRNPK;SMARCC1;NUPR2;ZNF569;SAFB2;MAFG;HSPA8;PPARGC1B;SP100;MRPL12;FZD1;ZBTB16;ELK4;SMAD7;OGT;TFAP4;GATAD2A;PHF1;GAS6;FOXJ3;SMAD1;CBFA2T2;ILF3;MAFK;BLM;YY1;EHF;FZD4;BIRC5;EED;NFYB;ETV6;MGA;IL31RA;DDIT3;PRRX1;NFKB1;RBFOX2;RBM15;HSPD1;LRP6;ACTA2;SP7;FBXL19;ARHGEF11;DEK;ING2;MED13;NHLH2;SRF;CEBPG;USP47;ZBTB40;SERTAD3;PRMT2;FOXO1;MYT1;MTF1;NR4A2;HTATIP2;ZNF296;DHX36;CHD5;HOXC5;NPAS4;ELK3;MED29;ING5;MAP2K3;PRMT6;GMEB2;GMEB1;MYBBP1A;RBM15B;DMRTA2;ZBTB25;RCOR3;GLRX2;CAMK4;PSPC1;PDCD4;UTP4;PPIE;SBNO2;NLK;TOX;TCF12;CNBP;GPBP1L1;DAPK3;UIMC1;PURA;ATRX;GCFC2;CBX3;BAZ1B;KAT7;USF2;GTF2H1;IL6;DHX9;WBP2;SP1;SRCAP;ZNF177;CCAR2;CCAR1;ZBTB6;CCNT2;TAF7;PHF20L1;HOXB4;YAF2;ZBTB39;SP9;CDK16;DACH1;PIAS1;TCF7L1;NR3C1;JDP2;NFATC3;HMGB1;SREBF1;SPIB;RNF20;EHMT1;SOD2;FBXW11;MEIS3;MTDH;ARID1B;YEATS2;CHD2;ZFP57;EPO;VHL;RFXANK;TCF24;HOXC9;ZNF18;PBX1;HSF1;RXRB;RUNX3;ETV4;PRKAR1A;NPM1;ZXDC;BMP4;CIAO1;ID1;SUFU;TEAD1;CALR;ZBTB43;ARNT2;KLF11;RLF;F2R;SMARCD2;NIPBL;NIF3L1;NSD3;PRRX2;MAP2K2;SP110;MED7;CD74;EGR1;AHR;STAT5B;PITHD1;ELP3;CREBZF;ASCC1;KMT2D;PBX2;REL;ZNF568;PEX14;LHX4;L3MBTL3;XPC;ZBTB4;ZSCAN22;E2F6;RXRA;MDM2;SUMO1;TARBP1;SOX10;ZSCAN20;MTA3;TNF;GLIS2;CCDC85B;TCIM;ATF4;EDF1;ZGPAT;POU2F1;HDAC2;KDM5C;SFRP1;MED6;GRHL1;BAZ1A;CREB5;NDP;NOTCH4;DPF3;CSRNP3;HDAC3;PIAS4;MYRF;L3MBTL2;HIC2;SMARCA4;MLLT6;TFCP2;ZBTB12;BBS7;NCF1;BTRC;CREG1;NSD1;TMPRSS6;NR6A1;HMGB3;PCGF6;ASCC2;SLTM;SNW1;HCFC1
prerank,protein localization to cell-cell junction (GO:0150105),0.46487692681714576,1.0516108473666648,0.4199743918053777,0.7038026343787457,1.0,6/15,14.00%,TJP2;ACTG1;JAK1;ARHGEF18;PAK2;ACTB
prerank,mRNA processing (GO:0006397),0.33638621280913017,1.0515993124468794,0.361,0.7034541664870181,1.0,107/287,28.66%,SNRNP35;CD2BP2;HNRNPA3;HNRNPUL1;ZRSR2;SNIP1;SF3B3;ERN1;RBM4B;HNRNPM;THOC1;CELF1;POLR2H;PAPOLA;HNRNPC;SON;PABPN1;PABPC1;CHERP;SYF2;METTL3;DNAJC8;SRSF11;PRPF4;SMNDC1;SRSF7;PRCC;RBM19;HNRNPK;HSPA8;GTF2F1;DDX39B;POLR2D;LSM6;HNRNPA2B1;SYNCRIP;PUF60;RBM15;WBP11;EIF4A3;PCBP1;NOVA2;SART1;PNN;SYMPK;CHTOP;THOC2;RBM15B;PSPC1;PPIE;PRPF6;HNRNPU;GCFC2;HNRNPF;UBL5;IK;GTF2H1;KIN;CWC22;DHX9;RPRD1A;SNRNP40;CCAR1;ZMAT5;RNMT;SRSF2;ZMAT2;SNRPB2;CTNNBL1;CPSF7;RALY;PRPF8;SMU1;UPF3B;SF3A3;LSM4;POLDIP3;SNU13;SRRM1;RBM22;SNRPG;POLR2F;SF3B2;SF3B1;GTF2H5;HNRNPL;SNRPF;GEMIN2;LSM3;SNW1;GEMIN5;SNRPA;SF3B5;THOC6;PPIH;SUPT4H1;PRPF40A;FUS;SRSF1;SRSF10;CSTF2;PPIL3;DDX41;NUDT21;WBP4;MNAT1;TRA2B
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.42218573836866746,1.05156052609652,0.40441176470588236,0.7031841468493337,1.0,4/21,14.19%,BCL2L1;NCK1;BCL2L11;DDIT3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.38171369832660107,-1.0515526483968967,0.4166666666666667,0.8170165795739875,1.0,6/13,15.30%,GRIK2;RAB3A;SLC8A2;SHISA6;SLC4A10;SHISA7
prerank,negative regulation of innate immune response (GO:0045824),0.3937365014043563,1.0510396515150502,0.4066437571592211,0.704128859866464,1.0,13/34,22.06%,NLRC3;A2M;TTLL12;PTPN2;METTL3;YTHDF3;RPS19;ACOD1;YTHDF2;USP18;LYAR;NLRC5;TRIM21
prerank,regulation of endopeptidase activity (GO:0052548),0.3643530518288764,1.0509201032147668,0.4095744680851064,0.7040672978751918,1.0,23/59,30.38%,ATP13A2;HRG;SERPINA10;SERPINB9;HDAC1;SERPINE2;SERPINE1;TIMP4;TIMP2;FURIN;SERPINF2;TIMP1;PRELID1;SERPINB8;PSMA3;BIRC2;PSMB8;SERPINA2;SPOCK1;APH1A;SERPINH1;SERPIND1;TIMP3
prerank,cardiac muscle tissue development (GO:0048738),0.3738457811222938,1.0505346626910552,0.41073384446878425,0.7046646202103193,1.0,7/50,6.69%,AKAP13;NRG1;NPPA;TBX18;CSRP3;SHOX2;SIK1
prerank,ESCRT III complex disassembly (GO:1904903),0.48826101447022996,1.050426295039088,0.4251748251748252,0.7041847547029599,1.0,3/10,12.26%,VTA1;VPS4B;CHMP7
prerank,ESCRT complex disassembly (GO:1904896),0.48826101447022996,1.050426295039088,0.4251748251748252,0.7041847547029599,1.0,3/10,12.26%,VTA1;VPS4B;CHMP7
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.40941865226464363,1.0504182321725373,0.4175691937424789,0.7038368353421336,1.0,11/26,31.24%,FBXW7;NCK2;ADAM17;SOCS5;CBL;CBLB;CHMP6;ZGPAT;NCF1;ERRFI1;SOCS4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.24312819806887453,-1.0503275926734437,0.39473684210526316,0.8175787258388449,1.0,12/80,7.75%,P2RY12;NLGN1;WASF2;PIK3R1;ANLN;EPS8;TWF2;TENM2;NCKAP1;CDC42EP4;APC;TAPT1
prerank,positive regulation of phospholipid transport (GO:2001140),0.5076108574995697,1.0502071342511725,0.4375,0.7040251636236605,1.0,3/10,13.25%,APOE;TRIAP1;ABCA7
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.37869092427513307,1.0500525621404728,0.41042345276872966,0.7040523979283609,1.0,17/50,28.04%,PLAUR;CD44;MMP9;RAF1;SIAH2;VEGFA;TRIAP1;GAS6;PAK2;USP47;TNF;MAP2K5;GPX1;PIH1D1;NOL3;FNIP1;DNAJB6
prerank,regulation of sensory perception of pain (GO:0051930),0.49295275613510037,1.0495840206805582,0.44070080862533695,0.7048620670098288,1.0,5/11,22.64%,ZFHX2;MGLL;ACP3;VIP;F2R
prerank,protein kinase B signaling (GO:0043491),0.41685933734336666,1.0495638781096428,0.4182041820418204,0.7045290873354102,1.0,4/23,16.05%,IGF1;CCL5;GAS6;KDR
prerank,neural crest cell migration (GO:0001755),0.3909638402653005,1.0495247305892166,0.4193181818181818,0.7042627636826225,1.0,4/36,7.33%,FN1;CORO1C;NRP1;ANXA6
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4109608479395775,1.0494862687974016,0.42178447276940906,0.7039972598859568,1.0,9/27,22.73%,AGO2;EIF4G1;EIF4ENIF1;EIF4E2;PUM1;IL6;DHX9;BMP4;MAP2K2
prerank,cellular response to growth factor stimulus (GO:0071363),0.3419846983003255,1.0493514312578909,0.39253279515640765,0.7039587411139904,1.0,43/151,25.91%,IQGAP1;FLT1;CTNNB1;ANXA1;CD44;CILP;SPHK1;NRP1;HSPB1;EEF1A1;PDPK1;ERN1;SOX9;VEGFA;CRKL;MAPKAPK2;RACK1;PTPN12;CCL5;DLL4;SMAD7;CPNE3;PRKD2;APPL2;KDR;MAP2K3;DUSP3;BMP6;ITGB1BP1;NR3C1;MT1G;SYAP1;BMP4;MAPK7;STAT5B;TGFBR2;KIDINS220;EHD1;WWOX;MAP2K5;SFRP1;DSTYK;ZPR1
prerank,Golgi localization (GO:0051645),0.48448723770462426,1.0491651584873065,0.43049932523616735,0.7040951804613672,1.0,6/11,32.91%,ARHGAP21;CDC42;HOOK3;YWHAZ;COPG1;TBCCD1
prerank,glucose transmembrane transport (GO:1904659),0.44092830610432615,1.0490235535707066,0.4188351920693928,0.704088926136034,1.0,6/18,21.79%,SLC5A1;SLC2A1;PPARD;SLC2A8;SLC5A3;SLC2A6
prerank,positive regulation of protein secretion (GO:0050714),0.3574378704098688,1.0490179944955196,0.39893617021276595,0.7037294483344667,1.0,13/69,16.74%,IGF1;ABCG1;ADAM8;ATP13A2;GCK;TRH;PTPN23;TREM2;WLS;PPIA;RBP4;AACS;BMP6
prerank,peptide catabolic process (GO:0043171),0.4220804357692297,1.0489168790695844,0.43309002433090027,0.7035842173822616,1.0,2/23,3.62%,ANPEP;ADAMTS13
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.41141515063895107,1.0488192892069175,0.41843971631205673,0.7034676042124481,1.0,11/26,31.41%,SRI;UBQLN1;ATP1A2;THADA;CALM3;TLR9;FKBP1B;DRD3;FKBP1A;GSTO1;CALM1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.40597885644961834,1.0487455278365294,0.4200700116686114,0.7033092438201191,1.0,12/30,28.68%,MACF1;OPTN;GOLGA4;GCC2;GGA2;VAMP4;VAMP2;GOLPH3;GGA1;GOLPH3L;RAB31;ARFRP1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4056007134007268,1.0486874296974762,0.41120381406436235,0.703095789248115,1.0,4/27,7.58%,SLC27A1;PLAAT3;NAPEPLD;CHKB
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4210858259541024,1.0484232973301724,0.42284325637910086,0.7034225415118018,1.0,12/23,31.92%,RACK1;VCP;HHIP;IFT122;SUFU;GLIS2;GPR161;KCTD21;BTRC;HERC4;GLI3;MEGF8
prerank,negative regulation of growth (GO:0045926),0.34568067587999424,1.048338727615528,0.3957273652085453,0.7032858920621003,1.0,38/121,27.00%,APBB2;PPP1R9B;SPHK2;HRG;CYP27B1;PPP2R1A;BCL6;ING4;DCBLD2;RACK1;ENO1;ADAM15;OSGIN2;SERTAD3;ING5;STK11;NME6;CCAR2;BST2;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;FGFR3;RBBP7;TMPRSS4;CCDC85B;SIPA1;DCUN1D3;SFRP1;SMARCA4;MT2A;SESN2;CDKN2AIP
prerank,myoblast fusion (GO:0007520),-0.3895976738322926,-1.0481875062944326,0.3967611336032389,0.8209670213740116,1.0,6/12,11.37%,ADGRB3;ADAMTS5;JAM2;CD81;KCNH1;NOS1
prerank,phosphate ion transmembrane transport (GO:0035435),0.48406212802121507,1.0479549425690005,0.3978494623655914,0.7038961048802865,1.0,6/12,25.64%,SLC37A2;SLC25A3;SLC25A14;XPR1;SLC20A1;SLC37A3
prerank,telomere maintenance (GO:0000723),0.3749580532964229,1.0477949837364844,0.4017467248908297,0.7039622614991996,1.0,27/50,37.64%,NSMCE2;RAD50;SP100;BLM;ERCC4;PARP3;ATM;RTEL1;TPRKB;PTGES3;TERF1;ACD;TERT;SMC6;TERF2IP;ATR;POLD4;XRCC5;TEP1;TERF2;HUS1;PCNA;RAD51;RIF1;RAD51D;TINF2;CTC1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3341916149328711,1.047247149690183,0.36036036036036034,0.7050177576313447,1.0,46/268,16.40%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC9A1;SLC24A4;SLC6A6;ATP6V1A;KCNN4;ATP1B3;KCNK13;SLC6A19;SLC6A14;LRRC52;SCN4A;ASIC3;ATP6V0D1;KCNA3;UCP2;SLC36A3;KCNJ2;SLC6A8;CCDC51;SLC6A7;SLC9A8;SLC46A1;ATP1A4;ATP1A3;ATP1A1;SLC6A4;KCNA4;SLC39A6;SLC39A7;ATP6V1F;SCN1B;CACNA1D;KCNJ10;GAS6;SLC25A14;TRPM7;SLC9A6;SLC9A7;ATP1A2;MCOLN3;SCN3B;KCNH8
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.45793449896767213,1.04724702356962,0.41857506361323155,0.7046484450291282,1.0,4/15,15.10%,AGO2;PABPC1;CPEB3;EIF4ENIF1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.438546960391543,1.046553512037203,0.41466498103666244,0.7060290833770446,1.0,3/17,4.50%,SKAP1;CD3E;PIEZO1
prerank,positive regulation of signal transduction (GO:0009967),0.3351815245266188,1.0463283028717973,0.3833833833833834,0.7062307571527996,1.0,79/238,27.73%,IGF1;HIF1A;ZMIZ1;FLNA;TEDC1;MGAT5;PTPRC;CD226;SASH1;ITGA5;MACF1;AXL;CYP27B1;PTK2B;NPTN;NRP1;JAG1;KLK6;TEDC2;GATA3;ZBTB7B;ERN1;TREM2;HTT;LIMS2;TRIM16;PRKCB;ILK;ARMC9;BAX;ASXL2;SMARCB1;C3;WLS;CD63;MAML2;DLL4;TSPAN5;GAS6;PRKD2;EVC;SORBS1;ASXL1;CLEC6A;ING5;BMP6;ATP6V0C;IL6;NEPRO;ITGB1BP1;SCIMP;PTGIS;RPS3;AGPAT2;CRADD;ENHO;RWDD3;LMO3;TERT;CD74;VPS35;AGPAT1;FGFR2;JAK2;SFRP1;NOTCH4;DSTYK;SMARCA4;FGF1;PDE6G;SNW1;DEPDC1B;PIH1D1;CDKN2AIP;FGFBP3;DACT1;LIMS1;JCAD;TNFAIP3
prerank,protein localization to chromosome (GO:0034502),0.3948876708958986,1.046219646715069,0.4065040650406504,0.7061444018531469,1.0,16/34,32.96%,TNKS2;FAM47E;WAPL;LEMD2;CHMP7;PARP3;ATRX;MCM8;ACD;TPP1;CENPA;TERF2IP;ATR;XRCC5;TERF2;SLF2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.41822129755163756,1.0461286331691857,0.4090909090909091,0.7060036987991495,1.0,10/23,29.54%,ACSBG1;ACSBG2;HACD2;ACSL1;HACD1;ELOVL2;ELOVL1;HSD17B12;ACSF3;TECR
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4935788352388303,1.0461185672371478,0.44105409153952846,0.7056583066482671,1.0,5/10,24.97%,NFE2L2;EIF2S1;DDIT3;ATF4;HSPA5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4352983526847401,1.0459690220920206,0.4319306930693069,0.7056784821817718,1.0,5/20,17.94%,CDK6;PTK2B;ZBTB16;HSPA9;PAF1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3819244984467925,1.045899467225346,0.43080357142857145,0.7054908171260869,1.0,14/42,27.54%,ERCC6;FIGNL1;PPP4C;ARID2;RTEL1;PARPBP;RAD51AP1;WAS;WDR48;TERF2IP;SMCHD1;KDM1A;ACTR2;FUS
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.39785990809877086,1.0458688612955622,0.41488162344983087,0.7052074811898004,1.0,19/37,33.61%,UBA52;RPS27A;ERCC1;DDB2;DDB1;XPA;ERCC4;RFC1;GTF2H1;UBC;GTF2H5;RFC2;CUL4A;POLD4;ERCC2;RFC4;UBB;RFC5;PCNA
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4776989208785783,1.0458638776763647,0.42,0.7048504489268829,1.0,4/12,19.31%,IL18R1;IL12RB1;CCR2;SLC11A1
prerank,modulation by host of symbiont process (GO:0051851),0.39629960270288167,1.0455066686836048,0.4326241134751773,0.7053849516514898,1.0,9/31,13.08%,LEF1;CCL4;NAPEPLD;HDAC1;SMARCB1;JUN;CCL5;SAP30BP;TFAP4
prerank,regulation of establishment of protein localization (GO:0070201),0.4733926460688293,1.045491014680866,0.4346103038309115,0.7050601044910754,1.0,5/13,27.22%,CTSD;TREM2;CEP120;DNAJA1;CEP295
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34233732209050205,1.0454381178123466,0.4050251256281407,0.7048413607785594,1.0,38/190,17.29%,BCL2;ARHGAP25;BCL2L1;PLEK;NLRC3;PLAUR;TMSB4X;DAG1;HDAC7;XDH;TANK;TNIP1;MCL1;PIK3CB;MMP9;PPP2R5C;CAV1;CD22;NOC2L;TREM2;TNIP3;PRDM15;PLEKHA1;RACK1;SFRP5;NPRL2;RIOK3;ABCA7;DDIT3;ARHGAP12;RNF157;MYADM;NF1;MAP2K3;PIK3R2;DUSP3;ADIPOR1;DGKD
prerank,regulation of response to interferon-gamma (GO:0060330),0.4660176426660846,1.0447567691305102,0.41688654353562005,0.7062632122109559,1.0,7/14,26.98%,PTPN2;JAK1;PIAS1;HSP90AB1;SUMO1;JAK2;IFNGR2
prerank,transcription by RNA polymerase II (GO:0006366),0.3351995703420652,1.0444289894949386,0.38,0.7067443681656126,1.0,114/305,31.85%,ERCC6;NFYA;NFIC;HDAC9;HDAC7;DEAF1;NPPA;NR4A3;VDR;NCOR2;MNT;PPARG;DDX21;SNAPC1;TAF4B;ZBTB7B;HDAC1;NOCT;NFX1;POLR2H;BTF3;PAPOLA;GTF2A2;SNAPC2;NRBF2;PPARD;E2F3;PABPN1;CDK13;KLF13;COPS2;TBPL1;AFF4;MED17;MAML2;TAF15;INTS14;ELL2;GTF2F1;PIR;YBX2;POLR2D;PRRX1;NFKB1;ELOF1;DEK;NR4A2;SYMPK;INTS6;INTS2;GMEB2;HSF2BP;C5AR1;TBP;ELOB;PAF1;GTF2H1;SP1;EAF1;RPRD1A;CCNT2;TAF7;RNMT;TAF6;TSC22D1;NR3C1;MLLT1;TRIP13;SSU72;CPSF7;TRIM24;TAF1A;RXRB;SNAPC4;TEAD1;TAF1C;MED7;GTF2E2;INTS7;RXRA;SNRPG;POLR2F;ATF4;POU2F1;GTF2H5;SNRPF;NOTCH4;HDAC3;TFCP2;NR6A1;SNW1;NR2C2AP;SUPT4H1;CSTF2;PAX5;NUDT21;MNAT1;CTR9;RXRG;MED1;MAZ;LEO1;CCN2;MED27;LSM11;CLP1;NABP1;TCEA1;ERCC2;XBP1;ZBTB1;NR4A1;RARG;CREBBP
prerank,actin filament depolymerization (GO:0030042),0.4860135759940311,1.0442576873662888,0.4365079365079365,0.7068137664033666,1.0,3/11,12.03%,MICAL2;MICAL1;GSN
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3990577130336129,1.0439501021990998,0.43123543123543123,0.7072639048366176,1.0,16/32,31.29%,TAF1D;POLR1G;POLR2H;UBTF;POLR1A;TBP;GTF2H1;TAF1A;TAF1C;POLR1F;POLR2F;GTF2H5;MAPK3;MNAT1;POLR1H;ERCC2
prerank,visual system development (GO:0150063),0.3914799900706057,1.0438418085829095,0.4342403628117914,0.707179231139586,1.0,12/37,24.75%,SH3PXD2B;BLOC1S3;C3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;PBX2;SIPA1L3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4167031759958858,-1.0436599836172933,0.4083044982698962,0.8314720631957842,1.0,6/10,18.30%,CTTNBP2NL;IRS2;THBS1;INPP5K;IL1B;RSC1A1
prerank,stem cell development (GO:0048864),0.4469240701529093,1.0429240892805616,0.44884910485933505,0.7091901181213845,1.0,4/16,16.38%,PTPRC;NRG1;NOLC1;TCOF1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4475139695166612,1.042918792945022,0.45692883895131087,0.7088344606643977,1.0,3/16,4.72%,PDGFA;NR4A3;NRP1
prerank,regulation of cell-cell adhesion (GO:0022407),0.38463288073533086,1.0421713180249712,0.416,0.7104041612898866,1.0,10/39,17.14%,ADAM8;GTPBP4;FSTL3;JAG1;CDH1;FLOT2;MAGI1;SMAD7;MINK1;AFDN
prerank,RNA destabilization (GO:0050779),0.43539175730689067,1.0420722499664508,0.43033292231812575,0.7102831216629687,1.0,7/18,16.76%,CELF1;METTL3;YTHDF3;DXO;ROCK1;YTHDF2;PUM1
prerank,cochlea morphogenesis (GO:0090103),0.49312787710400097,1.0419508276155875,0.4339360222531293,0.7102156092571117,1.0,3/10,18.92%,TBX18;SOX9;MYO3B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3537593377480769,1.0418730378171934,0.4367219917012448,0.7100477597995623,1.0,31/80,29.06%,MALT1;SPHK1;FBXW7;PRICKLE1;CAV1;ANGPT1;UBE2L3;RPS2;BRCA1;HUWE1;SMAD7;DCUN1D2;CENPX;UBQLN1;DERL1;PIN1;BMI1;WFS1;CUL3;LAPTM5;DCUN1D4;ARRDC4;BIRC2;DCUN1D3;HDAC3;CENPS;PSMD10;KDM1A;GSK3A;PTTG1IP;FKBP1A
prerank,glycerophospholipid metabolic process (GO:0006650),0.358898009635508,1.041836987226845,0.42992623814541625,0.7097644116709876,1.0,17/75,16.77%,PLEK;GDPD3;PRDX6;PON1;ABHD12;PIGQ;PIGZ;PIGA;PLCB2;SMPD4;CLN3;PIGN;CPNE3;PIGL;PIGC;DGKH;PNPLA6
prerank,regulation of superoxide anion generation (GO:0032928),0.4568297990134796,1.0413442331728002,0.4356955380577428,0.7106580703770071,1.0,4/14,16.06%,FPR2;PRKCD;ITGB2;SYK
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.36972028203264007,-1.0412782277150219,0.3939393939393939,0.8355588797054991,1.0,4/13,11.72%,GLUD1;GLUL;ASPA;GAD1
prerank,protein autophosphorylation (GO:0046777),0.3380948448402045,1.041138476434773,0.4112903225806452,0.7108115841934003,1.0,48/157,24.98%,FLT1;PEAK1;ITK;FGR;TEC;ATP13A2;PTK2B;TAOK3;PDPK1;STK24;SIK1;ERN1;RIOK2;TXK;IGF1R;MAPKAPK3;MAPKAPK2;PIM1;MAP3K12;PAK2;PRKD2;DAPK1;CAD;HTATIP2;KDR;MINK1;CAMK4;DDR2;RIPK3;STK11;DAPK3;NEK6;MEX3B;ATM;PIKFYVE;MAP3K9;MAK;LMTK2;MARK2;GSK3B;MELK;TAOK1;FGFR3;MAP2K2;FGFR2;JAK2;PDGFRA;MAPK15
prerank,cGMP biosynthetic process (GO:0006182),0.49165864315508845,1.0408133262581742,0.4279778393351801,0.7113093092402708,1.0,3/10,19.99%,NPPA;NPR2;NPPC
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3140140599403606,-1.040766686352698,0.3853658536585366,0.8338971741656671,1.0,3/21,6.81%,ST3GAL6;B3GALT5;B3GALT1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4241523230480531,1.0403940613357858,0.41947565543071164,0.712032116377726,1.0,3/22,7.62%,SLC9A1;HTT;STAC2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5003109616829129,1.0401633203721066,0.4360385144429161,0.7122389461679357,1.0,5/10,25.22%,PRKCQ;ZBTB7B;CD55;TGFBR2;NCKAP1L
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3445632146290172,-1.0400413190567153,0.37158469945355194,0.8327591716073316,1.0,4/18,6.45%,CX3CR1;SELPLG;JAM2;ADD2
prerank,positive regulation of viral transcription (GO:0050434),0.4175770883442569,1.0398137957721063,0.4332171893147503,0.7127499084010696,1.0,8/25,27.88%,MDFIC;POLR2H;GTF2F1;POLR2D;DHX9;POLR2F;SUPT4H1;RSF1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4076699183503389,1.0396244850468492,0.4420289855072464,0.7128382686130119,1.0,11/25,31.98%,PPARG;SOCS5;CBL;CNRIP1;CBLB;CHMP6;TNF;ZGPAT;ERRFI1;SOCS4;EPHB2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.31495664207818735,-1.039312238034867,0.39263803680981596,0.831694736033456,1.0,12/25,14.33%,ROCK2;DUSP22;RCC2;THBS1;ROBO2;CLASP2;APOD;DMTN;TLR2;SRC;PHLDB2;IL1B
prerank,programmed necrotic cell death (GO:0097300),0.4330930896045415,1.0392638813045683,0.43494897959183676,0.7133641757994992,1.0,5/18,17.41%,MLKL;ALKBH7;TICAM1;TRPM7;RIPK3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.48301965842280253,1.0385010548665299,0.4256198347107438,0.714958889164444,1.0,4/11,17.11%,STAP1;TICAM1;ITGB2;CAMK4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3900183194244593,1.038469049738806,0.4434389140271493,0.7146697425446238,1.0,5/35,5.48%,FLT1;APOE;XDH;CAV1;PPARG
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38306047083184475,1.0383367127728338,0.4370786516853933,0.7146371888031665,1.0,12/39,16.16%,CORO1C;GCNT2;JAG1;HOXA7;MYOC;FBLN1;RHOA;FZD4;SPRY4;ADAM15;MELTF;RASA1
prerank,positive regulation of catabolic process (GO:0009896),0.36483147782706526,1.0382017647275217,0.41870350690754515,0.7146141171945138,1.0,16/65,15.81%,ATG7;APOA2;C4BPA;C4BPB;SEC22B;PLK2;FZR1;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;VIP;FOXO1;BARD1
prerank,activation of phospholipase C activity (GO:0007202),-0.29522036006723396,-1.0381648703791853,0.4142857142857143,0.831836631603872,1.0,8/29,9.43%,P2RY12;GNA15;CD86;HTR2A;RASGRP4;P2RY6;NTRK2;EGFR
prerank,regulation of cellular amide metabolic process (GO:0034248),0.39537117173268255,1.0380455276266305,0.41809851088201605,0.7146330417558883,1.0,14/32,29.54%,PRKCD;RBM4B;EIF2A;NOLC1;ROCK1;TCOF1;ATXN2;SAMD8;EIF2B4;GEMIN5;CYFIP1;EIF4E;MTPN;PCIF1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.45543204768960033,1.037302894918077,0.4424083769633508,0.7161889230018033,1.0,4/14,10.83%,ANXA1;MALT1;NFKBIZ;SOCS5
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.47542970867013495,1.0369889588710925,0.43873517786561267,0.7166472780474957,1.0,7/12,39.46%,CAV1;SRI;CALM3;CALM1;GJD3;CAMK2D;CALM2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35430497285541845,1.036986973540397,0.44974093264248705,0.7162842926921154,1.0,34/87,31.53%,CD44;FGF2;GRB2;HNRNPM;POLR2H;FGF7;CCL5;FGF20;DLL4;GTF2F1;POLR2D;RBFOX2;CBL;HNRNPF;ITGB1BP1;SPRED2;FGFRL1;FGF18;FGFR3;FGFR2;POLR2F;FLRT2;SFRP1;DSTYK;FGF1;KIF16B;MAPK3;TIAL1;SHOC2;NDNF;CEP57;GALNT3;MAPK1;NR4A1
prerank,filopodium assembly (GO:0046847),-0.3566698239526993,-1.0364752297510047,0.39473684210526316,0.8339231936459691,1.0,7/16,16.43%,FGD2;FGD1;ARHGEF4;FGD3;EZR;SPATA13;SRGAP2
prerank,ATP transport (GO:0015867),0.49398248165768,1.036199641295436,0.44660194174757284,0.717932748529665,1.0,3/10,21.76%,SLC25A24;SLC17A9;CD47
prerank,postsynaptic membrane organization (GO:0001941),0.446868618203619,1.0361747902395473,0.4164588528678304,0.7176275639355868,1.0,3/17,5.81%,APOE;CEL;LRP4
prerank,histone lysine demethylation (GO:0070076),0.40570736224389925,1.036086341022437,0.4199288256227758,0.7175083723155908,1.0,7/25,16.18%,JMJD1C;HR;KDM3A;RIOX1;KDM3B;RIOX2;KDM4D
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3255899553493691,-1.0358545897303124,0.3918918918918919,0.8326157097408128,1.0,5/19,8.50%,SYNJ2BP;DLG2;LRRC7;PRKCI;PARD3B
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3577636307915675,-1.0349665288755787,0.3807531380753138,0.8321921802880103,1.0,3/16,7.75%,LRRK2;UBAC2;TAPT1
prerank,mRNA catabolic process (GO:0006402),0.37110235855172385,1.0349590571968574,0.4388327721661055,0.7200784585953798,1.0,12/44,15.49%,EXOSC4;ERN1;XRN2;METTL3;DHX34;RNH1;CNOT10;DXO;EXOSC9;EXOSC10;LSM6;YTHDF2
prerank,positive regulation of cell differentiation (GO:0045597),0.3319703557445282,1.034837912588302,0.405811623246493,0.7200135204930009,1.0,61/237,21.97%,IGF1;LPL;CTNNB1;PRKCH;CSF1;SDCBP;FOXN1;SLC6A6;LTF;LEF1;GCNT2;PDPN;ID2;GDF6;TCF15;RIPOR2;GLIPR2;NELL1;PPARG;SUCO;DAB2;SOX9;NOCT;BRINP2;RIN2;FBXO5;SPAG9;IFITM1;KITLG;PPARD;ATP6AP1;PKDCC;BAMBI;ASXL2;RHOA;CARM1;ZBTB16;CDC42;GPRC5B;NFKB1;SP7;MAPK9;SRF;KDR;DHX36;BMP6;AKIRIN1;DDR2;SERPINF2;IL6;FERMT2;BNIP2;HOXB4;ARHGEF2;SMYD1;VHL;HSP90AB1;SYAP1;ADIG;BMP4;LMO3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.32826570286424955,1.034795084915683,0.359,0.7197569865847068,1.0,112/366,28.26%,APBB2;CXXC1;MITF;HIF1A;TCF7;NFYA;PRKCQ;ORC3;TBX21;MYBL2;PDGFA;JMJD1C;SOX3;RNF14;PAK6;NFIL3;PERM1;TFEB;DAXX;PPP2R1A;RNF6;RBM4B;MSL3;NFX1;GON4L;EIF2A;BHLHE40;UBE2L3;ZNF395;MTF2;FADS1;FBXO5;ATXN1;CHD3;GMNN;FOXN3;NOLC1;THAP7;SOX7;OBI1;PRMT5;DNM2;ATF5;SBNO1;NAB2;CEBPA;TGFBRAP1;HP1BP3;CARM1;CDK11B;PPARGC1B;PHF1;NFYB;DDIT3;SMC3;ING2;SERTAD3;MYT1;TCOF1;MYBBP1A;GLRX2;PSPC1;UTP4;PPIE;SBNO2;NLK;CNBP;GPBP1L1;DAPK3;ATRX;GCFC2;KAT7;SP1;CCAR2;CCAR1;ATXN2;YAF2;TCF7L1;NR3C1;RNF20;VHL;RUNX3;SUFU;CALR;ARNT2;NSD3;PRRX2;AHR;ASCC1;KMT2D;ZBTB4;EIF2B4;CCDC88A;ATF4;EDF1;MLLT6;NSD1;ASCC2;HCFC1;GEMIN5;ATXN1L;FOXN2;CYFIP1;TERF2IP;SUPT4H1;EIF4E;CHD7;FUS;CREBL2;MTPN;NUP35;SRSF10
prerank,cellular response to chemokine (GO:1990869),0.375549301852866,1.034611875492034,0.4461538461538462,0.7198697502020367,1.0,9/46,13.81%,CCL4;RIPOR2;PTK2B;CCL13;CCR2;CCL7;CCL5;RHOA;CCL14
prerank,negative regulation of glycolytic process (GO:0045820),0.49623040359230486,1.0345801696980688,0.46573426573426574,0.7192199551188343,1.0,2/10,14.09%,HDAC4;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.49623040359230486,1.0345801696980688,0.46573426573426574,0.7192199551188343,1.0,2/10,14.09%,HDAC4;GIT1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.33618192798841273,-1.0344102136869806,0.4225352112676056,0.8305754893569882,1.0,5/18,8.11%,NLGN1;RIMS1;LRRK2;SNAPIN;RIMS2
prerank,second-messenger-mediated signaling (GO:0019932),0.34902373021654076,1.034198281780589,0.4354166666666667,0.7198195967878693,1.0,14/82,11.21%,APOE;P2RX4;FPR2;LAT;CXCR2;PPP1R9B;MCTP1;SPHK1;PPP2R1A;PDPK1;TPCN2;RCAN1;INPP5A;CCR2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.46261692412600086,1.0338966551975104,0.4436997319034853,0.7198679873106124,1.0,4/13,11.45%,IL2RB;CD4;GRB2;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.46261692412600086,1.0338966551975104,0.4436997319034853,0.7198679873106124,1.0,4/13,11.45%,IL2RB;CD4;GRB2;JAK1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3174081172543911,-1.0335157647095308,0.40782122905027934,0.830191242784212,1.0,4/22,11.44%,SH3GL2;RAPGEF2;NTRK2;NTRK3
prerank,glycogen metabolic process (GO:0005977),0.40712701150024805,1.0334487009210063,0.4462809917355372,0.7206636047595244,1.0,11/27,28.49%,NHLRC1;GYG1;GAA;GYS1;PHKB;GSK3B;PYGM;PGM2;STBD1;GBE1;PGM1
prerank,response to glucagon (GO:0033762),0.4251463638383628,1.033376771655192,0.4375,0.7204847617497337,1.0,3/19,4.20%,ADCY8;ADCY3;ADCY7
prerank,positive regulation of potassium ion transport (GO:0043268),0.38269417614438733,1.0328803246407459,0.4314606741573034,0.7213400770886707,1.0,11/38,20.75%,FLNA;KCNN4;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,transport across blood-brain barrier (GO:0150104),0.3469261134054211,1.032795829731073,0.4321503131524008,0.7211818551554795,1.0,20/83,19.68%,LRP1;FABP5;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC5A1;SLC2A1;SLC22A3;ATP1A4;SLC1A5;ATP1A2;TFRC;SLC7A8;SLC5A3;SLC19A1;SLC28A2;SLC13A3;SLC16A2;SLC38A2
prerank,regulation of protein kinase C signaling (GO:0090036),0.455173673288081,1.0325296826702453,0.45490716180371354,0.7214942966837651,1.0,4/14,17.29%,SPHK2;VEGFA;MYADM;DGKD
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.33805368620766,-1.0319050692285523,0.38961038961038963,0.8318814160063274,1.0,7/16,22.24%,SALL1;PAX8;PAX2;BMP2;NPNT;FOXD1;SHH
prerank,regulation of centrosome cycle (GO:0046605),0.41523882711860355,1.031344098618161,0.43911439114391143,0.7240585976605516,1.0,10/21,29.22%,CHMP4B;PDCD6IP;ATF5;VPS4B;FBXW5;MARK4;NPM1;GEN1;NAT10;SIRT1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4081754767034344,1.0309201186321948,0.44188861985472155,0.7247765105863506,1.0,8/26,27.88%,SPHK2;SPHK1;CYP1B1;ASAH1;CYB5R3;SPTLC3;SPTLC2;NQO1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4721051132100721,1.0308644225348123,0.4450474898236092,0.7245468636394808,1.0,4/11,13.52%,FBXO5;GMNN;ZRANB3;BLM
prerank,regulation of monocyte chemotaxis (GO:0090025),0.4079014915978481,1.0305952418114868,0.44014084507042256,0.7248569626425903,1.0,7/24,20.12%,FPR2;MOSPD2;CCR2;SERPINE1;CCL5;ANO6;HMGB1
prerank,positive regulation of ossification (GO:0045778),-0.27669627213830084,-1.0302474650874485,0.375,0.8338081197716768,1.0,5/39,3.33%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3521740885309439,-1.0301004277790498,0.4039408866995074,0.8310081037501095,1.0,6/15,19.48%,NLGN1;CNTNAP4;HAP1;STXBP1;ADRA1A;NLGN2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.45328923157698425,1.0300585679617458,0.4402035623409669,0.725872264397717,1.0,4/15,14.88%,HDAC1;WNT6;ANKRD11;LRP6
prerank,response to UV (GO:0009411),0.34585499084898225,1.0299655982711666,0.44593202883625127,0.7257314621541375,1.0,43/95,32.57%,ERCC6;MAPK13;PRKCD;NOC2L;MAP4K3;SDE2;EIF2S1;DDB2;ZRANB3;METTL3;TRIAP1;XPA;YY1;INO80;ERCC4;CAT;USP47;DHX36;SMPD1;UBE4B;CCAR2;CASP9;NPM1;USP28;REV1;ATF4;DCUN1D3;USP1;GPX1;KDM1A;ATR;RUVBL2;ERCC8;CDC25A;CCND1;ERCC2;ZBTB1;EP300;CREBBP;CIRBP;NEDD4;TMEM161A;MAP3K4
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4140722508847246,1.0299550621198217,0.4466750313676286,0.7253848472122821,1.0,3/23,4.88%,SASH1;TRAF2;TAOK3
prerank,extracellular matrix assembly (GO:0085029),0.4092121863839915,1.0297446489827562,0.44717444717444715,0.7255268332800603,1.0,12/23,36.41%,ATP7A;GAS6;EFEMP2;MYH11;LTBP3;EMILIN1;TNXB;FBLN5;LAMB2;NTNG2;QSOX1;TGFB1
prerank,primary miRNA processing (GO:0031053),0.4898834663688071,1.0293210379431006,0.4609053497942387,0.7261964834767074,1.0,3/10,14.33%,METTL3;SMAD1;HNRNPA2B1
prerank,vasoconstriction (GO:0042310),0.4824956547254298,1.029262867452923,0.44812680115273773,0.7259617645436436,1.0,4/11,24.73%,EDNRA;ACTA2;HTR2B;PIK3C2A
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4555595463073806,1.0290955052580704,0.4511082138200782,0.7260144175596295,1.0,8/14,23.93%,RAP2A;MSN;FOXJ1;RHOA;CDC42;PATJ;MYO9A;SYNE4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.43576017208742246,1.028900779710413,0.4450063211125158,0.7261434101816469,1.0,5/17,25.17%,PLAAT3;LPGAT1;PLA2G12A;MBOAT7;PLA2G5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.48752130299449736,1.028369644379988,0.45539280958721706,0.727147766700731,1.0,1/11,0.50%,STAP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.43590720644447867,1.0279047329582711,0.4534005037783375,0.7279448501231914,1.0,7/17,25.28%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3711893257860403,1.027845867794156,0.44966442953020136,0.7277108718201682,1.0,8/43,14.85%,PRKCQ;PRKCD;ZBTB7B;NCK1;PRKCB;PTPN2;OGT;SORBS1
prerank,monocyte differentiation (GO:0030224),0.4792574038075878,1.0278113514743685,0.4409340659340659,0.7274261321307084,1.0,7/10,21.77%,PDE1B;PPARG;VEGFA;PIR;IL31RA;MT1G;BMP4
prerank,transcription preinitiation complex assembly (GO:0070897),0.4624287157822083,1.0275134579955412,0.4530612244897959,0.7277811436747978,1.0,5/12,25.08%,GTF2A2;TBP;DR1;TAF7;BDP1
prerank,establishment of spindle orientation (GO:0051294),0.4011727060310591,1.0274051376422144,0.4424673784104389,0.7276870601468453,1.0,10/28,27.94%,HTT;DCTN1;NUMA1;LLGL2;FBXW11;SPDL1;LLGL1;CENPA;MAP4;ITGB1
prerank,lipid phosphorylation (GO:0046834),0.4995107344424238,1.0273843309314983,0.45866666666666667,0.7273713875848182,1.0,4/10,17.29%,DGKZ;DGKA;DGKH;DGKD
prerank,response to ethanol (GO:0045471),0.4544322790996571,1.0271192023166953,0.439374185136897,0.7276698547607977,1.0,3/14,4.20%,CHRNB2;TH;ADCY7
prerank,regulation of cellular pH (GO:0030641),0.3997625413884968,1.0265864174606605,0.439766081871345,0.72866323339499,1.0,10/29,17.72%,SLC9A1;SLC9A8;ATP1A4;ATP6AP1;CLN3;SLC4A9;SLC9A6;SLC9A7;CHP1;SLC4A2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.38974187967068413,1.026268460889001,0.47264260768335276,0.7291024962009737,1.0,14/31,31.98%,PTPRC;DNAJB9;KMT5B;RBP4;TFRC;GPI;IL6;IL2;SASH3;TLR9;STX4;VAMP3;XBP1;EPHB2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4698687664776805,1.0258698894121872,0.45901639344262296,0.7297204636375931,1.0,8/13,32.03%,AXL;GAS6;DHX9;AGPAT2;CD74;AGPAT1;MAVS;IL7
prerank,neuron projection fasciculation (GO:0106030),-0.4036301393665486,-1.0258526197042186,0.4115384615384615,0.8412506417922871,1.0,3/10,11.91%,EPHA4;CNTN4;ARHGAP35
prerank,cellular lipid catabolic process (GO:0044242),0.4038304188115112,1.0257594419452263,0.4565483476132191,0.7296185064717335,1.0,9/27,24.16%,CEL;APOA2;ABHD12;PPARD;CYP1B1;PLBD2;ACADL;ACBD5;LPIN3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4705130160635401,1.0249244818193641,0.46206896551724136,0.7313109305686606,1.0,6/11,26.58%,STAT4;IL27RA;JAK1;CANX;JAK2;IL12RB2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.45637045923016717,1.0248527375802816,0.4559789750328515,0.7311421596585772,1.0,3/14,5.31%,XDH;MMP9;CAV1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.38450962882685913,-1.0244635461955212,0.40942028985507245,0.8420701674987234,1.0,4/12,8.54%,SOX8;PAX8;AGT;PAX2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4790250797118948,1.0240230404702615,0.451568894952251,0.732882836903092,1.0,2/11,4.64%,ITPKB;FGF2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4182055837675481,1.023683812618099,0.4369645042839657,0.7333703764414082,1.0,6/20,22.38%,AGO2;ZC3H7B;SNIP1;PUM1;AGO3;TERT
prerank,regulation of actin filament depolymerization (GO:0030834),0.46558883297962855,1.0231728447149009,0.45910290237467016,0.7342468837670403,1.0,1/12,0.93%,PLEK
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.27900466931651063,-1.022677729183786,0.42857142857142855,0.8443517263896049,1.0,6/36,8.17%,OPHN1;FHIT;N4BP1;PRKCG;CAMLG;USP25
prerank,negative regulation of signal transduction (GO:0009968),0.32916631112052785,1.0226607830522765,0.44744744744744747,0.7351353006550424,1.0,69/249,26.16%,BCL2;LRP1;NIBAN2;PLEK;PTGIR;PTPRC;LTF;PRKCQ;XDH;PIK3CB;HRG;CILP;SOX30;FSTL3;FBXW7;PRKCD;FGF2;BRAP;SIAH2;GATA3;NCK1;OTUD4;PRKCB;MDFI;PTPN2;RACK1;LRPAP1;CADM4;VCP;SFRP5;METTL3;SOCS5;PTPN12;CCL5;DLL4;DLK2;TMBIM1;EGFL7;SPRY4;DCN;ASXL1;YTHDF2;RNF157;NR4A2;SIGIRR;SMPD1;NLK;NTN1;YWHAB;CSNK2A2;EMILIN1;HHIP;IFT122;CD47;SUFU;CALR;TRABD2B;WWOX;TNF;GLIS2;TCIM;PTPN18;SFRP1;BMP5;KANK2;KCTD21;TLR9;CX3CL1;BTRC
prerank,glycine metabolic process (GO:0006544),0.4664630572856519,1.0226154171406021,0.4549019607843137,0.7348914162536644,1.0,7/12,30.65%,SHMT1;GLYAT;AMT;GCSH;GCAT;RIDA;SHMT2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.35528892652290395,1.0222668006938727,0.470404984423676,0.7354117225115017,1.0,31/76,30.67%,NLRC3;TMSB4X;IRAK2;ANXA4;TRAF3;OTULIN;FOXJ1;ERBIN;DAP;DDIT3;CYP1B1;ACOD1;PRMT2;CHP1;HAVCR2;PTGIS;NLRC5;RWDD3;TRIM21;CCDC22;MAP2K5;AIM2;TLR9;PSMD10;UFL1;TNFAIP3;SIRT1;FAF1;PYDC1;TRIM37;MTURN
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.36327167318394366,1.0221443474253622,0.44756756756756755,0.735356919632811,1.0,24/51,30.56%,PLEK;NRP1;MYOC;RHOA;LIMK1;CDC42;LPAR1;SERPINF2;TESK1;FERMT2;ITGB1BP1;EVL;CD47;GPR65;PFN1;ARHGEF5;CCDC88A;SFRP1;CX3CL1;S100A10;SYNPO;SORBS3;CCN2;RHOC
prerank,response to ATP (GO:0033198),-0.3394960830182934,-1.0217914560180255,0.3939393939393939,0.8439285665376931,1.0,5/18,14.62%,P2RY12;RYR3;ABCC9;PDXP;CIB2
prerank,vesicle transport along microtubule (GO:0047496),0.41059271963708627,1.0216647489431903,0.463030303030303,0.7361802143962944,1.0,8/23,20.39%,DYNC1H1;HTT;TRAK1;FYCO1;CLN3;KIF1A;RAB1A;FBXW11
prerank,regulation of axon extension (GO:0030516),0.37934167452087103,1.0216261058522926,0.4623287671232877,0.735900068645901,1.0,7/37,12.71%,APOE;MACF1;GOLGA4;RNF6;RUFY3;DNM2;LIMK1
prerank,response to X-ray (GO:0010165),0.44913718104413164,1.0216186941815444,0.44931506849315067,0.7355493155354424,1.0,7/14,29.46%,ANXA1;BLM;ATM;IKBIP;NIPBL;BRCC3;XRCC5
prerank,regulation of mRNA processing (GO:0050684),0.38718645778110405,1.0215099879415634,0.441588785046729,0.7354711060348792,1.0,11/32,21.65%,SRPK1;PAPOLA;SON;PABPN1;CDK11B;HNRNPK;SAFB2;RBM39;CWC22;DHX9;SRPK2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4078633490961593,1.0213546547665597,0.4548780487804878,0.735494359332766,1.0,5/24,18.32%,HIF1A;C3;BRCA1;CYP1B1;IL6
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4510832439210973,1.0213291837368659,0.4444444444444444,0.7352008564735375,1.0,5/15,17.78%,EDEM1;ZFAND2A;SRP14;SPCS3;RAB3GAP2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3368053823478823,1.0206828887759571,0.45417925478348437,0.7364345356396302,1.0,55/152,29.39%,DKK2;PSMD8;PSMD1;MACF1;TNKS2;CAV1;PRDM15;ILK;PSMD6;PSMA1;CSNK1G1;VCP;BAMBI;PSMC3;JUP;WLS;PSMA8;FRAT1;GPRC5B;PSMD14;JRK;PSMD2;NFKB1;CSNK1D;USP47;PSMC6;PSMA6;GSKIP;PSMD5;ATP6V0C;PSMA5;DAPK3;PIN1;CCAR2;TERT;ZBED3;PSMA3;FGFR2;USP8;PSMB10;SFRP1;PSMB8;PSMD7;SMARCA4;PSMB6;DEPDC1B;PSMD10;PPM1A;DACT1;PSMB5;TNFAIP3;PSMB7;USP34;PSMC4;CSNK1E
prerank,cellular response to hexose stimulus (GO:0071331),0.40820023318817245,1.02056940380675,0.4477791116446579,0.7363534973984938,1.0,8/23,21.80%,ADCY8;ERN1;IGF1R;RACK1;PCK2;GAS6;PDK3;SLC26A6
prerank,urogenital system development (GO:0001655),0.4672343124848398,1.020095124097204,0.45529573590096284,0.7371628466755291,1.0,2/11,6.75%,ANXA1;SOX9
prerank,glycerophospholipid catabolic process (GO:0046475),0.40183240634102857,1.0200587835913195,0.45149700598802395,0.7368894258102887,1.0,4/27,8.59%,GDPD3;PRDX6;ABHD12;SMPD4
prerank,sulfur compound biosynthetic process (GO:0044272),0.3403339286993176,1.01984965667086,0.46224489795918366,0.7370358439298601,1.0,36/104,31.74%,CHST11;CSPG4;B4GALT5;SLC26A1;B4GAT1;B3GNT3;GSTA2;SLC35D2;ANGPT1;CNDP2;AKR1A1;DCN;BGN;CHST12;CDO1;B4GALT3;MPST;B4GALT1;GSTO2;LUM;CSPG5;ST3GAL2;OGN;SLC35B3;CHST2;CHST3;DSEL;GGTA1;ST3GAL1;GSTO1;DSE;FMOD;GSTK1;CHST9;ESD;CSGALNACT2
prerank,regulation of response to oxidative stress (GO:1902882),0.4680968989832735,1.0193482245471046,0.4742857142857143,0.7379619400772504,1.0,4/11,19.23%,MCTP1;SELENON;STOX1;AIFM2
prerank,axonal transport (GO:0098930),0.38447673085721357,1.018740222963034,0.4714611872146119,0.7391169883958154,1.0,11/36,22.78%,HIF1A;BLOC1S3;MGARP;DYNC1H1;DTNBP1;DCTN1;KIF1A;AP3D1;DST;FBXW11;AP3S1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.34666417976971337,1.0183388753136546,0.4618599791013584,0.7397794188500423,1.0,29/80,25.15%,ABCG1;EIF6;VIM;SPHK2;GSAP;PRKCD;CD28;EEF2;PIWIL2;RACK1;LARP4;CPEB3;METTL3;YTHDF3;EFNA1;CLU;EIF4A3;FXR2;IL6;SP1;EIF3E;UPF3A;NPM1;UPF3B;SAMD4A;POLDIP3;TNF;SIRT3;PYM1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41499685542843656,1.0182161479764378,0.4647713226205192,0.7396833140365345,1.0,5/24,13.44%,TRIM6;IL12RB1;PTPN22;LILRB1;ZDHHC1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3548269455513773,-1.0177051133629995,0.405982905982906,0.8530343008360979,1.0,3/15,3.27%,CX3CR1;TAFA1;LRRK2
prerank,histone modification (GO:0016570),0.3371993004070497,1.017310997575494,0.47897435897435897,0.7415735288204159,1.0,49/109,34.65%,HDAC9;EYA4;RCOR1;CPA4;PRKCD;HDAC4;MSL3;HDAC1;MIDEAS;SUDS3;PRMT7;HUWE1;MRGBP;CARM1;MAP3K12;CDK2;PRMT2;PRMT6;RCOR3;BAZ1B;MIER2;TAF6;PHF20L1;MORF4L1;EHMT1;USP36;NSD3;MTA3;PARP2;HDAC11;NTMT1;HDAC2;HLCS;NSD1;MORF4L2;UFL1;RUVBL2;BRD8;SIRT1;SIRT2;EP300;CREBBP;NAA50;EYA3;UHRF1;PRMT1;USP22;TRRAP;PRDM5
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4877790062455057,1.017104150863068,0.47761194029850745,0.7417252907242152,1.0,3/10,11.60%,ADAM17;CCR2;CCL5
prerank,regulation of phosphatase activity (GO:0010921),0.4095435977599803,1.0170439843272923,0.4585308056872038,0.7415185214449915,1.0,7/24,17.41%,PTPA;ZCCHC9;HTT;PPP1R35;SH2D4A;CHP1;RIPK3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.35259449282756816,1.0169898316028447,0.4751847940865892,0.7412917196269824,1.0,29/68,31.29%,TAF1D;POLR1G;POLR2H;PAPOLA;PABPN1;TTF1;UBTF;PRMT5;SYMPK;POLR1A;TBP;GTF2H1;SSU72;CPSF7;TAF1A;TAF1C;SNRPG;POLR1F;POLR2F;GTF2H5;SNRPF;CSTF2;NUDT21;MNAT1;MAZ;POLR1H;LSM11;CLP1;ERCC2
prerank,cellular response to ionizing radiation (GO:0071479),0.3653694813443306,1.016957146510934,0.45444444444444443,0.7409999089817031,1.0,21/47,29.46%,TANK;FIGNL1;GRB2;EEF1D;BLM;INO80;KDM4D;ATM;RAD1;TMEM109;RAD51AP1;HSF1;NIPBL;INTS7;MDM2;GADD45A;KDM1A;ATR;RAD9A;SIRT1;XRCC5
prerank,cellular response to hormone stimulus (GO:0032870),0.35439605278879016,1.016955412214562,0.4543524416135881,0.7406396480072538,1.0,10/69,8.02%,CTSB;GCK;MGARP;NR4A3;CAV1;SERPINB9;TFPI;ATP1A3;ATP1A1;UBE2L3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4222410400746916,1.0169051464336887,0.4629861982434128,0.7404025036449033,1.0,5/20,18.99%,ACACA;SLC25A1;SCD5;HSD17B8;GCDH
prerank,negative regulation of neurogenesis (GO:0050768),0.3895006357656042,1.0168536944559683,0.46704545454545454,0.7401554951321132,1.0,9/34,18.32%,LRP4;GDI1;B2M;RUFY3;RHOA;APPL2;NF1;HOOK3;IL6
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4057362983861327,1.016804273792929,0.4575242718446602,0.7399193292283123,1.0,4/26,5.83%,B4GALT5;B4GAT1;B3GNT3;SLC35D2
prerank,meiosis I (GO:0007127),0.40790013096193245,1.0166585342842376,0.4672330097087379,0.7399204819773192,1.0,6/23,16.55%,BCL2L11;SYCP3;FOXJ3;SLC25A31;ING2;HSF2BP
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3292663129707586,-1.0161759475151877,0.42995169082125606,0.8545225882637725,1.0,7/17,22.00%,ROBO1;NOTCH2;ROBO2;NFATC1;HEY1;HEYL;SLIT2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4851502531010392,1.0161682597282125,0.4597222222222222,0.7407626186328524,1.0,6/10,35.91%,DLL4;ARHGAP12;LRP6;BMP5;SOX11;NOTCH1
prerank,acyl-CoA metabolic process (GO:0006637),0.37761714497105514,1.0160937929279283,0.4644870349492672,0.7405577469724095,1.0,7/35,18.57%,ACACA;ACOT9;SUCLG2;ACOT6;GLYAT;DLST;ACACB
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4215109208596299,1.0153081128754673,0.46921182266009853,0.7422232791861527,1.0,6/19,24.85%,SLC26A1;SULT6B1;TPST1;BPNT1;SULT2B1;SLC35B3
prerank,cytoskeleton organization (GO:0007010),0.3331575660624997,1.0150143575566144,0.4799588900308325,0.7425812407376907,1.0,22/114,13.27%,APOE;ARHGAP10;ANK1;MICAL2;MICAL1;PAK6;FMNL2;NEDD9;SH3KBP1;FGD6;STRIP1;RHOD;FMNL3;CCL13;RANBP9;LARP4;RHOG;CCL7;DIAPH1;RHOA;RHOU;PALLD
prerank,fatty acid biosynthetic process (GO:0006633),0.3506653436665343,1.0140932604926052,0.4677248677248677,0.7444836541458927,1.0,10/63,16.03%,LPL;ACACA;ACSBG1;ACSBG2;HACD2;FADS1;SCD5;HSD17B8;HACD1;ABCD3
prerank,protein localization to synapse (GO:0035418),-0.3708908734419457,-1.0137402656245527,0.42231075697211157,0.8590163792015156,1.0,2/12,0.65%,NRXN1;NLGN1
prerank,potassium ion import across plasma membrane (GO:1990573),0.37009392197306407,1.0136852931885107,0.45342312008978675,0.745181649762929,1.0,11/41,21.21%,ATP1B3;KCNJ2;ATP1A4;ATP1A3;ATP1A1;SLC12A4;KCNJ10;ATP1A2;KCNJ6;KCNJ15;SLC12A7
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3659987495483394,1.0135015295405203,0.5022123893805309,0.7452626500440459,1.0,16/47,21.97%,LPL;ID2;PPARG;ZBTB7B;NAPEPLD;NOCT;PPARD;ASXL2;PIM1;CARM1;ZBTB16;HNRNPU;SYAP1;METRNL;ADIG;LMO3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4775607139516851,1.013483411005469,0.48055555555555557,0.7449431173049962,1.0,2/10,7.00%,CTNNB1;VEGFA
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.37957470011698125,1.0130906271998772,0.47740440324449596,0.7455148082091024,1.0,15/35,25.28%,STAP1;ABL2;PTK2B;CDK5;NRP1;PHPT1;IQGAP2;CDC42;DAPK3;HAX1;BAIAP2;ARHGDIB;BAIAP2L2;PDGFRA;MDK
prerank,multivesicular body assembly (GO:0036258),0.38574919969393684,1.012865084855439,0.46830985915492956,0.7457024420155108,1.0,12/30,25.74%,CHMP4A;CHMP4B;PDCD6IP;VTA1;VPS4B;CHMP7;STAM2;MVB12A;RAB11A;CHMP6;IST1;VPS28
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.44593535341734414,1.0126776857752626,0.46173800259403375,0.745828682783498,1.0,6/14,20.95%,NUDT5;NUDT1;ENTPD5;NUDT9;ENTPD6;NUDT15
prerank,response to ionizing radiation (GO:0010212),0.34428925326291554,1.0126304291263148,0.4740190880169671,0.7455822120311094,1.0,23/70,24.63%,ANXA1;TANK;FIGNL1;GRB2;EEF1D;AEN;ABRAXAS1;BRCA1;BLM;INO80;KDM4D;SMPD1;STK11;UIMC1;ATM;RAD1;IKBIP;RAD51AP1;USP28;TOPBP1;INTS7;GADD45A;DCUN1D3
prerank,regulation of T cell mediated immunity (GO:0002709),0.4800157625240524,1.0123311663147871,0.49591280653950953,0.74596651488647,1.0,7/10,31.45%,CCR2;TNFRSF1B;RIPK3;HMGB1;WAS;AGER;ZBTB1
prerank,cardiac muscle cell contraction (GO:0086003),0.4168455067746465,1.012053809550977,0.4796437659033079,0.7463053531639,1.0,7/19,16.74%,KCNJ2;ATP1A1;GSN;SCN1B;CACNA1D;SCN3B;PKP2
prerank,mRNA export from nucleus (GO:0006406),0.338763055138742,1.0119995343421648,0.483971044467425,0.7460770374009776,1.0,38/102,29.53%,NUP205;THOC1;PABPN1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;POLR2D;HNRNPA2B1;RANBP2;TPR;EIF4A3;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP50;NUP54;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SRSF1;SMG1;NUP35;NUP214;NXF1
prerank,microtubule polymerization (GO:0046785),0.39179208331421583,1.0118325591566126,0.4843568945538818,0.7461287140287748,1.0,6/28,20.14%,FGF13;TUBGCP4;RANBP9;CSNK1D;PIN1;SLAIN2
prerank,cortical cytoskeleton organization (GO:0030865),0.3659399206814861,1.011748375984824,0.4682981090100111,0.7459817466431493,1.0,11/41,15.41%,LCP1;PLEK;FMNL2;STRIP1;RHOD;FMNL3;RHOQ;RHOG;RHOA;ROCK1;LLGL2
prerank,organelle assembly (GO:0070925),0.32144987561262106,1.0114585632783832,0.4574574574574575,0.7463359134105871,1.0,131/384,29.90%,SH3PXD2B;FLNA;ATG7;ASAP1;CFAP44;TUBGCP4;TEKT2;RUFY4;PTPN23;ATP6V0D1;DYNC1H1;RILPL2;FOXJ1;SPAG16;IFT43;PATL1;CHMP4A;CHMP4B;LSM14A;TEKT5;EIF2A;EIF2S1;PACS2;PDCD6IP;PATL2;WDR35;HAUS8;SNX10;ARMC9;WDR45;RAB32;RAB8A;ABLIM1;CEP41;RAB8B;TMEM41B;RAB7A;TCTN3;PARVA;OGFOD1;VTA1;YTHDF3;HPS1;VPS4B;EXOC2;GSN;MAP1LC3B;CHMP7;DHX29;CNGB1;STAM2;CENPT;CEP250;ACTR3;INO80;MVB12A;UBQLN1;IFT88;RCC1;EIF4ENIF1;CSNK1D;TMEM216;YTHDF2;PLK4;LZTFL1;RAB1A;RPS23;ATG16L1;IFT74;UBAP2L;MKKS;RAB11A;NEK6;CFAP70;HAUS2;RILPL1;EHD4;ATXN2;RPS3;BBIP1;CHMP6;MAK;ATG2B;PRRC2C;IFT122;MAP1LC3A;NPM1;GABARAP;ATP2A2;LSM4;DYNC2I1;G3BP1;EHD1;EDC3;CYS1;IST1;CCDC65;GOLGA2;HDAC3;VPS28;CENPA;TRAF3IP1;RILP;LSM3;BBS7;STX7;MKS1;TMEM107;SCLT1;ATG3;RC3H1;MAPRE1;DYNLT2B;ACTR2;TMEM237;EXOC4;ATG13;DNAH5;ARL3;KLHL41;TMEM17;ARL6;AMBRA1;CEP83;RAB43;CFAP410;IQCB1;SYNPO;SNF8;PIBF1;TP53INP2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.33357424458510027,1.010996822422242,0.4821973550356053,0.7470955268072792,1.0,29/128,22.26%,CDK14;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;HAUS8;CCNB1;WEE1;CEP41;DNM2;DCTN1;YWHAG;PPME1;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2;FBXL6;FBXW11;CUL1;MELK;LATS1
prerank,regulation of cell killing (GO:0031341),0.4347698857412129,1.0109455322344836,0.4718954248366013,0.746861888453686,1.0,1/16,0.43%,CYBA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.47721604080217356,1.0107427178456851,0.48043184885290147,0.7470248884536314,1.0,3/10,13.20%,AXL;LILRB1;GAS6
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.37786745975516234,-1.0098635605422877,0.4152542372881356,0.8677884703652539,1.0,4/12,8.25%,DOCK8;JAM2;AIF1;APP
prerank,lipid translocation (GO:0034204),0.4108768003699116,1.009696973940064,0.4857849196538937,0.749191265229458,1.0,5/21,13.25%,ABCA1;ATP8B4;ABCA4;ATP9B;ABCA7
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.38239035762478873,1.0093180254871852,0.4730337078651685,0.7497589659526168,1.0,13/35,29.06%,PTPA;PPP1R12A;HTT;CD300A;BOD1L1;PPP1R15B;GSK3B;HSP90AB1;PPP1R15A;CALM3;FKBP1B;HSP90B1;FKBP1A
prerank,polyol biosynthetic process (GO:0046173),0.4332845109997554,1.009291794876911,0.4661558109833972,0.7494586780620303,1.0,3/16,4.64%,ITPKB;CYP27B1;FGF2
prerank,endoplasmic reticulum organization (GO:0007029),0.34415524279803034,1.008692606780536,0.4863731656184486,0.7505498869324749,1.0,20/72,24.98%,TRAM1L1;TOR1AIP2;SMPD4;SEC61B;GAK;HMOX1;REEP3;DOP1B;LPCAT3;LMAN1;VAPB;GET1;VAMP2;LMAN2;ALDH3A2;REEP1;TOR1B;ZBED3;WDR83OS;MAPK15
prerank,dicarboxylic acid transport (GO:0006835),0.38772987219930577,1.008692141657852,0.47287735849056606,0.7501867532706904,1.0,10/28,24.72%,SLC26A1;PDPN;SLC46A1;SLC19A1;SLC13A3;ARL6IP5;SLC25A18;SLC13A5;SLC26A6;GIPC1
prerank,membrane lipid metabolic process (GO:0006643),0.408317556646068,1.0083285424674262,0.4728395061728395,0.7506906369306382,1.0,5/22,9.31%,CERK;TEX2;SPHK2;SPHK1;ARV1
prerank,cellular macromolecule catabolic process (GO:0044265),0.36083155770290387,1.0079452145589634,0.47577092511013214,0.7512801062536393,1.0,15/49,23.69%,RNASE3;SIAH2;STT3B;XRN2;RNASEH2A;OGA;RNASEH1;DFFB;RNASEH2B;ISG20;RNASE6;DNASE1L1;PABPC4;SND1;PPP1R8
prerank,regulation of cellular component organization (GO:0051128),0.33084808179135405,1.0075840007298607,0.4974721941354904,0.7517968911902441,1.0,46/135,28.13%,APOE;ABL2;PRKCQ;SGK1;TRAF2;HRG;SPHK1;SGK3;SGK2;BBS10;CD22;RAB5C;HIP1;ATF5;BAP1;ATAD3A;CDK11B;RAB5A;HSPA8;RUFY2;ROCK1;SETD1A;SLITRK2;ARHGEF11;RASGRP2;MELTF;TFRC;HNRNPU;STK11;HIP1R;GFAP;TMEM97;MARK4;ARFGAP1;LATS1;SNX12;SOCS2;TNF;STK38L;STON1;PAK4;HCFC1;RAB5B;SPOCK1;PACSIN2;LAMTOR1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.41258759353976693,1.007525974900869,0.4701492537313433,0.7515814871311663,1.0,4/21,11.71%,CTNNB1;NES;VEGFA;DLL4
prerank,glycolipid biosynthetic process (GO:0009247),0.36983702612845504,1.0071895012818717,0.48451327433628316,0.7520399904930504,1.0,8/38,15.34%,LARGE1;PIGQ;PIGZ;PIGA;ST8SIA6;PIGN;PIGL;PIGC
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.35205093754751193,1.0066597796309846,0.5010940919037199,0.7529246148921551,1.0,17/57,25.47%,CTSD;ASPH;GRAMD4;MALT1;CYFIP2;SOX7;FYN;DAPK1;SYK;ARL6IP5;HMGB1;TNFSF10;F2R;TBC1D10A;USP50;TNF;AIM2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33088768063778523,1.0059905813361505,0.48390342052313884,0.754203469173405,1.0,49/153,23.23%,PRKCH;PRKCQ;SGK1;MAPK13;DYRK2;SGK3;SGK2;CDK5;PRKCD;PDPK1;ERN1;IKBKE;SBK1;PLK2;PRKCB;MAPKAPK3;MAPKAPK2;CSNK1G1;STK32A;HIPK1;MAP3K12;GAS6;CDK2;PKN2;PAK2;ROCK1;CAB39;PRKD2;CSNK1D;MAPK9;STK38;CDC7;TLK1;RPS6KA2;CAMK4;NLK;NEK6;ATM;PIKFYVE;CSNK2A2;TOP1;PDK3;LMTK2;MARK2;GSK3B;SRPK2;LATS1;MAP2K2;TGFBR2
prerank,positive regulation of cell cycle process (GO:0090068),0.3353894482005296,1.005949283188067,0.4855371900826446,0.7539332391732547,1.0,21/91,21.47%,IGF1;MAP10;PKP4;CD28;DYNC1H1;CCNB1;RHOA;RANBP1;CDC42;PKN2;INO80;NUMA1;TPR;RACGAP1;CDC7;PLK4;SVIL;ATRX;CUL3;DBF4;CEP120
prerank,myelination (GO:0042552),0.3622568835734414,1.0058968137717066,0.47045707915273133,0.7536905440747623,1.0,13/46,19.54%,B4GALT5;ACSBG1;MALL;AMIGO1;KLK6;MYOC;ABCD2;MPZ;MBP;NF1;EIF2B2;PMP22;MARVELD1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4060384063861606,1.0056524823044881,0.475,0.7539451928481271,1.0,6/22,16.11%,PSMC3;MED17;MED13;SRF;PSMC6;DHX36
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3824151790672855,-1.0055246270636158,0.4316546762589928,0.8716479799936846,1.0,3/11,5.60%,PANK4;PANK1;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3824151790672855,-1.0055246270636158,0.4316546762589928,0.8716479799936846,1.0,3/11,5.60%,PANK4;PANK1;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3824151790672855,-1.0055246270636158,0.4316546762589928,0.8716479799936846,1.0,3/11,5.60%,PANK4;PANK1;PPCDC
prerank,negative regulation of response to external stimulus (GO:0032102),0.3326163455543811,1.004728423685308,0.49185336048879835,0.7558700189220872,1.0,29/105,23.09%,APOE;FPR2;SIRPA;NLRC3;LTF;CLDN19;PRKCD;FGF2;MFHAS1;OTULIN;PPARG;GATA3;PPARD;PTPN2;SERPINE1;SHARPIN;ILRUN;LPCAT3;ACOD1;C1QBP;SIGIRR;DUSP3;LYAR;PTGIS;METRNL;TRIM21;PTGER4;MAPK7;VPS35
prerank,cellular response to pH (GO:0071467),0.42324158670595,1.004581521836517,0.4890885750962773,0.7558649003063902,1.0,9/17,38.76%,SLC9A1;CHP1;ASIC1;PKD2L1;RAB11B;HVCN1;IMPACT;HYAL1;PKD1L3
prerank,neuron maturation (GO:0042551),0.41883282254204396,1.0045356540106447,0.4625,0.7556029332144535,1.0,3/18,10.54%,B4GALT5;MTCH1;C3
prerank,response to organophosphorus (GO:0046683),0.4327679408733684,1.004494443415749,0.49232736572890023,0.7553268748012274,1.0,2/16,8.32%,P2RX4;TRIM16
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.23518847373187407,-1.0041632570907937,0.4482758620689655,0.8725655328581924,1.0,19/79,11.25%,LGMN;CTSS;DYNC1I1;SH3GL2;AP1S2;MFSD6;DYNC1LI1;KIF3C;KIF15;SAR1B;KIFAP3;AP1B1;CTSF;ARF1;SPTBN2;KIF4A;FCGR2B;KIF23;ACTR1A
prerank,negative regulation of RNA splicing (GO:0033119),0.4160058724102169,1.0041325541168233,0.47381864623243936,0.7558401801990188,1.0,6/19,21.13%,PTBP3;RPS26;SRSF7;PCBP4;C1QBP;RPS13
prerank,negative regulation of macroautophagy (GO:0016242),0.39375940191890735,1.0032252872195093,0.4845238095238095,0.7576892568614546,1.0,4/26,7.46%,SMCR8;SEC22B;CHMP4A;CHMP4B
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3414987981779572,1.0031000930061968,0.4827586206896552,0.7576225155120949,1.0,28/76,30.71%,STAP1;PLEK;NES;PTK2B;CDK5;NRP1;DYNC1H1;NCK2;NCK1;LIMK1;CDC42;NUMA1;PLK4;HAX1;PFDN2;EVL;VASP;BAIAP2;PFN1;BAIAP2L2;NCKAP1L;CX3CL1;BAIAP2L1;CDC42EP3;SYNPO;SORBS3;FES;ARF6
prerank,mitochondrion morphogenesis (GO:0070584),-0.3825550266148858,-1.0027767252567645,0.4342629482071713,0.8737887385780083,1.0,3/11,8.14%,SLIRP;PNPT1;MYH14
prerank,endothelial tube morphogenesis (GO:0061154),0.4803770733566898,1.0026919187722747,0.4772413793103448,0.7582815837129605,1.0,3/10,14.45%,CTNNB1;RHOA;PRKD2
prerank,regulation of defense response to virus by host (GO:0050691),0.3896428714968704,1.0021935787332172,0.4794359576968273,0.759143322596486,1.0,14/30,32.21%,TRIM6;IL12RB1;PTPN22;LILRB1;ZDHHC1;DHX9;RNF216;AIM2;TARBP2;TNFAIP3;MUL1;MAVS;PARP9;ZC3H12A
prerank,chordate embryonic development (GO:0043009),0.35832640259299103,1.0019044330825515,0.5135135135135135,0.7594819014094053,1.0,6/55,10.59%,XYLT1;KIAA1217;DEAF1;GATA3;VEGFA;BRCA1
prerank,positive regulation of secretion by cell (GO:1903532),0.33779536839502133,1.0018816677892006,0.4931216931216931,0.7591718728260375,1.0,8/70,9.10%,IGF1;ABCG1;P2RX4;ADAM8;ATP13A2;TREM2;DTNBP1;ATP6AP1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.438983806850865,1.0018069838062154,0.4768637532133676,0.7589789254820498,1.0,4/14,17.09%,NCK1;PPP2R2D;PPP1R15B;PPP2R2C
prerank,multivesicular body organization (GO:0036257),0.37932842103196096,1.0016660875335779,0.4847417840375587,0.7589614990213011,1.0,12/31,25.74%,CHMP4A;CHMP4B;PDCD6IP;VTA1;VPS4B;CHMP7;STAM2;MVB12A;RAB11A;CHMP6;IST1;VPS28
prerank,peptidyl-proline hydroxylation (GO:0019511),0.45423880100988134,1.0015956502567014,0.47304582210242585,0.7587545631754655,1.0,7/11,22.58%,P4HB;CRTAP;OGFOD1;P4HA3;P4HA1;EGLN1;EGLN3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43566468593985896,1.0015067418530375,0.48099606815203144,0.7586073634535918,1.0,2/14,7.85%,CD84;RASGRP1
prerank,calcium ion transmembrane transport (GO:0070588),0.33698577232830307,1.001486815820107,0.4855072463768116,0.7582886667969864,1.0,17/86,19.40%,CACNA1A;TRPC4;P2RX4;MCOLN2;SLC24A4;ATP2B1;PMPCA;AFG3L2;CACNA1D;GAS6;SLC8B1;TRPM7;MCOLN3;CACNB3;ANO6;TMEM165;STOML2
prerank,positive regulation of transferase activity (GO:0051347),0.327514633120047,1.0014075724182279,0.49390243902439024,0.7581202042796439,1.0,40/142,25.80%,FLT1;CTNNB1;PRKCQ;CD4;CCT2;AXL;FBXW7;LMO4;TREM2;UBE2L3;IGF1R;VAC14;RPS2;PABPN1;RAD50;NVL;PKIB;DCUN1D2;HNRNPA2B1;KDR;POLG2;DDR2;PIN1;BMI1;EPM2AIP1;PTGES3;DCUN1D4;LMTK2;HSP90AB1;ACD;DKC1;FGFR3;ARRDC4;CD74;FGFR2;DCUN1D3;PDGFRA;MAPK15;RFC2;DSTYK
prerank,histone exchange (GO:0043486),0.3698755309117614,1.0010964683081989,0.47635135135135137,0.758497278228015,1.0,19/37,33.35%,CENPO;ACTR6;CENPT;CENPX;KNL1;SRCAP;VPS72;NPM1;RBBP7;CENPK;CENPA;CENPS;NASP;RSF1;CENPH;DMAP1;ANP32E;CENPC;CENPW
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3973065315061604,1.0002140487493583,0.493491124260355,0.7602716369585615,1.0,5/24,13.56%,UBA52;IRAK2;RPS27A;TAB1;AAMP
prerank,purine ribonucleotide metabolic process (GO:0009150),0.34409276962749796,1.000169220674776,0.4894067796610169,0.7600155825899224,1.0,15/68,19.53%,GIMAP7;ACOT9;AMPD2;AK4;AK3;RHOQ;ACOT6;EFL1;SULT6B1;TPST1;BPNT1;GLYAT;ACAT1;ADSS1;SULT2B1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.46273237399310374,1.0000267438426713,0.49014454664914586,0.7600188216248694,1.0,4/11,33.48%,LPCAT3;VAPB;MOSPD3;STX18
prerank,nervous system development (GO:0007399),-0.22227762898248474,-1.0,1.0,0.8794361734716036,1.0,80/429,10.29%,NAV3;OPHN1;RAPGEF5;MEF2C;LSAMP;NRXN1;NLGN1;FGF12;ADGRL3;CHRM2;BTBD3;ROBO1;MERTK;CRIM1;ROGDI;RBFOX1;SERPINI1;SH3GL2;SREBF2;ADAM22;VCAN;CNTN4;EFNA5;ST8SIA4;SEMA6A;GFRA1;COX7B;MBD5;SOX8;SDK1;NOTCH2;IL1RAPL2;PTS;DSCAML1;ADGRG6;SCN2A;TBX6;NCKAP1;CNTN6;APBA2;PAX8;APBA1;VXN;ADORA1;STAT3;RBFOX3;FEZ1;CHRM3;CDH2;FLRT3;FEZ2;EPHB1;STMN3;DHX30;MYT1L;APLP1;NPAS2;NAB1;SHANK3;APC;ERBB3;IRF2BPL;HAP1;DPYSL2;CRMP1;ADGRV1;VLDLR;PRKN;MARCKS;ZIC4;DNER;ACAN;SH3GL3;TYRO3;INTU;ROBO2;NAV2;ECT2;PAFAH1B3;SDK2
prerank,regulation of centriole replication (GO:0046599),0.43017606945737563,0.9999805795840454,0.47342398022249693,0.7597719615717411,1.0,10/17,33.35%,PLK2;BRCA1;PLK4;MDM1;NPM1;CEP295NL;CEP295;ALMS1;TRIM37;NUP62
prerank,positive regulation of bone mineralization (GO:0030501),-0.2749530173533955,-0.9995856948542775,0.4444444444444444,0.8774455443468036,1.0,5/35,3.33%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.36872537816360174,0.9995348754516292,0.4868571428571429,0.7604963234056132,1.0,10/40,19.23%,MCL1;PRKCD;KMT5A;FBXO5;NEK4;ING2;FXR2;SMYD2;UBE2V2;CASP9
prerank,regulation of transferase activity (GO:0051338),0.4277839793095364,0.9995190108406012,0.48875,0.7601661858143649,1.0,9/17,35.24%,PARP4;ATM;NLRC5;PPP1R3F;JMJD8;SPTSSB;FEM1B;LDB2;LDB1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.42172400746560745,0.9994300479318724,0.49454545454545457,0.7600199944064822,1.0,2/18,2.55%,UBA52;RPS27A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3598122023807751,0.9992990872327941,0.49015317286652077,0.7599630219588733,1.0,12/44,16.76%,AGO2;CELF1;PABPC1;CPEB3;METTL3;YTHDF3;ROCK1;EIF4ENIF1;YTHDF2;ZC3HAV1;DHX36;PUM1
prerank,negative regulation of B cell activation (GO:0050869),0.4070328430124216,0.9989572232585822,0.49876543209876545,0.7604192847833422,1.0,10/21,27.73%,ID2;FOXJ1;SAMSN1;CD300A;PARP3;ATM;LAPTM5;SFRP1;RC3H1;TNFAIP3
prerank,negative regulation of T cell differentiation (GO:0045581),0.4847112382074934,0.9988779027932893,0.4986559139784946,0.7602585129510742,1.0,6/10,38.21%,FOXJ1;BMP4;MDK;GLI3;LAG3;CTLA4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4206468244603163,0.9986776026814553,0.48246674727932287,0.7603750112143409,1.0,10/18,34.09%,MCM7;LIG1;POLE;GINS1;LIG3;RFC4;GINS3;GINS2;PCNA;POLA1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3396827005068595,0.9986265803290517,0.5031315240083507,0.7601274601328387,1.0,25/87,23.23%,ZMIZ1;UBA52;RPS27A;GCNT2;ZMIZ2;USP9X;BAMBI;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;APPL2;FURIN;ZYX;NLK;FERMT2;LTBP2;UBC;DUSP15;ID1;TGFBR2
prerank,protein localization to cell surface (GO:0034394),0.3940352451171782,0.998187265820023,0.4811320754716981,0.7608117718104677,1.0,4/26,10.16%,CTNNB1;FLNA;ANGPT1;FGF7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3327090076588562,-0.998103464476946,0.47863247863247865,0.8787416325185207,1.0,5/14,10.24%,MEF2C;AIF1;NDRG4;IGFBP5;IGFBP3
prerank,protein autoprocessing (GO:0016540),0.4292831512598179,0.9979773852129842,0.5062189054726368,0.7609322309087067,1.0,4/17,15.74%,TMPRSS2;KLK6;AFG3L2;CASP4
prerank,autophagy of peroxisome (GO:0030242),0.4558334899353261,0.9979348222652196,0.4905913978494624,0.760669646407297,1.0,5/12,22.93%,SQSTM1;TRAPPC8;MAP1LC3B;ATM;ACBD5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.37014063195646935,0.9978891414049631,0.4866369710467706,0.7604190144799557,1.0,17/40,31.32%,PTK2B;FBXW7;RPS7;RPL23;RPL11;XPO1;CLU;CSNK2A2;DESI1;LAPTM5;LATS1;CCDC22;UFL1;GNA12;PTEN;NUB1;PDCL3
prerank,fat cell differentiation (GO:0045444),0.3539376347414653,0.9975320176817333,0.5127659574468085,0.7609400831140394,1.0,16/57,26.06%,OSBPL8;GDF6;NR4A3;PPARG;EGR2;TMEM120B;ATF5;CEBPA;FOXO1;NR4A2;MKKS;METRNL;ADIG;STEAP4;PSMB8;BBS7
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4142380333793377,0.9974584935795237,0.4825436408977556,0.7607426561734008,1.0,8/19,22.34%,ATP13A2;FBXW7;HTT;HAX1;CSNK2A2;FBXO7;SREBF1;USP36
prerank,negative regulation of translational initiation (GO:0045947),0.44581782711366014,0.9973721709187768,0.48891786179921776,0.760580959512789,1.0,4/13,18.70%,AGO2;LARP1;TPR;EIF3E
prerank,protein modification process (GO:0036211),0.3401042966035342,0.9972141990370504,0.49738766980146293,0.7606155347071512,1.0,21/76,22.76%,ABL2;MSRA;UBL4A;UBA52;PARP4;B4GALT7;GNMT;UBE2L3;ERO1A;RABGGTB;BAP1;TGM5;UBE2L6;STK38;QPCT;RIPK3;UBL5;DUSP12;CDC34;FBXO11;PIGH
prerank,regulation of centrosome duplication (GO:0010824),0.3823809816479635,0.9968150110068684,0.5005917159763313,0.7612527421674609,1.0,13/29,30.04%,CHMP4B;PLK2;PDCD6IP;VPS4B;FBXW5;CEP120;NPM1;GEN1;CEP295NL;NAT10;CEP295;SIRT1;ALMS1
prerank,protein targeting to membrane (GO:0006612),0.34285464413435823,0.9967084838976495,0.5036803364879074,0.7611445135111415,1.0,30/83,29.57%,SDCBP;ZDHHC15;ZDHHC18;NACA;CHMP4A;CHMP4B;PEX2;SIL1;RAB8B;ABCD2;SRP14;SEC63;ZDHHC1;YIF1B;ABCD3;PXMP2;ALDH3A2;PEX16;PIKFYVE;GET3;ACBD5;PEX14;RTP4;NCF1;SSR1;ATG3;ZDHHC21;ARL6;PEX19;FIS1
prerank,protein O-linked mannosylation (GO:0035269),-0.32845053547768643,-0.9963633697518138,0.42408376963350786,0.8809940658785099,1.0,5/18,7.89%,TMTC2;POMT2;TMTC3;TMTC1;FKRP
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4567632749841568,0.9960023269551329,0.4703448275862069,0.7624709110100794,1.0,3/11,13.20%,AXL;LILRB1;GAS6
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3192727307339654,-0.9957151893744544,0.4752475247524752,0.8798945158735101,1.0,8/18,11.65%,ROCK2;EPHA4;PICALM;LRRTM3;RELA;CASP3;SLC2A13;IFNGR1
prerank,ear morphogenesis (GO:0042471),-0.31219001605942664,-0.9956243826617064,0.46153846153846156,0.8770011364165297,1.0,6/20,20.39%,PAX8;MYO6;PAX2;OSR1;ZIC1;TIFAB
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3758791562200974,0.9954814852781523,0.4966216216216216,0.7634103860773913,1.0,19/39,33.61%,UBA52;RPS27A;ERCC1;DDB2;DDB1;XPA;ERCC4;RFC1;GTF2H1;UBC;GTF2H5;RFC2;CUL4A;POLD4;ERCC2;RFC4;UBB;RFC5;PCNA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.3701731922284961,-0.9954431933651644,0.4618320610687023,0.8744395420394441,1.0,5/12,11.37%,WNK1;GLRX;WNK3;DMD;NOS1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3750250600637486,0.9953965107528323,0.504,0.7632512806247587,1.0,10/35,19.81%,ZMIZ1;RNF14;DAXX;DDX17;KDM3A;PPARGC1B;RBFOX2;WBP2;TMF1;NR3C1
prerank,"transcription, DNA-templated (GO:0006351)",0.32320381473702664,0.9952894835207988,0.5205616850551655,0.7631457046473783,1.0,51/207,21.30%,ERCC6;NFYA;NFIC;DEAF1;MNT;DDX21;SLC25A33;TAF4B;ZBTB7B;NOCT;NFX1;POLR2H;BTF3;GTF2A2;SNAPC2;TTF1;UBTF;KLF13;PRMT5;COPS2;TBPL1;AFF4;TAF15;DRG1;PWP1;MRPL12;GTF2F1;PIR;YBX2;POLR2D;NFKB1;TWNK;DEK;NR4A2;GMEB2;HSF2BP;TBP;ELOB;PAF1;GTF2H1;EAF1;CCNT2;TAF7;RNMT;TAF6;TSC22D1;MLLT1;TRIP13;TRIM24;HSF1;TAF1A
prerank,endothelial cell proliferation (GO:0001935),0.4230127276666776,0.9952273051876644,0.48402948402948404,0.7629281879390717,1.0,5/17,21.77%,ANGPT4;ERN1;HMOX1;ITGB1BP1;BMP4
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.335650440701189,0.9951278063851263,0.5119667013527576,0.7628063825804412,1.0,24/84,18.30%,SRPK1;MBNL3;PRDX6;NCL;RBM25;CELF1;DDX17;SON;SRSF7;HNRNPK;PCBP4;RBM11;MBNL2;RBFOX2;PUF60;RBM15;NOVA2;C1QBP;FXR2;RBM15B;RBM39;HNRNPU;CELF6;CWC22
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4002159224029886,0.9950947381945312,0.48880597014925375,0.7625141256957706,1.0,10/23,26.98%,PPARG;TXK;PTPN2;JAK1;PIAS1;NLRC5;HSP90AB1;SUMO1;JAK2;IFNGR2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3544638971401412,0.9949152130530865,0.48964013086150493,0.7625887883596572,1.0,19/49,29.76%,NLRC3;RAF1;TREM2;IAPP;RIOK3;CDC42;CLU;RPL13A;HMGB1;GSK3B;HSF1;PTGER4;PMEPA1;HSPA5;TRAF3IP1;PPM1A;DACT1;AIDA;PYDC1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4085558127370133,0.9946129991747512,0.5012254901960784,0.7625743510185072,1.0,8/19,27.07%,DAXX;POLR2H;POLR2D;ATRX;TERF1;ACD;POLR2F;TERF2IP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4085558127370133,0.9946129991747512,0.5012254901960784,0.7625743510185072,1.0,8/19,27.07%,DAXX;POLR2H;POLR2D;ATRX;TERF1;ACD;POLR2F;TERF2IP
prerank,cell cycle G2/M phase transition (GO:0044839),0.327851119182008,0.9942340436263996,0.5299492385786801,0.7631035077750683,1.0,29/129,22.26%,CDK14;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;HAUS8;CCNB1;WEE1;CEP41;DNM2;DCTN1;YWHAG;PPME1;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2;FBXL6;FBXW11;CUL1;MELK;LATS1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.329132869873287,0.9937466548778486,0.5282631038026722,0.7639028778422705,1.0,39/112,29.22%,ZMIZ1;UBA52;RPS27A;GCNT2;CILP;ZMIZ2;SOX9;CRKL;USP9X;BAMBI;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;APPL2;FURIN;ZYX;NLK;FERMT2;LTBP2;UBC;NR3C1;DUSP15;ID1;MAPK7;TGFBR2;WWOX;SFRP1;COL1A2;LIMS1;PARD6A;ITGB1;CLEC3B;FKBP1A;SIRT1
prerank,DNA repair (GO:0006281),0.3160302683425594,0.9935781955774888,0.5240480961923848,0.7639337026975757,1.0,118/284,34.09%,ERCC6;UBA52;PARP4;RAD51B;RPS27A;DOT1L;ERCC1;NUDT1;IGHMBP2;ASCC3;TRIM28;ATXN3;LIG1;POLE;MDC1;RNASEH2A;DDB2;ZRANB3;VCP;DDB1;ABRAXAS1;MGMT;FANCF;BRCA1;HUWE1;RAD50;NEIL2;DDX1;ALKBH1;XPA;BAP1;HPF1;SLC30A9;KMT5B;MBD4;BLM;ADPRS;CENPX;INO80;ERCC4;SLX4;USP47;BARD1;PMS1;PRMT6;POLB;WDHD1;PARP3;UIMC1;RAD54L;UBE2V2;BAZ1B;GTF2H1;ATM;RAD1;FANCA;UBC;RAD51AP1;TRIP13;RECQL5;DCLRE1A;ALKBH3;NPM1;TOPBP1;WDR48;ASCC1;NSMCE1;XPC;SUMO1;PARP2;GADD45A;GTF2H5;RFC2;USP1;PIAS4;LIG3;ASCC2;BRCC3;CENPS;CETN2;ATR;PDS5A;POLD4;RAD9A;MNAT1;ERCC8;HINFP;APTX;SIRT1;TICRR;CSNK1E;XRCC5;PNKP;ASF1A;NABP1;ERCC2;RFC4;ZBTB1;TDP2;ACTR8;PARP9;PDS5B;UBB;HUS1;TEX264;WDR33;EYA3;MLH3;RFC5;FANCE;SMARCAL1;PCNA;RAD51;CHEK2;BABAM2;KDM4B;SETD2;POLA1
prerank,positive regulation of cellular component movement (GO:0051272),0.3973886726847592,0.9934924132417249,0.4964200477326969,0.763776626470816,1.0,7/24,17.91%,PDPN;VEGFA;ADAM17;PHPT1;RPS19;STK11;NTN1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.34182165606827697,-0.9932797413309664,0.45188284518828453,0.8778729944519815,1.0,4/15,8.54%,SOX8;PAX8;AGT;PAX2
prerank,cell-cell junction maintenance (GO:0045217),-0.38504036247658135,-0.9928329150671727,0.43043478260869567,0.8760236540554457,1.0,2/11,5.28%,CSF1R;TJP1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3359644829326109,0.9922412534140842,0.5168776371308017,0.7664576853935015,1.0,20/82,16.16%,SDCBP;ARPC2;ARPC3;ARPC5;MMP9;NCK2;ACTG1;PSEN2;FYN;RHOA;CDC42;EFNA1;ROCK1;ACTB;GIT1;ACTR3;ARPC1B;EFNB2;KALRN;RASA1
prerank,homeostasis of number of cells (GO:0048872),-0.3610272090388644,-0.99189019436903,0.4646017699115044,0.8758969921974111,1.0,1/12,0.09%,CX3CR1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4613861455057735,0.9918417279678794,0.492371705963939,0.767065299857796,1.0,3/11,15.80%,P2RX4;LMNA;FOXO1
prerank,protein homooligomerization (GO:0051260),0.33182109729859216,0.9915501036900398,0.5233265720081136,0.7674090171402879,1.0,31/114,24.26%,ADCY8;ACACA;MLKL;ALDOA;THG1L;ALS2;KCNJ2;APIP;GNMT;PRF1;PDCD6IP;B2M;SHMT1;SLC1A5;UPB1;OSBPL2;GLS;BLM;APPL2;NINJ1;AQP4;DISP1;EHD4;ACACB;CLYBL;SOD2;MIF;ASIC1;EHD1;STEAP4;TRIM72
prerank,positive regulation of JNK cascade (GO:0046330),0.3423587635647552,0.9913000620459915,0.5063291139240507,0.7676569641283454,1.0,10/70,9.85%,MMP8;SDCBP;TRAF2;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;RASGRP1;TRAF1
prerank,renal water homeostasis (GO:0003091),0.3941233572254538,0.9912551051668307,0.49696969696969695,0.7673949098033692,1.0,7/23,21.64%,ADCY8;ADCY3;ADCY7;AQP4;RAB11A;WFS1;PRKAR1A
prerank,positive regulation of innate immune response (GO:0045089),0.3803965816225661,0.9910371028672896,0.511600928074246,0.7675564241429277,1.0,10/30,21.58%,FPR2;ADAM8;TRIM6;POLR3D;CCL5;RIOK3;RPS19;DHX9;NLRC5;LBP
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3950133206012945,0.9909347401376427,0.49133663366336633,0.7674328167400397,1.0,7/23,21.83%,H1-0;DNASE2;DFFB;HMGB1;DNASE1L1;DFFA;SETMAR
prerank,protein targeting (GO:0006605),0.3294806583010636,0.9905859111023789,0.5313765182186235,0.767889581226836,1.0,43/118,29.97%,SDCBP;KIF13B;TOMM22;MGARP;ZDHHC15;EDEM1;ZDHHC18;NACA;ZFAND2A;TRAK1;TIMM44;RPL11;LAMP2;AP4E1;TIMM9;SRP14;SPCS3;SEC63;ZDHHC1;TOMM5;TOMM40;YIF1B;PEX16;PIKFYVE;FBXO7;LTBP2;TIMM17A;GABARAP;PITRM1;FUT10;TIMM23;GIPC1;RTP4;AP4S1;NCF1;ATG3;ZDHHC21;ARL6;ZFAND6;TOMM7;PEX19;FIS1;MFF
prerank,positive regulation of GTPase activity (GO:0043547),0.32197103436929153,0.9905006712766451,0.5376128385155466,0.7677077427698705,1.0,25/188,11.60%,BCAR3;RGS1;ABR;ARHGAP25;CORO1C;TBC1D10C;ARHGAP24;TBC1D22A;RGP1;CCL4;RALGAPA2;ALS2;PKP4;SIPA1L2;FOXJ1;TBC1D2;RAPGEF6;RASGRP1;RIC1;CCL13;RACK1;MMUT;RHOG;CCL7;CCL5
prerank,carnitine shuttle (GO:0006853),0.45895492378976477,0.9904149266305281,0.4924346629986245,0.7675515519679592,1.0,5/11,24.71%,ACACA;MID1IP1;CPT2;ACACB;CPT1A
prerank,negative regulation of DNA recombination (GO:0045910),0.36093082807063726,0.9902622809396135,0.5083612040133779,0.7675343614553698,1.0,15/43,27.09%,DAXX;POLR2H;ZRANB3;H1-0;BLM;POLR2D;PARP3;ATRX;RTEL1;PARPBP;TERF1;ACD;POLR2F;TERF2IP;SMCHD1
prerank,negative regulation of macrophage activation (GO:0043031),0.4242294679028522,0.9900993181987154,0.5081351689612015,0.7675512838140265,1.0,2/16,2.92%,PTPRC;CST7
prerank,regulation of monooxygenase activity (GO:0032768),0.39864521404367154,0.989614618179605,0.49521531100478466,0.76830692476488,1.0,5/23,14.48%,VDR;CAV1;POR;DNM2;NOSTRIN
prerank,positive regulation of intracellular transport (GO:0032388),0.3696616518484054,0.9895595001012718,0.51165371809101,0.7680859751636476,1.0,13/38,24.38%,DYNC1H1;PGAP1;RUFY3;NUMA1;TPR;VAMP2;STK11;TBC1D20;ACTN2;MLC1;EHD1;PRR5L;PLK3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.29768994629889234,-0.9895361927283507,0.4639175257731959,0.8800598870698104,1.0,7/22,20.88%,PDE3B;CCDC3;APOD;IL1B;HCAR2;ASXL3;ADRA2A
prerank,chromosome condensation (GO:0030261),0.3659259630455523,0.9895166102686707,0.4988584474885845,0.767830225353804,1.0,10/36,19.11%,NCAPG;ERN2;NCAPG2;KMT5A;CCNB1;NCAPH;H1-0;DFFB;ACIN1;CSNK2A2
prerank,polyamine metabolic process (GO:0006595),0.4411013635480445,0.9895038109373768,0.4773936170212766,0.7674989810145707,1.0,4/13,19.39%,SAT1;PAOX;ODC1;SMOX
prerank,cell cycle G1/S phase transition (GO:0044843),0.3473173484699182,0.9894928350580258,0.4962243797195254,0.7671646937979835,1.0,25/61,30.07%,CDK6;PLK2;POLE;E2F3;CDK2;RCC1;CDC7;PPP6C;CDKN3;GSPT1;CUL3;DBF4;CUL1;CDC34;CUL2;LATS1;PLK3;CDK4;CUL4A;EIF4E;NASP;MNAT1;HINFP;CDC25A;CCND1
prerank,regulation of T cell chemotaxis (GO:0010819),0.4634473212543743,0.9894647844564883,0.5112881806108898,0.7668685519838557,1.0,3/11,11.60%,ADAM17;CCR2;CCL5
prerank,positive regulation of DNA recombination (GO:0045911),0.3802082974114209,0.9892705830104155,0.4898688915375447,0.7669632737425888,1.0,10/27,27.54%,ERCC6;PRDM9;KMT5B;ARID2;TFRC;RAD51AP1;WAS;WDR48;ACTR2;FUS
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.381265561054371,-0.9890602757132495,0.43700787401574803,0.8784334218152493,1.0,6/11,25.44%,GTF2H2;GRK3;ARRB2;ARRB1;ADM;GRK2
prerank,myeloid cell differentiation (GO:0030099),0.36254252081423627,0.9888662828305006,0.521311475409836,0.7675846635363685,1.0,15/47,28.32%,RPS14;MFHAS1;RUNX1;PTPN2;CEBPA;ZBTB16;RPS19;HSPA9;TIRAP;ACIN1;EPO;JAK2;FLVCR1;UFL1;PRDX3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.32010696324046,-0.9886180508203987,0.44549763033175355,0.8766583653780705,1.0,9/17,22.00%,CASK;PCSK6;TMEM204;XIAP;DOK5;SFRP4;SULF1;TFAP2B;SLIT2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3654688261194605,-0.9881200934240917,0.4732510288065844,0.8751021560201613,1.0,7/13,21.06%,GLUD1;GLUL;NOS1;GAD1;PRODH;ALDH4A1;DAO
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3517378961138672,0.9877966896451569,0.49776785714285715,0.7697328765087675,1.0,9/45,21.77%,CTNNB1;BCL6;PLK2;BRINP2;WEE1;PRCC;NME6;BUB1B;BMP4
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.36634475052920634,-0.9877210890481691,0.46122448979591835,0.8733199983933772,1.0,5/12,8.91%,DPYD;CTPS1;DPYSL2;CRMP1;ALDH6A1
prerank,regulation of secretion by cell (GO:1903530),0.3470286404061503,0.987657943217919,0.5,0.7697147533047446,1.0,16/54,17.62%,ANXA1;MCTP1;CPLX4;RHBDF2;P3H1;RIC1;RHBDF1;RAB8A;RAB8B;KCNMB4;DNAJC1;CPLX2;LLGL2;MCTP2;VAMP2;DISP1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.41102344670682844,0.9873548253694607,0.5138190954773869,0.7700678691002117,1.0,5/19,18.99%,PIPOX;PHYKPL;DLST;SLC25A21;GCDH
prerank,regulation of intracellular protein transport (GO:0033157),0.3762975898634336,0.9871752307721682,0.5068493150684932,0.7701365184042019,1.0,9/32,24.38%,LCP1;ATP13A2;RUFY3;GCC2;TPR;VAMP2;BMP4;PRR5L;PLK3
prerank,positive regulation of vascular permeability (GO:0043117),0.4433024756120212,0.9870410762489655,0.4888010540184453,0.77010534436637,1.0,3/12,7.19%,TJP2;VEGFA;ANGPT1
prerank,negative regulation of cell differentiation (GO:0045596),0.3200301748179284,0.9869872520191609,0.5327951564076691,0.7698571219300735,1.0,46/181,25.45%,ABCG1;CDK6;ABCA1;HDAC7;XDH;ID2;SOX3;PTK2B;CAV1;JAG1;PPARG;GATA3;SOX9;NOCT;NKX2-1;BAMBI;RIOX1;CHRD;ZBTB16;SMAD7;EFNA1;ASXL1;YTHDF2;FOXO1;PKP2;ADIPOR1;SINHCAF;PDCD4;HNRNPU;ANKRD26;PAF1;IL6;NEPRO;FERMT2;SPRED2;BMP4;TRIB2;SUFU;CALR;SPRED3;TNF;ANP32B;CCDC85B;SFRP1;BMP5;NOTCH4
prerank,positive regulation of phosphatase activity (GO:0010922),0.40424409311218706,0.9864472279619506,0.5012285012285013,0.7707722188661803,1.0,8/21,23.62%,PLEK;PTPA;CD300A;PPP1R15B;RIPK3;HSP90AB1;PPP1R15A;CALM3
prerank,microglial cell activation (GO:0001774),-0.3078078450887174,-0.9860414016834065,0.49206349206349204,0.8752487170587062,1.0,4/21,8.25%,CX3CR1;ITGAM;AIF1;APP
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.44706349572134724,0.9859833064439282,0.5145118733509235,0.7715201112132026,1.0,2/13,4.78%,DERL3;EDEM1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.38013807667568833,0.9854389216732556,0.49820359281437127,0.772431195977875,1.0,12/28,32.07%,ERCC6;CYREN;KMT5B;KDM4D;PARP3;HSF1;SETMAR;WAS;SMCHD1;ACTR2;PNKP;PARP9
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3405245084745363,0.9854116871205412,0.5190274841437632,0.772133779079579,1.0,25/80,29.57%,CTSD;GRAMD4;MALT1;CD44;RAF1;SIAH2;VEGFA;SOX7;TRIAP1;GAS6;DAPK1;USP47;SYK;ARL6IP5;HMGB1;TNFSF10;F2R;TNF;MAP2K5;GPX1;FNIP1;DNAJB6;CYCS;SIRT1;FIS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.33025399200968314,0.985317474247202,0.5406797116374872,0.7719956172717528,1.0,36/96,29.53%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;RANBP2;TPR;EIF4A3;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP50;NUP54;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SRSF1;SMG1;NUP35;NUP214;NXF1
prerank,protein localization to phagophore assembly site (GO:0034497),0.46327453623975257,0.9848070347814917,0.5061898211829436,0.772797685144217,1.0,3/11,9.57%,TRAPPC8;PACS2;WDR45
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3691165383067856,0.9844523504612682,0.5149769585253456,0.7732851507968853,1.0,11/35,17.80%,PIK3CB;LRPAP1;B2M;HIP1;C3;APOC1;SERPINE1;HNRNPK;CLU;CBL;HIP1R
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.36208029353445115,0.9843199004185849,0.5158013544018059,0.7732307769694099,1.0,9/39,16.05%,CTNNB1;FGF2;NRP1;COL4A1;VEGFA;NKX2-1;DLL4;LRP6;KDR
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31830942051334793,0.9841796842575958,0.5547738693467337,0.7731869058448942,1.0,53/199,25.28%,GPNMB;CORO1C;IL18R1;HDAC9;ATP2B1;APOA2;PON1;TBX18;PTPN23;NPTN;LRP4;GATA3;SOX9;RAB11FIP1;SLC6A4;ADAM17;HOXA7;NKX2-1;LRPAP1;SMAD7;EFNA1;GAS6;ROCK1;DDIT3;PROCR;RPS19;DOCK7;SRF;NOVA2;ADIPOR1;ASB1;STK11;PARP3;SLC11A1;EVL;SPRED2;TIMP1;ARHGDIB;GSK3B;LAMA4;BMP4;SRGN;ID1;PTGER4;CALR;F2R;IL17D;SPRED3;TNF;ATF4;SFRP1;BMP5;MDK
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.38707528990579493,0.9837349239562212,0.5190930787589498,0.7739199701143326,1.0,5/26,13.56%,UBA52;IRAK2;RPS27A;TAB1;AAMP
prerank,oogenesis (GO:0048477),0.42786034375724613,0.9835482376983083,0.5013368983957219,0.7739997039833221,1.0,6/15,25.28%,PIWIL2;METTL3;TRIP13;KMT2D;MEI4;MDK
prerank,granulocyte differentiation (GO:0030851),0.4169743001868451,0.9834257660149064,0.5139593908629442,0.7739294428884748,1.0,8/18,31.50%,LEF1;CEBPA;CDK2;DEK;RXRA;CDK4;LBR;EP300
prerank,regulation of organelle assembly (GO:1902115),0.33780555191230616,0.9833355178258156,0.5256008359456635,0.7737852698730804,1.0,29/72,27.37%,TBC1D10C;TBC1D22A;MSN;TBC1D2;PLK2;PDCD6IP;NPRL2;GSN;RAB5A;VPS11;IFT88;TBC1D24;TBC1D22B;TBC1D12;TBC1D20;TBC1D19;PIKFYVE;ATXN2;NPRL3;NPM1;TBC1D10A;TBC1D16;MAPK15;CEP295NL;TRAPPC12;ATG3;TBC1D15;CEP295;DYNLT2B
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3422434084295394,0.9830421733588391,0.5154749199573105,0.7741152233162386,1.0,11/66,15.98%,GPNMB;CDK6;ANXA1;EIF4G1;ID2;ADAM17;WEE1;INO80;PRMT2;APPL2;CCND2
prerank,regulation of chromatin binding (GO:0035561),0.4684460360533237,0.9827426006169994,0.5150684931506849,0.7744363426305297,1.0,3/10,16.18%,WAPL;GMNN;KDM4D
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3475804553512804,0.9824390736915508,0.5325379609544468,0.7747439045793719,1.0,7/51,10.64%,GAS7;SGK1;ATP7A;ALS2;TAOK3;DTNBP1;DNM2
prerank,peptidyl-methionine modification (GO:0018206),0.4573875709378993,0.982334874012271,0.49934980494148246,0.774629914667035,1.0,3/12,9.78%,APOA2;NAA16;NAA20
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.40464150467076926,0.9821970816316168,0.5164556962025316,0.7746011909215418,1.0,11/19,36.26%,DYRK2;AEN;HIPK1;TMEM109;USP28;CDIP1;SNW1;SIRT1;EP300;HIPK2;PHLDA3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.34764610030837056,0.9817760343791216,0.517051705170517,0.775203808449087,1.0,17/55,24.51%,EIF6;XDH;SPHK2;SLC25A33;GRB2;SIRT5;BRCA1;CYP1B1;ACOD1;CCN6;CBR1;PIKFYVE;PDK3;RNF41;TGFBR2;PARL;GADD45A
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.44768532847920145,0.9817524290376545,0.5123537061118335,0.7745402194200778,1.0,6/12,22.83%,CORO1C;FBLN1;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.44768532847920145,0.9817524290376545,0.5123537061118335,0.7745402194200778,1.0,6/12,22.83%,CORO1C;FBLN1;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.38474874146640287,0.9808964113873891,0.5088131609870741,0.7762456507707963,1.0,14/27,32.24%,CPA4;MSL3;NAT8;MRGBP;KAT7;TAF6;PHF20L1;MORF4L1;MORF4L2;RUVBL2;BRD8;EP300;CREBBP;NAA50
prerank,regulation of signal transduction (GO:0009966),0.31902525047297575,0.9805509370228788,0.5640766902119072,0.776677882349996,1.0,37/190,17.06%,MDFIC;CD3E;IGFBP7;RGS3;FBXL17;IRAK2;CD24;DHRS3;MTCH1;BRAP;PPP2R1A;VEPH1;NCK2;MGLL;RUNX1;GATA3;NCK1;TREM2;UGCG;DTNBP1;ILK;PTPN2;UBTF;FYN;SOCS5;CD63;YWHAG;SHARPIN;SP100;OGT;PPIA;GIT1;CLU;LLGL2;GSKIP;ITGA3;GLRX2
prerank,purine nucleotide metabolic process (GO:0006163),0.39448209915845256,0.9804545924073117,0.48959608323133413,0.7765440235697026,1.0,12/24,26.35%,XDH;GART;ITPA;PRPSAP1;MTHFD1;NUDT15;PRPS2;PPAT;ADSL;GUK1;GPX1;HPRT1
prerank,negative regulation of developmental growth (GO:0048640),0.37697865460271973,0.9802901711986786,0.5141176470588236,0.7765800588004992,1.0,3/30,7.43%,FGF13;RNF6;SLC6A4
prerank,secondary palate development (GO:0062009),0.43498591804627623,0.9798267156629238,0.5186615186615187,0.7772868154230586,1.0,1/14,2.01%,LEF1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3310340572956578,-0.9797409776160736,0.4711111111111111,0.8917858150341209,1.0,5/15,16.50%,ZFYVE27;REEP2;RAB10;TMEM170A;ATL2
prerank,positive regulation of exocytosis (GO:0045921),0.35693331085968116,0.9793910470644561,0.510957324106113,0.7779787852829892,1.0,7/35,12.70%,SDCBP;ATP13A2;PDCD6IP;ATP6AP1;RAB7A;VPS4B;RAB5A
prerank,positive regulation of immune effector process (GO:0002699),0.37860025763418836,0.9793840169137699,0.5064478311840562,0.7776378343865192,1.0,8/27,21.58%,PTPRC;IL12RB1;LILRB1;CCR2;RPS19;APPL2;IL2;LBP
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2628336423597194,-0.9793591812632152,0.46601941747572817,0.8899890991685259,1.0,15/41,18.34%,ZFP91;ITCH;UBE2G1;UBE2O;TRIM56;PRKN;TRIM27;UBE2E3;RNF168;RNF152;PELI3;PRPF19;TRAF6;UBE2T;UBE2S
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.40360363326981774,0.9792273772601102,0.515451174289246,0.7776464681353682,1.0,6/20,18.32%,ITGA4;PLA2R1;GSN;PDCD4;ANO6;IL6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.43870567500455254,0.9791487865753233,0.5046357615894039,0.7774838327578901,1.0,3/12,25.85%,SOX9;RBP4;TLR9
prerank,regulation of response to external stimulus (GO:0032101),0.32190002251344807,0.9791306778049723,0.5446153846153846,0.7771652139145369,1.0,27/121,18.53%,P2RX4;ANXA1;TMSB4X;FGR;PTGES;HRG;TRAF3;CAV1;MGLL;BCL6;PTPN22;STK24;BRD4;TREM2;SAG;CELF1;CCR2;PDE6B;CNGB1;CASP4;APPL2;PSMA6;EFNB2;TIRAP;SBNO2;USP18;ELMOD2
prerank,positive regulation of protein transport (GO:0051222),0.3396277084803551,0.9790074597009248,0.5362473347547975,0.7771077742438567,1.0,20/67,26.18%,IGF1;ABCG1;ADAM8;ATP13A2;TREM2;RACK1;RUFY3;CLN3;PPIA;TPR;CHP1;BMP6;VAMP2;ARHGEF5;TNF;PRR5L;PLK3;GOLPH3;VPS28;GOLPH3L
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4600823174533812,0.9789511014374147,0.5170068027210885,0.7768929883072005,1.0,5/10,33.55%,TREM2;TICAM1;CD68;MIA3;ADTRP
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.36401579749046153,-0.9788823032216891,0.4744525547445255,0.8883092637028606,1.0,3/12,14.58%,TMEFF2;AP2A1;PF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4689536511950009,0.9783877624507223,0.5179063360881543,0.7774568240257317,1.0,4/10,24.26%,MBP;MYADM;MAPK7;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4689536511950009,0.9783877624507223,0.5179063360881543,0.7774568240257317,1.0,4/10,24.26%,MBP;MYADM;MAPK7;MAP2K5
prerank,artery morphogenesis (GO:0048844),0.3798939158894607,0.9783187352643818,0.5121107266435986,0.777260003415254,1.0,6/30,16.43%,LRP1;NRP1;JAG1;VEGFA;SMAD7;NF1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4192054995970017,0.9782336641430706,0.5103626943005182,0.7770793091083018,1.0,2/16,11.29%,CLDN19;CLDN18
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.38173897401970835,0.9782247891699107,0.5159010600706714,0.7767426804732497,1.0,5/28,8.06%,UBA52;IRAK2;RPS27A;OTULIN;TAB1
prerank,blood circulation (GO:0008015),0.3508336123822056,0.9779941983181357,0.5393873085339168,0.7769283304192766,1.0,12/49,20.86%,MYOF;OLR1;C3AR1;ELN;SCPEP1;DLL4;F5;ROCK1;ADORA2A;ITGB1BP1;CYB5R3;EPO
prerank,mRNA transport (GO:0051028),0.32687639050579753,0.9776800571689667,0.5595482546201233,0.7772589952801072,1.0,37/101,29.53%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;RANBP2;TPR;EIF4A3;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP50;NUP54;NUP98;MCM3AP;NUP42;NUP133;NUP210;ARC;THOC6;EIF4E;SRSF1;SMG1;NUP35;NUP214;NXF1
prerank,stress fiber assembly (GO:0043149),0.42660134839989516,0.9775815288531262,0.4934895833333333,0.7767529156328065,1.0,5/15,18.85%,PDLIM1;RHOA;SORBS1;ZYX;CUL3
prerank,contractile actin filament bundle assembly (GO:0030038),0.42660134839989516,0.9775815288531262,0.4934895833333333,0.7767529156328065,1.0,5/15,18.85%,PDLIM1;RHOA;SORBS1;ZYX;CUL3
prerank,neuron projection morphogenesis (GO:0048812),0.3176938129494093,0.9773585614026584,0.5478348439073515,0.7769054820066197,1.0,23/137,15.39%,ALCAM;IQGAP1;CTNNB1;GAS7;SGK1;ATP7A;ALS2;CDK5;TAOK3;S100A6;LRP4;ADGRB1;DTNBP1;DIP2A;RAB8A;DNM2;AFG3L2;CDC42;ROCK1;ACTB;SLC9A6;SLITRK2;DOCK7
prerank,regulation of chromatin organization (GO:1902275),0.42478288457560365,0.9769104569542454,0.5046113306982872,0.7776123419708373,1.0,4/14,17.54%,HPF1;SETD1A;TLK1;HNRNPU
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.38147703278995304,-0.9767842411215689,0.47719298245614034,0.891565718785311,1.0,3/10,5.55%,STAT5A;PRLR;STAT3
prerank,cellular response to glucose stimulus (GO:0071333),0.37385877996058414,0.9766671789291943,0.5261958997722096,0.7778059621959004,1.0,6/30,13.20%,ADCY8;ERN1;IGF1R;RACK1;PCK2;GAS6
prerank,lipid droplet organization (GO:0034389),-0.3027079926227939,-0.9765737904249902,0.4682080924855491,0.8891930441024634,1.0,7/22,29.39%,CDS1;PLA2G4C;PNPLA3;SQLE;PPID;HILPDA;CDS2
prerank,negative regulation of chemotaxis (GO:0050922),-0.27524479386363276,-0.9756392425260073,0.43609022556390975,0.8890205395429616,1.0,8/31,13.52%,ROBO1;SEMA6D;SEMA6A;AIF1;THBS1;ROBO2;SEMA6C;SEMA4B
prerank,negative regulation of neuron projection development (GO:0010977),0.3479145824725881,0.9754814992579142,0.5616139585605234,0.7801875532689125,1.0,12/56,15.96%,APOE;MYLIP;LRP4;GDI1;RUFY3;GAK;RHOA;PAQR3;EFNA1;CBFA2T2;LPAR1;EFNB2
prerank,DNA packaging (GO:0006323),0.41726159204342356,0.974876197617611,0.5226390685640362,0.7811785829162119,1.0,4/16,15.06%,NOC2L;M1AP;H1-0;CHAF1B
prerank,cell junction organization (GO:0034330),0.3380737748218502,0.9747382231843214,0.5569487983281086,0.7811533261655588,1.0,18/71,20.89%,APBB2;FBLIM1;FLNA;TJP2;LRP4;LIMS2;ACTG1;ILK;RAB8B;RHOA;CDC42;ACTB;PIN1;FERMT2;VASP;MYO9A;MARVELD2;PPFIA1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.30242760486757203,-0.9745998624928986,0.5257142857142857,0.8891280973745058,1.0,6/20,10.85%,BICD1;GRK3;RGS14;STMN1;APLP1;MRAP2
prerank,kidney development (GO:0001822),-0.23519319403887573,-0.9744093482649492,0.5066666666666667,0.8866911387085745,1.0,23/65,22.68%,SALL1;PCSK5;FGF10;VANGL2;ITGA8;PAX8;AGT;PAX2;GREB1L;ROBO2;SULF2;OSR1;IFT27;SULF1;PYGO2;TFAP2B;CENPF;BAG6;PKD1;MME;HYAL2;SHH;CEP290
prerank,nuclear export (GO:0051168),0.3331020831182724,0.974165842182132,0.5490605427974948,0.7821066288709874,1.0,30/80,29.53%,MALT1;EGR2;THOC1;ATXN1;NUP188;SRSF11;SRSF7;CCHCR1;XPO1;DDX39B;TPR;EIF4A3;CHP1;CHTOP;THOC2;RAE1;XPO6;DESI1;SRSF2;UPF3B;CALR;POLDIP3;SRRM1;NUP42;THOC6;EIF4E;NUTF2;SRSF1;NUP214;NXF1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.2651700737344809,-0.9740354654403275,0.4473684210526316,0.884800567643696,1.0,5/40,3.33%,MEF2C;TMEM119;ALOX5;ACVR2B;BMPR1B
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4034559165816602,0.9739605173372419,0.5283251231527094,0.7822334191260362,1.0,5/19,16.11%,PRDX5;MAF1;NAB2;CEBPA;DHX36
prerank,base-excision repair (GO:0006284),0.35227310093148434,0.9736561178697158,0.5532608695652174,0.7825637304670995,1.0,13/48,19.50%,ERCC6;LIG1;POLE;HUWE1;NEIL2;XPA;MBD4;ADPRS;USP47;PRMT6;POLB;RFC1;POLG
prerank,regulation of neuron apoptotic process (GO:0043523),0.3234127054590611,0.9735229675106454,0.549792531120332,0.7824889814603577,1.0,24/96,25.28%,BCL2;CTNNB1;APOE;ADAM8;PTK2B;CDK5;CPEB4;TREM2;BAX;CLN3;FGF20;DDIT3;RETREG1;RASA1;NF1;WFS1;SOD2;SRPK2;NSMF;EGLN3;F2R;TNF;ATF4;MDK
prerank,positive regulation of chemotaxis (GO:0050921),0.35150665998582614,0.9733866465807864,0.5232300884955752,0.7824301297721602,1.0,12/43,16.05%,P2RX4;TMSB4X;FGF2;NRP1;HSPB1;VEGFA;TREM2;ADAM17;CCR2;STX3;PRKD2;KDR
prerank,regulation of intracellular signal transduction (GO:1902531),0.3066353577510243,0.9730176645988483,0.598,0.7829125349192023,1.0,118/420,25.30%,MYO9B;ABR;ARHGAP25;ARHGAP21;ARHGAP10;ARHGAP24;TMSB4X;SGK1;GNA13;TRAF2;SGMS1;OPTN;SPHK2;AKAP13;CD24;TRIM6;A2M;DYRK2;PAK6;SQSTM1;CDK5;TAOK3;TRAF3;PPP2R5C;HSPB1;DAXX;NOC2L;PTPN22;PDPK1;STK3;TAF4B;VEGFA;TREM2;HDAC1;DLC1;ARAP2;KMT5A;RHOD;RHOQ;RMI1;CHD3;RPL11;TRAF1;ARHGAP6;ARHGAP19;PRMT5;ARHGEF1;BRCA1;PIP5K1C;MYOC;RHOG;HIPK1;RAD50;TAF15;ARHGEF18;RHOA;RHOU;CDC42;PTPN13;CDK2;ENTPD5;PAK2;BLM;ARHGAP12;PRKD2;RCN3;ARHGEF11;ING2;CLEC6A;RACGAP1;BARD1;KALRN;FAM13B;ING5;PIK3R2;PRKAG1;SMYD2;MINK1;ARHGAP30;ARHGAP9;TBP;STK11;PIN1;ATM;RAD1;TP53RK;ARHGAP17;TAF7;CSNK2A2;RHOT2;FAM83D;TAF6;ARHGEF2;MYO9A;EHMT1;GMIP;ARHGDIB;RNF41;SRGAP1;PRKAR1A;TAOK1;PLEKHG2;TOPBP1;ARHGEF5;PTPMT1;RBBP7;PIP5K1B;VAV3;USP2;MDM2;TNF;PLK3;RHOF;BIRC2;HDAC2;RRAGC;RFC2;VAV1
prerank,mitotic DNA replication (GO:1902969),0.4604439762303047,0.9730061072683516,0.5192563081009296,0.7825856238431226,1.0,4/10,20.15%,MCM2;LIG1;GINS1;MCM6
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.322915213693373,-0.9729902162683257,0.4634146341463415,0.8851433054693122,1.0,6/17,20.88%,RAPGEF2;ADRB1;ADCY9;GPR101;ADRA1A;ADRA2A
prerank,myelin assembly (GO:0032288),0.459493084148639,0.972833706360992,0.5113960113960114,0.7826183991957641,1.0,3/10,18.02%,CD9;NCMAP;PMP22
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.44447716367188317,0.9725205224009426,0.5274869109947644,0.7829843457555319,1.0,1/12,0.35%,CTSB
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.37935178821077475,0.9723625985080369,0.5347721822541966,0.7829755690168705,1.0,3/28,4.51%,APOE;ADCY8;SQSTM1
prerank,regulation of T cell migration (GO:2000404),0.41372077739629554,0.9723057860717648,0.5454545454545454,0.7827397610417988,1.0,5/18,11.87%,SPN;RIPOR2;CD200R1;CCL5;RHOA
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4281951642518982,0.972290007736196,0.5245033112582781,0.7824262016886697,1.0,2/14,7.58%,SLC27A1;CHKB
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.34980297289556644,0.9721254366288424,0.5290889132821076,0.782456191791478,1.0,12/45,25.47%,LPL;MALT1;PANX1;HSPB1;TRIM16;TMEM106A;IL6;EGR1;USP50;JAK2;TNF;AIM2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.2759090644240302,-0.9718921915368148,0.5036496350364964,0.8854179473982045,1.0,13/30,22.66%,CACNA2D1;FGF12;SNTA1;KCNH2;CACNA1C;NEDD4L;SCN2B;CACNA1G;KCNQ1;ANK2;SCN4B;SCN1A;KCNE3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.32465710754721094,0.9717491577540102,0.5575129533678757,0.7829641884550962,1.0,32/88,28.01%,MYO5A;FTL;BLOC1S3;VPS13C;RABEP1;GOLGB1;NAPA;CORO7;DTNBP1;VPS13A;AP4E1;ARFGEF2;DNM2;DOP1B;EXOC2;HSPA8;AP1G1;SH3D19;PUM1;VAMP2;VPS35L;FTH1;CCDC22;AP1M1;LLGL1;SCAMP3;CLINT1;AP4S1;STX4;KIF16B;EXOC4;ARL3
prerank,nuclear migration (GO:0007097),0.4400204644655177,0.9717189428603498,0.5514511873350924,0.7826820053678353,1.0,7/13,23.08%,DYNC1H1;DCTN1;DOCK7;HOOK3;FBXW11;CEP120;TMEM201
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2674635241881939,-0.9717002056339406,0.49107142857142855,0.8830230180056857,1.0,9/33,15.95%,WNK1;KCNJ3;CHRM3;WNK3;AKAP6;KCNJ13;KCNH2;NEDD4L;KCNJ12
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3217219990789023,0.9705727564869581,0.5474226804123712,0.7849326091571499,1.0,28/95,24.98%,RAD51B;NSMCE2;MCM7;MCM2;AP5Z1;RMI1;BRCA1;RAD50;PSMD14;BLM;YY1;INO80;ERCC4;SLX4;CDC7;SEM1;KDM4D;RAD54L;MORF4L1;RAD51AP1;MCM6;RECQL5;MCM8;NIPBL;NSMCE1;GEN1;SMC6;PALB2
prerank,arachidonate transport (GO:1903963),0.4679746804731285,0.9704775022711892,0.5416666666666666,0.7844343347159665,1.0,1/10,1.53%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.4679746804731285,0.9704775022711892,0.5416666666666666,0.7844343347159665,1.0,1/10,1.53%,ANXA1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.32175463203088667,0.970433141853788,0.5556690500510725,0.7841899309444442,1.0,33/118,21.39%,GPNMB;CTNNB1;RAP2A;KIF13B;DAG1;CHRNB2;ZDHHC15;FMNL2;CDK5;FGF2;BCL6;STRIP1;LARP4;RUFY3;PLXND1;HMOX1;RNH1;PHLDB1;KIF1A;SP100;SARM1;PAK2;INF2;HTATIP2;NF1;SH3D19;IL6;FERMT2;EGLN1;MARK2;CFL1;GSK3B;ZMYM4
prerank,primary neural tube formation (GO:0014020),0.37042404580455973,0.9699317305112282,0.5300925925925926,0.7849602549934795,1.0,9/30,21.13%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,peptidyl-arginine modification (GO:0018195),0.422350130041386,0.9699078175778137,0.5205655526992288,0.7846677665512978,1.0,3/15,11.34%,PRMT5;PRMT7;ART4
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.24781445967707605,-0.9698818534711822,0.5858585858585859,0.8853497591865124,1.0,13/44,17.62%,CYP27A1;OSBPL9;DHCR7;SC5D;INSIG1;INSIG2;OSBPL7;SLC27A2;CYP7B1;CYP39A1;SQLE;CYP46A1;HMGCR
prerank,vascular transport (GO:0010232),0.3265342058642512,0.9693123140182375,0.5428870292887029,0.7856533847983775,1.0,19/81,19.68%,LRP1;SLC27A1;SLC38A1;SLC6A6;SLC7A1;SLC5A1;SLC2A1;SLC22A3;ATP1A4;SLC1A5;ATP1A2;TFRC;SLC7A8;SLC5A3;SLC19A1;SLC28A2;SLC13A3;SLC16A2;SLC38A2
prerank,negative regulation of cellular senescence (GO:2000773),0.4346705298030642,0.9684670123139292,0.5352862849533955,0.7871631473581928,1.0,3/13,12.23%,CDK6;FBXO5;ZKSCAN3
prerank,inhibitory synapse assembly (GO:1904862),-0.364170018979597,-0.9681539146954365,0.4731182795698925,0.8876758448094876,1.0,5/11,10.29%,GABRB2;GABRB3;GABRA2;WNT5A;GABRA1
prerank,muscle cell differentiation (GO:0042692),0.36792687407488384,0.9680544044660002,0.5362149532710281,0.7877050293841933,1.0,4/32,3.97%,MRTFA;SPEG;SYNE1;TBX18
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.44204842028637187,0.9678190795318411,0.5231958762886598,0.7878777985224574,1.0,2/13,3.88%,B4GAT1;B3GNT3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3442019232870805,0.9674946084704268,0.5278688524590164,0.7882468603261183,1.0,20/52,27.13%,CNOT4;EXOSC4;PATL1;PATL2;CNOT10;EXOSC9;NT5C3B;DCP1A;POLR2D;LSM6;EDC4;EXOSC5;CNOT6;SAMD4A;PAN2;LSM4;EDC3;LSM3;CNOT6L;RC3H1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.40157411913754076,0.9674027885840631,0.5426452410383189,0.7880919621047167,1.0,7/20,21.11%,IL18R1;MALT1;TRAF2;B2M;RSAD2;IL6;CD55
prerank,cellular response to amino acid stimulus (GO:0071230),0.36776765584100735,0.9666675352024323,0.536036036036036,0.7893986426294244,1.0,15/33,31.44%,RRAGD;CPEB4;IPO5;CPEB3;FYN;UBR2;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.38297280901145386,0.9665188664288811,0.5173652694610779,0.7893842847364492,1.0,7/24,22.42%,TAPBP;B2M;SEC24A;SEC24D;FCER1G;CALR;CANX
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.45513962470645275,0.9664998338482829,0.5357624831309041,0.7890647505339574,1.0,6/11,37.73%,GDF6;SMAD7;TGFBR2;USP15;TGFB1;TGFB2
prerank,regulation of microtubule polymerization (GO:0031113),-0.24665366217244594,-0.9660061599665533,0.48695652173913045,0.8909308775630744,1.0,4/40,7.95%,NAV3;TUBB4A;STMN1;MAP2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.412267287848961,0.965999197637589,0.5391527599486521,0.7898769103381179,1.0,7/16,29.06%,ATP5MG;STOML2;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4127250861158755,0.9658244397898936,0.5309734513274337,0.7899281222435679,1.0,8/17,29.05%,CPEB3;ZC3H3;RNF20;CPSF7;HSF1;CPEB1;NUDT21;CTR9
prerank,embryonic axis specification (GO:0000578),-0.3364098700320211,-0.9657198141041868,0.4830917874396135,0.8887670305046808,1.0,15/15,66.40%,STIL;FZD5;HOXD8;COBL;CXXC4;RIPPLY2;MESP2;TBX3;WNT1;TBXT;SMAD2;PTCH1;SMAD6;WNT7A;TASOR
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.31800054045816945,0.9656206775120431,0.5701030927835051,0.7900270961935661,1.0,50/119,32.06%,SLC27A1;ARF3;TTC7B;ITPKB;PIK3CB;PIGQ;FGF2;PIGZ;PIK3R5;PIGA;PI4K2A;EFR3B;INPPL1;VAC14;PLEKHA1;PIP5K1C;SOCS5;MTMR14;PIGN;RAB5A;PTPN13;PIGL;MTMR12;PIGC;PIK3R2;PIKFYVE;PI4KA;PIGH;TTC7A;PIP5K1B;SOCS2;MBOAT7;PIK3C2A;SYNJ2;PI4K2B;MTMR6;PITPNM1;MTMR1;DPM3;SMG1;PIGU;PTEN;RUFY1;PIGG;ITPKC;SOCS4;SOCS7;SYNJ1;PIP5K1A;IP6K2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3638933828130618,0.9652061011304166,0.5299647473560517,0.7905960362276518,1.0,7/33,16.06%,PLAU;MUC1;HRG;SERPINE1;EFNA1;CYP1B1;SYK
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.42123029404376766,0.96446005810488,0.5358090185676393,0.7919581007056816,1.0,3/13,14.85%,ECHDC3;ZBTB7B;SORBS1
prerank,positive regulation of receptor internalization (GO:0002092),0.38670674219087514,0.9641789704878237,0.5303933253873659,0.7922290991956589,1.0,4/22,13.81%,VEGFA;ANGPT1;CD63;SCYL2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4298675207893162,0.964142208208133,0.5307994757536042,0.7919542607097676,1.0,7/14,29.78%,CRAT;ECI2;EHHADH;ACOX3;ACOT8;ACOXL;SCP2
prerank,positive regulation of cell cycle (GO:0045787),0.3329179609706161,0.963841383025129,0.5453586497890295,0.7922809741182492,1.0,29/62,35.11%,CCNY;SPHK1;ADAM17;CCNB1;PKN2;LRP6;CCND2;DUSP3;HSF1;SRPK2;TRIM21;CALR;FGFR2;USP2;MDM2;CDK4;CDC25B;HCFC1;USP19;PSMD10;EIF4E;RPS15A;CCND1;ASNS;CCDC57;NUDT16;USP22;SPDYA;PDGFB
prerank,positive regulation of cell projection organization (GO:0031346),0.31964115020691547,0.9638312776172261,0.5918367346938775,0.7919490522449927,1.0,19/115,13.67%,PLXNC1;S100A9;APOE;ABL2;PLXNA2;ALKAL2;PTK2B;NPTN;AMIGO1;CUX1;P3H1;SS18L2;PLXND1;RHOA;SCN1B;CHODL;FZD1;CBFA2T2;FZD4
prerank,negative regulation of endopeptidase activity (GO:0010951),0.34273010865766607,0.9637887821032488,0.5308370044052864,0.7916742512736268,1.0,16/47,30.38%,LTF;HRG;SERPINA10;SERPINB9;SERPINE2;SERPINE1;TIMP4;TIMP2;SERPINF2;TIMP1;SERPINB8;SERPINA2;SPOCK1;SERPINH1;SERPIND1;TIMP3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4578536089966296,0.963674425765152,0.5392953929539296,0.7915897851254573,1.0,4/10,20.78%,DLGAP4;DLGAP3;NPTX2;NPTX1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3455555050775834,0.9635310587486317,0.5534934497816594,0.7915617088776988,1.0,16/46,25.91%,FLNA;PRKCD;IPO5;TRIM28;CDH1;JUP;GAS6;TPR;PIK3R2;DHX9;GSK3B;RBM22;ANP32B;BAG3;HDAC3;ZPR1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.26310394266208154,-0.9629867625709115,0.49635036496350365,0.8938322932310429,1.0,9/33,12.53%,CCND3;FGF10;PLCB1;RPTOR;PLCG2;AIF1;EGFR;STXBP4;EZH2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.33784879343749924,-0.9629275250369626,0.48672566371681414,0.8910857860697884,1.0,6/15,11.54%,LGMN;FER;RBPJ;EGF;EGFR;CDH13
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3298302318605346,0.9620912241729251,0.5519412381951732,0.7944002732210251,1.0,27/69,32.40%,DERL3;EDEM1;DNAJB14;STT3B;VCP;SEC61B;UBE4A;DNAJB9;UBXN4;UBQLN1;DERL1;PSMC6;RNF121;UBE4B;WFS1;DNAJC10;HSPA5;ERLIN1;USP19;ECPAS;DNAJB12;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;UBQLN2
prerank,RNA export from nucleus (GO:0006405),0.3215617178315233,0.9612195962665641,0.5899280575539568,0.7959838552642655,1.0,36/100,29.53%,NUP205;THOC1;NUP188;SRSF11;SRSF7;AGFG1;DDX39B;HNRNPA2B1;RANBP2;TPR;EIF4A3;SYMPK;CHTOP;THOC2;RBM15B;RAE1;SRSF2;NUP93;AAAS;UPF3B;POLDIP3;SRRM1;NUP50;NUP54;NUP98;MCM3AP;NUP42;NUP133;NUP210;THOC6;EIF4E;SRSF1;SMG1;NUP35;NUP214;NXF1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.35746226917627694,0.9610642687372565,0.5485327313769752,0.7959666512063341,1.0,12/38,24.85%,MMP8;P2RX4;SIRPA;CAV1;GLA;CLU;PTGIS;HSP90AB1;CD47;JAK2;TNF;KHSRP
prerank,regulation of smoothened signaling pathway (GO:0008589),0.34399460921870784,0.9610215564454168,0.5674778761061947,0.7957072425753942,1.0,21/50,31.92%,TEDC1;FBXL17;TEDC2;RACK1;ARMC9;VCP;EVC;HHIP;IFT122;SUFU;FGFR2;GLIS2;SFRP1;KCTD21;BTRC;HERC4;GLI3;PDCL;TUBD1;CREBBP;MEGF8
prerank,mRNA 3'-end processing (GO:0031124),0.32703403621339483,0.960924940214721,0.5550935550935551,0.7955462811601528,1.0,36/78,33.39%,GRSF1;THOC1;PAPOLA;PABPN1;PABPC1;SRSF11;SRSF7;DDX39B;POLR2D;EIF4A3;SYMPK;CHTOP;THOC2;PAF1;RPRD1A;SRSF2;SSU72;CPSF7;UPF3B;POLDIP3;SRRM1;MTPAP;PAPOLG;THOC6;SRSF1;CSTF2;NUDT21;TENT4B;LEO1;LSM11;CLP1;CDC40;AHCYL1;TUT1;WDR33;SLBP
prerank,mitotic cytokinesis (GO:0000281),-0.25022056289767547,-0.9608947573999572,0.5542168674698795,0.8943075134343325,1.0,15/47,11.35%,ANLN;ROCK2;MYH10;TRIM36;CNTROB;STMN1;APC;NUSAP1;SPTBN1;KLHDC8B;KIF4A;ECT2;KIF23;SPAST;INCENP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.375681599839057,0.9607164786888389,0.5500603136308806,0.7956681053312767,1.0,7/25,18.85%,FBXL17;CLPP;ATXN3;VCP;LONP1;DERL1;CUL3
prerank,organic hydroxy compound transport (GO:0015850),-0.25782268745257875,-0.9607042493164448,0.5225225225225225,0.8919982910226536,1.0,4/36,6.00%,SLCO2B1;NCOA1;SLCO1B1;NCOA2
prerank,macrophage activation (GO:0042116),0.36178363734522684,0.960587111667712,0.5494761350407451,0.795578048237518,1.0,16/34,29.63%,FPR2;FER1L5;TREM2;CLU;ITGB2;TMEM106A;SYK;SBNO2;C5AR1;SLC11A1;LBP;JAK2;TNF;CX3CL1;CRTC3;AGER
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.312874757576179,0.9600557081161296,0.6129032258064516,0.7964077748284341,1.0,24/152,15.59%,RGS1;ABCA1;FPR2;PTGIR;GNA13;ADCY8;ADCY3;PTGFR;GNAQ;ADCY7;PSAP;ADGRB1;SCTR;ADGRG5;IAPP;ADGRE5;CACNA1D;ADGRG7;GNA11;GIPR;ADORA2A;LPAR1;GLP1R;VIP
prerank,regulation of cytokinesis (GO:0032465),0.32872442508304284,0.9593390937793865,0.5739400206825233,0.7976517186540075,1.0,27/78,27.41%,BCL2L1;MAP10;PKP4;PLK2;AHCTF1;KLHL13;RHOA;BIRC6;CDC42;KIF20A;PKN2;GIT1;RACGAP1;PLK4;SVIL;RAB11A;PIN1;CUL3;RAB11FIP4;CALM3;ZFYVE19;PLK3;GIPC1;CDC25B;KLHL21;CETN2;PRPF40A
prerank,sprouting angiogenesis (GO:0002040),0.344696861257579,0.959044740640801,0.5575221238938053,0.7979683770597162,1.0,10/51,16.05%,PTK2B;FGF2;NRP1;OTULIN;VEGFA;ANGPT1;PARVA;SRF;EFNB2;KDR
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.43724060003573006,0.9587442608736261,0.5540720961281709,0.7982733630790108,1.0,4/13,19.53%,SULT6B1;TPST1;BPNT1;SULT2B1
prerank,response to nitric oxide (GO:0071731),0.4253119524888322,0.9587212748110968,0.5421686746987951,0.7979724109034754,1.0,4/13,25.52%,CDK2;FOXO1;EGLN1;TXN
prerank,regulation of Ras protein signal transduction (GO:0046578),0.322581212654447,0.9587165564727937,0.5786163522012578,0.7976293948670848,1.0,23/85,22.37%,IGF1;MYO9B;AKAP13;RAF1;SQSTM1;ERBIN;GRB2;CRKL;DENND4C;DLC1;RASGRP1;CADM4;ARHGEF18;OGT;SPRY4;SYNGAP1;ARHGAP17;ARHGEF2;EPO;ARHGDIB;ARFGAP1;GABARAP;DENND4B
prerank,oligodendrocyte development (GO:0014003),0.41166940159900894,0.9585743390983855,0.5492957746478874,0.7975769631895286,1.0,1/15,0.28%,B4GALT5
prerank,regulation of JNK cascade (GO:0046328),0.31936503055410387,0.958514979041814,0.5912863070539419,0.7973549454568774,1.0,13/101,9.85%,MMP8;SDCBP;RAP2A;SIRPA;TRAF2;MAP4K2;PTK2B;MFHAS1;TAOK3;TRAF3;RASGRP1;IGF1R;TRAF1
prerank,telomere capping (GO:0016233),0.4072847799395578,0.9584645024847711,0.52925877763329,0.7971053962249735,1.0,9/16,40.16%,RAD50;TERF1;DCLRE1A;ACD;TERF2IP;TERF2;TINF2;CTC1;DCLRE1C
prerank,maintenance of protein location in nucleus (GO:0051457),0.3897765904156514,0.9584284291589796,0.5536585365853659,0.7968310784999456,1.0,6/20,19.77%,SYNE1;ARL2BP;SP100;BARD1;HNRNPU;SUN1
prerank,cristae formation (GO:0042407),0.3763634959080204,0.9583530564951446,0.5449101796407185,0.7966396642463438,1.0,11/27,29.10%,IMMT;SAMM50;ATP5MG;AFG3L2;CHCHD6;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1;SPG7
prerank,apoptotic cell clearance (GO:0043277),0.3633385795860996,0.9579829154105598,0.5494117647058824,0.7971089475449828,1.0,6/30,13.20%,LRP1;ANXA1;ADGRB1;TREM2;RHOG;GAS6
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32118723456154163,0.9578920329514936,0.5878725590955807,0.7969461673813104,1.0,29/101,26.77%,FLT1;CCNY;SLC27A1;LTF;ADAM8;PDGFA;CD24;FGF2;PIK3R5;VEGFA;RASGRP1;ADAM17;RHOA;CAB39;CCND2;RALB;FERMT2;SYAP1;FGF18;HTR2B;IL34;MAP2K2;CALM3;TNF;TCIM;FGF1;PARP16;PIH1D1;PSMD10
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.39414784103246636,0.9576769954597554,0.54625,0.7970538579717739,1.0,4/20,9.92%,BCL2;KCTD17;PACS2;BAX
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.35738152365372533,0.9575251552768123,0.5406320541760722,0.7970494715407154,1.0,9/36,19.10%,CTNNB1;LEF1;AGO2;PLCB2;PDE6B;FZD4;NLK;GNB1;AGO3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4507404996338874,0.957496177131076,0.5554035567715458,0.7967514382846477,1.0,2/10,8.93%,FBXW7;ADAM17
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3231003273304167,0.9573431624507502,0.5736677115987461,0.7967376776794944,1.0,31/80,31.48%,ARF3;SEC22B;PLPP3;HTT;NAPA;KLC1;TAPBP;SCYL1;COG4;ATP9B;RACGAP1;RAB1A;LMAN2;ARFGAP3;ARFGAP1;TMED3;GOLPH3;ARFGAP2;GOLPH3L;COPZ2;SURF4;TMED2;COPA;KIF22;USE1;KDELR2;COPG1;COPG2;DNAJC28;COG7;COPB2
prerank,negative regulation of double-strand break repair (GO:2000780),0.36711520874568077,0.9573169993756734,0.5547785547785548,0.7964355193945647,1.0,3/30,6.05%,ERCC6;TRIP12;CYREN
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3663278669102851,-0.9566370235222527,0.508833922261484,0.9008733982827417,1.0,3/10,8.54%,SALL1;PAX8;PAX2
prerank,cellular response to leucine starvation (GO:1990253),0.4583441276329031,0.9565295542655856,0.5573549257759784,0.7977795972544718,1.0,1/10,0.97%,RRAGD
prerank,apoptotic DNA fragmentation (GO:0006309),0.41036182913062086,0.9564271571924695,0.5476190476190477,0.7976586420689296,1.0,5/16,21.70%,H1-0;DNASE2;DFFB;HMGB1;DFFA
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.44092779004509847,0.9563060808262889,0.5136986301369864,0.797564019369225,1.0,6/11,31.44%,TMEM106A;TAF7;JAK2;HDAC2;SIRT1;XBP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.39452140180171263,0.955772963848621,0.5559655596555966,0.7983566800139615,1.0,1/19,0.06%,IGF1
prerank,regulation of cell junction assembly (GO:1901888),0.3720970897709192,0.9556777416388714,0.5531914893617021,0.7982315641923068,1.0,4/27,6.02%,PRKCH;CHRNB2;CLDN19;RUNX1
prerank,protein glycosylation (GO:0006486),0.31185237688051404,0.9555674908380354,0.5887755102040816,0.7981070106049242,1.0,20/125,13.59%,B4GALT5;MAN1C1;MGAT5;GALNT7;LARGE1;B4GALT7;GCNT2;B4GAT1;B3GNT3;MAGT1;B3GALNT2;STT3B;TRAK1;ST8SIA6;OGA;TET3;ALG10B;OGT;ENTPD5;NPC1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.2704751362933396,-0.9554087573794788,0.5634920634920635,0.9017536175983001,1.0,6/32,4.88%,WASF2;PIK3R1;RREB1;TWF2;CARMIL1;NCKAP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4449406591714433,0.9552659315966502,0.5257452574525745,0.7984145202407519,1.0,5/11,28.79%,EXOSC4;EXOSC10;EXOSC5;DKC1;TENT4B
prerank,transepithelial transport (GO:0070633),0.41218272826638924,0.9551472192955744,0.5357607282184655,0.7983229307251598,1.0,2/15,3.11%,SLC23A1;SLC23A2
prerank,dendritic spine morphogenesis (GO:0060997),-0.34339148341970693,-0.9550496728610383,0.5048543689320388,0.8999084633453169,1.0,5/15,12.96%,CTNND2;DOCK10;EPHB1;SHANK3;PAK3
prerank,central nervous system myelination (GO:0022010),0.44659177123787236,0.9549133206080604,0.5477178423236515,0.7984839613529503,1.0,1/11,0.28%,B4GALT5
prerank,ncRNA metabolic process (GO:0034660),0.35744353434761633,0.9546333784181983,0.5565927654609102,0.7987480747044531,1.0,3/37,8.70%,AGO2;PIWIL2;DDX17
prerank,tube closure (GO:0060606),0.36276400554400906,0.9544586110304927,0.546189376443418,0.7987808151565106,1.0,9/31,21.13%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,regulation of protein ubiquitination (GO:0031396),0.3165468141000929,0.9542298763379506,0.5973360655737705,0.7989234160630209,1.0,37/108,29.06%,MALT1;SASH1;GTPBP4;SPHK1;SQSTM1;FBXW7;PRICKLE1;CAV1;DAXX;ADGRB1;ANGPT1;UBE2L3;BRCA1;HUWE1;SMAD7;OGT;CENPX;UBQLN1;DERL1;CHP1;WFS1;CUL3;RPS3;LAPTM5;PRMT3;HSP90AB1;DNAJA1;BIRC2;HDAC3;VPS28;CENPS;PSMD10;GSK3A;UFL1;TNFAIP3;PTTG1IP;FKBP1A
prerank,regulation of filopodium assembly (GO:0051489),0.3538138484134635,0.9541367712031895,0.5679287305122495,0.7987795846455131,1.0,7/38,13.01%,MYO10;RIPOR2;PRKCD;NRP1;RHOQ;RAB5A;CDC42
prerank,cilium organization (GO:0044782),0.3068055088068586,0.9539048193124001,0.6273917421953675,0.7989297098752824,1.0,65/209,29.74%,FLNA;ASAP1;CFAP44;ODF2;TEKT2;PTPN23;ATP6V0D1;RILPL2;FOXJ1;SPAG16;IFT43;TEKT5;WDR35;SNX10;ARMC9;RAB8A;ABLIM1;CEP41;RAB8B;RTTN;TCTN3;PARVA;EXOC2;GSN;CNGB1;CEP250;ACTR3;IFT88;TMEM216;PLK4;LZTFL1;RAB1A;IFT74;MKKS;RAB11A;CFAP70;RILPL1;EHD4;BBIP1;MAK;IFT122;MARK4;DYNC2I1;EHD1;CYS1;CCDC65;TRAF3IP1;RILP;BBS7;MKS1;TMEM107;SCLT1;DYNLT2B;ACTR2;TMEM237;EXOC4;DNAH5;ARL3;TMEM17;ARL6;CEP83;IQCG;CFAP410;IQCB1;PIBF1
prerank,tryptophan catabolic process (GO:0006569),-0.3593177947302329,-0.9539030644588734,0.4844961240310077,0.9003906585307578,1.0,3/11,15.26%,KMO;AFMID;HAAO
prerank,pore complex assembly (GO:0046931),0.396166214162753,0.9538016024444294,0.530359355638166,0.7988057923304765,1.0,8/19,25.24%,NUP205;AHCTF1;TPR;AFDN;ANO6;NUP93;PDZD11;NUP98
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.38071612636575836,-0.9533190618855157,0.515625,0.8991701378036425,1.0,3/10,6.08%,SVIP;UBAC2;INSIG1
prerank,gastrulation (GO:0007369),0.4153419450963227,0.9529650287282536,0.5287206266318538,0.8003175301098965,1.0,2/15,3.90%,EOMES;NR4A3
prerank,magnesium ion transport (GO:0015693),0.4341164733503322,0.9528544672540427,0.5300400534045394,0.8002092883117894,1.0,4/12,23.19%,MAGT1;TUSC3;NIPAL1;NIPAL3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.31589683566115545,0.9526035711560485,0.6008230452674898,0.8004110741050258,1.0,26/101,20.43%,STAP1;SIRPA;VIM;AXL;CD6;CD274;PTPN22;TNIP3;LILRB1;PABPN1;TICAM1;PLAA;SERPINE1;CCL5;TNFRSF1B;RHOA;TNIP2;GIT1;NFKB1;ACOD1;PDCD4;SBNO2;PAF1;IL6;HMGB1;MTDH
prerank,regulation of viral transcription (GO:0046782),0.35698400604097136,0.9520931718313065,0.5720620842572062,0.8011469683779399,1.0,14/39,32.89%,MDFIC;POLR2H;GTF2F1;POLR2D;DHX9;TRIM21;POLR2F;TARBP2;SUPT4H1;RSF1;UBP1;HEXIM1;NELFA;TRIM11
prerank,protein localization to cilium (GO:0061512),0.3630085964902286,0.9520720954450129,0.5553021664766249,0.8008428355851974,1.0,11/32,28.29%,RABEP1;TTC21A;WDR35;SNX10;CSNK1D;IFT122;EHD1;MAPK15;TMEM107;ARL3;ARL6
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.42963419811622905,0.9520608036509008,0.5614973262032086,0.8005151950258311,1.0,4/13,20.29%,DCTPP1;NEIL2;MBD4;DUT
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.36841544820471117,0.9515455196613861,0.5647607934655776,0.8013034322156086,1.0,12/29,26.04%,EXOSC4;PATL1;EXOSC9;NT5C3B;DCP1A;LSM6;EDC4;EXOSC5;CNOT6;LSM4;EDC3;LSM3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.44205084788243265,0.9513010895356491,0.5521796565389696,0.8014661985282683,1.0,2/12,3.88%,B4GAT1;B3GNT3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.371922155887601,0.9508078115407146,0.5491124260355029,0.8021641757325367,1.0,11/26,32.99%,ATP1B3;CACNA1D;CAB39;VAMP2;ACTN2;KCNAB1;ATP1B2;ITGB1;WWP2;NEDD4;STK39
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.34498955470033743,-0.9504124165004879,0.502127659574468,0.9049648334404352,1.0,3/12,6.25%,PARP8;PARP12;PARP11
prerank,organic substance transport (GO:0071702),0.31570833924523917,0.9503606321973755,0.6012207527975585,0.8027764590056254,1.0,25/121,18.76%,MFSD12;ABCG1;ABCA1;SLC23A1;SLC48A1;HRG;CD3G;TOM1;ABCA4;SLC22A3;SLC6A4;SLC18A1;ABCA13;RAB7A;ABCD2;ABCA7;RCN3;ABCD3;SLC50A1;SLC18A2;SNX4;VAMP2;DISP1;SLC19A1;ARL6IP5
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3906265582880399,0.9503510973685296,0.554467564259486,0.8024419749033791,1.0,3/21,4.18%,STAP1;CSF1;PTK2B
prerank,circulatory system development (GO:0072359),0.3096798527734161,0.9499298571904076,0.5971370143149284,0.8030200443863085,1.0,20/118,17.65%,SH3PXD2B;FN1;MICAL2;HDAC9;AKAP13;PDLIM1;ID2;TH;FBXW7;SOX9;SMG9;MTHFD1;RBP4;TCF25;SRF;HSPG2;NF1;PKP2;MKKS;STK11
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3334014759081785,-0.9494695198843487,0.5019762845849802,0.9046911941829685,1.0,6/15,20.87%,TIPIN;NEK11;RAD17;MUS81;EME1;RAD9B
prerank,protein oxidation (GO:0018158),0.4442726987675544,0.9491737231329525,0.5569272976680384,0.804296149214137,1.0,1/11,3.55%,APOA2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4231076041853157,0.949066843071747,0.5509138381201044,0.8041697476265101,1.0,3/14,15.37%,UMPS;UPB1;CAD
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4016885145821904,0.9490004093180607,0.5478036175710594,0.8039666039099187,1.0,8/17,27.36%,ID2;EGR2;SERPINE2;TNFRSF1B;IL34;MDK;CXCR4;HES1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4268993198573084,0.9485064950211334,0.5573122529644269,0.8047261103621373,1.0,5/13,21.40%,ZBTB7B;NAPEPLD;PIM1;HNRNPU;METRNL
prerank,mitotic cell cycle phase transition (GO:0044772),0.307446694362566,0.9484170603002019,0.657314629258517,0.8045501331114336,1.0,67/203,30.14%,CDK14;CDK6;CCNY;FBXL17;OPTN;ODF2;NES;DYNC1H1;PPP2R1A;NINL;PPP1R12A;CHMP4B;PLK2;POLE;E2F3;HAUS8;CCNB1;WEE1;CEP41;DNM2;DCTN1;YWHAG;PPME1;CHMP7;PPP2R2D;ANAPC1;CDK2;CEP250;TACC3;RCC1;CSNK1D;CDC7;CCND2;PLK4;PPP6C;TUBB;CDKN3;GSPT1;HAUS2;FBXL6;CUL3;FBXW11;DBF4;CUL1;CDC34;MELK;CUL2;LATS1;ANAPC7;PLK3;CDK4;CDC25B;CUL4A;UBE2C;BTRC;CETN2;MAPRE1;EIF4E;NASP;MNAT1;HINFP;CSNK1E;CDC25A;SKP2;ALMS1;CCND1;CEP57
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.34353763400139836,0.9479543264182955,0.58006718924972,0.8052163504851714,1.0,12/43,17.47%,SH3KBP1;GRB2;MVP;PTPN2;SOCS5;RAB7A;STAM2;CDC42;CBL;CBLB;DUSP3;EPS15L1
prerank,intracellular protein transport (GO:0006886),0.3033997666762901,0.9476948122949359,0.669,0.8054323798637999,1.0,117/304,31.21%,TBC1D10C;MMP12;TBC1D22A;KIF13B;CTSA;SNX8;ARF3;GCKR;PRICKLE1;TBC1D2;IPO5;ARL1;STX6;RAB5C;EGR2;NAPA;TRAK1;RIC1;RANGRF;SIL1;E2F3;RPL11;VPS26A;LAMP2;RAB32;ARL11;NUP188;AP4E1;NXT2;WLS;RAB7A;CCHCR1;XPO1;RAB5A;LMAN1;STX3;TPR;EIF4ENIF1;GGA2;VPS26C;APPL2;AP3D1;SYK;CHP1;RAB22A;SAR1A;TBC1D22B;TLK1;RAB1A;TECPR2;VIPAS39;TBC1D12;PPP1R10;RAB3GAP2;XPO6;DESI1;ARHGEF2;LTBP2;LAPTM5;ARL4C;ARFGAP3;NUP93;SNX31;ACD;NPM1;GABARAP;TMED3;CALR;FUT10;CD74;VPS35;RAB20;TBC1D10A;NUP50;SNX1;EHD1;TNPO2;BAG3;SGSM1;TNPO1;USO1;TBC1D16;GIPC1;VPS28;GGA1;AP4S1;NUP42;NUP133;STX7;COPZ2;STX4;SURF4;TBC1D15;STX5;RAB31;NUTF2;EIF2D;TMED2;COPA;RAB5B;IPO13;ARL6;ARFRP1;PTTG1IP;SNX27;RAB43;NUP214;SNX17;RABL3;SNF8;AP3B1;SEC23IP;ARF6;BCS1L;TBC1D8B;COG7;RAB24
prerank,regulation of intracellular pH (GO:0051453),0.35691061099524174,0.9472360144345721,0.5698070374574348,0.8060748921441618,1.0,12/34,21.80%,SLC9A1;SLC9A8;CLN3;SLC4A9;SLC9A6;SLC9A7;CHP1;SLC4A2;TMEM165;GPR89A;GPR89B;SLC26A6
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4181943098163824,0.947206405294013,0.5658409387222947,0.8057854387675809,1.0,1/16,0.48%,APOE
prerank,regulation of cytoskeleton organization (GO:0051493),0.31252746800804354,0.9466708924137397,0.6018518518518519,0.8065724542815517,1.0,30/108,22.58%,IQGAP1;S100A8;S100A9;LRP1;PDGFA;HRG;PRKCD;CLIC4;DLC1;RHOD;RHOQ;CLN3;RHOG;PHLDB1;DIAPH1;RHOA;IQGAP2;CELSR1;PAK2;ROCK1;HIP1R;TESK1;PFDN2;ARHGAP17;BST2;BAIAP2;MARK2;GSK3B;TAOK1;ARHGEF5
prerank,regulation of inclusion body assembly (GO:0090083),-0.36571592356989285,-0.9465467157764315,0.4857142857142857,0.9103947899397027,1.0,2/11,10.43%,SNCAIP;DNAJA4
prerank,cartilage development (GO:0051216),0.3376729101999585,0.946368421955379,0.5779716466739367,0.8068600926990536,1.0,8/49,12.90%,ATP7A;CD44;FGF2;SNX19;RUNX1;SOX9;CREB3L2;ZBTB16
prerank,positive regulation of developmental process (GO:0051094),0.30576435674791436,0.9461032229332886,0.6497975708502024,0.8070660333723547,1.0,28/164,16.05%,B4GALT5;APOE;CORO1C;NIBAN2;DDHD1;SLC6A6;DAG1;AGO2;BMP1;ZDHHC15;LLPH;SOX9;VEGFA;FBXO5;LMNA;BASP1;CPEB3;PHLDB1;KMT5B;RBM19;ZBTB16;FZD4;DCN;NUMA1;SRF;C1QBP;TFRC;KDR
prerank,prostaglandin metabolic process (GO:0006693),-0.2768951408704387,-0.9459712498216927,0.5246913580246914,0.9091326770116144,1.0,4/26,7.60%,PTGS1;HPGD;HPGDS;PNPLA8
prerank,cardiac muscle contraction (GO:0060048),0.3585235925623284,0.9455458941686691,0.5722411831626849,0.8079168582220859,1.0,8/34,24.25%,CSRP3;GAA;GSN;SCN1B;ATP1A2;SCN3B;TNNI1;MYL4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.40884343557527414,0.9453745551602334,0.5561426684280053,0.8079345052428821,1.0,3/14,13.49%,PTPN2;DDB1;SLC45A3
prerank,outflow tract septum morphogenesis (GO:0003148),0.3736977987736912,0.9453154694767796,0.571767497034401,0.8077121154684169,1.0,6/24,23.64%,NRP2;NRP1;PARVA;BMP4;TGFBR2;FGFR2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.31909323013545654,-0.945158067688041,0.5350877192982456,0.9086348088916469,1.0,5/15,13.05%,CEP192;CCDC14;C2CD3;STIL;CEP131
prerank,recombinational repair (GO:0000725),0.3187207349263586,0.9448422552210242,0.5865687303252886,0.8083993823227944,1.0,23/77,26.25%,RAD51B;NSMCE2;AP5Z1;RMI1;BRCA1;RAD50;PSMD14;BLM;YY1;INO80;ERCC4;SLX4;SEM1;KDM4D;MORF4L1;RAD51AP1;RECQL5;MCM8;NSMCE1;GEN1;SMC6;PALB2;LIG3
prerank,dendritic cell migration (GO:0036336),-0.3174712994037744,-0.9447270396989302,0.5414847161572053,0.9070386439276674,1.0,6/16,12.13%,ALOX5;EPS8;CCR5;CCR1;TRPM4;CCR6
prerank,negative regulation of locomotion (GO:0040013),0.42791010587480804,0.9446269165248217,0.5609103078982597,0.8085269325998622,1.0,6/12,22.39%,GATA3;PTPN2;FBLN1;DUSP3;PIN1;WAS
prerank,neuron fate commitment (GO:0048663),0.416123808410345,0.9446031112374186,0.5776315789473684,0.8082317750056025,1.0,2/14,11.71%,ID2;DLL4
prerank,regulation of fatty acid oxidation (GO:0046320),0.4040206087704499,0.9445699838840778,0.5470514429109159,0.807963052934109,1.0,6/16,25.89%,NR4A3;SOX9;APPL2;SIRT4;ACADL;ABCB11
prerank,calcium-mediated signaling (GO:0019722),0.31385566859695696,0.9445127075887784,0.6035564853556485,0.8077389162008917,1.0,18/93,16.34%,P2RX4;SLC9A1;FPR2;PTPRC;LAT;CXCR2;PPP1R9B;MCTP1;PTGFR;SPHK1;PDPK1;TPCN2;RCAN1;CCR2;RCAN3;MCTP2;KDR;LAT2
prerank,positive regulation of protein metabolic process (GO:0051247),0.3130690830432564,0.9435757469425395,0.6184615384615385,0.809367190628928,1.0,38/110,28.55%,APOE;CSF1;ATG7;EIF4G1;C4BPA;C4BPB;SEC22B;RASGRP1;PLK2;FZR1;RANBP9;VCP;DDB1;OAZ3;RAB7A;HUWE1;TIPARP;CLU;VIP;FOXO1;BARD1;RAB1A;WFS1;GSK3B;RNF41;MAPK7;IL17D;TNF;MAP2K5;VPS28;TLR9;RILP;STX5;GSK3A;DACT1;TNFAIP3;MTPN;WWP2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.43342190325143426,0.9431788391438143,0.552665799739922,0.8098463353402986,1.0,7/12,33.18%,GART;ATIC;ADSS1;PPAT;ADSL;GMPS;ADSS2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3444375961697273,-0.9427257051083306,0.5204918032786885,0.9099673161537061,1.0,3/13,11.27%,NR3C2;PLPP1;PGR
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3735321437254003,-0.9426352278171642,0.521311475409836,0.9073576166617611,1.0,5/10,21.04%,SLC1A3;SLC25A12;PRAF2;SLC1A1;SLC1A2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.2124046322819293,-0.9426039179400403,0.5952380952380952,0.9046114736964599,1.0,21/73,19.77%,CRIM1;BMPER;ACVR2B;RBPJ;BMPR1B;PCSK6;SORL1;SMURF1;SMURF2;UBE2O;VWC2;XIAP;BMP2;ENG;LRP2;SFRP4;ACVR2A;SULF1;FOXD1;FBXL15;TFAP2B
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.30705761864004194,0.9422885073866889,0.6372847011144883,0.8114377332340361,1.0,39/140,22.58%,MYO9B;ABR;ARHGAP25;ARHGAP21;ARHGAP10;ARHGAP24;GNA13;AKAP13;A2M;SQSTM1;DLC1;ARAP2;RHOD;RHOQ;ARHGAP6;ARHGAP19;ARHGEF1;RHOG;ARHGEF18;RHOA;RHOU;CDC42;ARHGAP12;ARHGEF11;RACGAP1;KALRN;FAM13B;PIK3R2;ARHGAP30;ARHGAP9;ARHGAP17;RHOT2;ARHGEF2;MYO9A;GMIP;ARHGDIB;SRGAP1;PLEKHG2;ARHGEF5
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30875559493316646,0.9419184259780525,0.6367305751765893,0.811881472786887,1.0,43/144,25.91%,BCL2;FLNA;GZMB;FBXW7;PRKCD;BID;IPO5;TRIM28;UBE2L3;CDH1;RUFY3;JUP;FYN;HUWE1;YWHAG;BAP1;RHOU;VPS11;GAS6;TPR;ITGB2;CHP1;SAR1A;MICALL2;PIK3R2;VAMP2;YWHAB;UBL5;PPP3CC;CSNK2A2;ITGB1BP1;SAE1;GSK3B;USP36;RBM22;PPP3R1;ANP32B;PRR5L;BAG3;PLK3;YWHAZ;HDAC3;ZPR1
prerank,protein ADP-ribosylation (GO:0006471),0.36792282804317183,0.9417949207932796,0.5623529411764706,0.8117835798841737,1.0,12/28,26.04%,PARP4;TNKS2;SIRT5;ART4;HPF1;TIPARP;ZC3HAV1;SIRT4;PARP3;PARP2;SIRT3;PARP16
prerank,positive regulation of translational initiation (GO:0045948),0.39909675797532124,0.9415951398027775,0.5668711656441717,0.8118529860469184,1.0,6/18,21.96%,CCL5;YTHDF3;LARP1;POLR2D;YTHDF2;CDC123
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.34963342886856086,-0.9412846965833946,0.49333333333333335,0.9056881137566578,1.0,4/12,14.86%,GLUD1;IDH3B;ACO1;IREB2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3081370809382641,-0.941267045575453,0.4835164835164835,0.9029310327299319,1.0,3/18,6.54%,IL6R;MTUS1;CAMK1D
prerank,negative regulation of biosynthetic process (GO:0009890),0.4015976701958872,0.9412056477437842,0.5623342175066313,0.8123048127065005,1.0,6/16,21.63%,ABCD2;TRAP1;SLC18A2;IL6;EMILIN1;ABCB7
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3348616164667908,0.941202781005202,0.580110497237569,0.8119602373246929,1.0,16/49,25.85%,CD2;APOA2;SERPINE1;DDIT3;PRKD2;TIRAP;SYK;RAB1A;IL6;HMGB1;LBP;F2R;CD74;IL17D;TNF;TLR9
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.44595462659488294,0.9402174891157219,0.5687074829931973,0.8136906128062922,1.0,3/10,12.70%,NPTN;SYNGR1;RAB5A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3115418657217341,0.9402141057948858,0.6391437308868502,0.8133452945052018,1.0,17/110,15.59%,ABCA1;PTGIR;GNA13;ADCY8;ADCY3;PTGFR;GNAQ;ADCY7;ADGRB1;ADGRG5;IAPP;ADGRE5;ADGRG7;ADORA2A;LPAR1;GLP1R;VIP
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.37274824727408884,0.9398643622402991,0.5566150178784267,0.8137206550070389,1.0,6/25,19.41%,SDCBP;LRPAP1;ANKRD13B;APOC1;ANKRD13A;ATXN2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.43854356209054557,0.939840466476846,0.5525238744884038,0.8134188616147122,1.0,3/10,15.78%,RNF125;RIOK3;C1QBP
prerank,regulation of cell division (GO:0051302),0.32229538758798487,0.9394883640734311,0.6175847457627118,0.8138181225979317,1.0,29/72,31.41%,BCL2L1;PLK2;AHCTF1;PRDM15;RACK1;KLHL13;BIRC6;KIF20A;BLM;GIT1;PLK4;RAB11A;PIN1;RAB11FIP4;HTR2B;EFHC1;CALM3;FGFR2;SMYD5;PLK3;FGF1;KLHL21;CDK2AP2;CETN2;PRPF40A;BECN1;SIRT2;MYO19;CALM1
prerank,regulation of interferon-beta production (GO:0032648),0.3384047984177898,0.9394789981944657,0.5870044052863436,0.8134892158016159,1.0,10/46,18.34%,SIRPA;NLRC3;TRAF3;LILRB1;POLR3D;IRF5;RIOK3;YY1;TIRAP;DHX9
prerank,cellular response to radiation (GO:0071478),0.34304563476420463,0.9394680389472434,0.5851183765501691,0.8131561864386775,1.0,12/40,24.51%,TANK;FIGNL1;GRB2;EEF1D;RRH;BLM;INO80;KDM4D;RAD1;RAD51AP1;INTS7;GADD45A
prerank,regulation of cartilage development (GO:0061035),0.3965336312446006,0.9391789583629016,0.5526641883519207,0.8134480128839863,1.0,4/18,12.90%,SCIN;BMP1;SOX9;ZBTB16
prerank,response to thyroid hormone (GO:0097066),0.4214067664111801,0.9383341908728828,0.5697674418604651,0.8149111391346835,1.0,1/13,0.35%,CTSB
prerank,nucleocytoplasmic transport (GO:0006913),0.35133264761622307,0.9379680492453414,0.5739710789766407,0.8153168178154833,1.0,16/40,27.56%,NUP205;MALT1;ATXN1;NXT2;XPO1;HTATIP2;RBM15B;AAAS;NPM1;SNRPG;GEMIN8;SNRPF;NUP98;GEMIN2;GEMIN5;NUTF2
prerank,coenzyme A metabolic process (GO:0015936),-0.32165316248089754,-0.9378735358551173,0.5477178423236515,0.9098047221242216,1.0,3/14,5.60%,PANK4;PANK1;PPCDC
prerank,L-serine metabolic process (GO:0006563),-0.36485636409059463,-0.9373196943762934,0.5220883534136547,0.9085327573255,1.0,1/10,0.23%,SERINC3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.280397949393586,-0.936899655363105,0.5714285714285714,0.9068667214894091,1.0,4/24,4.88%,WASF2;PIK3R1;TWF2;NCKAP1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3529850337597921,0.9368691254392407,0.5924225028702641,0.8172815498804349,1.0,10/37,24.72%,SDCBP;RPS7;RPL23;RPL11;OGT;CCAR2;CSNK2A2;HSP90AB1;EIF3H;GIPC1
prerank,integrated stress response signaling (GO:0140467),0.41111001693956256,0.9365723916841238,0.5809399477806788,0.8175706572692111,1.0,5/14,24.97%,NFE2L2;EIF2S1;DDIT3;ATF4;HSPA5
prerank,cellular response to nitrogen compound (GO:1901699),0.38256569341852614,0.9357512275190105,0.5519399249061326,0.8189270837781802,1.0,6/20,21.28%,DAXX;RIOK3;DDI2;BLM;ATRX;HSF1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.38454337062813415,0.9355181829292536,0.5815147625160462,0.8190667440911739,1.0,6/21,21.63%,SIRT5;BRCA1;ABCD2;TRAP1;SLC18A2;ABCB7
prerank,ceramide catabolic process (GO:0046514),0.410203932514938,0.9352809786866131,0.562992125984252,0.8191865233621534,1.0,4/14,19.03%,HEXA;GLA;NEU1;ASAH1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.36612930202098765,0.9350503991745814,0.5805288461538461,0.8193294635892292,1.0,11/25,32.55%,BRD4;EAPP;CDK13;WDR43;HNRNPU;EAF1;RECQL5;SUPT4H1;LEO1;HEXIM1;NELFA
prerank,positive regulation of interleukin-1 production (GO:0032732),0.33248395404226244,0.9346342980827649,0.5907127429805615,0.8198768119476646,1.0,13/51,25.47%,LPL;MALT1;PANX1;HSPB1;TRIM16;TMEM106A;IL6;HMGB1;EGR1;USP50;JAK2;TNF;AIM2
prerank,non-motile cilium assembly (GO:1905515),0.36183751929497915,0.9334033137098788,0.5729166666666666,0.8220691871251375,1.0,13/30,29.74%,BBS10;DCTN1;TBC1D32;CEP250;IFT88;CSNK1D;TMEM216;IFT122;TMEM107;TMEM17;RPGRIP1;GORAB;PIBF1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4128871808798512,0.9328150566689413,0.5831202046035806,0.8229809339025942,1.0,5/14,19.64%,HNRNPC;MAPKAPK2;YBX3;TIRAP;TARDBP
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3304278664627501,0.9327620161109432,0.597860962566845,0.8227394613608554,1.0,23/56,30.41%,ANXA1;RAD51B;NSMCE2;EIF4G1;BRD4;FBXO5;ADAM17;CCNB1;VPS4B;STOX1;CDC7;CCND2;RAB11A;CUL3;ANAPC7;CDK4;CDC25B;UBE2C;ESPL1;KLHL18;CDC25A;CCND1;LSM11
prerank,import into nucleus (GO:0051170),0.32095678864180904,0.9322329430863366,0.6139240506329114,0.8235038460177406,1.0,27/73,29.19%,MMP12;GCKR;PRICKLE1;IPO5;E2F3;NUP188;NXT2;TPR;EIF4ENIF1;APPL2;HTATIP2;SYK;PPP1R10;NUP93;NUP50;SNRPG;TNPO2;GEMIN8;TNPO1;SNRPF;GEMIN2;NUP133;GEMIN5;NUTF2;IPO13;PTTG1IP;NUP214
prerank,phospholipid metabolic process (GO:0006644),0.3193958444854117,0.9318719366550937,0.6175213675213675,0.8238998121464546,1.0,8/71,9.61%,LPL;PLAAT3;APOA2;ABHD12;PLPP3;FADS1;PLCB2;PLAA
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.426017530739928,0.931823457523836,0.5826666666666667,0.8236372502336006,1.0,6/12,25.93%,ACTG1;CELSR1;ACTB;LAMA5;LAMA3;TRAF3IP1
prerank,mRNA destabilization (GO:0061157),0.3449496967445605,0.9318023855777924,0.6095890410958904,0.8233259202653519,1.0,17/38,32.21%,CELF1;CPEB3;METTL3;YTHDF3;ROCK1;POLR2D;YTHDF2;DHX36;PUM1;TARDBP;ZC3H12D;GIGYF2;KHSRP;RC3H1;RIDA;PLEKHN1;ZC3H12A
prerank,protein export from nucleus (GO:0006611),0.36357901179072394,0.9317245302629589,0.5934195064629847,0.8231399106195888,1.0,12/27,29.19%,EGR2;CCHCR1;XPO1;TPR;CHP1;XPO6;DESI1;CALR;DUSP16;NUP42;NUTF2;NUP214
prerank,response to metal ion (GO:0010038),0.32163087575778654,0.9315814773502041,0.614572333685322,0.8230939205088912,1.0,5/67,6.49%,BCL2;HIF1A;ANXA11;CAV1;KCNMA1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.34526074038796395,0.9315336555995883,0.6140350877192983,0.8228448222505577,1.0,8/39,16.74%,GTPBP4;JAG1;FXYD5;VEGFA;CDH1;MBP;MYADM;BMP6
prerank,regulation of establishment of cell polarity (GO:2000114),0.40508272282292607,0.9314131844580541,0.577120822622108,0.8227653726039628,1.0,8/16,18.45%,RIPOR2;PTK2B;RACK1;RUFY3;GSN;ROCK1;KRIT1;ARFGEF1
prerank,membrane repolarization during action potential (GO:0086011),0.42140611558586394,0.9314058208416481,0.5717948717948718,0.8224288907437641,1.0,2/13,7.23%,KCNJ2;ATP1A1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3446346149525975,-0.931367405984938,0.5492424242424242,0.9196177616178617,1.0,5/10,27.12%,CD81;FCGR2B;TLR8;GAPT;CD19
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.438079573149676,0.9310947991316597,0.5784313725490197,0.822716628725044,1.0,5/10,23.64%,PDGFA;SOX9;CHRD;TGFBR2;FGFR2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4153941546836689,0.9310417146170498,0.584573748308525,0.8224781482479441,1.0,2/13,6.75%,PRICKLE1;SOX9
prerank,negative regulation of JNK cascade (GO:0046329),0.3544898696827892,0.930999849105814,0.5873388042203986,0.8222137148068017,1.0,4/31,6.08%,SIRPA;NPPA;TAOK3;PTPN22
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.33707461501351094,0.9308350523325434,0.6004439511653719,0.8222009392202247,1.0,7/43,9.10%,IGF1;LTF;NELL1;SUCO;FBXO5;IFITM1;ATP6AP1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30620246828754677,0.9306190077737435,0.6629889669007021,0.8222831291631418,1.0,55/166,30.02%,HDAC9;HDAC7;NPPA;NR4A3;VDR;NCOR2;TAF1D;PPARG;TAF4B;HDAC1;POLR1G;POLR2H;GTF2A2;NRBF2;PPARD;E2F3;UBTF;TBPL1;MED17;MAML2;TAF15;GTF2F1;POLR2D;NR4A2;POLR1A;TBP;GTF2H1;TAF7;TAF6;NR3C1;TAF1A;RXRB;TEAD1;TAF1C;MED7;GTF2E2;RXRA;POLR1F;POLR2F;GTF2H5;NOTCH4;HDAC3;NR6A1;SNW1;NR2C2AP;RSF1;MAPK3;MNAT1;CRCP;RXRG;MED1;MAZ;POLR1H;CCN2;MED27
prerank,negative regulation of potassium ion transport (GO:0043267),0.42206131396550134,0.9303880522680045,0.5701298701298702,0.8224079168308317,1.0,5/13,19.78%,PTK2B;CAV1;CAB39;VIP;ACTN2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4427540989913016,0.9302177910477526,0.5780590717299579,0.8224368540358667,1.0,2/10,6.37%,SPHK2;GATA3
prerank,protein mannosylation (GO:0035268),-0.28900157549389294,-0.9299946988849822,0.5425531914893617,0.9207104712768619,1.0,5/22,7.89%,TMTC2;POMT2;TMTC3;TMTC1;FKRP
prerank,positive regulation of T cell migration (GO:2000406),0.3892193777948817,0.9298216581269791,0.5803680981595092,0.8229060016933221,1.0,5/20,11.87%,SPN;ADAM17;CCR2;CCL5;RHOA
prerank,receptor clustering (GO:0043113),0.36308096606477347,0.9290988420897512,0.5834333733493398,0.8240609109422542,1.0,4/27,5.81%,FLNA;ITGAL;ITGA4;LRP4
prerank,smoothened signaling pathway (GO:0007224),0.3514780211998706,0.9290984945230841,0.5887096774193549,0.8237105320870406,1.0,5/32,11.27%,DHH;DYRK2;PTCHD1;HIPK1;TCTN3
prerank,necroptotic process (GO:0070266),0.3942817671061233,0.9290619024113165,0.5769230769230769,0.8234395230726894,1.0,4/16,17.41%,MLKL;TICAM1;TRPM7;RIPK3
prerank,cellular response to estrogen stimulus (GO:0071391),0.40492741396550636,0.9288069388537454,0.5832258064516129,0.8236242988673383,1.0,4/14,25.13%,SERPINB9;WBP2;TRIM24;SFRP1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2954571661693801,-0.9286003581457937,0.5754189944134078,0.9218344630852153,1.0,7/20,20.88%,RAPGEF2;ADRB1;ADCY9;GPR101;PDE4D;ADRA1A;ADRA2A
prerank,smooth muscle cell differentiation (GO:0051145),0.4148643155864644,0.9283285375584921,0.5718157181571816,0.8242833780796541,1.0,3/12,12.21%,MRTFA;TBX18;MRTFB
prerank,protein destabilization (GO:0031648),0.35173702953869596,0.9280308150162935,0.5829383886255924,0.8245427038706092,1.0,14/32,31.85%,CCDC88C;HTT;PEX2;GSN;DERL1;CUL3;FBXW11;TRIM21;MDM2;BTRC;SIRT1;MUL1;EP300;CREBBP
prerank,autophagy of mitochondrion (GO:0000422),0.34441257285741866,0.92796590887865,0.6009122006841505,0.8243385949375283,1.0,16/38,30.12%,ATG7;SQSTM1;WDR45;MAP1LC3B;FBXO7;ATG2B;MARK2;MAP1LC3A;GABARAP;BNIP3;ATG3;ATG13;USP30;AMBRA1;FIS1;BECN1
prerank,dopamine metabolic process (GO:0042417),0.3924122873359317,0.9278808578021182,0.5777777777777777,0.8241576368156099,1.0,2/18,3.76%,ATP7A;TH
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.31880298020485154,-0.9269795812669996,0.5276381909547738,0.9236187163878988,1.0,8/16,30.99%,KLHL15;POLQ;SHLD3;MAD2L2;SHLD2;SHLD1;HELB;FANCB
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35097391930881366,0.9269122459233327,0.5761363636363637,0.8257410130240209,1.0,8/33,13.29%,PKM;ITGA5;PIK3CB;FGF2;PDPK1;VEGFA;JAK1;SMAD1
prerank,activin receptor signaling pathway (GO:0032924),-0.32401762019340863,-0.92679982234378,0.5555555555555556,0.9213991467329733,1.0,7/15,28.47%,ACVR2B;INHBA;ACVR1B;ACVR2A;AMHR2;SMAD3;TGFBR1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.38531501717026795,0.9267845582082447,0.5703703703703704,0.8256544775275434,1.0,3/18,8.66%,HDAC4;HDAC1;BHLHE41
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2853949070601735,-0.9267459178633387,0.5617977528089888,0.9188090740030138,1.0,5/20,16.35%,FDXR;TSPOAP1;STAR;STARD3;CYP46A1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.39084257763315844,0.9266597741945742,0.580964153275649,0.8255476651052157,1.0,5/17,25.88%,CHAMP1;IK;KNL1;SPDL1;CENPA
prerank,fatty acid metabolic process (GO:0006631),0.30516302744610996,0.9259840669559583,0.6387755102040816,0.8266047479638164,1.0,17/115,12.77%,LPL;ACACA;CEL;ACSBG1;SLC27A5;PON1;ACSBG2;PPARG;ECHDC3;ACSL1;PEX2;PPARD;ALKBH7;CRAT;ACOT6;ABCD2;HSD17B8
prerank,sodium ion import across plasma membrane (GO:0098719),0.39704098269659704,0.9259035629934006,0.5900621118012422,0.8264180215694554,1.0,4/17,14.73%,SLC9A1;SLC5A1;SLC9A6;SLC9A7
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.29665668803910017,-0.925623554381322,0.6111111111111112,0.9162797751319757,1.0,7/20,21.39%,MCCC2;BCKDHB;DLD;ALDH6A1;BCKDHA;IVD;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.29665668803910017,-0.925623554381322,0.6111111111111112,0.9162797751319757,1.0,7/20,21.39%,MCCC2;BCKDHB;DLD;ALDH6A1;BCKDHA;IVD;AUH
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4000788838472325,0.9254061866997395,0.6033810143042913,0.8270928647235088,1.0,8/15,33.38%,ERN1;DDX1;TSEN15;CSTF2;RTRAF;TSEN2;CLP1;RTCB
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.28954532299332625,-0.9253755800581381,0.5634517766497462,0.9141884268996334,1.0,4/21,5.77%,RAP1GDS1;SLC8A3;TGM2;MICU3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.30965597256797106,-0.9253000250780685,0.5428571428571428,0.9117169607410864,1.0,2/17,0.53%,CACNB2;CACNA2D1
prerank,icosanoid secretion (GO:0032309),0.42945360385849635,0.9252988455695371,0.5887096774193549,0.8269739534024767,1.0,1/12,1.53%,ANXA1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.27203825885613353,-0.9248655158533116,0.6129032258064516,0.9102254428675317,1.0,5/26,5.45%,CCND3;FGF10;PLCB1;RPTOR;AIF1
prerank,neural tube closure (GO:0001843),0.34750119323442685,0.9248547411041584,0.6034285714285714,0.8275339237887757,1.0,9/34,21.13%,DEAF1;LMO4;PRICKLE1;DLC1;CELSR1;MTHFD1;LRP6;VASP;IFT122
prerank,cellular response to purine-containing compound (GO:0071415),-0.36776510664524736,-0.9248029074293904,0.5130111524163569,0.9077302267398892,1.0,7/10,32.73%,RYR3;P2RY6;TRPM2;CASQ2;SLC8A1;CACNA1S;RYR1
prerank,regulation of exit from mitosis (GO:0007096),0.34213047755533493,0.9246752623960102,0.5873192436040044,0.8275462200385839,1.0,9/38,19.77%,UBA52;PPP1R9B;RPS27A;ANAPC15;ANAPC1;CDC26;MAD2L1BP;BUB1B;UBC
prerank,axonal fasciculation (GO:0007413),-0.3384497189961597,-0.9245885466777449,0.5591836734693878,0.9055809859820174,1.0,2/12,2.77%,EPHA4;CNTN4
prerank,translesion synthesis (GO:0019985),0.33848819721401896,0.924362979658436,0.6128318584070797,0.8278442939618589,1.0,18/42,35.67%,UBA52;RPS27A;VCP;UBE2L6;RFC1;UBC;REV1;RFC2;POLD4;RCHY1;RFC4;ZBTB1;UBB;RFC5;PCNA;REV3L;PCLAF;POLK
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3052163075866216,0.9243258955564558,0.6369230769230769,0.8275733704852738,1.0,30/117,26.30%,IGF1;LPL;ACSBG2;PPARG;SLC6A8;ECHDC3;MTHFS;PPARD;ALKBH7;SCPEP1;LDHA;ACOT6;ME2;NPC1;SLC16A3;GLYAT;AASDHPPT;GBA2;PDHB;PDZD11;SLC16A1;KYNU;CPT1A;FASN;PDHX;ACOT1;ME1;ABCB11;HLCS;DLAT
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.23274413924252765,-0.9239990424846012,0.609375,0.9044378492467812,1.0,27/56,22.17%,ANLN;ROCK2;MYH10;SPIRE1;TRIM36;STMN1;APC;NUSAP1;SPTBN1;KIF4A;ECT2;KIF23;SPAST;INCENP;SEPTIN9;AURKB;CKAP2;PLK1;CECR2;ANK3;RHOB;CIT;CEP55;DCTN3;RAB35;MITD1;BBS4
prerank,gene silencing by miRNA (GO:0035195),0.35391198643619964,0.9238861360974222,0.6006825938566553,0.8281381800866181,1.0,8/32,20.73%,AGO2;EIF6;ZC3H7B;SNIP1;PUM1;AGO3;ADAR;CNOT6
prerank,positive regulation of macrophage migration (GO:1905523),-0.29429097439293844,-0.9238699282600658,0.5849056603773585,0.9021017824121826,1.0,2/19,0.16%,P2RY12;CSF1R
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3952618833975011,0.9231335953547375,0.5816993464052288,0.8293570091517112,1.0,5/16,18.34%,HNRNPM;DDX17;CDK13;PUF60;DHX9
prerank,spliceosomal complex assembly (GO:0000245),0.327740295624143,0.9230815644337326,0.602436323366556,0.8291168204233447,1.0,17/46,28.26%,SRPK1;LUC7L2;ZRSR2;CELF1;DDX1;DDX39B;PUF60;PRPF6;CELF6;GCFC2;SRPK2;SF3A3;SNRPG;SF3B1;NOL3;SRSF1;SRSF10
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3478566970127064,0.9220661320179196,0.6076388888888888,0.8308679608716215,1.0,3/32,6.23%,P2RX4;CAV1;PDPK1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4379641663124208,0.9217401904030369,0.589041095890411,0.8311720611282982,1.0,4/10,13.01%,RAP2A;MSN;RHOA;CDC42
prerank,cGMP metabolic process (GO:0046068),0.419125909957809,0.9216509290032039,0.5975609756097561,0.8310157752680446,1.0,3/12,19.99%,NPPA;NPR2;NPPC
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3706458715978645,0.9213170155452073,0.5804020100502513,0.831350965085794,1.0,4/21,14.78%,TEDC1;TEDC2;ARMC9;EVC
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3213088607038908,0.9212538731019887,0.6596858638743456,0.831135386226997,1.0,26/72,31.23%,FGF2;GRB2;HNRNPM;POLR2H;FGF7;FGF20;GTF2F1;POLR2D;RBFOX2;CBL;HNRNPF;SPRED2;FGFRL1;FGF18;FGFR3;FGFR2;POLR2F;FLRT2;FGF1;KIF16B;MAPK3;TIAL1;SHOC2;CEP57;GALNT3;MAPK1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3756234235226814,0.9212281398769954,0.5853051058530511,0.8308370208456309,1.0,7/20,31.41%,SLC9A1;ATP1A2;ATP2A2;CALM3;FKBP1B;GSTO1;CALM1
prerank,cell junction assembly (GO:0034329),0.3089983272547727,0.9207985719399269,0.654994850669413,0.8313592142344625,1.0,17/100,14.00%,FBLIM1;FN1;TLN1;FLNA;PCDHB10;PKP1;PKP4;CDK5;LIMS2;ACTG1;CDH1;ILK;PLXND1;RHOA;CDC42;PCDHB11;ACTB
prerank,microtubule anchoring (GO:0034453),0.4203081018059406,0.9204267712178215,0.5859788359788359,0.831745667993016,1.0,3/12,12.06%,DAG1;BCCIP;GCC2
prerank,regulation of actin filament-based process (GO:0032970),0.31533481433719635,0.9198994339189558,0.6409431939978564,0.8324357722834587,1.0,22/70,24.43%,IQGAP1;LRP1;PDGFA;HRG;PRKCD;DLC1;RHOD;RHOQ;RHOG;RHOA;IQGAP2;CELSR1;ROCK1;HIP1R;TESK1;ARHGAP17;BST2;BAIAP2;TAOK1;ARHGEF5;CCDC88A;RHOF
prerank,phospholipid dephosphorylation (GO:0046839),-0.24093923919971905,-0.9198219046710137,0.6166666666666667,0.9105757911697576,1.0,12/37,16.34%,PLPPR4;MTMR9;SACM1L;PLPP1;SGPP1;MTMR7;INPP5J;INPP5K;PLPP4;EPHX2;INPP5B;PLPP2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3874140418201892,0.9195078971315398,0.6047678795483061,0.832862219164658,1.0,7/17,29.06%,ATP5MG;STOML2;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1
prerank,regulation of mitochondrion organization (GO:0010821),0.3283296602881346,0.9194637701000504,0.6160520607375272,0.832604079463235,1.0,24/47,31.50%,ATP13A2;MGARP;SQSTM1;FBXW7;TREM2;IAPP;INF2;STOX1;PRMT6;HAX1;CSNK2A2;RHOT2;SREBF1;GSK3B;USP36;VPS35;PARL;GOLPH3;GSK3A;FIS1;MUL1;MFF;MYO19;EP300
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.30400799466369827,0.9185935649094115,0.680161943319838,0.8339580272339494,1.0,48/138,31.85%,HDAC9;HDAC7;NPPA;NR4A3;VDR;NCOR2;PPARG;TAF4B;HDAC1;POLR2H;GTF2A2;NRBF2;PPARD;E2F3;MED17;MAML2;TAF15;GTF2F1;POLR2D;NR4A2;TBP;GTF2H1;DR1;TAF7;TAF6;NR3C1;RXRB;TEAD1;MED7;GTF2E2;RXRA;POLR2F;GTF2H5;NOTCH4;HDAC3;NR6A1;SNW1;NR2C2AP;MNAT1;RXRG;MED1;MAZ;CCN2;MED27;ERCC2;NR4A1;RARG;CREBBP
prerank,DNA modification (GO:0006304),0.37385447270124333,0.9185109661569061,0.6165865384615384,0.8337772250050721,1.0,9/22,27.07%,EXOSC4;NEIL2;MBD4;PARP3;EXOSC5;TERF1;ACD;PARP2;TERF2IP
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4193985040422175,0.917688737021754,0.58,0.8351192615033652,1.0,4/12,20.15%,MCM7;MCM2;CDC7;MCM6
prerank,sulfation (GO:0051923),-0.34723564822135816,-0.9175207957022757,0.528957528957529,0.9141544777940154,1.0,1/11,0.73%,HS3ST5
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3301379503072212,0.9174489726149109,0.6094276094276094,0.8352648888655331,1.0,10/43,22.53%,TAOK3;FZR1;FOXN3;ABRAXAS1;BRCA1;BLM;UIMC1;ATM;TAOK1;TOPBP1
prerank,histone H4-K8 acetylation (GO:0043982),0.40167439685569445,0.9174289498454868,0.589974293059126,0.8346058294802251,1.0,7/15,27.05%,ING4;WDR5;OGT;JADE3;KAT7;HCFC1;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.40167439685569445,0.9174289498454868,0.589974293059126,0.8346058294802251,1.0,7/15,27.05%,ING4;WDR5;OGT;JADE3;KAT7;HCFC1;KANSL1
prerank,regulation of ossification (GO:0030278),0.3402911267587034,0.9166973572440165,0.6143867924528302,0.8357023220252625,1.0,8/36,17.24%,ANKH;CYP27B1;LRP4;SOX9;ECM1;ZBTB16;LRP6;DDR2
prerank,neuron development (GO:0048666),0.30207437476161547,0.9166335762048273,0.6808510638297872,0.8354784890233588,1.0,36/141,21.49%,B4GALT5;APOE;ERCC6;BLOC1S3;LRP12;ATP7A;PPP1R9B;ATXN10;UNK;GPRIN1;GRXCR1;CDK5;RUNX1;UGCG;DTNBP1;FRYL;TBC1D23;MYOC;DCX;ROCK1;STX3;TBC1D24;DOCK7;SRF;MICALL2;THOC2;HS6ST1;RAB11A;IL6;GBA2;CDK16;HMGB1;GPRIN3;PBX1;GSK3B;RUNX3
prerank,regulation of TOR signaling (GO:0032006),0.31895753436705393,0.9163908579406348,0.6357827476038339,0.8356129770529718,1.0,22/67,30.15%,RRAGD;SMCR8;TREM2;NPRL2;GAS6;UBR2;FAM83D;NPRL3;LARS1;GOLPH3;RRAGC;HDAC3;LAMTOR3;PIH1D1;GSK3A;RICTOR;FNIP1;LAMTOR1;GNA12;TMEM127;SIRT1;RRAGB
prerank,aorta development (GO:0035904),0.4081845600953856,0.916288597439868,0.583969465648855,0.835482495792046,1.0,4/14,19.29%,LRP1;JAG1;EFEMP2;HECTD1
prerank,7-methylguanosine RNA capping (GO:0009452),-0.25468668203227585,-0.9162145572089387,0.6439393939393939,0.9122882117817481,1.0,8/31,12.10%,GTF2H2;RAMAC;GTF2H3;POLR2C;CMTR1;POLR2L;POLR2J;ERCC3
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.25468668203227585,-0.9162145572089387,0.6439393939393939,0.9122882117817481,1.0,8/31,12.10%,GTF2H2;RAMAC;GTF2H3;POLR2C;CMTR1;POLR2L;POLR2J;ERCC3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3860839859537551,0.9159928084705015,0.5791457286432161,0.8357325892627108,1.0,6/18,20.86%,MMP9;CAV1;CAB39;ATP1A2;SLC43A2;EPO
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3122240328143064,0.9154493284763844,0.6426264800861141,0.8364818660387761,1.0,6/69,4.83%,BCL2;APOE;HIF1A;ADAM8;PTK2B;CPEB4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.39286871990809286,0.914943995330102,0.6113924050632912,0.8371814515240739,1.0,7/17,34.30%,SRD5A3;MPDU1;DPAGT1;NUS1;ALG1;DOLPP1;ALG13
prerank,mitochondrion disassembly (GO:0061726),0.34600809611710315,0.914329642850113,0.6127167630057804,0.8380702337300745,1.0,15/34,30.12%,ATG7;SQSTM1;WDR45;MAP1LC3B;FBXO7;ATG2B;MARK2;MAP1LC3A;GABARAP;BNIP3;ATG3;USP30;AMBRA1;FIS1;BECN1
prerank,membrane depolarization during action potential (GO:0086010),0.36280655115548943,0.9139257455328201,0.6011695906432749,0.8385072520727122,1.0,6/26,16.20%,SCN4A;KCNJ2;SCN1B;CACNA1D;ATP1A2;SCN3B
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40952761904698526,0.9138724116211,0.5931972789115646,0.8382650987753363,1.0,3/12,13.30%,SDE2;FBXO31;CDK2
prerank,protein import into peroxisome membrane (GO:0045046),0.36958022883262853,0.9133239399166562,0.6057692307692307,0.8390326271696102,1.0,11/22,29.57%,PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14;PEX19;FIS1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.38160594566148565,0.9132685498287388,0.6144278606965174,0.8384344312532015,1.0,8/21,25.61%,ERCC1;DDB2;DDB1;XPA;ERCC4;GTF2H1;GTF2H5;CUL4A
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.38160594566148565,0.9132685498287388,0.6144278606965174,0.8384344312532015,1.0,8/21,25.61%,ERCC1;DDB2;DDB1;XPA;ERCC4;GTF2H1;GTF2H5;CUL4A
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.37284101020227944,0.9129867498511954,0.6024844720496895,0.838650876682167,1.0,5/20,12.28%,BCL2L1;DAB2;RHOQ;PKDCC;TMBIM1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.35512073620159335,0.9129784141736607,0.5944976076555024,0.8383219954516425,1.0,11/26,29.22%,NFE2L2;HSPB1;FYN;PPIA;FBXO7;SOD2;MAPK7;ATF4;TXN;NOL3;SIRT1
prerank,rRNA transcription (GO:0009303),-0.29949582055724083,-0.9129465531747867,0.5643564356435643,0.9184634027723236,1.0,4/17,7.24%,GTF3C2;BRF1;GTF3C1;GTF3C6
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.26572911426076373,-0.9126332184751762,0.5902777777777778,0.9166435562757752,1.0,8/27,14.07%,SYT10;RIMS1;SDF4;SYT1;SYT2;RIMS2;PPP3CB;SYT9
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2936813004418976,0.9126245260106886,0.7128514056224899,0.8387045036378141,1.0,25/198,10.41%,LPL;PTPRC;PLAAT3;GPD2;ACYP1;CERK;ITPKB;ALDOA;GCK;GK;SPHK2;PIK3CB;PLCB4;SPHK1;CDK5;NUDT5;PLPP3;PFKFB3;INPPL1;PLCB2;HK1;PFKL;PGK1;PLAA;INPP5A
prerank,thymus development (GO:0048538),-0.32673843689706994,-0.9125958470442176,0.5523012552301255,0.9141145245263504,1.0,6/13,28.47%,FGF10;SOD1;FOXE1;SHH;FADD;TGFBR1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.40044894088274485,0.9125123308978683,0.58311345646438,0.8385827890397315,1.0,1/14,0.86%,BCL2L1
prerank,monocarboxylic acid transport (GO:0015718),-0.23097894446613843,-0.9118540899272627,0.6125,0.9135229015918583,1.0,8/51,9.51%,SLCO2B1;SLC16A7;NCOA1;SLC16A6;SLCO1B1;NCOA2;SLC6A11;SLC27A4
prerank,histone acetylation (GO:0016573),0.3172570842960995,0.9116037986060007,0.6628511966701353,0.8400474321370963,1.0,19/69,20.64%,LEF1;CPA4;MSL3;ING4;TRIM16;TADA1;WDR5;MRGBP;ING3;CHD5;ING5;JADE3;KAT7;DR1;EP400;TAF6;PHF20L1;MORF4L1;YEATS2
prerank,cellular senescence (GO:0090398),0.35454740836305393,0.9107788533208659,0.6241217798594848,0.841335953377904,1.0,3/27,4.62%,NSMCE2;ID2;PRKCD
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4091963366991732,0.9107187991423505,0.5957446808510638,0.8411012691048386,1.0,2/13,9.55%,NIBAN2;CADM4
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.32118642231102645,-0.9101912147061838,0.573170731707317,0.9152645941570986,1.0,4/14,9.07%,IL18;CD81;LGALS9;EBI3
prerank,cellular response to metal ion (GO:0071248),0.29976587849045694,0.909400264209406,0.6924643584521385,0.8434071410686634,1.0,30/123,21.28%,IQGAP1;P2RX4;SLC25A24;ADCY8;ITPKB;ATP13A2;ADCY7;MMP9;DAXX;CLIC4;CDH1;B2M;JUN;CPNE3;RASGRP2;MAPK9;SMPD1;BMP6;SYT8;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC13A5;CPNE6;HSF1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.40309532731595366,0.9093877061914307,0.5906666666666667,0.8430814806457322,1.0,7/14,25.83%,AK8;AK4;AK3;AK5;NMNAT3;AK7;ME1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.37710953246739076,0.9092108821424406,0.6055276381909548,0.843073107227792,1.0,5/18,21.84%,CCT2;EXOSC10;CCT8;CCT5;DKC1
prerank,acute-phase response (GO:0006953),-0.33503968108868565,-0.9087002835264244,0.596,0.9166561201743485,1.0,1/12,0.20%,IL6R
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3357460711417352,0.9084356019470674,0.6259977194982896,0.8442284885535662,1.0,18/39,33.10%,TTC7B;ITPKB;PIK3CB;PI4K2A;EFR3B;SOCS5;PIK3R2;PI4KA;TTC7A;SOCS2;PIK3C2A;PI4K2B;SMG1;ITPKC;SOCS4;SOCS7;IP6K2;SOCS6
prerank,sarcomere organization (GO:0045214),0.3562573752621364,0.9078521853420091,0.6188769414575866,0.8450072958174655,1.0,2/27,4.79%,TNNT3;CSRP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.3609848825901825,0.9074656481598267,0.6327272727272727,0.8453841765897213,1.0,13/25,33.10%,STAT4;CCR2;GHR;IL31RA;PIAS1;STAT5B;SOCS2;JAK2;IFNAR2;STAMBP;CTR9;IFNAR1;SOCS6
prerank,RNA interference (GO:0016246),0.38430758155096534,0.9070571226204889,0.6104725415070242,0.8458157501279928,1.0,7/17,30.62%,AGO2;CELF1;DHX9;AGO3;TERT;TARBP2;CLP1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3766806586615344,0.9057460654098681,0.6168108776266996,0.8480114767746116,1.0,3/18,2.22%,PTPRC;HDAC7;TBX21
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3115408693933791,0.9054242406755306,0.6645898234683282,0.8482923685723486,1.0,8/76,6.08%,MMP8;NLRC3;TMSB4X;SASH1;HDAC7;TRIM6;SPHK1;PTPN22
prerank,positive regulation of catalytic activity (GO:0043085),0.33832737277302405,0.9054146223428263,0.6484018264840182,0.8479611159620734,1.0,8/37,18.08%,ABL2;ATP7A;CAV1;PSEN2;MID1IP1;CHTOP;SLC5A3;YWHAB
prerank,protein localization to cell junction (GO:1902414),0.369136552745073,0.9051222345590596,0.6160287081339713,0.8481982872933274,1.0,6/22,13.50%,NECTIN1;TJP2;JAK1;ARHGEF18;MPP4;PAK2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.31749590565616126,0.9044828634406804,0.658695652173913,0.8491349166862231,1.0,17/54,27.73%,CTNNB1;GTPBP4;SQSTM1;CAV1;ADGRB1;RPL11;SMAD7;OGT;CHP1;RPS3;PRMT3;TRIM21;DNAJA1;DCUN1D3;VPS28;UFL1;TNFAIP3
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.34555701471050837,0.9044087274429704,0.6559263521288837,0.8489257039448697,1.0,12/36,26.13%,BCL2;SGMS1;TRAF1;PPIA;NR4A2;ING5;CSNK2A2;RPS3;CRADD;PTPMT1;TNF;CX3CL1
prerank,epithelial tube morphogenesis (GO:0060562),0.3426003172103732,0.9043151505369207,0.6299303944315545,0.8487647598608268,1.0,4/32,6.74%,CTNNB1;GATA3;MTSS1;COL4A1
prerank,neuron migration (GO:0001764),0.32429436360044933,0.9042579022915608,0.6374458874458875,0.8485259308448201,1.0,9/48,13.35%,FGF13;LRP12;CDK5;NRP1;VEGFA;USP9X;NAV1;CELSR1;DCX
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4134030173666189,0.90398992127098,0.5975935828877005,0.8487025200794485,1.0,3/12,9.92%,ERN1;BCL2L11;BAX
prerank,negative regulation of cell growth (GO:0030308),0.29792980391598345,0.9039570460499594,0.6778797145769623,0.8484154563100612,1.0,19/121,19.13%,APBB2;FGF13;PPP1R9B;SPHK2;HRG;CYP27B1;PPP2R1A;BCL6;RNF6;DCBLD2;RACK1;ENO1;ADAM15;OSGIN2;SERTAD3;STK11;NME6;CCAR2;BST2
prerank,regulation of sodium ion transport (GO:0002028),0.3414061575075989,0.9038214539322776,0.6314580941446614,0.8483034258931907,1.0,9/34,16.74%,P2RX4;PRSS8;SIK1;ATP1A1;RANGRF;SCN1B;CNKSR3;SCN3B;PKP2
prerank,negative regulation of catabolic process (GO:0009895),0.3251451107869635,0.9036955545507915,0.6549062844542448,0.8482036975308187,1.0,6/47,6.44%,FLNA;APOA2;AZIN1;HDAC4;ADGRB1;SF3B3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.34118140142511505,0.903347432906252,0.6343457943925234,0.8484857615667019,1.0,7/31,13.01%,ANK1;RAP2A;MSN;ERBIN;PDCD6IP;RHOA;CDC42
prerank,peptide metabolic process (GO:0006518),0.31093703367273884,0.9031247529197362,0.6816239316239316,0.8485580966405636,1.0,14/75,17.06%,ANPEP;ADAMTS13;GSTA2;CPXM2;PSEN2;AEBP1;GSR;DNPEP;NAT8;SPCS3;CPD;SPPL3;FURIN;GLRX2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.38893376248593825,0.902269935396054,0.6093143596377749,0.849856557391151,1.0,5/15,27.83%,CCT2;CCT8;CCT5;DKC1;RUVBL2
prerank,adherens junction organization (GO:0034332),0.3240338874645714,0.9016405988401195,0.6594124047878128,0.8506903257119732,1.0,10/48,14.00%,CTNNB1;NECTIN1;CADM1;NECTIN3;CDH1;JUP;PIP5K1C;SMAD7;PAK2;ACTB
prerank,mitochondrial transcription (GO:0006390),0.4346326325220462,0.9014923701467015,0.6233062330623306,0.8506318359284335,1.0,3/10,14.94%,SLC25A33;MRPL12;TWNK
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.34614466273988803,0.9013974387257314,0.6277712952158693,0.8501031661943627,1.0,14/29,33.35%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;NASP;RSF1;CENPH;CENPC;CENPW
prerank,CENP-A containing chromatin organization (GO:0061641),0.34614466273988803,0.9013974387257314,0.6277712952158693,0.8501031661943627,1.0,14/29,33.35%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;NASP;RSF1;CENPH;CENPC;CENPW
prerank,regulation of hormone secretion (GO:0046883),0.3889990595118178,0.9013116535589114,0.6146907216494846,0.84991783945029,1.0,1/15,1.53%,ANXA1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.39284195478944306,0.9008445086393013,0.6190476190476191,0.8504671498111864,1.0,5/15,18.54%,AK8;AK4;ENTPD5;AK5;ENTPD6
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3396214092935316,-0.9005451938790586,0.5592592592592592,0.9358491861342734,1.0,3/12,7.75%,INSIG1;INSIG2;TAPT1
prerank,positive regulation of neurogenesis (GO:0050769),0.31012489908922775,0.9003872168349116,0.6712765957446809,0.8509929478422122,1.0,11/68,12.83%,PLXNC1;CTNNB1;PLXNA2;NPTN;AMIGO1;CUX1;VEGFA;SS18L2;PLXND1;RHOA;CHODL
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3369827855614516,0.9003515239256551,0.6334841628959276,0.8507119243609337,1.0,2/35,0.62%,HIF1A;CDK6
prerank,response to sterol (GO:0036314),-0.3521501836885049,-0.8997928746899105,0.5714285714285714,0.935291061631136,1.0,2/11,6.08%,CCR5;INSIG1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2714524720093416,-0.8991207341029505,0.625,0.9344188722435613,1.0,1/26,0.04%,NAV3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3878059107357741,0.8990350812402891,0.6229299363057325,0.8528903653503873,1.0,12/17,39.30%,VCP;SEC61B;DERL1;HM13;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;TMEM129;AUP1;NPLOC4
prerank,cobalamin metabolic process (GO:0009235),0.3817321744665125,0.8989811233641176,0.6142322097378277,0.8526460653529156,1.0,4/17,16.85%,ABCD4;MMUT;MMAB;MTRR
prerank,maintenance of protein localization in organelle (GO:0072595),-0.292743805834022,-0.8987690006282366,0.553921568627451,0.932660364709357,1.0,9/19,23.79%,MORC3;SUPT7L;TAPT1;HK2;BCL3;TAF3;PML;BBS4;TAF8
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36226760170699185,0.898644158874309,0.6182472989195679,0.8529804791820701,1.0,4/21,12.68%,FLNA;NPPA;SCN1B;CACNA1D
prerank,N-glycan processing (GO:0006491),0.37884343834586914,0.8985450891507947,0.6111111111111112,0.8528078947886872,1.0,3/18,8.75%,GNPTAB;MAN1C1;ST8SIA6
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.41874556461294465,0.8984693089330753,0.6201657458563536,0.8526082647032996,1.0,2/11,3.02%,ANXA1;PIK3CB
prerank,regulation of protein localization to cell surface (GO:2000008),0.3392768685484367,0.898397490098081,0.6522727272727272,0.8523937468122307,1.0,11/33,29.63%,CTNNB1;SNX33;RANGRF;ABCA7;STX3;ACTN2;HSP90AB1;TNF;STX4;RAB11B;LEPROT
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2718332018233435,-0.897969780363406,0.6242038216560509,0.9322085288996232,1.0,8/24,16.84%,AGBL4;TTLL7;NAA10;TPGS1;TTLL5;TTLL4;TTLL9;CFAP20
prerank,neuron differentiation (GO:0030182),-0.19072064562111699,-0.8977493126937807,0.7142857142857143,0.9301939515683311,1.0,23/165,12.68%,ATP8A2;OPHN1;MEF2C;IL1RAPL1;PTPRD;PBX3;WNK1;TENM2;ACSL4;CASP3;VXN;MYT1L;WNT5B;EPHA5;NTRK2;NRBP2;WNT5A;DDIT4;INHBA;WNT2B;BRSK1;ERCC3;MYEF2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.301364080057376,0.8975260392998309,0.696969696969697,0.8536897696174011,1.0,29/87,25.28%,IQGAP1;LRP1;ABL2;PDGFA;HRG;PTK2B;PRKCD;DLC1;RHOD;RHOQ;RHOG;RHOA;PHPT1;IQGAP2;CELSR1;ROCK1;HIP1R;DAPK3;TESK1;ARHGAP17;BST2;BAIAP2;ARHGDIB;TAOK1;ARHGEF5;CCDC88A;RHOF;PDGFRA;MDK
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.36304756911605124,0.8974788537701702,0.638755980861244,0.8534390582921825,1.0,5/22,14.76%,MALT1;TRAF2;IL12RB1;B2M;HSPD1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3589698676831575,0.8972026569512508,0.646562123039807,0.8536161526886159,1.0,1/23,0.06%,IGF1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3601722487944287,0.8971673635067987,0.6227106227106227,0.8533335360388107,1.0,12/25,30.65%,AMPD2;GART;SHMT1;PRPSAP1;MTHFD1;APRT;PRPS2;PPAT;ADSL;HPRT1;GMPS;SHMT2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.37576241674303285,0.8970545250062298,0.6297709923664122,0.8531963490127081,1.0,11/18,34.94%,DDHD1;DCN;KDR;VPS35;BNIP3;FIS1;MUL1;MFF;RALA;RALBP1;MCU
prerank,regulation of striated muscle contraction (GO:0006942),0.35144734074700074,0.896498996826477,0.6107784431137725,0.8538963275608523,1.0,5/27,15.29%,P2RX4;TNNT3;SRI;SMAD7;ATP1A2
prerank,tetrapyrrole metabolic process (GO:0033013),0.37709561668075087,0.8962244513366068,0.6267166042446941,0.8540800332328766,1.0,4/18,16.85%,ABCD4;MMUT;MMAB;MTRR
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.29606307826400063,0.8960710198835223,0.7263479145473042,0.854026471534557,1.0,32/128,23.46%,ZMIZ1;UBA52;RPS27A;GCNT2;BMP8B;GDF6;ZMIZ2;USP9X;BAMBI;RNF111;JUN;ARHGEF18;TGFBRAP1;RHOA;NRROS;SMAD7;SMAD1;CBL;APPL2;FURIN;BMP6;PDCD4;ZYX;NLK;FERMT2;LTBP2;UBC;DUSP15;BMP4;ID1;TGFBR2;AMH
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.39468610547564087,0.8953614281451922,0.6379084967320261,0.8549968494836091,1.0,11/15,39.30%,VCP;SEC61B;DERL1;OS9;HSP90B1;HERPUD1;SYVN1;FAF2;TMEM129;AUP1;NPLOC4
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3067885775763895,0.8952449400222754,0.6747368421052632,0.8548600966262573,1.0,13/75,15.76%,PLEK;RGS3;PPP1R9B;MGLL;KLK6;SAG;C3;CCL5;PDE6B;CNGB1;ROCK1;GIT1;RNF157
prerank,regulation of fibroblast migration (GO:0010762),0.3651171994224172,0.8952143912528284,0.623279098873592,0.8545698712327678,1.0,9/20,28.42%,CORO1C;FGF2;CLN3;APPL2;DDR2;ITGB1BP1;PRR5L;ITGB1;GNA12
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4006027611583382,0.8951803814047545,0.6289222373806276,0.8542819626082335,1.0,5/13,20.95%,DCTPP1;ITPA;ENTPD5;ENTPD6;NUDT15
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.39022103072784287,0.8949303224779793,0.632051282051282,0.8543897883383639,1.0,7/15,25.93%,RIOK2;ANAPC1;TPR;TACC3;NEK6;ANAPC7;UBE2C
prerank,tRNA processing (GO:0008033),0.3112398696468834,0.8949290437103657,0.6652360515021459,0.8540439883024885,1.0,24/61,33.38%,AARS1;THG1L;METTL1;TRMT10C;ANKRD16;DDX1;QTRT1;SARS1;FARS2;NSUN2;TSEN15;ELP5;CSTF2;TRMT6;CDKAL1;WDR4;POP1;RTRAF;TSEN2;CLP1;LCMT2;NSUN6;TRMT10A;RTCB
prerank,determination of bilateral symmetry (GO:0009855),0.35888290892685715,0.8946980703978341,0.6307151230949589,0.8541343704676724,1.0,7/24,28.38%,ODAD2;FOXJ1;MKKS;BBS7;DNAH5;ARL6;DNAH11
prerank,negative regulation of cell aging (GO:0090344),0.38595771451504357,0.8946555314445606,0.6385696040868455,0.8538637223545663,1.0,3/16,12.23%,CDK6;FBXO5;ZKSCAN3
prerank,cellular protein localization (GO:0034613),0.2888788946455834,0.8946256621035391,0.798,0.8535638150763452,1.0,105/285,31.21%,SH3PXD2B;CTNNB1;TBC1D10C;RRAGD;FLNA;RAP2A;TBC1D22A;CTSA;SNX8;ARF3;ZDHHC15;CSRP3;FOXJ1;TBC1D2;ARL1;TRAPPC8;STX6;RAB5C;ANGPT1;NAPA;PACS2;RIC1;SIL1;VPS26A;WDR45;RAB32;ARL11;FGF7;WLS;CD63;RAB5A;CELSR1;STX3;CEP250;HPS6;GGA2;VPS26C;AP3D1;RAB22A;SAR1A;TBC1D22B;TLK1;RAB1A;VIPAS39;TBC1D12;RAB3GAP2;REEP1;FERMT2;ARHGEF2;ABHD17A;LAPTM5;ARL4C;ARFGAP3;GRIN3B;SNX31;ACD;NPM1;ID1;TMED3;NIPBL;CD74;VPS35;RAB20;TBC1D10A;SNX1;EHD1;SGSM1;USO1;MYO7A;TBC1D16;TM9SF3;RTP4;RRAGC;ARMCX3;GGA1;LAMTOR3;STX7;COPZ2;STX4;TBC1D15;STX5;RAB31;EIF2D;TMED2;COPA;RAB5B;ATG13;CORO1B;LAMTOR1;ARL6;TM9SF2;ARFRP1;SNX27;RAB43;SNX17;FBLN5;RABL3;PIGU;AP3B1;RRAGB;SEC23IP;ARF6;TBC1D8B;COG7;RAB24
prerank,ureteric bud development (GO:0001657),-0.30189970357329055,-0.8942768155902332,0.5869565217391305,0.936727037098214,1.0,6/17,22.00%,SALL1;ROBO2;OSR1;BMP2;NPNT;SLIT2
prerank,interstrand cross-link repair (GO:0036297),0.318462994117726,0.8942295795249217,0.6688524590163935,0.8539688768762304,1.0,18/53,27.40%,UBA52;RPS27A;ERCC1;VCP;FANCF;XPA;CENPX;ERCC4;SLX4;FANCA;UBC;RAD51AP1;MCM8;DCLRE1A;WDR48;USP1;CENPS;ATR
prerank,arachidonic acid metabolic process (GO:0019369),-0.24116110078777853,-0.8936603802913705,0.6521739130434783,0.9357289380990218,1.0,10/35,15.59%,PTGS1;ALOX5;HPGDS;PNPLA8;CYP2U1;EPHX1;DAGLB;PLA2G4C;EPHX2;ALOXE3
prerank,heart looping (GO:0001947),0.33155245645833686,0.8932620305824812,0.639080459770115,0.8554286083764792,1.0,3/39,3.29%,MICAL2;TBX21;EOMES
prerank,negative regulation of cell cycle (GO:0045786),0.3066033090133307,0.893141988933684,0.6831578947368421,0.8553067499428805,1.0,18/73,22.26%,CDK6;IPO5;GATA3;NUDT6;BRINP2;GMNN;LILRB1;CEBPA;NUPR2;TFAP4;RPS6KA2;PDCD4;RNF167;TAF6;NPPC;RUNX3;BMP4;LATS1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33771109317951453,0.8930691198110525,0.6606741573033708,0.855114520867422,1.0,6/38,11.91%,NLRC3;TANK;TNIP1;TREM2;TNIP3;RIOK3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.31736504254632075,0.8928257614247592,0.6421514818880352,0.8552439902390447,1.0,17/50,30.07%,GTPBP4;CCNB1;BCCIP;BLM;ACTB;STOX1;CCND2;CDKN3;GTF2H1;CCNT2;HSP90AB1;SERTAD1;GADD45A;CNPPD1;MNAT1;CDC25A;CCND1
prerank,organic anion transport (GO:0015711),0.30322342681692,0.8925503909716316,0.6736621196222455,0.8554093891543721,1.0,17/76,21.80%,LRRC8C;SLC25A24;SLC23A1;SLC22A3;SLCO5A1;CYB5R4;CYB5R1;SLC52A2;SLC2A8;SLC4A9;SLC35B1;SLC4A2;SLC19A1;SLC16A2;SLC17A9;SLC2A6;SLC26A6
prerank,response to alcohol (GO:0097305),-0.2601182879631337,-0.8925500176870309,0.6402439024390244,0.9359172663480668,1.0,8/27,17.21%,GRIN2A;CCR5;GRIN2B;SDF4;GRIN1;SOD1;GLRA1;GRIN3A
prerank,regulation of heart contraction (GO:0008016),0.30011336991911264,0.8924236767438443,0.6914344685242518,0.8552947745625143,1.0,28/90,29.96%,ASPH;P2RX4;ATP1B3;ATP2B1;NPPA;TH;ATP1A4;ATP1A3;ATP1A1;SRI;NPR2;SMAD7;ATP1A2;FXYD4;ITPR3;NPPC;FXYD1;ATP2A2;CALM3;CORIN;ATP1B2;GSK3A;FKBP1B;HCN4;ITPR1;SCN10A;STIM1;NPR1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.2984620872275733,-0.8920488700112669,0.5972222222222222,0.9346899366212882,1.0,2/17,5.73%,PDE3B;SORL1
prerank,cell junction maintenance (GO:0034331),-0.3048927440471613,-0.891546904484127,0.5950413223140496,0.933385680859165,1.0,1/14,0.16%,CSF1R
prerank,positive regulation of cell communication (GO:0010647),-0.2683308580055567,-0.8900801499356011,0.6441717791411042,0.9347132030627961,1.0,6/28,8.11%,GRIK2;RIMS1;CLSTN2;CLSTN3;SYT1;RIMS2
prerank,negative regulation of blood pressure (GO:0045776),0.40547381275426997,0.8896516015901411,0.6518324607329843,0.860156030387575,1.0,2/13,10.05%,NPPA;SCPEP1
prerank,signal transduction in response to DNA damage (GO:0042770),0.3180979781317601,0.8887225594618946,0.6826608505997819,0.861541269990941,1.0,17/49,28.74%,ERCC6;DOT1L;BID;GRB2;TRIAP1;NDRG1;ATRX;ATM;RAD1;CASP9;USP28;INTS7;GADD45A;SESN2;ATR;RAD9A;HINFP
prerank,protein autoubiquitination (GO:0051865),0.30987416172722876,0.8884940586554886,0.6948608137044968,0.861609981443415,1.0,20/61,30.55%,TRAF2;CNOT4;NFX1;DDB2;OBI1;BRCA1;BFAR;KLHL24;RNF157;RNFT1;CUL3;RNF41;TRIM21;MDM2;RNF13;WWP2;ERCC8;TRIM68;RNF19B;TRIM37
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.317256601432406,-0.8878980294629205,0.6211453744493393,0.9376812308085504,1.0,10/14,34.16%,ENPEP;AVPR2;ACE;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,hippo signaling (GO:0035329),0.34772802718419915,0.8874878304362934,0.6520681265206812,0.8630823814838504,1.0,9/26,25.44%,TJP2;STK3;FAT4;SAV1;YWHAB;AMOTL1;LATS1;TEAD1;MOB1A
prerank,protein insertion into membrane (GO:0051205),0.33858109948267595,0.8872609927580798,0.668235294117647,0.8631619828217478,1.0,11/32,27.14%,TRAM1L1;SEC61B;HMOX1;GET1;VAMP2;ALDH3A2;REEP1;GRIN3B;WDR83OS;RTP4;STX5
prerank,inner mitochondrial membrane organization (GO:0007007),0.32014360887479365,0.8869406617145074,0.66996699669967,0.8634199434545735,1.0,16/47,29.10%,IMMT;SAMM50;ATP5MG;TIMM9;AFG3L2;MTX3;GHITM;CHCHD6;HSPA9;TMEM11;ATP5PD;ATP5F1B;ATP5MF;ATP5F1C;ATP5MC1;SPG7
prerank,rRNA methylation (GO:0031167),0.3621860476245879,0.8867877711437835,0.6386554621848739,0.8633515433282557,1.0,10/22,27.37%,MRM2;MRM1;FTSJ3;MRM3;METTL15;NSUN3;TRMT112;DIMT1;FDXACB1;NSUN4
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.39384600016147475,0.8867611196106366,0.6379310344827587,0.8630525081795897,1.0,5/13,32.16%,NAMPT;PTGIS;PARP16;PARP9;NAXD
prerank,response to purine-containing compound (GO:0014074),0.37987268917000594,0.8867357686681748,0.6417721518987342,0.8627425767113537,1.0,2/17,9.08%,P2RX4;P2RY1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3806163491654617,0.8866594395059814,0.6296296296296297,0.8625330967835211,1.0,5/16,21.40%,ZBTB7B;NAPEPLD;PIM1;HNRNPU;METRNL
prerank,cranial nerve development (GO:0021545),-0.3460478987740784,-0.8864659463113389,0.5791245791245792,0.9387211198554171,1.0,3/11,8.54%,SALL1;ERBB3;PAX2
prerank,positive regulation of double-strand break repair (GO:2000781),0.32214017898017916,0.8861921887167991,0.645413870246085,0.8630323304844331,1.0,13/39,27.54%,ERCC6;MGMT;KMT5B;ARID2;KDM4D;PARP3;RAD51AP1;SETMAR;WAS;WDR48;SMCHD1;ACTR2;FUS
prerank,neural crest cell differentiation (GO:0014033),0.3702297320463409,0.8859666983446377,0.6368159203980099,0.8631006026780208,1.0,5/18,16.38%,FBXL17;NRG1;NOLC1;LRP6;TCOF1
prerank,regulation of double-strand break repair (GO:2000779),0.3257028171056992,0.885757837853405,0.6662883087400681,0.8631568760956052,1.0,17/39,33.93%,FIGNL1;PPP4C;TRIP12;MGMT;DEK;RTEL1;RAD51AP1;WAS;TERF2IP;KDM1A;ACTR2;RNF169;PPP4R2;UBR5;SLF2;RAD51;SETD2
prerank,peptidyl-serine modification (GO:0018209),0.2898410038798562,0.8855047259756614,0.770854271356784,0.8632752686422477,1.0,45/166,22.26%,PRKCH;PRKCQ;SGK1;MAPK13;DYRK2;SGK3;SGK2;CDK5;PRKCD;PDPK1;IKBKE;SBK1;PLK2;PRKCB;MAPKAPK3;MAPKAPK2;CSNK1G1;STK32A;HIPK1;HPF1;MAP3K12;GAS6;CDK2;PKN2;PAK2;ROCK1;CAB39;PRKD2;CSNK1D;MAPK9;STK38;CDC7;TLK1;RPS6KA2;CAMK4;NEK6;ATM;CSNK2A2;TOP1;PDK3;LMTK2;MARK2;GSK3B;SRPK2;LATS1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3894265006063384,0.8850869863715642,0.6302952503209243,0.8637137279726285,1.0,3/14,13.87%,WDR12;FTSJ3;DDX18
prerank,regulation of cilium movement (GO:0003352),0.41484106361681494,0.8850633634753916,0.6391891891891892,0.863413453982833,1.0,6/10,32.22%,ODAD2;CCDC65;CCDC40;CCDC39;DNAH11;CFAP298
prerank,nucleoside salvage (GO:0043174),0.42383013391453983,0.8845839922064181,0.6216968011126565,0.8639390875563597,1.0,7/10,38.70%,UCKL1;HPRT1;TK1;TK2;DCK;UPP2;UCK2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.26535699832812487,-0.8845550116752878,0.6521739130434783,0.9408998045581463,1.0,11/24,23.64%,CPOX;PGRMC1;UROS;SLC25A38;ALAS2;RSAD1;ALAD;FECH;PPOX;COX15;ABCB10
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3853324323338674,0.8843224151945095,0.6242038216560509,0.8640717713670915,1.0,5/16,20.94%,CAV1;PPP2R1A;PTPN2;ADIPOR1;VHL
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4012791287062229,0.8841133418725328,0.657608695652174,0.864108618671478,1.0,6/12,30.23%,FZR1;RAB1A;GOLGA2;UBE2C;BTRC;PTEN
prerank,cell chemotaxis (GO:0060326),0.3075739439768755,0.8839060439601997,0.704812834224599,0.8641162772076212,1.0,11/60,12.38%,PRKCQ;LEF1;CXCR2;PRKCD;NRP1;VEGFA;DEFB130A;RHOG;CCR2;PARVA;CCL28
prerank,mRNA polyadenylation (GO:0006378),0.3462832066644521,0.8838585262533597,0.64,0.8635102881141542,1.0,14/26,33.21%,GRSF1;PAPOLA;PABPC1;SYMPK;PAF1;SSU72;MTPAP;PAPOLG;TENT4B;LEO1;CLP1;AHCYL1;TUT1;WDR33
prerank,RNA polyadenylation (GO:0043631),0.3462832066644521,0.8838585262533597,0.64,0.8635102881141542,1.0,14/26,33.21%,GRSF1;PAPOLA;PABPC1;SYMPK;PAF1;SSU72;MTPAP;PAPOLG;TENT4B;LEO1;CLP1;AHCYL1;TUT1;WDR33
prerank,synaptic vesicle localization (GO:0097479),0.3988453321685461,0.8837689980714851,0.6435124508519003,0.8633389217708204,1.0,3/13,10.64%,CDK5;TMEM230;DNM2
prerank,nuclear membrane organization (GO:0071763),0.3616621085760977,0.8835194047334077,0.6234256926952141,0.8634584058632625,1.0,5/19,22.51%,CHMP4B;DCTN1;CHMP7;TARDBP;TOR1B
prerank,negative regulation of metabolic process (GO:0009892),-0.2215689199628503,-0.8833230635768321,0.7051282051282052,0.9414881402208664,1.0,11/54,15.03%,PLCL1;ADAMTS5;ACVR2B;RBPJ;IP6K1;MAP2K6;CCDC3;PCTP;ABHD6;IL1B;NR1H3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.37904776832756015,0.8832206083675179,0.6373056994818653,0.8636765721005569,1.0,8/15,33.65%,RNASEH1;ZC3H12B;ZC3H12D;ZC3H12C;POP1;NYNRIN;ZC3H12A;NUDT16
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.34808662761000697,0.883171262191938,0.6577017114914425,0.8634258629346625,1.0,7/23,24.38%,PLK2;WEE1;PRCC;BUB1B;SETMAR;ZFYVE19;PLK3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3799449407942478,0.8831308354922255,0.6508563899868248,0.8631528302692973,1.0,5/15,17.80%,PIK3CB;DAB2;SCYL2;DGKD;HIP1R
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31317253786764704,0.8827238912000206,0.6663007683863886,0.8635530282616899,1.0,14/52,17.95%,MBNL3;RBM25;CELF1;DDX17;RBM11;MBNL2;RBFOX2;PUF60;RBM15;NOVA2;FXR2;RBM15B;HNRNPU;CELF6
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2594170079967397,-0.8826231515898633,0.5882352941176471,0.9407073686632258,1.0,1/28,0.04%,NAV3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.42001170034407737,0.882622479144515,0.6508152173913043,0.8633906503106894,1.0,3/10,8.87%,PTPRC;KLRC1;LILRB1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3154829278514833,0.8823008769101637,0.6798245614035088,0.8636276318470677,1.0,16/51,22.69%,CSF1;FPR2;VEGFA;MOSPD2;ADAM17;CCR2;SERPINE1;CCL5;GAS6;C1QBP;AKIRIN1;ANO6;IL6;HMGB1;CALR;IL34
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.334048896031503,0.8817100812509867,0.6585365853658537,0.8643898378110156,1.0,10/31,23.35%,PEX2;TIMM44;DNAJC15;HSPD1;TOMM40;TIMM21;PEX16;TIMM17A;TIMM23;PEX14
prerank,I-kappaB phosphorylation (GO:0007252),-0.33906263007137194,-0.8814117358299238,0.6114864864864865,0.9411457060042665,1.0,3/10,18.29%,MAP3K7;TLR2;PRDX4
prerank,regulation of neutrophil migration (GO:1902622),0.41642167048188655,0.8811805881959681,0.6401673640167364,0.8650141039401839,1.0,8/10,39.98%,RHOG;NCKAP1L;OLFM4;RAC2;MPP1;RAC1;JAM3;RHOH
prerank,protein K63-linked deubiquitination (GO:0070536),0.33879796595790307,0.881092924423034,0.6494117647058824,0.8648248451301019,1.0,16/31,31.11%,OTUD4;ATXN3;ABRAXAS1;PSMD14;UIMC1;USP33;OTUD1;USP50;USP8;OTUD5;BRCC3;TNFAIP3;STAMBP;USP13;SHMT2;STAMBPL1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.22732105978926934,-0.881049716309593,0.7115384615384616,0.9395438842822453,1.0,7/46,10.50%,PLCL1;ADAMTS5;ACVR2B;RBPJ;IP6K1;MAP2K6;PCTP
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.32280175838821357,0.8810449394332516,0.6777777777777778,0.8645744789243267,1.0,11/41,20.75%,FLNA;KCNN4;KCNJ2;AMIGO1;KCNMA1;KCNMB4;KCNJ10;GNB1;ACTN2;KCNJ6;KCNJ15
prerank,neuromuscular junction development (GO:0007528),-0.269183711991862,-0.8807620426995373,0.6724137931034483,0.9377969542111833,1.0,3/24,5.30%,CACNB2;LRRK2;UNC13B
prerank,covalent chromatin modification (GO:0016569),0.3967356262525984,0.8801298998882184,0.6463730569948186,0.8658768067793982,1.0,5/14,29.22%,HDAC1;PARP2;HLCS;UFL1;SIRT1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.38892509816842363,0.879961085498202,0.6529562982005142,0.8658343336967506,1.0,2/15,7.32%,NLRC3;TREM2
prerank,negative regulation of ion transport (GO:0043271),-0.2563854201456187,-0.8798678971546026,0.7073170731707317,0.9375448027200413,1.0,6/24,12.26%,WNK1;CD33;PXK;WNK3;NOS1;INPP5K
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35540003445210744,0.8793836364022013,0.6485148514851485,0.8665301981406182,1.0,8/22,29.45%,CAP1;CCR2;CACNA1D;NF1;CAP2;ORAI1;DRD3;STIM1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.30547082501245393,0.8793392861449254,0.6914660831509847,0.8662685418591954,1.0,14/57,22.53%,TAOK3;SDE2;FZR1;FBXO31;MDC1;FOXN3;ABRAXAS1;BRCA1;CDK2;BLM;UIMC1;ATM;TAOK1;TOPBP1
prerank,mRNA splice site selection (GO:0006376),-0.25138286374251706,-0.8791627019210481,0.6833333333333333,0.9367109990088073,1.0,9/30,14.39%,CELF2;LUC7L;SRSF9;ISY1;CELF4;CELF5;SETX;SF3A1;LUC7L3
prerank,cAMP-mediated signaling (GO:0019933),-0.26461623489205266,-0.8789090571572733,0.6608187134502924,0.9347711887383267,1.0,10/24,17.63%,ADGRG6;ADCY2;RAPGEF2;RIMS2;EPHA5;AKAP6;PDE7B;PDE4D;PDE2A;RAPGEF3
prerank,endothelial cell migration (GO:0043542),0.3305184500575986,0.8786989513715415,0.6575654152445961,0.8670900262140867,1.0,14/37,34.10%,NRP1;VEGFA;PLXND1;RHOA;FSTL1;CYP1B1;ID1;GIPC1;CORO1B;TNFSF12;NR4A1;LGALS8;DPP4;CDH5
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2992589055820042,0.8784485375406281,0.711558854718982,0.8672015467907418,1.0,13/69,16.59%,IGF1;PIK3CB;PLCB4;PIK3R5;GATA3;IGF1R;PLCB2;PLEKHA1;RHOA;OGT;C1QBP;NF1;PIK3R2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4162193708242249,0.8782957266217241,0.657103825136612,0.8671553719869278,1.0,4/10,14.67%,MUC1;HRG;SERPINE1;CYP1B1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.30254400860113806,0.8781203477156658,0.7055084745762712,0.8671177828811073,1.0,17/75,17.75%,CTNNB1;NIBAN2;HRG;ANGPT4;PPARG;ADGRB1;PGK1;CCR2;ROCK1;DCN;HSPG2;APOH;CCN6;SARS1;SPINK5;KLK3;KRIT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.37176151917986305,0.8770993534713564,0.65625,0.8686293951352553,1.0,8/18,18.45%,RIPOR2;PTK2B;RACK1;RUFY3;ROCK1;LLGL2;KRIT1;ARFGEF1
prerank,visual perception (GO:0007601),0.2993096718355033,0.8768738683290078,0.709278350515464,0.8687124646783109,1.0,11/84,14.11%,CHRNB2;EYA4;RDH12;DHRS3;TH;COL18A1;SFRP5;ABLIM1;RABGGTB;CNGB1;CEP250
prerank,female gonad development (GO:0008585),0.36025115135972446,0.8764579434519085,0.6585662211421628,0.8690914750155431,1.0,5/19,23.92%,CYP19A1;VEGFA;COL9A3;EIF2B2;EIF2B4
prerank,polarized epithelial cell differentiation (GO:0030859),0.39481130752569404,0.8760673114225652,0.6503957783641161,0.8694559581544183,1.0,4/13,13.01%,RAP2A;MSN;RHOA;CDC42
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.33718010599107273,0.8757215521444423,0.6550522648083623,0.8697222378880846,1.0,4/29,5.51%,DEDD2;TRAF2;CAV1;BID
prerank,positive regulation of cell division (GO:0051781),0.32770917894958573,0.8755057321325249,0.7073446327683616,0.8697734694898341,1.0,13/38,25.99%,MAP10;PKP4;RHOA;CDC42;PKN2;RACGAP1;SVIL;CUL3;HTR2B;FGFR2;GIPC1;CDC25B;FGF1
prerank,receptor catabolic process (GO:0032801),0.35322303109981235,0.8754458343981437,0.6787003610108303,0.8695433326482962,1.0,4/24,14.65%,MYLIP;SNX25;ZNRF3;MVB12A
prerank,mitotic chromosome condensation (GO:0007076),0.34700537768028206,0.8753753257668448,0.6759371221281741,0.8693190598744543,1.0,5/26,12.02%,NCAPG;NCAPG2;KMT5A;CCNB1;NCAPH
prerank,positive regulation of hydrolase activity (GO:0051345),0.2888205764714558,0.8747594644861597,0.7494949494949495,0.8700457707210533,1.0,37/137,26.13%,BCAR3;RGS1;RGP1;CCL4;ALS2;PKP4;PSAP;TBC1D2;RAPGEF6;RASGRP1;RIC1;CCL13;RACK1;MMUT;CCL7;CCL5;RHOA;CCL14;RCN3;RASGRP2;NF1;AFDN;RIPK3;TBC1D20;PIN1;FERMT2;RPS3;GSK3B;F2R;LARS1;CALM3;DOCK11;SFRP1;MAPK12;RAB3GAP1;SNX18;CX3CL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.39575245088599886,0.8745681911966332,0.6511024643320363,0.8700375934483346,1.0,2/13,9.77%,CAV1;SRI
prerank,positive regulation of cyclase activity (GO:0031281),-0.3141572591264966,-0.8741377959128821,0.6234309623430963,0.9439975707627707,1.0,4/14,13.86%,MAPK14;MAPK8;NOS1;CACNA1C
prerank,retinal metabolic process (GO:0042574),0.400910906466143,0.8738839128135364,0.6563342318059299,0.8708866568072888,1.0,4/12,21.90%,ABCA4;CYP1B1;RDH13;RDH10
prerank,cellular response to drug (GO:0035690),-0.2639513012127591,-0.8737772181664664,0.6875,0.9423426163516107,1.0,2/25,0.60%,MEF2C;PPM1E
prerank,production of siRNA involved in RNA interference (GO:0030422),0.41576287259325573,0.8736465073656206,0.6736694677871149,0.8709543206921295,1.0,1/10,2.24%,AGO2
prerank,regulation of protein polymerization (GO:0032271),-0.2456663075032814,-0.8732726183783042,0.7112676056338029,0.9411101433449932,1.0,9/35,16.14%,FCHSD2;MAP2;TPPP3;DBN1;PAK3;ARHGAP28;TPPP;ESAM;CAMSAP3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.33602595110316097,-0.8725902149233347,0.6021505376344086,0.9403156607664728,1.0,4/10,14.36%,EMC2;MMGT1;EMC10;EMC6
prerank,inositol phosphate catabolic process (GO:0071545),-0.32054341787435847,-0.8723420446338419,0.5907335907335908,0.9384248521742242,1.0,5/12,16.99%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,protein processing (GO:0016485),0.293020719984722,0.8723175638818041,0.7417695473251029,0.8729707432648321,1.0,24/102,17.36%,TMPRSS2;ADAMTS13;ECEL1;CPXM2;KLK1;KLK6;SDE2;HP;HPR;PSEN2;ADAM17;AEBP1;CLN3;CD5L;DDI2;SPCS3;AFG3L2;OGT;KLKB1;CPD;SPPL3;CASP4;FURIN;KLK3
prerank,mitotic sister chromatid segregation (GO:0000070),0.2874205394383221,0.8721221405423123,0.7303370786516854,0.8729703254280979,1.0,33/98,32.24%,NCAPG;EML4;NCAPG2;CHMP4A;CHMP4B;KMT5A;PDCD6IP;CCNB1;VPS4B;NCAPH;CHMP7;INO80;KIFC1;TEX14;RAB11A;CUL3;CSNK2A2;CHMP6;SPDL1;NIPBL;MCPH1;CENPK;ESPL1;EML3;PHF13;PDS5A;KIF22;PIBF1;NUDC;BECN1;SET;PDS5B;NAA50
prerank,chromatin remodeling at centromere (GO:0031055),0.33024591329223885,0.871567785578655,0.6640181611804767,0.8736234484591663,1.0,14/31,33.35%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;NASP;RSF1;CENPH;CENPC;CENPW
prerank,inorganic cation import across plasma membrane (GO:0098659),0.2994473358429795,0.871486438291826,0.7105538140020898,0.8734148548645053,1.0,13/75,15.29%,SLC9A1;ATP1B3;SLC5A1;KCNJ2;ATP1A4;ATP1A3;ATP1A1;SLC12A4;SLC39A6;KCNJ10;SLC9A6;SLC9A7;ATP1A2
prerank,angiogenesis involved in wound healing (GO:0060055),0.40387216204950743,0.8711972401722431,0.677376171352075,0.873595814129722,1.0,6/11,31.43%,VEGFA;SRF;KDR;HPSE;NDNF;MCAM
prerank,renal system development (GO:0072001),-0.21960533690509798,-0.8711864195841386,0.7441860465116279,0.9387134412533394,1.0,19/52,22.68%,SALL1;PCSK5;ITGA8;PAX8;AGT;PAX2;GREB1L;SULF2;IFT27;STAT1;SULF1;PYGO2;TFAP2B;CENPF;BAG6;PKD1;MME;HYAL2;CEP290
prerank,regulation of smooth muscle contraction (GO:0006940),0.3596116875937039,0.8711575545404032,0.6642156862745098,0.87332232229047,1.0,3/20,5.31%,ATP2B1;SPHK1;CAV1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3314991299310249,-0.8708354321962902,0.6094420600858369,0.9371338407626243,1.0,3/12,19.50%,ABCC9;TRPM4;P2RX3
prerank,neural tube development (GO:0021915),-0.2925453688667966,-0.8707921146828739,0.6359649122807017,0.9347832657950389,1.0,7/15,30.65%,STIL;PKD1;ALDH1A2;ARL13B;GRHL2;HES5;SOX4
prerank,axonemal dynein complex assembly (GO:0070286),0.3425029135079456,0.8705730474990142,0.6613995485327314,0.8739791205378271,1.0,10/27,28.82%,ODAD2;DNAH8;DNAAF5;TTC12;CCDC65;DNAI3;CCDC40;CCDC39;DNAH5;DNAH17
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.29011823465751146,0.8701338685922383,0.7396265560165975,0.8743724806498042,1.0,22/95,18.32%,STAP1;SIRPA;VIM;AXL;CD274;TNIP3;LILRB1;PABPN1;TICAM1;PLAA;SERPINE1;TNFRSF1B;RHOA;TNIP2;GIT1;NFKB1;ACOD1;TIRAP;PDCD4;SBNO2;PAF1;IL6
prerank,ERAD pathway (GO:0036503),0.29412156825004754,0.8700221321801699,0.7238493723849372,0.8742382857361201,1.0,33/83,33.77%,DERL3;EDEM1;DNAJB14;STT3B;ATXN3;VCP;SEC61B;UBE4A;DNAJB9;UBXN4;RCN3;UBQLN1;DERL1;PSMC6;RNF121;UBE4B;WFS1;UBXN6;DNAJC10;HSPA5;ERLIN1;USP19;ECPAS;DNAJB12;OS9;HSP90B1;USP13;HERPUD1;SYVN1;FAF2;UBQLN2;BRSK2;ERLIN2
prerank,tryptophan metabolic process (GO:0006568),0.4069434425395523,0.8699377281455491,0.6649076517150396,0.8740432609421702,1.0,3/11,24.48%,ATP7A;IDO2;KYNU
prerank,negative regulation of biomineral tissue development (GO:0070168),0.35516900206002333,0.8699199911992522,0.6830188679245283,0.8737281800423223,1.0,5/21,13.64%,PTK2B;SOX9;ECM1;GAS6;ROCK1
prerank,glycerol metabolic process (GO:0006071),0.4140777643317533,0.8698556352528739,0.6535859269282814,0.8734976232306849,1.0,2/10,16.79%,GK;COQ3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3092973155147755,0.86947111290295,0.714898177920686,0.8738142164528522,1.0,14/57,24.21%,IGF1;PPP2R1A;VEGFA;PTPN2;ARL2BP;CCL5;GHR;IL31RA;IL6;IL2;EPO;FGFR3;JAK2;TNF
prerank,tight junction assembly (GO:0120192),0.30838113251548155,0.8694541399610273,0.6986899563318777,0.8735056426516128,1.0,10/49,20.41%,POF1B;CLDN19;ACTG1;PDCD6IP;CLDN18;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.31794005771608946,0.8692746653739628,0.6970046082949308,0.8734800452368342,1.0,8/38,13.46%,PTPRC;NEDD9;CAV1;NCK2;MVP;EFNA1;GAS6;GPRC5B
prerank,peroxisomal membrane transport (GO:0015919),0.3409707008477989,0.8688186015332697,0.6860189573459715,0.8739174518628189,1.0,10/27,23.35%,ABCD4;PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30867199881064844,0.8680285915896145,0.7121046892039259,0.8749312044061172,1.0,18/53,28.42%,APOE;FBXW7;TREM2;RHBDF1;PSMC3;XPO1;PSMD14;PSME3IP1;PSMC6;DESI1;TMF1;NUDT15;HSP90AB1;USP14;GPX1;USP19;UFL1;GNA12
prerank,apical junction assembly (GO:0043297),0.3092476431142938,0.8679846592957723,0.7253599114064231,0.8746665250620219,1.0,11/53,20.41%,POF1B;CLDN19;PDCD6IP;CLDN18;RHOA;PKN2;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.30095157657213945,0.8679465222445647,0.7061965811965812,0.8744032605658296,1.0,12/63,13.30%,MUC1;CNOT4;SDE2;PLK2;FBXO31;CCNB1;BAX;TRIAP1;CNOT10;CARM1;PCBP4;CDK2
prerank,macrophage activation involved in immune response (GO:0002281),-0.3139336504070593,-0.8678916468653731,0.6454183266932271,0.9394375288910519,1.0,2/13,3.71%,CX3CR1;PLCG2
prerank,regulation of axon regeneration (GO:0048679),-0.3175545847799933,-0.8678542315826999,0.6181102362204725,0.9370607044842777,1.0,2/12,3.32%,EPHA4;RTN4RL1
prerank,regulation of mitochondrial fission (GO:0090140),-0.26491512711662657,-0.8676612081405998,0.7065217391304348,0.9350156817647407,1.0,3/24,3.48%,CYRIB;LRRK2;SPIRE1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3443070525480422,0.8675363075850144,0.6703296703296703,0.874773291384975,1.0,8/24,20.89%,BCL2L1;DAB2;RHOQ;GDI1;TMBIM1;LZTFL1;ITGB1BP1;PPFIA1
prerank,response to acidic pH (GO:0010447),0.39197313616369167,0.8671924395310313,0.6409921671018277,0.8750393659217798,1.0,2/13,3.41%,SLC9A1;GPR151
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3512964779102143,0.8671865161641893,0.6694915254237288,0.8747035678159724,1.0,6/22,18.91%,NES;ID2;DLL4;APPL2;TOX;SLC16A2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3241614767553106,-0.8663633225934426,0.5945945945945946,0.9356618773595363,1.0,6/11,30.05%,TIMM10B;TIMM29;TOMM70;NDUFA13;TIMM8B;TIMM13
prerank,positive regulation of histone acetylation (GO:0035066),0.3456776659818733,0.866055959484983,0.666267942583732,0.8763465590382742,1.0,10/23,28.10%,SPHK2;MUC1;SMARCB1;BRCA1;KAT7;WBP2;GLYR1;PIH1D1;RUVBL2;MAPK3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3296629752056609,0.8658806405084974,0.7091121495327103,0.8763086982662105,1.0,9/33,17.87%,MTHFS;PYCR3;ART4;GLS2;GLS;FPGS;CAD;SIRT4;OAT
prerank,cellular response to organic cyclic compound (GO:0071407),0.2862687500518606,0.8656600972388053,0.780264496439471,0.8763238218114655,1.0,26/141,15.29%,CTNNB1;SPP1;P2RX4;MSN;ADCY8;ADCY3;MGARP;NR4A3;TFPI;ATP1A3;ATP1A1;UBE2L3;CDH1;P2RY1;JUP;BRCA1;DIAPH1;CCL5;RIOK3;LARP1;TIPARP;BLM;ACTB;CASP7;CYP1B1;ATP1A2
prerank,anterior/posterior axis specification (GO:0009948),0.37631531543799135,0.8655721046498993,0.6684350132625995,0.8761392288171113,1.0,2/15,14.19%,WLS;DDIT3
prerank,protein localization to lysosome (GO:0061462),0.3352802479987773,0.8654491650331877,0.6678403755868545,0.8760201202881815,1.0,4/28,12.06%,ATP13A2;RNF128;RAB7A;GCC2
prerank,cellular response to retinoic acid (GO:0071300),0.3158207857986542,0.865442712880514,0.6784140969162996,0.8756831252098803,1.0,5/42,9.04%,ABL2;PTK2B;SOX9;BRINP2;WNT6
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3202308120917664,0.8653994251872558,0.7114317425083241,0.8754128844186491,1.0,19/42,35.67%,UBA52;RPS27A;POLE;VCP;UBE2L6;RFC1;UBC;REV1;RFC2;POLD4;SIRT1;RFC4;ZBTB1;UBB;RFC5;PCNA;POLA1;PCLAF;POLK
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38802478569287163,0.8650101044014745,0.6433289299867899,0.8757550432240634,1.0,2/13,4.51%,ADCY8;SQSTM1
prerank,regulation of viral life cycle (GO:1903900),0.3475671916814573,0.8644594915089008,0.6670761670761671,0.8763810952144364,1.0,4/21,14.03%,AXL;TRIM6;KPNA6;PPIA
prerank,modulation by symbiont of entry into host (GO:0052372),0.37147897054210177,0.8644366863635256,0.6705426356589147,0.8760804932433058,1.0,3/16,11.72%,TRIM6;CAV1;EXOC2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.40114888046399466,0.8643342665364573,0.6745718050065876,0.8759168972962914,1.0,6/11,36.41%,IL6;BMP4;MAP2K2;RIPK1;MAP2K1;TGFB1
prerank,metanephric mesenchyme development (GO:0072075),-0.3441687251896988,-0.864282056552014,0.6138996138996139,0.9380779855224127,1.0,7/10,32.76%,PAX2;OSR1;STAT1;SHH;WNT4;WT1;SIX4
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3264488272002034,-0.8638219255329118,0.6088709677419355,0.9366594491473584,1.0,2/13,3.31%,MEF2C;RBPJ
prerank,embryonic heart tube morphogenesis (GO:0003143),0.31414057641777315,0.8638009879514755,0.6845637583892618,0.8765117689838,1.0,3/43,3.29%,MICAL2;TBX21;EOMES
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2753340365283973,0.8635326818404635,0.843687374749499,0.8766506301055694,1.0,83/259,29.74%,SDCBP;FLNA;RAP2A;ASAP1;CFAP44;PPP1R9B;TEKT2;PTPN23;NRP1;ATP6V0D1;RILPL2;FOXJ1;SPAG16;FXYD5;FGD6;MTSS1;RAPGEF6;IFT43;RHOD;TEKT5;WDR35;SNX10;ARMC9;RAB8A;ABLIM1;CEP41;RAB8B;TCTN3;PARVA;EXOC2;GSN;CNGB1;CEP250;ACTR3;IFT88;TMEM216;PLK4;LZTFL1;RAB1A;IFT74;MINK1;MKKS;RAB11A;NTN1;PMP22;CFAP70;ANO6;RILPL1;EHD4;PARVB;ACTN2;BBIP1;MAK;FGD5;IFT122;DYNC2I1;EHD1;CCDC88A;GOLPH3;CYS1;CCDC65;TRAF3IP1;RILP;BBS7;MKS1;TMEM107;SCLT1;CYFIP1;S1PR2;DYNLT2B;ACTR2;TMEM237;EXOC4;DNAH5;ITGB1;ARL3;TMEM17;ARL6;CEP83;RAP2B;CFAP410;IQCB1;PIBF1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3126793956836884,-0.8631069889698503,0.5785123966942148,0.9359630243978143,1.0,4/14,13.71%,ALDH9A1;NOS1;DAGLB;ACHE
prerank,regulation of cell aging (GO:0090342),0.40433766581407526,0.8630680090154657,0.661437908496732,0.8770953570304516,1.0,5/11,23.47%,LMNA;NEK4;ING2;NEK6;MIF
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.38943663922968075,0.8627730625580085,0.6554508748317631,0.8772710151150521,1.0,4/12,24.21%,NCOR2;IL6;TERT;TNF
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3609494879670388,0.8626800379739102,0.6649417852522639,0.8770765403542555,1.0,9/19,35.31%,IRF5;HSPD1;DHX36;DHX9;TLR9;TBK1;MAVS;SETD2;DDX3X
prerank,positive regulation of interferon-beta production (GO:0032728),-0.23987009946085325,-0.8626610635879798,0.7322834645669292,0.9346280270546936,1.0,13/33,25.72%,OAS2;POLR3F;DHX58;TRIM56;TLR2;TLR8;OAS3;FLOT1;TOMM70;IFIH1;IRF1;ISG15;POLR3G
prerank,organonitrogen compound catabolic process (GO:1901565),0.30473997620593335,0.8625810480550243,0.7204301075268817,0.8769105448950477,1.0,15/57,25.17%,ANPEP;RENBP;ADAMTS13;GNPDA1;NAGK;NPL;TST;GNPDA2;MPST;TRIM24;TPP1;AMDHD2;CLPX;PDXDC1;PLA2G5
prerank,Notch signaling pathway (GO:0007219),-0.21333838149265455,-0.862372739041968,0.8035714285714286,0.9329192043128859,1.0,9/59,6.10%,SORBS2;ITCH;RBPJ;NOTCH2;DTX3L;WWC1;PSEN1;KAT2B;APH1B
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2667013616342426,-0.8623628649569868,0.6612021857923497,0.9305802322968169,1.0,4/23,7.94%,GRK4;CAMKMT;FNTA;METAP2
prerank,cellular response to virus (GO:0098586),0.3352547764646537,0.8619860067027016,0.6816037735849056,0.8775941664234347,1.0,8/30,20.73%,HIF1A;BAX;POU2AF1;CCL5;RIOK3;IL6;VWCE;EIF5A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.33229973366413296,0.8619429111907012,0.69965075669383,0.8773248443468957,1.0,12/31,26.04%,EXOSC4;PATL1;EXOSC9;NT5C3B;DCP1A;LSM6;EDC4;EXOSC5;CNOT6;LSM4;EDC3;LSM3
prerank,embryonic appendage morphogenesis (GO:0035113),0.39224651162962776,0.8618660307674466,0.667574931880109,0.8771143133362701,1.0,2/12,14.88%,FBXW4;LRP6
prerank,ruffle organization (GO:0031529),-0.2829689675554811,-0.8618015645998922,0.6623931623931624,0.9294324015699449,1.0,3/16,5.45%,CSF1R;CARMIL1;AIF1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2944280119399607,0.8617110551405454,0.7365648050579557,0.8770270378450123,1.0,25/78,30.61%,CCNY;GTPBP4;IPO5;ADAM17;CCNB1;BCCIP;CEBPA;TFAP4;BLM;ACTB;CCND2;CDKN3;GTF2H1;CCNT2;SERTAD1;LATS1;GADD45A;PSMD10;CDK5RAP1;CNPPD1;MNAT1;CDC25A;CCND1;PTEN;HEXIM1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.41084760412433136,0.8614198470296259,0.665283540802213,0.8772133925574883,1.0,2/10,6.15%,RIPOR2;CD200R1
prerank,muscle cell migration (GO:0014812),0.4158252963497107,0.8613750276763298,0.6581769436997319,0.8769430467546295,1.0,3/10,19.26%,AAMP;ROCK1;ITGB1BP1
prerank,actin filament capping (GO:0051693),0.3677593587701731,0.8611962944898204,0.684010152284264,0.8765684438804369,1.0,6/18,25.72%,CAPG;SCIN;GSN;SVIL;TRIOBP;ADD3
prerank,barbed-end actin filament capping (GO:0051016),0.3677593587701731,0.8611962944898204,0.684010152284264,0.8765684438804369,1.0,6/18,25.72%,CAPG;SCIN;GSN;SVIL;TRIOBP;ADD3
prerank,protein insertion into ER membrane (GO:0045048),0.3177726505849015,0.8609574294804058,0.7068181818181818,0.8766250765057706,1.0,10/37,19.36%,UBL4A;TRAM1L1;SEC61B;HMOX1;EMC3;GET1;EMC9;VAMP2;ALDH3A2;GET3
prerank,odontogenesis (GO:0042476),0.3241538339274047,0.8609167227186632,0.7008055235903338,0.876361341991331,1.0,9/35,25.40%,HDAC1;WNT6;ANKRD11;TUFT1;LRP6;BMP4;FGFR2;HDAC2;COL1A2
prerank,regulation of fat cell differentiation (GO:0045598),0.2933880650433005,0.86059901421342,0.7471022128556375,0.8765876447785903,1.0,30/74,32.99%,LPL;ID2;PPARG;GATA3;NOCT;PPARD;ASXL2;CARM1;ZBTB16;ASXL1;FOXO1;ANKRD26;IL6;FERMT2;SYAP1;ADIG;LMO3;TRIB2;TNF;CCDC85B;SFRP1;CREBL2;SIRT1;RARRES2;FRZB;SIRT2;XBP1;ZC3H12A;CEBPB;TMEM64
prerank,lipid modification (GO:0030258),0.32143405485329274,0.8603579801517546,0.7001140250855188,0.8766668393501825,1.0,7/37,17.29%,DGKZ;PLPP6;PLPP3;LPCAT3;DGKA;DGKH;DGKD
prerank,negative regulation of viral release from host cell (GO:1902187),0.38432227207379394,0.8603454654638039,0.6705882352941176,0.8763521884340337,1.0,6/13,37.37%,TRIM28;TRIM21;TRIM8;TRIM11;TRIM35;CHMP3
prerank,protein secretion (GO:0009306),0.30439016974626604,0.8598406585616877,0.7247007616974973,0.8769008336318426,1.0,15/56,22.42%,ABCA1;ANXA1;SNX19;CYB5R4;RAB8A;MON1A;RAB8B;WLS;RCN3;VIP;TMEM167A;LTBP2;ARFGAP3;RAB3D;CANX
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3481515631670698,0.8596404906722703,0.6707168894289186,0.8769199199052733,1.0,9/22,30.40%,MGAT5;CCL5;GHR;CYP1B1;IL6;F2R;TNF;HES1;CRLF2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.37615303781508214,0.8595247990476321,0.6783398184176395,0.8767768240384186,1.0,3/14,15.89%,CD226;KMT5B;TFRC
prerank,DNA damage checkpoint signaling (GO:0000077),0.3357818202914585,0.8594681093239492,0.693491124260355,0.8765196924334329,1.0,12/28,33.85%,ERCC6;DOT1L;ATM;RAD1;USP28;INTS7;ATR;RAD9A;HINFP;MAP3K20;HUS1;CHEK2
prerank,negative regulation of organelle assembly (GO:1902116),0.32689905997358204,0.8591387295459149,0.7134703196347032,0.8767476961948176,1.0,5/35,10.59%,SMCR8;SEC22B;CHMP4A;CHMP4B;BRCA1
prerank,positive regulation of signaling (GO:0023056),-0.23351790283125268,-0.8578109223549345,0.7256637168141593,0.9362639821945934,1.0,6/37,8.11%,GRIK2;RIMS1;CLSTN2;CLSTN3;SYT1;RIMS2
prerank,regulation of GTPase activity (GO:0043087),0.27955038698608753,0.8574761908272245,0.8157099697885196,0.8792305503722799,1.0,55/177,27.94%,BCAR3;PLXNC1;RGS1;GPR137B;PLXNA2;RGP1;CCL4;ALS2;PKP4;TBC1D2;CPEB2;FGD6;RAPGEF6;RASGRP1;RIC1;CCL13;KLRK1;RACK1;MMUT;PLXND1;CCL7;CCL5;CCL14;ARHGAP12;RASGRP2;NF1;AFDN;ARHGAP9;RAB3GAP2;TBC1D20;PIN1;ARFGEF1;FERMT2;ITGB1BP1;GMIP;FGD5;GSK3B;ARHGEF5;F2R;LARS1;VAV3;DOCK11;RRP1B;SFRP1;VAV1;RAB3GAP1;SNX18;CX3CL1;TBC1D15;S100A10;LIMS1;TMED2;ADAP1;PLXNA1;ITGB1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2553551831579322,-0.8570002767828983,0.6948051948051948,0.9357979967076997,1.0,6/28,14.33%,ITGAM;KCNB1;C2CD5;DMTN;INPP5K;HRAS
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3535679543399681,0.8569304918922668,0.6687116564417178,0.8797835330759635,1.0,3/20,7.65%,AGO2;EIF6;CELF1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3108385209660578,0.8567014964781399,0.7144420131291028,0.8798295543750374,1.0,20/44,30.56%,NRP1;MYOC;RHOA;LIMK1;CDC42;LPAR1;SERPINF2;TESK1;FERMT2;ITGB1BP1;EVL;CD47;GPR65;ARHGEF5;CCDC88A;SFRP1;S100A10;SORBS3;CCN2;RHOC
prerank,gas transport (GO:0015669),0.40796810417497487,0.8564867900935297,0.6757123473541384,0.8798427072562925,1.0,1/10,3.83%,NGB
prerank,RNA biosynthetic process (GO:0032774),0.3332652017450727,0.8564644559605925,0.7039170506912442,0.8795493977668374,1.0,9/31,27.88%,TTF1;PRMT5;TBPL1;TBP;TAF7;TAF6;TERT;POLA2;RSF1
prerank,negative regulation of angiogenesis (GO:0016525),0.2917664245384311,0.8556657791658132,0.7533960292580982,0.8805531932517896,1.0,19/84,17.75%,CTNNB1;NIBAN2;PIK3CB;HRG;ANGPT4;PPARG;ADGRB1;PGK1;CCR2;SERPINE1;ROCK1;DCN;HSPG2;APOH;CCN6;SARS1;SPINK5;KLK3;KRIT1
prerank,regulation of protein localization to membrane (GO:1905475),0.3295218159229994,0.855412408469817,0.6905615292712067,0.8806371717176823,1.0,7/28,17.31%,CDK5;FYN;CLN3;GSN;CRIPT;ACTB;SLC5A3
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.32982685063381334,-0.8552973273511417,0.6174242424242424,0.9374004022452506,1.0,4/11,15.77%,PICALM;COMMD1;TAX1BP3;NEDD4L
prerank,carbohydrate derivative catabolic process (GO:1901136),0.35905664515458746,0.8547250581114647,0.6900878293601004,0.8814351787969907,1.0,4/18,11.60%,DERA;STT3B;OGA;FUCA1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.31953460433408215,-0.8535425865110865,0.6595744680851063,0.9390037148772185,1.0,4/12,24.84%,PLCB1;DUSP1;SLIT2;SLAMF8
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3411272124116306,0.8533202162853526,0.7016706443914081,0.8834651671943546,1.0,8/25,25.22%,SDCBP;NRP1;ILK;CCL5;PTGES3;DSCAM;MIF;NCKAP1L
prerank,piRNA metabolic process (GO:0034587),0.35274385430632205,0.8531544771946121,0.6764331210191082,0.883406635120743,1.0,1/19,6.25%,PIWIL2
prerank,regulation of chemokine production (GO:0032642),0.31891582527568607,0.8530650639666939,0.6893424036281179,0.8832069153376221,1.0,5/36,10.09%,LPL;HIF1A;TREM2;ADAM17;HMOX1
prerank,plasma membrane tubulation (GO:0097320),0.3860600669682124,0.8529550174506307,0.6662269129287599,0.8830479682019604,1.0,5/13,28.05%,SNX33;CHMP4A;CAVIN2;BIN3;PACSIN2
prerank,actin filament bundle organization (GO:0061572),0.3249377863998231,0.8526725402220391,0.6993087557603687,0.8831674495630284,1.0,12/33,28.84%,LCP1;MICAL1;NEDD9;RHOD;ESPN;PLS1;BAIAP2;BAIAP2L2;RFLNA;BAIAP2L1;CORO1B;PAWR
prerank,regulation of cellular senescence (GO:2000772),0.3309006601411778,0.8525380928814342,0.6963657678780774,0.8830452868751842,1.0,7/28,18.05%,CDK6;FBXO5;NEK4;B2M;ZKSCAN3;ING2;NEK6
prerank,negative regulation of nuclear division (GO:0051784),0.39592580445043557,0.852381291526675,0.682825484764543,0.8829783639758328,1.0,3/11,21.77%,FBXO5;NME6;BMP4
prerank,cellular glucan metabolic process (GO:0006073),0.3985445233074005,0.8523154867522124,0.6975806451612904,0.8827606884688063,1.0,4/11,28.03%,PHKB;GSK3B;PYGM;GBE1
prerank,defense response to tumor cell (GO:0002357),0.39942618143681075,0.8516658569815055,0.6761517615176151,0.8835118129785344,1.0,3/10,20.69%,PRF1;DAPK1;LAPTM5
prerank,organelle disassembly (GO:1903008),0.3230617598300672,0.8511739889507797,0.6974595842956121,0.8839967857426512,1.0,13/33,27.56%,DENR;KLC1;UFM1;VCP;RETREG1;ATG2B;GFM2;PLK3;GOLGA2;STX5;ZFAND1;UFL1;EIF2D
prerank,determination of heart left/right asymmetry (GO:0061371),0.3114565952777162,0.8510258535303904,0.7032842582106456,0.8838985295494323,1.0,3/42,3.29%,MICAL2;TBX21;EOMES
prerank,positive regulation of tissue remodeling (GO:0034105),0.3975424860846042,0.8510061145716686,0.657103825136612,0.8835845161237534,1.0,4/10,19.53%,HRG;TMBIM1;ROCK1;IL2
prerank,ncRNA catabolic process (GO:0034661),0.32590726225241046,0.8507666944148453,0.6982035928143713,0.8836303274743099,1.0,11/28,29.75%,DEDD2;EXOSC4;ERN2;EXOSC9;EXOSC10;EXOSC5;SND1;XRN1;TRIR;TENT4B;POP1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.28791488269937204,-0.849706735976613,0.7043478260869566,0.945283536272757,1.0,3/15,9.72%,PNP;EBI3;NKAP
prerank,response to retinoic acid (GO:0032526),0.2991754496221209,0.8496260924202059,0.7301075268817204,0.885159844099925,1.0,9/59,15.39%,ABL2;PTK2B;SOX9;BRINP2;TRIM16;WNT6;FZD4;RBP4;ASXL1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2856307049542898,-0.8489004620761186,0.7079646017699115,0.9447192050210554,1.0,4/16,15.41%,PDK1;FOXK2;PRKN;PDK2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3149434109819568,0.8488547608602682,0.716589861751152,0.886061459500088,1.0,7/36,16.70%,SIRPA;TAOK3;PTPN22;TREM2;PPIA;FOXO1;DUSP3
prerank,histone mRNA metabolic process (GO:0008334),0.32812754909189545,0.8485733051260399,0.6973224679860303,0.8861894828430545,1.0,13/27,33.75%,EXOSC4;EXOSC10;ATM;XRN1;SNRPG;SNRPF;MTPAP;TENT4B;LSM11;DCP2;TUT1;SLBP;ERI1
prerank,positive regulation of cellular senescence (GO:2000774),-0.3285003746350897,-0.8484839998576418,0.6470588235294118,0.9433489024857477,1.0,4/10,20.84%,ABI3;HMGA2;ARG2;HMGA1
prerank,regulation of Golgi organization (GO:1903358),0.36186634944451535,0.8482890576524711,0.7002518891687658,0.8862942571970197,1.0,1/17,0.42%,MYO5A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.37843704468645467,0.8481235022882461,0.6731571627260083,0.88623146795966,1.0,2/13,14.19%,TMSB4X;DDIT3
prerank,triglyceride biosynthetic process (GO:0019432),-0.2777157751333973,-0.8478283998095393,0.6771300448430493,0.942403268779184,1.0,6/18,16.82%,AGMO;LPIN2;GPAM;GPAT3;PNPLA3;MOGAT3
prerank,positive regulation of cytokinesis (GO:0032467),0.32708808354239693,0.847662105395839,0.7312572087658593,0.8866345196872608,1.0,8/32,18.85%,MAP10;PKP4;RHOA;CDC42;PKN2;RACGAP1;SVIL;CUL3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.33875926651128574,0.846645914658318,0.7065868263473054,0.8879618270096147,1.0,10/23,29.74%,PTK2B;CCL5;GHR;CYP1B1;IL6;F2R;JAK2;TNF;HES1;PIBF1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4038717285686634,0.8465914271873846,0.6825613079019074,0.8877084566040813,1.0,3/10,25.05%,CAV1;SUMO1;KCNAB1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.37596308808237877,0.8461948736027157,0.6680053547523427,0.8880356765969085,1.0,7/13,31.26%,RHOA;ITGB2;IL6;TNF;MDK;ZDHHC21;ETS1
prerank,muscle tissue development (GO:0060537),0.3824325436409897,0.8459650325009779,0.7011795543905636,0.8880463297504317,1.0,4/13,21.77%,CSRP3;NF1;CSRP2;BMP4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.30078812826703355,-0.8455521617113849,0.6977777777777778,0.9450915601243209,1.0,6/14,20.12%,GPS2;CCDC3;PELI3;RFFL;CARD16;NLRP2B
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.33780385264715707,0.8454591912566278,0.6951672862453532,0.8885218748119562,1.0,7/21,20.52%,FBXO5;TPR;TEX14;IK;ATM;BUB1B;TRIP13
prerank,protein import into mitochondrial matrix (GO:0030150),0.3574570759002701,0.8452818918852502,0.700507614213198,0.888467397623676,1.0,6/18,22.78%,TIMM44;DNAJC15;TOMM40;TIMM21;TIMM17A;TIMM23
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.38052356731295167,0.8450084347356053,0.6837016574585635,0.8886178620280115,1.0,3/13,14.94%,ANAPC15;CCNB1;TPR
prerank,gonad development (GO:0008406),0.3060624864001982,0.8445335622016263,0.7076222980659841,0.8890570719625757,1.0,9/41,20.82%,CYP19A1;GATA3;SOX9;KITLG;BASP1;IRX5;COL9A3;MKKS;BIK
prerank,vasculature development (GO:0001944),0.3573817657093098,0.8445191777912147,0.7010309278350515,0.8887430071294715,1.0,7/16,34.10%,FBXW7;STK11;PDGFRA;NOTCH4;APLNR;ERRFI1;CDH5
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3493558483944782,0.8441131514447173,0.678117048346056,0.8890884841658372,1.0,3/18,14.00%,CDK5;CLN3;ACTB
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.4007047293663837,0.8438743281287371,0.695054945054945,0.8891201799667293,1.0,4/10,29.06%,ATP5MG;ATP5PD;ATP5F1C;ATP5MC1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3257422197120897,0.8437271836303597,0.7015276145710928,0.889023448463862,1.0,14/29,33.10%,STAT4;CCR2;GHR;IL31RA;PIAS1;STAT5B;SOCS2;JAK2;IFNAR2;STAMBP;CTR9;JAK3;IFNAR1;SOCS6
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3022104014889237,-0.8435306055367934,0.6723404255319149,0.9472976734463864,1.0,4/14,7.76%,WNK1;GLRX;WNK3;DMD
prerank,regulation of intracellular transport (GO:0032386),0.3160916211951623,0.8431900212248639,0.7170454545454545,0.8895268166068795,1.0,3/38,4.86%,LCP1;ATP13A2;DYNC1H1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.35240082858886435,0.8428169113070109,0.6977329974811083,0.889806338950635,1.0,4/20,14.45%,NPTN;FGF2;SPRY4;PRKD2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.35518461501447623,0.8428003489879771,0.6854219948849105,0.8894934872072986,1.0,9/17,32.29%,EIF4G1;CADM4;SMAD7;SPRED2;CALM3;SPRED3;SIRT2;CALM1;DGKQ
prerank,electron transport chain (GO:0022900),0.3649834330873821,0.8422291111664877,0.6951530612244898,0.8900923522694434,1.0,2/15,6.17%,POR;SDHB
prerank,cardiolipin metabolic process (GO:0032048),0.3761195644326542,0.841514696408518,0.6828947368421052,0.8909221461438797,1.0,5/13,25.17%,SLC27A1;TAMM41;PTPMT1;HADHA;PLA2G5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3993188611864187,0.8413250978727405,0.6867305061559508,0.8908802420968965,1.0,4/10,27.13%,CD274;CRTAM;PRKAR1A;RC3H1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2879436441769031,0.8412528169427186,0.7794871794871795,0.8906632113962851,1.0,19/85,22.91%,P2RX4;CHRNB2;MYO1A;GRXCR1;RIPOR2;PIEZO2;TPRN;TIMM9;CACNA1D;BIRC5;HOMER2;SLC26A4;USP53;WFS1;MYO3B;ATP6V0A4;MARVELD2;NIPBL;CLIC5
prerank,regulation of epidermal cell differentiation (GO:0045604),0.34296236556812365,0.8412002539490926,0.7062423500611995,0.8904156077680028,1.0,6/21,21.77%,MAFF;RUNX1;MAFG;ROCK1;SULT2B1;BMP4
prerank,positive regulation of neuron projection development (GO:0010976),0.2837131805416861,0.8410622014511412,0.7890382626680456,0.8903047124076422,1.0,7/85,4.45%,S100A9;APOE;ABL2;ALKAL2;PTK2B;ZDHHC15;NPTN
prerank,nucleotide metabolic process (GO:0009117),0.33453069066977764,0.8405687572002986,0.7032569360675512,0.8907549350962739,1.0,9/23,25.83%,AK8;NUDT5;AK4;AK5;RNASEH2B;NMNAT3;AK7;GUK1;ME1
prerank,glutamate metabolic process (GO:0006536),0.34580668570546247,0.840168910453765,0.6862026862026862,0.8910796701487844,1.0,5/19,17.87%,MTHFS;GLS2;GLS;FPGS;OAT
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3368640884874155,0.8400678634398637,0.7134071340713407,0.8909045460655017,1.0,7/23,27.94%,HTT;DCTN1;NUMA1;FBXW11;SPDL1;CENPA;ITGB1
prerank,response to light stimulus (GO:0009416),0.2946098195308284,0.8397894004887893,0.7542918454935622,0.8910091693694633,1.0,9/55,18.77%,ERCC6;COPS3;MAP4K3;DDB2;ZRANB3;RRH;ERCC4;UBE4B;CCAR2
prerank,regulation of lipid kinase activity (GO:0043550),-0.3267993818002735,-0.8397509039658221,0.6931407942238267,0.9533842838642761,1.0,2/11,4.55%,PIK3R1;RBL2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.30092963615071744,-0.8396792386605968,0.6956521739130435,0.9511820881026024,1.0,3/15,5.83%,PRKCE;PPM1K;IRS2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.30064033873872864,0.8395675750751704,0.7328918322295805,0.8910065684379804,1.0,16/45,29.50%,CD44;IRF6;PRKCD;IRF8;B2M;JAK1;IRF5;SP100;GBP2;TRIM21;JAK2;MT2A;IFNGR2;TRIM8;OASL;TRIM68
prerank,mitotic nuclear division (GO:0140014),0.29058543356281014,0.8393854395019928,0.7408184679958028,0.8909651637046325,1.0,20/71,26.51%,FLNA;NCAPG2;CHMP4B;LSM14A;BCCIP;ABRAXAS1;RHOA;CHMP7;PPP2R2D;INO80;SMC3;KIFC1;RAB11A;TOGARAM2;AAAS;STAG1;GOLGA2;CENPK;UBE2C;ESPL1
prerank,regulation of acrosome reaction (GO:0060046),0.39833736174951456,0.839292572520666,0.7018030513176144,0.8907756086794961,1.0,1/10,3.37%,SERPINA10
prerank,hemidesmosome assembly (GO:0031581),0.38270335919611703,0.8390921659941306,0.669889502762431,0.8907595277107497,1.0,4/11,21.45%,PLEC;LAMC1;DST;LAMA3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.319372617721985,0.8389181530127297,0.7350230414746544,0.8903701562414482,1.0,12/29,36.99%,ACOT9;ACOT6;GLYAT;ACAT1;ACOT1;ACOT8;DBI;ACLY;ACSF2;ACOT4;ACOT13;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.319372617721985,0.8389181530127297,0.7350230414746544,0.8903701562414482,1.0,12/29,36.99%,ACOT9;ACOT6;GLYAT;ACAT1;ACOT1;ACOT8;DBI;ACLY;ACSF2;ACOT4;ACOT13;ACSL6
prerank,nuclear body organization (GO:0030575),0.3834874771819796,0.8388005366025693,0.6863517060367454,0.8902163608565705,1.0,6/12,34.02%,USPL1;SRPK2;USP50;ZPR1;ETS1;HIPK2
prerank,histone H3-K36 demethylation (GO:0070544),-0.3271612574258519,-0.8387898046935044,0.6411960132890365,0.9507644237654785,1.0,3/10,10.09%,PHF8;KDM4A;KDM7A
prerank,central nervous system neuron differentiation (GO:0021953),0.3154688401553773,0.8387035689612216,0.7170900692840647,0.8900460335978986,1.0,8/33,19.63%,CTNNB1;ATP7A;LRP6;NR4A2;CHD5;TOX;AGTPBP1;GBA2
prerank,negative regulation of ATPase activity (GO:0032780),0.37007615329778076,0.8386942451766572,0.7048748353096179,0.8897291518347537,1.0,5/16,32.93%,LTF;THADA;TLR9;SIRT1;PAM16
prerank,inner dynein arm assembly (GO:0036159),0.40493070324943464,0.8382742649745589,0.6857142857142857,0.8900574415379577,1.0,4/10,27.33%,DNAAF5;DNAI3;CCDC40;CCDC39
prerank,embryonic organ development (GO:0048568),0.29285983756870915,0.838242517080016,0.7595744680851064,0.8897682536910365,1.0,17/61,24.47%,KMT2A;PDGFA;NES;GATA3;KITLG;TBC1D23;PKDCC;RBP4;KDR;IFT122;PBX1;TEAD1;PBX2;TGFBR2;FGFR2;TNF;ATF4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.39634894776851115,0.8376721629246009,0.6943661971830986,0.89034910881212,1.0,6/10,36.14%,RTEL1;DCLRE1A;ACD;TERF2IP;TERF2;RIF1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.38969946490030477,0.8375924823019751,0.7122708039492243,0.8901342263691324,1.0,5/11,23.64%,PDGFA;SOX9;CHRD;TGFBR2;FGFR2
prerank,heme biosynthetic process (GO:0006783),-0.25376455807226356,-0.8374409923121673,0.7157894736842105,0.9513123057677252,1.0,10/22,23.64%,CPOX;PGRMC1;UROS;SLC25A38;ALAS2;ALAD;FECH;PPOX;COX15;ABCB10
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.26188150262127696,-0.8374218702297815,0.7251461988304093,0.9490265301890857,1.0,7/20,20.88%,PRKCE;HECW1;HECW2;OSR1;NEDD4L;PLN;ADRA2A
prerank,regulation of astrocyte differentiation (GO:0048710),-0.31874636651218746,-0.8372329824669384,0.664179104477612,0.9471419821395567,1.0,2/12,2.00%,BIN1;EPHA4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4030623329089598,0.8369453499789131,0.7110215053763441,0.89086438628583,1.0,2/10,9.40%,PPP2R1A;PTPN2
prerank,cilium assembly (GO:0060271),0.2670215959361915,0.8368752983890434,0.914914914914915,0.8906344116588902,1.0,87/296,30.14%,FLNA;ASAP1;CFAP44;ODF2;TEKT2;PTPN23;BBS10;ATP6V0D1;DYNC1H1;PPP2R1A;RILPL2;FOXJ1;SPAG16;NINL;IFT43;TEKT5;WDR35;HAUS8;SNX10;ARMC9;RAB8A;ABLIM1;CEP41;RAB8B;DCTN1;TCTN3;PARVA;YWHAG;EXOC2;GSN;TBC1D32;CNGB1;DCX;CEP250;ACTR3;IFT88;CSNK1D;TMEM216;SPATA6;PLK4;LZTFL1;RAB1A;IFT74;TUBB;MKKS;RAB11A;CFAP70;HAUS2;RILPL1;EHD4;BBIP1;MAK;IFT122;MARK4;DYNC2I1;EHD1;TNPO1;CYS1;CCDC65;TRAF3IP1;RILP;BBS7;MKS1;TMEM107;SCLT1;CCDC40;CETN2;MAPRE1;CCDC39;DYNLT2B;ACTR2;TMEM237;EXOC4;DNAH5;ARL3;CEP97;TMEM17;ARL6;CEP83;RPGRIP1;CFAP410;CSNK1E;GORAB;IQCB1;PIBF1;ALMS1;CEP57
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.28361042811852155,0.8368507983102108,0.7678756476683938,0.8903405342953411,1.0,15/82,18.29%,ODF2;DYNC1H1;PPP2R1A;NINL;HAUS8;CEP41;ATF5;DCTN1;YWHAG;CDK2;CEP250;CSNK1D;PLK4;TUBB;HAUS2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.27563510711967937,0.8366166281354723,0.7957099080694586,0.8903752441478205,1.0,19/109,14.40%,PLEK;SLC27A1;PLAAT3;ARF3;PIK3CB;FGF2;PIK3R5;PI4K2A;INPPL1;PLCB2;VAC14;PGAP1;PLEKHA1;PIP5K1C;LPGAT1;MTMR14;RAB5A;PTPN13;MTMR12
prerank,limb morphogenesis (GO:0035108),-0.26559390833312735,-0.8363858784142557,0.6833333333333333,0.9466165172597271,1.0,2/20,3.33%,PCSK5;BMPR1B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.25314743029302395,-0.8363724807833622,0.7396449704142012,0.944350177660857,1.0,10/23,24.95%,MTMR9;SACM1L;MTMR7;INPP5J;INPP5K;INPP5B;PIP4P1;MTMR4;TPTE;MTMR2
prerank,B cell activation involved in immune response (GO:0002312),-0.29974825206774686,-0.8361379065514464,0.6806083650190115,0.9425880457077149,1.0,5/13,29.09%,FCGR2B;RNF168;GAPT;CD19;RNF8
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.29548281658459286,0.8360160409923098,0.7698924731182796,0.8910124101437322,1.0,15/59,21.27%,DYRK2;CDK5;PRKCD;PDPK1;SBK1;HIPK1;MAP3K12;ROCK1;PRKD2;CAD;NLK;CSNK2A2;LMTK2;MARK2;GSK3B
prerank,hematopoietic stem cell proliferation (GO:0071425),0.38589728242188315,0.8353462670669324,0.6927374301675978,0.8917289071583248,1.0,3/11,15.49%,RUNX1;ETV6;YTHDF2
prerank,nucleoside catabolic process (GO:0009164),0.3904425068706551,0.835091715531896,0.7083333333333334,0.8918008248409505,1.0,2/11,12.17%,DERA;UPB1
prerank,bicellular tight junction assembly (GO:0070830),0.29851058104203004,0.8350038981886927,0.7450331125827815,0.8915983720979541,1.0,9/46,20.41%,POF1B;CLDN19;PDCD6IP;CLDN18;PAK2;MICALL2;AFDN;PATJ;MARVELD2
prerank,renal absorption (GO:0070293),0.3949204334119455,0.8349105753744273,0.7095435684647303,0.8914103219076461,1.0,2/10,12.03%,SGK1;GSN
prerank,regulation of interleukin-10 production (GO:0032653),0.3010400076626913,0.8347799471162225,0.7392739273927392,0.891280546260053,1.0,10/44,22.04%,MMP8;CD28;CD274;LILRB1;HSPD1;SYK;IL6;HMGB1;CD47;TRIB2
prerank,ERBB2 signaling pathway (GO:0038128),0.31716173125106295,0.834725541960724,0.7134767836919592,0.891024640984231,1.0,6/31,13.63%,NRG1;ERBIN;GRB2;MYOC;PTPN12;CPNE3
prerank,skeletal muscle contraction (GO:0003009),0.350704605464397,0.8345026119442377,0.7082785808147175,0.891036291451554,1.0,2/19,7.62%,TNNT3;STAC2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.27060628223701416,0.8333011784441066,0.8308004052684904,0.8926472762725866,1.0,26/159,15.51%,ALCAM;CD84;ITGAL;NECTIN1;PCDHB10;CD6;CLDN19;NPTN;MILR1;AMIGO1;SELL;CADM1;FAT4;NECTIN3;CDH1;JAML;CRTAM;CLDN18;MPZ;PCDHGC3;EMB;PALLD;PCDHB11;SLITRK2;ITGB2;TRO
prerank,regulation of small molecule metabolic process (GO:0062012),0.32386002241297207,0.8329343841574546,0.7391812865497076,0.8928766491532115,1.0,6/28,21.84%,APOE;NCOR2;ARV1;ADIPOR1;PDK3;ACADL
prerank,embryonic limb morphogenesis (GO:0030326),0.3118925312913755,0.8326472647131091,0.7427912341407151,0.8930028675746696,1.0,12/34,32.09%,CTNNB1;HDAC1;FBXW4;LRP6;NIPBL;ECE1;HDAC2;GLI3;RARG;CREBBP;MEGF8;MAP3K20
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.371436275271818,0.8326393478922528,0.7028061224489796,0.8926768866166612,1.0,7/14,33.18%,GART;ATIC;ADSS1;PPAT;ADSL;GMPS;ADSS2
prerank,actin filament bundle assembly (GO:0051017),0.31790065946925294,0.832552118854081,0.7311703360370799,0.8924870767372879,1.0,4/33,7.77%,LCP1;MICAL1;NEDD9;RHOD
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.3211449077103544,-0.8324290745526688,0.6254681647940075,0.9460254289999759,1.0,5/11,16.99%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3211449077103544,-0.8324290745526688,0.6254681647940075,0.9460254289999759,1.0,5/11,16.99%,INPP5J;INPP5K;INPP1;INPP5B;IMPA2
prerank,neuromuscular synaptic transmission (GO:0007274),0.35449636036364063,0.832394021593474,0.7023959646910467,0.8924021943662725,1.0,4/18,15.05%,CHRNB2;ERC2;DTNA;TBC1D24
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.34919142628202726,0.8323662403228573,0.7229381443298969,0.8921124891543489,1.0,9/17,31.26%,CD44;CD74;MIF;MDM2;PSMD10;KDM1A;PTTG1IP;SIRT1;RNF34
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3117833458148291,0.8322399123075436,0.7268571428571429,0.8919702804668315,1.0,4/35,6.75%,APOE;NPPA;CAP1;SOX9
prerank,regulation of kinase activity (GO:0043549),0.2782195895288646,0.8322105705848464,0.7816091954022989,0.8916851723652444,1.0,11/89,11.33%,FLT1;CD4;FGR;AXL;LMO4;EEF1A1;TREM2;IGF1R;VAC14;NPRL2;RAD50
prerank,regulation of phosphate metabolic process (GO:0019220),0.36161442635019114,0.8311617966577035,0.6900510204081632,0.8929892359925016,1.0,2/16,4.29%,CD24;MCM7
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3028450550906929,0.8308853365465384,0.7371428571428571,0.8931081373501573,1.0,8/41,13.46%,STAP1;FBXW7;NEDD9;ADAM17;FYN;EFNA1;GAS6;GPRC5B
prerank,rRNA modification (GO:0000154),0.34231909592387166,0.8308204981975915,0.7172582619339045,0.8928784529447615,1.0,9/21,27.37%,MRM2;FTSJ3;GAR1;NSUN3;DKC1;TRMT112;DIMT1;NAT10;NSUN4
prerank,regulation of dendrite extension (GO:1903859),-0.28428024664864593,-0.8306834350308666,0.7079646017699115,0.9474117119075581,1.0,7/18,15.77%,RIMS1;SYT1;SMURF1;SYT2;RIMS2;CPNE5;NEDD4L
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3862071807015268,0.8304741382536885,0.6895640686922061,0.8930708080516132,1.0,2/11,7.23%,KCNJ2;ATP1A1
prerank,cellular response to UV-A (GO:0071492),0.38227600299307674,0.8303087071063339,0.7092105263157895,0.8929886401438565,1.0,1/11,4.38%,MMP9
prerank,transport along microtubule (GO:0010970),0.3690159871808779,0.8293723801434978,0.6858288770053476,0.8941306387711426,1.0,3/13,14.41%,ARHGAP21;CDC42;BORCS5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.33480204245287815,0.829262113164486,0.7233250620347395,0.8939728047345824,1.0,6/23,21.21%,SLC9A1;SLC12A4;SLC9A7;SLC26A4;ATP6V0A4;SLC12A7
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.2705132481981629,-0.8285557934590626,0.7433155080213903,0.9493483499245059,1.0,3/16,3.09%,AOAH;PHKA2;PHKG1
prerank,response to leucine (GO:0043201),0.394981963928696,0.8282848999415812,0.6968503937007874,0.8948492713047004,1.0,4/10,26.28%,RRAGD;UBR2;LARS1;SESN2
prerank,cellular response to leucine (GO:0071233),0.394981963928696,0.8282848999415812,0.6968503937007874,0.8948492713047004,1.0,4/10,26.28%,RRAGD;UBR2;LARS1;SESN2
prerank,protein acylation (GO:0043543),0.3086240999336639,0.8280436817545103,0.7196885428253615,0.8948785061390586,1.0,7/38,16.44%,SPHK1;ZDHHC15;ZDHHC18;ING4;ZDHHC1;FOXO1;ING5
prerank,double-strand break repair (GO:0006302),0.2676951822923693,0.8280036633072034,0.8333333333333334,0.8946003560046619,1.0,46/158,26.48%,RAD51B;NSMCE2;ERCC1;CYREN;AP5Z1;RMI1;MDC1;VCP;ABRAXAS1;BRCA1;RAD50;DDX1;BAP1;HPF1;PSMD14;BLM;YY1;INO80;ERCC4;SLX4;BARD1;SEM1;KDM4D;POLB;PARP3;UIMC1;UBE2V2;BAZ1B;ATM;MORF4L1;RAD51AP1;HMGB1;TRIP13;RECQL5;MCM8;DCLRE1A;SETMAR;NSMCE1;SUMO1;PARP2;GEN1;SMC6;PALB2;PIAS4;LIG3;BRCC3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2845384167155823,0.8277886792448611,0.7676874340021119,0.8945960746527064,1.0,22/72,26.28%,MUC1;CNOT4;ING4;PLK2;CCNB1;BAX;TRIAP1;CNOT10;NDRG1;CARM1;SP100;PCBP4;TFAP4;ATRX;ATM;CRADD;CNOT6;MDM2;PLK3;GADD45A;CNOT6L;SESN2
prerank,positive regulation of isotype switching (GO:0045830),-0.2864424113124558,-0.8273945609123063,0.6909090909090909,0.9494312555750051,1.0,5/15,18.52%,PAXIP1;CD40;SHLD3;MAD2L2;SHLD2
prerank,positive regulation of DNA repair (GO:0045739),0.29922238419009745,0.8270458534089958,0.7581920903954802,0.8953975924110668,1.0,11/46,20.12%,ERCC6;EYA4;TRIM28;ABRAXAS1;MGMT;BRCA1;CEBPG;UIMC1;DHX9;RPS3;HMGB1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.27735644026204676,0.8269786439195967,0.8078512396694215,0.8951554107071619,1.0,35/91,31.23%,ABL2;PTPRC;FGR;SPHK1;NRP1;CD22;BET1L;RAB5C;RAB8A;RAB8B;HIP1;RAB5A;CPLX2;RUFY2;SYK;VAMP2;HIP1R;RAB11A;ARFGAP1;RAB3D;SNX12;MAP2K2;STON1;STX4;RAB5B;PACSIN2;MAPK3;RAB11B;SNX17;FES;RUFY1;RALA;OLFM4;PTPN1;MAPK1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.37076692397989647,0.8265986266219247,0.7131782945736435,0.8953983563301903,1.0,4/14,14.94%,SLC25A33;MRPL12;EARS2;TWNK
prerank,eye development (GO:0001654),0.292992744917805,0.8265727768487953,0.7524012806830309,0.8951026193493336,1.0,13/54,25.73%,SH3PXD2B;BLOC1S3;HIPK1;SMG9;SMOC1;RBP4;CPAMD8;MEIS3;PBX1;NIPBL;PBX2;SIPA1L3;RAB3GAP1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2814903561707075,0.8262848664476473,0.7780104712041885,0.8952189237503255,1.0,20/75,24.51%,APOE;PIK3CB;PRKCD;IPO5;CD300A;CEBPA;PAQR3;TFAP4;PKIB;SPRY4;LRP6;STK38;NF1;SMPD1;TESK1;PRKAR1A;BMP4;LATS1;HEG1;GADD45A
prerank,retrograde axonal transport (GO:0008090),0.356057740338609,0.8261840601885356,0.7027707808564232,0.8950430519842726,1.0,5/16,20.39%,MGARP;DYNC1H1;KIF1A;DST;FBXW11
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3727224516359704,0.8261619394732391,0.6985195154777928,0.8947477782827925,1.0,1/12,2.14%,ADCY8
prerank,diacylglycerol metabolic process (GO:0046339),0.3350074531171379,0.8261263981059246,0.7019230769230769,0.8944671850841598,1.0,5/23,17.29%,DGKZ;APOA2;DGKA;DGKH;DGKD
prerank,positive regulation of chemokine production (GO:0032722),0.29987755121261395,0.825388590228619,0.7428884026258206,0.8952937502757508,1.0,14/44,25.85%,LPL;HIF1A;ADAM17;HMOX1;MBP;TIRAP;SYK;IL6;HMGB1;CD74;IL17RA;EGR1;TNF;TLR9
prerank,heart development (GO:0007507),0.26639305662622315,0.8240120009993251,0.8444444444444444,0.8970786985380503,1.0,13/150,7.55%,SH3PXD2B;FN1;MICAL2;HDAC9;AKAP13;PDLIM1;ID2;TH;MEF2D;CSRP3;SOX9;VEGFA;DLC1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.33363926853547216,0.8237418628661454,0.7252475247524752,0.8971377509091254,1.0,10/20,29.06%,NKTR;PPIA;PPIE;PIN1;PPIG;PPIL6;PPIH;FKBP1B;PPIL3;FKBP1A
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3327827842239674,0.82322524604587,0.7151515151515152,0.8975698901057036,1.0,2/22,4.05%,CYP27B1;VDR
prerank,regulation of catecholamine secretion (GO:0050433),-0.23744306623143646,-0.8230390121356724,0.7837837837837838,0.9558973728674562,1.0,6/29,10.51%,SYT10;KCNB1;SYT1;SYT2;PRKN;STX1A
prerank,phosphatidylcholine metabolic process (GO:0046470),0.28382787667287457,0.8229656538823895,0.7643923240938166,0.8976313746062466,1.0,7/70,7.58%,SLC27A1;PLAAT3;PEMT;APOA2;PON1;STARD10;CHKB
prerank,response to growth factor (GO:0070848),0.30015656243300115,0.8222074238066691,0.7630121816168328,0.8984745902131781,1.0,9/41,25.13%,CTNNB1;SPHK1;RACK1;CPNE3;MAPK7;STAT5B;TGFBR2;MAP2K5;SFRP1
prerank,protein acetylation (GO:0006473),0.3188767306835778,0.8217577652129162,0.7306791569086651,0.8988199729981503,1.0,14/30,32.24%,SPHK1;ING4;NAA16;FOXO1;ING5;NAA80;HAT1;NAT10;NAA15;SIRT1;AANAT;EP300;CREBBP;NAA50
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.31661605342892735,0.821583473652449,0.7267508610792193,0.8987249887751062,1.0,5/29,12.70%,APOE;MCTP1;SYNGR1;CLN3;RAB5A
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.31816880079889487,0.8212483850278911,0.7455197132616488,0.8989202124656578,1.0,13/27,33.65%,ERN1;RNASEH1;ZC3H12B;RNASE6;ZC3H12D;XRN1;TRIR;ZC3H12C;POP1;NYNRIN;ZC3H12A;TOE1;NUDT16
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3732533291747353,0.8209778932071734,0.7120211360634082,0.8990053453056221,1.0,3/12,18.61%,TMEM199;CLN3;TMEM165
prerank,positive regulation of dendrite extension (GO:1903861),-0.28429012875347914,-0.8207814877097823,0.6711111111111111,0.958263588394988,1.0,7/17,15.77%,RIMS1;SYT1;SMURF1;SYT2;RIMS2;CPNE5;NEDD4L
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3860386972005515,0.8205263082382411,0.7097222222222223,0.8993564609690444,1.0,1/11,4.72%,NRP1
prerank,cellular response to sterol (GO:0036315),-0.2927401219135838,-0.8199382407339315,0.6774193548387096,0.9576307874184867,1.0,3/13,8.02%,INSIG1;INSIG2;OSBPL7
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.34590798351680097,0.8198373470168308,0.7232472324723247,0.9000350146689033,1.0,6/17,21.11%,LTF;SASH1;SIGIRR;BMP6;SCIMP;CD55
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.33149454770647085,0.8195374214438274,0.7461077844311377,0.8998248826206491,1.0,3/22,13.44%,ZDHHC15;ZDHHC18;ZDHHC1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.33149454770647085,0.8195374214438274,0.7461077844311377,0.8998248826206491,1.0,3/22,13.44%,ZDHHC15;ZDHHC18;ZDHHC1
prerank,negative regulation of neuron differentiation (GO:0045665),0.33017653279647574,0.819203432917538,0.7304878048780488,0.9000033708041927,1.0,8/22,29.16%,SOX3;SOX9;B2M;NEPRO;GSK3B;CALR;HES1;MED1
prerank,cellular response to misfolded protein (GO:0071218),0.3365779320618854,0.8188109939800374,0.7468827930174564,0.9002581394593415,1.0,5/20,18.85%,DNAJB14;ATXN3;VCP;DERL1;CUL3
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2527709784565876,-0.8187795794995986,0.7251461988304093,0.9575852681605097,1.0,3/24,8.88%,ITGAM;KCNB1;C2CD5
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.2699153170959029,-0.8187191344374191,0.7232142857142857,0.9554639434309258,1.0,2/17,1.23%,F11R;ROCK2
prerank,negative regulation of hydrolase activity (GO:0051346),0.2921359487331738,0.818438572257747,0.7744034707158352,0.9004907872330236,1.0,13/49,20.51%,CST7;APOA2;CPEB2;ZCCHC9;CSTB;KLRK1;PPP1R35;ECM1;SH2D4A;CHP1;ARFGEF1;EGLN1;GMIP
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3179948442526067,0.8180911618876172,0.7549132947976879,0.9006673186267316,1.0,9/29,25.16%,GATA3;NKX2-1;SMAD7;EFNA1;ADIPOR1;SPRED2;SPRED3;SFRP1;BMP5
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3886395149671189,0.817810342156116,0.7318435754189944,0.900760967824735,1.0,7/10,40.71%,PIH1D1;RUVBL2;ZNHIT6;NAF1;RUVBL1;SHQ1;TAF9
prerank,respiratory electron transport chain (GO:0022904),0.356775036946856,0.8174983013797057,0.7238605898123325,0.9009195157535792,1.0,2/14,6.17%,GPD2;SDHB
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2872486754109305,-0.8172413601655851,0.7465437788018433,0.9561611878700739,1.0,3/16,8.76%,DPYD;DPYSL2;CRMP1
prerank,development of primary male sexual characteristics (GO:0046546),0.30293015784487487,0.8171109134651418,0.7435897435897436,0.9011900880824653,1.0,4/34,8.69%,LHFPL2;GATA3;SOX9;KITLG
prerank,miRNA metabolic process (GO:0010586),0.33364773170125456,0.8170454655723255,0.7209876543209877,0.9009580853335423,1.0,6/20,28.79%,AGO2;DDX17;SND1;KHSRP;TARBP2;TENT4B
prerank,embryonic digestive tract development (GO:0048566),-0.2715594776982001,-0.816349101214728,0.75,0.9557095741282265,1.0,2/18,1.28%,SALL1;PCSK5
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2614613602824254,0.8163259576194081,0.925,0.9016910160592431,1.0,51/291,18.32%,LPL;STAP1;ABL2;RRAGD;P2RX4;SIRPA;VIM;PRDX5;AXL;NR4A3;PTK2B;MMP9;PRKCD;CPEB4;CD274;IPO5;SOX9;BRINP2;TNIP3;LILRB1;AGAP3;WNT6;P2RY1;PABPN1;TICAM1;PLAA;VCP;CPEB3;SHMT1;JUN;SERPINE1;TNFRSF1B;RHOA;TNIP2;CDK2;FZD4;ACTB;GIT1;NFKB1;DAPK1;ACOD1;MAPK9;FOXO1;TIRAP;DHX36;PDCD4;SBNO2;P2RY2;PAF1;ATM;IL6
prerank,sensory perception (GO:0007600),0.29639310296483407,0.8161368849246925,0.7703141928494042,0.9016460724829035,1.0,8/45,17.49%,P2RX4;PTGES;CHRNB2;ASIC3;CCR2;ADORA2A;RETREG1;C5AR1
prerank,regulation of lipid metabolic process (GO:0019216),0.27606966897826235,0.8151258948217901,0.8232848232848233,0.9028140471835745,1.0,27/88,25.66%,NFYA;ACACA;ID2;NCOR2;PSAP;CAV1;PPARG;PPARD;APOC1;CARM1;MID1IP1;ABCA7;NFYB;HELZ2;ADIPOR1;SP1;ACACB;NPC2;SREBF1;TM6SF2;PMVK;MBOAT7;RXRA;EDF1;FASN;LACTB;HDAC3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.284707919899056,0.8146335530075254,0.789010989010989,0.9032115614919588,1.0,10/59,15.51%,CD84;NECTIN1;NPTN;AMIGO1;CADM1;NECTIN3;CDH1;EMB;PALLD;TRO
prerank,receptor recycling (GO:0001881),0.3868792819762742,0.8145499107749056,0.7283783783783784,0.9030071200211599,1.0,5/10,29.09%,REP15;ARFGEF2;LMTK2;PLEKHJ1;RAB11B
prerank,skeletal system morphogenesis (GO:0048705),0.29801721118592883,0.8144586208220865,0.7631578947368421,0.9028047124061963,1.0,12/42,24.88%,LTF;HOXA4;ANKRD11;LRP6;HOXB4;HHIP;HOXC9;FGFR3;DYNC2I1;FGFR2;WWOX;PDGFRA
prerank,regulation of axon guidance (GO:1902667),0.37877154047238465,0.8141523649462135,0.7142857142857143,0.9029495571575152,1.0,4/10,22.51%,NRP1;VEGFA;ZSWIM8;ZSWIM5
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.23441752818502,-0.8140752479007242,0.7593984962406015,0.9578352215345767,1.0,11/29,25.34%,LPCAT2;PNPLA8;PLA2G4C;PLA2G4E;NR1H3;PLBD1;PLA2G3;PLA2G4F;PLA2G2D;LPCAT4;MBOAT2
prerank,purine nucleotide catabolic process (GO:0006195),0.36648626434048664,0.8137002432132241,0.7280108254397835,0.9032978890135952,1.0,4/13,26.24%,XDH;ITPA;NUDT15;GPX1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2730034136981586,0.8136707048811431,0.8269824922760041,0.9030098266467653,1.0,28/94,30.75%,ODF2;DYNC1H1;PPP2R1A;NINL;HAUS8;CEP41;DCTN1;TCTN3;YWHAG;CEP250;CSNK1D;TMEM216;PLK4;TUBB;RAB11A;HAUS2;MARK4;MKS1;SCLT1;CETN2;MAPRE1;CEP97;CEP83;CSNK1E;IQCB1;ALMS1;CEP57;TTBK2
prerank,fatty acid elongation (GO:0030497),0.3612862004464635,0.8135032275217187,0.7174770039421814,0.9029412145530008,1.0,4/13,21.82%,HACD2;HACD1;ELOVL2;ELOVL1
prerank,protein maturation (GO:0051604),0.27048385624089244,0.8134219457047505,0.8104508196721312,0.9027290541701098,1.0,20/95,16.09%,ADAMTS13;ECEL1;CPXM2;TSPAN17;SDE2;NFU1;PSEN2;NAA16;ADAM17;AEBP1;ISCA1;TASP1;CLN3;DDI2;AFG3L2;TSPAN5;OGT;CPD;HSPD1;FURIN
prerank,oxoacid metabolic process (GO:0043436),0.3185768514935915,0.813219402597871,0.7473435655253837,0.9026936641008887,1.0,9/27,30.22%,GNMT;SULT6B1;TPST1;BPNT1;SULT2B1;MIF;LIPT2;BPNT2;PPA1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3626253340646969,0.8129697193875002,0.7225891677675033,0.9027187775517174,1.0,4/13,21.82%,HACD2;HACD1;ELOVL2;ELOVL1
prerank,regulation of lamellipodium organization (GO:1902743),0.36008133710967594,0.8127669095667347,0.7217280813214739,0.9026819153002876,1.0,3/14,13.01%,PDPN;CD44;CDC42
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2977750120246972,0.8125130430819242,0.7628635346756152,0.9027179000537721,1.0,8/39,16.20%,SPHK2;FXYD5;RANGRF;SCN1B;CACNA1D;UTRN;FXYD4;SCN3B
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.29889384774290123,0.8120964043311077,0.7593643586833144,0.9029718625496455,1.0,10/39,17.47%,SH3KBP1;GRB2;MVP;PTPN2;PTPN12;STAM2;CDC42;CBL;DUSP3;EPS15L1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3666499991173862,0.8116061281432266,0.7305151915455746,0.9033464156589357,1.0,5/13,25.22%,RUNX1;ZBTB7B;RUNX3;TGFBR2;NCKAP1L
prerank,T cell migration (GO:0072678),0.3644405353778382,0.8114266613992098,0.7259158751696065,0.9032685078643248,1.0,4/13,26.03%,MSN;CXCL16;MYO1G;GPR183
prerank,intracellular protein transmembrane transport (GO:0065002),0.29387057038503867,0.810863115866237,0.7678767876787679,0.9037970984285681,1.0,13/42,24.97%,PEX2;TIMM44;DNAJC15;SEC61B;SEC63;HSPD1;TOMM40;TIMM21;PEX16;TIMM17A;TIMM23;PEX14;HSPA5
prerank,mitochondrial fission (GO:0000266),0.34378889043977756,0.8106227270518255,0.7215025906735751,0.9038037582020841,1.0,7/16,29.97%,DNM2;MTFP1;MTFR2;MTFR1;FIS1;MUL1;MFF
prerank,potassium ion transport (GO:0006813),0.2664195029111772,0.8104540417591646,0.8346938775510204,0.9037377534677457,1.0,20/120,16.40%,SLC9A1;SLC24A4;KCNN4;ATP1B3;KCNK13;LRRC52;KCNA3;KCNJ2;CCDC51;KCNMA1;SLC9A8;ATP1A4;KCNA4;KCNMB4;KCNJ10;SLC9A6;SLC9A7;ATP1A2;CHP1;KCNH8
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3255373932576586,0.8100294846949272,0.75,0.9040203605529922,1.0,8/24,31.41%,SELENON;SRI;JPH1;CALM3;FKBP1B;FKBP1A;GSTO1;CALM1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.27456528745594266,0.8096175278561784,0.8286893704850361,0.9042993921123657,1.0,19/86,26.43%,SDCBP;BMP8B;GDF6;DAB2;ADAM17;RNF111;RBPMS;NUMA1;ING2;SH2B1;BMP6;STK11;NUP93;HSP90AB1;BMP4;JAK2;GIPC1;BMP5;SNW1
prerank,neuron projection development (GO:0031175),0.2640917087163866,0.8094002229959258,0.8816449348044132,0.9042968791288737,1.0,36/168,21.27%,APOE;ERCC6;GAS7;BLOC1S3;LRP12;SGK1;ATP7A;PPP1R9B;ATXN10;ALS2;GPRIN1;GRXCR1;CDK5;TAOK3;DTNBP1;FRYL;TBC1D23;DIP2A;DNM2;MYOC;CDC42;ROCK1;STX3;SLC9A6;IFT88;TBC1D24;DOCK7;MICALL2;MINK1;RAB11A;IL6;CDK16;HMGB1;GPRIN3;MARK2;GSK3B
prerank,ganglioside biosynthetic process (GO:0001574),0.35297030069907,0.8085320990687387,0.7144702842377261,0.9052267135006482,1.0,3/15,13.96%,B4GALT5;ST8SIA6;B4GALNT1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3054080303018307,0.8084030684476115,0.7593023255813953,0.9050720803436039,1.0,14/34,30.97%,DUSP9;PTPN22;PTPN2;DUSP6;PTPN12;PTPN13;DUSP3;DUSP16;PTPN9;PTPN18;PTPN6;DUSP5;PTPRZ1;PTPN1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30240277790023395,0.8081782063072266,0.7577854671280276,0.9050655501749956,1.0,9/35,18.99%,ACACA;SLC27A5;SLC25A1;SCD5;HSD17B8;AACS;BDH1;ACAT1;GCDH
prerank,negative regulation of fat cell differentiation (GO:0045599),0.30205651889310015,0.8078084543592591,0.7697594501718213,0.9052898940380653,1.0,9/34,24.33%,GATA3;ASXL1;FOXO1;ANKRD26;IL6;FERMT2;TRIB2;TNF;CCDC85B
prerank,regulation of stress fiber assembly (GO:0051492),0.27616220185991264,0.8076093358672721,0.8077731092436975,0.9052612561240099,1.0,25/74,22.58%,SLC9A1;NRP1;DLC1;ACTG1;ARHGAP6;MYOC;ARHGEF18;RHOA;LIMK1;CDC42;PAK2;ROCK1;LPAR1;SERPINF2;TESK1;FERMT2;ITGB1BP1;EVL;PPFIA1;CD47;GPR65;PTGER4;WAS;PFN1;ARHGEF5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2679029595324946,0.8065974321538874,0.8449848024316109,0.9063585169644828,1.0,27/124,21.35%,APOE;ERCC6;PLEK;BLOC1S3;LRP12;PPP1R9B;ATXN10;ODF2;GPRIN1;CDK5;DTNBP1;FRYL;PLEKHA1;TBC1D23;MYOC;ROCK1;STX3;TBC1D24;DOCK7;MICALL2;RAB11A;IL6;CDK16;HMGB1;GPRIN3;GSK3B;MARK4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3342612515444279,0.8064788271715417,0.7422680412371134,0.9061918114393313,1.0,2/19,2.87%,PTPRC;PTGFR
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2981843138895821,-0.8058257710055466,0.7354085603112841,0.9718256128631984,1.0,5/12,22.12%,IL18;IL1B;CD80;PAEP;ISL1
prerank,steroid metabolic process (GO:0008202),0.2774054784176326,0.8056616357417794,0.8077324973876698,0.9070241990721678,1.0,12/72,19.63%,LIPA;CYP19A1;CYP27B1;VDR;DHRS9;ARV1;CYP2A6;NPC1;CYP1B1;DHRS11;SULT2B1;GBA2
prerank,ventricular septum development (GO:0003281),-0.21515985791599634,-0.8054715282871583,0.8031496062992126,0.97022801274909,1.0,16/37,30.79%,SALL1;ROBO1;ZFPM1;ROBO2;PDE2A;MATR3;HEY1;HEYL;SLIT2;CITED2;GJA5;BMPR2;ZFPM2;TGFBR1;SOX4;BMPR1A
prerank,rRNA pseudouridine synthesis (GO:0031118),0.38064555750644147,0.8054415285877032,0.7174515235457064,0.9070225636307214,1.0,4/10,24.42%,GAR1;DKC1;RPUSD1;RPUSD4
prerank,maintenance of blood-brain barrier (GO:0035633),-0.2357549351993304,-0.8051688709573054,0.7888198757763976,0.9685712438961012,1.0,12/30,20.29%,F11R;JAM2;TJP1;SLC12A2;WNK3;DMD;CLDN12;ESAM;TJP3;SLC1A1;OCLN;CLDN5
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.29313497659207366,-0.8050666418525818,0.7195121951219512,0.966512938575614,1.0,4/13,13.37%,CNOT8;PNPT1;GTPBP1;MOV10
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2889272110516576,0.8049411218033821,0.7830923248053393,0.9074197788354134,1.0,12/46,25.17%,DGKZ;SLC27A1;DDHD1;ABHD5;DGKA;DGKH;DGKD;AGPAT2;PLA2G12A;AGPAT1;ABHD4;PLA2G5
prerank,regulation of muscle cell differentiation (GO:0051147),0.30996007702431433,0.8046753146339592,0.7719298245614035,0.9074794825905578,1.0,6/31,15.46%,CTNNB1;HDAC9;ID2;SPAG9;CDC42;SRF
prerank,protein K48-linked deubiquitination (GO:0071108),0.3224851506448739,0.804460360604701,0.7610837438423645,0.9074683707250556,1.0,11/23,30.82%,OTUD4;ATXN3;USP5;BAP1;USP33;USP50;USP8;OTUD5;TNFAIP3;USP34;MINDY2
prerank,negative regulation of developmental process (GO:0051093),0.2769910124576234,0.8043206674054184,0.8042328042328042,0.9073388600882919,1.0,19/69,25.45%,CDK6;FOXJ1;SOX9;VAT1;SFRP5;HUWE1;GAS6;ROCK1;TFRC;SINHCAF;PARP3;BMP4;FGFR3;MIF;IL17D;BNIP3;ANP32B;SFRP1;NOTCH4
prerank,protein depolymerization (GO:0051261),0.31077818684078296,0.8041270425261468,0.7733175914994097,0.9072805365495966,1.0,4/27,12.03%,MICAL2;MICAL1;VPS4B;GSN
prerank,pulmonary valve development (GO:0003177),-0.252740001203827,-0.8027090091851408,0.7821782178217822,0.9686053261067044,1.0,7/18,22.00%,ROBO1;NOTCH2;ROBO2;NFATC1;HEY1;HEYL;SLIT2
prerank,digestive tract development (GO:0048565),-0.22844699922597367,-0.8025710179014145,0.7662337662337663,0.9665916460079218,1.0,2/32,1.28%,SALL1;PCSK5
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3200389478316295,0.801810886528923,0.7417783191230207,0.9102617547894488,1.0,1/24,0.26%,FGF13
prerank,signal transduction by p53 class mediator (GO:0072331),-0.23096146255912664,-0.8018039033455002,0.8089171974522293,0.9659096950792051,1.0,7/30,17.35%,FHIT;PAXIP1;MYO6;PDK2;PMAIP1;BCL3;E2F7
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.32523575687898154,0.8010076821493924,0.7444168734491315,0.9110939532623743,1.0,5/21,25.47%,LTF;FYN;USP50;BIRC2;AIM2
prerank,DNA strand elongation (GO:0022616),0.3379121857423204,0.8007136005793961,0.7527812113720643,0.9111815612515506,1.0,8/18,34.09%,MCM7;RAD50;GINS1;TERT;RFC4;GINS3;GINS2;POLA1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.28455753085192326,0.8005625265626294,0.7822318526543879,0.9110505629491925,1.0,16/54,26.11%,MUC1;CNOT4;PLK2;CCNB1;BAX;TRIAP1;CNOT10;CARM1;PCBP4;ATM;CRADD;CNOT6;MDM2;PLK3;GADD45A;CNOT6L
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3124737857155743,-0.8004709945017077,0.6937269372693727,0.9638775563139031,1.0,3/10,12.04%,CDC42EP4;APC;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3124737857155743,-0.8004709945017077,0.6937269372693727,0.9638775563139031,1.0,3/10,12.04%,CDC42EP4;APC;WASHC1
prerank,substantia nigra development (GO:0021762),0.2960143374571006,0.8004322802153533,0.7874285714285715,0.9109096285243347,1.0,13/37,26.36%,BASP1;SUDS3;ZNF148;RHOA;CDC42;MBP;ACTB;RAD1;INA;CNP;CALM3;HSPA5;MAPKAP1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.31802805822609553,0.7985589927236499,0.7637426900584795,0.9131825286523331,1.0,3/25,10.65%,B4GAT1;B3GNT3;NDST1
prerank,sister chromatid segregation (GO:0000819),0.3097116809320733,0.7984237638315244,0.7865707434052758,0.9130256995806655,1.0,7/31,26.51%,CHAMP1;NCAPG2;INO80;KIFC1;LATS1;CENPK;ESPL1
prerank,regulation of cilium assembly (GO:1902017),0.2781233892644931,0.7980816278999558,0.820021299254526,0.9131465901499725,1.0,21/62,28.02%,TBC1D10C;TBC1D22A;KCTD17;TBC1D2;HTT;IFT88;TBC1D24;TBC1D22B;TBC1D20;TESK1;TBC1D19;MARK4;CEP120;TBC1D10A;CCDC88A;TBC1D16;MAPK15;ATG3;TBC1D15;DYNLT2B;CEP97
prerank,heterochromatin organization (GO:0070828),0.350925868163159,0.7964882144094145,0.7411764705882353,0.9150811906256201,1.0,5/14,32.27%,HP1BP3;SETDB1;SMCHD1;SIRT1;BAHD1
prerank,epithelial cell development (GO:0002064),0.33598351483852945,0.7963706524038521,0.7636138613861386,0.9149216176182342,1.0,6/20,24.75%,POF1B;RILPL2;ACTA2;RILPL1;TMEM79;SIPA1L3
prerank,stem cell differentiation (GO:0048863),0.2941303720862023,0.7957479644693569,0.7842696629213484,0.9154917497219365,1.0,10/39,25.13%,PTPRC;FBXL17;MTF2;LRP6;SP7;PUM1;HOXB4;HTR2B;FGFR2;SFRP1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3242909387595943,0.7956521476315292,0.7527675276752768,0.9153021256086404,1.0,6/20,20.89%,BCL2L1;DAB2;RHOQ;TMBIM1;LZTFL1;PPFIA1
prerank,heart morphogenesis (GO:0003007),0.28218360703603584,0.7956435304893403,0.8004434589800443,0.9149796449684298,1.0,4/50,7.55%,TH;SOX9;VEGFA;DLC1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.26992872280108476,0.795633887048335,0.8291666666666667,0.9146581389097831,1.0,29/86,30.71%,APOE;PLEK;COLGALT1;PTK2B;NCK2;NCK1;DCTN1;DRG1;LIMK1;EFEMP2;NUMA1;CLU;EVL;RPS3;VASP;SLAIN2;BAIAP2;PFN1;BAIAP2L2;NCKAP1L;CX3CL1;GPX1;STMN2;MAPRE1;BAIAP2L1;CDC42EP3;SYNPO;FES;ARF6
prerank,regulation of osteoblast proliferation (GO:0033688),0.3341099660094138,0.7954406340152927,0.7683686176836861,0.9145956277982197,1.0,3/17,11.87%,LTF;NELL1;RHOA
prerank,sulfur amino acid catabolic process (GO:0000098),0.3778757337046712,0.7953859749471716,0.7447405329593267,0.9143440642107138,1.0,4/10,19.57%,BLMH;MTRR;TST;MPST
prerank,cilium movement (GO:0003341),0.28905372525284917,0.7949709042426713,0.7902173913043479,0.9145739492343022,1.0,13/47,28.82%,ODAD2;TEKT2;CFAP251;TEKT5;DNAAF5;CFAP70;ADCY10;DNAI3;CCDC40;CCDC39;DNAH5;DNAH11;DNAH17
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.25981136681411776,-0.7947093610274882,0.7904761904761904,0.9722151606985373,1.0,6/19,16.22%,DENND6A;TJP1;NEXMIF;PTPRU;FLOT1;MAD2L2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2873719791095601,0.7945938237531089,0.7975929978118161,0.9147692776065699,1.0,12/49,24.21%,IGF1;VEGFA;ARL2BP;CCL5;GHR;IL31RA;IL6;IL2;EPO;FGFR3;JAK2;TNF
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2823885601023243,0.7945350124139792,0.7984994640943194,0.9145127492545146,1.0,11/54,14.08%,FLNA;KCNN4;KCNJ2;CAV1;AMIGO1;KCNMA1;CD63;KCNMB4;CACNA1D;KCNJ10;CAB39
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.36131082065245756,0.7943466008405454,0.7579365079365079,0.9144500343663198,1.0,6/13,37.40%,NRROS;FSTL1;DAND5;GREM2;FBN2;GREM1
prerank,cellular response to fluid shear stress (GO:0071498),0.35883893243049536,0.7941134797761699,0.7459016393442623,0.9144361236734244,1.0,2/12,6.67%,NFE2L2;MTSS1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3203779371608101,0.7936917288837405,0.7300995024875622,0.9146644519430461,1.0,5/22,14.65%,PTPN23;PLAA;VPS4B;UBAP1;MVB12A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.2752111984456437,-0.79335584701738,0.780373831775701,0.972477079305865,1.0,4/15,8.46%,DAAM2;TIAM1;WNT5B;RSPO3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.2957187892795867,-0.7933525584902379,0.7759336099585062,0.9702558101627836,1.0,5/12,18.93%,EPHA4;EPHB1;NFIB;EPHB6;MYCBP2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.36073087223282185,0.7929520728568705,0.7427821522309711,0.9153591801118782,1.0,3/13,15.71%,SRD5A3;MPDU1;DPAGT1
prerank,mitotic spindle organization (GO:0007052),0.26111163565137663,0.7928553134490169,0.8958543983822043,0.9151516080682025,1.0,41/153,26.55%,FLNA;PTPA;DYNC1H1;EML4;LSM14A;PLK2;AHCTF1;CENPO;VCP;CCNB1;BCCIP;ABRAXAS1;RHOA;XPO1;CENPT;BIRC5;RANBP2;RPS27;DYNC1LI2;RCC1;SMC3;KIFC1;RAB11A;NEK6;KNL1;BUB1B;ERCC6L;TOGARAM2;AAAS;TAOK1;SPDL1;DCTN6;EFHC1;STAG1;NUP98;GOLGA2;CENPK;CENPA;NUP133;MAP4;CENPS
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.2506412213991227,-0.7926404936406193,0.8085106382978723,0.9692350277633923,1.0,4/19,8.55%,CSF1R;CAMK1D;THBS1;PTK2
prerank,microtubule nucleation (GO:0007020),0.33137674629025954,0.7922993577447668,0.7739130434782608,0.9155834050864022,1.0,5/19,25.29%,TUBGCP4;RANBP9;CSNK1D;SLAIN2;GOLGA2
prerank,chloride transport (GO:0006821),0.2717773530931844,0.7920691775957657,0.8296296296296296,0.9155668978974687,1.0,17/74,22.91%,PACC1;SLC26A1;SLC5A1;GABRP;ANO9;ANO8;CLIC4;SLC12A4;CLCN1;GABRA4;ANO5;ANO6;CLCN4;SLC12A7;SLC26A6;FXYD1;CLIC5
prerank,positive regulation of developmental growth (GO:0048639),0.284142528520519,0.7920319157117409,0.7990970654627539,0.9152898131352767,1.0,10/49,17.91%,MACF1;GOLGA4;ITSN2;PLAA;RUFY3;RASAL1;LIMK1;GHR;RNF157;NTN1
prerank,apical protein localization (GO:0045176),-0.3086029504813387,-0.7918739390361533,0.6925795053003534,0.9684036386823557,1.0,2/10,4.90%,INSC;VANGL2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3468417326068817,0.7914750215904987,0.7383177570093458,0.9157063547229642,1.0,5/13,27.40%,PLA2R1;ATM;SPRED2;SPRED3;ATR
prerank,RNA 3'-end processing (GO:0031123),0.27254355421858906,0.7913195221632401,0.8319327731092437,0.9155955314013586,1.0,25/69,31.05%,THOC1;PAPOLA;PABPN1;SRSF11;SRSF7;DDX39B;EIF4A3;SYMPK;CHTOP;THOC2;RPRD1A;SRSF2;CPSF7;UPF3B;POLDIP3;SRRM1;MTPAP;THOC6;SUPV3L1;SRSF1;CSTF2;NUDT21;TENT4B;CLP1;CDC40
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.283999180199647,0.7907146764674666,0.8004385964912281,0.9161195408404513,1.0,13/48,29.21%,SELENON;PTK2B;PDPK1;SRI;DIAPH1;JPH1;F2R;CALM3;CX3CL1;FKBP1B;APLNR;FKBP1A;GSTO1
prerank,macromolecule catabolic process (GO:0009057),-0.23698343813358655,-0.7906881353700748,0.7875,0.9683274991677402,1.0,3/26,5.78%,CAPN3;LGMN;SMURF1
prerank,histone H2A monoubiquitination (GO:0035518),0.3354170386567422,0.790665310442688,0.7493734335839599,0.9158614271231172,1.0,7/17,30.59%,DDB2;DDB1;RNF2;BMI1;PCGF6;TRIM37;PCGF2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.28314340818302725,0.7902081314459329,0.8220994475138121,0.9161395599477681,1.0,16/47,32.37%,RAP2A;TAOK3;RASGRP1;IGF1R;PPIA;FOXO1;ARL6IP5;SCIMP;TAOK1;MAP2K2;MAPK3;MAPK8IP3;AGER;QARS1;MAPK1;PHLPP1
prerank,negative regulation of mRNA processing (GO:0050686),0.33887011014469604,0.7899811348478414,0.7454068241469817,0.916141651237866,1.0,4/15,15.81%,SRSF7;PCBP4;C1QBP;BARD1
prerank,DNA biosynthetic process (GO:0071897),-0.26918104336763843,-0.7898282045906486,0.803030303030303,0.967615110750147,1.0,6/16,15.46%,WRN;WRNIP1;CDKN2D;POLD1;POLH;POLD2
prerank,mitochondrial genome maintenance (GO:0000002),0.3644640722845406,0.7898091269385594,0.7420249653259362,0.9160415327205161,1.0,3/11,14.22%,SLC25A33;LONP1;SLC25A36
prerank,mRNA metabolic process (GO:0016071),0.26697139059029573,0.7898050675284481,0.8504098360655737,0.915716561953012,1.0,28/90,28.61%,ERN1;CELF1;SON;METTL3;SRSF11;RNH1;CNOT10;DXO;SRSF7;LSM6;HNRNPA2B1;YTHDF2;KIN;AGO3;SRSF2;PRPF8;HSF1;ZC3H12D;SF3A3;SNRPG;SF3B2;SNRPF;GEMIN2;LSM3;SUPT4H1;SRSF1;NUDT21;RIDA
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3617319532258373,0.7893741654301857,0.7404891304347826,0.91599287700641,1.0,6/11,32.70%,UQCRH;UQCR10;UQCRB;UQCR11;CYCS;UQCRQ
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.273668979046801,0.789232838216156,0.8431578947368421,0.9158613357717416,1.0,14/67,18.89%,MYO10;TBC1D10C;P2RX4;TBC1D22A;CAV1;TBC1D2;RAB5A;CDC42;IFT88;TBC1D24;TBC1D22B;FXR2;TBC1D20;TBC1D19
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.30213146552095865,-0.788733652690542,0.7649122807017544,0.9675249688641382,1.0,1/10,1.73%,VSIR
prerank,regulation of microtubule-based process (GO:0032886),0.2975573001180454,0.7883123930953864,0.7859569648924122,0.9167945572896713,1.0,11/36,21.99%,MAP10;MACF1;ATF5;PHLDB1;DIAPH1;MEMO1;ROCK1;MARK2;GSK3B;MARK4;TAOK1
prerank,regulation of cellular respiration (GO:0043457),-0.26610823136390976,-0.7879187784154056,0.7562189054726368,0.9668075491772233,1.0,5/17,16.01%,CBFA2T3;IL10RB;PNPT1;PRDM16;IFNLR1
prerank,cell part morphogenesis (GO:0032990),-0.29238771548998255,-0.7878641645996796,0.7268722466960352,0.9647223895325094,1.0,3/13,8.14%,SLIRP;PNPT1;MYH14
prerank,epithelial structure maintenance (GO:0010669),0.3653438543355699,0.7873763976317665,0.7651006711409396,0.9177124281085128,1.0,2/11,25.85%,RBP4;TLR9
prerank,response to UV-B (GO:0010224),-0.29962155406683494,-0.7869586704816449,0.7480314960629921,0.9641646997566728,1.0,6/12,32.91%,RELA;MME;HYAL2;MFAP4;IL12A;IL12B
prerank,negative regulation of protein ubiquitination (GO:0031397),0.27953393367205215,0.786833451738161,0.8127053669222344,0.9181222676140848,1.0,15/50,27.73%,GTPBP4;SQSTM1;CAV1;ADGRB1;FBXO5;LIMK1;SMAD7;OGT;CHP1;RPS3;PRMT3;DNAJA1;VPS28;UFL1;TNFAIP3
prerank,generation of neurons (GO:0048699),0.254780322674021,0.7867142264671529,0.9226130653266331,0.917966679702479,1.0,25/190,15.88%,FGF13;CTNNB1;CDK6;ERCC6;LRP12;CDK5;NRP1;RUNX1;HES7;BHLHE40;BHLHE41;USP9X;WNT6;OTP;IRX5;NAV1;PRUNE1;FZD1;CELSR1;DCX;FZD4;DOCK7;YTHDF2;RACGAP1;NR4A2
prerank,anterograde axonal transport (GO:0008089),0.2961583642831623,0.7864395741677408,0.7820069204152249,0.9180260309228657,1.0,6/37,11.98%,BLOC1S3;MGARP;HSPB1;TRAK1;DTNBP1;KIF1A
prerank,glycerolipid metabolic process (GO:0046486),0.36658450551801547,0.786194551543494,0.7390710382513661,0.9180245058367104,1.0,1/11,0.75%,DGKZ
prerank,positive regulation of RNA metabolic process (GO:0051254),0.28582751453441163,0.7853997102717266,0.8097345132743363,0.9187431995593109,1.0,17/45,27.83%,ERN1;GRSF1;RIOK2;HNRNPLL;WDR43;DXO;NFKB1;IL6;SLC38A2;BMP4;MAP2K2;RBM22;TRMT112;DIMT1;ZPR1;SUPV3L1;RIPK1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3551180486684038,0.7853766241828659,0.7493333333333333,0.9184425949050965,1.0,6/13,32.55%,EAPP;HNRNPU;RECQL5;SUPT4H1;HEXIM1;NELFA
prerank,response to amino acid (GO:0043200),0.30257660342847725,0.7851787202192525,0.802784222737819,0.9183772252450173,1.0,13/31,31.44%,RRAGD;CPEB4;IPO5;CPEB3;NSMF;LARS1;CPEB1;RRAGC;SESN2;LAMTOR3;LAMTOR1;RRAGB;XBP1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.30533777268496926,0.7845975067344804,0.7842669845053635,0.9188480084545648,1.0,12/26,30.96%,NLRC3;LTF;ILRUN;ACOD1;C1QBP;SIGIRR;LYAR;TRIM21;TRAF3IP1;TNFAIP3;MUL1;SIRT2
prerank,dendritic cell chemotaxis (GO:0002407),0.34911695605299287,0.7843697165834411,0.7542932628797886,0.9188418018518746,1.0,6/14,26.53%,CXCR2;CCR2;CCL5;HMGB1;GPR183;CXCR4
prerank,chemical homeostasis (GO:0048878),0.2729608314797483,0.7842674343993042,0.8315565031982942,0.9186571475954979,1.0,15/61,21.85%,ATP13A2;FBXW7;PPARG;TLCD1;TREM2;TLCD2;ABHD5;CEBPA;SLC4A9;AQP4;THADA;SLC4A2;USF2;TM6SF2;ACOX3
prerank,placenta development (GO:0001890),0.35447445563754115,0.7837229522288023,0.7466124661246613,0.919041420750367,1.0,1/12,5.48%,PPARG
prerank,negative regulation of cellular protein localization (GO:1903828),0.2957796673192349,0.7836517519379033,0.7789232531500573,0.9188221124443389,1.0,10/34,23.47%,RIPOR2;MFHAS1;SNX33;ILRUN;ANKRD13A;LZTFL1;ACTN2;GSK3B;LATS1;DNAJA1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3720477439636906,0.7835658508306547,0.7609289617486339,0.9186139197082508,1.0,1/11,1.07%,ATG7
prerank,bile acid biosynthetic process (GO:0006699),-0.22952913803647393,-0.7821823504144575,0.8258064516129032,0.9703796759488046,1.0,6/24,11.84%,CYP27A1;OSBPL9;OSBPL7;SLC27A2;CYP7B1;CYP39A1
prerank,ceramide biosynthetic process (GO:0046513),0.2902978429643238,0.7818193683579153,0.8070953436807096,0.9206614530550352,1.0,16/40,33.73%,SGMS1;CERS6;SPTSSA;SMPD4;ST8SIA6;B4GALNT1;SMPD1;ASAH1;SAMD8;SPTLC3;B3GALT4;SPTLC2;ST6GALNAC3;SPTSSB;CLN8;SGMS2
prerank,peroxisome organization (GO:0007031),0.3127721231675699,0.781789139855581,0.7838479809976246,0.9203775560484606,1.0,12/25,31.95%,PLAAT3;ABCD4;PEX2;ABCD2;ABCD3;PEX16;PEX14;ACOT8;PEX19;FIS1;MFF;PEX11G
prerank,negative regulation of chemokine production (GO:0032682),0.3402012011113433,0.7817802664433618,0.7549668874172185,0.9200617510897745,1.0,4/14,24.26%,SIRPA;SIGIRR;IL6;MAP2K5
prerank,regulation of feeding behavior (GO:0060259),0.3637057600124445,0.7814908484292665,0.7720685111989459,0.9201273522610155,1.0,2/11,13.13%,NR4A3;AGRP
prerank,protein heterooligomerization (GO:0051291),0.3384306773988639,0.7814907952875633,0.7647814910025706,0.9197987353494937,1.0,5/17,20.94%,TMEM120B;HSD17B8;FARSA;FARSB;CPSF7
prerank,phosphatidic acid metabolic process (GO:0046473),0.2774153828897636,0.7809870881962779,0.8155872667398463,0.9201330241705284,1.0,12/48,25.17%,DGKZ;SLC27A1;DDHD1;ABHD5;DGKA;DGKH;DGKD;AGPAT2;PLA2G12A;AGPAT1;ABHD4;PLA2G5
prerank,cellular amino acid catabolic process (GO:0009063),-0.1726436652480845,-0.7805458622876871,0.9736842105263158,0.9709722211906782,1.0,23/87,21.48%,HMGCLL1;MCCC2;GLUD1;HNMT;KMO;BCKDHB;GLUL;ASPA;DLD;ALDH6A1;NOS1;GAD1;PRODH;HAL;HAAO;HYKK;BCKDHA;QDPR;IVD;ALDH4A1;DAO;AUH;CARNMT1
prerank,mesonephros development (GO:0001823),-0.3134550104038051,-0.7803941048876271,0.7681159420289855,0.9690555314516297,1.0,4/11,13.17%,FGF10;PAX8;PAX2;OSR1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3479713700550142,0.7799621503475187,0.7715404699738904,0.9211586590119348,1.0,3/12,16.36%,PTGIR;CBL;CBLB
prerank,centromere complex assembly (GO:0034508),0.2894944309732128,0.7798140730941542,0.7972972972972973,0.9210092346535574,1.0,14/36,33.35%,CENPO;CENPT;CENPX;KNL1;NPM1;RBBP7;CENPK;CENPA;CENPS;NASP;RSF1;CENPH;CENPC;CENPW
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3393187976206753,0.7797649239469003,0.7637292464878672,0.9207437640092107,1.0,3/14,16.05%,NRP1;VEGFA;KDR
prerank,ubiquinone biosynthetic process (GO:0006744),0.34424724798040673,0.779634871019818,0.7918313570487484,0.9205891343185817,1.0,4/15,17.40%,COQ10B;COQ5;COQ3;NDUFA9
prerank,metanephros development (GO:0001656),-0.22489586837743888,-0.7789336449312358,0.8764705882352941,0.9693208735581356,1.0,9/26,22.24%,FGF10;PAX8;PAX2;ROBO2;OSR1;WNT7B;FOXD1;PKD1;SHH
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3429715680764528,0.7781577482097911,0.751696065128901,0.9222171455770711,1.0,4/13,25.85%,IRAK2;TNIP2;IRAK4;TLR9
prerank,positive regulation of dendritic spine development (GO:0060999),0.31931776337290374,0.7779113976593298,0.760248447204969,0.9222192309764145,1.0,3/20,10.04%,APOE;LLPH;CPEB3
prerank,positive regulation of protein deacetylation (GO:0090312),0.3451655289648649,0.7774120031900933,0.7882653061224489,0.9225405529531507,1.0,5/14,28.16%,ZBTB7B;SAP30BP;ING2;NIPBL;APLNR
prerank,endothelial cell differentiation (GO:0045446),0.35555057718729244,0.7773303960112061,0.7567917205692108,0.9223040870929182,1.0,4/12,24.48%,JAG1;FSTL1;KDR;EDF1
prerank,cellular response to interleukin-7 (GO:0098761),-0.2640610314856122,-0.7771684560160641,0.8247422680412371,0.9680062802239174,1.0,3/17,5.83%,STAT5A;STAT3;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2640610314856122,-0.7771684560160641,0.8247422680412371,0.9680062802239174,1.0,3/17,5.83%,STAT5A;STAT3;IRS2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.32997146484190815,0.7760240395201561,0.7773584905660378,0.9236904574660596,1.0,3/17,8.24%,CD8A;JAG1;BTN3A3
prerank,blood vessel diameter maintenance (GO:0097746),0.29211108051221635,0.7759737120731169,0.8030127462340672,0.9234199723539446,1.0,8/34,23.57%,EDNRA;SCPEP1;KCNMB4;ROCK1;SERPINF2;ITGB1BP1;HTR2B;ECE1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2781336119387705,0.7759555589168953,0.8300438596491229,0.9231177286096116,1.0,8/51,13.29%,FSTL3;PPARG;BAMBI;LEMD2;CHRD;SMAD7;FSTL1;SMAD1
prerank,mammary gland epithelium development (GO:0061180),0.3462685796960772,0.7755167289260558,0.76657824933687,0.9233731918818702,1.0,2/14,3.48%,ID2;IRF6
prerank,regulation of membrane repolarization (GO:0060306),0.34796600417245116,0.7746030164354455,0.7853403141361257,0.9242300318382839,1.0,2/13,5.31%,KCNJ2;CAV1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.35968239378965083,0.7744354269749479,0.772,0.9241222257409276,1.0,2/12,11.70%,NR4A3;ABCD2
prerank,regulation of transposition (GO:0010528),0.34993119779625126,0.7742662312493034,0.776,0.9240123208267819,1.0,3/13,24.18%,PIWIL2;UBR2;SMYD5
prerank,mRNA methylation (GO:0080009),0.3394822821296143,0.7737296798287384,0.7901726427622842,0.9244117154419317,1.0,7/15,29.54%,TRMT10C;METTL3;NSUN2;CBLL1;METTL8;TRMT6;PCIF1
prerank,potassium ion transmembrane transport (GO:0071805),0.25394401886458223,0.7737160097932978,0.8915046059365405,0.9241007056288393,1.0,15/135,9.49%,SLC9A1;SLC24A4;KCNN4;ATP1B3;KCNK13;LRRC52;KCNA3;KCNJ2;CCDC51;SLC9A8;ATP1A4;ATP1A3;ATP1A1;KCNA4;SLC12A4
prerank,N-terminal protein amino acid modification (GO:0031365),-0.269461772062216,-0.7735700496701883,0.7657657657657657,0.9716616241959781,1.0,3/14,7.94%,NAA60;NAA10;METAP2
prerank,artery development (GO:0060840),0.31092690847374155,0.7733006151065808,0.7892857142857143,0.9243096420325593,1.0,6/23,19.29%,NRP1;VEGFA;SMAD7;EFEMP2;NF1;HECTD1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3375179651296927,0.7730252645691501,0.7857142857142857,0.9240177046634737,1.0,3/16,10.16%,CORO1C;DLC1;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3375179651296927,0.7730252645691501,0.7857142857142857,0.9240177046634737,1.0,3/16,10.16%,CORO1C;DLC1;ARHGAP6
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.30417744133739955,-0.77279622471093,0.7665369649805448,0.9707226915782399,1.0,3/10,11.81%,WHRN;ADGRV1;SOD1
prerank,positive regulation of heart contraction (GO:0045823),0.3222056135377901,0.7725399721451603,0.7936305732484077,0.9242991687712825,1.0,5/19,27.34%,NPPA;ATP1A2;SCN3B;ATP2A2;GSK3A
prerank,erythrocyte development (GO:0048821),0.3698015192334772,0.772101580262115,0.760053619302949,0.924572838508147,1.0,4/10,29.16%,ALAS1;LYAR;NCKAP1L;MED1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.365435380450677,0.7718385105995137,0.7520215633423181,0.9245860079006871,1.0,3/11,20.94%,CAV1;ADIPOR1;VHL
prerank,regulation of lipid catabolic process (GO:0050994),-0.24354882662298943,-0.7717934843162986,0.825136612021858,0.9703355905958542,1.0,6/19,21.97%,PDE3B;ANGPTL3;IL1B;HCAR2;ADRA2A;TYSND1
prerank,spermatid development (GO:0007286),0.29382776524699655,0.7711260836638975,0.8018648018648019,0.9252106717705817,1.0,9/32,30.14%,SOX30;TTC21A;SYCP3;ING2;MKKS;CDYL;IQCG;TDRD5;CEP57
prerank,positive regulation of cation channel activity (GO:2001259),0.2826841679619806,0.7701705216318664,0.8179800221975583,0.9261506531324064,1.0,5/40,11.21%,TMSB4X;LRRC52;HTT;STAC2;CCR2
prerank,regulation of neurogenesis (GO:0050767),0.27387577769232707,0.7701159707133077,0.8281081081081081,0.9258862459356834,1.0,11/55,18.32%,CTNNB1;HES7;BHLHE40;BHLHE41;B2M;PRUNE1;DOCK7;YTHDF2;APPL2;HOOK3;IL6
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.32016375157083443,0.7697938261409236,0.7866831072749692,0.9259664440352768,1.0,4/19,14.14%,FGF2;RUNX1;PIM1;RBP4
prerank,smooth muscle tissue development (GO:0048745),0.37206630112131467,0.7696059185285853,0.7920656634746922,0.9258769634435751,1.0,3/10,21.77%,EFEMP2;NF1;BMP4
prerank,negative regulation of defense response to virus (GO:0050687),0.36355830989876786,0.7695812039195841,0.7566807313642757,0.9255822677688997,1.0,5/10,29.71%,ILRUN;C1QBP;TRAF3IP1;TARBP2;MUL1
prerank,tRNA 5'-end processing (GO:0099116),0.3353322948494247,0.7695221568560087,0.765814266487214,0.925335024505858,1.0,4/15,23.38%,TRMT10C;PRORP;RPP25L;RPP38
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.3177157768252999,0.7695080726610272,0.7814070351758794,0.9250288312989721,1.0,8/19,28.15%,GATA3;NFKB1;TMEM106A;WFS1;MAPK7;TNF;MAP2K5;MTPN
prerank,positive regulation of blood coagulation (GO:0030194),0.32370622323199916,0.7693642571610343,0.795483061480552,0.9248789023865435,1.0,6/17,22.64%,HRG;SERPINE1;APOH;SERPINF2;ANO6;F2R
prerank,negative regulation of cell projection organization (GO:0031345),0.2754763625095106,0.768619912996881,0.8220994475138121,0.9254946341850959,1.0,8/48,15.96%,APOE;MYLIP;GAK;FYN;PAQR3;CBFA2T2;LPAR1;EFNB2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.29410459539513134,0.7684669166453608,0.8099652375434531,0.9253752581329223,1.0,16/33,36.76%,PAPOLA;PABPN1;SYMPK;SSU72;CPSF7;SNRPG;SNRPF;CSTF2;NUDT21;MAZ;LSM11;CLP1;WDR33;SLBP;CSTF3;SNRPB
prerank,protein prenylation (GO:0018342),0.37095016154996685,0.7680875749908663,0.7583798882681564,0.9255335317166207,1.0,2/10,10.51%,PTAR1;RABGGTB
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3035928682745282,-0.767471541268309,0.7604562737642585,0.9751330473761071,1.0,5/10,20.52%,TMEM100;RAPGEF2;CD34;ASB4;RRAS
prerank,regulation of membrane depolarization (GO:0003254),0.31896330924437294,0.7672162368896789,0.79182156133829,0.926306728934764,1.0,4/18,16.20%,RANGRF;SCN1B;SMAD7;SCN3B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.31672549729647587,0.7670584492220338,0.7957124842370744,0.9261713637745552,1.0,7/20,24.21%,CD6;PTPN22;TICAM1;CCL5;MTDH;LBP;TNF
prerank,megakaryocyte differentiation (GO:0030219),-0.2917582072688469,-0.7667761172941534,0.7866666666666666,0.9742141781913934,1.0,11/11,70.85%,ZFPM1;TAL1;KIT;SH2B3;CDKN2B;GATA1;MPIG6B;IL11;THPO;UBA5;MED1
prerank,positive regulation of histone modification (GO:0031058),0.28951078248639733,0.7663508972369141,0.821590909090909,0.9267298137740717,1.0,13/33,28.16%,FAM47E;ZBTB7B;BRCA1;SAP30BP;ING2;CHTOP;PAF1;GLYR1;NIPBL;KDM1A;RUVBL2;MAPK3;APLNR
prerank,cellular modified amino acid catabolic process (GO:0042219),0.33506763470837814,0.7663255763216898,0.7966101694915254,0.9264372934608749,1.0,1/15,4.27%,ABHD12
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23178914501173414,-0.7661204199501649,0.8444444444444444,0.9731023622178703,1.0,5/24,7.60%,ABCA3;CRLS1;PLA2G15;GPAM;PNPLA8
prerank,negative regulation of cilium assembly (GO:1902018),-0.28445105349223637,-0.7654482099798708,0.7740585774058577,0.9721179943687913,1.0,3/12,13.04%,TBC1D30;ODF2L;TCHP
prerank,negative regulation of insulin secretion (GO:0046676),-0.2547530126440805,-0.765337137137708,0.7794117647058824,0.9701942584093078,1.0,6/17,20.88%,KCNB1;PRKN;REST;KLF7;MIDN;ADRA2A
prerank,regulation of microtubule-based movement (GO:0060632),-0.2861133497092975,-0.765333385449926,0.7795275590551181,0.9680890153775034,1.0,5/11,24.09%,MAP2;HAP1;TTC21B;DRC1;HDAC6
prerank,mesenchyme morphogenesis (GO:0072132),-0.26019278272684876,-0.7648658624402372,0.7926267281105991,0.9666618129528257,1.0,6/17,22.12%,BMP2;ENG;HEY1;TBX2;HEYL;ISL1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.27763664194625587,-0.7643633609930325,0.771551724137931,0.9653661786616484,1.0,4/14,11.67%,PKIG;RAPGEF2;PRKAR2A;PRKAR2B
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2606160153523215,-0.7641713982241101,0.8138528138528138,0.9635775901785938,1.0,7/14,22.71%,THBS1;TLR8;SLAMF1;LILRA5;IRAK3;CMKLR1;MEFV
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3089935605900037,0.7638445595962972,0.8082026537997588,0.9292456534274587,1.0,13/23,38.01%,RIPOR2;MOSPD2;C1QBP;TIRAP;CD74;NCKAP1L;MDK;DPP4;MCU;RAC2;MPP1;RAC1;JAM3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.35254026869687305,0.763136002090031,0.8020969855832241,0.9298300942165133,1.0,3/13,9.92%,VDAC2;BCL2L11;BAX
prerank,regulation of chromosome segregation (GO:0051983),-0.24508070181378927,-0.7628719260730673,0.8154506437768241,0.9635906994582696,1.0,6/16,20.42%,BUB1;IHO1;AURKB;KIF2C;MKI67;HORMAD1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3623162995012303,0.7625866254428993,0.7811217510259918,0.9301839275166944,1.0,4/10,25.85%,NAMPT;KDR;JAK2;TLR9
prerank,vasodilation (GO:0042311),-0.274530606640052,-0.7622322262505437,0.8155737704918032,0.9624556923498493,1.0,3/13,11.81%,ADRB1;NOS1;SOD1
prerank,vasculogenesis (GO:0001570),0.28657984193427455,0.7617753479038437,0.828735632183908,0.9308742487269527,1.0,5/32,16.16%,CAV1;VEGFA;EGFL7;KDR;RASA1
prerank,regulation of cell size (GO:0008361),0.3074538983065942,0.7612409985089279,0.828125,0.93120916399429,1.0,2/23,1.78%,PLEK;MSN
prerank,positive regulation of type I interferon production (GO:0032481),0.26329988342847693,0.7608715154862965,0.8690228690228691,0.9313372084475539,1.0,13/73,18.34%,CTNNB1;PTPN22;POLR2H;LRRFIP1;POLR3E;POLR3D;IRF5;RIOK3;NFKB1;HSPD1;DHX36;DHX33;DHX9
prerank,nucleotide biosynthetic process (GO:0009165),0.32380397133310057,0.7606470866189063,0.7878787878787878,0.9312804756572497,1.0,9/18,26.35%,GART;PRPSAP1;MTHFD1;PRPS2;PPAT;NMNAT3;ADSL;ME1;HPRT1
prerank,peptidyl-threonine modification (GO:0018210),0.26497784846597217,0.760490239684763,0.8595744680851064,0.9311545941017637,1.0,15/66,21.27%,DYRK2;CDK5;PRKCD;PDPK1;SBK1;HIPK1;MAP3K12;ROCK1;PRKD2;CAD;NLK;CSNK2A2;LMTK2;MARK2;GSK3B
prerank,regulation of glucose metabolic process (GO:0010906),-0.20878910532742734,-0.7603146176311631,0.9007633587786259,0.963215121123831,1.0,8/34,15.86%,PDK1;IRS2;FOXK2;KHK;PRKN;ZNF692;PDK2;PMAIP1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2891788287567411,0.7596689318463105,0.8090803259604191,0.9318630731322665,1.0,9/31,24.88%,HOXA4;IRX5;EIF4A3;HOXB4;HOXC9;DYNC2I1;TGFBR2;FGFR2;PDGFRA
prerank,spliceosomal snRNP assembly (GO:0000387),0.281704693476078,0.759434059191784,0.8219484882418813,0.931814813273465,1.0,19/38,36.76%,CD2BP2;PRMT5;PRMT7;SART1;PRPF6;PRPF8;LSM4;SNRPG;GEMIN8;SNRPF;GEMIN2;GEMIN5;SRSF10;PRPF31;SART3;SNRPD2;SNRPD1;TGS1;SNRPB
prerank,response to prostaglandin E (GO:0034695),0.3583642139085989,0.7594034007786865,0.7695417789757413,0.931518056875908,1.0,3/10,25.13%,GNB1;PTGER4;SFRP1
prerank,response to nutrient levels (GO:0031667),0.3281594669761567,0.7588571080776297,0.7971938775510204,0.9318887970835279,1.0,2/17,6.43%,EIF4G1;SCTR
prerank,inositol lipid-mediated signaling (GO:0048017),0.2675730098928855,0.7587900177445365,0.8421621621621621,0.9316451863486934,1.0,7/50,13.03%,IGF1;PIK3CB;PLCB4;IGF1R;PLCB2;RHOA;OGT
prerank,ubiquinone metabolic process (GO:0006743),0.335095070179709,0.7587794775139867,0.8013071895424837,0.9313355650718184,1.0,5/15,24.68%,COQ10B;COQ5;COQ3;AIFM2;COQ8B
prerank,epithelial cell migration (GO:0010631),0.2833579468119165,0.7584288286170501,0.8149425287356322,0.9314495723822125,1.0,8/37,18.18%,NRP1;PLXND1;RHOA;FSTL1;PKN2;ROCK1;CYP1B1;TESK1
prerank,amide biosynthetic process (GO:0043604),0.2735839811752172,0.758215205811133,0.8268398268398268,0.9313861867943978,1.0,17/47,33.73%,SGMS1;CERS6;SPTSSA;SMPD4;FURIN;SMPD1;NANP;ASAH1;SAMD8;SPTLC3;ASL;SPTLC2;AANAT;SPTSSB;CLN8;PM20D1;SGMS2
prerank,cellular response to gamma radiation (GO:0071480),0.31984447896557344,0.7575320525934038,0.7843388960205392,0.9319242839465464,1.0,8/17,32.09%,ATM;TMEM109;HSF1;MDM2;KDM1A;ATR;XRCC5;MAP3K20
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.31519246720541616,0.7569623514036368,0.8289308176100629,0.9322848155644168,1.0,3/19,13.64%,PRKCH;RUNX1;ROCK1
prerank,axon guidance (GO:0007411),0.24308072678769946,0.756690740131569,0.947,0.9322897696346483,1.0,25/201,13.27%,PLXNC1;ALCAM;NRP2;NIBAN2;PTPRA;PLXNA2;PRKCQ;DAG1;PIK3CB;LRTM1;NPTN;NRP1;SH3KBP1;GRB2;VEGFA;DOK2;RANBP9;PLXND1;FYN;RHOG;DOK1;SCN1B;EMB;EFNA1;PALLD
prerank,response to calcium ion (GO:0051592),0.25303107034450395,0.7566240705983008,0.8969072164948454,0.9320426881033418,1.0,8/102,6.49%,IQGAP1;SLC25A24;ADCY8;ITPKB;ANXA11;CAV1;CLIC4;KCNMA1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2864645253760772,0.7560216593341496,0.8306997742663657,0.932469890203414,1.0,15/35,33.61%,LIG1;POLE;MBD4;ADPRS;POLB;RFC1;POLG;RFC2;LIG3;POLD4;PNKP;PARG;RFC4;RFC5;PCNA
prerank,neurotransmitter uptake (GO:0001504),0.3489191353723786,0.7559951468520564,0.796,0.932173688754633,1.0,3/12,15.29%,SLC38A1;SLC22A3;ATP1A2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.36213932404787724,0.7557143219086325,0.7971631205673759,0.9321947222564345,1.0,1/10,1.37%,NFE2L2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3129302815759652,0.7556390555942439,0.8094645080946451,0.9319562182092601,1.0,5/20,21.33%,CCNY;ADAM17;STOX1;CCND2;HSP90AB1
prerank,cyclooxygenase pathway (GO:0019371),0.35442491640588253,0.7556118220090031,0.7864864864864864,0.9316630007523329,1.0,5/10,25.20%,PTGES;CBR1;PTGES3;PTGIS;TBXAS1
prerank,replication fork processing (GO:0031297),0.2755350095441473,0.7555771742357026,0.8137369033760187,0.9313774689255079,1.0,16/38,33.84%,THOC1;ZRANB3;BOD1L1;BLM;CENPX;ATRX;RTEL1;ZGRF1;SETMAR;GEN1;CENPS;ATR;MMS22L;SMARCAL1;PCNA;RAD51
prerank,establishment of endothelial barrier (GO:0061028),0.2947699476850212,0.755466662905288,0.8122119815668203,0.9311879310630863,1.0,7/29,20.41%,MSN;TJP2;RAPGEF6;MYADM;RAB1A;AFDN;MARVELD2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.33742640749242014,0.7549764380686224,0.7938420348058902,0.931470568450425,1.0,2/13,9.10%,ASPH;CYFIP2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.33089859380435865,0.7548584319900632,0.8039735099337748,0.9312953649128649,1.0,7/14,33.38%,DDX1;TSEN15;CSTF2;RTRAF;TSEN2;CLP1;RTCB
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.24324808905739057,0.7548532421358256,0.9195171026156942,0.9309776308557064,1.0,50/172,27.78%,DGKZ;SLC27A1;DDHD1;ARF3;PEMT;PIK3CB;APOA2;FGF2;PIK3R5;PI4K2A;STARD10;INPPL1;CHKB;VAC14;PLEKHA1;ABHD5;PIP5K1C;CLN3;MTMR14;RAB5A;LPCAT3;PTPN13;CPNE3;MTMR12;TAMM41;DGKA;DGKH;PIK3R2;DGKD;PIKFYVE;CSNK2A2;AGPAT2;PLA2G12A;CPNE6;HDHD5;PI4KA;PIP5K1B;AGPAT1;ABHD4;MBOAT7;LPIN3;PIK3C2A;SYNJ2;PLA2G5;SLC44A2;PI4K2B;MTMR6;PCYT1A;PITPNM1;MTMR1
prerank,regulation of peptide hormone secretion (GO:0090276),0.2624877530673578,0.7534142382889595,0.8814102564102564,0.9324090487779375,1.0,10/67,18.96%,CACNA1A;GCK;SLC2A1;CCL5;CACNA1D;SLC8B1;GIPR;GLP1R;IL6;ITPR3
prerank,lipid biosynthetic process (GO:0008610),0.2552175912441961,0.7528271341038344,0.8688352570828961,0.9327911167730829,1.0,6/77,8.42%,LPL;ACACA;CYP19A1;ACSL1;FADS1;SCD5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.31765426211212844,0.7505564246493522,0.8165605095541402,0.9352365565013794,1.0,5/17,19.36%,UBL4A;EMC3;GET1;EMC9;GET3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.34589177616893163,0.7500506803168736,0.8023872679045093,0.935498722276979,1.0,3/12,17.35%,NINL;DCTN1;HOOK3
prerank,somite development (GO:0061053),-0.29068065465023696,-0.7496060442509933,0.7955390334572491,0.9770019856259465,1.0,4/11,22.39%,PPP2R3A;MEOX2;SHH;SFRP2
prerank,positive regulation of insulin secretion (GO:0032024),0.2784474249231878,0.7493734106260356,0.851335656213705,0.9359851437246919,1.0,3/36,3.41%,ADCY8;GCK;TRH
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.27816457876409606,-0.7491996301808312,0.7689393939393939,0.9754533032309622,1.0,3/13,17.20%,PTS;PRKG2;QDPR
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.35729019503877424,0.7491099361208776,0.7794729542302358,0.9359809718879836,1.0,2/10,13.03%,GNMT;OGT
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2905148236817875,0.7488890144834083,0.8362989323843416,0.935928184853991,1.0,7/28,22.82%,FBXW7;TREM2;PSMC3;CLU;PSMC6;LAPTM5;CCDC22
prerank,protein dephosphorylation (GO:0006470),0.24580746763508032,0.748301985448488,0.9292214357937311,0.9363029122498548,1.0,31/135,21.20%,PTPRA;PTPRC;EYA4;DUSP9;PPM1J;PPP2R5C;PPP2R1A;PPM1H;PTPN22;CTDNEP1;NCK1;PPP1R12A;TAB1;PTPN2;DUSP6;PTPN12;PHPT1;PPP2R2D;PTPN13;PPP1R15B;DUSP11;DUSP3;PPP6C;PPP2R2C;STK11;PPP3CC;RPRD1A;PTPN21;FBXW11;SSU72;DUSP12
prerank,heart contraction (GO:0060047),-0.20664481134396562,-0.7475472464760301,0.8787878787878788,0.9757601986471238,1.0,21/41,34.04%,SGCZ;SGCD;DMD;SOD1;KCNH2;SCN2B;TNNI2;MYL2;KCNQ1;MYBPC3;SCN4B;ACE;GRK2;TPM1;CASQ2;SLC8A1;TNNC1;TNNT2;MYH6;MYL3;MYH7
prerank,signal peptide processing (GO:0006465),-0.27644156028849387,-0.7471916406013732,0.8326530612244898,0.974194201157062,1.0,3/11,10.36%,PCSK5;SEC11C;SPCS2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.24288348553872494,-0.7469995796563463,0.8439024390243902,0.9723831891312371,1.0,2/20,4.38%,BMPR1B;DSCAML1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3224660800543203,0.7467544918620851,0.8091603053435115,0.9378004928412431,1.0,2/15,7.23%,KCNJ2;ATP1A1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.31766627925461033,0.7460496470442712,0.8060075093867334,0.9383235573330991,1.0,4/18,14.45%,ADCY8;VEGFA;CRTC1;PRKD2
prerank,cellular response to organonitrogen compound (GO:0071417),0.25145180291354313,0.7457473761396285,0.8993839835728953,0.938332047657901,1.0,14/99,12.29%,CTNNB1;RRAGD;P2RX4;MAPK13;CPEB4;IPO5;SOX9;CDH1;P2RY1;JUP;CPEB3;BRCA1;DIAPH1;LARP1
prerank,positive regulation of rRNA processing (GO:2000234),0.3560439123077019,0.7451026004133949,0.7977839335180056,0.938763519659978,1.0,4/10,24.05%,RIOK2;WDR43;TRMT112;DIMT1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.29415288093669695,-0.7436383354836037,0.7709090909090909,0.975102097443936,1.0,2/10,7.36%,BICD1;APC
prerank,regulation of bone mineralization (GO:0030500),0.25944282181579964,0.7429123726388618,0.8589881593110872,0.9410209823494046,1.0,12/55,21.82%,ANKH;ATP2B1;CYP27B1;PTK2B;NELL1;PKDCC;ECM1;BMP6;DDR2;ANO6;BMP4;SRGN
prerank,positive regulation of peptidase activity (GO:0010952),0.3042458288078273,0.7416252692167397,0.8109452736318408,0.942237844706139,1.0,6/20,28.53%,TANK;VCP;RCN3;PRELID1;MAPK12;APH1A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3292740683803737,0.7412483302702867,0.8121621621621622,0.9423560887521454,1.0,5/14,24.26%,CARD10;DLL4;RHOA;ITGB1BP1;MAP2K5
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2732137015754393,0.7412337539052047,0.8605990783410138,0.9420490193875442,1.0,7/37,14.13%,EIF4G1;TRIM6;SPHK1;CADM4;SMAD7;CAB39;STOX1
prerank,regulation of vasculogenesis (GO:2001212),0.32356860160511514,0.7403588413604099,0.8134715025906736,0.9427136321581161,1.0,3/14,16.05%,XDH;RIN2;KDR
prerank,protein import into peroxisome matrix (GO:0016558),-0.27731252844687937,-0.7403046055332112,0.7958333333333333,0.9776738461103751,1.0,3/12,9.95%,PEX7;PEX5L;PEX12
prerank,cognition (GO:0050890),0.27193770322204475,0.7398829975774645,0.8581005586592179,0.9429284544634474,1.0,11/42,27.42%,CHRNB2;MAGT1;PTCHD1;DOP1B;NF1;TUSC3;C5AR1;NIPBL;TNF;CYFIP1;CHD7
prerank,ribosomal large subunit assembly (GO:0000027),0.2946114712921826,0.7397280184601528,0.8174224343675418,0.9427953799153441,1.0,4/24,15.33%,BRIX1;PPAN;RPL11;MDN1
prerank,cardiac muscle cell development (GO:0055013),0.3040159884184366,0.7393984736122415,0.8308270676691729,0.9428584680227619,1.0,5/20,24.88%,CSRP3;VEGFA;MYH11;ALPK3;PDGFRA
prerank,nucleotide-sugar metabolic process (GO:0009225),0.34162425171688426,0.7393828506646972,0.8260869565217391,0.9425506964884669,1.0,4/12,30.62%,EXTL2;GALT;GFUS;PARG
prerank,regulation of hydrolase activity (GO:0051336),0.2554539088484065,0.7390655254761077,0.8709338929695698,0.9425831114434768,1.0,6/71,6.77%,PLXNC1;GPR137B;PLXNA2;CAV1;FGD6;RAPGEF6
prerank,myelination in peripheral nervous system (GO:0022011),0.330760730533026,0.7388532609880442,0.7959731543624161,0.9424976307313002,1.0,3/13,16.43%,MYOC;NCMAP;NF1
prerank,action potential (GO:0001508),0.2707570363921503,0.7384420354801625,0.8512035010940919,0.9426633969969939,1.0,8/44,16.20%,GNAQ;SCN4A;KCNJ2;SRI;CLN3;KCNMB4;GNA11;SCN3B
prerank,prostaglandin biosynthetic process (GO:0001516),0.3073659250629248,0.737987912644549,0.8356510745891277,0.9428403341880524,1.0,7/18,25.20%,PTGES;CBR1;PTGES3;PTGIS;CD74;MIF;TBXAS1
prerank,linoleic acid metabolic process (GO:0043651),0.31268081471162434,0.7375405963922699,0.8236808236808236,0.9430259628938759,1.0,4/17,21.82%,ACSL1;FADS1;ELOVL2;ELOVL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.34421622280368436,0.737266712581058,0.8145604395604396,0.9423754998630162,1.0,4/12,26.51%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.34421622280368436,0.737266712581058,0.8145604395604396,0.9423754998630162,1.0,4/12,26.51%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.34421622280368436,0.737266712581058,0.8145604395604396,0.9423754998630162,1.0,4/12,26.51%,NSMCE2;CUL3;ANAPC7;ESPL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3007722930685885,0.7371536314770479,0.8197320341047503,0.9421920717521559,1.0,8/20,31.40%,PMPCA;AFG3L2;SLC8B1;STOML2;PARL;SLC25A23;SPG7;SMDT1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3449148144938542,0.7363713271867309,0.8072625698324022,0.9427503092092013,1.0,4/11,17.14%,TJP2;RAPGEF6;RAB1A;AFDN
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.2933543990820999,-0.7363570311669636,0.8133802816901409,0.9789760145421904,1.0,4/10,17.98%,NFATC2;NFATC1;PPP3CB;ADGRB2
prerank,calcineurin-mediated signaling (GO:0097720),-0.2933543990820999,-0.7363570311669636,0.8133802816901409,0.9789760145421904,1.0,4/10,17.98%,NFATC2;NFATC1;PPP3CB;ADGRB2
prerank,neuron projection organization (GO:0106027),0.31824733275452677,0.7359943185337097,0.810012836970475,0.9428522039322252,1.0,5/15,21.27%,ATP1A3;DCTN1;ABCD2;PLS1;GSK3B
prerank,regulation of rRNA processing (GO:2000232),0.31577256836654044,0.7355096012815128,0.8132992327365729,0.9431056104052481,1.0,6/16,24.05%,RIOK2;WDR43;YTHDF2;USP36;TRMT112;DIMT1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3203014773857531,0.7353064799321449,0.8140127388535032,0.9430033978565283,1.0,6/15,24.27%,GAS6;TPR;GSK3B;RBM22;ANP32B;BAG3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2821463133390635,0.7348796585309763,0.8518518518518519,0.943157115737537,1.0,3/29,7.68%,GOSR2;VTI1A;NAPA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.30711530257551156,0.7346940699128474,0.8318695106649937,0.9430387943924178,1.0,6/20,21.33%,P2RX4;C3AR1;C3;ENTPD5;ANO6;HSP90AB1
prerank,mesenchyme development (GO:0060485),-0.25776372388576174,-0.7346545544649715,0.8487394957983193,0.9790519328358429,1.0,8/15,33.25%,BMP2;HMGA2;ISL1;SFRP2;BMPR2;TGFBR1;BMP7;WNT11
prerank,anterograde synaptic vesicle transport (GO:0048490),0.32254429325478384,0.7341582501015079,0.8254777070063695,0.9429926885360294,1.0,3/15,15.95%,BLOC1S3;DTNBP1;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.32254429325478384,0.7341582501015079,0.8254777070063695,0.9429926885360294,1.0,3/15,15.95%,BLOC1S3;DTNBP1;AP3D1
prerank,prostanoid biosynthetic process (GO:0046457),0.31717318724449667,0.7333938602441423,0.8102766798418972,0.9435420961143006,1.0,6/15,25.20%,PTGES;PTGES3;PTGIS;CD74;MIF;TBXAS1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3062730834449354,0.7331542329791656,0.8343711083437111,0.9434869585194318,1.0,3/18,16.69%,FAM3D;CRH;SIRT4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3407186036627885,0.7322730784370866,0.8165137614678899,0.9441480529851923,1.0,3/12,20.19%,LPCAT3;MBTPS2;SREBF1
prerank,response to organonitrogen compound (GO:0010243),-0.1929305620340791,-0.7322288340746353,0.9043478260869565,0.98005800132753,1.0,13/38,22.19%,GLRA3;SEL1L;CCDC47;PRKN;GLRA2;MEAK7;GLRA1;INAVA;IRAK3;MTOR;TRPM2;RNF139;NR1H4
prerank,sensory perception of light stimulus (GO:0050953),0.24988825175003748,0.7321305885311206,0.9129533678756476,0.943977043447755,1.0,10/87,12.88%,CHRNB2;EYA4;RDH12;DHRS3;TH;COL18A1;SFRP5;ABLIM1;RABGGTB;CNGB1
prerank,regulation of DNA metabolic process (GO:0051052),0.2651305125935624,0.7316328434229583,0.8592017738359202,0.9442298948421117,1.0,17/44,36.21%,PDGFA;THOC1;WDR70;STOX1;UBE2V2;KAT7;USP1;TERF2IP;SMG1;TICRR;XRCC5;PARG;TERF2;MPHOSPH8;IL7R;MYC;MPV17
prerank,anterior/posterior pattern specification (GO:0009952),0.257120244762285,0.7312197289272083,0.8657865786578658,0.9443746585367905,1.0,11/53,21.18%,HOXA4;HES7;BHLHE40;BHLHE41;BASP1;HOXA7;WLS;DDIT3;HOXC5;HOXB4;HOXC9
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.29087222519662354,0.7302644934750249,0.8243727598566308,0.9451347129391505,1.0,5/23,25.17%,PLAAT3;LPCAT3;PLA2G12A;ABHD4;PLA2G5
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.2650154533584629,-0.7298387931753181,0.8311688311688312,0.98116800143557,1.0,3/13,13.21%,SESN1;RNF152;CASTOR1
prerank,modulation by host of viral genome replication (GO:0044827),-0.26002008066387994,-0.729781486130909,0.8155737704918032,0.9791959189847149,1.0,4/13,20.80%,YTHDC2;PRKN;NUCKS1;FBXL2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.31200716298782805,0.7292516506022281,0.8271446862996159,0.9459723251060459,1.0,6/16,28.59%,PRPF39;WBP11;SART1;RBM22;SRSF1;WBP4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3299033347857785,0.7292428367399041,0.7955493741307371,0.9456557290264775,1.0,6/13,28.60%,IL27;IL27RA;JAK1;CANX;JAK2;OASL
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.32999394904331647,0.7291439833894887,0.8386243386243386,0.9454327706660178,1.0,3/14,14.06%,FGF2;GATA3;SPRY4
prerank,mismatch repair (GO:0006298),0.28648544698848233,0.729143406746749,0.8283062645011601,0.9451095809398874,1.0,11/27,36.61%,ERCC1;LIG1;RNASEH2A;PMS1;XPC;POLD4;MLH3;PCNA;SETD2;MCM9;PMS2
prerank,histone H3 acetylation (GO:0043966),0.2732426814680753,0.7287367245817186,0.8569844789356984,0.9452303193156184,1.0,10/40,20.64%,LEF1;ING4;TRIM16;TADA1;WDR5;ING5;JADE3;KAT7;DR1;YEATS2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.28776663437635097,0.7283531626580201,0.8399044205495818,0.9453376928442123,1.0,2/24,4.86%,NR4A3;COQ10B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.32068935094419837,0.7279802305595983,0.8093385214007782,0.9454135458556365,1.0,8/14,31.23%,CSF1;CCL5;AKIRIN1;IL34;MDK;MAPK3;RARRES2;MAPK1
prerank,secretion (GO:0046903),0.32277312963269583,0.7278598867316932,0.8324468085106383,0.9452210908338365,1.0,6/14,29.96%,TPD52;VIP;ABCB11;DRD3;FBLN5;NPR1
prerank,establishment of mitotic spindle localization (GO:0040001),0.278900261389115,0.7277034860387582,0.8491879350348028,0.9450727631703816,1.0,8/28,27.94%,HTT;DCTN1;NUMA1;FBXW11;SPDL1;CENPA;ESPL1;ITGB1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.29265722961899254,0.7271396851597507,0.8357843137254902,0.9453399100059696,1.0,6/22,18.44%,ABCG1;GSAP;RANBP9;EFNA1;CLU;SP1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.26090898687677067,0.7269771198678762,0.8644808743169399,0.9452003664632588,1.0,18/50,31.50%,MMP8;SASH1;SPHK1;ILK;RHOA;PDCD4;RPS3;LAPTM5;ACTN4;TNF;TCIM;TLR9;TERF2IP;LIMS1;TRIP6;AGER;NOD1;EP300
prerank,positive regulation of dendrite development (GO:1900006),0.35251096141335725,0.7268196388910582,0.800818553888131,0.9450462680606799,1.0,1/10,4.20%,ZDHHC15
prerank,DNA conformation change (GO:0071103),-0.23561083593593124,-0.7267150085263382,0.8578199052132701,0.9809826544130503,1.0,5/17,17.49%,NAA10;TOP2A;TOP3B;ERCC3;TOP3A
prerank,endocrine system development (GO:0035270),-0.22848879428809127,-0.7265427940776292,0.8615384615384616,0.9791432997138197,1.0,3/21,8.86%,SALL1;PAX8;TG
prerank,Golgi to lysosome transport (GO:0090160),0.3359948311800015,0.726524850164143,0.8071135430916553,0.9450498852241727,1.0,5/11,26.75%,GAK;CLN3;AP1G1;LAPTM5;LAMP1
prerank,regulation of catabolic process (GO:0009894),0.3072159374832907,0.7263509521067816,0.8364779874213837,0.9449238295261686,1.0,12/18,36.15%,FURIN;ODC1;FAM83D;CHMP6;MDM2;ITGB1;FAF1;SNF8;RARRES2;CHEK2;CENATAC;ZDHHC2
prerank,response to cholesterol (GO:0070723),0.3052978267798436,0.7260634506994322,0.842985842985843,0.9449072754820018,1.0,5/17,23.23%,LRP6;GRAMD1B;MLC1;PMVK;TGFBR2
prerank,determination of left/right symmetry (GO:0007368),0.274808686354507,0.7260133742059308,0.8597491448118586,0.9446392323607621,1.0,10/36,28.38%,ODAD2;FOXJ1;MKKS;DAND5;BBS7;CCDC40;CCDC39;DNAH5;ARL6;DNAH11
prerank,nerve growth factor signaling pathway (GO:0038180),-0.28913912678462766,-0.7250718844049903,0.8233082706766918,0.9789146851758591,1.0,5/10,34.45%,RAPGEF2;BDNF;NTRK1;NGF;NTF4
prerank,negative regulation of lyase activity (GO:0051350),0.30945649984139806,0.7249430288989097,0.8209718670076727,0.9455072646130862,1.0,3/16,16.85%,CCR2;PHPT1;MTRR
prerank,aminoglycan catabolic process (GO:0006026),0.28094065656175954,0.7246281796444846,0.850412249705536,0.945543091821543,1.0,8/28,24.68%,GNS;GLB1;GUSB;FUCA1;HSPG2;IDUA;SDC3;SDC4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.20593558706341564,-0.7242665858961796,0.9523809523809523,0.9778935810240741,1.0,4/32,10.40%,CAPN3;HAP1;P2RY6;AKAP6
prerank,atrioventricular valve development (GO:0003171),-0.25355744793381213,-0.7230898155957998,0.8258928571428571,0.9774438438770792,1.0,6/14,30.79%,ZFPM1;BMP2;HEYL;GJA5;BMPR2;BMPR1A
prerank,cellular response to glucose starvation (GO:0042149),0.26212683642525353,0.7230465970421476,0.8804824561403509,0.9469405493177896,1.0,13/41,33.67%,CPEB4;SIK1;MYBBP1A;PRKAG1;NIM1K;ATF4;HSPA5;SESN2;BECN1;ASNS;XBP1;ZC3H12A;BRSK2
prerank,V(D)J recombination (GO:0033151),0.330936324034465,0.7230133335842064,0.8070175438596491,0.9466533940930344,1.0,4/11,29.67%,LIG1;HMGB1;LIG3;HMGB2
prerank,protein complex oligomerization (GO:0051259),0.24464169871780217,0.7227164000533872,0.9128630705394191,0.9466574972499865,1.0,22/85,29.29%,LRRC8C;SLC9A1;ADCY8;ALS2;TMEM120B;PRF1;PDCD6IP;UPB1;BLM;TWNK;NINJ1;EHD4;STOML2;CPSF7;EHD1;TRIM72;NOL3;ARC;FUS;NUDT21;ZNHIT6;CLDN1
prerank,protein targeting to peroxisome (GO:0006625),0.27873019660470366,0.7224945759334688,0.8509389671361502,0.9465743432745647,1.0,12/29,29.57%,PEX2;RAB8B;ABCD2;ABCD3;PXMP2;ALDH3A2;PEX16;ACBD5;PEX14;ZFAND6;PEX19;FIS1
prerank,positive regulation of filopodium assembly (GO:0051491),0.29090211669508215,0.7224259437790227,0.857487922705314,0.9463251368301537,1.0,4/24,13.01%,RIPOR2;NRP1;RHOQ;CDC42
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3249011557551753,0.7220069544172752,0.8279009126466753,0.9464634401386639,1.0,3/13,21.66%,EIF6;XPO1;NPM1
prerank,microtubule bundle formation (GO:0001578),0.2639238730634569,0.7218926928320651,0.8777777777777778,0.9462647954026375,1.0,9/42,21.35%,FOXJ1;SPAG16;NAV1;DCX;KIF20A;NUMA1;CHP1;AAAS;MARK4
prerank,SNARE complex assembly (GO:0035493),-0.27469668532389724,-0.7215633904213354,0.8260869565217391,0.9772458737636667,1.0,5/10,22.38%,VAMP1;STXBP1;UVRAG;STXBP6;VAMP8
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2844651668684726,0.7211321585122724,0.8588235294117647,0.9468095425630063,1.0,5/24,18.67%,BCL2L1;RACK1;LPCAT3;CLU;WFS1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.24948532349311825,-0.7211182020419075,0.891566265060241,0.9757962257893288,1.0,2/13,8.84%,GRM3;ADGRV1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2456823135047435,0.720227377167936,0.9001040582726326,0.9474694824021291,1.0,11/79,14.06%,NIBAN2;FSTL3;FGF2;PPARG;CADM4;BAMBI;LEMD2;CHRD;SMAD7;SMAD1;SPRY4
prerank,mesenchymal cell development (GO:0014031),0.30033384069342056,0.7202132019176563,0.8366834170854272,0.9471628067784826,1.0,3/18,16.38%,NRG1;NOLC1;TCOF1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.27264230097775366,-0.7200252054870923,0.8286713286713286,0.9750662487244679,1.0,1/10,0.61%,BIN1
prerank,glucan catabolic process (GO:0009251),0.3123615448632186,0.7195473701728728,0.8467243510506799,0.9475513272699223,1.0,6/15,25.64%,GAA;MGAM;PHKB;PYGM;PGM2;STBD1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2818729172991921,0.7189476467110993,0.8600237247924081,0.9478782211029343,1.0,8/30,24.72%,SDCBP;RPL11;OGT;CCAR2;HSP90AB1;USP14;EIF3H;GIPC1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2904323455633523,0.7187278077245333,0.8686131386861314,0.9477765388585049,1.0,2/23,3.90%,SLC9A1;NR4A3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2933767519363972,0.7179831271892063,0.8709273182957393,0.9479207500410493,1.0,9/20,38.78%,GSTA2;AKR1A1;GSTO2;GSTO1;GSTK1;ESD;GSTT1;GSTP1;MGST3
prerank,glutathione derivative metabolic process (GO:1901685),0.2933767519363972,0.7179831271892063,0.8709273182957393,0.9479207500410493,1.0,9/20,38.78%,GSTA2;AKR1A1;GSTO2;GSTO1;GSTK1;ESD;GSTT1;GSTP1;MGST3
prerank,histone ubiquitination (GO:0016574),0.2954851098232928,0.71778872254391,0.8403575989782887,0.9477873052851218,1.0,9/21,35.70%,HUWE1;PAF1;UBR2;RNF20;CTR9;LEO1;UHRF1;USP22;UBE2A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.29487421899430283,0.7177324229449699,0.8661800486618005,0.947523473211325,1.0,7/20,30.61%,IPO5;CEBPA;TFAP4;LATS1;CDK5RAP1;PTEN;HEXIM1
prerank,protein hydroxylation (GO:0018126),0.3072339604865474,0.7170716626484767,0.8533163265306123,0.9478891532918018,1.0,4/15,16.60%,ASPH;P3H1;OGFOD1;VIPAS39
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3307675412710629,0.716459258278635,0.8228346456692913,0.948205819298226,1.0,5/12,26.03%,PTK2B;POU2AF1;IL6;DOCK11;GPR183
prerank,regulation of ERAD pathway (GO:1904292),0.33133610809980696,0.7159723191731142,0.8353741496598639,0.9483739469465009,1.0,7/11,37.00%,ATXN3;RNFT1;USP19;USP13;HERPUD1;AQP11;RNF185
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2659364638380068,0.7158933111461064,0.8607021517553793,0.94813584987948,1.0,11/33,30.23%,PTGIR;PPARG;HMOX1;EFEMP2;VIP;PDCD4;SOD2;OGN;TNFAIP3;PRKG1;PTEN
prerank,pancreas development (GO:0031016),-0.27442669342968273,-0.7158002807921693,0.8433734939759037,0.9780557734005586,1.0,6/12,34.21%,SELENOT;TCF7L2;ISL1;DNAAF1;NPHP3;NKX6-1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.24805009882688558,0.7157938204205265,0.8952991452991453,0.9479148439178302,1.0,6/64,8.31%,AIG1;ACSBG1;ACSBG2;MGLL;ACSL1;FADS1
prerank,myeloid cell development (GO:0061515),-0.22997935618848298,-0.7151948863041618,0.9077669902912622,0.976801086426059,1.0,5/18,13.22%,APP;DMTN;TLR2;ALAS2;SRC
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3066286472478498,0.7151477757078102,0.8488664987405542,0.9482694112877255,1.0,3/16,14.49%,DDX17;PPARGC1B;RBFOX2
prerank,alpha-amino acid metabolic process (GO:1901605),0.25694363635121653,0.7147506579266507,0.8978675645342312,0.9483368147912999,1.0,14/45,27.31%,ATP7A;GNMT;MMUT;PYCR3;GLS2;GLS;MTHFD1;MTRR;OAT;MTHFR;NOX4;SRR;PYCR2;DDAH1
prerank,histone H2A ubiquitination (GO:0033522),0.30072900514680484,0.7145622704323189,0.82375,0.9482053611909781,1.0,4/17,18.37%,DDB2;DDB1;RNF2;UBR2
prerank,embryonic eye morphogenesis (GO:0048048),0.337100266246966,0.713620696252733,0.8519003931847968,0.9488289489043347,1.0,2/11,14.88%,TH;LRP6
prerank,brain morphogenesis (GO:0048854),-0.2746625821433684,-0.7135806216611008,0.8521739130434782,0.9766082670063359,1.0,3/12,8.54%,CTNNA2;SHANK3;PAX2
prerank,pharyngeal system development (GO:0060037),0.31241589297303923,0.7135367173167473,0.852752880921895,0.9485953198579191,1.0,4/15,27.36%,GATA3;BMP4;BMP5;HES1
prerank,respiratory chain complex IV assembly (GO:0008535),0.2890076779618128,0.7132118764499247,0.8619447779111644,0.9486145937603672,1.0,6/21,20.55%,PET100;SURF1;COX10;TIMM21;SMIM20;FASTKD3
prerank,establishment of skin barrier (GO:0061436),0.3064571136272075,0.7129648211870225,0.8243064729194187,0.9482392662097822,1.0,2/15,11.30%,UGCG;HRNR
prerank,regulation of water loss via skin (GO:0033561),0.3064571136272075,0.7129648211870225,0.8243064729194187,0.9482392662097822,1.0,2/15,11.30%,UGCG;HRNR
prerank,response to gamma radiation (GO:0010332),0.27952330864227215,0.7128624818805452,0.8507821901323707,0.9480316414556276,1.0,10/24,35.08%,ATM;TMEM109;HSF1;MDM2;DCUN1D3;KDM1A;ATR;XRCC5;MAP3K20;MYC
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2810990092255649,-0.7127518212194348,0.8293515358361775,0.9756429849671522,1.0,1/10,3.66%,HNMT
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.24202207324229108,0.7112418189054458,0.9010638297872341,0.9493874786431086,1.0,18/72,22.47%,FGF13;APOE;PRKCD;TREM2;IAPP;MID1IP1;HSPA8;PFDN1;CLU;MYADM;HIP1R;PFDN2;ARFGEF1;ARHGEF2;EMILIN1;PLEKHH2;TAOK1;PFN1
prerank,positive regulation of mRNA processing (GO:0050685),0.2888997202066123,0.7104882019474306,0.855072463768116,0.9498343282935329,1.0,10/21,33.23%,PRDX6;NCL;DHX36;PAF1;NUP98;SNW1;TRA2B;LEO1;CIRBP;DAZAP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.28962515527014304,0.7103811519526956,0.8574908647990256,0.949624999424783,1.0,8/21,30.81%,CNOT4;CNOT10;CNOT6;SAMD4A;PAN2;CNOT6L;CNOT9;SAMD4B
prerank,positive regulation of response to wounding (GO:1903036),-0.21406055122193235,-0.7087674138361637,0.946236559139785,0.9780291807657062,1.0,9/24,20.88%,PRKCE;KANK1;PTK2;HBEGF;DMTN;HRAS;OCLN;MYLK;ADRA2A
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.30398414686436326,0.7077448015196461,0.8528301886792453,0.9520205491152371,1.0,2/16,4.34%,PRDX6;NCL
prerank,ameboidal-type cell migration (GO:0001667),0.2545226432460577,0.7075450882959052,0.9055555555555556,0.9519058796973369,1.0,4/51,7.33%,CORO1C;PDLIM1;ITGA4;ANXA6
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.30202754648926305,0.7069476815140072,0.8404255319148937,0.9521917729366983,1.0,5/15,29.06%,FSTL3;SMAD7;FST;DACT1;FKBP1A
prerank,positive regulation of cell aging (GO:0090343),0.32954080190106827,0.70609228481793,0.8534246575342466,0.9527592655873651,1.0,2/11,9.89%,LMNA;B2M
prerank,peptidyl-lysine acetylation (GO:0018394),-0.2728938738880654,-0.7058262991245858,0.8592057761732852,0.9794222679647243,1.0,4/10,21.24%,KAT2B;KAT5;BAG6;ESCO1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.32010247504908523,0.705101528091916,0.8337912087912088,0.9534411163638596,1.0,1/12,0.83%,CSF1
prerank,positive regulation of cilium assembly (GO:0045724),0.29808186899569045,0.7049524123821842,0.8407960199004975,0.9532825093894912,1.0,5/18,24.07%,KCTD17;HTT;MARK4;CEP120;CCDC88A
prerank,oligodendrocyte differentiation (GO:0048709),0.2903626650404904,0.7048381886016586,0.8491048593350383,0.9530817829357444,1.0,6/19,25.70%,CDK5;SOX9;EIF2B2;EIF2B4;SOX10;MYRF
prerank,Notch signaling involved in heart development (GO:0061314),0.32498313168661325,0.7045517080769405,0.8611859838274932,0.9530613643733912,1.0,2/11,11.71%,JAG1;DLL4
prerank,negative regulation of ossification (GO:0030279),0.2813254730863593,0.7039949861249211,0.8571428571428571,0.9532848831932998,1.0,4/23,12.08%,PTK2B;LRP4;SOX9;ECM1
prerank,metal ion homeostasis (GO:0055065),0.2583822860852707,0.7038853774540856,0.8822222222222222,0.9530706399789652,1.0,8/40,21.21%,SELENON;CYP27B1;CAV1;SLC12A4;CNNM2;SLC7A8;WFS1;SLC12A7
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.27874492490418934,0.703365931484253,0.8559218559218559,0.9532785777326208,1.0,7/25,21.33%,RPS7;RPL23;RPL11;EFNA1;PSME3IP1;CSNK2A2;HSP90AB1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.33228947576044554,0.7033412762283712,0.8373655913978495,0.9529815408361216,1.0,3/10,18.77%,THOC1;DDX39B;CCAR2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3262975928474662,0.7033221009259752,0.8440492476060192,0.9526850459039977,1.0,5/12,32.55%,EAPP;HNRNPU;RECQL5;HEXIM1;NELFA
prerank,neural crest cell development (GO:0014032),0.254207014540064,0.7029983903040594,0.8922222222222222,0.9526723364357106,1.0,4/44,9.45%,CORO1C;NRG1;ANXA6;NOLC1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.31536965616054197,0.7026480025955697,0.8647925033467202,0.9527014059696068,1.0,6/13,32.73%,CD2BP2;PRPF6;PRPF8;SRSF10;PRPF31;SART3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2641120001397864,0.7025745156625234,0.8805104408352669,0.9524515090682679,1.0,8/33,26.28%,ID2;FBXW7;INO80;APPL2;PAF1;FAM83D;TCIM;PTPN6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.3291554345531475,0.702397113214915,0.8407202216066482,0.9523051094080822,1.0,5/11,34.64%,DAB2;CSNK1D;SFRP1;CSNK1E;MLLT3
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.24758030799225753,-0.70172344315555,0.8644859813084113,0.9818452760752117,1.0,4/15,24.23%,KMO;HAAO;QDPR;FAH
prerank,ncRNA 3'-end processing (GO:0043628),0.3090176858236108,0.7012376397105502,0.8623376623376623,0.9531397695704644,1.0,6/14,33.75%,INTS14;INTS6;INTS2;INTS7;TOE1;ERI1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.24662568473736926,0.7004818439486283,0.9029850746268657,0.9535652735121747,1.0,7/59,16.03%,LPL;ACACA;SLC27A5;OSBPL2;HSD17B8;CH25H;ABCD3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.26146655003387875,0.7000908999948744,0.8773809523809524,0.9536493683164614,1.0,8/32,22.23%,DYRK2;AEN;HIPK1;MYBBP1A;STK11;TMEM109;USP28;CDIP1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.29797010253957307,0.700056216375367,0.8565989847715736,0.9533647195936698,1.0,3/17,15.98%,CCNY;ADAM17;CCND2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.26846183231791454,0.6987496196327166,0.8820754716981132,0.9542901346444768,1.0,6/30,20.12%,CD28;CD274;HSPD1;SYK;IL6;HMGB1
prerank,protein heterotetramerization (GO:0051290),0.31580714475789673,0.697776033680757,0.8464619492656876,0.9548987341928046,1.0,4/13,20.94%,HSD17B8;FARSA;FARSB;CPSF7
prerank,protein K48-linked ubiquitination (GO:0070936),-0.1766322970102209,-0.6977606746522377,1.0,0.9839308089934995,1.0,14/54,19.63%,ITCH;KLHL3;DTX3L;UBE3A;UBE2G1;PRKN;UBE2Q2;UBE2E3;RNF152;RFFL;NEDD4L;UBE2T;HACE1;FBXO38
prerank,purine-containing compound catabolic process (GO:0072523),0.31377876750330186,0.6975405406918532,0.8605898123324397,0.9548115953418778,1.0,4/13,26.24%,XDH;ITPA;NUDT15;GPX1
prerank,protein localization to centrosome (GO:0071539),0.2943651586357192,0.6969109447695222,0.8754764930114358,0.955087931767142,1.0,4/17,17.35%,GOLGB1;SNX10;CSNK1D;HOOK3
prerank,endothelial cell development (GO:0001885),0.28182947563855104,0.6964100251665217,0.8705463182897862,0.9552733449164273,1.0,9/25,34.36%,MSN;COL18A1;MYADM;MARVELD2;PECAM1;RDX;RAP1B;COL22A1;PPP1R16B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3076735870288522,0.6961693387490754,0.8634538152610441,0.9551817351454054,1.0,2/13,10.12%,NFU1;ISCA1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2576107147174378,0.6960658910245451,0.895152198421646,0.9549589420361364,1.0,17/39,33.08%,ABCA1;RAB8A;MON1A;RAB8B;RCN3;TMEM167A;LTBP2;ARFGAP3;RAB3D;CANX;GOLPH3;AFM;TANGO2;COPG1;COPG2;MIA3;STEAP3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.33388766842070805,0.6960619479306159,0.8644986449864499,0.9546442867686172,1.0,3/10,15.53%,CCNB1;CDC42;RACGAP1
prerank,positive regulation of neuron migration (GO:2001224),0.3217930247920971,0.6959925313554148,0.8367071524966262,0.9543928649408671,1.0,6/11,30.92%,PLAA;ARHGEF2;NSMF;NIPBL;MDK;SEMA3A
prerank,ventricular septum morphogenesis (GO:0060412),-0.20866914678236437,-0.6957339260005788,0.9632352941176471,0.9840637532616927,1.0,12/27,30.79%,ROBO1;ZFPM1;ROBO2;HEY1;HEYL;SLIT2;CITED2;BMPR2;ZFPM2;TGFBR1;SOX4;BMPR1A
prerank,DNA integrity checkpoint signaling (GO:0031570),0.26080289234778065,0.6954710484746981,0.8937142857142857,0.9545809251353311,1.0,13/36,33.85%,ERCC6;DOT1L;ATM;RAD1;USP28;SETMAR;INTS7;ATR;RAD9A;HINFP;MAP3K20;HUS1;CHEK2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.32719509564474797,0.6954158525080529,0.8681318681318682,0.9543187980204273,1.0,5/10,24.04%,DGKH;DGKD;F2R;HTR2B;PRKD3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.26748708288307194,0.6953824125483217,0.8612099644128114,0.954038808342793,1.0,6/27,16.20%,FXYD5;RANGRF;SCN1B;UTRN;FXYD4;SCN3B
prerank,positive regulation of coagulation (GO:0050820),0.3279004051932081,0.6949194527225966,0.8461538461538461,0.9538609807361361,1.0,4/10,28.28%,SERPINE1;APOH;F2R;HPSE
prerank,positive regulation of hemostasis (GO:1900048),0.3279004051932081,0.6949194527225966,0.8461538461538461,0.9538609807361361,1.0,4/10,28.28%,SERPINE1;APOH;F2R;HPSE
prerank,negative regulation of TOR signaling (GO:0032007),0.2616935495155593,0.6941579590329946,0.8794084186575654,0.9542552768516681,1.0,10/36,29.22%,NPRL2;STK11;ATM;UBR2;NPRL3;SESN2;GSK3A;FNIP1;TMEM127;SIRT1
prerank,cardiac muscle cell action potential (GO:0086001),0.2661914079873873,0.6933844849295796,0.8831018518518519,0.9546758205874841,1.0,7/30,16.74%,KCNJ2;ATP1A1;SCN1B;CACNA1D;ATP1A2;SCN3B;PKP2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.2321476202028333,-0.6933260253309403,0.9151785714285714,0.9845727393976768,1.0,7/17,21.84%,RBPJ;WWC1;KAT2B;NOTCH3;STAT1;MAML3;HEYL
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2684335061900287,0.6928675786840478,0.8952380952380953,0.9548460207622016,1.0,9/28,24.08%,COTL1;RASA1;HAX1;GBA2;PLEKHG2;LATS1;WAS;PFN1;NAA80
prerank,regulation of histone modification (GO:0031056),0.3067078510073642,0.6924893547890064,0.8551099611901681,0.9548836452156386,1.0,5/13,36.94%,HPF1;MTHFR;PARG;AKAP8;FLCN
prerank,indolalkylamine catabolic process (GO:0046218),-0.27100695012838755,-0.6923898449002911,0.872,0.9835978741744055,1.0,2/10,15.26%,KMO;HAAO
prerank,glutathione metabolic process (GO:0006749),0.25453764385985417,0.6918578574932472,0.8958097395243488,0.9551640117654384,1.0,4/38,10.31%,GSTA2;CNDP2;GSR;NAT8
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2886339949345875,0.6916659625892221,0.8559113300492611,0.9550300976008619,1.0,5/18,20.55%,PET100;SURF1;TIMM21;SMIM20;FASTKD3
prerank,regulation of neuron projection arborization (GO:0150011),0.3001481515296579,0.6909036001987482,0.8719898605830165,0.9554137182977043,1.0,9/15,37.61%,MACF1;FZD4;MYO9A;DLG4;MFSD2A;NTNG2;DVL2;SPRY3;DVL3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.18670554872337902,-0.6906210367620227,0.975,0.9833163260650715,1.0,9/37,17.67%,IFT81;KIF3C;IFT46;KIFAP3;IFT80;DYNC2LI1;CEP131;IFT27;TTC21B
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.32446065033873717,0.6904401501553716,0.8622159090909091,0.9555321719988393,1.0,3/10,25.45%,VEGFA;BMP6;NOTCH4
prerank,isotype switching (GO:0045190),-0.2752304072537248,-0.6903875119875676,0.8467153284671532,0.9815956734144868,1.0,2/10,12.13%,RNF168;CCR6
prerank,positive regulation of vasoconstriction (GO:0045907),0.3045544219479858,0.6893819795117162,0.8732212160413971,0.9561622238339985,1.0,1/13,5.31%,CAV1
prerank,mitochondrial protein processing (GO:0034982),0.3200285736646893,0.6883824942404105,0.8664021164021164,0.9567850778920713,1.0,3/11,19.40%,PMPCA;AFG3L2;STOML2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28777795153232394,0.6883774991726874,0.8942065491183879,0.9564702364591053,1.0,5/20,19.06%,CHRNB2;GNAQ;LY6G6D;GNA11;GNB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2767883419808963,0.6873774967729408,0.8694029850746269,0.9564595908482303,1.0,6/20,20.52%,TPR;TEX14;IK;ATM;BUB1B;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2767883419808963,0.6873774967729408,0.8694029850746269,0.9564595908482303,1.0,6/20,20.52%,TPR;TEX14;IK;ATM;BUB1B;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2767883419808963,0.6873774967729408,0.8694029850746269,0.9564595908482303,1.0,6/20,20.52%,TPR;TEX14;IK;ATM;BUB1B;TRIP13
prerank,cellular response to organic substance (GO:0071310),0.22859370224019068,0.6871557864694661,0.9600409836065574,0.956335122189016,1.0,30/116,26.53%,CTNNB1;IL18R1;LEF1;SPHK1;PTPN23;PTPN2;RACK1;PTPN12;CCL5;RHOA;TIPARP;PTPN13;GHR;CPNE3;CYP1B1;SIGIRR;HAX1;ARL6IP5;MAPK7;STAT5B;TGFBR2;SOCS2;PTPN9;TNF;MAP2K5;KHSRP;PTPN18;SFRP1;PTPN6;CXCR4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.21283511907476177,-0.6871545134886256,0.9397590361445783,0.9828811250977647,1.0,6/22,16.52%,PPM1E;PDP1;PPM1G;DUSP1;PPP1CA;DUSP7
prerank,sensory perception of sound (GO:0007605),0.23428284244593447,0.6869106598310649,0.9516957862281603,0.9562553912048679,1.0,18/88,22.91%,CHRNB2;MYO1A;GRXCR1;RIPOR2;TPRN;TIMM9;CACNA1D;BIRC5;HOMER2;SLC26A4;USP53;MKKS;WFS1;MYO3B;ATP6V0A4;MARVELD2;NIPBL;CLIC5
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.30463200359221976,0.6865753542556269,0.8656330749354005,0.9562433500090955,1.0,3/14,18.11%,ITGA4;PDCD4;ANO6
prerank,negative regulation of cyclase activity (GO:0031280),-0.23479995532731993,-0.6853608198176592,0.8931623931623932,0.982689680088028,1.0,2/14,8.84%,GRM3;ADGRV1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3160745460359151,0.6852433586542074,0.8745098039215686,0.9571606790874951,1.0,3/12,16.74%,CAV1;JUP;PKP2
prerank,protein K11-linked ubiquitination (GO:0070979),0.2679064250824556,0.6849991220317864,0.8804347826086957,0.9570739947882659,1.0,7/27,25.93%,UBE2L3;UBE2H;FZR1;ANAPC1;CDC26;ANAPC7;UBE2C
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.26975705996301563,-0.684787757077582,0.8560885608856088,0.9812675725071324,1.0,2/10,9.56%,CORO2B;NDFIP1
prerank,glycogen catabolic process (GO:0005980),-0.22922442282222105,-0.6847819421784334,0.8846153846153846,0.9793223813551136,1.0,4/15,13.40%,PHKA2;PHKG1;RB1CC1;PGM2L1
prerank,cell-cell junction organization (GO:0045216),0.23492145716351318,0.6844959895526653,0.951092611862643,0.9572204837518183,1.0,10/79,10.04%,TLN1;NECTIN1;PKP1;PKP4;TJP2;CADM1;LIMS2;NECTIN3;CDH1;JUP
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2830241934137293,0.6838973475372155,0.8785625774473358,0.9574442176550123,1.0,1/21,0.26%,FGF13
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.22821480123857404,0.6823418965057588,0.9464469618949537,0.9585503571043812,1.0,31/104,30.07%,SLC27A1;LTF;GTPBP4;HTT;CCNB1;BCCIP;RHOA;BLM;ACTB;CAB39;LRP6;CCND2;RALB;CDKN3;TESK1;GTF2H1;CCNT2;SYAP1;SERTAD1;TRIB2;MAP2K2;CALM3;GADD45A;PARP16;PIH1D1;CNPPD1;MNAT1;SIRT1;CDC25A;SNF8;CCND1
prerank,membrane lipid catabolic process (GO:0046466),0.33176446491978273,0.6816466993075522,0.8848821081830791,0.9588531567760459,1.0,3/10,24.46%,FUCA1;CYP1B1;PDXDC1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.2946800901293146,0.6805805183957526,0.871261378413524,0.9595282487051795,1.0,2/16,6.10%,NPPA;KLK1
prerank,acidic amino acid transport (GO:0015800),-0.22969674832350642,-0.679719705062789,0.9090909090909091,0.9821481312971376,1.0,4/17,10.21%,SLC1A3;SLC25A12;SLC6A1;PRAF2
prerank,regulation of protein export from nucleus (GO:0046825),0.27255356517265616,0.6795870747906496,0.8853658536585366,0.9600969851938751,1.0,8/23,24.27%,SP100;GAS6;TPR;BARD1;GSK3B;RBM22;ANP32B;BAG3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2370342775963788,0.6793076918825727,0.928495197438634,0.9600129033663913,1.0,23/62,34.64%,POLR2H;CDK13;AFF4;GTF2F1;POLR2D;ELOF1;ELOB;PAF1;GTF2H1;EAF1;CCNT2;MLLT1;POLR2F;GTF2H5;SUPT4H1;MNAT1;CTR9;LEO1;TCEA1;ERCC2;NELFA;SETD2;MLLT3
prerank,exit from mitosis (GO:0010458),0.3135750851595609,0.6788484781736639,0.8678237650200267,0.9601287585909877,1.0,3/12,12.97%,CHMP4B;CHMP7;PPP2R2D
prerank,regulation of histone acetylation (GO:0035065),0.2588178111721061,0.678752985321401,0.9041713641488163,0.959888373677384,1.0,4/33,10.59%,KMT2A;NOC2L;THAP7;BRCA1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.27717033855908624,0.6784961437795299,0.9032258064516129,0.9597929911357616,1.0,6/23,29.06%,ID2;SMAD7;PKP2;FGFR2;ADAMTS9;FKBP1A
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.22698731633806357,-0.6783463619547287,0.8945147679324894,0.9815210776575881,1.0,16/16,77.33%,SGO1;DSCC1;BOD1;CDCA5;HASPIN;RAD21;SMC1A;RAD21L1;REC8;POGZ;RB1;MAU2;NAA50;PDS5B;PDS5A;NIPBL
prerank,osteoclast differentiation (GO:0030316),0.2712827251221609,0.6776322587104272,0.8691931540342298,0.9602303860339041,1.0,3/22,9.41%,CSF1;TREM2;SNX10
prerank,amyloid-beta metabolic process (GO:0050435),0.2904676147230819,0.6775264651356459,0.8782722513089005,0.9600029970876709,1.0,3/16,13.25%,PSEN2;NAT8;ABCA7
prerank,early endosome to Golgi transport (GO:0034498),0.3164702224312027,0.6774199520619384,0.8642951251646904,0.9597875359857,1.0,5/11,27.14%,SNX8;LMAN1;SNX1;SURF4;STX5
prerank,monocarboxylic acid catabolic process (GO:0072329),0.2763506380616464,0.6773950235422411,0.8733087330873309,0.9594897983799429,1.0,5/21,27.19%,CEL;PPARD;ACBD5;LPIN3;ACOT8
prerank,serine family amino acid catabolic process (GO:0009071),0.318703227784822,0.6766478464244081,0.8643835616438356,0.9598426440691725,1.0,5/10,33.87%,SHMT1;AMT;GCSH;SHMT2;CBS
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24067928188126864,-0.6763179548319126,0.8949579831932774,0.9813218982282484,1.0,5/15,18.03%,PLCG2;ATAD5;STXBP4;EZH2;CRNN
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.289569943063119,0.676016340860677,0.8802083333333334,0.9600809560386413,1.0,4/16,15.54%,RMI1;CENPX;ERCC4;SLX4
prerank,negative regulation of cell division (GO:0051782),-0.25502082214189303,-0.6759292310027774,0.8885017421602788,0.9797498128722478,1.0,4/11,17.35%,TXNIP;AURKB;CHMP4C;E2F7
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.27193915979192834,0.6751771211619811,0.8960396039603961,0.9604955477645452,1.0,4/21,16.16%,ARHGAP25;SPRY4;ARHGAP12;SYNGAP1
prerank,snRNA processing (GO:0016180),0.2885290286016766,0.6746541723078441,0.8883116883116883,0.9606330362521791,1.0,6/16,32.59%,INTS14;INTS6;INTS2;INTS7;TOE1;TUT1
prerank,zinc ion transport (GO:0006829),0.2710270978024385,0.6732048322481207,0.9079601990049752,0.9615684107962568,1.0,5/21,22.37%,SLC39A6;SLC39A7;SLC30A9;SLC39A11;SLC39A1
prerank,positive regulation of protein acetylation (GO:1901985),-0.2516822684342666,-0.6724782294467706,0.9068825910931174,0.9809083777933008,1.0,4/12,17.63%,DIP2B;CAMK1;KAT5;RAPGEF3
prerank,male gonad development (GO:0008584),0.24923110360685974,0.6706393392438071,0.9148191365227538,0.9634324936656837,1.0,6/34,20.82%,GATA3;SOX9;KITLG;ING2;COL9A3;BIK
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.29982914635434915,0.6703728795610624,0.8826739427012278,0.9633238727369076,1.0,2/12,14.85%,ZBTB7B;SORBS1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.2230218527228825,-0.6694542314474282,0.9023255813953488,0.981704159053134,1.0,9/17,27.36%,NOS1AP;AKAP6;RNF207;ANK3;KCNG1;KCNE3;KCNRG;KCNE4;KCNS1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.27034367558164285,0.6693890824800355,0.8975308641975308,0.9638524711142856,1.0,7/22,21.26%,NPPA;STAC2;SRI;CACNB3;CACNB1;CACNB4;AHNAK
prerank,quinone biosynthetic process (GO:1901663),0.2991778100433133,0.6691199938149099,0.8956406869220608,0.9637779951359267,1.0,3/14,16.79%,COQ10B;COQ5;COQ3
prerank,regulation of insulin secretion (GO:0050796),0.22317198389862858,0.6689442944497859,0.9564766839378238,0.9636157202018978,1.0,16/101,19.69%,CACNA1A;GCK;FAM3D;TRH;SLC2A1;CCL5;CACNA1D;RBP4;SLC8B1;GIPR;AACS;GLP1R;SIRT4;IL6;ITPR3;CDK16
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26988733811092347,0.6686383290742328,0.9049881235154394,0.963566174698342,1.0,7/22,30.61%,IPO5;CEBPA;TFAP4;LATS1;CDK5RAP1;PTEN;HEXIM1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2676492334639913,-0.6686287626166149,0.9139784946236559,0.9804806533717448,1.0,2/10,10.43%,SORL1;DNAJA4
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.28072249462036347,0.6682763734532798,0.881979695431472,0.9635551955867329,1.0,8/18,35.19%,RNF125;C1QBP;PUM1;BIRC2;OASL;USP15;GPATCH3;PUM2
prerank,regulation of vasoconstriction (GO:0019229),0.25654761955889016,0.6679436507602327,0.9091981132075472,0.9635227857780435,1.0,3/27,11.95%,ATP2B1;CAV1;KCNMB4
prerank,positive regulation of RNA splicing (GO:0033120),0.25769678739553065,0.6679125594396016,0.9113475177304965,0.9632335616448447,1.0,4/29,9.03%,PRDX6;NCL;ERN1;HNRNPLL
prerank,regulation of tube diameter (GO:0035296),0.3050119497553614,0.6677353363368063,0.8986842105263158,0.9627533964063534,1.0,3/13,19.26%,SCPEP1;ROCK1;ITGB1BP1
prerank,vascular process in circulatory system (GO:0003018),0.3050119497553614,0.6677353363368063,0.8986842105263158,0.9627533964063534,1.0,3/13,19.26%,SCPEP1;ROCK1;ITGB1BP1
prerank,embryonic digit morphogenesis (GO:0042733),-0.21979188582659823,-0.6673753313534038,0.9040404040404041,0.9795943982807611,1.0,3/18,13.17%,SALL1;INTU;OSR1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.29618977916287226,0.6671347859411495,0.8888888888888888,0.9629554615224344,1.0,4/13,25.85%,NAMPT;KDR;JAK2;TLR9
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2526741922057292,0.6670739819591753,0.9178571428571428,0.9626888737809175,1.0,10/31,25.85%,LTB;IRF5;HSPD1;TIRAP;SYK;SCIMP;HMGB1;LAPTM5;MDK;TLR9
prerank,ureteric bud morphogenesis (GO:0060675),0.28493123213108856,0.6669624012858824,0.8833333333333333,0.9624675923529732,1.0,2/16,6.37%,FGF2;GATA3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.297108200362186,0.6664297229902194,0.8920676202860858,0.9625876736711853,1.0,4/13,18.67%,LPCAT3;CLU;MBTPS2;WFS1
prerank,regulation of macrophage cytokine production (GO:0010935),0.29271621995459945,0.666012402236119,0.891566265060241,0.9626171379229645,1.0,8/13,37.73%,LILRB1;GPRC5B;LAPTM5;CD74;SIRT1;CUEDC2;TGFB1;TGFB2
prerank,myelin maintenance (GO:0043217),0.32011519279864936,0.6656492436300611,0.875,0.9626014954574811,1.0,5/10,30.23%,ABCD2;CLU;MYRF;CXCR4;PTEN
prerank,regulation of dopamine secretion (GO:0014059),0.25867966307188733,0.6654531822975955,0.8951132300357568,0.9624579903129364,1.0,3/25,11.66%,CHRNB2;DTNBP1;FGF20
prerank,positive regulation of vacuole organization (GO:0044090),0.3224725012126965,0.6652186177305973,0.8774104683195593,0.9623326021781193,1.0,5/10,36.73%,RALB;RAB3GAP2;RAB3GAP1;GRN;LRSAM1
prerank,glycine transport (GO:0015816),0.3144097896929403,0.6633519513179372,0.884016973125884,0.9635142171855391,1.0,2/10,16.35%,SLC36A3;SLC7A8
prerank,negative regulation of bone mineralization (GO:0030502),0.3004287958094906,0.6629450761220583,0.8906666666666667,0.9635203160377998,1.0,4/13,27.26%,PTK2B;ECM1;SRGN;RFLNA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22113293480359153,0.6625563778604614,0.9725888324873097,0.9635344133627556,1.0,32/125,27.30%,PTPA;DYNC1H1;EML4;PLK2;AHCTF1;CENPO;CCNB1;BCCIP;XPO1;CENPT;BIRC5;RANBP2;RPS27;DYNC1LI2;TACC3;RCC1;NEK6;KNL1;BUB1B;ERCC6L;TAOK1;SPDL1;DCTN6;EFHC1;NUP98;CENPK;CENPA;NUP133;MAP4;ESPL1;CENPS;MAPRE1
prerank,reticulophagy (GO:0061709),0.3022494906233406,0.6621673667130736,0.8923884514435696,0.9635315018150439,1.0,7/12,33.89%,UFM1;RETREG1;ATG2B;UFL1;UBA5;TEX264;ATG2A
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.22995022290911485,0.6613631279500113,0.9382978723404255,0.9638468153870225,1.0,23/64,34.64%,POLR2H;CDK13;AFF4;GTF2F1;POLR2D;ELOF1;ELOB;PAF1;GTF2H1;EAF1;CCNT2;MLLT1;POLR2F;GTF2H5;SUPT4H1;MNAT1;CTR9;LEO1;TCEA1;ERCC2;NELFA;SETD2;MLLT3
prerank,dendritic spine organization (GO:0097061),0.25965333552065073,0.6608461353053058,0.919664268585132,0.963936075093382,1.0,6/26,17.04%,TREM2;IGF1R;DIP2A;FYN;CDC42;ITGA3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3089393531824248,0.6602297254560143,0.8877980364656382,0.964138496801086,1.0,7/10,37.35%,TNFRSF1B;EMILIN1;DPP4;ADTRP;NOTCH1;TGFB1;TNFRSF1A
prerank,response to UV-A (GO:0070141),0.29330181879434214,0.6601573740947556,0.9102902374670184,0.963879398069682,1.0,1/14,4.38%,MMP9
prerank,embryonic organ morphogenesis (GO:0048562),0.24096729727647775,0.6601420114950505,0.9336283185840708,0.9635755424579958,1.0,10/42,27.36%,ID2;HOXA4;RBP4;HOXB4;HOXC9;NIPBL;DYNC2I1;FGFR2;PDGFRA;HES1
prerank,regulation of Notch signaling pathway (GO:0008593),0.22663085312109885,0.6599867447524496,0.9454354669464848,0.9633853270896476,1.0,16/76,21.30%,ZMIZ1;NIBAN2;FBXW7;JAG1;METTL3;MAML2;DLL4;DLK2;TSPAN5;EGFL7;LLGL2;YTHDF2;NEPRO;ITGB1BP1;ENHO;PRAG1
prerank,negative regulation of nervous system development (GO:0051961),0.28401124107567627,0.6596796809253203,0.8810126582278481,0.9633156248181324,1.0,5/17,24.21%,B2M;APPL2;HOOK3;IL6;TNF
prerank,pre-miRNA processing (GO:0031054),0.28832106067697316,0.6584273986856738,0.9059278350515464,0.9639730546744164,1.0,3/14,19.33%,AGO2;AGO3;ADAR
prerank,lung epithelium development (GO:0060428),0.3114237959508288,0.6566970443117688,0.8773181169757489,0.9650029535253467,1.0,3/10,21.77%,FOXJ1;RCN3;BMP4
prerank,negative regulation of cartilage development (GO:0061037),0.2971063182556476,0.6546180969313128,0.8918205804749341,0.9663328612092251,1.0,1/13,6.75%,SOX9
prerank,heart trabecula morphogenesis (GO:0061384),0.2781228261265425,0.6544710853349885,0.9055415617128464,0.9661211338093909,1.0,3/18,14.14%,NRG1;DLL4;RBP4
prerank,positive regulation of wound healing (GO:0090303),0.2400130180738727,0.6537658135061399,0.9331065759637188,0.9663654158591615,1.0,9/36,22.64%,ANXA1;PLPP3;ACTG1;SERPINE1;APOH;ARFGEF1;FERMT2;INSL3;F2R
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.23996206254765293,0.6532737190982996,0.9383003492433062,0.9664156989132288,1.0,5/39,15.04%,GCK;TRH;CRH;RBP4;AACS
prerank,negative regulation of protein depolymerization (GO:1901880),0.2627208982112259,0.6530389381285386,0.9087591240875912,0.9662811309918137,1.0,1/24,0.26%,FGF13
prerank,bone morphogenesis (GO:0060349),0.2889919537174076,0.6515203625978294,0.9062087186261559,0.9671440796828868,1.0,4/14,23.64%,LTF;LRP6;FGFR3;FGFR2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.22427636627797576,0.6510555011450135,0.9650793650793651,0.9668939592584462,1.0,19/78,23.11%,CTSD;DYNC1H1;KLC1;DNM2;DCTN1;RAB7A;SEC24A;CTSE;DYNC1LI2;SEC24D;RACGAP1;AP1G1;FCER1G;PIKFYVE;DCTN4;CANX;CD74;DCTN6;AP1M1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.22427636627797576,0.6510555011450135,0.9650793650793651,0.9668939592584462,1.0,19/78,23.11%,CTSD;DYNC1H1;KLC1;DNM2;DCTN1;RAB7A;SEC24A;CTSE;DYNC1LI2;SEC24D;RACGAP1;AP1G1;FCER1G;PIKFYVE;DCTN4;CANX;CD74;DCTN6;AP1M1
prerank,extracellular transport (GO:0006858),-0.2344632768361582,-0.6506511929848527,0.9033613445378151,0.9909734203581788,1.0,12/12,76.58%,TSG101;SPAG17;DNAAF2;DNAAF4;ROPN1L;SPEF2;CABYR;ARRDC1;SPA17;WWP2;CCDC40;ADCY10
prerank,negative regulation of hormone secretion (GO:0046888),0.3149342956781958,0.6501008391558756,0.8763736263736264,0.9673194420636005,1.0,1/10,7.16%,RAB11FIP1
prerank,peripheral nervous system development (GO:0007422),0.2596296204352637,0.6498811526177629,0.9253731343283582,0.9671910933885597,1.0,5/23,18.30%,ADGRB1;EGR2;NF1;PMP22;ALDH3A2
prerank,rRNA 3'-end processing (GO:0031125),0.3026523460588589,0.649099899422716,0.8879668049792531,0.967467510951983,1.0,5/10,33.75%,EXOSC9;EXOSC10;ERI2;ERI3;ERI1
prerank,cardiac myofibril assembly (GO:0055003),0.2816868765895308,0.6486788812162279,0.9035202086049544,0.9674613575640115,1.0,3/15,24.92%,CSRP3;PDGFRA;NEBL
prerank,motor neuron axon guidance (GO:0008045),-0.2219845473428751,-0.6478109657456879,0.9333333333333333,0.9911989779196522,1.0,2/15,8.15%,EPHA4;TMEFF1
prerank,regulation of RNA export from nucleus (GO:0046831),0.30237649325365645,0.6477668715031156,0.8878378378378379,0.9678013816264678,1.0,3/11,19.03%,TPR;DHX9;NSUN2
prerank,negative regulation of heart contraction (GO:0045822),0.2998168285882083,0.6477051138920294,0.8861788617886179,0.967540375289993,1.0,5/11,35.51%,SRI;ATP1A2;FKBP1B;ZC3H12A;SPTBN4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2551827534175041,0.6472128485044983,0.9269461077844311,0.9676129192932429,1.0,1/25,0.52%,HIF1A
prerank,regulation of steroid biosynthetic process (GO:0050810),0.29949201956024707,0.6470286385905601,0.8763157894736842,0.9674298406723586,1.0,7/11,37.22%,ASAH1;EGR1;BMP5;SIRT1;DGKQ;NR5A1;FGFR4
prerank,protein monoubiquitination (GO:0006513),0.2400790831454029,0.6467214826843586,0.9426605504587156,0.967354961025959,1.0,10/36,30.27%,OBI1;HUWE1;UBE2R2;PAF1;CUL3;RNF20;TRIM21;CTR9;LEO1;KBTBD8
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.27723699923393164,0.6454794514751666,0.9063670411985019,0.9679604527948903,1.0,5/17,27.57%,TAOK3;ARL6IP5;SCIMP;TAOK1;RNF13
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.27332472816884446,0.6450671037447504,0.9194805194805195,0.9679425931080748,1.0,4/17,20.37%,PPARG;EFEMP2;PDCD4;SOD2
prerank,cardiac atrium morphogenesis (GO:0003209),0.27356838465768324,0.6440200693823629,0.9166666666666666,0.9683919787265726,1.0,2/16,11.71%,SHOX2;DLL4
prerank,basement membrane organization (GO:0071711),-0.22880964122524755,-0.643688870598719,0.9390243902439024,0.9922577833562564,1.0,3/14,14.80%,CTSS;NTN4;HPN
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2677016160398594,0.6431023311744893,0.9221105527638191,0.9687337932858762,1.0,4/20,17.28%,PSEN2;ADAM17;NFKB1;MBTPS2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2833002975999944,0.6421212095999957,0.9057104913678619,0.9691496339864732,1.0,5/14,32.59%,ERN1;CPSF7;CSTF2;NUDT21;TUT1
prerank,regulation of cellular component size (GO:0032535),0.24846670215006925,0.6417117621342788,0.9437428243398392,0.9691195374582722,1.0,14/30,31.95%,MSN;ATP13A2;HP1BP3;RAB22A;PPP1R15A;LARS1;VAV3;VAV1;MTPN;PTEN;RDX;RIN3;RARG;PEX11G
prerank,negative regulation of centrosome duplication (GO:0010826),0.30520597342835765,0.640830430664183,0.902834008097166,0.9694472650717479,1.0,5/11,34.80%,BRCA1;MDM1;NPM1;TRIM37;CENATAC
prerank,regulation of ion transport (GO:0043269),0.22050037888644092,0.6407991291907492,0.9626556016597511,0.9691550062657444,1.0,9/76,13.16%,P2RX4;CHRNB2;KCNJ2;SIK1;ATP1A1;DTNBP1;B2M;FGF20;KCNJ10
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2884328688234323,0.6405683935375273,0.9036144578313253,0.9690128864004773,1.0,3/12,18.17%,GMNN;BLM;KAT7
prerank,histone H2B ubiquitination (GO:0033523),0.30842966228100427,0.6401107759097081,0.8801711840228246,0.9690187834052477,1.0,4/10,29.58%,PAF1;RNF20;CTR9;LEO1
prerank,clathrin coat assembly (GO:0048268),-0.21828211462054073,-0.6398348406439971,0.9424778761061947,0.9930050444377592,1.0,6/15,22.95%,PICALM;SGIP1;FCHO2;CLTB;AP2S1;EPS15
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.25528685274023916,0.638613753450502,0.9322660098522167,0.9697410093794926,1.0,4/23,14.13%,TRIM6;SPHK1;CAB39;STOX1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2596894024089641,0.6378672034751609,0.9242979242979243,0.9699333481027147,1.0,4/22,19.53%,RUNX1;BCL6;FANCA;IL2
prerank,regulation of microtubule depolymerization (GO:0031114),0.25593548456515125,0.6376204420036689,0.9277845777233782,0.9697960976243947,1.0,1/25,0.26%,FGF13
prerank,negative regulation of cell communication (GO:0010648),0.2555813688152783,0.6376104705592164,0.9207100591715977,0.969492446436386,1.0,2/21,10.83%,BRAP;SOCS5
prerank,inner ear morphogenesis (GO:0042472),0.2580204829319194,0.6375395742007616,0.9332509270704573,0.9692274750060198,1.0,2/22,6.75%,TBX18;SOX9
prerank,camera-type eye development (GO:0043010),0.2535047298596573,0.6370559106989986,0.9305882352941176,0.9692530205879585,1.0,5/25,21.13%,NES;VEGFA;CYP1B1;NF1;IFT122
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2720187206095036,0.6364343894980359,0.9151898734177215,0.9693508664013487,1.0,4/17,25.17%,LPGAT1;PLA2G12A;SERAC1;PLA2G5
prerank,regulation of cytoplasmic transport (GO:1903649),-0.2404471922764274,-0.6362409861056567,0.9308943089430894,0.9934804937263224,1.0,2/11,13.22%,LRRK2;SRC
prerank,dendrite self-avoidance (GO:0070593),0.27754762058452304,0.6356426670458526,0.9302325581395349,0.9695869925197306,1.0,5/16,21.94%,NPTN;EMB;PALLD;DSCAM;IGSF9
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.18593556068781691,-0.6326147245706253,0.9700598802395209,0.9939575483531138,1.0,4/23,15.66%,NREP;SMURF2;LATS2;ENG
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.27432209549027126,0.6318734641512447,0.9229747675962815,0.9718435742394043,1.0,3/14,15.78%,SRSF7;PCBP4;C1QBP
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.21351046239941213,0.6317613530755197,0.9813278008298755,0.9716045443120952,1.0,16/87,22.59%,NDUFS7;SLC25A33;NDUFA1;SAMM50;PET100;NDUFAF1;SURF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;SMIM20;FASTKD3;TTC19;NDUFAF4;NDUFAF2
prerank,motile cilium assembly (GO:0044458),-0.22834183061489308,-0.631191993063119,0.9473684210526315,0.9928804069538848,1.0,5/12,29.57%,E2F4;RSPH9;DNAAF3;DNAAF1;BBOF1
prerank,BMP signaling pathway (GO:0030509),0.21872010597510344,0.6307387153170497,0.9560557341907824,0.9719684074470833,1.0,8/62,17.12%,BMP8B;GDF6;USP9X;CHRD;SMAD7;SMAD1;BMP6;PDCD4
prerank,ganglioside metabolic process (GO:0001573),0.2606154329617963,0.629874268506077,0.9384615384615385,0.9722358787853316,1.0,4/20,13.96%,HEXA;ST8SIA6;NEU1;B4GALNT1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2687271293476837,0.6289065465057821,0.9198998748435544,0.9725523899899609,1.0,2/17,14.09%,HDAC4;GIT1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.295120870116016,0.6288218750963167,0.9230769230769231,0.9722891695006783,1.0,2/10,15.79%,PRKCB;APPL2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.23871591931628056,0.6274431565029713,0.9507620164126612,0.9728834921265094,1.0,6/30,22.64%,AKAP13;GPR174;LPAR1;PRAG1;GPR65;F2R
prerank,myofibril assembly (GO:0030239),0.22960786444634718,0.6257991309274137,0.9581447963800905,0.9736806458865546,1.0,2/42,4.79%,TNNT3;CSRP3
prerank,protein palmitoylation (GO:0018345),0.23887590879597995,0.6254025663401629,0.9457013574660633,0.9736237408126628,1.0,2/30,4.95%,ZDHHC15;ZDHHC18
prerank,autophagy of nucleus (GO:0044804),0.27366694466006614,0.6244394917468504,0.9304123711340206,0.9739212836757573,1.0,2/16,9.57%,ATG7;WDR45
prerank,peptidyl-proline modification (GO:0018208),0.2420864199438347,0.6242071034983363,0.9302045728038508,0.9737690508209362,1.0,12/25,29.06%,OGFOD1;NKTR;PPIA;PPIE;PIN1;PPIG;PPIL6;NTMT1;PPIH;FKBP1B;PPIL3;FKBP1A
prerank,negative regulation of vascular permeability (GO:0043116),0.28452560178392916,0.6228362606147194,0.9205479452054794,0.9743436150700412,1.0,2/12,7.19%,VEGFA;ANGPT1
prerank,organic cation transport (GO:0015695),-0.20086556131259622,-0.6228305633337227,0.967741935483871,0.9961573055907156,1.0,7/20,28.26%,SLC22A5;SEC14L1;SLC25A29;PDZK1;SLC22A18;SLC5A7;SLC47A1
prerank,ovarian follicle development (GO:0001541),0.2762671185168212,0.6223821175139667,0.9104084321475626,0.9743192941806625,1.0,3/13,23.92%,VEGFA;EIF2B2;EIF2B4
prerank,histone monoubiquitination (GO:0010390),0.24647727322305582,0.6219542206743639,0.9328537170263789,0.9742897547590981,1.0,9/24,33.30%,DDB2;DDB1;RNF2;PAF1;RNF20;CTR9;LEO1;TRIM37;UHRF1
prerank,cellular response to BMP stimulus (GO:0071773),0.21392572288692752,0.6217533202039823,0.971307120085016,0.9741147069962492,1.0,12/66,25.16%,BMP8B;GDF6;SOX9;USP9X;SMAD7;SMAD1;BMP6;PDCD4;BMP4;AMH;SFRP1;BMP5
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2260459003537861,0.621154400252497,0.9618937644341802,0.974196078846384,1.0,12/40,27.40%,THOC1;POLE;ZRANB3;BOD1L1;BLM;CENPX;ATRX;RTEL1;SETMAR;GEN1;CENPS;ATR
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27096289332232115,0.620608700401741,0.9241466498103666,0.9742071326896291,1.0,8/16,32.24%,NAA16;NAA20;NAA80;NAA15;AANAT;EP300;CREBBP;NAA50
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.23366634930217806,-0.6186468460057243,0.9310344827586207,0.9967445080575102,1.0,4/12,18.84%,RAD17;CLSPN;ORC1;STK33
prerank,negative regulation of viral transcription (GO:0032897),-0.22072948709900184,-0.6164176817346587,0.9372384937238494,0.9961650542912004,1.0,13/13,77.95%,TRIM27;LARP7;TRIM62;TRIM13;TRIM32;TRIM14;MID2;ZFP36;IFITM3;TRIM11;HEXIM1;UBP1;TRIM21
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.20201008793102537,-0.6149218164052512,0.9476190476190476,0.995064664994121,1.0,8/17,21.62%,TDG;NEIL1;NEIL3;UNG;NTHL1;MUTYH;ERCC5;OGG1
prerank,purine-containing compound salvage (GO:0043101),0.28083077180249416,0.6147844353578986,0.9162162162162162,0.9773810939615643,1.0,2/12,14.50%,AMPD2;APRT
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.29117274041070884,0.6134012812867868,0.9256198347107438,0.9778794024578827,1.0,3/11,19.78%,CAV1;CAB39;ACTN2
prerank,negative regulation of transposition (GO:0010529),0.26351204330369654,0.6126187337876644,0.9394329896907216,0.9780277057588291,1.0,3/16,24.18%,PIWIL2;UBR2;SMYD5
prerank,regulation of interleukin-12 production (GO:0032655),0.21612514659390225,0.6113307578464907,0.9704918032786886,0.9784481320621748,1.0,16/47,30.70%,LTB;LILRB1;IRF5;HSPD1;C1QBP;TIRAP;SYK;SCIMP;HMGB1;LAPTM5;CD47;MDK;TLR9;AGER;PIBF1;JAK3
prerank,steroid hormone biosynthetic process (GO:0120178),0.23579539779921455,0.609805755674153,0.9457274826789839,0.9790258905833097,1.0,3/29,12.77%,CYP19A1;SRD5A3;HSD17B8
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.21617378795894437,-0.6096463209355939,0.9453781512605042,0.9959975589469586,1.0,5/14,25.74%,IRS2;MTLN;PPARA;TYSND1;ABCD1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.26481716179914494,0.6090083911385537,0.9324503311258279,0.9791462853469185,1.0,3/16,13.96%,LARGE1;ST8SIA6;B4GALNT1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.2636172156779317,0.6090047242678953,0.9395886889460154,0.978834863320357,1.0,2/15,10.59%,CELF1;BRCA1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.1935638763488126,-0.6073147739895681,0.9400921658986175,0.9953192864475827,1.0,13/19,36.89%,NFATC2;NFATC1;PPP3CB;PLCE1;ADGRB2;GPR62;EDN3;NFATC4;NMUR1;EDN2;EDN1;NFAT5;NMUR2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.18944781072871436,-0.6070650477933096,0.9841269841269841,0.9935625930345127,1.0,5/20,21.84%,RBPJ;BMP2;ENG;HEY1;HEYL
prerank,neuromuscular process (GO:0050905),0.26194214566328,0.6067245316975943,0.9292035398230089,0.9798080148008451,1.0,4/16,21.60%,CLN3;DCTN1;AGTPBP1;TPP1
prerank,embryonic heart tube development (GO:0035050),-0.21145153189352087,-0.6048378928451792,0.963963963963964,0.9926767400055818,1.0,14/14,78.88%,NDRG4;TBX2;CITED2;PITX2;SOX17;RYR2;TBX20;SOX18;FGF8;APELA;ACVR1;MEGF8;HES1;IFT122
prerank,regulation of stem cell population maintenance (GO:2000036),-0.19642071985371412,-0.6022708252093547,0.9653465346534653,0.9920963835946562,1.0,7/18,31.09%,REST;CNOT2;HMGA2;ESRRB;NCOA3;KAT2A;PTN
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.26057912367493263,0.6018250523010464,0.9375812743823146,0.9821687911430271,1.0,7/16,32.07%,KMT5B;KDM4D;PARP3;SETMAR;SMCHD1;PNKP;PARP9
prerank,mesoderm formation (GO:0001707),0.25570697886747984,0.5988854308976588,0.9421593830334191,0.9834028327594577,1.0,4/17,27.94%,EOMES;ITGA3;ITGA2;ITGB1
prerank,aerobic electron transport chain (GO:0019646),0.20654628699199473,0.5988761012708876,0.9819341126461212,0.983092730031465,1.0,15/68,24.60%,NDUFS7;NDUFA1;COX6A2;COX5B;AFG1L;NDUFAF1;COX10;NDUFA9;UQCRH;NDUFA2;COX7A2L;SDHC;UQCR10;UQCRB;UQCR11
prerank,dephosphorylation (GO:0016311),0.19511565248790225,0.5965616437810971,0.9939148073022313,0.9840043547705936,1.0,27/147,21.20%,PTPRA;PTPRC;PLPP6;DUSP9;PPM1J;PPP2R5C;PPP2R1A;PPM1H;PTPN22;PLPP3;CTDNEP1;PPP1R12A;TAB1;DUSP6;PTPN12;PHPT1;PTPN13;ACP3;DUSP11;DUSP3;PPP6C;STK11;PPP3CC;PTPN21;FBXW11;DUSP15;DUSP12
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2362540798393171,-0.5963438305826607,0.9468085106382979,0.9929738439426845,1.0,10/10,76.40%,GNB5;CRHR1;CBARP;DRD2;DRD4;GPR35;FMR1;CALM1;DRD3;CALM3
prerank,cardiac ventricle development (GO:0003231),0.23914752557920527,0.595026955340034,0.9382871536523929,0.98451768149719,1.0,4/20,19.29%,GATA3;DLL4;DAND5;HECTD1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.209554899868165,-0.5914899772623254,0.9651162790697675,0.9932594437584931,1.0,13/13,79.07%,CPSF6;CPSF4L;CSTF2T;NCBP1;CPSF4;CPSF1;FIP1L1;NCBP2;CPSF2;TUT1;NUDT21;CSTF2;CPSF7
prerank,regulation of protein acetylation (GO:1901983),0.2696130988154274,0.5896454479018234,0.9372496662216289,0.9868797025979783,1.0,5/12,29.22%,GSK3B;TAOK1;TERF2IP;CEP295;SIRT1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.22324895969634723,0.5884826083016285,0.963718820861678,0.9871328821064632,1.0,4/31,16.74%,NRG1;DLL4;SMAD7;PKP2
prerank,chondrocyte differentiation (GO:0002062),0.22138434809589397,0.5875736019747074,0.968677494199536,0.9872499864499431,1.0,4/32,10.73%,SNX19;RUNX1;SOX9;CREB3L2
prerank,heterocycle biosynthetic process (GO:0018130),0.2563626538835263,0.5872524844018362,0.9458388375165125,0.9870965751593246,1.0,7/14,33.47%,MOCOS;PYCR3;PYCR2;MOCS3;MOCS2;MOCS1;GPHN
prerank,amino sugar metabolic process (GO:0006040),0.2814209321293821,0.5853616260462413,0.9403409090909091,0.9876841381929453,1.0,2/10,16.73%,EXTL2;ST6GAL1
prerank,NAD biosynthetic process (GO:0009435),0.23930044402751213,0.5850413061496036,0.95593635250918,0.9875212659572149,1.0,8/20,34.46%,NAMPT;PTGIS;NMNAT3;KYNU;PARP16;PARP9;NAXD;NADSYN1
prerank,cellular response to mechanical stimulus (GO:0071260),0.21229312049648277,0.584860033063217,0.9701657458563536,0.98729322475052,1.0,13/46,29.28%,SLC9A1;PIEZO1;SOX9;PIEZO2;MAP3K1;NFKB1;CRADD;PTGER4;BNIP3;GADD45A;CASP8AP2;MAPK3;TNFRSF8
prerank,phasic smooth muscle contraction (GO:0014821),-0.22658799899573187,-0.5844857192302874,0.9836601307189542,0.9944419133696603,1.0,10/10,77.36%,TIFAB;EDNRB;EDN3;EDN2;EDN1;DRD2;GDNF;HTR1D;PTGER3;HTR2B
prerank,detection of calcium ion (GO:0005513),-0.2075184133722104,-0.5834517128393312,0.9623430962343096,0.9929931488789357,1.0,6/13,28.40%,SYT1;KCNMB2;KCNIP2;KCNMB3;CASQ2;KCNMB1
prerank,negative regulation of B cell proliferation (GO:0030889),0.2677367518841787,0.5826763296572286,0.9252717391304348,0.9880285234096379,1.0,3/11,27.13%,CD300A;ATM;RC3H1
prerank,heterochromatin assembly (GO:0031507),0.24147486294594342,0.5825475557358722,0.9589552238805971,0.9877770995779178,1.0,6/20,32.27%,HDAC1;H3-3A;SMCHD1;SIRT1;SIRT2;BAHD1
prerank,bile acid metabolic process (GO:0008206),0.2291757858000075,0.5817049701784881,0.9661214953271028,0.9878502651625803,1.0,10/27,29.78%,SLC27A5;OSBPL2;NPC1;CH25H;GBA2;OSBP;ABCB11;ACOT8;OSBPL1A;SCP2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.2661048615987809,0.5815803301811459,0.9389110225763613,0.9875958144266206,1.0,1/12,8.09%,CNDP2
prerank,alpha-amino acid catabolic process (GO:1901606),0.22329801695087,0.581568054928191,0.9742690058479532,0.987286407289805,1.0,10/29,36.38%,BLMH;ACAT1;MTRR;IDO2;KYNU;KYAT1;HOGA1;CBS;SARDH;ACADSB
prerank,axoneme assembly (GO:0035082),0.22571783558999797,0.5796675256778834,0.9609644087256027,0.9878529705967141,1.0,8/30,27.33%,FOXJ1;SPAG16;DNAJB13;DCX;TTC12;CCDC65;CCDC40;CCDC39
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19959034557155453,0.5792122476031689,0.9904559915164369,0.9877393849786866,1.0,15/69,24.60%,NDUFS7;NDUFA1;COX6A2;COX5B;AFG1L;NDUFAF1;COX10;NDUFA9;UQCRH;NDUFA2;COX7A2L;SDHC;UQCR10;UQCRB;UQCR11
prerank,C4-dicarboxylate transport (GO:0015740),-0.20641564481409425,-0.579122005670788,0.9606986899563319,0.9927871782481148,1.0,2/14,6.59%,SLC25A12;SLC25A11
prerank,iron ion transmembrane transport (GO:0034755),-0.2272303233251159,-0.579025953928718,0.9453781512605042,0.9909614057004463,1.0,1/10,4.29%,SLC40A1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.21843546737807504,-0.5785163886912185,0.9589552238805971,0.9893040463086512,1.0,3/12,10.82%,PTPN14;UHMK1;RBM4
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.25917517968085174,0.5766799869969704,0.9453125,0.9885645770712083,1.0,1/14,6.75%,SOX9
prerank,response to progesterone (GO:0032570),0.24403847270176765,0.5765853697699698,0.9408212560386473,0.9882866649963447,1.0,3/18,18.39%,CAV1;ACOD1;WBP2
prerank,negative chemotaxis (GO:0050919),0.2175140882639587,0.5755943708921011,0.9727272727272728,0.988420687747819,1.0,2/33,3.58%,PDGFA;LRTM1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.1622561735088678,-0.5748119942360058,0.9935483870967742,0.9889215463396038,1.0,11/29,28.47%,ZCWPW1;IHO1;MAJIN;HORMAD1;BAG6;SIRT7;TEX12;KASH5;MEIOB;TERB1;RAD21
prerank,regulation of isotype switching (GO:0045191),0.2539274696591027,0.5742048785320145,0.96,0.9887076916454451,1.0,3/14,17.85%,KMT5B;TFRC;PARP3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2125190439135646,0.5739712227296055,0.9740112994350283,0.9884924347576757,1.0,5/38,19.35%,NDUFS7;NDUFA1;NDUFAF1;NDUFA9;NDUFA2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2643274119640955,0.5729499855750411,0.9503355704697987,0.9886356436299321,1.0,11/11,73.59%,RTP4;PKD2L1;PKD1L3;PIGR;RTP3;GNAT2;TAS1R2;GNAT3;TAS1R3;RTP2;LPO
prerank,positive regulation of lyase activity (GO:0051349),0.2562187128963622,0.5718221113064692,0.9561752988047809,0.9887965432826726,1.0,4/14,29.45%,CACNA1D;NF1;ORAI1;STIM1
prerank,cytosolic calcium ion transport (GO:0060401),0.2226571561774613,0.5716328539847406,0.9648711943793911,0.988557222898733,1.0,9/28,31.40%,ATP2B1;AFG3L2;JPH1;CACNB3;ITPR3;ATP2A2;SLC25A23;SLC35G1;SMDT1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.21582757310078868,0.5699476514222745,0.9836639439906651,0.9889245032067339,1.0,12/31,33.47%,CYP19A1;MOCOS;PYCR3;DHRS11;PYCR2;MOCS3;SCP2;SRD5A1;MOCS2;MOCS1;SRD5A2;GPHN
prerank,glutathione biosynthetic process (GO:0006750),0.26610994078462796,0.5696663056719823,0.9402985074626866,0.988722114934801,1.0,1/11,8.09%,CNDP2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22420556713276837,0.5696090798642888,0.9713261648745519,0.9884310597634305,1.0,7/27,28.89%,C3AR1;GPR174;LPAR1;GPR65;F2R;OPRL1;DRD3
prerank,positive regulation of heart rate (GO:0010460),0.24073169245973625,0.5678278331663525,0.9684741488020177,0.988840962476834,1.0,3/17,22.31%,NPPA;SCN3B;ATP2A2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2270370397286074,0.5665845300001419,0.9696969696969697,0.9890276297234232,1.0,1/21,2.47%,XDH
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.27046199345680855,0.5654120133078926,0.9508867667121419,0.9891970820325988,1.0,7/10,38.43%,MAP2K2;RNF13;MAPK3;MAPK1;MAP2K1;GREM1;GSTP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2038637383874343,0.5623151807497146,0.9866814650388457,0.9900510579464444,1.0,4/41,8.42%,MGLL;ACSL1;FADS1;SCD5
prerank,negative regulation of secretion (GO:0051048),0.26698017959646453,0.561857651493186,0.9601139601139601,0.9899144630765364,1.0,1/10,3.32%,NRG1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2468774899316047,0.5562664059310288,0.953519256308101,0.9916365377499508,1.0,5/13,38.13%,DLST;IDH2;IDH1;L2HGDH;PHYH
prerank,protein localization to mitochondrion (GO:0070585),0.2582243461506946,0.5560345836327782,0.9461325966850829,0.9914028755705535,1.0,3/11,23.47%,HK1;MTCH2;DNAJA1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.22053886113272914,0.5552933219673418,0.975,0.9913400609459121,1.0,2/24,7.00%,NRP1;VEGFA
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.23744710031624122,0.5546587862782039,0.9627249357326478,0.9912547477485966,1.0,5/17,21.90%,COX6A2;COX5B;AFG1L;COX10;COX7A2L
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.23871450529737548,0.554131882625954,0.9647058823529412,0.9911231386811092,1.0,5/16,25.28%,RHOA;ITGB2;IL6;TNF;MDK
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.16035435593151787,-0.5535721702322718,0.9879518072289156,0.9938812236905906,1.0,12/29,34.04%,ZFPM1;BMP2;ENG;MYL2;MYBPC3;ISL1;TPM1;TNNC1;TNNT2;MYH6;MYL3;MYH7
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2563781354538316,0.5513548142478942,0.9636363636363636,0.9917670811825637,1.0,2/11,15.25%,VCP;DERL1
prerank,eye morphogenesis (GO:0048592),0.23172074474667742,0.549282083518317,0.9744525547445255,0.9921622888131055,1.0,5/19,22.68%,VEGFA;NF1;AGTPBP1;IFT122;NIPBL
prerank,synaptonemal complex organization (GO:0070193),0.24226795963273118,0.5489057570653588,0.9562334217506632,0.99166576691783,1.0,4/15,29.77%,TRIP13;SYCE2;TEX11;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.24226795963273118,0.5489057570653588,0.9562334217506632,0.99166576691783,1.0,4/15,29.77%,TRIP13;SYCE2;TEX11;SYCP2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2145549769047256,0.5474656847223691,0.97352587244284,0.9918372838211503,1.0,3/26,9.00%,TREM2;OTUD4;FLOT2
prerank,synaptic vesicle membrane organization (GO:0048499),0.22933232433868933,0.5472771237567073,0.9735516372795969,0.991583337976106,1.0,5/17,26.55%,SYNGR1;STX3;AP3D1;SYNGR2;STX4
prerank,tRNA 5'-leader removal (GO:0001682),0.24364148353202464,0.5468354925879313,0.9722991689750693,0.9914169084771196,1.0,4/13,29.75%,PRORP;RPP25L;RPP38;POP1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.25938489431784334,0.5450310312394732,0.9595141700404858,0.9916705339337192,1.0,1/10,8.97%,DIP2A
prerank,kinetochore organization (GO:0051383),0.2448920139890921,0.5442095102218134,0.9731182795698925,0.9915991864078749,1.0,5/13,33.35%,CENPT;CENPA;CENPH;CENPC;CENPW
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.22653653138260438,0.5375708546914447,0.9836683417085427,0.9932432072099129,1.0,2/17,11.71%,JAG1;DLL4
prerank,Golgi inheritance (GO:0048313),0.25371646939524073,0.5373997688235178,0.9653333333333334,0.9929805580486897,1.0,4/11,27.14%,PLK3;GOLGA2;YWHAZ;STX5
prerank,zinc ion transmembrane transport (GO:0071577),-0.16577006138168765,-0.5352149065169012,0.9943820224719101,0.9966159191982192,1.0,6/22,19.71%,SLC30A1;SLC30A4;SLC39A10;SLC39A12;SLC30A3;TRPM2
prerank,T cell homeostasis (GO:0043029),-0.2057549288512431,-0.5312678329223158,0.9852941176470589,0.9956101907094019,1.0,5/10,29.02%,FAS;PMAIP1;FOXP3;FADD;ZC3H8
prerank,regulation of viral release from host cell (GO:1902186),0.21602474021516177,0.5307861300859152,0.9826732673267327,0.9945172946709778,1.0,2/21,9.77%,TRIM28;DDB1
prerank,neuronal action potential (GO:0019228),0.21621648698860257,0.529460046565795,0.9774346793349169,0.9945477217900277,1.0,2/22,11.95%,SCN4A;KCNMB4
prerank,regulation of endocytic recycling (GO:2001135),-0.1979160128052225,-0.5283890133041558,0.983402489626556,0.9943474192917172,1.0,11/11,80.23%,SORL1;PLA2G4E;PLA2G3;EHD2;INPP5F;EIPR1;ATP9A;RAB11B;ARHGAP1;EHD1;ACTN2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.17062295905551367,-0.5281137937289928,0.9947368421052631,0.9925539180749502,1.0,18/18,82.96%,ODAD4;CFAP53;SPAG17;DNAAF2;DNAAF1;OFD1;NPHP3;DNAAF4;ROPN1L;SPEF2;CABYR;RFX3;SPA17;NEK10;CCDC39;CCDC40;ADCY10;AQP4
prerank,proteasome assembly (GO:0043248),0.2459041613290678,0.5277837125466972,0.9683195592286501,0.9946845219539399,1.0,3/11,30.35%,PSMD5;PSMD10;POMP
prerank,bicarbonate transport (GO:0015701),0.2099427012681208,0.5276672851559642,0.9807923169267707,0.9944047712362307,1.0,5/25,21.80%,CYB5R4;CYB5R1;SLC4A9;SLC4A2;SLC26A6
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1856810701271126,0.5267812489755469,0.9989130434782608,0.9940026729763206,1.0,9/56,22.59%,NDUFS7;NDUFA1;NDUFAF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;NDUFAF4;NDUFAF2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1856810701271126,0.5267812489755469,0.9989130434782608,0.9940026729763206,1.0,9/56,22.59%,NDUFS7;NDUFA1;NDUFAF1;NDUFAF8;NDUFA9;TIMM21;NDUFA2;NDUFAF4;NDUFAF2
prerank,energy reserve metabolic process (GO:0006112),0.2201052754572071,0.5252480994189772,0.9817295980511571,0.9940677798229672,1.0,8/19,39.04%,PHKB;GSK3B;PYGM;GBE1;PID1;MYC;UGP2;PHKG2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.20461921390798846,0.5245338271190625,0.98698224852071,0.9939210348977741,1.0,6/27,21.26%,SELENON;JPH1;CACNB3;CACNB1;CACNB4;AHNAK
prerank,endocardial cushion morphogenesis (GO:0003203),0.21609363147268665,0.518443585140769,0.9850746268656716,0.9950525261105618,1.0,3/18,23.23%,SOX9;BMP4;TGFBR2
prerank,regulation of chromosome organization (GO:0033044),0.20688775942192092,0.5140088661977861,0.9846547314578005,0.9957228603398789,1.0,8/22,36.38%,WAPL;SETMAR;TERF2IP;SMG1;XRCC5;TERF2;MYC;CENPV
prerank,cardiac ventricle morphogenesis (GO:0003208),0.18328003491997252,0.5102709700331407,0.9944567627494457,0.9962070549088936,1.0,8/41,23.64%,JAG1;GATA3;DLL4;SMAD7;PKP2;BMP4;TGFBR2;FGFR2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2375243236457224,0.5065231381128145,0.9888268156424581,0.9966126552681016,1.0,11/11,76.26%,SLC19A2;NT5C3A;SLC25A19;DCK;ERH;DCTD;CTPS2;THTPA;SLC19A3;TPK1;ENPP3
prerank,calcium import into the mitochondrion (GO:0036444),0.23156214340834744,0.4967719964049357,0.9780821917808219,0.9980623021131195,1.0,4/10,34.94%,AFG3L2;SLC25A23;SMDT1;MCU
prerank,nitric oxide metabolic process (GO:0046209),0.21770574476698623,0.49300171571287055,0.9804432855280313,0.9983741359283116,1.0,3/14,27.88%,CYP1B1;CYB5R3;NQO1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.20143517162162217,0.4921972143292133,0.9902080783353733,0.9982001866549709,1.0,6/21,31.41%,SRI;ATP1A2;CALM3;FKBP1B;GSTO1;CALM1
prerank,nitric oxide biosynthetic process (GO:0006809),0.21772324851344227,0.4831137815442746,0.9840848806366048,0.9992605223879564,1.0,3/13,27.88%,CYP1B1;CYB5R3;NQO1
prerank,UV protection (GO:0009650),0.22989476108512302,0.48016992514793083,0.9928876244665719,0.9993451594674728,1.0,4/10,31.29%,XPA;CAT;GPX1;ERCC2
prerank,B cell mediated immunity (GO:0019724),0.22376974189910906,0.47902240604734553,0.9772727272727273,0.9991997759637019,1.0,2/10,22.90%,FCER1G;CD74
prerank,muscle tissue morphogenesis (GO:0060415),0.1981453179696635,0.4636332222111373,0.9908496732026144,1.0,1.0,2/16,21.77%,EFEMP2;BMP4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.21985441232083636,0.46321144469991093,0.9879839786381842,1.0,1.0,2/11,18.34%,PUM1;DHX9
prerank,positive regulation of cellular respiration (GO:1901857),0.21464831567361062,0.4631341069207399,0.9890859481582538,1.0,1.0,2/11,23.15%,VCP;PRELID1
prerank,xenobiotic transport (GO:0042908),0.19718457508444415,0.4601332445633599,0.9924337957124842,1.0,1.0,1/17,6.71%,SLC22A3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.19635157064543463,0.45790528352437243,0.9908496732026144,1.0,1.0,5/16,31.41%,ATP1A2;CALM3;FKBP1B;GSTO1;CALM1
prerank,spinal cord development (GO:0021510),0.20922787193973624,0.45532592657751847,0.993103448275862,0.9999183129564202,1.0,12/12,79.09%,NF1;ZPR1;LOXL3;SOX11;PKD2;GLI2;VIT;SOX4;DLL1;SOX12;RELN;PKD1
prerank,nucleic acid-templated transcription (GO:0097659),0.16341123116922,0.44798280222209036,0.9989035087719298,1.0,1.0,8/42,25.12%,POLR2H;DRG1;PWP1;POLR2D;NR4A2;TERT;POLR2F;RRAGC
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.21217638336409705,0.44669172609787455,0.9902097902097902,1.0,1.0,3/10,30.35%,UPB1;NT5M;NT5C3A
prerank,epithelial cell-cell adhesion (GO:0090136),0.20798907909747563,0.44667381828630526,0.9919354838709677,0.999713126758882,1.0,2/11,23.42%,JUP;SERPINB8
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.1702942260184915,0.44614681948235513,0.9965357967667436,0.9994418500098936,1.0,4/30,17.04%,FSTL3;SMAD7;FSTL1;ITGA3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.18100318306917693,0.4325792510973637,0.996268656716418,1.0,1.0,4/19,26.35%,AMPD2;APRT;TERT;HPRT1
prerank,histone deubiquitination (GO:0016578),0.18262228615721807,0.428251877733811,0.9950556242274413,0.9999395312987199,1.0,6/18,34.36%,UIMC1;USP36;BRCC3;USP15;USP22;TRRAP
prerank,microtubule-based transport (GO:0099111),0.19604313956665642,0.42747881592758946,0.9936061381074168,0.999673202317744,1.0,4/12,32.48%,HTT;ADCY10;CCDC40;DYNC1I2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.13515683862976446,-0.42312868736836784,1.0,0.9996366010191615,1.0,7/19,30.79%,ZFPM1;BMP2;HEY1;HEYL;BMPR2;SOX4;BMPR1A
prerank,endocardial cushion development (GO:0003197),0.16802833243790904,0.41535596819737436,1.0,0.9999364243147248,1.0,1/21,6.75%,SOX9
prerank,response to ketone (GO:1901654),0.16004086813597831,0.3994729978732189,0.9988412514484357,1.0,1.0,1/24,5.31%,CAV1
prerank,snRNA metabolic process (GO:0016073),0.16406132257880507,0.3853027714422216,1.0,1.0,1.0,3/17,23.54%,INTS6;INTS2;INTS7
prerank,phosphate ion homeostasis (GO:0055062),0.18446336465025517,0.38386774142212654,1.0,0.9998646681341695,1.0,1/10,18.23%,XPR1
prerank,in utero embryonic development (GO:0001701),0.14464983539360096,0.36584676416099804,1.0,0.9997833708073292,1.0,8/25,33.60%,VEGFA;ARNT2;ZNF568;FGFR2;CHD7;HINFP;EGFL8;LMX1B
